%PDF-1.3 % 407 0 obj << /Linearized 1 /O 409 /H [ 1168 2830 ] /L 1621931 /E 924141 /N 113 /T 1613672 >> endobj xref 407 36 0000000016 00000 n 0000001071 00000 n 0000003998 00000 n 0000004216 00000 n 0000004464 00000 n 0000004856 00000 n 0000005194 00000 n 0000005440 00000 n 0000008491 00000 n 0000008928 00000 n 0000008969 00000 n 0000009010 00000 n 0000009032 00000 n 0000009725 00000 n 0000009747 00000 n 0000010405 00000 n 0000010427 00000 n 0000011043 00000 n 0000011065 00000 n 0000011655 00000 n 0000011677 00000 n 0000012265 00000 n 0000012287 00000 n 0000012878 00000 n 0000012900 00000 n 0000013536 00000 n 0000013558 00000 n 0000014156 00000 n 0000014265 00000 n 0000016943 00000 n 0000406807 00000 n 0000801161 00000 n 0000905757 00000 n 0000923881 00000 n 0000001168 00000 n 0000003975 00000 n trailer << /Size 443 /Info 405 0 R /Root 408 0 R /Prev 1613661 /ID[<7a9383a58eb64b73611e8d98e9f2efb4>] >> startxref 0 %%EOF 408 0 obj << /Type /Catalog /Pages 401 0 R /Metadata 406 0 R /PageLabels 389 0 R >> endobj 441 0 obj << /S 4507 /L 4740 /Filter /FlateDecode /Length 442 0 R >> stream HV PWBB"*&!(P mK:e "jgN&s^sϽ?% 7;`peE<[!rn0袇A$xį`2@Ph'p/ L$5,FH p9B.Ab`\1T7.#FmDMw" \#qCpga2p+uz;>FG\=aɵr\`h 2a0B:\*p&ptZН^po(B AIi47,8?*=ʍr('ٝY٦ C2|E_S`W >)ܕ]#f F!ըQY$q۬("ϙ^oZzHuHn,sܨ5;Q$&*"ٮmʯ~GP#WG 4ICj8&Oa2-0<|ZNRKVG &tkx,*Q ՆO) x?H^>d DFJWdJCj l2R/{J"s<3l>9ճʲP,[Nj!v۰_aВ]ذGTk# #$VGfn\ P WXK.E~Wb{c5'!Crezw$%T=`{m \ M^[S<*v=n}|atQ{6? 5xR 13JRrkޞ*魉}^]*:ZVj? )Oz'NgB G2*h\hDSY~muNmصeN?J/3ߛ Pц[uWVNN{\H\5eMv"h%|ڴ kj,55]-]}1 -j$X* UO^ָF ^'6%_IybͺXwx\!y Ri0gLMFHmOK_˷pC"!'+O)1Ri'ȅo=d}_3h(,=lje{nT6?:VXj+h䇶QWFWxcOy%=Nwj^ÏB2wJQN$6+T&ѝ #3W`4.Pz#;}V$ ZQ$T< {<{n&գ˧-<=_&\y ;9*fv0T7.GhF}ҝaߛTX ]V:%{`O%;M'100 W2OQ%&V 3X2 ݶ}I|aHntKu~Ǽ^qDԞЇ>Y;z,KU )iTS( f,£?pӖet'ѩtÅxImL˥9B¯>@?RW$ڏ6IqxMlrEM9o9\@B#$2^& {X)cI:5-=lCNm*ރ`[ Qh6W$cnS$.7;0>?j8lOdT>@c\ʡHbxX6P*1ɼe^{cف%GʙJ̘I%ʘfimV4C2IJ"/pL-nx0` 7{GW3۬ɒbִXشKjt)wcU.\2_M"{bIⶅ$VKY5OUSX^hQt :r9!GVs.zJH n y60_L~yDRbl@#t)uDFs>gycf^ kHTPGV-􅌔bA> endobj 410 0 obj << /ProcSet [ /PDF /Text /ImageB ] /Font << /F1 415 0 R >> /XObject << /Im1 437 0 R /Im2 438 0 R /Im3 439 0 R >> /ExtGState << /GS1 434 0 R /GS2 440 0 R >> /ColorSpace << /DefaultCMYK 417 0 R /Cs6 416 0 R /Cs8 417 0 R >> >> endobj 411 0 obj << /Filter /FlateDecode /Length 317 >> stream HTQn0{LՃQ$%QPKTeȁMS=.c;AQp4޼F൷I0SXih&t9~!{L@zW؜O"N7q@;C m D잕{Q`w^ lm<蕽"4򩅦R-5"*.R>i)U)meĒp^LapQL[BޫK[Ɂm l Dt8L~F,)`I.U 'QV,5&u8#ïuX߼Ó98N1) endstream endobj 412 0 obj << /Type /FontDescriptor /Ascent 729 /CapHeight 729 /Descent -221 /Flags 4 /FontBBox [ -173 -229 1001 770 ] /FontName /GHJBEJ+AdvP642A /ItalicAngle 0 /StemV 0 /XHeight 525 /CharSet (/I/n/t/e/r/a/i/o/l/E/h/c/G/u/d/s/f/B/m/R/v/g/H/S/b/j/P/p/y/C/O/z/M/paren\ left/parenright/w/W/two/zero) /FontFile3 414 0 R >> endobj 413 0 obj << /Type /Encoding /Differences [ 40 /parenleft /parenright 48 /zero 50 /two 66 /B /C 69 /E 71 /G /H /I 77 /M 79 /O /P 82 /R /S 87 /W 97 /a /b /c /d /e /f /g /h /i /j 108 /l /m /n /o /p 114 /r /s /t /u /v /w 121 /y /z ] >> endobj 414 0 obj << /Filter /FlateDecode /Length 2958 /Subtype /Type1C >> stream HDyPSy_<PE-E`aGPAP!GE@$\%`+r-8 Sb0kYS{/TmtfOWw۟!FF3;-&=o;Ө͡=wb n. F4~ _;\x"^()3%\(QxQ"/*5U%eċxQx* 1!bACdAli= qFw1r>h1iڴϨQдH%7ٵB3K*]>,6b'Ӄ25̩>䯑lڸ.2,M{NA/<^CoC !$ = ` 8\8,О~69#Wl3W7%1ysVCϗ멛NxGG4%YEbJ;6؏j#:{}M=NEKv>RM|Mp,_R] mT‚~:6<lsnW_ha)xDm^Ȩ"&4O9n:ƅUg6GekTx?'Pgcp]9oG鶏(+xm%gG]_.}R[ Me2NhK9,.RA!!6Dc%ҭŁ1lAᑿM'1n@I9 Eh$"`%vhS@]@}@]h9Ur-66xV8J|K#1p^;БZ[Iqi$# e_dJ;'4X0Q.ÄyIDprJx) mQx{%Jc\rOV>_Y&:"N݋+)J1~px !kQL47k6JaN`gdvf` nFMխT|>dz69ٙŹ4@nN>W1 D{osGu\n W~v R<˖d$iHCY⻥5cͭNEPJ ⇙sA i`zTɀ 7ԫޯ1GlɬdCEիX 6J5SkZqT@u:$dʽ{t6/c\u_YsP׷^ 8Ng-U݃zn:.|{$C4#>:/Kj r@&[QlBگ̯3#HdX8= $?ç޼GtTt_Q2?t rDV`يqjU{JWrB:=PÒ04,/N3Η$_.9vf,j7>"n)=/ٕ:*չ<%\&эr "%駓<5qE.aRWfߖ*{ʺ]/FZآ1ʇ؉crcKcmR_bT1jn[l@֟q-5㎱*:\Ss:fkmkY[Y{&3/P!jc*0Dzm3˽L6/,14YB t (_X[Z6kYK(Z];4ihGbƼyo7'Pe"y8ޡ6L~F~$bۿʧ9F>P^!mv- :n506V-C d즴]vq6=jqE8U\Gzk)Hϭ1~Aw;Zg0j0XI ?W6* T="ݠlhӂG2_􅠡^g -aRٯC,{ߚdI9D#s(S vߝ3Hn}qp/)`R2x3k֘Q]8g+ԯcwICKzsu+kԚ7t?ϙhltmV+qr9ZQ`c'7ï^eucc!7lA&ArܤO`޻_ϕ^/+XI}Y 5xԻ#γZ-ԈdTJSMǻiSp<&eZCք;MJ+F̶$ $S/g"eAi`RV)Vn&oCp\SG2TċraJy1$`N 98g cUCc) &sAg ODbs@b9x /V,տ_bF7~YRlKV)e/.(`5- endstream endobj 415 0 obj << /Type /Font /Subtype /Type1 /FirstChar 40 /LastChar 122 /Widths [ 322 322 0 0 0 0 0 0 552 0 552 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 666 718 0 666 0 770 718 270 0 0 0 822 0 770 666 0 718 666 0 0 0 937 0 0 0 0 0 0 0 0 0 552 552 500 552 552 270 552 552 218 218 0 218 822 552 552 552 0 322 500 270 552 500 718 0 500 500 ] /Encoding 413 0 R /BaseFont /GHJBEJ+AdvP642A /FontDescriptor 412 0 R /ToUnicode 411 0 R >> endobj 416 0 obj [ /ICCBased 435 0 R ] endobj 417 0 obj [ /ICCBased 436 0 R ] endobj 418 0 obj 613 endobj 419 0 obj << /Filter /FlateDecode /Length 418 0 R >> stream HT[O0~45>\LBm4I ~Pm0M*OhM4B8Ap)NBm`h5P>C)0G8PRt"NE~IfoYD 3[9PJ v2fwڍZymg#y5=pxAD*H&o;v/Z5гnɌ t Ω"3J;^ٚ: gW&mlp<;߬ >Z gȺm"->;u$61P*qyeB6r.۬^{6CFK5qY L8=҇eQFpƓfRv۶<E_Bv/˶C.-ƙq ےeM:U Py^\O"s6_yVuMS>v}^*g"rɶFy&iv&FvQ]`Q|6no'nP8pe@$#$_Lhw+,~qz`8b.7 endstream endobj 420 0 obj 578 endobj 421 0 obj << /Filter /FlateDecode /Length 420 0 R >> stream H\SK1 =A!;AB, B4IUMMq//|}u3V~Ct\Xڐ,ʿg{xrjIy$Dɭb NQ$&vY&;7AZQ)bXZ\lIv4#`r%nFUA1>;X ' TN |Yv0[ VnNSCzWI+K`坺S)X=xu~m x4K-;Q80Wl+5WZuΎDGImBWmcax_53x>OWg1B"+ C\AszFhi^2?t̜0[#g8}l1$ScykMƴ [evHA\-c0ш.Zl%Ed#|gJcn\SBCJ صv|~Qs̎wN&67"Rsٷ.*ո '8Y1[ pm=+FI"̖60 endstream endobj 422 0 obj 536 endobj 423 0 obj << /Filter /FlateDecode /Length 422 0 R >> stream H\Av#1DO; x 3Y8ߦ -۫XVSPqW&iqqb8wYu^>?TCĔJ P!kAuyҖBDդSyѡ2(GڤĂ44 w5PR"Chv}SyٗQdIEQ@&jp$CrRA/V&@%pc41s>!^MVXxf ?ˑՌC$w%:ǒ0%WFZ'_z>meZέ355?^ppTjRZ3OBj BԊ`ʈ<@Ƅ|TFg^ΰo/\{ɂJ^k9\,{> stream H\Tɵ0 =>QZϿ!: NNydǴ$~ $kR̸Aq==2Ұ3BfQj"S`bW,F#'̅Jḏg ae5(AknaUIcTŢeX)db [w||tS;tcL ̆M&V$UCl4Rj84P̟}Gq~[>{㌼A¤&QlЬMP\J31X-1S&؝PQ Vu*Mk$5\~j^yva0yg5.8֊_ 5rɆGstŨ/DZz\o[<;c!׵*oߒr`Balm$t֍I^oO o9鱚SO_VAɐ['&po!)U )c;NMNՁ lrur{He֑g^-,4N??E ; endstream endobj 426 0 obj 508 endobj 427 0 obj << /Filter /FlateDecode /Length 426 0 R >> stream HdTM0;A<ݼE'pd HCrPlAczH2$2I>␘8x|{ͨ?(ѯ<*69Ncq; tz&tY8h->3$]p` ,<5hd^4y}2[l4 oodʮ." Oi(9/:טB}2]3P:Q⌟_M %V ih1( #L&̴Ѳ:j`(d_ͨE!B 40'-Yf@V%N[TvЫ-_mGR_ hn^ku-"MM![NB1$jm^|XbgPZO|=!/h,vfAeUz 3ȢPKҬ|jpchDT]x֖cMs[Ź_x endstream endobj 428 0 obj 511 endobj 429 0 obj << /Filter /FlateDecode /Length 428 0 R >> stream HtTAA{P=53i BH~D#ΌO9egC4}*!ĀJLbA)[ٲxpMkuM͖Dq(jVj!N| xͭ9!J uŜB6cnQzM_:ZXU+~-0SpYB*d5,ao [&h@+sU;V$£!viY Ն =.6Bz -,ߵ1;e}fh;oFYZ _~xuh3AtS< ܌vLV3S]-hT+O ݲZ F?^LVkq>nV5V܉o =ŝűshX/bHYoa Q<.m(NTÉ( #@# X=e VФ:]$_8 endstream endobj 430 0 obj 556 endobj 431 0 obj << /Filter /FlateDecode /Length 430 0 R >> stream H\TK@<'54 :a|${l[*&#h7''ch2YnVH{TG`ZS/l^4EO +c2DՔjVVT k!IC|Bl* F=F""zBvb\sΗg++(VF YoOS=1.|ڟx M[W # ;W, n`#%Mik83 J~̻LҌ];g0-ғ̭Si>2 K_߆zV`= 3O&u>9;`k6&FEDa JnZ`WQ2>i)׶V?!(/ϭ.טqPJ/h]XV-I O-ۏ kwۤ#?9&\z$Oj QA<+dW.5*`xΛ (%{Ġcr>䔾QPt f5B endstream endobj 432 0 obj 518 endobj 433 0 obj << /Filter /FlateDecode /Length 432 0 R >> stream HlSI1 |Y0?N31n$2KJJE,Ki$_2 SӖ7Y<pPIr=0US2wF72HCPY"rC&j_hRmD j)bZX@k. #\HcB^tR*8R|cn-ZѝvѝXy ao_3Y薸B,enPH՚2L\I%c;D ʅQCTytQcsF?`%FsZ VtD( ΞԅGhj |W j⌇_4Nksp%fUa[xx 9?3/qx`wƒÛ(ϭ/vP?D`dbyǫE> endobj 435 0 obj << /N 3 /Alternate /DeviceRGB /Length 2575 /Filter /FlateDecode >> stream HyTSwoɞc [5laQIBHADED2mtFOE.c}08׎8GNg9w߽'0 ֠Jb  2y.-;!KZ ^i"L0- @8(r;q7Ly&Qq4j|9 V)gB0iW8#8wթ8_٥ʨQQj@&A)/g>'Kt;\ ӥ$պFZUn(4T%)뫔0C&Zi8bxEB;Pӓ̹A om?W= x-[0}y)7ta>jT7@tܛ`q2ʀ&6ZLĄ?_yxg)˔zçLU*uSkSeO4?׸c. R ߁-25 S>ӣVd`rn~Y&+`;A4 A9=-tl`;~p Gp| [`L`< "A YA+Cb(R,*T2B- ꇆnQt}MA0alSx k&^>0|>_',G!"F$H:R!zFQd?r 9\A&G rQ hE]a4zBgE#H *B=0HIpp0MxJ$D1D, VĭKĻYdE"EI2EBGt4MzNr!YK ?%_&#(0J:EAiQ(()ӔWT6U@P+!~mD eԴ!hӦh/']B/ҏӿ?a0nhF!X8܌kc&5S6lIa2cKMA!E#ƒdV(kel }}Cq9 N')].uJr  wG xR^[oƜchg`>b$*~ :Eb~,m,-ݖ,Y¬*6X[ݱF=3뭷Y~dó ti zf6~`{v.Ng#{}}jc1X6fm;'_9 r:8q:˜O:ϸ8uJqnv=MmR 4 n3ܣkGݯz=[==<=GTB(/S,]6*-W:#7*e^YDY}UjAyT`#D="b{ų+ʯ:!kJ4Gmt}uC%K7YVfFY .=b?SƕƩȺy چ k5%4m7lqlioZlG+Zz͹mzy]?uuw|"űNwW&e֥ﺱ*|j5kyݭǯg^ykEklD_p߶7Dmo꿻1ml{Mś nLl<9O[$h՛BdҞ@iءG&vVǥ8nRĩ7u\ЭD-u`ֲK³8%yhYѹJº;.! zpg_XQKFAǿ=ȼ:ɹ8ʷ6˶5̵5͵6ζ7ϸ9к<Ѿ?DINU\dlvۀ܊ݖޢ)߯6DScs 2F[p(@Xr4Pm8Ww)Km endstream endobj 436 0 obj << /N 4 /Alternate /DeviceCMYK /Length 389758 /Filter /FlateDecode >> stream HuTKtKKJI,t(݋4K%ҹH4J#Ғ(H wqyy~3̙g<3Y9El @ ]!O-@\+BVKK :OX~WCaiHKL0qY `5ck X]x= 8 XĿ׽>.f#aPn D^{y8  dp H st:Y׬cxc IV?S!:_9[YbQP~+rA ShHht^ '0߅™kYXY9Yqqpl'WzEE$%D>,^|t*K)%/`\ҫ:&D [7dplDa5|mb4,yy{e5 3⚅,t+whlA   m k xYUH&%Ȥ qO'Mz3KT@v[NUnn^\o]abTrtlmE]e~U+jאZ:zaqi5};CS[\_ۆwCaQ1;>L$Lz}4:%8M7l̎Χ/}XT^]X>\Ym[n!ycskkƶʷ;v{pIs0Xݯ3s󝋒&$WWW*)!$$%!e$cHNOAKIMEq ƕ;KLw@YX;ؚ8^+DspfKOTCPpJ%D=++O%$*8IZ\Z^UK_wL"dx]}>9=;߲Ҭ8/̹N!z[<=2|B}PQzlH0Wc(Een|Pds::5&89yFT"od䳔i/ZK^&gd:fgQl kJХeJ*+篍kj5U[ZUh0|em6]B@`PpH?QM1Msψ*iϛ.Z [JYZ)X-]R޸Ѻپw?@?5 ǖ'vNg W3gLC#u!MMMEvAms˔FVNA̝GLwA̬,llؿsݛnͽ+!B²" 'R&k?3?4+:6oT\ұڿ6VʝoF?LT;:>::>:;eqvx^sawݥʕ'_EFO\DKLtAnFF)F|ԭ6\`@z?m+F;LwiAhy͖)Mgw~_ @ZH_XA,"F)%/*9aZ:Q,\B^_AU񡒀2 *'[j o5[uR1uh`fm$1xJgBdrltlyyEe$feg-g#`dGbwj0TOC9; ܨݿxz6zx8IP=A!.aAxۑϊ}bG-ޒēx`G/Ԝq_O?0"۬խЮ˯ǰı²µŶȷ͸ӹۺ 0@RfzƏǦȾ *GcЀџҿ'LsٛFsM6+1MZ:{T?~ò~i~L}~cbA~Dad~ty~W~O>~\/~|~`Cx}%H}1X}%z}K} {N}׋<_~7A~-ψ||Dz|+E|[s|z} ^}wO@}-~ċ {Gu{Dz{]Ĭ{f{Zx|[]|ϕM?}R<}Ǝz]YzHħz|z={LNw{\|=>|v|ېI8z/r z;bz'sMzd6zɬqv{D[{0> |;|yyaIy?yazYvzݮ[{^=c{ФI{R*y߄yfUy`VyyuKzZi{ <{z%zȎ~+~}͇}W0}3}HtЄ}Zk}=~zɇ}!~Єd*s}Y<9wpSwuuVrUW؈|;,뇔{RsѲ;:8q)PCV:4.8Ȅ2񡂡?Up Vu9S c bփR.ՁNn U388A/ͬδz6߆өn1T\e7݀tXT)$̯̕6;eCʷˆ imw3SƀV7M \lGNػځNāa5tNzlߴS<H6*-N}o2ن N%է>w֣A}⇤\fXMݘ2, KԐ3g°[} 0e6M _1 ? 1ӣǾI^I|B̯dܪwLe1$: rW] 1S{z|diL g0\ U{[G{!{ ޔ`{&yE{xbie{Jr|/c5}~ ~:f#MKx+Ca|uI~.yW ώәߎ%¡唘[w!^T`^H*- 5GȨ瘎=Π4rv_ҍRGf,ދ̋|,ƕ{ Ҙtٕ^1Fő,;',#h%T,Qۥ{[s:9󅼓&^!Փa@!" y .Jl6mHju,bU6+s hܸd-ʥ}wi-sun=0Ľi-_*)U_ˈb$na+;ϧT;ppA7C4.*Iߥa8Mm.ACi7\j|fiԫ)]ޭjʄU]3(í whJch-4x7h׿*P0H됎L랇ڡuÂ,{Bz}8vggҲd[!XTZZ.vlAg {;Sm`vؿ`~?ga. 3Ì{L^WYe4]L7ok!wI~Ira^=C#Zh`Wu}p)"z7ff&3$FJ8Ҷ5m uR_,^VS&aR~PfLL_Dw*`\-9]q  TI6)>u6 D`e͢/xqY%9ʜ;åOd\˾P&eRz;].R<oΡ]P{?: r̨\ʻb Ҥ3|m s؟W9oZt]RnÅ\cW#+nI&gyAjsN06HiD'@J+a5V~cRI̫vwtUc[3+?F|l(iU^+O?Rs1Hqil$Wþh=(RE 1BvџnF/ BsGMY9>ܖ3ȗqI ڣ5V_1ȣβiJiX0WVH[8g_/ n3 ` 38A.|f|ј0I6bv%& ;Y㿜҄#dD.).p'3J12K[Duɥ$s8IƊ.z^48e!R6}vcMiozo0'=~i,3:?-?oS,9w#ROa; ?pB ֞IO ݟe#}ԯN$\l?], y,>&Рq0Ⱝ)ĝFҍ:--ǟc)K9գ127琷᳢<>h;|U dpG ƫ`&!8al`83>.qɂnA9 ; `HByg KB*k㰗2fF=#OM eT? mTm_OBۊV<ɆF('n3uG~Ȯ#7Њ9[١`Ns.P..콤 'KnpF\? B>-WO«Blf ^b-_x&*/(j_=߆󑊢zF`LdE:SNʔ@S 03|TOKokto}bFz$4-,.m'j*J|)J6BP ^3ewܫpX.*,07xPڳ:2XOT21|"7=0ߴy}ĸB)H[Fs V+̯+Y(I(x&9JAI'tXmyG=X[8TK)2<TSRvxlȓGO|g/{>4/gRFȶ&A52 uЯ*B幃AuFǞѧuD)B,*?n` 'qQIzK֗4{B_g68#ʉ2.A$69!̒ub1&D3Qx" >ɏnνxVG&TۨÓ)sxd-5KxߣD&1±jdGjJ|J{Z ޲f6/vTp̄ub PmBU#gBg˷)-*E ar>>Ƶrn[ɭF-IByѸP=ĶKUC wG D}"vN.p]]Q8uY{#qCv}sax_oyiNr( d8aw2CQ}V8UWO\g \yk@dcZt9$u p-1z(=f) vě92 w u煼ת#{P6+Dq3HIi%BCb!kc5&U ):X$܎[b2*@PkcӘdoTB_L1Uwi")=2#pI9,RO>T@>;bnDPuCfk^^\G~ oLRcHqܮ=-8^5Ońy*9:-\g8:T<?*C;[yX+I;lRL߭$DvYTQ6DyVmfy%/sIsmXP1Lռȭvow)QBb_LVwupeėO*|+](uHװ4WU.{ 4\m.QwR~MAiRz+%BKz?'{ k҉aa{H]sX}da~3_auQz VM\ĵv5I0LM)DŽp1:5,&4 %!$}ocޤA]R^xT◬M&/B:DwA24?cd&g]5b4a?iǐ Ĉ.OA 6vfvsd(5yTH/P=(a;zUs bWxDa)Eʼ $sgPJreY3w`cFo0|U[j5k.5J&eTor È´}I lpjC8c5J=g%Uo|L58E" ِ[Ak]J͆VBM"{NrQihЦ@Y?6^߫ZWٯ]ذc؋hKSLj:>O ɲ.ݰQ{5mm<ٷ?^v"}ъw9O&vX7km[ ,70nΒ7|eP\I;-wgFN cIP#qWI ;NٶA)H~7i thl~~dzY Cx2>*c&mb{9f1X*L #> V@g蒼]7n249=MK% ;,F\j 1klZi؊ΐ.|Q9а$_.!;̿lE,ɥDi}D3^a`Y5g{J=mɳy3CM'jM-iЦm n5? SJE+U~ ;q.tXd~~p*QeS%.Ћ"ưBsZ6-6[\d;^z4`;64藸ͱw;|+&AfLU3XTm)lF'l VɺgcGObbɜ9;v \CL, >B?KGCe"z -@EHILp<5'҉$>8#gL2m c1 c Fw)P+rkC qp/u8#!*g°Pa`vu@oH`"Ž:z_Q<,D>'ӅWP .`xW3|!6 5 El[",0 e[Oz0~lUO+&xkPc|u$k.?{Qp""kr6isVa=~@W_ .<7 2#h?c~m'rE_xs6aG+K 14L^kUp^^_mS^dШ'>}5$:τ!E[bJx&n t(m;ZsF5uqX.ՂBqKP *l%{ٓ{'f';,TT,bhUq2Z3;}T9vwRR;GD K*/@hUv$j!@ vyבm,W|-͢ ^ ~D_􆭍"ĉ#c禘*X/Ϝe>|XH;:)d9gƖ4aBQ4Ew,C ۯBU#>SV$L-5gV ϯ*B#} npþtdU$Db&$^\^&Z"/˺+-}%Z:}9AYu rTlP0"~! ͚*@5K?߫Z-P=j>܈[O?)a5 ?WUsy5^(ge${Cm> "Gգ+$踿ϫ& Xw8?g,'ō="/xNM)'EFqrf CįQ9ZY$r!6m)4 V9kJ$# FьX٥Cp[ģ)CS;rFP#ImKGɺj>>9,Z-ቫkȉ8˚?tP񰿰_Ⱚ:촥ձ6/3<֭ztea'cLaM lz&,f^_!?l2x2Xyń3D)\?ye ~4O+9$  EVDTSؓ7X?MM!ԼuOtP Cbt;iްa@gW#@4c9.Do z2>M5i~u0 qswQ9ǸLt삟Mz)>kɝI;io"U)]$YL >$$T:gUo$UK,C`sCMAJMÄKC(g]ٮ9sUG0?L5QM%0Ol5&`Ƒ1,x'{k+mY}-Js#\d:i/NK\8HstQ#-ND).s*Zymnf\1l{(E=VGW9s:?wǟQZsC6A1ƃ6K@8OUY^`7j6@9?,yt4&}"T- \Y&kVx녣391ٵqQ=beMq\`/nņ|2͌JkzDmͫIR4\~5NlօKɁZ]TC3l̅D3jSS)tWw$IX[wV WTUw^PeUhWE^ؓ~Wchs sIg`wgs (5mr] B`7JfAaA3ƓG?{O[ ?xj/Z*7exXz Ά})C?`KcMՌ&)Y5J]q':]$؞]Yv x(ıH1eU>_0b?*񸨎b¤،D;Wxm]|N7U13*;.=>SÜj)CM>.eI1/QvН6Tkk+Ɯn\\FFV#Xde&~WE7"bju^I@j@bQ Wk8w_D ^z xZKA _`T}] x}ЁM0S,rV+ KO&ƈ`;E{irf0F] w86f fm_8c3V<)r1p +hs|p!QP'Ղʛ2rӤej4Y r, r?4! Uq]f(*&umM+;1 -c8CjL=L1TDJ7>)BH*cHY}~xI,{7WjWާʇhg_YovMKiN> QRǧ}AQj^G syJG"?txt,L>֍p员>P$հ<%}KDS4 *S<ܖyd;éIJ~JMn>ȸcI6uɖژ䩊i77_5W2' 9t^}/8%wd0k)ͦF9kih3ShPBULzs'0$Y/L3ol|f ɪ\AW#siS-O^I+36xas @M A hm45V-' ѵ1S+ ~*%~k˝ʉl * lك=3_2~OgPs Ccd[aے{<ХjA {! ߲ۓ;O'9+wEHE&JV?fiӺ j05瀶bhWZxo=ƺ 0zhK5mov (YOut;e=R*yMVn,$v:QڳE.yVl;svn,Wi.[@34SD_!MF>J柣ND @$Y~-CMu (+lBpБ^#$~2è /@̣6 3nh ;۪.3Fq3\َvZnZ"/vNFNJ2V{#ΚVse_쑮Ta8C¢!Η>FL\M{5eH~7;F AB?VY=۩Q i9J.sӿc%FVbdեiL`a)kD=W \ne>NX7Ƒ†2IYf-to7/~Uas[`W*v3_`~:kjR("E * e)DDIss,f_n6":hmh+]AqñQqSa9{~8|~bh6GZĠםN\h+(E30~kTMGβ1:zka'LG2>,gt X&@?e% =@Ihs)HUOeX^m7R7~,, \jJԌfͬ8!*]JR:WR]Mɚ PZ;JN.8ɦ,[r*Α]MM"waX)Lbjd`>:?|:?u>^G$fa. ʥ_S%ED8 J=ĕK{6r zGG Ui<Kg"^ q I6vPWy^,uc/5@:ǹ+[N+li{P#^yv,ñ-NѳH⺣<֡gxV</nb6󴳜Ρ +nhB˾PoT(W##ĉTwZU} w-vT-9O᭺HIz) z9R'dI5aZGS˟agW=.P1ٜ y?2X)r4VaGXBe`9Q1͚@85$W?D}z2* pt +;Br\ܕ'> -vCNeʔL-ʌqKHr 7I d<BgNelB^փRγF2AqCR&t7߄{" D9u)Cw1t}?"'[7o̩~1{>Ru* ʖdClutqf2[l~{S4>J$.nQnlP#x])By`r+wLH?VD:|iUG~ժ+&+Rb gP>}WԹkQǖ]WSkqwZ DQdVd24KGMvU35KJ~4&jwJ*y;X߉˔O@5hw)񘴕o-9E:_̂o&6#V(ѽS-te$ פp}4%4mrnzhe4KX*KÃ29ʩ~'Ǥl|O5ÍB ;^j㛑Q`exH;J\*`l˴Khk &tF|(8VǡܷR:ϳoG*UjSKknRgl ޅ-6&Nŗ7O4rGmO[du_TvY{ ̏Iy\aRKy&P7ݪJ)l"W5{K S_j0WSW;wixF1^lО伴^'1b%OAXhq)L7j}=9PX=n`ɗKX#CùA *7{ jWܴTByufכd=Af]F=_u*`q+_i݋\^`BaE|S&%Z a8+QgQ[IK-jIKr2Tcju=A ʧQ"7{ٮם*X|,Yzѽ}ƈf:jCo[>]x^hlhNrϳEDkcCǪ ת9c Ht<)}z!hE~DBӳ2S͆i{;ouIp??砃46ٺ^"1R<-65sjpCSjqi6dzھİ紈 41.$5EG9:=ob쾄 v#[xﯦAF+T(C@RQF772I$^a$Eq>.AEbiO0]ТK5ΫPÛG ZdJ*$d ^}E*֤>?Ƅ$dO _tl%$^7[KSECqz"$]*B]}W zT[Rk"n]EUYvFUW\B6-RB^Me2B4/ͺͳ4k5˖<1U[tD>Q!.kR涧7uJc>c l/i^3;iڐ0sĀZnS qW7Np:([568ViAFޜ~h9Pldüj2dO +61--1Ewv =JCHW34܏&x8,&#Rc3Dvz6RSyu_N/nmكvT֥Y˼?RFװKzn9Q4gC^5l`P\ܲG&ޫ` 9PҞٲXr6 V4,{a؄\tcY`]lǿԾar鴯؏=b!&Yb ^[\aYt$w [R)i[{$7f"o Xp zBz'hO|Ō4ǐ|-j :}̴a%Tv5Y9QK d0 ?$ćH|#uD3 phrd@,@XmVKY@ou([8#!OM~.7SoJn%OG" Ü3N|/'O-R_1Vh&׺ NPz8de 勊ZTH;XQ6}+'h_|ȋCcuHjBA,NOS{3 L`]1> A rxӴ*E^.ؐ`Q5 v{`=W6뼟\9avGOXc& v1w~0W:ʎ~f: 0/˵%m KRKAcR% P#CSߥfmD5oEx17B0<&Yd8"1wܡ5 TaaJ3p57A>+yIMcu Zd?Bk1x-rsV9sH6p]DGgO| y5S$aE`$Ls [Ym ~u8p`6*I ߕ`S88sn9O3nXOE /7f^lbN[PBFO.9Z_.5>F S̉R'}ΪѬ`_dX|{dHXԾ3QlZe7PRqشO5OkZrx5u`aǂ:*`T), DPQʮdߓJRk=H+ *#u)h) )B6s9߹瞏HZGzGT"93hDͺ sr|b4y $TK "$I~$v(B#].qi?CN ~ޱ|ܷLcOnT~vxj̦5<.f\K<2p:CpSy,66>|zC E T)f/:X1}J+>_~Q;^ㆪvs&۸>.k7yZS:˩㜍rݖۜaKa!l.g57Kv0!;ڗfe %]"XT J3aժlwVj=v姠αe=bI/gH& :g,(y 27>aba88fVVqɌT0NɉB`( _"fo! t}Wg_0}HX 9,Qx=~Jٹx>ӱe9M2mFS)Vk-eZFF٥btg0O?Dǐ%7eyښ6WSCyeUS}l`a8i g"1лJ"|PKڝc,$+&PvꖴGBoj_t4I vqf熚(eC!b׼^SbYi1¨;2W`/7uh?4 !z@#(T 6 ^!R S#>E/Sq9z_ /G%ӈ0C9[ۼ@(٩P ,}XTOkpQȫUG6 x2e,> -?ϭQެYz/T5FL^`tީ3\#̬D:,vw[mDW)TBZ`0Ֆ`3tBQ˟kks41y `\޸cV#z`XHhwA0چFTyqӵܫ*F˪%*/>9 gS'"b'zL=N)cs*bR)W<#S 癛)K &L\9WtW!Y17i*%wJ_ 閥nWJ!p-0T`:K6B+SzlL,~J#ZLHBEe߈Eq1 ڸTD}bB;*OTCnՍl$OYQ0mz7o9NŻ|hDV[Ve֩b7YZÖHl~I)ܻJ5oOݑ%(,hZGҼmRd!/NEWutV57z;jjs^^lDǾ0-a_aL؁w44簍b^ppi&nX uƻ-݂ -cY4_g ?jGIfH %J҂[%ϩC6OzvWzoZtA$?z;ؼFT2/+0@@S<@>0bSuqw;j4S'/4sEթ(P[V^5ƊHkg/ۄw 0*֭ ajyB5TC J(_F4!m, RN ?S9 :״OfOV"յڇ1,V)S@._ #Q`K|ͨ%cj/&\: [Ft^Z"q٤Jm뙊jMarח`VCg w"~>< 8i}XT8dzQVY<p%HG/Û`rq;Nm~Ms\/Zh:(MXа^F.꜋.Ys}5`a((X0T+JS 4&~|iB!! !)$)ʰ WFY]E븎3x,˽}|dc |i-0Ws Q_GpRjy0׿tjT̎ԍD1څڍ›N:ka? 7ek_%]a;זF=9-b= &Mm0-vD'^j+/5(er^+EL F1$1KWE|fOFMKm::1`ڥfXЩM*i9 l?+Lw?-Nx͈wɳ\C0瑃f sM;iđ`$O0z*RٹB9@"k5v~.lB?ug]ed8JAj͹um.DO^^v:y;ske+,L¶vŝҼخd_5Z;q#k> MU\J{l*͟ґ3Doy"UDcu#H)BPit/ v`_Sʝ{e5mpPpy=-2[m+v6*.WۿSǔ] ^DMk,2.#ɲ\!{^I4Ԉ.~çlDcBU\b"c jvJG|H`_2rHѥ tHHBaG :Bf{'9 [jaЧe &hz6Fdy?>gۑx&l$^:^nx-'-]O 5@S Uڏy]Tu _,zWPT|BJ,ɕ}`8ߴy?p7gˢu\JO(_vOUue4+Qbi?A.jCxyRJ駥Pt㸲rTfdd$ֺFR>PaL'v2M*׵T]`W*cD*hAe#"ɆKO9JKL2J( KgK3jԉfZnL5oM(_>FӹҾ<@w#Ndhoo4Y ̾Fٸ2YAz$W֜5Copli\ 32l;a<;S?B>zprjsm1tZc̥{s/J{c*#3ހfϡneh->Bc9SJ"չO8'8ހ `yHϤu-*` x[c')Oy\x!QS9q*;$;d'=NY ,|ܶ34qT=ka%hs䬺UX7Fl[ o1apuxf9QGk4;e ˸7荇5xB:yZdͫ,`2?_a[0~9iY Fs3g Ë9u<,yx87 1Ja,O@/gO㔛94 |.]16'^@1'p:XtwL,jVQv@wl{έ̱\?R^UV\GI+9D03oyd[R<""" .2}"!<4tH~(-r25DH@l"K濣,/S}"+~wF}V dRz,:w&?C~FqJ}JݢJirjzEgU#p]ZF%+[PjewVjlW7wR/*C%%jGx @EFH)&0_Օ|Xu DRNXA\0JSH307͛73 CWc+U#r# aQOL4Eљ?s~{sIy?y>ҒLָKd-ޣJ1v*fH 6hz+~BO:IQqZUՍP[UD#BM >$ z|?^!J0W8N WzXfщ@'h< %sdR۔e[$z,Z2H5[&Ht L UO 췯+52j&P6uRɮ! a+rk!o4 `ܗP)f%VQTF(Z]s,TR|O)O?ho# ]6yл)OU,F٠E})gsٴGyҘp/kw~˖I'Y;TdgYU'I8@F* 8 $I+A2((+y8OϋWȗE {բbW"@}@C׌teYgvֈHofE`eagbN_4!/e%O;mhtWv6[iyFy4ʔat V] au #QYm3rM/q{~tjD 7fiɷ  . =[n`4qShBrx_5wԐ %nQ~x'G[ `+qb]Q2Ըi=UGn~ڋJ(Aݪd E7Kz +M]!} jnh-Cզ_魺a٭Dfrj6$-4nUZF)Zpux'@]U/ٳۿ3Ug`iU}ڰULWu+SU[;uXJPvOŀ{$KF,qQruH.}imfZh~atMBb0*iWC䶧jZmn[nKfi c+.&oV.&ʭ{5_s9dmIA. *s5: 1Ů m!|fl'6#N Z>\oMkCZ8)*bEE@(27{I" $!0a=+vUZŁ`-xEJUǺ ~~7TSsV6i1=2J眆Jh@ Uu;7!0 ߽\醮%-;=.e/T7D$v{.ʫ|ZѮmcDֲ+-Cu_{>1H1]"D^nR ٺ:E3[h9 7TJOW+3 vœLimc @6'[c`Ǧ8v!bR{1_ӵuoPE2\@;4"mO m{ ߺE1dA}C=WB}[3']\PJG5VmnYG Xyahd'J[U~ vWۅWo]WnGnR9H7ѨAu 1vZm]lUrTVA sj6lhm,My4A*0vJR? Ĵ>2C!*#q0MJ!:ŏCR|dFa?2݂ch3dBzSIt?%LmF[AxYGҏ0m;GY1űh%[sጒ@9 q_8G>r Wn)jodEzC.qJviN&If8bg v|sd%:uTf&L0~p.(RU ; _)w%$/ t# ~#u`u[w.qsY_-*'̳ɩk/)2* i9$7fUzflc9}],툏WYCIkS-ty7>! 26Kݲ m&cӣh' ..+upC6&@j5tdP0=I˂Ė C{޶$tR:(ϭuOR4$=jluq1?פ9Si|cqF!_z^SK}`d%DT wV>;<'V=(5H%jWMV#9YD2֓p~~J }D]gNSsjJmn->,vg&SLl#>^i8ʞ%4'RJDhRN0hBA0(r0K+aMY|"EGE_R^v4/?m[˨yN`K/5[71[Gؒ' '铯RGhqꭁ]>iIX 5'\GB ćd^ux+[^%e ֪pxE  6%!Itި@Ҿ#% :*h$r7שׁ55׈Ց'I+6*ЮwȰ%U#zD+Jt BaUؕ 6}uOr7dP Cu}FEua7RV"KST20 EN{^lkƕ$vW(,F7b ˢÞOy<"_).kh[n 9W?gڈ7yș*ӼuA@ OpIRrP($e[iVYR n#(aFq&mq3%\g?%ӆM5XD3b$ʁW ƿ5&͔D4®KcᏊ . 1Zo ^`~¿`6z q aXǰ)Ӽ܄'84 n"Db.yC<K d},{*h ڸh>wMv^ c8Iƻ(~j? eoyl/Dl5Żרpy1ܣܵ^004{ .%CA22dWuQ>ok<5.ſȠiffh7S-|^TjX[wCY*sG^1Ve֗+˃L3 /2y{+.;CtJ } ->٫6< WxA_PZ? Q y1>yK\.!OqM 0Cl];Sk)=RZ@[ɷ5JBeǐ$Ni"0 -úR4H~9.☫|Dϸah-)r~"eoMK%4 _7"‘e QD~0T.>"x*O>酧.Ey+HVy55RWsEk*PxEGB;(J X(8hiqmh^ 0`}_APWDLZ‹]<4zG֦`oyZR|u^gCF#nr)Va5ƪw9njyIt xI1bIy>}-AگOShKFx6xqqQ 3SU\ka椚̩Di~ ?{>J3mtߐZt]YNju]ɒQYlZZsNѴѷW>Sݥ0Bj+7q҄fU7m :8^;#eտ+*,_CY3MSU*LX.jQȖg_IWJ5a"9R'C\y׳qH)VU-Z.\+Ѥ/aen/|F[?SPkr" ^Y>VH9 &yaIxQfd}+] U.o.=q-y][viRgk*`/pLBu+A@[)&PYQ?im/K,Y*gu(i2`؀V"fJSs=RU@7+>dْsmY)w=U?ο3D qjv83׽} 1r@vy:{Eͩԡ.޸,珈~CH{ksv_l毁@"lOR."0Fl]]C˧Mfi nq˶Q{56ef e l[IuY_(i&;to 5kZ/ jjp~Ch⨿䦿iRs!G-֠5 &wa7WAƫXUr8+}E)oVӃIÌ}qZlh<gw A?=$6-ޡ|,)!<*ǘ*z!8߀ϸuPpD|Ŝe=sm4'ҢؽYaPOZ(vj?VGgxI=V-̹uMCJH_-C]B~2A\8*E8PTΔTo 9/whaߣby\'F,Ռo%wU/ժnM*T Ƌ{5NJԢT9L;y _fXD\uַA:x")V%V/*]1# )ԋ@X"SVӅ4u.f?Uչk%Nj;c~?]Pۺ˄WҌ=V듍1 E ֻqd{q׉; NYHdfttc #&vPtQjd1o ­R)ʽ@}<7 &8wyybH04͂@>o` ~M`Oi#T2"-!NSn\ z$SC%Q%;OzcT)!M.wf.Po1U=Bl1F#F0HD\u̞rڜ*ujQO5u8E$7:"І(UuANgulWYE*Z"cT\kTxlx)$8(YBIY`[}.Bb T$=U8Oŧ yP-x$]0_ j(sOH|/=wKR` ptl>*ӡܱ<=Ts(&zpKA?sLo`N0Mq+~*m-~F7^5惬H]${|-Ҷ9Y&=X'Vu+^ϖEm Y/0X cAdPc_X VRx6b|C6^FeC]o-F?f7Q3V>͝yFsy]ݯMF͊k^NնI#FZ.7ƆQfeϫCJn;AjB JFw mԗ6t(I5beElXQ͌ i,)6QS 1zJezVBf ۹ʹ/ HQ89SnE%o-4NJ``,)~utyQN]vحp+e"xN6y*,7$'x\CQL[8.d@}CɏE)1D?@晹b$?7 YM N| _Td'wa}0Z<9|3閗3~o=Y>l0Wb=P1jmE XR[louv:.C=;.a.BřS[nWJ3ǟN1='\Xr8۲:KXj6e g΀ap%z"K1.c1ɇzɭGTRiVBe-)K@iͬ!u@_`&2q up%P SЧ|NWP !o-t_ nyV|ؤ賐e`HʏE=>\Tǀ|cҎkIST!%Gu,%[IR'+#T}m3\/df)`n2#\M(CQd6flqGv첵).Z&wITe{JQܕQE\m`p`Ҵ\z[v7OVo9ݜQ}$SSFMWdnyuя: *o[3 O FRJ0ոl+L+&oE+d- @?^fEkoo\fyJ8zΰXmi  -Nw}OYpz&@>gݪHc. ]7Mz#fe"g\a@\qyºJc\3ܔ r'WQVE D|PLs\h_h#9Z-TdL>˼!W/ni3.1Ǡ3P¯v¾O&-8ךeȉɱʱcař=շm<<$+UV66do88{ηzkG}ڻ<<7\jvg!5M!w&GmpfSgO3x? wZsLRq/~lK]QV:om<Q' R]AMXyu ^ȩ $}! 9LHaH8hʡrTtD-*fY]]wuu[bgg޼ߛ"ȹ I7HR7HBHudt *Ჲ=eJtj| #TI/W?{ΝO^'`v'$^E=7ITF2˵7-^'Z"[x ;[U7,QyWrr9E6cy'I gIRm2ZQ {0K,^H/>>G@l`T=FZnZH ѳ$m¯鵩KA3D;w7ŏw^J<`i$M_x8wU-,/h!pbP1|*k _U;N45jX_:]$ %ͫX+é Miwzz{7`fOE5FohX}fL}k%Jq_b_A54WK'h?:lTHmm. m&"X7rV7l̨b]r+ OpK[{0EuwrfӵFajCCPktMݻVw[FR(Y-VE8 P?)p>͛5 #TtF%3 qhk ;`LVOpZۓ. j&\Cʡ <*g!r)J;ȁ&xK0N\B&Գ$bԍ7fpt(0H23ӲG1d?ź bVֆ|\[w+tjj?b7hwJCmm#b.^VBDRb8E]4J 7LGc.Xd/a&ڎ @顢zQuֈ4Tqi˽èb˕ 43~,ymoθ[0 l} TCuLBt 2ZW>Eh@+[Řy0= sU"r];û](̏{e E=ma^2'FKv~.Оm0Oj(esߺ Pk*!3IBЦs4{^|{6k\* }XYǠD=A %$hǹWǂORV UBꯪr+Ca6 Kԣe :Zڿu6&?W&k).]%],lb7MX][H"}WL)RIrfr?AƁY&I~_IB${XlZXE&|w#؆`_vߢfu3fm89?9 ̟NՎ`jz1*.@爎܋`oْJ_+-4α6@/DWEjE}HRDl;Y+ z/1Dѓ(z)oι&;.4aZ#gsbZ+XWi;<~n"( M'b6!G lP<^\nM8--aG+dyXP^s:0q \p3bWu.,R&rm#қs)lej(^ ,=/FV6fj;ex%Dk%!FW@ao2QTvs 5h0B{UHiGCOzL'pbIq+'_1Lv QA%$[H~}{1fKٲ:HmWS ëd}2w7 j< O7i2G;SWݒ!@YsZ~*PƐ6xQܡ/9i7cGHVf3R>K2jZxH"Z")vHD} @} YJ64T(P_(*C]miSJqOZgA(ny8}wν37;?߇*x"D6HaeZ 5K e tE=H\ƒW8 72ym]Ly 1N<8͍@:> >6跄ӹ$.7$C$pA)hJewT*FmKg-lm*{{v\ܲsJa>3_*ݑہ>V5|WG_>RR_YL!RFjz S5fځO2< `}I\:XiZkRH*4[(xX$u|I9̺TkVzl_׼gC%*wXR nY)N.9+wZ[E9ľWJ%wp`Nj[.b|JOsdW,R~#* ĽyFdwCp*L(8OelL˞)A vfFʹ.Knd~A򥾺]Di(i]YʯJߟ?>w[侾7KK6w"!eDp5V* 3VEa{:KoEDcɾJ#oOU44lTjFk,>{S?ýSk>Su=|j}T SU.nk.mcŮ)RxbT<TV*yÙ<+`RC;S^0-itp<ȗ2IZ_0ȡVVKHWol9=fd jb%}DCy{sI*{ZL1r`n}+D_*Uz3}i779_kjxL+u ;FxL.mmQ`sKzK#>&ޗxiBV^\s3_XX_رC+ҭj|S kϽ|j|[X ΆBL.?\DCqߢ7nO(M&JOiݖw0IJLM,NCOYPoQRSTUVX Y#Z:[Q\f]x^_`abcdfgh#i3jBkRl^mgnqozpqrstuvwxyz{|}~ˀɁǂф{pdXL@3& ֜ȝ|jWE3 תū}kYG6$ڷȸ~kYG5"ŵƣǑ~lYD.оѧҐyaI1ڲۘ}bG,{W3qHvU3sIa)\ Z,      !"#$%&'()*+,-./0123456789:;~<|=|>|?}@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`acdeefghijklmnopqrstuvwxyz{|z}o~dXMA5)ۈʉq`N=, ٖɗmZH6%ؤʥwog`ZTOLIFEDEFHJNRW]cjr{ĄŊƐǖȝɥʭ˶̿*7DQ^kyކߔ ,8CNYcjnoldVD/h 2 R e r xzzzyuph^RE7)4=@?:4 ,!#"#$$%&'()*+,-./|0p1d2Y3M4A566+7!89 ::;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{||}v~oiaZQH>5+! ؎͏Ðxpjc^YURPOOPRUY_fnx̰߱ 8Ql»!Ceª9^ɂʦ2TtҔӲ6Lat݇ޘߧoX\[VL=*b/fMq T p_L7! }tfUA, !"#$%z&d'N(9)%**+,-./01y2g3U4D526"7889:;<=>?@ǵ䱫ٱ~% ہ‚rW; ϊ}bG-ޒēx`G/Ԝq_O?0"۬խЮ˯ǰı²µŶȷ͸ӹۺ 0@RfzƏǦȾ *GcЀџҿ'LsٛFsM6+1MZ:{OX͙~ʹ~y~eL~j~Qc=9~|4~cl@~]̳~nf~C~لOiZ/gP8v}6q}0}>ϲ:}i^},~ ׉_LpK-~~,*~&E()D9vyowy=TS3wI!D)J%OBvwN64;>FVWm S^Di*bPkpة?%"1#!ϼK`L<n-e2*+) X䥂C@v2l Q?(=0q MzǃIz7MEY; Y@K (-\U&>rI^2IMe;Ya"VN,S;o_%sD;fƎ.R?l ;0Dq>8K)3+&<4@n͗0EO94#ҐnW9 b_7}B2yːv/ąJH삻Ȧp$ȫވy;Æǘfo虔F¨LsI,KhW2!AjHE^τ _wdlXggΩr!jU)[%B\DCfp <_\?k,.wȲirJRݐ=>0+cvZ{HllLVAc۠ ^{6oCҏSمbȏ:sz 7jP@Q;[wg|z30Uq`!P-~|X3+z2lIђ:_p-FOJ*Yr(".O'qäfrCRJ'dc~h!€?`}WzBd;hѲGϲmT SAij9< ߨ%@`8xLTqė=,Mk $hJdx_r̰gʱhtG,KytomVK0X?R=Џ ]ٛa`sʠ7g&Grŀ?>r&z`b>&z%sxbw&{~څ]"WR%c"zD zA rs!֝=jcf]rmANJl$ے#ؑ >wҹF699<׵.'SZ*˺#-Jl.ZZx%m*| o 2ӝ_TWK4eRsu33'jRFBWl| Fgml0L1, y+Hu2f;[T0BE{:qntoT]okI, LgV_R:Kϋ0dP?= vE̷փ(M4m\Tk׉o,H=Zw/EI-LQ[ 8F/g֖'$?[u~fghXjݚ- VImKՀ,%ibQ*e97WKMYiHtXTBUDw-49#iԗ/r]hGވ/ lD2 h‘%TTT*Fdw">GY?"[f r5ʊ4`TAo4H5rWS8Xy;$Yr'q vUPV&4m/5LJE:S7Hvy.. kPXAl` ,e: E$@BKr.!{A$A,CY[EA;| TJkU>41aƜdcT.Us R&BchR) Pd;ʟHbl?1;_:i^mMh9Ӝ+,x+(‡j3=P6u>a}&b (0=.À<2&m%u9_~zL!S`(6͟>թl䨸5p!2< PR%wC>ubvbF.0UK$K;؂P,!rA5%\v" [2gwdxJ:_'Eښ_+^Cژ I! v,V72UJLNITUKɎIy/R+=+(֨v6!M @PB%R--3|4-)#ͯ w.ܘ<;b#;*>$eG >3"و~AZ$xOUx f𜓜x;٥Q h X(Zx=`dš 8b†id, ϐ!enZ b /޲І2P0~ +1baktT ?g)˧9 С`.ޓ`>'4\DRdPaxԗ?i|9,t Ĵq]"m-9OD'Ex>#Bz6Nk%tm6BDzVQGq,2O: y{iHcy[]vaZT5 ȨR 345N@qG!fYXr{3^M7HX1ey87ҙ;NP9tn/D=}*I:2s̋%G{7abTBm6ۺ4JZmI׶Fהz\FD*rEyք ̣V-8ˉi#7XmZLW:2 $Iⷱd`U+z3 8"}Y\E^\Qܵ)<&uZ!FM)V"ڟ}&à/ ď 5 O546PW눤0 fGlEbdc 'ƪrӬ[{K("M/y%0=zFBx}{w6{Y50%,40R}ԓvTp>K@fR$7HU( /10f<,1BS>٨RI3#&&pa5j19#yTH9cI[էjU̟~? +7NzM`k|-kqJ}(Ҙ2SaӼGi ; b:`uǤayU}T 2Ftm̔%OpuDU0m~L-_:qWg0~huw-] NVrP =<]x;Y1iw@8,n\(zqb !$zB&5dn61Q& & CuЎy#c%$7]w'z\0Lk{8 ;fGS Fx¬P~Km%t3MccM(bCB$ _ J,@՜ %ӸZ;.6B)PT~~:_tHNITScΤ5_3bO6-[o 7$cn:zNqnE2~7\NT' "[fTT^2F&+c5r~ԕ(jl 48mWDC]X#<n_ T 45 C0 V~ m&AGA7w@w;Q8Q ?d9#1yʕq_eS]y|d*&6Q30J(WG>HN vAg+[o:y1ډGmUV'pJ{"M@3X|*oƙޞ%sfJ<ߔ[-0R'G i++qNPF\&XT~ykPx>–~u2LX'P MOW rة Z?qU\+w>-q/QQJӰ737Kaڳ̷E8ݭ,վ!PV$ԸΚ׵bu*z-fi8ٲM/ŲFʳ<`w[Uq. Y!'i7L' Rz$v]c-ީ%HY~ٕ 鞀ws{)Wa˹ԑ`{[z ϡZ& z - U@uBP.8jz B{GtϤ1ޕq# ^o2N*`DZm錞c@QY@Oy`ŕ^ )H??s %J@f-H%{#}řPKn@u5w:=YX9(5#p 9#Av(~-"]Qb'䠡ya '£ +vO@%7_*Z-r*~z Ց4!wBpG-q.a+c"wmqk=WfB +k^0>npu5㞃= m]0o-1:ǒ~%ui;pVO/a3;0oKܼL6Ed@ZU%{ ^ ͰyOVNHLmu?uMBEQ1\IُOui@L7Nk\dd[i|lRܰ3"rW^  19~(VZQjsfb5~Nl, $LAE \Yv3k"*Ie.gj4uDk"*T~~g^ ~<|1cPx7kF84K(/AI\%HG;'6`kK ZJAFqKq$5GT#.a;1 p't.t-SSUn;QY(sў*M8= BHZ# GcDS{d',Utl=,}*vcr+](_1rØ@?A[KDlv'”o>=ԏ[?Q ôn!ܘeoiB]u3PzP'ߧ%44Qw L7@?;gSVjgohop7syR\7V%xL| 3n|2Q|-GotuV֘Gk}fd'̐yQ/;^+b#&~ي2(ɚpTֆ)$Dru:5zj,|~0T\~>*,6Y ]7E9!7;au*8Y?Ң#WfiA~\mB\$OwDhE16:_JqBR%*X3 !O:`Iok2+}Y'1%Y GPMJ{rK w_ L&N NyA'ճmﺾo4gz"v;L je %Ɯ{NS6U'*@djNcvo^=Bi 795l€Aⶫ627ICkyV_}B.I=YR2U^c~o\Ƙa3Ƹ2@eU*Tlmcӱ~ xnNU)o`Iχa]PFŚVTC&ϣ࿋Y=d]/..FBXs+$=}buM>RWm6Ŗ6ᢐFX 5x{v*j;zv<_~AVUJϐ^IjQxシuQo=lK_ՑEkZ\4sqU7vOa J?Q)4C^\k[{3y~M|J'g4Ay,$0( jHl:Q"V҉1X&e s)MZ(W |Ϲ\88&tcpҔa͔ CC GU$^fb|8u̸&A֍9ke7;㥦koAvՏ0o5y'M3"$@Ó=ݎP1) \!B;U!)/C$N$A³ueuU},3Y'/Jc .8_[ON-<"NawGm_+yj~P]ſ^\y X,r-|㒒ܳ<L^T},^eDR,nkqց%|r,!gJx=~p{"\eeEN;Þ=${q@Q_\?/иLe>u#Ѳѱ'۶n_<q㼅Ra8pLB=(YK[l`BKB#4;c;HS^OA>Ʉx\+0lkOԼ`Fcfup.wlCnKJIi]&fXPAn1کFTKBoI!ӮZ f)~Xhy9 ݨOC5&|T2ӲnSLB5eD0:yP;(w9mΪnWhKu{`wk kH>*ڲ1 wp5Q݌$;LvvJ1f3n*Tg@oO#9|}?V0M5.ۀz{" NK?C_$ P&B̆e>(qIu`|ob|_0l2WꂝsCܴLTIa?f(/+PIwB WhgšH EiŮ(G6 "  "(H2̙dfr $xZEP>ţCEF:< \{ % rH6N$(߫Nᷘ_%1]2:$o-8ȥ I-qt;'kTjJW^}kfQUr\ulNkHn᫂H*Wd6M2 *{`V%VRoJJ`+"yO|s86Vy8 :+;9ɨ=.qqѝ=ɥ^ӏwldG;fH^2`zBȳ ŞO*{M2MoR0i:T~%$9ED~cj<}${.-+P]c=Vzpwz\S;!?C:GFIױqYŞ ݇>;]mS)yrEz_n˕aI"l|sGvmߵ_7e]֭>ГU)i:D΂G}V W5*{f? ($p\)9D$ZYr|(4D܁OHʳ ;ܫv۱jxLr_r ;Wi nV|Rudܦ;@YNl-QnJȲc/14C:'K&̕BOJ{ߴzfsW|F-q2 ?}Y[pXdY<\v+M{ir8~LJޯ vlL: ?@o[g`}>?UrǛI2Lk.}GpI8QRV%܂L0/PUE ?ɹTcۼfHs^QMC!)$ ; ej uIy W6#LMi9ĦͱP*HʘFg]mߝn+|X$Z6K'OQJq m(B~ljSuZ ťbhWP"z@UVJ΂\,<\HA 5Oaf΍C75O Uݮx7F>QL~:ʥ#][eTS2%c Æ~EWg9i%3W4ފ:}޼0_X|-ƣµVu8H{YF"qĔ-F95E!L/3zLw@"FRmOQ&[#ZO/xˤr~9T00bܬ 4Pߋb>Բѹ%MOaN$ʡ˖~ &($~>tBM%^i3ϐEf8UB '`-icIaͨ+ دR=ZȾŁ=5U#5HR>njky/s6H؃E oLyCG/?QE%FvMMz)=ZB.ϡƋ/•3O85&YKլ(ST eҝZVx'xaV4Ë*H]z~h~ i0d,K8CZy{jCF')b|xNJ>V{0#E1狛*R"37B⓴ξ(3<ݥ%-tɫBetƓpx HuRuɵ)H?mf@Iz͂qrgM_D|Ce ӯ_wCՄYK/Ԩ 佨/Y0y̸7.]*ѳa !d[m9#{-;W[ U$mb?ci3ؘsq6ĂT t֠} dlv{Fyt/ټt̰KQ8 N"4ʻc'׸Ns6I ][#?wsb,4U_ f)Eď* uä6Go76ɵ{'CGa+RUA=@5_rgs1OUG*ʚO&Q͡4%nlc=%Z vY Zeਝ4? eC` _wvĦ10KB/*Brv4όwM 0r `$CܝGa6;g-N_&ɰ.` `0M/s\PMf`p3 $A7 i c(y jӍ 5!UiMSD-rBFL&^:OF-T4w T3c q]2Rd/3U\;?Up=@b TYRJ3O)*+sWu.[L6ǼA. 귒hoN_=C|HW Gz}w\2h{?Ur_ס,[<4DmD〷C/Fl Mr_򑹾g"P\TMIiDw$=` IӐ }6.jYx^h}]"]l 8"ӽ΃ǐL"Hڝk:^֖Tm.^@1~qxTlU#U75:LE|4&W25exz*̖̆;M0do^lpmaIS7kD#'͊$"lL?bADINmEh 8Ԍ*"vұE݌5Z5 `z~x[MN&a|b(ǁ$ch |cq)M_Ɔw>bSО$  Dpz!G@o3a]PnN2);K4 U"p+q 7bLay$04iCc9(6>E3a{ R䏡0`?s07y9'`Lq`ScLr&MP.ڽ,_ru/F=܏=1ltŜ 9>1lם KX_t+ =#ثL uuWK̹ u)F@jR_$YuBśGbQl+$,o8qlg!) n2QήU>Ytw(^'Y! %GU9, &>YcwU Mj"Zo6VWF9=al mynqA/2AI̐i qAN?!9NxlbO{eiYQ̶>SZ .&sbj?1_ǡPkٟx`дY!n6fVJ?ffon06l)7BuyMAѢ&m>>Nj#4J%&|E]ۊ:i2g0io*6zXh +҂3;1"2ҍ+O?KjaY|nMHpA/LsI5cu*ΐDx!W {|mpq%qehrYbBt M7uA- w%5,x+ z!Ί}|%wpȩxeXx|Yy$M}yAz5{+=}5"6~{άq~p^Q~Md~*XŸ~,LU~S@~5 ~+f2T"P{pUIpf P[AE;Z1ٓ0U)Fj"0΂op~7f ![BPY_EE;T\1撠C)k"djpmfr=[M,1P\ǑES;`Ћ1')}"Ρmfni=pkqr^mtolVurX wtDyw'0|Yz>̾jqźjlr`ntpu0rnvgkbtgwWIv~yCtxz0b{x|bh|~j|l|^n|~pp|j\s}AVtu[}Bw}0z~l;fׇ i 9kDmh5})oviNqꂿUtXBEv=/yVǧeP{qgi卞|l{nohLp(TsuSAv@Z/ryX_dִ2f}}hƖMk/zmtLgdojT3rxAKuI/8xσ[c&5e[}gܞrQj.xylfoDSr d@u/x\ębp vdܫg%iwy3kyenbSq@to.wUad`RfWh-xkkemn)Rq\@?t@.wZtf4uhvjxxm0xyosekz.qR|{itP?|w-~zK'rp{sqԜu#svFtgwwtudxw*Qz%x?E{zb-}|Xpzr'zssj{@(t{vxv|cwy|Qy }>z}-R|~H(oYpq݃^s=uPt;bvSPPx <>Ay-|0m{opzrt?s^auQOw+T=y>,{¹luSmoou{psGrlatqOvk?=txj,{ @k mܖnlprxqؔM`WsNuȌ=&x,zj׫4lgmomqq0_s*9N uI_|2so|u]}@vLO}xT;"~z-*|Ly(x*yyr z$y gWTaˢĮkTd@D\dPPp-HG&]30;sCg( 1DE*n6ܵaz*&>P3ĸg| ,X񦁓`S$>BG DǕu#i#܌-`xJ!wم:(`[HWeQ2UFD`|:Cd2~TvkdEeUb2̽p ʠ~[@QdF!7H$ #dLt!BOK*G-iCrB.UlmO> ,B2W<+367ߛ@ )۠&KO 0ޏO igm82=D 4FB[!AIb4~Z *fz\OtF&ӝN&3xF[Hjz&3n14bM zB! |+ /hw{V\lsTjg?қ۟u 깮D}û.5ʺ(wM ұ=Ljeo(u\ yPXƢ8p2232"uh0 ;(3-ybݷ3WdsF@w ,8#!H*9)iF^ P7Dg3I33D_)JQNdOm2ta':=J.۱ s`d+uu- ǵiȵ\L kw/i&G1|91:H^gW@-Eif?QF?/KvřMkz݈uN0:ӎ3BJ]PU@׊VVzDPC9>RTl{=EY^ScyjN96b~mwj[ Zl'd}[YގM:tU9WI-#d=sѣS IKuƷ6i/JO{s{c@6oPU,'9cV~M6IQ1WwoT+mlF0\Od?oi4M4MC%HfM[r0p[p|R’/Ld/_c8]׍ YpFKM(Ewo@jjI0/kad[H>|/ѓL |00SVRׂV2Cæav4x,'L82'7&n&CĿf]9-f]i{Ta4EeNٟή"V_ǔ3tf65ҷ, jP6Ex)ͻUSu@6M6dFVSˬGŦwƠuy@>.TȆVO?#驺⳦A),<ـB*7ij,\P#;}}~r4fxO"ZhNMBe@(78,iA#FaN}qǖ*lf Zۋ M2HB-7߅,yY#p9|qeےNYƐ*M}"A튘6؈U,ۅ#||(qW,esY!MANJje6Ç,}#5tPcjOf=_`rhTkHm=op2s(Hv "zbtu5k#jl_-$nnSjpDHrB=tytn2ݑOv)yL |triIs ^ٟtSuSHt#v=_.x02y)B{! }~st(o.w]^`cCcHlVf+;t)i0aldOȯ>tsw[-wnw\-_AMb0ke#SsShA!a7kO|o>#r -v0[Dn^aaShdL%rg{`j哟On-=rfv-vm3Zp]­ `܄cr f؝C` jRNnb=q-vBw~o`^q&ccrfBti quk_wInN1yq<{u8,-}pymjynlpptnRrp/qsr_;utMwv2>@?nC)HKс#Eu$%`^>[ (?`~^x0_+OËv&"YD>s5x']~-if~>NF" P^OG# ǖ0<7ӆ7 :sXL!kݱrx{6Rt"+@q*7k1U誘Y}(~\H`J䞂\ 52[{F;Onݦ *C{2Hpuw0D(MHOB$vKѻX{'V' 5c sh]T4I DGãTD(2BNlz9eB_ ݫ.#JUbGɰ Pc36߅!3?o/˼ 4Ta1l-vKWZApɾ<>\Щހka8Z5$GdW#{{ߢ! e8l&Vlu4ʚ@ԸQWJ"쎛)9(6gf y'1?JL)b쭢l]4LkۘPpuﲹ)nCA Ŷ+2dEH'Hm&Y3uѷkѽӭ1n]_Z<ڮRvӛpjm9G݂#j}dA-uڠ 0\C"dhK>مٸ:IFq\BVhF'$[I&3BtK\ D'`;I ["%#N\I |?a8+ş3"-Aש_ZZKO%u6`X{cͯw1 $+OM{'E],jz6+~ Qk a=_/E qbVk&S7fg\"&]KOÑ: %ijeB>%j:l=T1e~/ߪg I0^YV)<^ϑ% զՏQS-WGpaθD8ߠ9D֑ՃXM' UJ]I"mteuuE)-3`Ҍ SoO6Ju@$ZZǚ;oam>݄92)@m{>-V|WU>r$Ӳ]qّ¸zEYuɔ>GT@蚩\'}њG9mp.d.@L4c&,r;b ӂdlt3ݦ]Q<b-w Nk k bK%H@ j"W4sf|Aa{8c%J@bW\E':Ehsř=}9fǹTW !3ߔ% פԘ]YzĀ&XIkWdPيb]9gbIi $ O1wu_)xS$P)m/UI .mpsf5Uwl}oyh 4;=DUIKSDSjj:?2*w0P4o+G4O6jeu HW)ϛ=ݮȆs51 okaIӽ֒Wo0%>#}?V5N_r}%7 Լ{!`D}K_4 !Q\HҽzȔHN>uA-^Ჰbg%+k58W #wi+q0khcuTT[`5Z[`J &-v**cs0:-7o3G(Z!d  z Q}vx'E}aQ#*'viƷ|'in˵Y;eR{E1vikYT24o/;K |O c Rr_T'UtKyγzaL= zs#k)|OĀ܇:axim&&^cŽoIѓ` W82K/ױϬ˽^ipuO:JD:WtG<8YJ] ՄyiZP-|xm4rQe`dZH ;4SX1̚`wpu>7 H2%Cd>zES?+&e{\Q>+) ^T9ZPFV+@l@ A B r3L2$$x *,^-ڷ[]<**RInpdk ŻΫ :C>ݾ<_TTՖqcs.JmZEŒ:^΄hsVIbm8tSX&^ a*Ɋn^m=A2s^mICca|k`K{"Y١:nf,ڱW x_n~ !f睥# Aɧo(u gįVg攷E)?n/ؠbdSu3QQIB`\C!d P,2QC[Pһn`RXYU^',|Y5G4-},V{:T5zGFdx|4Zٲ u'ʦ"Ww[f^'0Xcx2rKJJDJmB|CÁ=55oc/hNL9'0jI. =$!_3s^>pX0]ScԹ`gi9Q?+,O|ekkC)6bf!),MjQZF_Y[-ۈfiv&mH!`5oIxudP#F P&h_2nnmMsC?wOt[Pk+jnA ǐHځY*zל`L﵋TL01|w:44o(%j̨5YJ_|fyl00DO+/.5T"$8[g)T`MH?Ɠ\fިÕyL/\Zj@Ν(Wڢud>P"Yd'$$ʗVJ+W>pG[^Gڻ2|M 5kci{ZJbILFʭ7<]'wKÍQXb* $f»~ ^̈́:)]}pA(+RXzE;b1t!9ݠBj` d> !L7gh%7nׅ _Qg1R2Ǽĸ:@n\KX)'WIC0hݤ!XL}4l5 Vh2,?bLb#(sÀytk]:ibP_"2S&F ߆*:/~5l6fݻ Ӡv(1u;8qi7L@Wg Y<#nMDyYZOEX;/C<_IfGuROM++c7S 4ƊaZԃu Mߊ]>]o/m^&=Nh̕.g*>d_$ ]koj-]wz`g`@XRSZ^6uV^og~XQ 濮a%{s Tp4{HLydW)YU&R?FD/'gH7yOG S0᪄g :po)-.XF:e*diG{.㯙nwn.tY<"`7dsSC!x$g:SX9Y%r_']4K . q cYv.㏢Mrm*ADbW냊M1Dqby9mT'buq7Or }yXK8`微.;~1K}wҭrB;ҏޒ &6 Rr*?j䆑lugICkM|vhZYHn8VzQ3N??֫zGP5|No(RGJ[5&Hs)qq}^&2n:zǰkFmP03;7Nsi+ZiӍ ^zs7Tm , zb@p22{96ʄ/= 4)c x t&83B-(;^SedSy7yG^H@Es7<AQ|h[\jeZҎy1|i-M']|k!3h{&m5&[KiK%}UEk̀u hT[*FkkOZ e ev]G ؼ;GLW[d;oo3xY{OEk[@|l2섐^򒼗F6a 9uUQ[Em'*uWAw:^WfAw:Rc$DZ9-N7~c ?;A34VfO 5*DvUe_Rqr_pMv]{қ[;f4( c5ڑGdxEjO-n | g8 KٶŲ]{r3J(?ұqlu;S7qWA}ǰ=o nxg|GCTpTaH͗O0U`llڤClt0jh~pڱY_,x',IUjn\[M zDBb<Ô]T7S0Co}2%sF͘MQ ś!7fSѕ&.!mFk(+O Oȏ@ W1fG 0JZ-#=qb>@@gIxFz|޴\E=Yg6atҺ*SY5T9vh  %2{}n}I90v zRf8kOʼjVo:*xH3_ 6WWx4\;5juK::i7rʶYAd~X:J1<;e (;MsrlڪU[y5vw(k -OlHWeG㐣݆L9sŠFp6i&xИp0C2}TxmCH#ѽZyڇm{+EAaWdVSy%ې8bש"SLL14$Bs&Bj&d@Y?O+82}-D^ݒD(PR{Ѭ.s!$4Pڣo\i(#u"D8 :]C>6ڒ׶*m@1GQm lìOrusg# tk-ۤ^G) yۂ2b+PgDWB;T+4Qv{9輵;!f6~/ė|@r~EM$,<`2+oMҿ$ȵk뤆)<$\nnu|LX+z-]:r"Xꗺ.KW;–YFC :Aǔ+IU u+U>.+͋;SN@] LUXKx6 ͑8=*U4^qݗۥ>S韒+Ż eLsf v?m!'粈Yv0zْ2GwT1e{BHM, &fr(y)% P Ehl% $EVDĶt o \~6-s//E 2<뤪t :mbpVn(Q7:ziZNl*3miИ` snX U\Пbi0^Kc=!!{pwpyKH&Ș/UDg#M@1&yf_sIrŔ\ Bc7HexXltbu!hI &) ֩ršbps;Cu GFq~~c6RbO'l"<͖z [T0}5y V|EWrф\2aAA0 /ɷW&aA AK]מ q\kPU"Jѻ?W{j#'rG^$U)~VHDTup7eÊ⚊R"I^w0^+mOXiMi-T5ȝ'N]~{e r5Ճ-wA-VYF~UgBOJt8y0.{KO(vlJ uS0փyk^?6Wc+ Cl]Eko%ݼ脦g}h0[ڡ㈳ٳۃ,U̴X?4:<X s%هU)<@ZQ/[6 . 0A=fxIҗQl3\PBoJ]Դ\>[3?,ЛMOyIOi> '|2kxo6oy*Zo9XYifNP?1k𾠣 *_BupֲB[ 4Xφ}P73d"dٮ&<ăT>x4Y"GXF%Ngt2S 8.hpq܏#~2HleҢ(j =~n$ Y9PKC‰/q䢘&lrS1|8+ۺp5q Z(QӸAX!\$$$CsrL2$L%,*OQuOłBuUX뵊]xV~n,[|nC -bY@X?(e92"կ)fm6@>_|Xȼ L N+VJ2v&ǂga:y*=>C,꽅zqwΣaVbP$Ԇ3H* |tc^7CvfCUʆN\A X)MȊQrK{Fۏe"j%hCi24.$ҲɹDӮ?2]HMtaPZ+C9J*_r%QNH4r{W) |em}^e ٻ .v_.e'T)V4(FoUgzf0=rƣ[(hGjKҢy}%]ʟ%(y쭬0L1sR1w^NJO7 نyoxõO`i0)¿6T@JJL#״C[!)9!w+@,&TQ0GU5a 5\1(-9]s41y3yʍ/ G䇫~IĴ41_35g%@.1N§ N̡Pi'74@rz8Z? i;f cENOri@Du{A6.ѱ>1_:, Jf?/LCNN*E]٭!mq=p)ݍ cFMH?b;t% 7r~L&3>ﰞ~6slD'9?6T­ϙ^ 5; k[}gX0^hq$WKJm3qV/f̔&|}31sO[9"6ε6 9K+|dj8a&kɐ=9wUͩ?|0,lugzeU,}* e-^uGSoy77bC#Qşn[,( l^ 6!ʌ>":jbiq2$V1\$ǕwkGԣQ%[`ѐJ Ή `]+Y)u!*5(HIdaoElw17hYxЈrMyA39ScLYgBل*dlQ P/Džml)IR`i?ĞAY訌:et/ ysn琸M>dSG&HPe*p:vFӫ}9|%*CdڌTm ؍θSVkq~VQ< f CB'LH? 6ǍZWzjxA|+cshi#a43 KZr?'H:m2AĽ eЭdcM^k^Cj#,@DL2I~tHGǫJ̀e W`_qZb "pp߄CH I&d2L)xʪ*jXEtJJ]EZ_=@XY#>(UT#tgE UO4E]cDix`Ffw0b(U Y]sAvjfhw@A,bx#iu+E_Xx˼U-EW'_@ce2b1( h^EN `V[@-kbn_Pe:60lu-'\j|Dme;tHGD˪&աD!ߪ@M?B=rΕtSwo2Y!;DLž]򮆁˶Rf;˷-r0ۏ첸R}"?5#mk+3((.RxP{K$ ~?uX m(U$C[KIl9vL"F]C2q.OI61Qx 1iQZxle_)O&uZCj7$6} A~8zXmb|n^i>]fQBchJDj^ k]rou#Ih 8ЂTc1)üW+-*kxueI~PE:LR] &t-¬^*$M4-bB c鎳A9ZuKDۄT}pp;dzx0w 7 ? rlJU/3BK3hf@jm1RזD*p֓2O(Vv ndmMAO;1S`M-a6)N˛,_ l[c.Hі%Ŗش+#]lcٶ$ s~&b~In^Y6-쪸ʟ/FRa` Ei|o$Գh:)=kZv6g|V'E;R^t\"ZW YnN'⢒LiK[!6bjnf$=+ *.ӃKvIchP*%zډ,1-pGsD8DC7x&X8e!j5kL4Y &XqYLA)$]s_g^.[fx́{sHq  o݌ KFaa)1$PoגיDO̐Ńwq?0$װޮxYZN8$8 _ُ$`lcZ6ݐ?ȇY+0H5zቔkQ}Ö!~QQ2&P{BcH|7gz9^sylu^A ;RckU>)vQ 8:oVcsK68#7>Ա_<w*>mڹ3"ΨŢl` D#ޣ7W-#hD:G"DxA4 >X( 6b-X>*'qkxOOX+{5| fP|~NEzEy?|S-2<3}=`[~#ltGPj_ _߷,cn$kaM=UlMQ"gɆ 5iЉ5M%7R%qvLSG[]]M vKsw>q| 7pL=#.[CjϨ^wUOlTvCe]j20uuFfձʪ:AƆ"E*S'_ !Z:Qpt47rv윽Ys9{<Fr׃d+G1 F~ /bm1&&x, ^ LtZnDz4g?x7o߽06m3fB|=ksΛ 4|K5~Xp%&(*,.0<664^?|X@`PsB#b$ PX<1A͹O3l.O IrOS#?UBP' BPT;} *~>22 EOL_~[ g ,v,cy]zFl(}FVύPq㫪J6A$*H$Ρ`v0;f×9zL2ٞQC|QM5xzAR+Ԕ k*xGjsH%Ť^Vaݼr~Lȡ3h5$؋#2'$ ,FP].V!foDc&2`* _'ǹ{# ݰw%{2>aQ*X SV*5r1V/\2dL9x~dE ]0 ^z[AKmILŤSK``;m\ojc{.]w{]}A][UT5䄚T9"#֑$-QJ֙ (R;7n^윆a:VVTST@e& PkLlvw6ԷU8{`>5#8-Eʦhc5Ij ɱUx(EUu=XU=ux}{tjG 4a(=Gr(nËqZTivU肝 F7 :&|ؾĮȬ8CLNlG\nt{Bvx~T2?]ъ?:B': nAS+w."nG%PBRBz^MLpz&*T@ mHh؇Dc΢&ZT_Wj 5yI5LOї5m һE/`v0;fˡp;ϙ־A}UlK8SQC#kדtYFUVErAF̾!b7E|{e wY쓌E8T@V4U4<7IIiA(R@: j:8vug*tE@EQ*r 럄B; !rIC@V@]_ӇQ5UW/)aY/-Ry%F2"  InK/i"tY{p8d|Q\Đxi'6ĩ/UUi5gԧyebLY(ke&\1q(h-Ev;wΛ6 !5kC(xH@m՝N&וy UFeaf5n\+#$,۾.wAڐ&T%_}ؗY6"s 9G&j ơR9aWLt~-m ANv$&! 2p0t{z$?5Z uTj]Ġ`9t& f,h؈!%gS$&T<6ncK /'z&bp`F*8b(@H3x!}': yo8IP&\P{C@Rt(ɓʌ*rH1𵐗&dx'McČ`$f>m|S~䃱ؕ$x0mq]Pe& i#eF6AWB~8QChiTɞ <|]z[u*nz!bg9Ԓr3lq Xr3" >4SPh=m@A8 {Ͼ+\Ǖ--F3a@4M6;ҩ'Z8JԐpjj6 DzQ0'չ=;Qv(X N#0-z#}2Ң>ƾ#Ahw8Vw5C/[r:mU5fYH7H)N6S PX'>}<5ӽe~y'NNdtOݗdjM Z̓x3YAdECM&-ڀjG ož>ْm\-u ZTS#%xG;Ѣ8]0^`#Hƺb~ںnA-9*ViTR8 `'yM>aATm#GђZVZ˪ݐETD_l }mϒdo8zPc)VdjGT *:YϪ z*MSqKP}W7K۫Ov*om;Czzqt}JeVl|eryItV2j)kb腳h ?|lIlN^mzQr}\E+ݫl([Xp1ٔZ[m@_Xi䮠pvfy?q)?GZ3=@W =T2lvsdrڰP챢ށzE     q5YTp yOCŻReb &l[Ghmb9M%>]8!p~{gkl’B42?ȩVnI6 e%2G-8o QP6ncN/J/FQ&= }-9>#, +>nƙ,Π z,>3'ЏԍI6Mo$GWdosfܐT:jGyhKڻ)k[Leٓ#ceA>Vl oiEǪ2p˪lMe.{J~IT"Cvnc53}-"ÐhI'ِ,kHM"D[YjsUZCM:fD˂+)U Naa␽Zfk@ 0,"IBLtrAlĐ  N9Vr:#Q1ha x!coDjԀE_dLqi&]8NLSNIS/)WKlƜ5==\[jTv]٨@(WKsm!fwO)iiLڤ?鑓#tɕOL=?ٯ9,o9̳t2UAP@C6-!d!@ BB6BĂQDkop94Mre9*ӍRMd0W:rB5*G1GRBd; ib"P'dh8^`B5yϕJ\ L΄*nW2b߭L)3t*E&' sdr* i@s?/=:Vh,~ߗ;{u15k}6EnA;xobhS$u,N%ɕ8j 'q/qO=`S)г ,Tרs=@o5-z$^˚Fk3(lUA?5(!4v(_uw1ff:w-}hXKvzqAOQ NϜ@:&z$B/ $Gc*8?z0;ߗ]/ZZV#sY]X&qzlKNCd P¶GFޜ=;èj!,z5ϥ+D`C^n"NJf90 2?}ɉ=yΝi*mJnL6M$_e A ($eEU Ȁӏ^9,>IoGs}YEHBWh֯յYTwL3rS1MOeS-)*d`[hh%؝jӣ͓\$|[XRK@-_JoЌ+כŋ8V"]?/&{d_$]B?,kʯ2xF5xun#s [oyDs?{how1,8 fL?CVAyE% K.?)-amU [5[ڜȺMtM0o?s}*Ϝ|-.̩ {JZVu (lIneC6%FQnj̍;\M{w 564q@p${{bKXQVx &\^fA{O򒻭m.B0b @ħ/d?4m/o y0wA6kloz=vVtbd.RC{,DŽ4]@Г zӁ4#L#y,xK|}]XÿC>A𵲇i6pD1|܎,HψP(@c ii@Rq2[eaU^FR6Jz!` {v' fQm)0}^(6Rc$5 (r~P,y9wM:(^։gDHDϡyl"0A4t!5F5bl ”#@ )ۚ+Ou`;\ mqׂZ4++'8bqu2ǬN Gt$ F7 G,)O '6bgSo/+WuQ.mlc`rj($oQM 0rIF?i#@I_S>8Z7gW-[ܫ J?&[1Ck\B"mф;[ 7qD $fØt;Sj͖%qzfg,;-^Q`-}"ҘGHv- 35Sl.J7oÉ@ 5pNgmwٱٙmu*ꊸ/#7H NH  @HB\$77!PxE.ov[O8bD>Π)6Y-aWjLұ-Ǹ71@3ư=ۉ <'#Gޙ?uߎo qxeP IÉh1nzY=Wu Mզgԥ'(e]-gCGi.];^ɹ>~o[?) oOP^M!=aǠtRl69m^rU4\ O%%-,O]TB*s;?Mw+Pmv{ւC)#HܥO)ih\LC.!K'b1 HQs.w{ϟ/2Tp c6#s6"bI)i+˰exVz:;9 sYAnSKG?vOW{$a R*ը1o7l ˯WC^kh+qf7 :B|J+*u}B2#PCѦˋS%e*:g cCh܁li) `Fm5{kï 5!>s^sUXt9UJ厓7YΆ-P7 $*gz0W]yl`\:XA>IJ97<5'&cE=ffӕDdyix M8ZH6."4Fm Iz9)d1 ź F+)mju@a7gDfFiUcԝRڊXxi>6|XG/@@+$kaQbќ0/nMҋ]%:c!רZTxY jq4Fּ]Xyw?=5a'v:u]㌵u=,"@n9 $$!+E@AHGBBpEA."(hA P뷙ӗ}Їw oPEiԑ9qͩ[ q)Q<\Uh.gY}WS(35QEJYj)zS h/Pk<^~'?aS| A :8}F/R+|cha 4Y^HjZU7 [C1 ?w<}Aw{_Kyē]Pmp\+ؐ- TźˠRVYĐ[tX;-i(i7[9GPq4zg6@0=4kֈ\c-MANTij *A+7V |ZQ4fmld/ 5@ ݽ#]w̋Usri07mN wˌ|!WQRQIc fWlerU:Gg&{ q? n. |f0rg$u͚B869A$Vˊ:bVoi L,EUJ@!Og)Л@v4>4=A[+g $fy4"nv,9r1gJc:5J-AYL :J匞Y*ϗȭy5Zg!W6@@6,GDOMBӆF`+٘^-+*uj/iuUcnC9K)7hsz 5]Nٰ;Td~>TJ4& *ow} u?zXcΑggS+~P2u.3MV&*1Z,_e%I#\iPpYRg/PphmsY}~'kGs4Tj`ޅX~>3en؈24"y 'ʸq~tZh/5kofصOa8s߸F_$@3q˰>'n9;7^^^=1.5?jD'_X,D,Qn?t/J\p &w!ב0؋gTStZ*j| D„=bCB3WYx{ot}5[,w$ 4LBA#oaQQ\xąʈ}IHNK ȇߠ Ke's}*_};v$p;$p\,1~ ?$  ! 9~|?}SRwp^@YH{VDrqQ"Ş'VpoTU$VdDױJtzt *BM"{i1a=~oضR[ Q!q/eUV.yVH[(`IʪYL 1KWiE2c9rg0]DgQ])ܚd]ѯWiMU}:o@:vN?ćѱ@Fq?.[cT(y1oM70œh~8Jh.#lQDҭWF[3j;E#@O<~.;YKhk&qtd=rT}J+zPUX}Ψ9gTz<#8:<1)y/%O$yevUm:>Cn^!R$,@P18Qr .eFҺs&o|<#AD1@q47剜_NJ5yvAT8a@Â*2 hc^3~13JEi颸r!:Aj$U^NMrs!&xt~8ۀ>4@sWѴm)9PV-kQŸiP8SYFR4c4Kl] IC4<Q zás!{2 ЅfNxfKH~JμΟuF^4܊prfJ@г:6BRBd Am-[[ꍏm@Ch[kd+>~r`vS!CkBD+Y]d=a&JD;Dlw؛7c_so` y툈z6tk4 6֗7Z *-Kآ&%ת#qfB׆cʡ2 GMTC?.X [ZH5:Wt6譥dUEFIҬŋ(ZǗkxZ,z0= >=?ۘ9=14t$aiݳ%!LL巡Զró!ٴܲ<s`i ,{߸?xQ#/Ne`%zyx+UnGz)xVY'iNCV`k"|FyT&`y'_z>#n/F\Lz2Cs/)Tb%Ӌ\8yU B+|Ȫ/: {7Ӟ޸ho;A[,8N(V'O7* xUzjޝ;Wd(aCV%l`PPyp<}捑^gՕBkQG5wa…g7pkŭYlhd˿L^b/IİK(9w} ۿy7S[Zh=(L0~l.}-ZYn@."@P gSDFd{W5d˸:n8 \o3K>^=ݻ_%%4$&8 j%| A oմĶ^Ƿî:fԌ& 6-LzH| b?ӑu[}U ^^_b6QYU82Tݘi-434o'iͩZRn ZoH͟sӹ?}W>ߪm7 b#1en ?#s"*aQ{u5k ixtJK} LjH 0}0:[gAM vtv3tљvZuծ]uC;rCDD @ !`BBHHBr;\BZPXnŋu ؇}f~/76ذQ @Bbh\Yuun^R! lQwLs6H-M{#RpRʒKʓ7k׌MrM'?gİkS!" q8@& xw3KsޖG!禼:􊑟 %X~H<齾vmWkaİu~AD (Dh>F,AC~I)o|J"&xŭԤǮ03bgF}PM}3-z[6|ǓoK@C' 룐A PtD`#c{xʢHjl80bÀ!s'<jc/q/Ӄ@ | 8- QMxFeU>𾱏H|/1{.K<['-<+AIgPW7 K g N H]iD/X"IYEMo( g]Ytd_6]8|pR~ =)L}Uz{@ yf4HsRA:VPRX[CYqDu*ܹr. Y%3XlsZ~=*UN^i\U^,t{gP5y - AEr(ӣAeQq>۸<<)`?5Y^2]b+0gnϪn]T_\Vc/=˚%>x[@A#I=,-B- g Vm<Ǿ_%߭PfZewJ-۸?{5# %SryUC ݠ>Ф'ʂ鳹Crs0%ŭҐǞ݌!Wi KFMvWZfC?]>jqF-VTyl?d^6b#Sl0bYKO̹4KftDuE5spx!DGSvWLv|j'mmcUZգ_E&Ѕmc~0 ֑ܙyWk:nv}þv sv$4y4A֏K磻2nuJUaDG222qwQ؃RpaWPgM/ uLnmXivu:3_0%yN䍡I/ɴQ:8nj %bP,|Tv@^@q;$8ΐBOGhOtP___r:!͆i`=li_(x1ra q#Ь$ $v@mdx8$ F{8 ;("a)^STS 7 Ә>ɟAdL bc!3쨠bUom`kRS2i@1ȏlr>>^@=͚#K+ڴW+lc4`}_81CQ~u6hxF 0l? y;H !?)|$Y"3?iV徊H!fLSI̝Itx#{vMH!!M@0cr?H+e.%fNMcH͐/dLk V-I9wȫ_G 7^P6P%Ȩea-\`XL)jYFX| ך3"紒jro/&ꀣmjv;!NzA1 1+d)VasYV.o*X0N?'Tg<'TZs{ZI=yw)=?S4О\ p|*N{?(ы Q#eMeXqiJѳRSFz9XFRwOMnUzwOqKqOVgKx}E5qcu(:ʢ2 R^P)R @JHC"BE0 A\ gnև}99? ^!HyYz@-F*#1KcH9}b_Rh2/s/gf 97y7 HPa 0WRX3aA *v=A)%(j*5ybf?7 +@\MH@2 P7]APeB<*#q r|h%x\N/bz|VViè- 5(n@ ^$k $ub wkd߁zf0]1>F)\d7KheRUr:[Dx%2Q5I%euaYI+tJ^%(G-il \~NSyU0.FyaM𔋵dCPq d&؜L,QdJ)BJ)dB֋$SC wNyߧ6Ʈ6/> qJhMIlm"Y+q &WQ%+ŕm Tbs@@ӞEoܭ-~b0䤶2'rą >UepKyBBc^3XVVIqUz1 >7O;AtzB;~ICțF-LZ,8GK(^4#J]cz9@YA}O_\;nzGPLh%%lƲ.I*\Y(ؼX%mK$ik ^-!Bs@i ?lu?ov9цwD%HS2{31| n)c!5*!/Q)Hj&I A |sPsp3F>M/Gl|tĺκ>mw3ȭUNӑ98żbt,Bw2IjVs:L&9Z&9&^ MaݕɤvOeq'Ey+_hbh'GDzCȺB(kAzE*f5Ό0"4ӌ)ftPnjXo]+o?سB쨅手e36M$Po(u v02`Ry=0^G/z*TN k㷩a#3 sr%ۿ Ve ˴?si1ߓAԇaqIw3SY*v5(Y51讆to40xQ9rl|Wӆus^Y~mKw|NQ^#Bqsғi1s̈9Zn0/GϷ`{|{cn[:6-2vk-oVZm-FC q4Fcqƴ(c j&Rߕ}L{#}9,Wϼ3 , S!VCfi}ؼþMGNK?z8O.{—`bc?[BD/b>绱Ȩo93){<#}Yw:W@F4 WAZY۾[hΪ8,v ]#xA7̀}@a zZ`C? O-"ܖ#>65ڷ;2"{+vM%\ -ypI^vq2_gQMg9=ǥ=Gg>(*(Ȏ;Hd%| ,심@EERVOU0l*wo{_;Ci zCg н|_H)Om;ݠ0ʃ]ʬ_Y4("65p`63q' ܭc~3!>G P~؎wr+ ..:rN@uᎅEc *lظ zHMQ xzAԾDkW pN8t8@`s$@fka;PYln "b HQƺoc.᮳cً9 ܹ11?` v뀍5}wG!Bj/YD}鈿S +5wqY.棇xcy/q14o(v7kHx AAn8x|A e=1ı.${5pנq &+0ȋ9 55l eԄJtJ{UK?Mj>">G>s7ڙ+2k1`0)쉑KxP{ ]D#؄t J2:xՙ&V"_8Cj71RuӲ 6YPsMҹ>jY,BOz;[Rd:MRhg75V]={__Зsbc kAENBv?k|?0j78H89PE -aoPoꤜYB#k 5*a\pP&k, E|>O<3KbXC㟡m+y~oߛ`b<&Uȥ\59颦lY€VɋTg*uũ 6cdJ3Ft@6cv`^GKq;}^] h;c;H N]/eS  VUfRe $7eMZYWF0W-3|@oΗ l1a ؜um%]V;B=vB\pW-%\gKERSy*ʐU(E_0}&79 @͟ S߮\tncuO:>hp{+!Z#9RM2Ǫ* KH)T*mN6M2յ4\DgB9_2?B p%MumwuL@#pBA^ ST::8iQimlY"YY9}^Pd9(R6 D)LI3 %8)|'r2$E9)yW ro?(}Sӑ) ֩ COǥ]%c7M5Y,iY!iFy-_RM-ϻR?{9,Rl|RRF$5tYqE7 )ɏ<ޑ)  Y4PSF5;/xWg-^f72.ԊU!AyW2*R/}8Bfzc%9gʥAgjĥ:NwJCrgECzu6Wzsmsw~a5eJmN qȈԪkRbWH:&*_V/+w_rDgfIkU[4Pe1vGO}MO@ٛK_omϕY' YwFHNM?x=G_sb:Uݔɬyɮ|ɭRAb/+զtU|J WmR}mNW)6'|cDŽ6%ňw3\Heܩ%w_J{1 GV(d2*uTnVyxիE5.vmyN5ҏ.b< >oDrZc}[-U$rD$j {.TB2/^#.SjПS3gi{ݒ>'Oqb_B]\~gݑ&ft{w t\ ꨎltz9)z68D WoZ?u#ꇗT ,iCzҏNF<,iQL?ЛO`S,W}ueyUL+vS;3$~S' j#*eߩ]o^T,7Y+O;'=#e4@ӑ/rdbO,B&xȏYhuX#wvݗ C3깢L!L:󻺱&&%T˴<4Mt /fVwWkS%*4ҩǡ; Ra:6p`F~ 0cFnuF##G! E$Ks@9]0D Te8v,`X` N70I>~ r>ę["fȱ2E>ރwf6uw r3W)˕ 0b WS $x9[LkpXBA{c7$;C#@!MO/ X/AbAh)c52 E0"Z+l xj=ir$5w« /Urc3\嬃hD1w!av%8?)b|Jؠs~S6$ o=OQ3MAdpm:f2ɷ@Hq$KˡS YeLT~Sz7I}t _(Âh#t! NuM5exuH،x1bCp = Ȣ{v)Ki5)Zޤw=@0A}N7PF,`Ȅݾr<`&OlX+m$9CiFg#Zd= ̠W5o*oQ+~(F{.0F0Lw$sD% lggEw:v/@2ڿ.bϰ=l.R-:{RUp#V$BB Y$9Y$0Baod(PW+^!,E^y>9/yw}qzP!qO( CT=gd W o#oŸ_F M"#Q/IѯȷP(7b5. 0w~B~`9PXT?9; @X\V?, !tǻ4̡Y%ԴjH#uz:~CCoX}:No\{5MU?ͯO+r3nwfB` 9HY}LpuD(09ZMF5M.t+y&A ?,'L2򤨈2% `uM%;Ěsy~QC| %'bzjb72zjRXMI\I-)'Kb mB\@ḨOH8Ww~rCsk 3s63Q64r6[!¶K&~˙F"D]?L 49.5%Y =7pH`1],Y1W|rTMOweC/0m|L"H Qo\JhKٍU}_6HϵIӹ{n OO?|{e/ʏU{Pu''L٠KT2^fq OhgK ^\RQ?& lLjwxѬw݂{"YMв֞\;Tw}˄ nʦD֤ctB5YN7)S92 C'NEEC,PGI1YR PJ[rY¹}'}K5Uv Y/Ηg1c|I'SCR(NYd*R!Z2_ɞ*!hTAc2px3H]}=@]_Y0^}gwt# cOU EttAVJNSrY&U+UJJE1HaU@5ikwxN|ҹk5zC'KԘ<^-j3$/K5u&-Qp5 J暒Qr4rn,Am@7dK[>Tluٰ}së otxՕ`ߦ*P'B2p5 (\R' G&w5\gZ׻^<|}WwVPr9꘩{.+a%R!(Pq9g83mRa. $rt >SWV:rk>WX}rKEGK 2؀9ZG@$Ub\TDc+شB-h.YK}6(E[%XӸ$.wBly; OU+ڼGr꽳ݳҚ7y(n)(A=Ǯ52:ZVf$+̂J]#EOP)=@/q֯/qxpoӡrΟ}=K+3FNȺ :VMi ӒLC5vDS7<]~QmP.rF/Pm`C߽yݏ:6Žў%GVg  uDЏ fB)7^^Lu)6Z2>u䝆c Ъh](VED$ *d/FI  Œb#ngT-.uGܷ0n B39+r?%RC]9˻RzU.y;w;l`Wqy-g?cS_iy=*| BKZJO6>b)MSXT*4VUj^cu:ZvctWn`>ӳ~˴[9N;W/9'%j:f8#mϲLviTv:^֚ۖǔ.[Wd1uV#eߴj%?Pbv$k4mv!&2yҶ]7tG۝8 /t)]8IWN0׵^bvWrRsLyc?=*˷ /m $KQ TL eP`F80+c_ĴŦXJU$& U% J>=r25j"#C##KnD]=q=ɑgDGw>ѝW!p|!ݲ7=^Jp|Rq^>(9!Q( HaY1!;BG.;QȞX?2n )~c3:Q/H&à r"d(|!/1B?T`GMG b ֶj+}<Aw#` 'p3nI`ǃѴ(ȦG@=# :d Ry=[9}Ʀ߷ V|aStD}Hp GP''C>>ð<9S|P6%_z=P5uv1 ġP/r. ܙIH@Z^(%Q| DJ/&8X`a:$I!a xa;{K!Ȉra93aӡ@ eqqu1Syn-\Hnlf裆XT?go"aHi9C crY3aaH @FVҖECm<$ 1n&x k&i}V3 #~{Pi کaa5, >.A C+Ĺ!<20DC:oe@Xu QS|pS\(nD{;rPo,'!6@f A c8Lש( _6 hLj] 䛙āh'#NwY3a)ݑ<,a&Fc42Q)mkD,Bg_ ܒZTO.P&6+%_e- / _'E}4pR4Bo`,L\jV[x~IvX%=!+9x-7+__)[T-=YsSn\V/*G5f. 9sPl8PY^X#*EP.r`i^|onI)k-筮EҗvElSecM셦Y֓~G>A^—֯;8"߇Uɳ-5ᦲ)pڳS2$kɴ4UՇ5絷ɕٷ7ձKzܯᔦp?VM63rz\?Y Brs9z!p2;ik#|r[a[!g=,Ʈlׂw1XWef ƫVD)tL^Nn?Γ8rFJF7qxg3Pr|UO3& S5`їƽ}/0~_5t<᳷9h[C䙆xO$_TN r0󖻍g'9ߎZ-՘ѫ%59v!5@ݠĖ1گGyPdв.809< smOvcb8fZp(%-$T,,5K34HDuQP"KٗdZN<9\vupdi}{>Q `>7ZNHM$RCÆGda+2ZB'pĂp2SHr] j yhC_K^hyb5b=lО# pQ,[8XG*cE_ODNCVNš)i8GU;ۈ&_HfPHZ!I!q"EmB"~>"pg#!(Ohg3aNQ4NB8kC{-!v,t5J d @T~|p7c1?#HKAo*V"t@' @ P{}dY7` b u: Z34b(@,i!֡%`D(0~N} G69?CL  [(B[= q.Ш=4Bqq%xg`]y=;{5x5,k 2)Blp'0\Wx@c2;U ._ QM;#tp[\6scc~pG{ÜʘT e0} 5alZ(~'gYb.cny8=לOO11v {*D̿D[!އ-L쑾h hśH 1%:K谺8|H!rP6 ca=,(^%~wBx/[bE܋=!9a grܑN6C=ڵQTUnE/?%'bW/wsᓸےRȬCAIɃL;8bXɜ!|n>sZzs~Ē7 ѯ4[؝>sQSYr_?ߓߑǷKWҋayu!CNF ;ڢ0xǡؐ|Ѹ#i{KcmJqkjobMZ:Oo tgw%;y}w,p>zݭB/M6小\!8D߲^7ZՐUPq̸%5:=iszGRUgcefobEf b,g":z_Jמ 獡#NvF:unrsԱLvSQpxWZy}&6K&w*簩2yCgu9Irr{A"rYLtފ#oserɁ`{&^ɛu6LfJSdSy:qMP\Tee`KBE~Cb2isjrqؤϷ&,%!T ; (]@{:!PRB( R'DD H*" qwPagȇ99ߒs9I$(BVK S%> ~"^=7y^as`&ETSYAʨcGq'y3좂s‚nÔ/.w-XOlDde1%PD _*s:bhqИvN~Vqt`~xv>ǵ6Ç_TSq4Һ"މDnW49z)p}8EGדrlD@`VFExߡ³JdT=bH2`#7>"ak{?~л>;0y&6)!3)l09l:`9e̒ (FPyyX햅#`\/X˜pQ<cr9Ut(PZ=/2*PmC|zu;+lrJ'&I̩ZgTn$VlDt_$ X' ڤEmۓJper7ujRzdYgg穾P3Qֵ]SNA&&t.C#I.^hz-;XO#v>c>N6nkRlrk}xg.+98=7Q; pa``4ݣARP.F}CycJO$ ]ㅾjQPpav:MaC/ao,lfʹ%?wHo, ןDY\$o4(^U5"kUfJglYsVXV^ R x_md-;]:fֳ{l`^`h>jd~rgc" t^hXx@@!`CӘJ*䣃t'w9O~[=>*~fnsK;jZ|[=8t#42B/kd@su:pPQD-JSь6t7t䌞[_Ce!S "gf(`*`Tݍ=.ne4.OH"Q(D'P\ЈhCFG t}JaFK!k.:7ict5A=Ș0EƬ_lWXi?M12qJ$ވ:&$*eQyPEY+:긺 (# ~| G E 3N:8ͺ;8Oz@5!8&cǴ |5;Gk :{nq#x9g 8fӸ/<.ou[@1?s!p@3 if o^9-j y;Rf5@nrv' tR/2}e_^S\?zqfLxÞ7$>hp ANAF\2r6hjіI,[t;RZq3~.Ӿg\^3E&$ߑN_%| , @`iRkCٽV@8y5l 9H:ff (wĬMқ\?'?z u:Lw~v{ S?xJ;oe;5CB"/oSlKlYk3)Nd;9ut3{ܟ1N|ʸI/WIs >@e@>AngkJXO]%i2Bӟ֯eǤ鎣2Մ!n 1!ktkk:K7J?(}\[0G}Eb=l Ad猰!ڮ{µzn4)(6;<ⵠ*+6EI>9?nj3qf K10$H 0<_^ ꝉh4 ]\ܒ\w,_!5{omwrqqQ{/3=.iH}!徽jϾ&)id`Oˬc6'vMUE]sz=H٤[ ע/Kj{FܕXRgkܴ?ZWLdUE7pQ=’_DőEQoQ3C:~AW= 1%ޙhFIiV V\-[SOxgWVS{zTg*|$1ZpqXqU_-khbOc/scs^r⦅sx!!n꽫QZM}y6Tvnj Ҁ' ;#=T>)2U>(I*ي.Q$]qWVS4)u߀`_vP@cMjM給`:IkOk[ lZ ϗΉ#j3I%iCibVvr/]$8)NIC5Cǝ/: ;/1n&K `ŏX4jFtM@- aPBzVYaLYㅘk|kObX3ٱ~&6r6ȻOOG6ɠDW9i"ӽQEhƜ ,0b*e9,'aՖS3c3{DQ4H0)ځPqE! <Q=0i` 4LOt=.a.ʰ"aDCE4TQDU8 cPf([ .Rn(ASxX9xG r09ACڗZ1Jj ֨IGբ8hJ*\'8(>Ѱ't b`8dLT;YR6*q~uF.J=QrNި?(KGyR$%zQQţGC1 0Vg်Qf@e;b/CxbQި$D*,,  ]彂w9zЧ[0OE-z c LZ` c16\0j #ڭaMzo0|?@uDЧj*[>*/氨ʯ|ݣ|ݥY0< }c% \*fS1wM\H tdrtqƽ7jCd n]7{G}^kNtiD/5D/4Dj=|f~Rc5uԙqIDQ⊈ȾCHrsH }; #xZʴiZԱuZ>9羴Ƀ񐊵n.5YMAJ"KA 5 *#pL6#-pͶz7ӦJWn]Rc&S٥";H+,%p jHVJbe)Qa^b(,D y)|Z)qn3כ X)a zmVoRG,K)kȫvٕɎ|3LV&V%XU?@Uw(1ſ!1Ő(ZeW0Wi x6}=A{a.'M6eKȞ&!>6!$.ݙ[+tOfUUFW#ȑWy{R"wypьÝs8>Zﵡ7"fi-hgMoKKiIuHl7Iz7QCi n \+k{'B>p6?7{qevCd]@?ߓv> eЛbw8Gv廝xw{S;|)W[E?r/~V迒g9jfjk`s@=aSN3w1_3"ܑН]QM^i@AH ,!!   aȢ ѶNjkkGfܵ"hE .qj3/s{{sfW/=4rl4:&eUԉU'br(PV_}P#>NW8,9u >ܴʾԅ/a坟ÝyDUD^Rj NOD{Z\oO#"V7ЊwXN)iQOͿjr˹jʺZ\25/$7'6}&o 7}״Gm:i=ic l:;wP^Ս Ϳ㌊|QMD[}fpNۊ<zǷ1tmk|cm_blԶݜǸv ?6OvwP;;ye*pALdRԩ3vΰOJuvuO*vt/v^^ٳK޳[s.=͐^cHzak=U>GhùwK[w@9(+JcԾ"_L+)qZ;@U=h̦E;ȇ#J$ëpKi נZV7n7ˁp;8]~QBi8 c>H7'""zBJ*'T"}kC]dR!EBXd/48pܑ~p֑ ͎,xx5quoC('u"4c )d $L.9t?$\0Q ‚̷C|n Pݠ}f>g#Ѕf!8w W(|!g5q ̤+$a.9N )Br=H$$(H-@TPiwgpZwl!_t1 b v{ cbh01dU!$Ą Va8*Ĥ@= >re(>/}K _2AR]`O!tZ WR`HR~E$bP ev0CKq'@7' - r\>&@~ aأ+{X>߀8rɀ7(qVH pIj*$&9f̙!vh7z+bMDbGd*FU'9oTת+-Πӧ<S@?IH䓐0)IO0M_=_3[|5略3h5gx/4x57xk}10=c ֟.)~ HEnZ{4:ML5y$҇V'c0l{nj]^An}SwQDMЮ$M|[:A8n@,ҘHB>#/~Ē2U<}̷;u 3+ޣ&Op/Bh3Pxtp_t=ᙨ*рK_걺I& (NBQ(e(:\ Ź77ǽ#g={ U[Zm7SH!zʿE-!ƚ+ƛ9ji&"N}} {o7sY Rʳj)s\ΞMoBVkNŲZД!cR֐ȧ̻$VqSmDcYi@~<4VJ' s<0,bK%!dW"fŹbR~]ʀs> *S߱패';Q̨<Ѡs,AԽ"ijBu)ўְеXȶ[ȯ).<9q]QMi$((H*"@V,f5@ !LK@(h5x92NGǶsȇ߹~z}c)̓*u96Ϝ e^*3WuZM?YP2r}mob ZfkVPa~RM|%Qz|Ǹ$~(ŵO%n %ZnUSOPj8=G`ߡ_ҥhܟ)<fA%z)U#%ܫefeE䶉ò3. ҼMBZ P+ڰ¦9$P%+2-%&DqlZ`ߗ+ ks9l3k2"Z*?﯊"you@+a{6 }jKKKbA*huE!j iTo5&#YP>e~L`C&ZSXQr5\k޸qM>ʮSkMmeCJ)׻_V& *W"5QXN< @>o!-"3$0½5:<̶ɖøPFm[ÉZUGJ>EMʪ|oHY8T*Wy-$W6Ec-sFF*"odRJ,48X`f:` -ؼbt̡Bpק{+y~š@~,6<_ɮdUL2d tt[Z?tBɐ!䭐\oJީr1p {@0uָ]r]Ky뀨1dzX]ksTu BV&*)LU*CqP|Ce¬Aȿ!mpLp~Wy z{ô1){˻O9w&)HWԖu㕧4K3!i03"Y3JJTϑ+ r|ȭ^:OuW) {hshF}p|f+iZ@՜#H1\%wc홗.:3.f$p㦥NNzj5y˟>?}?Oq$6nfDgpG p =I=@+B;D7xxK>ؼ04+6g|`rŁfڵCk3eO=IW_zFοC#fwv~Qir os+ k cLV-&۞˲?f`;Dx; ejgA'зhv 7|fkg/] z ٿկ{x`),@ [ߙ@C 8`64f1ƳGm4c5ȵ4W+jv8N Z] _;{ z LpA8"4```"pP, RFC` l¥zb'&jA'^R 4TxPQ HG</chm6F&Vjr l&e #n#D eSNCCC@:*"=S,kP%;LQRBlt$js_%nsFΐـ޻9sG^x ճ-Tj}'润 MuyVMg/hF5DӠDdEa0$L!g*Si=j0DG3t9G.ߌzFZd-tm%mӅZ!?9rNGؠq;EQ=QGNZ (M4LfΙIJz{zX[3ح ټkqyVcW\YgCSǟ"8(s9~P~Tx>좸6xx!IM8JEo`iǒ7g`Yûl;x ʩg[at5#}!UgєPp6i 6-)>$VG7yTE_UF?UcP=LxI ds0<Z@{-ΑR.¸j8]ECF.-D ǣ_:N N&!Ƚ2~"RVws܏^ZqO%(ߓok"!dc@13E4wкXD]c[lظ ]lq|,úՙ3 \+ֹM.}7מEIRN+g^3?*I1ބS8Ä́!9&1<&_b7r2Wi1_ì͍dIUTfgT6k^QIɷ<^3{{j϶:-畅w_u+7nJG騘=C<R}ZVry^).jpdI*/Wy`vs-q-[ 5gdBV.YMY2O(g6yK.omZ>a"^.#NzK\ g8@U+beV%y:Ewn_Bu.Ϩ<PD H)#LQA,"tІFpF RD *1XQp]f%'nf=G}s=WR*x-^nAIܐ84wQSQQ;aQP_B61xCTT0^,p̕_-]Qךnܔm^`UfWH+v)OmRIޒ)ܤ޹oEDBLH$ oA26.98]pfnt.*[;hQ]&8+e6lDzBY[Q+HouSEg|2R>H{-H#BK&E20\ߖpQ )qXt)*+4W֕V"ҭ &ۖg:J $\IN^vNWFv -h[i Q^R"K0T꺭bQ#U+,-}).$)" &{d1pq5k7٨&+46r5 j:^q:(X̝),dEK9wkE5/snAph}OQQQF_,Õ2ڃJwfm4Յlț5{V5d7DbRd+>6)uSu墈&ކ.uCq~hН) Sxgz7.^܃ZZi>5Pt:2e^iRuI*Knm7rKs=M2 JnHC{p OpCpC:=zW? -4 ]@e*{磤ϖ)sg.VY97[pp֮(f):v!;ikw۪n{B.^R=lRMPzA]H-u̕IrbVύ>u4BcuGLBd.XPWvﰢqy7N}7{;s& 9:t}C@HĶQc$:2%@`u#BF6_s*ppqp5~'[-LjL.7h21=ٍ[!܍?./ߪr#icؤ#7&s,17]Կ+_6dǁ\DU#c$&3+Y+&lU}'|2爦4SJM&-m):S]{ýqwx+}P2 d.W)6ncmm,m ib191 qBG|KV@E1aɂ:3jQ!9N,vP>'Sߨ־XԤN]O}&gI}D]\wa% R)i~=>BO͂82ٙ!.g.CX~خe6JlQ*\iTS@H.!y`b FdA@A 4 aJ"cD'( (
Pϱ+߱}`:{uI ,c`#ց]{I|OdE?Xc{< 8b¯37*535.ClU4-B 8۰::paQpڱX'v1e| 2F9#a[ lA{̷Sɥ,s0\; "_ h@ |9 fрW2:pb5 a|'&Gq b{̽D|^'Fa7BMhXt'=o) <_YؗڝW(5ܞdZnQcU!-[j!.z5{%-dp_jI:Pw1 d_hwWеL*D:臕fJ>Y)hץ(Sc +e&Ir2j}S_l_W- TC|)3]':&ͺ(fðz/.XBVJ/)y+nd)˼hYh=w2٬ )vQ,yvi%)YaYYWCoadbτd`Π6AfҊ`u ؋M,hSbE nU/*H,X%%.ls>abAǐSN7=p w %!9kųx)-vbE8{`u,= *̃/ŖŔ fL7=[+"|WhW+BwK' ,:}mDss^R(shRX\)wPCTffU*'EL;mV1$bل-mWC_^!S~\[~ uI}q-v P߻`G)@N9@ΡKհSk km N3<:fjm0ormڹ55K֤Uk|YxWWENѨQ?0%ɒrڰɼ%ǘג3y)P@w_wOqץu*N:ڕyw[6~_U%1/;{xb ؅>K= c.Ul&׮VsǭX[-uMu^uY~%U4uyqx"*ʡvlC5ިxxŃJs`Vm\clTf3iwNl׶ݴMnc3w<>]لmqN `TRiyFxs.q|r۵yyo띭}w8>9԰DZʖҵ-ˤ=UΧ䋻)𸿁"<#“QZ2\b$D+ mk ݾKvxr~Kqf(/]p6Q43` (; e /r*x> ].< ^9e>gx:,fٌ M`tWDL+p`_+ǐ5|U"wxP w`EĄ+͸EQ"\!dAל8#P ܆Vk=!㼽ay4gTh֩ȑtG] ;z6& ,}sQD%IV%~pYJFii~Nu?V,'ZBsS` 9}yt{\T_b޼1zDw5Q]_Z|#x~sKn)$U9 48U*婄\C"⁒RX?"ZB =zOᨮFgyfG*˒V{3f{OBlMz 4eεFO >pZ`JUD/y:Ľr y̿_ # C{-4k-CF(^ԽfjppQ0f|7\^a3d{wUҕiM դ 0ь]}QNbWT.ŪUV^+1\"h:еg=Փp>j -b oЫ*CH׵Gh(MAcj1:QLtwxBOg tZf݈kVߙ^b]jP!SXIsGN/l7O3y|-0?a LYB6b>@p-3(.7RFvsնD7ó2?YWyĪw6vXhŽ]ٖ eɳјJgg]ȳfPQ%L^`}a`aQ PD0÷Q )Fal7Ls:q&3sޜ0e \[%%I8ù s>pٴi ]ʞQK @ ?IoUWp㠻6DC{=7ff:47BsP u~ڪ`v? lo>mnVGA '&:n1ߒBӡC U(| YO"$=3!Q2 @ׄBz=HfX0IF)_u@wPlP ( PC2hM? tB"A kSRsӚEs@a=2`8Ȩl3q}JCHb >$L$)^>8qZt^wK-uD'3Ÿ2q'vABpaRNH^ɛB~ CXHPCnnDOZu T 52^HF"$W셺=W3uЯGnj6{ΆF.f#W'~#{;֫e=֥?:CןdNvå_…VW.D.rah+i 8Jc=a} Xa2bak7lcwݿfwܳmЗ=25ۂ4'ϕ3o7>xDxG#G퍼y13K~{ԷofÆ_$TT.nTwR7\v43g7p$I42w7y Y<=Aߎ~m1[b~(h-hHh\`%li<?"ﻝAtWΰ)83Aq^aQYpZӀ4ۥWsN)LjK$4%Ygu 煵Dğ |1SPk_yd`ZT[0VFr2zeN K<׭EhJ3y5YxS}k]|tDP%VHEfuIcQؘo1}c%殺9Us0clƐfӧveٷ͙.J[}FG]z%WPt!A|BT*˗$S^X`EаtP7)r>0Oc m@o6Sm9`ߨIvV8ת\+Urg̬-l/VʣBYNxBKdń3_ ܣگ逋"`~ǸCBGGAӢñG%8XrӜ+wcNg3de7 }|aQ$G}%@~HJQbB'Ry"es8Ba+z|tٰ֠iEU9H.%:!_YW˫mks{H=%Qi/dj )Բb-in({HWFG'5ԗ25e;8a\sI}iqp)2t|b ~VA `T;!V.J亻r'?$ K߱!u="!{KsH_[p"$bP[*( b ݜB~xmuSv%2MYY^aS̃$0(8qKQ[Q&']%3ZZ:WtCY?֠ȺYwrpnvC}V}^8vw֕z&Vk}j15,(-aW¨/U V]uTz>+C4-(lA~*h7#};jdEqmim2Gi9%5\y볿_x,?:_/aa ճ`>GSʹ -]=m]]@^7^/dٿA0Xnb>/!W[cv 幷%ޮB:B:㦉fz~t.tV.=Q7![@$oGx(3͉OF"Ʋ9u5ctmim##?r>o<Y, Q}hPv ec@¤b=%F:ފ] gBgb=3) ΙmU?nqxkzq 7/ޜS'Xc@ v>ʵ sH:D&u9_[sc>oχ`|mq2oTh3q6٬܍~Ivl?ᮝn9~Wc2 Ng9ឋ@e.,x p iq6.a]xj_Ǻ%,e%V/YUKʥ#LyFr6#Y,/<爯1E#T{'trcIICm׀759`w ﮃ^ł_9}PV )x=χ_u1>FH}oM+@ lzx> չle D((`W% 1`A,H@Dņ(< C-O1D!ODQDĂg0;=;{9F 9PY0s C Yҿ#DHNb:D X ACFr<(g3J,Z=X=OZ8 `] h%+"6!j&;@:5ͣ1n@hm }k7jGK(]48Zw }0`W.e@~5Gn+jM :kRsG?:=@ON}DoG=b{}`]$7bu)bѽ5t?+f 5(F?C?b>`hUŗ`RwŮ`0o4H%$"H>)k xCxjth(m0k0QLɼLDcOWI%KrW߀|ExNyn@߅BV5ջ )ڂ,<:t6ᑬt7J+&BZ7pC]h2ehTsE9塡|(T7Tj :U3PŸ@7QMVen)wr{q]yMWՌCkp^øZsƝ{=fKm`f9/c)QDy P+Kz?'\z?#qnU듸c>;sC V}ҮBܾUXfLXD%L3lw`φ1H6G[g\qǜqy,wy"y_sW8-q;-v\#,s:Jvv:;9:wlqfLm|N:h{u A!8bnqm* [u_epKؐ**2,m7֛l1l5)0.7TJ6 W\:dk\^V2Yg`(vF#9. % }#cwJFscS[ŋ6-X f%YZ=_ڽXU9 ֥t'+mZ#PM88>(cEV~O8qT oDѺk6+Y"ʐ-ʑg{fzmS,maeye//L:}?>4sЬD}>͟Po ;`k@xry`A1Zѓ٣L2eit,ET-RBg}[~=h(1:ӑ (X2 d 3lj2|/N&I I?Wbиlqr1_5׸S3Xejf<.iSGCp" 80(ٯ[u^ȉ̘AȈҢ}QXqR9Ӥ'S E ]|j)ǻMk"-&1sT?pjPEq췍Ҽ3NZ,ҿqBj;(v<.@0wlpvL8!f)xy\ԨLȵ" uyGEuqwgfd`.誈i*e60 URUZb2XYK(nQ@M\)GO-hknQ999s{}b<31=uO\u]D1D[~:s[<ס='ˍykP0e P0I(HҜy2s&3.N#56CiuXShvNޠGGp>36o_kE QY|7jdYc?4bIQ4I\tl-4 6)1D")!ΐc/T+b۵ \z/NFŋ~>\3T`'ٔuy%&G,5E^rR!+ea򗤚a6IѶE $}LR¤r'Vaܦ 7w 3wY`%Rf5Q|'&`_ԥ;I 2ۭ^8cGbt8Nşi kܭz a5_b[7 W`=.Z ׆]4T[]Mo:`+@. L p? f' iA̓0 8 ׃S {t{Ȁ>-fn)Eϖ:4@ro9tXr0y TO&`R3`Q19*hZ]nusp2Nm U{0C{2OAy vP7A%PJ^uqW}@w&cN7sG80u p>-*ka{l(H/xArA$upup}DwPA;6yDt3=S-iw8O.ձ]#Zr_`HD)PY^K:_KFn )kp9}5O= G; pKŦ@ ؋+p By:xyDM?} :[KWO21 F.~EG+#ɗK q_po-~#nT]:˪^nb 8K!N><O}'iǠd[[k;ϯEf\ wNrgũ!p/394L`""}*/@%Spk6\KÍ8†NQp: jp2`9Nű yy9t>`:G}vm(/cH?5'Ip?P;2z4.c: 'i8ڍVW0.bfzWt[=h/ n{h˸_E zyɓTb5 O7?OEOHhq`t Dg)`Cʘ!]Zv{*vkphsѦŭ!CΉׇ7OZ4gI{Y*w}? A/zPg&2S:Qh MP3}:5<@SnT6hZ4uuqUҠ%YVkNq+5WSHOQZ*HyYITꩤމ&8biޡ'H}1 "'b{d86Gji`6D3-vv]m / %^^%^DR[- & +[v\^'_H {BWG7&3ҿ| )-F{lM16ͱhIbƤ2l}C<@,L\5G$jW3NpZzfyմyQG}*.*D=P̎NQ-xyO |JOi:D'mxZѬSQ7uOg x $>[TujZ*W+F^kSRΌUighUjP yj9n/L]ns!I!X2)!K CmJ,S,HNe'e%9ĕىeܬJiybLR^[(TĻ|~$A& \9 4{IF ǪXnZ㻨1b12h![\npI%\BZ_ +/7+)ەN}?&zAI(^s?dN~7_mSJ<ñ TMAeZ$Sa2s [jfKS\q7K]*Ӵ'Ԥ1n},)F??2 J/W袙!k.(9];q#IĦ3ԇ8U(1} $pGn?cUk(b,% J,v-I.. Eu݊#ʘOʘA'GHotE,9g0@X3}9ݓT84ɬOOZqIP/y_,*ʷ8o{PzN-gߑn1>c ӧ#% iJ-,KRĦwIp^4;D!:gk{Re܋$$ӻ0 Lg6)C8cl7FgaTV?x B\,Il|ଥҨղYeY&rM"<'"*WB[+XIYIoR٢M^s=\wD\C5`0D"83ƹBqfL7JHCvKCviH#iȆe!Ԧ.e.I ^ ̦{~F`8[֘B99c@"u(AxI$ %_2JF_Tf!شzS۴Ne*Kv PrQ? _H \ la d5i!݉tOR r+ZJWޕeE9X 0e,sòb 3КB[m(xuQ!b#IY}XLa[8 l5N /xF6#n7LŖ-lڶ* joAe}u͏Dt##s*g16Jҿ< pnPBUNP6t>2 kgBCfQttR@Z| 01O'06 z? 'Q@86!=Õx-~ 0h兠V>xڸ\[ 9/G0+"<5`#Ha 8iAu#y㼖➼ ŜG;/"WX_B_-'{9ȍN2I{F(;޾^S@y\|N u'^5Mw6'݁t$jV; . ={\\ ry =f 0^-z~I8m|E&w͜>ɤDtح;DM"P2$ydIOK exJVғ;؀DW!-tUU񭸆2Gq?"G@ο\!/"o™89iͦ=zГQ3pkMrpqUFjFgъSm$3‘O"%Cpb.đh8!x ܒNuY"o$[ TY:Sf*/G|6Eр&E :=؝~@JDd j|<\5x]7\uK18 Ψ)ؐ<޷=||E>86pcQgvǡJ? `>e TNXI(ћ`Pl67HCNI6ܒCHrCEIίx̲\fimc?p}a2lEa$&4lLY(6COBao/}\)A55J .{]8..]n r[ۊ(%*XԱmSӦi3δv!mӴt2M3Mil/2f9ߞ>f&mJ`OfO-'_Ʌɍˍ "ܱj}6p/{Vp\qz܊5)hF+" ӚjLjIMs"fÙ!v43gNsCܠ"\4wYSe}~@DPCܦ+;t/m"hUc*7'sMέdFNfXa젶 i{~0ק=hgnK.UEg_  yyBrpeCmnNSgcDǐނA}ۘ~#ۥ悺\noӝQ ~+BY_٤+Ш>BIN1@QD,60aL@ش æ4g"dGٌt*tUVG5U~B$Zʜ5!M^Z{&Mpݵ6W&dw*&]g] ] +"\F5uWep2CiJi zE{RpqbS#uEuSnCw}jwςb_c٘B5Y3xwZ. וywy_sjJ`&FOy]7Gif-PO՟ f"1j=d\?_T䴼n"[n~i~-J#0GLQ;;ZPŽ0wn)j2@eE~W9tYV2s܁wyu65WGyu7HJxZ)st~P@1лoA^nhRqp@P>CfdJ U!#:¤zq65qMMKr)=kJu.ӞF D5-ʞ[ d!st#2ƶc8ia=R|+,a_؉pH0ç] M&)|II74eָLZqhcq=dLO ej=N'$$O`fbI"qH+FB3sH\3oFH28O1p#Mύ!Z-v87 dRLL=e\,'`f< )H\8شhlX|s/#~qxqo n=<9) Ch_$uh ПfIH^6]p) D"\ށX"vŌu+XEJʕA|-p~I|gėPG@pS%gi9i%ҿL/וP1M}SQQB_CRJSNhHER !|dB29>eȲZfǚ550żmw\]繟њ@ҚCeSeSE؈xxu`E D994|Cݬ`@c\ 0^_o !(`$' NRp>ٜ69<Z[9ɭ u;yr)ɘ+ƫf0jRӢ P676 }@R;Nl_lL:X;:8 u'F7yۀ܋ouQ`= PSy *_6XAEl<sDw' L7;0x0ZSלV/R"ȭN'w97?=G3sǼBOٌ<݋*%_꺑aуBFqd$$o+%9V)6 *5 Gp-'.o Y]> C+"/NyYG(2ꬢ:lΧq&9[<`_Gz)s 1'#`uQ/Z)ʤN`uSJY1ks4r.f~/Ȣ!ӝ7:WGP3ٌV"uC.b,lN%3_gpqoZ躙Y<8I + ᧾dJQϟ0ԊhI>K\P\͜E140M\ts :k42JC斒e.F` J.$A"gѦV84%^:e^.R/NZ*4؉zzu uawc3vE= 2,wwȍ>6^X㴱;MI(M"pX2 ʏqPze6>WNbOr۱t?63/QmvU揱-xN,+? bIaJ.l?=*q|]?o쵘ݖѨ)nyfQ%*W`U56YQ1 ^GXmnzxj3%Gyg{GFhh:!m3;m}PcjQevlMv`7v9Xgka}9VoE{X^nA+'C %bY(zԿ=}bi}z5 56t38zc?*ð1ӱ#9JYXR<,u*BSPۓ C%(Cg( <'bg$LCRimE/R. aǜ|+W㬰@=ծL?2ԡHWO,TcNiB:[H+~vHZENһ\b͡\l{Jza|7[ +Θ_!90IB|B\`/.> \/E(TL : <&JAigV29Rz)d>rIv!cv RC⎙!c1# !a ؐHĄ ѡIBTh0=4W -mSL '-kzaRYA#[]dK3f H0$h\FFhM04ᘮiBdx0%|09_#M273(Bj+7& "0#2L*8y2T2E$\Ct2_ۮfFmo^R=|yߔ-}ԋRR-)>Ϝ"3*{$efEim4%wW^zQM ʶ&fPndXVL#1Z[W,2Z2cI>&6!<@ۖh!Y>q4M`,e,x 9*#fT{RclO8MIE,%eF+amڭku!u j[5Vm8պʭVU_Z-mߺC[[7䷦A-Vsy\۾HJ1eRl4^kЯBnfs nԢ:D~aj^)K`eổf+]M"ˁ샓4(-wZ^;ir) 㞓nwF[Zi&sMk.:⽏B8jijpkxju-HN~spRb]05g9#э܆AV xE{M\0pvƎ4Gh 1.::6zIù:bQG, r/ֱ>[#>AVG%h8ٜh[mӝihml҉GccPϡ_ONIt=.9_9%tzuR glf13] &;Jw>%}iBPWf2PWIU̫8rf`Db405nt;xZj~yl ҧp>HKo[ȝkrf>7vߐ@a5쇃L  B,$B&'fѿHi5\Buz}M=żtC:~5V)@C(M44sћ 4棱XׯuSDg-:XsE]>c}X+]`F>/jh   Ѱ'({)e=lK59cnE鄩zj>^TPnBHȅ@B.@!B- !"BAQDTRuκεgzvvnݥ]9o|=y2|k1;nmmW׆p%f.Ōb^pe^wqbpGX}qQ,MB!R}[;q+67Dĕ8.n0np̆vr|'p"~b!MX‘8p1Slӛ+,ejwѽW6\ڔsxiXJ$+܂d'wc.#2-޺[b_77 I}O0vG1QݟP{WH{1jm }=]8c,Pxub'k&j~GIF(}Ls1.è( Qv 0 .E!qbz]BgNtW2)ZXKM於C~ʚ%X$|@5敏)pS=e勔Ǡd#$Jr#K*C@ZԂvenx:) -f$sSk48?&"fE9OO5_{Hcq2Kc^2F9)_<Ay)(ѡ]QVE9*(Mp+Фtl ;|Us^lcQQfU=|ƌsdL3NY)GQF@:,xphRRW€ WzPW [jƙEsjN1Ǩ}|H@1jO'Pݛz49D&N7@9z_ЦG t|4j JQU*;,:7:?L>fԏ /1*Go6Gg!=GrO4\Q|̒մoѽ =?eiѬ_> Tx `5\@mj#5uiBuc:NVefZq1^Tr*L#NKT֬`o+&&uh<͔zSy(CC xIe_3LVe(%dtSV@uʹ[hUIѶ X6# D(ЯvB / ?02xmY/sd?q5iݧg&#?E^`!! rB*d lnFf2SH/!-|H }z+NRi2Bz'6@m W7Dd;灼i06@0{]1K%5edX+aXo/m` ƣP;612@:Xvp {KO"ޣbrϯ.˥*4q~d%dԳճ|$$;G؍=g~Iރs{Ecpnk*>'͓|]%5!qw4V BB%}lN:PBp$aIvg9s~DD$<Ɂ' =Q%_BfjDd{=YpN')|FLN3,19%]`aB.(}INPWʤ8xd8Du:1>J;돟Ч[o pp p&t;1({@}>np/p_b?'v5Q5M+[4[Rjcr}Ǯ{GﱷEsS{^ =9כ `.AFhC+qrCH_i!eWk2[EB ;ɳtUvZ+~~vuGMD]쟀F3A#bÎZ̙m e|??[#(FXI 5hHKS?(4HИ9hb4qR<_Zق5b.@dP+^?jFؤsbguC |h4)ڏ$/{;vk.rrkmOqR-Yۤk#ވ ?;@_e.hza}D Bc>رÎر;ꔏ<-zUv5ZVJ*T)W x+>hv@Iy _bh4ICgV)B^fUllF-n~TTj{OĎ\봷hh{NC-U'5vk}?UV0īܐe-5LbCfaJh*w\*v:"*p~9.ϔbUnܜoGEچ{hsVDh_wTb-pMD(9IQ&1S9DqpŚjdt/ a44ztc-Mh`yн\g̣:0+*"EPEaeXT7( .ǚb&Zq_c5֥1xXҨZMD? \{0t^>|߂3s1TG9y%41W1~PŌV1V$ٍ6es[2͔-WJ3-WAMJ`?fr1 6 k`T78bEqgO9+h`U9Kq&(%a,pFIJHc0'+ ?:cx#%S3=|K!1'tTN쉽/[P%5)J)Iq$[d-`.s\ŧ<+SJM2ZbSI Qg[)#Si)ZdQ5DJH5ʜ4LiK+Rm9-QtzƦoԘТKj0;1Ue v~ۘ7m]Č~2g V|F2-cY1YVEg56@cehKoPxve G r+^eti)̇ ߶LUvyWMP*սj4ʳrUS99~nբf@ pWKXN/`^ @8)a3/ffl^˹-~**uv4{Wnuٕ-thFt2K` Py;Nn{7M.v77\ĵ7TN(WRjgpG˽_&h'?mM^!A918P~!0qGBAlp.|7ݾ\Gx`K:9:A$'1 G f:GMhI ކ* ]{.CvyH8ZZg8 U|J}'|/Fk~Eo#v{n;tk`3?M—Nñ=]|m--M< W8/t?úB9sIm|y=C魇 ЏF{ok:KkOB<u:=K[Dp\џDlAOЕp@F=+1ɤI *!q|@#q8մNjB)odJOXWGta(V2:h䳣:FGqK]k!*WmWxvjgvBm1<{/H.ΐ}"1++YO䱜LYvNATúuLM&آMG2ӤO<JpW0`6``6` $&!IsM4I&kf]zd=Uuӎv6դQҺN:mkUv޷dz{>I/x¼%սŋ7Ӵʥ:&ѷtS gb"㙏5;e2|+ O =.V%?{ewV,Y ,de#l33a*pN79nek4y g((FsP;."7)R.JŎ].%Yˏg m K(dXѢV 2X4Lq턶GIPݦ2=Ke6ҿ7Q׾H_Ny5K/Ib$SCrM6MNJ)&X:@w8]eos[<7C_kҝ6GYyҾLh_Fͱ 3k6Tmqeioi⧣"D{(Uh:D,xlO}fۯ_\DVyFWf/k\2,'XL5v IM[aS4,d +48/QxKEDd'{VwQi> fѩ6n5zqmIޚNuk>VֶJTzx#f(-Q[仗G~C(7_eJ"(YRZ X;TvPљN3eՔ1[(80EQ`#.x O~S U..HgI*1'k*j;ʃ(`KO>=&z(쭥z MIv Y =DFۤ~&~OF'dDwK렴ĔDPKINA? L!w("d U9@pA҆GI#ydGΈ$ ?KŻ$ }*wJkYEHM%ZcUVQ[cȘ06HD:)y$OyZ'$bcxMćOb_O7xG?#~<Ši1"ѡ5UIJQ٘U!}z I$m8Ms`/68e|/Hu^dD~@cL<0""2 * 5"(Ȧ(( (8* +˩₩1n&DQc%i[5ǦMjԨI44>99=Ǚ:++ϖ''- ŏ;q?>Ə)&ժ"_uyY+ݳO~>/~ط-7(=B>,)մ^)P+[]G9DFx!Ngu%yab Qh@#`52yi>ZUƏq@Vf*%cDuX;;M,$ǩW5Ġ1 㱟LVUG$oV*V[rcգ_Ks4g [{/^g A' hEc)hdc)E ZV,""[.v._iswr# kG>>wpelwUSVw JhYG%Vu.ZꚢZL-q"|Y܊TVjZ֤y-*s?RwTcxJ1lD%G(1,V aAي /иrF,؈lCuR#~=;iAo m 1 ǽl09C"J (EӸъQ)5UkTtFF[4b0dǼa1|`!vS\7ya&po K#.M ̣>0dQvMvD}}GEepcĠ`Ԉ\Ƹ5qiFkUظ/MjzbNs5MSTk7IOsf`f{{K9YeIPfRIIHJWzrҒR%SJMJM]j%7)MG`A,W}́z@y>9JTqd2јTI)& `ҧ)1ݮEXgޭX`>78ن7m30*ǔ.3(;9%VL(}t jK4l)w)We 7v2l {Emg6k|m~sn0(z8E BװH~Rr_&,K8p.+*.]tqíAaa= Gw1]_5 ͩPFs([\!k\>Jɩ*-䱎jb`;6{[ Vf6SDEVFr{ 6xh$2.c}cc}ǹ}7TGKH1Ia1y5빑oz v^x2 3#jrK y36 Y+0;g6~K8N[ u?E\vih2@o!ނ18I59͌# </W/RK ե e_&*F;Djǒ7pjY`\ U \eN>aFї2gl MVżuؠu <=w'-]U'mu}r uvxa}k}Ӹ_C<ω <74}tWE/JD3|t*Ш-6KANw}eE|y\Y"qyW(29?9<{=;BDzQDJ^Gt<ΐ))y|5<\i0w|G'X4HG# |4J=ͫ O[;i$Nb''sqbױsqiRM6Z:umU]K+T(L\Mh B6&B Ć m0ډ3??~:w}~{cc/V0]b -|Q_75O op}$1s4WG :kѡ\i5ϫ~j%?L FX0i*\ъvif/hGɋ*ɒ5Q&>d eEi׸?-Ye,-5jԪJ-ЬyC =ij׌!ƔiM5a<NjĮ1]ר鞒ה0F,Yڬ^FzЧ}c~,lZsLf1;5mnДEami21˘F-Jn\U c>nzRqU Zju~?>./8l>Xz{f,3qږ)Q)&iU֦-,xwnm~LъksxUa WާyEit-<3M2s36{f 5dw*nנݧG=9bVr\Ym(TO5wU:koÇgZI"r=I8ce^FːH_mUPY^g8[R&Au׎*X;EuTo͉[=?kh=Rioޡyd,}TckDָTߖۿG.Ljj7T2|[/iW?ճ@su~NB/ ]m|5j RC%w{jc@霑sE՝GT*^eٻހ_p7ά濏YjN~#?yJ ZUVnTTeOLCS-isCO,| $[[&[=>Vy54ИVA:R#Շ}…rn1*bQe\HnUCe٢CFS]C;'Ḵ{Mb?9WY73hzϣ3N Aۄ%n໣RU_*KT>`RـUA6 j`#e )>s2/]_SIǴ0:tf|0^ B-'F)ՃRuPAED6$dLeHKɘJ 'w([*H^T^r*7C%~(cFgJ D H~hObl3ɘ*QIʤ&*Lժ ըT@aتuL.EL%*Pl܎3% Ce{ˇvLJmϳ?ݿ}" JH%:bv̠RѰ$H@phĈ`ּ>5&ym xyX{g(b5 s/w)1WΣ0JWAJc6ԔG1 #uơK?C"<˚eße.o-q3<{>Mzmx_ShB?ʹ |5[By=g®r'oϳ.0gK2{9 2{2r{ 8|oaׄnZr1xvfK04&{CYi>>椏 ~q>J%?A۹B>zƸ%9j]cF2ur9ACa?/~곟B;i8'U9@mcAg|FW(ćW$ ^~Ea{3ظ!'}q=/XRl $Ip.G&& ҝjKt>oKOlH1ӝS{7$ۘ~S M̫2ґZv>Ϫ@VOS;tF=ğI |ݞpOѩye \0]׹ i"'kL>RXf)'Z:%t,ev+-H|';!.'v5LqTa'&3iB/mt9.hXIdn9L?Ev( ,r5^qOCr1/$v9u&q'-[|c!.yds.3: On1.̓ي U2E|$E/"|,||\q7˺LOgTT2CeO8[S6[.R^/i8:4D# <4(GJ31yJ}P\M曓Tp$:`v [6 jV^?!=8-:qHCh(fSwԫMԡAS4>. Y2a ݩЃj =!vA@{ql5[=0fO53\6;ܠICtgUaɚR{Xi Tkh79|uq 5D,P}JEnGBTaT,5VŶDٜ*e/Hy&)7U9]N%}Ik2*#\gsó֣T= W|$^h)Ub{ Fʳ'+מle'I.;FY)LTc|Pr:#x>3zhL9eHc_#yVR!: qq)ˑLS,yJO-QZZRL#}R\ z@IGeǕ6|W<h5 ћȅL|}^d+ W\QhŔX]tȑ_$4(c,J*t=TO\K%7MEF4 gR]AQg]wEЪ(* -, BmăD3iFUi;1&ͤNkNc̴L56i֣c,d?Y罾}FL+`WJQdv|dȕQ Jv\*C ~;+ιOcqX^8V±`>( *id_+;IFYIJdT'[y*u)ڋ'/ыp| <<_h&q;(@1τ;~$J ~dʼnJ**@0 :3"$ * !yURxP JlL_qÿ~Llu1JXbPt|R.Fz#ìCH Njų#aKgpK-/p PH9ĜE̓}O?/Q_µEgKO F+k+:w%KF.(\/Qu`;ϰ-DMT\~vPBsy&1O _?f4`9VAZM.?Ppxs{Ez3r [d!m\@̳p}jΫ)$C7XlaX?X6N`LM6s6U|RMySpw+TQ"͡|ի^3uK a·A? XWY q/O=r, w}qKCM~'q~g<>,O ڙzb/ku?#|agD:a/Caq0&Xku7F4(8!8G䠿&M sA ";`4"hu&x`x?NsfO8)w /:r΄;M6HhD9pɈH#88rpu\,b%% ~O y.!MwAQj@|ν:+OQ8|H❧I~E?"sphBp;C->Un3o>$}|QX5=:7j ~{=Hj=k? Ux3z]W]Rt+pk>\P\fFi3[GP'^uz|:z:~CE0-{/J'i : A ƸE+Zd$,%ض㷋\DKè!A6]Tyxscu9/pޏ#N[f|a Gb]m;V]a;l/nvS<7v#dr EA+|2;17bۊtf.v#ʎ^DZ=B]F yBz}d%,ã%2vb\lQ*'a{:sυ.#U{~=7QBy5df'ީ~.=$8#`; ۓ=beد~ ?:CZEKo rzSL9q,Ǭ`#vpFHo~:b&'2B". 8p@wtұkuԣj .3HxU32_ Vq G-*3VÑG&ȃceTY 1GT5Ii De=G(\jycm+U5qr ?'L84^zJKXk'/SIF-6X3k,!K.l-HWMbHQuOzU&.UUfRqJL/tBEp |'6\p-^~w[62UcJӔjTM3Te|S**7WUV㖫hjͳUk}Eso*!=pm`cmzk.|q⛃SbUeMRŢ MI*NS5[ֹ*ZS;IyW)7urR٩O+fL9p{HC U |w*_ԖTRST:A575Kslʳ*VDEʞT5#}2.5-cD55,! ¿4`$|e}oJx  b I5AI*;œVYKfnVbUQyUۺuն]ﶹ]n9 d'y^z|*|̍W%Yety-Y*R OGrjU(Ek &-V_vl4~PVg~”߬8Ki̥*PfYI(/TzT) jhQjE'Uo@ɾA%;Ċs2T\*>W?a;Rԃ|ǤJ pϊ|THپx&')ʨLiԪP*JnRbuDŚXFwlU|^U կ+|DUݬmo W TP *1Q <|.HF3ńٴF4P(NiO;JN3X3.kᡖ&lAĵ)0(41{$f[3K7E,^mfv)##ψvl/ dx:4z0^oQ&R1&J ȵ Ny=/亭Mԃ>!g}6blS|s>imd7yp.]6E,`c 5YQ>9fq/r9br9c/[yfg0% .,Ƕ:H䚄Yk7-P,`'&'ߡQ!وʈ"'(~֯ϫ5*]M,!{3<&Bh-TlDŽ0 ň2=r?F(8 a:tPuVr4%-|4.F&1BJg蓳q\E?OAr3!pFpvR#<+;<au:Qx\(.A]6}fJ#+{^8i=syS~}=*:+G /P]Wiԟ%.~J~B.i\:ops0^/c_>Q\f 4G5t̻jL?~ʹy -JCxЙOEh47jvP}hũ߄3,ji0)(' L5{ #u̼M`pEWhT՟W<~`;۹v0Ŵi%mx} %rǘ as9jj=7{L`e R5:%.Z;}Q`O#6Zm/u؞{݌VlEݥ Te е/iVқbX1\G.t욱k.l{]Z쇰V+#]Lb Y:1~6ktv 5bׄE g?RX a2)snM?ӳٮ:e05&9(Fd}{\,XH.&=Fڍc~t!셱ۦv,n/f:z43UaKH}$A+oX&fp:9/:jQ6LC8JdRruaĉc;ǗN8NvlDZs:M$m״ K֭bBJAVSV1Dm0؀A h*h6&.ZQPG'e=:3Hì1V*f젗 c%Xz>A4lsGX 㰔gKH ;;Ѩ$:u42to>.& zg=;6%ʯc³x/U|8fwcniL".|5ը\nsL]:Yuv0-WxZ(m٣fA,ǔVr vM{RaG^{jSWKVZliDҸZJJ[;lWʺPɲ1%(n۬mjS" ۧ:\G8N 6 CC7]'caVDY]-vJ~%uJأjw)UԱ@ 1E(llVG!~*h<G W^k[KBzNUy9-粼u7 ;\MZL3v@gi%r1O5m ջ+rW]'OWT]HU+ީJ.Uq}\Kryr{oj'荓@.pm4$x#FE[תסץjWU DJ[զ~UT㟐ۿA |EFpJ偋rPOtk#Z!kR]'D~vy*婩&.W0#gGڅ2j<4)Gh/òRYcm݆]h44O#"YePP\u9rWɨUy}4t'[d"kdlUidJ%#DN *\d ԿEسA,$!=P ˀ91B4B6Lֺ"og4t@ mM@mݍ>T𚱮Ծ86l&c-0'3/<~w4\|tzFaɪ{Yנ6t-#Hb3ı8VjXCc1dOT 3oce}~z.hE75L\=5-Ch,I5$so%{sIFMı817v0&;XTVfH3׆A!s++z ))"ö[/:@ndwt/ ıv?~ޗ}S) kyR{꣯s"!Rt{^sk^nh Ƃz8K!Lt?I!q8feep#TxplCN.a0UXR|e>oH])a0K$SgX'0ٟq%=y2ղ1@ۏk#VR+{ @^y3xޔT'Y{.o?$ %KE&<{ŋsgW ml}y`}ò{ސ͚:Lm`VKs%O,~ccl:W {ś4썓dŧpO/yC/s /d"oGG,~~ͤyIKLWW^/}_%Կ,jg'ހ Ufyw?6sZ) :2qӺ{Esxq~&̳gcۼ8m~v|;׉8iM鑶뵵)F=Cݠ$@cL ILHCC􏩈C$PP}~{<$% ݜ73 0(_fѯ=MgP^ O߰y ކ!$=~7V!Rd cse e:#h$>+xyK+Dgt*sB?Lm* у_u]S25t,v#Wȑq?>2S{#ⲹհC/6*< 3ϋJ\;-[Cw6Н@wY4:0 Gt7)T 2d V9-hm[=c0g!X=GG xl'[p3=ѲЄqϞϰǦ!Хڭ-&؉c'ة`;ڰL$҉\՗<:ށ(Na |ayjiȓ*ʝʕ3ݔ=$[愬epf(Hicc{SP2(:x$!(*n?/UK/w6$gGL*)r F%O9s* rg}-ckl@%!4 AhߌM-]N9K-uma*$MG+],ljj@iCePPo)CН$PnNS!6J@e4U6]?MS'hu>Ӱ4ܚ:@zʱ{-󴡳<2Lrr®Y~ΚE~A!ah66@A<0ǀfq&m&А ឦ ]` ta/)q ĮQaE{HYaNaV6 3]Qg6{9d7l[ Pb F *e(P*SS J/Pʥj-2 ʴ:ڱj 3Hm-ɞt;oel?V~YpYKbr5 c̉ջc,NY{&Μ&38]p~ᣴX,k:gHL6}?ѯ' v ?mI[-~x;gr!q68wsΕΒmQQ]·˨#rs[ 7c?}&{vdVĻH"8sIKi&xA;.Gd##h^e~WN0?HH3(qe3~VpNEj'[ٜ;nG<$H9X< WU~H<^W^ef\. euqDINۿ^p᳹ϏU6K<`,D$+5>>ɿJKb&>f- | Ol.>IQAaM2z 2zQ{u΢k~8 p ޿z]uq-l$.%~u9Gem~~|?D~bz":'~BiUh ^VXe]SNڟ&hq48Zj%v؝lj~>^Ԇ.NC)ܵގ}ı!~ى_v<mv\pǝ;vd`IЈ"v;;eZu&v;#bl/"Vc(p< 4z"%kЙcp_/;muiG:ў؊ @ENA{;ӱ;arXeQÛ rW+b f8S a@䩾";=}ll>B~ *YoaT1v|*8=ط{Lcz\cQlz+۱ݍ>l`o6 ;s:>GNU QuCt~1lEоkپ Tc ~o~;@VdjYdg:YG-e:5c_ ;~σaWuMC,lr2ژT2c^y;u£)TE G7Y.wmkUh9WJ4fy$;B5ur%X| EΊ}ṗs&o/E̻,HK}ܥx#+iժDb񠂉jO˓˝lSMG;lqf܆i I|HbxSGdQh- ϻ|Iy"QX+3SD~ & y24Xr5 9gϢ)K{caq+X³Yφ$/"\Cedj(fsI>'ݲ=&=#U0?;ӼMvū_nF5#\O&~mXflؒ! ||e6;A+h9/)>O&d\25 r73D V:HJW xmǶAlcoC%K"K+>|pN+=`hiy׀)ޅ~F5}faX5 ZZ" nUƱ3h:Z+neJ;=HYB6BIH@P !Ѻ/NT;նK2x:ɇ0p=!?}f^LRpφ`@Vr@G Aw"0<A!\ŜԪX<71 1 '#hGw_C0" 5m ṫ` ",B",BPGbP !BpS/ t3Ϟߧ"$/0` %:BrXa`F6;XApٕVb\r>i:_PK -:G/Ґ9c+.q|h"|X ~5.5uбFl 0a|x=u04.zE4)x C$Hl- yױ;'jn i\ W8tl-бk؎nA pNlEMlaY6{ר` Y;y80_w97=Ecg@Ҁ= бQR$Ή {P1j` B΃Vݕ Yk`Õ(,7U U+'F|` ^EMB@n/+iQ'B/ paT/D;C!XB"0cr>Q88/0݊M?xʲ07c˧0)Ms(˰2/¯YƳz·l۾ܵ"ވ־#Ҿ?>36ğ=>1)BY"D-ɱ5ڂ¢侱TźƦfݴp|ײܼ}ŗ_oO%}1<\'_ gK"0X8d$ D0QPp)#`@L6-F8n#mO@zH(=&c̾dݽz~x FEyy = % G X'$`(,K?W-=C o"[ ;=Qo;p0ȱ4Ï?!Idr -bXwAWM1 0 z޻}_>xo=z;xɓOkMuDT__ba~CٖsJ:CR Z G#e&\WfHKi h0a@À 4 w|kfdKeUh_ݯAųs94HASe *g)AxӀ n_ToO*HSoTb.W]ޠZA Р%4(ײ3n膆>nE$YL!`*_mԝ/QsР 4y"ySIfuaƹgc,i0,5pCu~S9Ѡriȇ۝+]xWY"Z:ӸdM3^Dv 97V0N6CC4N۝#>1tdBG*@C'ie$5hͥotРUrS!\ʖrz$N:Ҡ#{脆ƒn#Hi КʷkJ A˱)sNy6K"cwgI=q:E+6 Zg Uo-/4CTРa;rV(ՕБu9'_4qbf՚ *ʶ̅ڸ|5ǢT۳,8Ȅ#Eƾt^鎗{<6XjwУ-VZzQQYkF}QLVנϋIh4X$&}49߻w?cW{YE˫}?Q ˱lpWDL|rV\`ƉмVmӰi4l6 m{Pdžg0|ǐ0aV]ց灡F!ʺ[Kn۹l{`?)`oh@lǧ"sf\޼-RtɌ)Nm-në= 5e'#1=0htHh#EAg"F Vh•Ibm0;;6 7`2>A :SvIQĢU]1W B% OXoL[n` `Q/c×hޫF'Jcs_+!DtU3(˗vjYy`xN+1™-x[VJf AƻC),ȗfjkۭTkëK/ck$fLGz(6;<)7m}Uɰw>&t%4aS&Hĉ!e;lհڱ԰0ݸ/¾oƮOW}/>{cI_ᜲks,p!m,g9@Ov.Rgu6A$Ⱥ[5X=ښWǖͯslwrl$&";$&,aqJ'=ʲ[_vwMæaӰi7X?ښc˖9_ 0tJddD'%x:,&rA>'>\0EEh`NӽGWpkz^`x +Wc"R,Bq&<$Lci7_uA[=kV};Ǘ/ b$fǢ* ˱\PW@i.wEfx΁HmjiHW#-]`0(̩ IHL` HwEĴϙqrxsvB@E͌:yn8~ ^I3mfځ6MmҔK IJ qCwI֣yGﻭѾobKl˖%[^ p(t4uU}\?ɩk3Xb?<1{B1 )ʠ)u e;5+jK״4Œ^S5x{z~q_=a8 ie/ŴxXj(Q@ӨʨVf =[rSPԤtuEhx{~ {/ͩ0/!=k[8P&ڪY V $7yMRULMogn`##4n%ubD@tPf*haTIȚ^ʸ,oe>OUq x -"8g3h.PԗMЬ] U,*WPW2M~K(d+\+x{ڍ^o_=NioYz!pg'ئb Z(e^ik{dEDUۆa}B{_k_ӜB3sޔJ(6y %<$iCPMAcqd"mnf:p~0HA\^0K Ì*QJ 82Eg`*)=P3؏6r[h/w`}o羣=\[u᣻nj:|ͶoZp7ȗ|ImKu:mlB%a50as5ޱwDGI^{Ivx\/$ٝh cD,IFIdB#mZ47"TՁ>m3V?1Yiޯ-:B}Ky/eN(^, юd,A#$9Z6mtoJZmio=aqS5ݾ|OӂSacO0.v8hx'#TQ*LIHLʆt ޜYޖ~0˪a аm=ć“!A)# xB1B 3QFg2R!@ R`, }owYr6[iì+auc71'R 9#lD}qNܱqZӝNUzuuk@zWEAAP I\Bx $F$@BȅpAEVԺ9;m-ʶ?*9M8bɢv:jh"(VV@ߠTei4EJtLpavwk}n䅜4~1+=n*(NU <L;sYINiBx6 _sZfFGܰZ)HB':!TUr_JDot$ H\$\VQ"Fa]|VaG ^j2#(Q6"*r*&!i"$]0 k A]0ݺ4!>DZр/rz[IV-9~`qL45z]ECmdULDD](ՀOICVt^DA$"C V[+{$SL:Q 1hG 5M|CF^kʇZx3UAPi/  n҄di=ۊ~i+zd%C6@>k\OX["d>Еq]iB6gx;iذ% gd9 $*MM//uxUakfR2ȕ\o`*X( 0,OƤAq.<1*; O[T{j8lQƒ .3&Ba:A8/ W=hS g4IC΢/}ڐ:=kJ]* *8l]Kh-nH6j &_ciS 3Ҁir`xaؚDy]Mݧ 1M&o Zr-s.j)kjTAAdGO۸7`pHGܤM$Հ!o?f*wm2~\?h2b۩z2lnʯK @1'TYY0FG)2UhӲ4`^2nK֬f{}Vm&pҁ-ZwZܥ5UUz(ԦMjJ m3GrA A%h4 `Z ЭlVy1>~ |y؟~uG? ӷmHozޯ'|%:WS 8#^87Ѐ`SӏT]=r{L&u~C*gN{i%8 dp?3 x \aheeh jOy`~RMOU!KrUh>Du38lj,J0pzT~ޡ{&`jmյk˦t˸("R(HɼX&QoAqq˓2,ah6EeX=7eNަ ;63e0uOɧ4]jnH"QRĀvߌ帶la,/1 G#Œaܔ>󾱝31<ʞ1tȧiPQ'5D^LRMl)l8q(˛G| 0#xeX+)z 9Ys{xJ1?o'ud^H2kq2,9ʄq00|hahe>o옵fϘ+&;jpQNj$ %h>鵐ifqfb5\Éߊys&``1k{ڦ4vTᢁ/AɩYL"2B5=+ v:̂*;\q`r!=\= ycʚqOZO:ᢉ/),duPbM97Fz\Wjz{Be7&H΋ ( un̬uyP>8Z?]'[E(fjY1)QUoh"^jN^l^$oGs4o-Ҁ28>u9Ƚyhlu^sKO3;(jzIyD. As\5KT1E7w>u>3mu *].NQ!iWcZDX ޲=7B^UtpQ+.hD2-hM;[l'Apd:d;,{OHgpj]<5jT:hCjJ ]QI%d@ [[ߎA;.}߆w[|pRB\G;A-٤}SKUT*K0)!D=eRoh`2xo.cxk{wt#;]ds=c?bv> k6`B:EM{MDZ"VE Ӽgwo2oM{ ireӇŢ#3PS }fj;8wym>3tE`uÅzAQlnwG6{xϫkE7]HH ~5_8ɯs뜀gq+>~?>].Lm`=acܜ>"ˑ~RJaiVUXaS/%(\bxa@ @Յ e nH\tzK?Y)ƶX f#fHvuqҨFą^DJ +a]XH:$?y.d_Y«ѶOo~~ZJ^]rrj[Eۛb.A\Ԓwͽ xYbN8ww`{-CplInF'LǬ/F>-/,zTB^O>{.V~1vtnYHI׽{Bc{C: >gώP:}$%_z^US~nˢeϪq%kҔIe?R˒6^L|,Oxri' ޥ^y/ >9}Ǿ+22AnB:@$dPɈğ?Ǐ۠d~u9;3'ܝd}/Ds;d~>O`?T.@WY4v,dG$xPt2\11 ЧO| @<(1>0nN\x??G )eUMuƥ6-k8b#S͢v횮馐J~Ү*`wo2`i(`!8):W@KD|Ъj){g3Wzǫqdq 1>, Ay-"8YhfNS%o_%B)X7oǶ;LyeT;- DA  p[ZT ͷ4zS>KkL7tDa 3fY`l^{j{~8 &x@ ?= R7 EUne2^dQDLr9I[M#D%@P؆~?VN8 o @A$o @ (pM@/6,qkًxդfu㍼*d %vk\Cn\ӂ9Xgh ?)lń(9 R7DkPPqKf9T$Y?. c(w 5A3xی{6gsv` ;llHklԪa *,ђY.I38aOr791fkpoui6ٶ0 ( KJlK-Xo;_*%/K8 P*cK3\iaY< r|^|ǐk2L=>_USI;İ 6mNH OHT$+U=Td웒rl+Z3! 6?9(zI!73`zѯP^e-'ڜ2a@d#LҖ*1:HFמӼ(/J pEHy,pWt:;7 ^)m.3ȷ '=Zs&6qg 6q[ͷOG$$_py"!hgT6! !E f_+Rl.[buũ@36.}"~'>]W6SL 1f񌒢Su<*qOhfuqi6gAm8%h?w=Oe4Ĕ=1a$P[k匭sH_g7)hv!oFVϷ0&96gtdul`5( _YT8PG]s߉5{4;~elH&{aL0Ejm<,P2|sszl e1- ?N٭s׏oPʝ~w8 JW14Gu'C0VЮ#ԫ%JFWV]R-fE`%la*2 & 7Ym((C U5XB~dgr[7h~ }hč87w*A?:Lڞ64^or]҆Xѝ&jL/RiYvCA)Tu6Ae} {48=?pkbPVg(3]BGiK{hnzicgXeTCP T!١} փNt[>59w#;vމ)/)+F $ev+Ӥ(󻒔.RPtSj]Τ eGrJc(D 5f&P}j-~&swl&n.Yh)YQtвE~Nkbr[iWra;=VCjRic.TڄjP E &P)46_.K{OkVW<>D:Ewa>r:lHd(qm6r[uKT[|ks+AutpP.0Vhaf' ,լR:!]: sep1"@L)FK%tەYݑ@ 29!kZb.zۖ7.nޭY["B>ߝ1cEGC z)?"WWc{5: DUՄ/ jDA?iW7lZ7ʷ;[%NJd&Dr'IY\hR60r-ʺ6WC`}UI$P,1oDAÖ/V:eņ-`,oY/ݱ)|! 1iTܽشDιt^73h0!-/]6(֣5~c#턉ӗR05nl:CLy! a1Q_sOq!)%5#03g!0̃T2^6:ע4C_XW L: ip='>sCa@Ci4kP z#T=saTؽ;`fVg  ;`xN@vvG! R\!pJCPy8Otغ.̾߄?m?.N8BpDt=~8+[Z!H[Ck#`X 0- - "dl2.b" >c @gaЫ\BXK&=ה%?}*_Ŗ͐iŢIbhX<" JFA0(&~> C e Cfpc/شLVbJ-?k.A7_"NDˊǣ%cƒ1;;AͲ^bYgT2Cb!,OK= yЫ7DvZC&3O&L%Hq1|4JYqZy->i':OJ|C> 1d#LĐ3ѫorٔTÛcM'M$cؚr]0IU=uf# ȮZT!΢<0ZOsjӞqkuQj-"eA` @XB$d%!@VI %$lj@AA VG;ߙuzݼ٦$DbRfw9WiQ^cUT-U3f5URmJ*0P 5ṗƝK@ޱ C?  ;61|3$-!xUF1x&(bJfX,tf(FނOg5p}o1(f|Sv/%V})$;͚F.MeםuEmvC'hQCݢYаsh],^trx77n97Lw@,Ddu,B %k{=eե:uS.uܥʐt*ڿB۷/7&V,tOmx} o*<^DAxbyލ0>,8OĸٷT6.H:9#յAŷ%=3ϭ/?ŷۂ%/==:U?Hde2дy73ɦ{d8⇃ȀX <&(Gdl1?Ƞʨ13?3vjjqBn8J:j`G'`21| ;7`&oPh1G a}C )ȁedD#O/6 P{]䈪F (䠀Kc.#KqgKhpu?ŀ׊@ؿtAC}"c_zAW;(v@ہ;\BPn  :w#-ya~ C'z6 UC_ B 9t ;{p?*NN& n nlw p?8_QC< Lq;FVk)+>eRƜ%Y8ωgz4Q0kMa?M47q1콌!} Xu;1pC:b`!7Ey!%x„LiRK33oT-"֋2$+Ill2_;$'I$ʻ厐7Fz, \ GN-M"EǚT`R%~BL&6.dN(&pG~H988l' +]mE P7ȌE2&GrpI/9iγ"Szx2*}L|DjP'^81Nh~ʾ}8K ii1U vp9l Z$N0gy4x2L6AT'f=$7< Kl#&s)' /S՗@ A N*1hb d| Q&O%xΗL(Ɠ+jU) QS4w75}M{Ҁ6D6%h'h ĈADA pm|("F-lTže 'Z88kaVmFwII7 i~~~}FY;A2 Πq@PB ^WfΔT! sF.JsѯzJrИk8W\+e^_4 1b ,oB! APw}A"NUqSJxBrR9aC۴s%Ime]+nnYfSV)) !cHɽ_oCP% I/ ֔J zP*5aniԚ>Z*|a98fkz.7q{ʹ=O@dA (F0aDY0H R'uJP ;-ִWSXmzNf+2~D]nt1k%~fo2 0~Py]܊?K ՉLMeQkj\rU[kתKmVHaыLzqWb1CO@s0 &߷uasQOԑLe-ZyUqR+ Ygԕ[j2ZkkU6NQt.bA&b#VgL{BPz7CF7}V3GvHwVeU+mŲ.5[4my6kR-4UN#rH|jx>A2 91PRo<݂x.NW@Ʋ5΅ʃvz!0$lŜ KHH"N_Ԥy=Hzg04Ay,Ey٬,G} "}bg}OXeeK'!vD _0Yǩo"ȋąs^kJ86׍z99`t2~@2ȓCByvK߿靐E?)ԯ&X׺5\L^sv:F"ed? ƿK \⇻)t{]ue5yn4nq2ueI 1@&d tGeɍRR؞Z`nvb, S!O" Hu rK}*e:.װ~vxcOѥ$Z"oieLMoʲ@[ F{^ ؙΜ.zD{@,D۵rZ ?8rD݁A bfL6lL0V;f`Kdp3% d 7 l+Gq@#[8ko G-x ,=j] bOrT!H4dT2-pSbj'tC>ZMISs?Ç k LDFr$j@#H$C!ױAU&46Aw'(vGUNkp+o5SB!JbD}ӃP*CD}qIE3 aQ*qGt7Z#`&gV[VpV0wEJz@٦ }}/DІ.ݐr%`U 0j(6 pUa/S 1f-u%o/&|E@j R|iA ~9_y" -c>CzϐBT0Bh2@EjpB e(;`uzP/R e@SWI-A+vw>o/e<{g@|˚]b={ǖ lMi24kp/70D'^' RʚBka~mg}#|%#3a&ϰ&5==-:+ZQԣuTD+ʅuBf! H,'$!Ҡ("e(U(Lx@e(λO}s7i /l>G/`X/Ш[ DՄ.3#6'=0] 3ĉjқ:kci!i{JFӚ0#NI@Z ݀xr 9{"=qH{\v[laSBzYF Hz1|`D>e1̦X 5Q5P7y7@?H @O< qzܻ,\>5F})b_d < y`ۣpnapE?tݦ,p89 ٹi$,~'<=E3ch/qǘcӬ*h䥄gx=?1x~M\!_;_[ 8> yȷ/5 Yt Ac|bIo#e\=;0 cÑ͢GV\_͘>؇:Cɹ>q%y?h] zjPo4L A f~ 'J8=leC5Q QI^M|or=񁬊@vܛ|ܛ,`:jp!ul,Ap#@䐏bv/f<#|`l \QރR܎V^N9OJtQ'i= G,`Ow& iנ8 `ڹ} 3 ѻkJ&DD0 GMIT: wc;rjޑnct3:S ])lG en G `2w, oo~g1Ag[$KiPyRT'5kkCWlǷiYjl|(9Uѱrfr% 503o':M,s&[W8nR)UK]^6a֖ 6X~%dgEl|AWIg)E b K1F|q B̳(V=1mxCY0;̂c&εk\,č `rlLjxcWʴ|Yu6NQaK:|a6.ݮX:ҝbMf*7CIC<\:W{}w/<صSS~ՍuquDPQT(bIl$$,D*0:ŒZ;NZ:nǵZP*2)UdK9}m^|^K.7VzaZjBK5}F_\c<\mzGiafӛ0ܻ=|j|4쳨Ǟ$MW?l{I]voqf"k[եm+UnzZh|:^Eh[m[?QIT"bŋxFR.p\T*m?;1te!WrΉDyjx,k#]!ԳQ>ňX&gk *Y>cȎcd%rQ)#5Ңq+QhG3bwF-!?&H#!EjZQq_qY_iRH #ܰ8΋ŊhM\ sp1nq9fG!~%d͠3Y /RLtFkӡ\Ob ICo2 : Ʃ:KayU4c&ϜBp,4? #G2_%dBR+>a.| sxF=qs@ ݄Y0)։AXISQ-~bOqp?;"s;TR4HH6•%t0 `Hp\"b4GvnM-13Vw_,Q1_@? `g]!gCzztPh á.r=3'CM*${yCBEXtY m Rw26MV/z/钼vH?i3 lhS`¨DFf(Ь\_ܜvCrH1D%3O ;r,jߥh@aEvy7;S0 A1lz, 8HA6 MPnK|bH- z9DWUB𘂠z'~٨]BfoU A %@ǰlr2p`^cI<BW(w8 V)%$uWT5!zJ _6+_(ltrH e&f|U7h2}`t06 cP2A J$7?OCj!L0lSAG~DuAYgV\7?QtR6?I:?K 94d0 \`Qr$TOCl6Vh%o eLpq__ӫڣI7?k~"-ցjWuDd !I 2 hQP(ThI ǭ{{̋yy~y$A'b*37EmJO%\OŚx4C  b'iݑ/f F}KF-%:v22vfAi:Oǡs=_H`0Z:*J?,m: 20% qqChmݨ6foT?'j݆49u NU<*А^ _b`406YAP24]f2e\w|D x~j&TxXp%=6s@4j rѐǓ ) [`bc1` i,p<f;/_ |A;sT!5஘I 7X- eI$->CX?\Ij(cO3 4#76N0 Zd{߽\ml׷m#šC.9 !ƶ˜LV]Q[j6,KeDŽ =<Àd0 x9h@ZjKf{p?pjw˓S?+<ڕߡcSX8Z-PKj~!Bl0{R2Y:=,VGr=/mDP\s`z[k sBfjv,t^<{ j]7wZu@E מVET$xb%Rν)S $"B˸D5ŕhڷxHGz,߾ோ;^5YovYcS%]7+Îj~jrXUPPl,S.)Du2qrgH\&餢aH8, DO7"@@*,XSiy}-z.h umǟѨ1yHJ%e+f% b~jږʑ!K餈tXHFy1_d 9i9%FWa`FN֏oU6>1ҧ"6խU"!<32%Q*f<%Ii#b|TȖ 8)GjD́dtm-,_tmkŃ]_t_w]|`eDAmLpfV"tnKR%q)yI㲇%dՈznLHK B@ 6X֬6c7WG0}wv]:֋5-a9AZRNV T#$Jđ%"\hrLǟ7J#rn<[%/sڥY-xg ~5=?Xt,S~gZxB/sI$4IŎ gj/C5z*4 F.!gCȚ0 -Em-xlۀl@З}pƁ}U7ܭ>"Ϳ{IŒ81k5Rji`MK vXQdbF0 v<[_o7l@陣UeEmz]~?hn/$%8vC2]$ow/4WԀWKկh!Ab;,å` tYk24cGfMcݬ?Q }#ف!'Gz6⼆pq^o 7}:Y0y!`XNKg j,eUL9or^!p]/?4$BQ.X=㴞0&+Am;2]>0GzbL;Z hk ,A}kPdk-[me{Vg]1f=Ϝt{jx&{9:jo|}{׉ϾGt~;߁pF:0Yc>:̓|ޖy9ӡ7Fy:-p.]gQMy? q .,* l!!!{ I 7kKGwKU#-X+:uA=zL[8 B|潚|w]=hil*5{.]0wp3GN RqU"֘[>s")ڵ>G6ڸ-xHY4Є(ϔ> a@TNq Gq2͓$ߡ(2)*%`8z dE!; qL.}6D3e|4|Es262'aqh/Ȣhf3 2* (\GAi,; <As Ru t:3ALd> 1y J ' JCʀÄF KTaP-!DXK/ldAV'ɺ.g Ivg|[xbd=xM4d'ѡ`1IgB'^9pGCI<ے!ٟ tNf@x&v.Ywg!>Y/yB t&xCȀ. &E [D(@/8nBܖ>E<C!ρ ُQx /(#hPy#o1&BPPCUꓠ4 ʝ =GBH#3 KGR9 &'}HNJ1&QOn=[}KAݝ <Ϡ#4>(:qLT}å A1(Iy -|v{8TgP^RWhʟk4Owyw:?.)4½a#*}P23L}*QhAd$?ҵj}jzoW ˦QӅQ9g0"7x&XśU@|e渱jGʰs)wtuV+neEc88ᑾx_~aKyrpf.l=tГ|{]Ċ:&N'ؐ=ա#1+mWU]GF&K_ n[nZd(0[mmECSC-_zl/yAo"ؔ-Y#zY[|%+p2\+9TcqK?gK:-;,J/Y_8Z4h 8NJ),9yL~#d+ȷ.ͱLlK2ȟ9( vmpo]_JSMk{As_%Q{k7%γfGpYeM>'( dȾWOz4̣a[4;Yp؛=n[m .ѕ++ۗn)ztAGd9׉+eU|Yy+׾ʾݮ~.'0FfQC5&2%?1Ad袻[~mC?h9|{ɉǪ]]mK:j\]Etm_Wly8yƟ8H%CESf_˖889v!5dl!ҴeFiK4L^XYA@3AZ6]MDj+.;fw9&G7%ƞgTF.8M$, %tIIlb樒I^֥N{:+vxof:4 kRe i"anH^lYXVt/#\Ԉ 5=/%z*"9z&,9j649j>$)j%=֓0{"_B4{YS.uEp@ k%Y5_qOfKf|Pw .F &BWLxYN\;.v% #<{+UͤHߴzrLNM~jK ODdg%222YI„)x䇑 ~d7*a:<:~7ǎ.DDaDrxY~nSћjᮽ&ʷmZ_s2P"wZ~ܙ *d 8ᇧOq#Rgy)~[& `A O_B'=q/n&yd,@؆%`mY`Yn`ug=w4{@7|I:H5 ?BHI t`{R"n>|bf/s/m!?삐OV"xF`'!,ɹ 0z}OX ҂Ag,7{Ɇ_g"D.ǃ QvGlYMtBt"s+]*W5Fh+ !:i__#;?=G+b `>7ҁO=3@$fAb"h%[WWGmtp:f}6aי D @+5zq$X?r'j"Du"֕ S g8@> űᴳϾ+<: D3q,]bk,d;2{!8?Ds3듀UHXAPAK },N&-*unH2 _x+lƴEwÆ؃Q7Q9/9}pŀw3Wq>&!?{ԯZ{d>@V#֊ArArUU=,7J$6^Z^%s^[%*7!q+C;Q 8/DN&A-d_Ɠ|Ň-֑{@w. …lٲt[R["WQT;KRgIO{[7c! qe#C1$WLhb- #G4g _4egy?YH_κs[+▲%kҞ+o.J{IEeW@ܩj$>đ|)֑6UTN-g7G8/yZ\ИNn}%7,ܫQ=V!Jy27ңv[V-@g_Bidg'=6M%sz_e_- ~6K]nt^7 r 9戞;O?O9$w&8|[ٮ]ٖ2h[ͩ㲦ԷƴwI dgQ@zlZhRjwZOkCf>շ˳ܳ$ٳ!}*$±#I8ܧjѰ귚}#ꆵշƸ[)!ًm@6<l&} ԭmݣFyN$,P}U.+*wWdS6g4e6d\Kٙ٫NQdsqYUDH$[G dΥ‘2VrG6O]m5n6;^.{vW6g?h䷙6 [ +eyU; jks?լ}0RiN0-1VU0.{$mJ l޲T͡ p<߽Vԫ{58xthWflYWf6nIY\#-lTWO0vZn|Z^03 iMqTU?(˷y{)L|28k݃(7x_h {YGՌF6Z Ě*yeNfSkʦԒ4Sb:ST41L a&.&{S͠|>rǔmݭ%"J};uʍbBf\.1M),,ոLZ^ُĀ>ӐX:)(UƔLV&Bٜ3(CU沧iFuh:'ʿ۝j[W[Ģx=rzSS nW&./fkIiViqUX٬5X9SY׺-CuyTe4\ѪuMBXEAaIXE@0qWzZD REAPAܵEܗ#n=3v cNUԞ,gg|~zy}?ѐf͂1=ŧoA4ӵV+ok2?mW{$QRYk+;.b}˶S"{qIyy%w,>{I@m˶\6E~у*!ݮ3FtmuM原Tյh'ly}OqOj# Ǭ;&a)*>K_X?+w᜜}md}=@V^`O2w  Y٧DN6 u1ֳ.3&sՒ"/jT6慮;TnuÛf=,=sӪo2/ UYeCswFRևD"_IUǧ M%S,\RU\,=㰽CQ>wݩy'G,iY5-yc\vSѬc{SkRNo / Æ/?R>*FGRGCo#zTFtb=tG_]ҡkT%^ 1MmDd+/d/>08g6;>'^:1U>>f6#9(TѰ臝Dw]۽j/qTyÈM{\]ۑފ_q3m,k |VS\1s6zڌ1יӣ vyŴ#>3϶խ!h?ٰ뮈ӖO8:>˼&<ت};hVFByCx]DFvAu:yDgD7#jnfʯӖ"kNkzżr =ZkCO]JOxVcz>Fȵ=U͊t2T8w(C@u752ω.4>/N͈V/y/eTFWfɯfOxdחa3/N׷!oc.܂M |{FD7$/!5Z!Dul+Xvv'_=7-)_3{p~jZxY4C UClw~d5IJAlbY?hGXaD|K#Q;#JÎ7n:Z(3 BHc?d`l.ATVK\_0l_Lj*P5˿C)EpVCԿ.4YEjE( "A% #@#r A("HM׫XVG+VWZ]gߝ/g|g]ך$i VcjD0!D hzG[Cq n@=_\r}As}F} ns[x ϫAy9*Φ9|f9DY@DB(KD*׌F!.mz?2a4;Na1vk ZC狰oR # ~H{/px*ٽ_ LJjٰb׻ͷ=o:~y_#!|\qw| $|ÃQ>P@)wusW`Qn2#5hyR/ף5n3Q-߇/5uM  N :!x\$hB6&P(APo8.S3)mOEHd`\iXf6iK'Ed Rtv阽';' :>|$l*@zg!U 4S V, =vS^jR \g [ͨ.Ǭ="w99)xOHKU|%i t D0^y(ewE&:bh F 0$@@)=Į%Ωs?A şS~+[ovlLqɥgr"2.GRIZYEࡄc|;+#vl6Knsc$SA j)0@7b-ǮȳCcSSfz3%쥓a㹱.#->J ;,3*o&e=d}06ߐp]PW%n 8r r`d0q-=-@Ѝ}M>*./.qL'꒮O+IX") ]E7!=*nFgfONTF*=ERώ\>fP陕}z;D/*'Dˡ9a~5i(akRe -D}/ =˷Duz|o.5-Bg7߿f6x@ wqo]GSI:mu~nG߶a6޲z1hQoge!̩R^[.*KחkUM/+(L U~P^^Z6j`0pXWwT hu:yMt52-&bEKh}]m[UM6]e_Q*P+K+njQ@ɵgCe"y;B;9S w!!tC}fh@nj ՔUOguUMbW]CVm7ϐNԱu/ D{X[~|pL[V)DBwNc=fh rͲ]5gm[Gn˞YʆܠRzBNQH~T Ș Ht@ĖZYpـp{C |i/CC._-+aNn݉[S;mŴݭՌV"0G)js23^;B|3$toL>,u'{RFj+E^O?dr7 N07]X!@*Bw]Ad Bc _ݤt{+հ/7дܰճ76mDԲ-[;cxD崥>KҩћԂE->8)@n;)T%35q0Ͷ̳y–5;d&ҲS-<D6zvc_֍Yco,dYbjmt"\8\ۅHMkD Ds;^ ,4㹼~ocd 8= TxV{ .\;vhH5mL¯.CwC׏ma3>^gsX~G[BQ(e>*  MCraxayFc xGaw$xKp' l`3vog&_$*BM# |Ʉ@CBZ(( *.\,\ xH` X&c ࠇW!fpU3+l?D"\" Hų: Ix C =q?/8T 籎簝'c??g5|M˾Erb(xS(b DZDhĒT /j!8K"f5SdZm$=m2] { -HEbfy"z} ];ҏ|!iү 9ꏨbD2wa1xd] ԠkyXzLVG'zB9 q h( F|?b2 ?ɜgfn3~_r B,#dX,TzGPA}1a4{W#"f2ς友#; @vȨAKH?0q}5HpvE,UO ɯ)cI n e@t 1W͈1Ҵʶ﫧4mbۄ?++M:Hv>ɻ3q3r57`g0/i9XߎM9#sdkQ5nBN y\8 <; ?QB+ y#p!uNxʶ [Ÿ] X&wg<%ݫ:0/<8S6|n:9@틼H뉸Axh|KD~F!ZS4.y} |&t3I l}#fr+Ȧ0k4f,9nD$s& J{jUwQ1k n$o<.x:rVȖQF"vIv$5 Jst0k울 NeNEOU{JX( Z0D] (ަi0E&pJהFߍyǷ ʣl2v2&%ݵI ť3ɵD K%)^U / Es !Bh`/ {o. c2{WTKEV}9{[I rU:]M/6 %}_7[͖7[|ĒC_dD[ :U7JHu!ܪ5*5LNe莖˜=jС&K<\YH)ʨ+d nQnz 1!Y*bRSv10x{J.7[$5; לvU< uSTbt<%7GEϒ׳dYa$8̯~Lđd"412D Xp;O눠kXMaщԭq-5ǷUWFRW%TVzeRkYE;')O'̝{/!s[Y)(J"j& pk0hkZ1i8f .ZU*+{H˔Ԥj<|/_|b +.1]$[=gp{W#vVvYB{>bc'ٸQ9jU#'!@jYR.:S%񫚙'+|*'88|"*;R%S"h5[KLqf`34&w3T1Lz-#6-.Y(l5+ȼ&WdC#- n Va#FpV#ZX+*_ͿE{Wp ``#6ფ!ly +@N{Ss\»JC:՞A=q;mAԣ͈zL(Auy{oq`w0@-vвuq1Q -q/xl#GN *v:s9>Վiq\r@ o/"s;ٿ}52GpsgN kdӻ iWRX0o39jUmW;'2w(tێLݒc} 9. ra ut 4|$@MH3v;b=IQ>as7[MΦ[sf fjvg:`Kږ:duȎ1{\E+WwA'@?@ίXΟH m!f[Bਞ_l쫏^'1)i}g6Ky+wVn|8x8]Mh_ο-3'pC"HvY(9yѡY&/J9hZru3W/~,=A}ny;P gD.~gЗL{(m# a!: 5px7?ՙSa20 f`FP"JQ,X"q%Uc jtE=.Y{uƵG"%( !;O}}'~$~0Ofh#v^R+uBW e{; F;m_ x(6Q}اD֍"j)]5GPps`|(|H?-"")bϏ߈5X/v~nH>6J-߳* .C4'DD8?( А:H>0ZArCOY yJLX R`Ev%,M4/q-T{cDAD 38Ӆ㡽.Cw&]mqm{w'♯E^d֬QSzɫly]jyh'P=9]}GK4wV{Ju#qg|&xBSFӉПHD1v( Cjxm#TFtfNLPɮ+( }߆}fDTDDYaVePYM*X&FM0.59Ѵ1ihKs޼[ą3r { ʏ2hnڒ۪1Sb_ǯ*Ҫ=RDna_Y9sMF"",MB0R߯iPQt &VX) wj+\ټwIl徼Tʜl~Yv)(NBQj& S(Xlaᮔ^;4>#80Pk=uL{Ӽ/xE}ZhBg./c$18%#p0U$MK]O=O>d(NGQb. w`1JD}P:}'ih`A=hcZU4u kbMeՉV9iҊ~-FX_r'N>++D8E; QB`4ԃs5ԃz{vH[Cje-ZEM+c-$u))Y$TzU7 Uxm];xs6pk bJsS 5PH3@/*Ʌ.3rev.+k_ٶ0Ӥ{,wdh9(w辩KpBr_:lEX z.,^.Vô6T~GK5=Z)GvMw[n̳>\Q缮kD{xv;a="zNϤB 4MC rfh a]';m$gxF[bFl6_7 o7䴺)AU輺ɡQA5h8AzvV,Ns!eL83 Gx*NgLбB㐱Um kpooȱ>^AwP~1?OH1Łi=3LL{յ3OǨޥzZtnT!ACӷyFsh"D3\p-Ds8I?DMy`%6U" lBgE b eJ2L^U++fMOe?Y-k7g]ew+bG)F)O+a5Xs\3 )ς@x+܊f֟btRk(j/˔? 'ODT up~ `$lF򙔱xV2eы,?xO{*PuAo_t?_#?%7j`X~|0^@0WANx絔Ahieޞ`og?hΓ|9g|Ht7B|{`'  zh%hp440ppX%B0H1Bo FʗRQ>= X=Q[LɅCy+)hEˉH #[!`|E~\BAYpS8RB7(ˉ ro }bL x`B/Hb͇C<hƠ3̕A#z jAM,H`Z&)&5t>2L$U)}~D^ KK0hȠ ]̝ACo l`rI$! 2A%r|INeJvv :2hOZ1[•XB\RJj٨B: Bw,\'u}GEugqSFA"3u DPAd230 ",BK5ZWcM=hbY-b'su߻}9(zy'V&q_ Nq%]ev^Hihde-r8hQA:'hE"[|}mqBLb?ǖ( zŨ-,rw( e}ow?$kxo%7WCgҋ_w?=߷{'+E;oKQܒ(['e8s21E3fNPxpz]8oW.Z ?Y̬ Y 0/2]7\ g'\e /p@w$@/#@oZP/^z~>+]}A&ݙ;U'b;>3_q)0JƧ(:@38Տѳʰw҆<4{~ެ>;Z&걫ٳg7'dY>=5qχ&<ޚ~f

#z}b!\ C a ZdC_E yN68=qh~y&sL?ݢ?`xOn>A]gwd-MwN6]V@A`Wal-pM9G2p:ҋ},b>H.p ,ݨ?$Ev/6߹r{Z6A[K:K7]`'QkԱO/&f~e%<疈JGT؃q=ѱ{#4=]7nmtۯ6lM%YK#٪w͡hOPc8O7cq>_'d$8,d_۝P=>Ұ;.AԵ$lSlEGtmMֈ6eY˩1sC9z:N(#5hWұ0e7gRYp" S'g67c{g7'upKJFu=1Ŭ-![ܪYĕ6/Yn"UVѩ6̥2+yy]7Li :Ƣ8н}I ڍ0۔)oS1ņ,؛m ;s䬞l/^g\Pu1$U)&uMCR.־:acE|sejkQ)Wjvţ3q$2 ÍxAe Z!3|gVglnG^[΢ DY f itMuZ<ʾ$ɱHѩII'ܴI7r/Z52ĉȴI0.x82LcTe} AO)tX6eiʟPj=VٵuZaIBC]U(ReS*,˶I+-K5;w01E]#.BdSc PFF 9Pg?\Nay4;ʛfq+ Fuj,ĚqҘFYdNʊmLXŠKhLX9:RXU[<^H}ݍkW J8 (8g6NZ`jNmzN?f`afnMPEESkٺn]6eyZ(*X )JYYػہΞ;0}'MZB׋ǽ2-c$)nJjG%W?ō'=vpUB`J56<ցYki3d^S`gꪉ~E+߷bz + |NXc.tsȥձK,i)X,1$f=baoy-~KU^)5cFi(ޔmJצJGxiqoMnx$p̆; .X$lhIix^IUDnIcDܵZ"sVIdގ5^u+7r~v'l3`Jy*qEX[Qsl$S}Fna)kֹ9[V̭3ʮ؇-%$}0=5P-gťʁi\&TwWQXJ(W wݣwy2df3]/ӪKR\;-] lI6h )wHp8_\ɞ:P;`yVCNdQ7F׍j)3u{&կro7$1T(c1f`6ɝ.`2Wûùf6hXt$ G<gSFcwAUQ˴2-Z-~ˣQ;"ijro`R?PTY@Ƈ& cO!g|&_$#%;`?;}MCO"h-ݰ} `;+BgDi#3~n`k/b݅ F I'3@9=.ak[,m03Lv^NOй^6Am?tuނvU*3N5?evSO Hflo|oa1:w4;pPA7 -`s̟ɹ2;ك?e[V`'` x@7BdNqL9ćᇡ7\.,P.W/{rg̎ X>̽o,v$'ehB| CG{"$(C iJ0~OzJclr}jO][B 9 <9Sb(T/yf(ў:-TDA@'/R'yN[ߛ3?;nD$_}š-&¸P9^<~4^.0#;ߟi%G\ )PaI6Re١Ԫ֏ k괶MM6ѮAbN} :F9UrꧠǕiE`_PKufT :kA+i_ !7!q6Tt-? A$b@k"q$>ǫPZ%vٱDX}ب]ti;֨ڹS+D7Lj:##ݢ{-T3$88t%|t$ˉWӵ ki-Η=>wqڹ\wYsssy6%6{6&]jH`T$>5@| q4Ay@+#Wӝt[ZF⋴dډS5?gcb)+ )yLeKgMi4Hm5M'UvSUX*iIXgkYᱹܳ5 Sհ|w cemyUWo5+ o" JbZE( K!@k@E(޸junkn۱vvt;ad?=s9s߰NJbMH k) ^ ك{x s%' 0!n%&,%^JR/5|ϹR3qS։ةPG2{4!xW!s΀e$ kg|¾Ct+J\V卵WI*9}V8=0MTL$[ƒۘI=!CCY=2/.H]r³ זDظTuYc繥ΕAt_fMMtf<gTF0즎Їyj^]w!S[lϩ mn6gu4Caͤ&s>*Ie#YBCDHYCB>9Ήװ{^.p!g 0e b GP5&0z ޝ,}`k~ I_Zȭusf털\;')Yh?P[xJ$  |s×jߢ7 A R7 `LRʢܺKeM "]`Ȭ3VVs͆v~YQaIH?+)/n(|+)1"4#Ucpу. {F[UQyнŜX[W]_]j6BJj9%m|cqP4*Ht+rޠ5~#0t`aB 8Y0O0{Ͳny\VQS (2UXEj/-唞ה^dޗd3MD1AJ^W%fA=X4By#45Zѫ ޥ~E@C]S_kͭif!azSz;\Yu:\YHUITf"P _]AxkC?4 `Cz'f,@w ;kW j0\Ž-nؾ$mˉuY [uMeW/ة)ZxM* u]xpNA{&q38;p;@57h~D@t[ۛ NDn^>pW BCȃz`uP y2cc}8ܻy3itu` cOx>>ޏ;氨lFຕ@Cq \֥)bJr:ɣP-g< <ܗ\;JܖᦼUp8^E' 霽:'8^vMm -,U)Q٬jifM~/-߿-4˩ŸS۟*p-lQ犓|P:Ma(UOUϰfRn1MPm6MWf7 l0Ԭ7m\keYb׭Vh %? Z+jslgXgzj~:J[EJ,6PnLW . )lڜk\]n^bԼfy\d\h,7W9aSs\ Nq+H eu-??;w WtX1QcJejtȴ* OY4KTh;7h.?~vP}^P}n#~zБ]N-:3.mKvʺ{:+=TFiXCEqYZX, SvfU6zY_L.4W:~Frǜ !{vziBЏdO%⹷7ubM7gjHwP,,ΏL떢u͌lsdvq);|a\NwYo _G=97Y#Y.{{3~,K`E=^&W{^VocvJ4yRp }بR=9$A_ٍCf =s c;eH~kZLtNr"}zpppc-4CJbe6%%ppj\&#}YI %)֘ꌉ!;_3T#R4b JIOde7 1P,,.V:,UHA@*`-k1Xb]QQD#UѱrԊ:k+ڙs@wŤ,F/(GFWύ8;jSxTQWc(a>_# }xk+$|dm8IZ%BN(If4-yYrR"!1ba\eLBUt|M,9"V6:p kv A>0^舶Kgųf] ޹>-)9;r=$eѹȜ9aّʰ4$Khz: w=}lIV|(fYb.sFx <%!e3˦˂KQ~-'-Vy[M(Yc^IWؒSڎ]*lH!)6=g;ؖm^!I.I}*$BP# `hKWjlҪP3yU UeXxUYRzVnQyTWW+>j a^c{s2|s@鎭WU[` |7q8P3kH̐ Y I{6+1n2w55w1lmxk:VXX\s;}FZ:K+* <moԪYG]׏[\?Mx,i+q1K6HVȆjdCLN2T+䃶^7τ={tW MDofm]2 kPO  3CwǀPosc6.C}$NKE%q\[Hv l#z,za ˞u?0 &5M:0h`<c=F`ӒrXBz\U3X>"$d382;s `. 00(лв]:!e mv0o E2 N?!kvN}'5) i{M'܋HDrA..iT5/Z\/_\JyC2h/`pB/뭐yO33OW:赦;X_*8kx!v7\[cی@77,]N)KOgͣp4x0mځ=jz/ȏI~"r~T<</qC.נ(++7&F,(,ȲܖEvvrY˂+  ".!xCEh&Fmc6If:i:MSM[vڴ}z<_9y>|e >X6e7pmŕOK\@$ dXqu,xFVe *U-])[kkݵMp={aj1drrr_w~ko7CfC $r"CkKGmoWkqKp/4 nRZ.GRZpP9E;}VC)g~֬(b}Bq}Lq==WΑHH둄CHW ׇG17r}G͛`!:)3aNi(-)>)ɲfiêQ2{88}Hca kl!Mw07ߟWЧ>(U Qϊ귙.=CӞOQ[2 $<%b޿{?@ωlsc9ʅ49Lføv33 @fkזs5ތF~OF-L/jOJ[>})iNؕND"BWO_zp}b0L &tRݱp@Gt>ի/`wg[]6^g@ێ֬@wV?Ӓt3Fݼ^wKZVw#ơ#"$9p7\G߷`=` ci`@J0C1)Q0󊸞<+ߝ[ВrE 9{NÈaޒWޕ m'2H1D>O1wW9K(D}7 A) iN3X&{m.,5V4 ZE5=!8)Ae_HSGD瘃[xqz~\__z_ΒhlViI]lvcI>Yb9Jl5N-,+̃RaYLPZIXn6iH; \>b';(}-ügyQۼxQ}z ?jXxc^.=.vv)jdҐ0@+w(RV, Ư\2ZBm6^V{Nr1糨{{i'҈ߕ>԰<ɃȣP]S!> kjX?7vy@E}eaOp}P, (q]ՠƂADET,NPXh{,G$1qu]{Xۏ{@xgygΑڛ%_>`Q2l]f(2C/)멷4y赌A.| b38~Z9P rxë;<+"Q1ír\\p4éUp,2!9V3yLYǻH?RO VF*gS݀cju#`WDak261ZCcIڲ*K%\@]+!=bԝC݉Eݸr6ԯ_ȠAVh6#GdeYPV: S^ jO-Pwm.߃k=?CIl3Yw8ߕF6eل\dikbR5љ&+"CV!V`zmDQ7+|; R@.Wtll]> 7 Lb|II}g'&w!h!y6N(F{;Q׋]# DuOrLhv/C?[7lO 1yI#_ҐWhv<xռmּExD3=桍i<,`!Pqk6@kA? $#dYM6RDJvRK!u/+~xI!쨭PpW;H32$t䐍dur .2i.'WG ƙ5H?2|B>N"u9RkC:k%2SVo>~CG7A8RWm! GzjXjMf|tX@Tjds"@# ~I p'4q7F \hK_hZG9&ۇGx}Lԙ0&He%rM8O_ŠS 8tZ%#R9SThgG8A'5qU˲h%|:bN+qJ'98̃UYê 4jpHՀ&|W2cjAxQeNW^/'7~}6}pV7lGX3`?`8nsWu2:AC=84aT9F@YBz7ˈn.yJ\C;N;tQwðԹGT{$aL敃*|Tx{JHfKi IA3!!Z=k, `;孁Pg} lʎcPR(bdl HVJ TX)Iy'e~LY֐՝FRK03Ov@ol=P4[Gas8OgHy!s!) !!9!5!U!쐣eOKC"#TțY?]8iG,=c~3XP7la(<`G`q8AZc"[eLeʳƕLFEq2ݸS^~EX(\(I< ԝn_>|r8nU =+LXcFie%-7e&2Lt\E)EjZL1S-0FlSϏ8gj1=6 ,Pe s :W|j {Kھ>XX? #e&5E\F3+Pydvf>6#hE ()Tm(O|ǧJx bca@OdFwƒ0XiQGdcNR̎LNNγ]mMV71.!Fh*a`+"}ccbuX2qH &̏(͍͎)K#"q4!SR4VhuGEyafav .D&葨((("0 ̌ (qh]\Q0.cMh4rZ=&Ic\kmm&A;8}}yIirjIjI4j{'JxU?3~F[6a>(ѠԦ*CPnH t$=WV^PVOW5MߡYgMYHc֋*^TZRES.qaQؑlZVudD9TfCi*LiPlJN]Y(_Yeƕjq&˸KΘqZqC&#CT ҏ}mf`69x%RuԘTfbK0ʬcQbBA>dbJxyhI%){rs~0AZy(R+‘R9HLT I\E4L6-U]ު^WY>J",JB2)ʰ8]W߳F@̯񵲹瞂ĺ0ǝ"ĸ3Իd宖N/nO}><<P{ ~u@7hYGo ڥŠ$;Fc@G8;#\<өG]  <M hw=n];G;65+P`0^ہN``~ jCp(C!EAeaqC1}C"? 6je6րv1.Ao8]@8B{|a#hB>n~psynu󘈿+27ԝXg&Qs459=@{?0# pZM3lF{p3,?gyٟ!a{(pm>/д.d/`=fC70ԧ'J"H5K\~¿ƍ b^?EnD|B]k4RCIX= (z%-BR&kOm?rw޸p0>&?624LIþxq1G擕ܸ*Ǎ+GsѵԝP20l<@?F-5Aո޸5ZxWXwq+0"<⢤MT8UKƱs qW\ %uW7hZpYӉQ\ňv ¸C8? ΍3n&<ĉIdGoN~:G ӊx0n11W&%atrF&0- _NI~GH) ^?`ST!|:lG0V#ӝ84ߛш3۱j웹 Cv`p>ݳ10v%%U'8V? _LHjȹ{<3&̬)8>'$r&cp{T`: 5cgP'vö~ak?|^ .l >/څCք|/@܎FcyG92]ұcq6-.Rlw/# û º]bO~qui;X\/=R}F4XLk6c9 b r&G/Ė$W|ٱVW.jձ*]إ[/vI!-;*ޕb$7SjU=c;3Ҙ?ov$/޸ذ, Xn}+Ra%=W.H Ƅ'NQ?RjjWr^\ Ekp4riӊ 2)I~<'yNGWJVRn0͐/BBl4ԉC6 rUe8T.j* w4eߓ(N*;STu˯lU' j^,^h71nFȘyP"\ֹ-B-΂d,NJ`/( bAAdHyղ֯dۆ4fi,5L}2dZU%3_S11׫=W̽H;Xx:O#c㳪EpFIB81(rБ-6!Q"ګ{dwY>ey&& MCMZMZr4;ej\A+XEq 挄2r˲S/dSYlN)ݹINuVR55I4)I%)RCm|GiJ%i"ߋk$UNjr!ۥɕ,]]EBLHuW ]򲪣r|ը纯UUT U+Wg`/*!mMVXE] k#ݳFz}IEDŽdAyZ8Z1~SIOrYSZU!ϸ\R㻤Ž@H55 IFJd$LEb<[ðu ⽉f`ׂX.omBw{P ޻bh'bh*6FU {'Za'|/^@,%#k& jU8"W-EĪdĢn+ºKuG|qXYĖ,$&niTUk_p "$DԒPJ2UcLUjj:Jϕ:Gr#y<꒕Ȭ g*]FhI#tM#44B3`i M7-a *tfpY Sa*gC~mw@^dQbOE*<7Ps#)7Fay 믐  ̟j_v;\y)`jcmAv3yf.fN5`={e!/b򥈥Rpq/R?- T@iڔʿ4A~kS>᳾Ҿ#WO?V&ٸ\)"K/ʥk%<Xp1Pom$5qQ cXFTޕe) SM4PIYhx>]B IϕR)51JjIb۶21 ocR P RCk(b Wovm7) ĚzrjE oTK;$]++>v۽ c~ǏZZ}-ͥbbjW#0Gi%oFɺUh$/5?(G ~ŏc0$~b9EQ:_|F^}I;l 5wKa MchJV0E:\:Ǣt%B{ KuL/gds2y4]!T=AOI.?H+XMXPܥq>gA*KczM#c/v?>>~_zNo:ptp0JSjc &C0&51II1/gה_q0ބ10fXP+` -6ПPOls&\wV6= 0a&~j [Z=W^u_:Rtzme.4+k4xƠF )O ί/@ȉ+f7!>w7%,ҹYn!Kٜv> KP_ ٤4*3ZzCǪljjm3S/`R _Z- N!Mhon6\[b6R\wϑc*=Vc=?jCZyF+n{>@NZ5/bF*#r#7i{YQǍԨ+ƌG(HyNd7xg{=Ê6Wvg"7*l.an ZЭ跔=Js'jvLbR53fg̈YaT2c?5b/ScSbM#I̯\%gˌ\}2|))enE1>=*U)@=Da)fn$[IcuhuX&L;by7q3qFzWhD{o͌ qڽ]iVK4+>B =5#>4`%ۆ)6ZSmD{d[1ѶИ`+UXj,m\Fλݳ 1g$b>ã0{ KHe K"I&L2IfLB&$$C!"ITBR, @!(}cVVc] B_Hg3s9|/>X$E ҐcU8E5IsT@U-wdґ G@2#Xa:Ŏ;BGYn;[ycq9.YK$_mqg.j]L,kc acSUU TE<',ݩӣgFsQ3Lw[,q+'+yN+fNj?g8IK+MuJ,Ty]̈Qif3ȝ;KnEFk\mǽvo[Vr_\GF9ƱlMԀxꉧ,'r`fE8;J9SU3GK= qɔϛ\o@^o1Mfg<`9={4cVy+󱕒c}fCV?8+/n-xBRgT7\c_-or}'w*Q?_n0#b&w[I^+Z\xm&}$=o%PF0 7f|>xhA,BeVVQ2#*RzTVj|&)ԥ`- V(!x lc 4o2cؒbی-͸"ۈ+c/bO~o&j`C5(](ӜUʥj֪"ͬڹԲԴnѩ=ɵ(ۚ\16&貵m<h|Pu<شZՃ4>\3 i7ѴxMmthJcuC2Mjӄ6ii|qkzCz[Qk`mD#hl#Yy&-)tS4s!&E:TKXܗ.S p8.jkaR3нAWe4ހRbc‡/L>e~>g|A`fNmh5@8 q P`%:X>qBx_]}%~1%ޅ&V#7B%B70vޯեh>g^}~$%zEs`@}xËWbCaADA z,EL Fe;{v0-[nrt#Lqjh8Чm>ҐĞEP0'ǩݧ׈?L0?gpjJU^lbPx;w@x#F7b;&"awQ\r㑗#G~-QXM7gQ;O-SQp2"G#q$*q`i9-2 v/kΘV#cak6X.#/a86`Cj~c>11_Cqy,$Ȱ31;VcJlYi$+6%90HAOPKL=PISA&ze?Z#tI %UoW9R2yWP~XaJy;RU496*pz9֧1ڌv d?}ѓݙCM7!Y'KG=2%|'>KL!rl/碗͙s1  ec [Do=9 V8PxWtS9ڕ{QNUy^ g#?¡3m>K,;&Ygɸl`\*cїyŸ_΂j ([ OaZ p6¥jJ4 ꚰ>ªzB$a-@Sf4(cCO# 1.aV-EWQ|řh/΃D*.m^4aS$E0 u3J$a"?JE>Nśi^t!:Q%,r\pVhЬEv6VZk`n&AaԾ& EQH5咸Oͫz4KI='=駛qfܚ%piQ)CSU6UhԕêӣAgF&}F F@NZOIB[%*%qX'{j}񻋿UZLXj`-P:FC#j -1tBo Ag}Bcr:#w#K V5HA 5Їf$&"p|wHdꓰb | .&7P[M`븪oR#$32R$uHYjA\, iD"*cDAtH8MENLm]'{LwXǿ *pʐ%DqEׁ /BEyjMl`֓&8֪16Mn?H}~~=~_Y⦎%( )Dn(/WS:`ʖ@Φ%r2mKʡ|2LhLcx, W<$Rk3`\r2#s͡jgQ[ ٙek,3ƛvsZ+*Pb[嵅OΗg S3`VjeSˌ[ۑCh(u:.:.Xn0g<̙+[F_sa SyH1g`^.@Us$z 4fp'Eg  m=E'{xK4bX94s퉮j#MCd;srÎ]ر;ر;h(|Ful]pwr߇ {)5՜ ݌>4Ap&B4hΏ{Hc_N`G#I#ůKuX4`;1'-cٮqux-tɞ%CR[1Y~ւ}8694.HbU(Mm™&>v ~fتnc8!;ݪu.4@W 9| -Mywt{>Sӆ#I? {YrU nGL_M%݁{ց 0=&&OVۃAcYp drXw@0C̄9P eP`~aY̍;ټ' K==⭇܁uޔ_8 l4r9 scxƎi )>s]u ~˯| | \K68ش +/cHgi? ؂.c*Zkl7ң49Y}]ZZ9flAMOŢ:#WϚdDǵ)ֲϴhN0ľᷡE&U봥w+¡۰m]w?<5nk0I!vßWÕ_n/*}cJ;U *4X;<1*J,{T\,POfӌov?)E]C)!*mU2a.mTAE5k)7Vy~7L9ɚ?^3kz7P2VkJ6Ҥ3J &=UjE7%gaz<+Ŗ7fn^ jzM9X=G(eJSF,BW(5x&k\A yOcB+%FXZ(.EQ6XU<+Ė|l%69i!]552{+w >4)l&MPjX&и /SJ ج%E҈ CE#\ 06C9,{rhaVᮚɑJ쭉}5 5D㢒46jR'ktQ@#bjxFOCcNjH, Q-נ\ZZ#mPGjRRc<5>_b5&.)o%%ŧ津4,ޤ5^أ'-?<*?we1 $n "" 2,0QNHAA(MqZ5q4զM6mzĸ&ƚXa9}"ΡlX?m _fK1SU@Y(/ir'+; ,E&C2 2UZJRSdHPR>%RBNJO %$HrT#,g= 3 boeȜ6RpeE+#=ItsjLJ26(\MG'qA;Nw(4bS:F @QU5ճwU56=ճ5!r>><ekzP )iluOy-P0yڇ>+7{4>]5o_pS$l7SO7=ϡ~z&j"9Ff3A(h ܚ4K}i~i<[dZ8ZL-P kygຈmlyh*^/|3Xs"kĚC 7IÚ%%m,1ϵxXE# C N01ҾCP"p8iFjz͚ 5Jc{Jj}?@?6f p뤰;YT':ppzybFcI7xZZ+ow^BmxBP\wFzw>{pbGs֏ ŜC9VM(gU8@xuq?Nx;AEquO/Nj[9WuqN ?%wŗ̺75f/NLN>V 1,vb{%Ө;[|;xR>prWJU}s_DщTMNΨ@Ə7𣋼:~ŏZu[8}D|E Bm'|.85go-/(t"шZ:s_lخ|l6bsll29=قldsۮ"G'#$:D b]Pr\l.`w,$ ϓTVWUD̮r]9 ];A1B9 (hr4*Ѩf,Ry ZDd+G#r"pvrԾѿ+`ܵ^ Gk4:ıT-TiL\Yn0˰/2,3,31 $vcxKʭk7V괪*RRU~V.Q*Jc;R{;G: rq+YȦcn:JFd)ﱰG}VuWj폴~UeZr6f_T=/F|Tg"S8%S[K8]ͱlsrx[}嘽,Lr fÄce.vLg2=&> 1,wvi9Tk%?k5t2Y$Dq"nG9orj8`!E8\IL&1B(iK{SH9#3jJCq'_vDSyʝi%SK,'r %pj6iLU1݌2ьQfL4-0`tݙ2y_ d2LG_d}>'.zi{XdU˜jɌf*3Y&w/4i'p y-0ws_c=om)]Ɲo6t=&ezX✖.kߜ,ȔjٯZ͛ٗs J*fwa=V|En+x O=ūt?*%o^ΒVGaֺ"tQޓDY3%R=V =xz1{GN]a92k=c`~53tRLrH[(m $`H#Ϸ\_!9 }ue1ӿH4)$(~I$ =5XE_Z#_t ^}Wt,RT$k$S @:;I Th$9")Obp/ yvOL\Mb&&+#rrC|ǥĠp!ҮZjBVCq$Y!6BLaCSl aTdo1'"lgqHLݢէ9(Ji+"J_1uBp:ع DSbsMa}aܰnBywx fkf?T#VJ٭aH=Aa+\89JI_4)ҟMDZYXI׃(ORS_US[Ƕ\[U\=%=@vP5,O8"Y=%]6mzI0H_)K0l>.wR )ZL-vj5!/Cp'V54Xք,(z۩g C|D' z "9&5xZpT% -vz'57` BcㆎS}&Tyi0(:5 : HtRwKc)j<)^xrS긭Mz[95YiGcݲ9S OkI7e.5ӍB 2{2ceey(Kk]XXXv]`9DPEEE-}3Ѫ68ƨǚ&5UcըʹMG϶&iLL9l?qg~e}yG㣍 Y&FaV[O?r&4ݑ Cƹߢԩ~?pҪ 'Ki.g]l穋 LhݷS c)+C7`?vj $ur.{gxhV.37kznP7I7M;*D2f;y6U+6S|}.UXzM|;]jsrE5zH]< t9}" v@ Z3a,tS|=t}M>|\sOzO BVȆB}24FQG@Ǘ9 3ЕbA\Ru!u>}p?^0zݣ׽C.RC('~n>_~fb/%||% x6Otk?Sn)qG>HWԟqϨu8M6u*ާVc%>V2e e摍ϯilJfSQM49αͷhf x%{Z1p"ơ4-6o,P 4jИTmnq_x y-5+8{wn}W0zh%KdhVWfvWc!޽LӺR8MI~Tc&X[Us<1=/gjjb(Gˋla5øph?YCif5iJ_&U}M (Q]HѸ8C5 TFU[UWo<=ߏ2pFqZ#-93#gjҔ>(BlQmp֘~+~e_UC,dlְڪ!T~q >O ИUEktI"2¡9*PJ4@);҃i Vgd(͑TG9du(9YgdrF wAF2:)SB}ځγ$:P^ ,g3_Yٲ5(ۢt%ggWk̮*\Jp5fuoQeEຬ(]EgS WgђL1P%PR]e`Yr#+sY<9Sg<);S2Ez7+;y*sIaSDn[X,4&rP ^pV,o4 P!2WdU薡PE#Q4NE -ZE'̃>8dY]p9dj FEvǮ"!fRzD1j56$HӚ1ZsL5Gڴ4uSv~LLJ=}}}J,}Zҗe-=/kMي\!iZP[OhgJ(~ԏ0h.CM& lXoӈ`]~񣇋5顸{ ٽ ]k4N>brK $B])f:[`ki8`ogg~rr9H};¥{Ev$9P,z)YJ\BcU?t-=7L0cQq-)8ť|?ct$`]9sMxB@w~DŽ q` a2B5XXQfezE|^&WT_?xNDH x&@QGՠoLNי1]e ?>Ǐ?Y>c2D|oI9d 88>//ɕ@<)3̤NL ?>ď0՝?{wgROyN9%x%cd5^ \{%e3)/&.lخlln应wEVوvϓ:^<@G!.b(?hDcy2ĶuDڄ]?Sm+_qх*?J&v%} (nC D:\fkmt*t3zs7]/Rk3ɰZ嶥jm\Lʤ"iʒUTZM8K[T`T}wj9ME$QnrvJˤ3i ƗR-gE)v8T:Lũ#5-u&0PiєA^MԬI_ ەO_ kx G҂Ҋ. `+ܔ9"T0k#Qi*7eyG(AuY`w]`e]]6xM0xD⠉hhԦ:M4=$ΤvI۴;^37{y{wiJ>SMM,)O"t]-)n~]6pDo}=׿%؃ M|!.oNP9M1#U3&_,UVSSE嶶i] u.XwzHb=xpgيlAS!|(^UEUY\QYM29m^a,-<ٗоY.e|9)-0pvӍ*-M0 &]*pĪ̑,Wi*-5,TRŮ:&5UW27j{/h*u]9rFc3e.KFB|P e;GYli*.RQyVe(S^&OF{f)ӡQ]FV>L+y>FG*^3T͑[|oF׸[SQ5SӨ|3kWo2|ەۯ4 \UZ FoTQ=Fh.& B }/P06Fk[yoHCY2uLRz` XmJ-ocB2)f(= &rkxȧPPɡf%*!BCC݊S\bo+6znڌ5]0Pp]W>mĤݥ6&*%p¹4,p(.ܨ0/6&f,496樎5ƌ@=D'Rb45ڸ@pDT#M<0iBSBca<}P{{$7eh6ugrј?v6ʜMncښ 0mx9c8GXfH⽓1[s)V)m)nql( ".ɣ=åM$wc:<_O&(ӧ &⩒iX tSK(kRˆpp [eg%yt2'9drcN/8&s-[ֳji'7UjCm^0}ƛnr ]"W4y&걙ztG7B=V6,Ԣ\1ovaM]QD:Ro ig3tt:~͍[`+<(f"$#I̯e'{5N1bhof=Cc@~ Wad 0*r޸ΞqM&:$fϼɀ$`8dA>ؠAd,-=qB~#M][}wuO|ʯ~g ryAXzEa N n2.SY4yy]C4b9eh'{̻Ja,#tZ\S Z!}5}L>U3 xG;h^ms{V3]8 Je|INS4hTO[}?#ĞIybZg)W*7eƻjArz}}Fwㄧ ShGV4\ԭ~b&Tb n_}ث ѫmM-v,ϵ'`| />g,ƒ8B-^T*G_L|7{٢mӉ9:w [iɨ Fܤ`< W;k,ExNT2yg?fۈ_FtA7 Z9#9NZ֓I:Y' \9yv2È?#KBh&t0UjgBF5׏p6XfƱZtR'e]o;v.p8qNlp9&MNv-mvJWrT+[v h5[@QZXA\1&  !:'}<_+Qˌ7ъFQ4$M,c]OxaYEVW^eN{{J;Q>!cٲ:ݏ6;I:ڳѲѲطQڣ")Qݶs< uM!}*FjT tj"W5=dƲ7k 7,jpV7PE,+s_ܴb%4J{JCvJ.Ym\)Weʘ&+W*ߩd~ Z4ZHAD˜*@#S4hтk"6P:MAZ]ƴwRIJfa X<1ٔ0974dnҀ9~sb}kIieF˜, WrFAeY*]YzJ9ZM `<ĉeȖ" X-V(b ֣.:c 7(hߡ} Skj.7-}G\ܓ<:B %CYXc)O/;Qb-SOYrʫYVI6+^UrD~ǤZ[ث&xFNjr;^Ɋphƒ8$:j0.kQmRD5jq*P mZjj9Ffy|Bu|A5WU| qOPٍQ4` z=^0>ĠüװīP.Zj«ɱ/ۧv5Gճ?(g.&9=A6Á23|43 #7964U_.4&ab1۸zsVW6t-ribAL"c+ǶDObIcN9TYPs46LJs;0c`w^@nwUf 5V1!a5&9f6Ԍn&لnތc+Z$_-xIL|1yyuz8c}:`?GgisyǼO& ٷ=0ۃ>9g4Ni8)<|.[O+q8O^aX\ūÚRZ#u}g\"ӿ30+FHaW MqM7-:uqSu_qp?a`ә>^h^; s͌I.1_^ }C~w=ue|>r,!݆!ytVLX1K/W[e2c̦Z^ً@'~yy_=ͫ O8v?;NDZ%n;7zImvݺ6[E֪] Bҁ( ʠ*kT.T`@`m2sQS>w{y+8!hn X_8wp@7)82}]c^e?̫ <߅o79|NFb-COoc\#Wp9/|^u¹|<~KhM^#80lO1|e.c_ރw&2؉_3/^P'=C%i/pZO~|1!} "zARBLy,|>Osyx4c$csyy0;G{ W=hϳ<*wnY6e6NY]adZyN8K΋eT/·df }?edNaA{)tg"֣=Sqy9 ܯ3 OTnawj~ m+'`6@;vahO0y$>Τ;{ղ2ŵϰ޶a<_֜B~c7EE]TK2/{]B?J5hgI8Zrs̜y)u&x"<参 ǃ-hQt1"Eo2KnB>6X=ҵRکڰ6Kc@ ZbKI~hyYE6VhF~ , )Y}E SQiT]ILkiS;,>Dj+>V%%9ib"6N&!ˀXf2ez˪cU99Ty:;QޣeJZV2V˼jQAE-\RrU!u9Eqs mohn0*]7t ԵTiU)CjꔴXSҤZnicƄYEyj0*h|JTgX>E:'?'n݅=XK۳|ý49u_;-s)(WaQV+TѦhEJgάkpnr*[yZsrW^Ru pSngN5pwoc-u@[>C )VB.1WljtU(r+RW:긂 ܫuonkUsJ5_#9ϫ}*s:Ļv|OA?tbqo&FxL y,j+P[ZޠMyu7)6U>(g9|'e="|Ruޜp-ĺV|e:^$Z"s~|KwF@܁rҪ d%"#O Y_%xQgTxSJ}NBw3h&hڡ{Pa\a.UF|rFBt-:'kt,=2GWY!D.5Wi8{ 5سly Cc~;7zUSr cN1d5OQy|Lj78SEc*hct U 9?ހڣس^V>7CPǵIrag+Z eʖʚpȒp1xiE%ɔL%I$1ILY( IpB'Po+h{$qh~\r߅uc H^"sʢ!Sʩ%) S jV `V4NaRRRl֝Iّ]hϠņd6h3//LH/S/9t5Hu i࿏{vw #A<0sqsc,1|rl7mF1f#+>Ͼ<>]s 4y%lH*P_rsN0+8t&ܧH()^b)e`.ɐц?:񣛜M'х.;q+\̎ ')'/aS} 0Pc7!g y?QK9d% .5u!}0klVO)^ތ6)`{`5=0XI}ƏuaK}u\kWr@nzcyGY<D^%-ći 5M7a&X90Os6&j>괟+V곟X!Ⱘ6ϟ!s=U</hr뭁H(!0 XBqaC*5?+8plI>| L}_cuM;9`ͅ9x7Z}k -Ǹ(dD\,FN?#'')3q˥|xCulb3׻Z>W]yD&Qp$ U\0!Vs%q@ϓs ,QTg~)!ĻeW9IнFsƺFA}pC&k@&0@>r0u-ys% kTmr YWIe{1܏-S׀CX5ȵG6(пјwUH}r:~\eM! s?ΣijOZ{$U1#1J ]v[>_mpmu })'hЗQ* 8fy >=w$) t9Ïa|$љY;6f_)b 5خǶ&b{gbx O)5dt;mG/Q'*;)p XUf{&wѺИPn.NVjd ~E=Kx:\?דDtO`X >-`U2K@ +\gQQH/5?z ORz^Nl߰Ǩc~g;h$i= lYnl WP:l7`{'!n-n_%sŃtAzDwm_P|ت]>`tdJa7#u:IDQR-4,MGZYmbÛV͵ǐy,G1C,E'9 'F;5:KQL䥅L>f2H6lq~+93=\ssAOǾٚ5E^8BpDJ8jnV_D*P#ĸc7|8V3pw1wG6Q)pd‘GnRx੅M؟Ld4HR1è:g(UW^1DwAýxK#>6s13:mԐ`ˀ)𔰓U W\ᚈxC v~nw]Al}`hi`, Y̹ßI)&;U^U'4$yRTRLPij݊.V8uS_T(u)G9%RQ}_ι_m>@xV˻JP=Eՙa2åL2TYrEm5WEA{kߢ^y䶝UrF8Xʸ HjFJޗO4:Vđ,Y**U" 3X|WF\~96>>`b:ɧ20ہZyVJ)7WJI*vf*RRY N@9U*!k]S˵HNZe^+쮳9ALk=YHI;cQ5WR> K?/Ѿ< *ϗ'';A׃AA?L pew^g;n ,$$\ T D8V^Bq2ZN6#2Ң >q;9oyn'[鐫%g+{ ]Il% e VP!d"Z "8<<]LpUq-@ԉhܛ_! c> ) $Uc֥ &Sa (Hw#)<as29C>q-JFP .~1͵~L{ MHi 4 -JG ll+@5c`*o >40E70cۭ +W/pdK,1!a7fF3bll m B&xjG؄;@ |Ro.<)> ?:cm9&'4^6O/3JκsܺbCg\o3@jiy\g6^g8 9@/}o1DNQCbwD&AzkN# -:Ncnx_`='d62!'#FW?r&eRR;㚅ͬU[uv ~&v6IZFPI`%XEnE㮥>yl>7 ,f=F5\3KTh\5!%>擤!s`1kD- ^[csX|0>CMlFY} s$A n–Z5d||X`5?b ߝ%b&&ϰo_`aM<~H{xy71RX:8{WYIň%@#_&A%WL$u8xWXQ>8B>0uUJ &^pKd|G|FwUV3]6KD_PLpoFp*%U~/N )ڇGNvSO8jQv85mjd+~Ɵ9ٹ!Mǧ);+jO,*.彦ֱRmʅ*Ϟ!y7'q&ջ>@g³;))*ɳ0Ğb*(Ѭj-JsHOU/Zl( "Tr O%*HV^SSSI++5W0*7BMJ3:eK1VmlxRS4Na\ɑJb1ǐ' A9J@!%7=A9$e(ϗP&#}cr?8ʫ o6$,fwI6l~vIHBH&@J$ $AkJJJRZjŢXZdZQt:0VvږaV;0/۽=s}o |ӷCyd}Ke+{y3݌slP⼫`M2|ey*(!Uh+ت`>9ò7RN-F 6`|KZi |A|lr :)wr(4KP Q~RpBpNˆ/B׏܆hDѲ!|PNc%|a#hpJF0ߕKżbxLq㤸Sn~ǐ Ѐ (%]%\a8g|JHlHOq4di X65|ՆoexhE0W!Д./n{y೎Y|< scZlŏv0 :rEE0&u٦0k@3nIk%e o!ya|HsvB!'KA#KYd>`]*Y Ճr\tuL-1GlkKx_ o8I/9kA!h.\c 2ꄯMS~w9Xeqrđ&fNjn q/X6,ao=puV?&kyGC&g3dL(9!Qjgky?ۇG>-})wžk) !#6ko,c\ɊA(fC~yCv&ړ{OK߹F*JyW=烀% qe#3pH\΀j<9y{@&/|N:gT "bc|'ku4Jg-_-__߃?[mrrz{ҿrGQ -@t%"}v̨N|StLF8$P3\PEM/3y^b}"3ɹ#LV92l+C 3l3ԑ)eX%x?<>j* -tL4&qXsh^x_xONjqJtR{L(P&˽v+p^Z!3Ne8qY Squ sa(C2M~] {mf{Lm5:'`6?)=|w|_APŎL籟.Li$_y=Bz?"kzDZ}p_!B%}'] J)(<5kn tb#BŅ9!:NwpCȎn$|_)nSV"xfO*xlyxH%k7xxSspd;I쯇o9r8+[@ ԁ8cҕhC|E\ ;{Tn6ٻ4wX܍*ɝyyrgEo/(3?do%3$$`BH@ Ud(Q"EED TPM(Ȗ-Z""Kw;=4s3_sg}ߖ6(M@rAk&Ь%vJ^ ; KgM@ úZ|u9I<9v,}l+팸 O8:C_ mk<b$J.!)A-A&.~OHtOHZsѴѪŭ$NVi%M["VxsRܢx:{u>4 gqYBzt}N}.ѽzDEģgq%+ġ~ŢNy}d8/aKbrg*bNE} A3A "M~K[4[<~M [[%VA[rNj?]༆ey|1G@(h`*]S@K!M>b Gs)4 N_(| SC,u%7$ђ4ų `6уv-dwCaآļb1a11NSaȤϋ8!5F -ESw':{U!<\>y0?*>⎤3&C̙",\&57K?GӚ 4JC96g! -dSCI23!rm3A{Z"%I cfqdZ$-*<|6xcw!^"0Å("qkNƤ5!96"M%3 Cso#:24s4/%RLZJkM[f ESjhrٓ\gRGB %xPEWjI],-VI^T0 GFZќ^IRkA#VN,c.'ZϕW:g/\hL1$iRUkkuRG[bNڱEAΚh˺نTIn}Rɻ@S3$( 4[f\" h /\4DSGwΆ݊+yލCF3gDv6gTT a[>u 4UFhF4B@?hI| baX_MbHДt%0>BS .z$f*|ըj@8:FF0'YPyH`pΪ4M LH9:KFf T{|jHh#OS4puddq'qm*i~RRB7 ೛%ljۛ ZoIq@>}j~&%x8(D笚|9*Ŭܱ֘²/wϱ籷2,A5󼎨(S)Չ$ф׍uUyd./(ǘ+ДЬB݆j>׍l[ {T38؂r99<cBvOUdN[`(Y9y 6izEqe-Z^Yqխ暶U_WݱSv7٫w8vC 1r17~¤Snco5{gκos~?.x?.|EO<䩥˖xz3ϮZ k^Z~Ɨ7ymn߱s[{o{>Og𑯎~}Ϝ=ϟ.\JJ]IYWQdg+/RKrR+kAݔ7) nƃe-ʅpa2b"NLUV܉w+3~ܘP~< y G+K<Ô+/b:&e+8fMy[sP>| T}<:I?().^J>\ͻ%~__b2lvǣaO G8#1<\|LҚ7?3' t뮶;f[mq&O6}ƽfϝ7 [xe+.j[ȤƟILiLT*Nhj~o'G~83gϞ;w?]pƶehbm֮-;zW_5a3Жj꩛sӲZdOG. 54PCC 54PCC w +u%^]/9 _ԏ-~kwe ܝVOѢ'~HPG VFծ=Ͽ1}C&|ww>/n{y /Mٵzo.Ѳ{_d'װ6Rk]/޳̾{ttp|gvzffgi;fiNд2/AoF)TLP. E["-)'-߶g/yޘᎀN"_ )Uka"a>W~ՓĢ ?J!&vezzc-̣>$CkSFkCe\ )j3J-)|ʉ鱶d(;nZs>ɏ'71ڿDX4 >J6 3O;F.^hW}F]υ {E"f(/c`4Ѭ7h^!}w>85KhʙHAΡ 5.-F\ |{Gq{im=/ZtUppdK*8+#KD0 3{717@AoPa.57d0~DK2qH9yBCOmHLU1tՔl2"8dX2, K%e( %6@du= םj^A\ˎ*$,!2.KGv[=ZP $A=]+#zw^ XaF*bZ*SRD &^\4h`C͏@v~'x<\վAGi]8^@(WI<}IXA-edYÍDVa( e Zg:8QCHz,I^PQ%xI-02,탡2Ad jk.s[g-HQ$Xi}yJ&E|Ne2@ZFO AF# zw/؄9Ќވ0RYeJ($9J;C`M􂜇}0 P/69&Il됼:y*LYT~?W@lͥt%SYBfaC*Pn;ӑW_ހ}]M*'(bN)%O2qbzȅ)}^KgX $'mo N_u_q y[r=P"fUdVp=!:qܴ.K``ZJ s^9z5-&i *ઑ9u(I#ObDQHnƖP VKE2jVwn '\G&ǼԲ֠m0NJ\ɰuUH Z %4Y@" 5Pog1ip`䉳ߦq/g(MEɱZ,T"V $KM2TjA})Ï9;g/(Ė>Ȝf+Z5b m @92v~ jl̆q'G%7B#~̇ސt& n磛#XB. xю?S]1a^‹w>LpP8:H"Ol@H4@D E> Eߧh x 3{ =p~@bIb)y`o%65~) }OztGr( yĆ_ x {L|@mT+5s7*Nȁ3GR]xڅ)|9x^d\ \dyb.pPdmkkm_"8'q*)c{&B?P|5 b} \hXL35j1|%/h`?b!4У( ^@9 Sa6r%'Pb 5A(=)|FIS|F!'AcIn#V4jBkn    {C.bE aԞ=ag*"tVP*GhHLf)sUQ͚H%PY~5[y6V!zgkhpwK Ly}\DM3 3]WdkijJ$#d=U$yA 7B-P%P_6`ׅ3$}N+5AIL62U`#%yWFSE E[V\Ks2[nh`ԱCbx. 蕽|Đ Cű-NV>ߊ=jVy& ޠe=ή0ۯk@G *h\̰O^LA m(U42fwO'pxa0|YPa47(t%1 Ο;\0^vwvgԟg oB l;e^cdUd ~Pb07(PfG?^;87rzĸ~_|)8Wх5SSrITdC!b@ As/=s߼tD[gnyQAA$LN'3 c8FBm}.)u#=g4b4~noUc[Q8ܾMYBy͇fBHOI8t8:K |H{ȠLdT}ūoݸ\7gMӫ[e`Gp=ϡnO"@EdYs@\4yjlflV/o.=ٴBj:*n%}lNmg[SeJKn/T^P@QQQ@@PA/],YinmyRؽ e[ C>yE@)H;a#ssEfKϖ?,?_V3|~lEfAx8䌃XH?Br_({Jh3[^^0_S 3`p^AkOot7$磐dmÐА P+6/ f^ Gp1~)$T1|RB.玦TMI千.YoA777SCkCɦC ?#4wPO?Nfo0qZbNYLn~(VbOKmkZeu8MB ̵Օ??#Ȏ,kNDs:#:'>V\9Oe t̚R2'L掞8Nhmנ镡1!?mb#~GPqEfV 7UO$K.R+ \f9\cLu%uMXyߪoNhkGWF 5Ak(9ԁZ$)93Ε4RfiNb]6*MZInAӉW2v -&Ġڷ6[ɐiuL Ye>3YK@e6rU/"4 SjbMCb"5b@ ЇIUBEI*w:SW.+Է[i>9Eߔ+UKr7Se@p^*6A3x!Y!,!*y-vANEM&ACӫ cuԆnvC$e^X_/.bm[rĠyb g \)ƴ&} IQRVmz;hgyn46,bhغ ;WB;b>tv/KWt:A`jNmg\}CEŴ6NΠ7Ҥ}4E111t"/,1AaO\4FٴC AJd2ȫ(8Um3R HaD ذ$[n+A? cSΙ# ͺvUD֜Zא )F/ (F;Lj! 14! rfס^w Y]1|6QHUU5gvŹ=utsԚSͳe׈2xRKFEMP81H|ZOgk15zq4`.dzXFPV(3Kd&Z/asbP+KVPBCǎOf{~4]=|RPIZ-` I-|M)z圾ЂxME os?߻IocA?c)ґ]쉗RtIZbAe򺣕EHE)B)2*AW8/1/o\#=s#ǒF#l{t%/NՓ % ʸtM~aB4|}MG 5 qtl^44ra8((>' ) 1tIDIz*5+ @};XpgӻG\^km'#!_ٴ_DTXrR,-s4A8K`qqY9UX[~M6®QUA۠]tw \ԮUGg<6`**9".# 7 '8́j');m{k&h ho''DX_A!NW1K)LY[FfZy on: L㆚ P 5ۗ@+@t =  򆶤YIVS~AƷST*e\W;^^'cF:/n΢wt@s[\d FPEt$H3>eOsJ0)/(kh@>Ӭn fvhN1{vgo'h9_ >u6EgZcin=aqWu7h4(N~ ="l'h0SFI721MGMl/ 4d`B mȠ84'<@sgV;5Q9Ts ny*rQ(FRiھ,&#{ZsJgK|ݶ ۷6@|ftgB&'=TeH[H}U{˚6˪Zs}I/S9K 'h߷ T7P1!O I=;scPcƪQm%WY.(IM7ـ Ad|LgGX"nJVx+9J%rS}Zd5LV%THdHm/6%^AfdP] ={}-*[[|SJј*9(#6a"[R)|Υt9Xe*\of{{8 o@eЅ փos{Ȑ選 WtEi2ȕMe*icAfa<&ZOki*QCP:gZd`"/zn߽ʯ'mytSqф̚t^s4{g%wQ5g,lmEڬJgd୛ m?gz݋NP*|3I;! RʼnC䖸 5mkey_goMi#֊NǺ_ъbZԊ"( D K! ـ!!@BB "ua(nXQHU^h?ܿʪ@-g{~o٦w7iaݯ'^ EQG TŶȟEa|1Hx]&]-E"͚`^?eܡaWtLmqu~)~?;I _)OԄi_hY=A.3+ݑq+rnW-n/^2禰gl}'=$qϛ2 &[ftC2.L?+N z*)ShSes s )[+,vU%8Zyps T z;v6ُ.3 -#0l&. . x D ꞏ|ces`"5^Y{JOD'"E5 2p!8 ;Bq(7n\v{>F+,Uyv.5ก .I- vA@Dl 8p}!:.uXb,15(`ռbYȅK2Uw ׇ _ yC7^R@qX;o;w]8|6s\FV[a4,/Aqp[k=;\ȯ f+7@!H26:C6 pm mlO +8{q\ׁD!P@rԣag BdIR&ԉqMYϢhc.ƓޜG{a87Nso5dX݋`J#o;A ccx⇿LNHVvL7(I sU g F3LcL.SITS󞞹's1{.bXܛ|mz^y3-9D^鮒d L4T ~m8d{嘳@_h[;V'(PJIki)%F'\WTonuwWIeU'z+fjol/c}I6K m+ΨU\f\VnFeoÅwE*I> fh:֥ݰ˧֚.n&(袔[1Z(>D$h $k+{*%KGuS[o{d<5mq|셽qj??gpzB9(RF/oeV[׃ZE-M]5rI@.i' 7crk]:_Szp؜q봋sd 2hD Ӌ>n_ҧʫW\[1(\Ax*P& e~Qaўw5rr,` )||dh2e"1!>1M><\( WyPzѿdf--hxomP1^R#g¦iIIVD6)/D~R:.rЬ,N/TV ֭],[y )u߃'/RBHoƒHgyQ0 L=ED] DI(>݂]+Q[W_M[f1-cC\ÿDa)5:6`5\,+E$Eq$rV7z߂jZ'W ۄpN%4X`E3@D߅P Y &( Nv /Wm FI,ˣF9"/*J~ ?*\8 'C| X d}51RL܁i k|s'Z8B$1"۳ uod8:;r8 8DC+D8CN@;)/S~l ZCDݑA5"*{&#Ud8p@>3Nl ]80 {`ma CVsX@s`5Qd3c&?.n)TC*בֿ$\)/]N`,w[V6/SW1F@g JUTC4$"1 Bg $*AHP ' `jAj9H7Z $d;A, Q^jC>A6*8$(g<59jCo_j@nEDioK 0W, `{kX3_*yBJZJEZ n $/F.D>y;5?5oI>,1<, 5ujS h5<:y)!j@Ky4@ݿ4$ig>3MM$" q:y;*CaӇ,.1ҽ?'qL.\|Q&$NzEseP ONM%O_P@<Ґֻ<eh@!Z jYu&o5C\D.S^GU$ͅ`̐n1p=pS4\:9x Va dYˤ~Hg/$'gK'd= iN%  t=n?e5&S74!i HCJ9@ї^\Z;=z4C1O#  FI%>Ѐʨ9,&<4А͛lG68`H7K ANmtaLs)JM .QY2%Y")u"bb] q@$8@50Eڿp0̿bv9YCu7DrV,8dI6Rr<ĵH i(ߴ׵G>trÛV/,أO[C0L]5SI =V E fKt XBkUSjOL~Wi_  鶅 ^9k>=퓝#ۃ͑QqMzZA(VIXb>Yʙ,uIr- RzV]@j 齒B  dW'`#g! ƽßo=UǹC;|{Z#"[o]MIjRE6') oTWV(VX5֝U[++h(\Aj|l>m/^7K>fs,ؐ'NYJdXʮK2_f dzh F<ߪ!zA=P4;A%r@Esw]kЙM? _p8#,-:Ym+jQYņ<YK G*hez}I$jp^ixo\GJ9t[ivO=W{y{7QUmqYd ݄/4s b)R$Ī8V}pKsةUu_8t#Tov4t_6=sꋈw]`X ҊsdU4a|S$$E#LMaT! LdN)σM~kcK_o}vvo8~,x8<⻘4j̒byƉ_Qy"Z4`k0mz{i4hހ&ǁqܵy 9O"n|@F 'gR> ݈6fYM\d2m&Vp73pp,gnWA8vx2 5c/OOp>D962{"1>m"S^gEYQϸĐ҂z6 v|yl@jGr j`bCo+ o=]ޜ3a93WgC3"㧉1ԸkxI!/)uJTm sE7Cj?EXzf?l^s_);xًٳa'fKf`cfKʂCgy!$a~W}g{e(]P;# Q7la 8 ` xd( yBr&gp>;}ҵ*!))6<קix A;/CԞPH i =H1= bPz\Qoh<-^(eCUM-tZ':-"%,X8.λی-~^m灴\qJw֮ udO~q|2PG( ac>lpNj2[Ke8vGEłH "BH)$${$!H*(( X.l"(3{9W?p.Y{ofF0  dI_}Rb/Wx"xW]^ <|s8ųq0}<Nb8!cVx} sɪ[1,Y䕱LQҬ-վ¾ܸۏ@< ␋ _x:[9pˣ!5Q-e'& 㤞-Pq$FDk (ܚ|9ǻenkxn1P` #|"Ȝ̍j]w{MEP[[L('1F:רgKjJPER+.4ŧ3M7XN-Kt_>kDP"ga^c'qqK>˞^=SgsוGŜ*OJ)*JS9ZSXW tr]:ǐ,ȣ+*,4EC>UuӜХKe"[q`/j, IgMk@76޺|tŦڳ1ѥ|~y M_La˭LQM-àͥXL$}9UBȹn&;t$=)Y-0epD`anj{9vZkgoaGQudC g Kv1[F?!RS zdH4%Y0aN8u)H d9s8g[lIJŴ\u]I㚚G1hhjsP+]ռ\}xn~sDr^G{TAPI =uz:ڬ5>tk7ͤ﾿Mw/uk zDs7u#)y)6YAO9e;푷T֦P{@!AsSwZCRs?U O>Rj&;ߨ}M[Z W}^w76MUK,Ց=8RAbyڰsԁ ֫ uTqZV"D '(`A^Iyݿ20duQ琯UPi5w["I^OjfƵ<ɕawY9*y;zZ]k^wiT4لݔxwg 10dBVI۰ՙ!NG|=xa~iw\p7?W^)m,m*m+w4XƋk/ TA!GRpn .q.qst [q3c>VFn=RRL{ e"Ibw:C/8hΎCBh$3b\PpJx֮CyK2c~q_vdrT]ptInpF"Sp},t66!l"FMl I3Ff9X!AN{H+RƍQgSwy*wlHڨTG= cpsdX"[,G\Z $7@t6KH  /im>MKH{ D6XkBA2]d (["O@~bN{@i 9Z F?x9 ϙacǩF9ݬۜܵ1HH?ʦ!&i#.QiȰղԷB!<y1v> eJ ?Vެ#Cbhw/e=(}z,~L:%|HŞcdA@6}GnRŨj=˱j*n_J2}rcf32gҎ$MIٔqQ~7לG᜻ vfOJsE]Y*HPkPNaZnZweCI~T~%c"7*kHNT$Kc͢ܧEw/ sGxvt'g@B6$7ϰ&5oT#G:i)E edY$oH I؄ld)C@+R>}/Ç}07H^0iƟRO~O$,i,K0)QN|BȢ`z@`/A\$%%!5v_k]7t 7S.lt9nF f=ް|܁Uǵ6[B!ڐgiznT[$߮sڀxoʐ8dgWos0f3iApZ@bڢ2Mq? n.a~DX+"UP"  "d&R0 w~T]sJ/)h k0x QbF-&*E jQQDkbaĠ8?R9Q_3kỵ@` ܦO_,Z_t86]aɿe?'#a ɻëVڜL:@?}b#o$`W{tC 5@; A_m@%kPkj~CfeK0Jjn@A((g4:I?|kXyI*x $%Rtfffjj3Q*jS$bZ\uab'q(\} Tp0zSs( 2A hBmT‰c4탱!]~^qD:M"!#M)Xag 'd&n,D#fa$ȋO0K!G>(B'j m6s+.\I9MD*9N` (7Fx!$fツ^kx]2_K,GT-t@B{,Z_]$$)\Na8XE= Ìzs\2Nl숄^ RMVBd2ePڠfV*`u}P\\cB瀿<JmQۂG0ց~Ӯ^ 7Pz<^O$B°7yi}>Ǎh'>B':8<WC𼍑2M0,؀oNXׂ䣮wvkʯHH|;čWH^: 4.x#=h1, -GrR:" `q'yq~=@$= &j ڐw c!o& 0 *r4bY0CFsȒ,!M[t=NU")3`^D`0~폰I𱤡-YI|89H  #D:#eDN3afȎ\E%+!_q U7xw܎ pN}!kH) 'c-uh&W؁/1("B`p7Yke9⬐˶ETxATGLroc?KO~K RSS?{i_c#:u6ᐼJUOjoSp 'r"Rqΐ1QcM#)'XkF/%mG{~B?d%KD.vX5u3Qi`slBE|q볢0H+z/}+K~?Hcd`v1n O ?dh=L-6kq=NƙLR =d,GJfb *`[%ƶh>U^ذl`=>ԧٝG0odg>$nޤ__I\2s)pFn[lu4v?5c5vwֿ) eG+ ˙%5oDH:2p~LξɹΧ}⏰O2t.KC 7:y, TzdVG[ʾ=VF9Pis.)/w"`8P#~}bC:1J"n!ȼ=sSbMsF])c~.SPnrn(W%3ʓNcžQ[=T ,BBxyɮht9e5hp[Ԋ˓vja̭J9jsT}vi.|oC#$ $Z-2dAC.q {'i:&C D,{ږ^;2(+r9gJ' *GUYs[eu-FvAdOse}N6V i(&A;}_;c䰛p­s}Vt*YIVe˯W6嵨~[TsdJiujejekq@H[2YD,%!iAGF>s:jh[i~W#J:Q#gW *J-eٍŻuMj*UgirYB?uz@Q5B];sk:~#-4)A)ԡZ I - *HDP]@?8*~Yѳ}ssv: {:,{~'ŠBzjZƲԨ3Y i%9ՙp0W(D/D)췉y@4!M?a{g6-—KR.~4qj4h^\:Y]_^+(.*N/gd)ŒԌ 񟱒@:mCySn~c+ǯx`q_8ΩZAd ёTaiEfFajŜ¾#E%/KiG $I;8-88 w>\/~e*=3rpAO^?۶[cK8!)LjFU^Y\Q/?//[>_LRZbٛ$8I rԫ⾶oý؁{q{nvh䘽a^k]gOhV0qјĴdL^M0TWõO5Ki1oxU+q@6\ET)I}QFˣ{*޴!ݖ17ݶa LjiO$3#>$Mr,ȅ#q)MU2Cu6d7m\N ;~8I jTDfl\o,jo: {FeDzS{“zbb#; WקjHjNgv̦_ -8$t%diF4;$ݑFSh䑎T^Ŗ86_p& ׄ!q쁊D$߁!c`V761=/{5JqP)^^ >;JBf6gdtmB᱃F՜ACƾ,ǴPOhޝ6wBš(whñԉ9mb%~cPI _}8-ۤН /οQKrk{5.T@%uR=w1щXE_R^K>KC  />/iE%FoZgaAլ HkU-ɫV"WCW9FHՔ}B[Z~Z/9})gOrveNfB82GuRbE| |#5lYwT [`wi} ӣ}x={ɏPcMeC0cy^a[I2ކP_B-7:=P&\hΆ80dWPh' bpN't/}hc{6m@]Ĭ Pet7||ϔA$י T%OX黀 >]4.#`\5ƨ LϬ_9,P-R ,?S@5"Ib-adVp'EBP>0O]QM^[TzYuQ Ɛ9! I@ @ A@(rUZPE *Ȱw;9]笇ظm@X  o#D/a$vla,|Fk~`We0;xۜ{!p .B i+n hkrx[6?nǹQ'q-[FÖ8āh=н0 D Aq1O#pR=%~h@m 3@ ҵ@ez$|e[IZ؀ ws*CfV=zG%v?&W0e 'waO"w6x   Æ9~/ϸnl$;C8 T7[ځ|فa䮛 N!F#{4i!U!_ٔ>o%;9-<þ$`ODfhl<%n|TQG wN::>~u.;ܺm`.W&<AȍԄȾD WA3JJb;D|IoKIyO%^H>J3*dS 4p1:?,y7s_pyP]yW~1GyFԦЎ'XGE6&Z,L( %;Hi{I 2+F,,jB&)&:Wn*J.eW{;i4IsȒVIT|(0g-$Z.UíN2 +TU% iC nE>rSiT՟՟y z ߾C7u27ۉZ5/[|ٲ[WjʙN[QM*jmU-M-4cR<7U>42_%di> 35LA,ty ]lrxOgwۂ_;CO=aCAֶ2fS<֨ThX%B}0/D=$קUR:U)?RHӎ1thkuNf Gkf,ںkyWS:s-=hUR*S Y#0deIU+*"0$N%ǘq5@:g6t1f_Km^t?p#`:Ἇ7R4ԲwVW e2raS(hr+F$!ˬeHP<3Sd[X15@ cbfq݉Ř]K0W4t QrFVXY_aS֗pRK qb\&-O+=JA]4_8̗-,qi O 1P= f<^g̍Kv;φڻp;iSe #ݓ &ZJMr`:/2O_^*yNi7.*a^\W<ƴH=;af~.al̽s0W0}Wu8/l_t.ҳWl:j~IH (" ;BBB@aG(Vԩ#.uSw ,0EtVEq=c= bʎϼO;~|}&GPnj'Stbo~~́ՍҴ껥? eUe>6 S9Gg?2ɃVEnvK7rk. ^H /usYq[[ 7sbMFuaӶ9Y k U E┆u9&NMit tIn3 .3^9w^SǰVՑ|פЭ37\X%XQ"L{~:ܮԶʬymdmC9TeZl7$chI-if+ qA3$MScCV{n Э _}#/zq|εIJŕJ*-A#HOr{kJxBrA7좑ܭt~NZn2I##rߒwYQ۞7<{7ú{cDfknNS2KR2LH.$ &zrX艨Y? ^3C \?bY>.Ԉd#hݐky˰qooLlqd)jMlp-:2{-O)zIH8!J"HX>--t?x9g#0 ee:@i5 !e96̰p\C8hՇ" `Bʂ,R)!*Bk ;[s@\#/x7){4<ǃ.fqq!cBE1"ST,B%W"=U^jo3v+w)n࿡) >HmW] f{!և‡ T\cMPCj1de6C!>Q DHhu«)5QʤL @JM 0&jTًH CָCR6 Qrq Zلq鄏 gLQغ|AACil2} fl)2HϠY_8!e+<8!vCKľāIp1\h"G$wH .HpAFڕLw8(XahS-^dltf',rw6&`FQ4%oL::!Az;׈Qɛo%Cҹ7I{-GK+ D4ȝP*yLa5%B )mP1oL6Ɍ=~iޫԆ&7rGQo1IyCWW/dclLg)BCBt!ő,:飔c}!"LPƷ:̚ bϱMr6s_`kcN8MEqkKXܪ {H @ b B-@"D@D A^VPֶ^u9ߞ3)1 ŌyD>$ < {>p}n0 1[ n32+$lw} b:XۯQ)GrU`0kq&LxO1 Q f#@O[ a#O}kTm=0}ډ}Bs"oףX}i$6hWѰV0+ s~1e9XET2K^Q9A~E6fLH@S@V@((C^ d!o5n3aNKǪ]/wt9Q~uqXN-Q1J8yj^NB03S?*?g$z$ {s羚P?llew]O~{GI=VkȉŔe&tir:NfQJ8Y9$Q)JRR^y:m<$HX|\^ԯsv-K.O}ݪ7rV>VANfgf1ӋjMOu^>/NPJԷ$?IIeH\@\k X :G.5yionm>Wg(ɔ4#%']ƍϬfƴ$:7<-3.#%. lb$ zob0[=\&:7;/j;E W_v_U*є(ɧB-K^P•Djω^H;)ʋ*|˔|J d!"5.7 Eg0ri={vUM-ݥ :gv_cĄr5-4uFxb$[ܒ\A?LQGl2d=iv'poٻǩѕ7w6qiD>YP|]>&Q*4qw mWB-PA;?k#t{h5h0phUw-uHy^/;,1 0idҌ,M6ɍOhoht#$1a-0 pF;0r]m3`fouw)^lw+{/J#E] J ˒B'Q:*(v#-3>xJ÷!a m̝`,߷A ,hrO-i~%s0ɇv9-t9(ax@!p`9 l ,n0aߌ@v;(ݎ[G%];1MοÞOʾ\O%(wƁfdlfGmrޟ~n^BL Ѿ"4 I\dLCpfbc!Ń5RlOh0P¡Ej9Nh8b#MN dBBgCbrDd9CVI;hdFo۸O@p꣞Sc>k ᳐ENCP@^ᆌE gސlB@|<:S!RԨ/Do/G [1|l hf;U:A=*$(j='os背f2N/d~~C]'^OaM)^Rq|m$ y$ rȋACrr]3CS2.TkyP~@ȏA~6dJ |:a9z[ gBƄ>c8i80 :W=79>Эvc4ۂnAPAu,lȗQ!ѿ)^E*T'* d#d@G4LX( aaV4D{%1K튢|O"Ə y%~Gnwv?DsdڐT ߳`F5}E=z&L`dcn= '\y0.+\2lZb憘gMOsN=ɪHӞK{*+y&O\0TAtLi/vNuĂ 7ucżsJ>?.0}Իm9,?-ַɲo?Ƕ崥$ܙ0R.ḁ.͇=/4[/ڶ$ɿ(*n)1ƎKNw=鱹<[7E)F$z".5,uL,Xo?T48˽oҐ17*fhiHRRF酒EMs-3ԧL4'L]c;ڣϳۋd)!J~r}EoY{|_y"űo2ksk._YB|Ʋ.͊c/5K9P|>wϹ%VKedZ n)J{4/#/x b}_`߻FܽR|~vLU k,WTy|zߜ_);qc2i@Vs%dM}Q ỐOsڷYVp3? c> tF}i1\Ci`mrkU{*7iw<狹_(o3~n9h2m:oHXնf>L0?I8XUA)ғ`B(@( =jjA@P((2눸zQ 3{f{vV|>_NnMF*1&8xxot~ |NΌъXQuTY٭9.}|gWF>UVJoO&51/'&Tſ NZ 4D#/C +2TVkrRtLgve뢰%1Gz ;ryr)R~1)ܿ>YƪLa&KEļus->TC"{٘p#W7 ưnA:hO6zIw VzE':J 9U*%IeQ'Nt=h/L@ TP![ ד`]tk 5]Rwҗ]&ok7BۣKq-IM79'LWBȎr0yL, M1e?0Y~rD#CdUV&z 0_@]=hxVr⸁pD0`ƿޟ:esZdjJh*dAC1b)VO(P T{kn~x{oeFgC5='ݼios~)wC,D쏹k5t$9ǐ27zO17ml36E|blՋ6<ȕ~WNP0- 7HP5 #(^C}lgIqLO΅sd?8{ &`V`ǘ9f32g̠촋#:JR%n+Wq gC5(~/r!Z Ɯ% Ygf~,"/|&x6dtmGUnߣCnO6p`sY9P@ -HUY.B )RyLR7*71[hP),SOeNwen6sew,~^p\O;Cde.|-{2!aYb3V]5+ꊟJJMWӌV}(>;66ە/a+*p<@k:> }Kې_|4kC:(r:k!T 5C^pZ>}w <H[_Hh \~:L:IvMQ" ְD{P9Jڍrw2Iu|u &9+m8)@ g)kHE vȜ` dYTg;Av5&@ $$$6!)67,E*n8RA[EQ}k=ťӊ֭Uq3_ۙx;}srpig0 bɴA$ ZH2E1ʴ JYec'6PT9I~(“Fp [83ؘǰ' hiCzu%icj&v&ON߃Ѓ`O B Jπ_.xzǂ6p0~b8A\4uxg3O>C|x\-,@0Yï {M;H3)W;=%wÔ/x0ȃ&|<BDd,H:τ(} Xict `)$- ?&^[?i >Th\H>D,Ku YB !2m@½V"i EknٓWB_ a5W\R'H#ݘZXc!F](#,2S֛CMʆd͔dpG#vg&W߉ڏux!px.S lH`8G!ք`gr{Qv4bgمD)t01&*4 _c3fE;v7{^u~%;4 sI\I>{7s~c RV$4ePͦ24/-!E: >&ϵ|3So"j9O=w60G=/xߑI;vM +3 " D[1`@*&D3>+ߤL_$~YT|?V.z}nFs#b{=bwUywTyߥ7 Q> v&c a$7d;3,!7#ўL {g c NrPչ_Khȹ&v߅s1D <}Ip"Xˀ|ăs8Ép'4!ιtl2K %dsobɬ&?$3K/w)|*Ι=G :Pui㟈&LUw( dx CIb̀B R2 {ƛ*WI5GneЌeJѢDNgN˽^w05@rp_Rhhɠj_Ȁ꘴?lww}Kop[b RH~6[EFVQlƯuNV+.Y*Ns:v(@Vo?,r=K%};;RC ˷W$VCؓ/M7&wУ(#Qo̩G06NX'3ZȖgaks&%C>_GT䷫I+&gRVRZfQ6Qmv>-"{9צU[^RZ*^Q$ސA.o9wGxS#VD5\j}\?!m,DPSO;!oQzR[3~:7SohUڻR]\Qo+/]%n.Y'k*ڤXUMYW0Y?U)aDm{gՕAP_&(TLf ֦CnAlMU``|wBmMIs2<;?n-_[])XSY/^],+oWԖ~*鏬(9]VrUQ.rՕT iiQohjl5M]_M:4:-p|澮PѶ[ZT.kzlXпBаliTW}" aQ(B @ؑm( ""PYdY(.Pjg: eLm 8ȢTEgǙ3=a>~s>9 f?pfތ=!)B3&w7- :íT~!3߷1 ײ~\btqjZVWdx,ҬdX]~at,^}w:}.();x{Br%FeTA:']Hx uE:L8˄M|j2$Z%&EŹ;itK+L)(I:Z㟘75Qp|o~ ^BD&}8jh]π4\nAG byэWYoP|&lmM95qU;U.puVnTUy?? Ȫ=us5:r%j8Of.-lHa^ttz/Z}=b]Zfx;:ƞ͒G7(=:}B|BF:V7^:{Nx ۵W:?yO^T]ׇ^+F5);ǃѽAOﺴ4BU\ۘ{>ȔFν^v=#}#m6'ᷡՔñ].;HO2ӱ)0?c³-эcǚD&ܲԼ*<ZG+2[2Q)'9O7^F;uߑ.> g_E̟d+?Āp{߆L3Npp~; ơwRL2,X kmb>E !T*ք!>8^LI dlT,q*+N׶>~LW4Ӡg3s'|:Dx ꩻDa5`ɿ | 9_!(_SW"y֑vuc8aڽ԰ye=c\\tm2YYpO'-Ba -|P&(Pq%HђBW=iS `0F3 1 Ә+{XY2kY|uS}.?@O߁2``Aa1 5ZJTP+Л^4#h=up,08XKt0Ļ75LU$;x #0%uj}4d/K P@領F)AWJ) (t" EƖF;R!"Jh`8 AhyǵHsq'*.Zoω7r,ɖXD8(g?E,A660G \ QJ\ Y ?ψrȝ/j:YB(>\E t1QB0MƲ!Y 2Pͺ(EQK  gijoĨ;Kx,(RfBҜ0SD% ݂5%;_t߸Jkx(i ZG>9 z }z3u< qz:O|I~`V=.h` t "7N qQTM ֆAH$2Ī3l5c ~[>`-c5Sfe~ #Ɯ}Ƃٽ0L ƋBF cJjH}1@LIJQz#r߇zVM#ٳn'AF}xiۻnzЂL0X^W6!``U8ߐ4|3-5.!q1GQkG,7[޸VNa{rq&ՐΗB;_ y4F=֧#TX`̿6M{W"H7Bd]沼5_g.}ʎ{fk"f|*k1vWZ~޴b.#" t?>1>Kg O.Qx,ŀ^ `38xػ,|+>Iq峜DKm%8opks=}2f43J>}pIʡ^~3G 4@x{;W`2@_VBkcڝ"_!y٦9zw,;XýȒp>IdY>--\!BEݔjoBWhN(Ԏ}ɂWD+,z*2m;xBa"4hR~/C);ªțfc?]Y뫊]H[@Y1BVaߩSGB:j&Z4y/#g$H;$l61ױTW*H}$B%M\(/,  nOY xb - ;jp:DUʎ0\2ckY,ͦ&k\wUEbʊ:NFQ _r*(VP~[|(B0l5g>BU t]*щvutc%߱0Nkc,l 3R5n^Ԑb]P+uHd&3e#30x=HU=i;0ptn.>'n_Zm}W >H[4@oƤ`GLspf=1Ze_LRs`6`a(nQ5 S≧3JӾU_zk;qolcoLc9a91 5Rk)C:{PWX\(nvW(hdDzs۵ DQ:8[3.O08ĵ}ݶYٶG1ֻ5]ƶD\"ΡKԼ */= 0"&\Bֿl!:!#ԑufq:': ;#;?:kXݵ&$F$W1h|~z=}?o ? n3b{˜XFӛ̊VsBs>)Kk ~ׅBy yV?Kv@x D? ŸBG0qLd0%c Mc{ xgu7v+{u+}u+5=Jp_A_F9\w`l7@0JttTa4F1ned8 Y8ebIeI 52@cs'?25P@` EԔP\ 1l1 l01LF>ba c/jwJRC,Hn!? ۞ Fz0EYf&\TOal>/r* QD('UDE 尢O\\DEM‘0Qn ƹ28_BX=&P3] ^"°O,ߨ[VeJڤRUUG/Tgs⧪+⇪n}Sq[{jVwF@/eP`}\zi=u\Ԏc|p<˘VtS~U*~QV@do}v5uv^ͥQw5y2FkHWɕ(az{tGh.R0#3{g$inuD;nݽov%n=N7coK;bOIǶˮޖ]}$7,5ƣSk<:OQ0-mH8&dհd'dXdYIgs3e]~õ5NW7HL4\rA׭][ަm}^9U3~fݐ{S"6&d2:HF'6Q7t̓МЏyTbq~t[]͙i{iBέ\ΥM8t2&}w }q_GRJEϺ4tKGtfmL,+zwNq›NxLdnG*/ZN~I[rMuG5}qIK@H &8L 5! !!!!B-D~AumγMzvqwHEӒԫ|90;Fzx5OռQQBgC$kP|sKMgZ;> .=w$e@q<;eb6tU!ŕFQ=.Q#U"tGr VMN|D#2fo+) ;i Dokvpa2v\wz`Ys:P{qG2ˬ6d:jH343!ZHXi\:!$;D0ut [8?^|WA ,9ai;d8У;^rji&F7Q*Vnbh CJdCJ,K!).R.>H_RT DQ!5({AW ie$J/wwT_ZIqae-Q(w=|kXhރk}twKfWvzoUk%ƜyTe7J| EueTam5-hftd֌W RUXz͏eDL5;hϴ`!@[+{} =L۪_9w^ܧHr+pڸVwU9)ECi6P3&4l6m&lbB&fBdk*=[\?ޅ;`@Iv0ʾd Qџ\ЛvPԓ}-bnնľ>0-<m[8u{\r#?Z_#3M/eȐoewbp8S-]YrNaUy,"_M|Tn'UԐZ\&MaSހׯT%=Oz{U z9gIO1!E41C׹z. 銌hԯ-iw {=k aC,CRDNئC Ggsۂg./1_ߘ7ϰd8"46[4X3 嵄 37%_A_Kn^ ,Pisc ?\tN B`hDSEoOu̐&ʡ'Q <8H1&FTȅ?G|&^(=7ت.Dv6ltvS!{lOVԆ!aP~`*ZpӄqtL:R͠LCsR|I_EuqӱKO,^&?u-Ñ#w6N/►*♺2jw*vEME4ʈhn ҵПƃL##Z3p'S2'2h,ď,Q ;mu\ݾU{w+igaˣlnsۧ.eqhWD>F` }lAmstl6+Bx4sPzd\yʔŊBb5e Λ]7w+w_cmBKI"KPUvv4 t6L睦y 4,B8,pc7p5aFrD{̔=jG|Ŗ6\!uSiz)kN>*ve]]q+aMLtX*b72):F[\B:qP?Y@PU/bT5?F37Y-gUYv|cVtbYk25X2}ۗiӾ-K;4NҌA^6 ru КHW?w|98/#j8g> ̛fM -KeKr?R|Z9E5.fo/u$F!@n ulJA@5@XYE#.`ǕxZjUlF2Z;sng.8g>>&u)1$~*2~DV]Y$ILLl'bopk9@[D;W"!+H^૫QMmG3ӭ>ȵNSWV:u.NLVH:.K$Mr"91{b7P.8EC`{Jm]inTśXVʳmʲ Y咢LSAFK^z:kQ;kiZ2E]\PUnZV=CU`QJV$YNM.)g')v'(ds8]ٚ&3&I*`Fga4g˨}=@W:Eh[+WV(DVerی"ԒJiRqì5Mh'*o{DZŜb'z|K}jpvAH{WALl:O^UniCan4:vfGɖiY6I55تzv++ETuQOL9DU0DR/i?WS (l BԶ۠rW~>oJn 㬖u1D mRUjNaug}Pw5n|5s U3b7%zCt}v=7[*J5PjfqoEz S:BL6ψiO3ڐk6V*Y%]ֺ)s`7΁-Zòf&^l'~L !߽PvK'^e.=ӑ#Af'OЏl=R-4+Y֕mYdbkufM_Osak%[F~mf6zP(hU((H"y5E/_fm7A|oi=3zj,}{=e{g7>=f>yz LwoTy#@D rH!O.tȇe|5r B<x GhfL{'0yZLA8 c< 0~2$o򏁜a?O@ ([@z0F=7 30z ׋z9cQ- 7ö́1j5򄌑+)?W $ïK(ۍ(0` 2=1 |f Lmo08qLJ8 ƍcGg 0H YG6.Yc \#'+q/?dyTSWK¾!/@ Z*,ʾHHXHԸТH݊8mک^ENw~NrOqw¢)^/  (sHlCbh&M+_<8 xKKO>Nctf' HbGZdAC6=|Gwѽ8}|K ߑgcr?F>c!SMA\=iOcOg#SbH5|'.5ԘhZz%BSE]3QDtNSEWG-M1fO u?Ax}aM>nۓO_)S 'zRC*}I d+d[}̛~?$'7$XW<.z60s;pv*f} τp-#k ,IK`btV`Y.u˻w52U&߽6]n|ѳMF<My~ozIfC޿Ʀ76# uAmaG-Ƽ\%9Zy%FjM0=favo}OOՀ)c>׬>~?l\Ȃ aha߿~}'l_o0'([wb+`50@hlFcYqeF9 3Йۨ(֑p< u}ֽK{BVq nn +ogY^G-=w[k [?0^c_t-ě:aqFbe=-V؝՜vkNo o ;(61'ǖg;͑ض9 |/=7SЅt>LCO!l/5ѓc;)մ31bGں=[n[cm\L_&X'\=* 1X쁭! Bwa0$Ѱѡ 1&T,ҨCh-Mfٚޔ$7'V94%6ҫVovZC,nKCQQ}܈.K]¸c]"0Iiq' AR :Jm(sEM^ğPи(Ƭ Ų\+gjm܂RZW#P BUQVW-Su=#*x!Tc' jLޤQ8' •\CT" RFM.P1ha, 1(6-+Id,[MQPSV ;ej׻ȵe=nRq4ew8],X\iP%28Z2 XNvQSK髂X& Z:\Q-Qg9(J+FuiWIcn(YS üIwypB{a4ܷ 7XFU7(oE42 ÍbrkS,klEV^UM*U.$W4 *\ݢXq04k 3!A4(ADqpU֩Z X+ 8"8KlUk+.D:Zu}_Z?y}r?hL1+'Ǫ$;LZ_3~Pec^:A?iÖ8g~&h;+Wƒ&^I>7AR9{u{d*`}¬4=f15x/j\jѫ;|v G X{EwϔLmn5l%$ ݓWoy?8lJeҁ529ega:__qڋQq=C89NwnXۚ]2xuj8QgCls4و<+al܃?/ b, q=0DGcr504/"~}Ts{re.r,EvܜGD7H}zQI;q-ri9Ѩ }>mmV ⭱5^tWtSYNq̟Xbߢm_6*m管;k莿+gs' v}8 .B- 8Dz 6PF mmmmdۤ}hͮnyc!xP:շn+9 d ;H΢l@@ѺEA0[TV%=вdKƠE4++JDuIU>%Kſ+ T Oﳿ&3{_3[_ wE .R.uCKɗ"ۡrAWY E ] ombj/e?fSXhf? rh^U?mwfpػ>pbP٭P؋!vI/3xG@S` j'hjXU5@¨#񥤆5kxk ^]zB/Hf,d~Љٖ@ˀO&|P:t^;5o @] a\:$dwXNR]% RJ:RpUu~ߜ%Hx]/dϦ{̽j  ~O9^D.Ue纍.O<Otc BTPwk`w%襸MtlVGKf#d<3#Kwa5,Ն!]jr}va2v7Ἰ}[S-.R\ @!nӀ\!Cu~a/ZlEY`<7"{n\$n q͸Ah?J ŀ2EyuŹf)4S6b*B:Ul| 2ۚ0#Zŭ i4UT$wT9Si̴MuڴWUb*PԅJc~ 2W :b\Qq}nE%󖱢2YQjPYl:e^Ɯ>iNs8ar8.hvO820|aj|tmGF8BF"xY;ը&(n1PO|3Bq"zQt8/ǃKGhE2 jĪ}Eb'{c\jl!B!$K@$6Ibر@ 8X$vl'Y&vL=i&I:Mm433{y9^+b?uUL$L(8/~?b.JϤTJ> FI l |,Ki #ޖ_LAYB e"dDG_ŞvQe sIZOKB/yȝK3kFJ0}n3уL̽{T rr\9fW 9eAEEr5 z!֜l=+;ŝ\2S cr0GY)kXP!JEBlkdJ'+RRD.0ԓy 5LG aŸ!5Gh@h@DЯ$a!0\̜/񨻍(#AḦ́˚Ͱy 4iӥr)uQL6WlzUDQs=\,+ {xw/\: >uG<>ʇ=<𞍄r98 z1iVIEזƌ3SZPJ\ܞx"Y|RԡZoS'&>Ij){|K !hQ< 0*A-3^d hE0cJ!MaCqG_NU{ʭ.m#۩mv4BfFԤYJh,]KNi~ɦ[ڴ߮%'7؇1wޭF0w]żcX[kN&U&VfG TF4nQZjFn5r]FЮk/'Yt6~5F_EO,g50_.|\}DW1y+Zu/iВFEtUG9*=QYhc5T4sm&Z@bbR&# ӏJ!@xU&K>zpu6͘79o=Flc 61]ASF4[˩ ʪnX;恸Jqʟp|&]ՇȗIz"CG/_p3u8mx 8لǚyRHG"^mQlFY]gTֵL}qq:46ZGHX#*qe_k%xa>}g6ּ::1wvw ҠMζm֖Ljn=LnhG; -Zeijg[nAYè>_b9Qe5^Rs|^b;Gxa}x&ּ+?1s [ܮhhw~{I6W*֕IvFVvǘ:˩ zy{-ns[ [gDdܖ$E,,ȴJôݱC<(ds r뀯hf'07!_R:WƊ2B_}(VM* 6U M Me0?;ϋgnse@@Ӏs%`-TMP^q7W;AT(ĉff>XxkU@c^_ c?\p/0Qz:Ue@+ n:ԤnZpC͐7݀3!/o)ca؉?DZڏCKswُM>0U﵀&Ѓ)yocܤQ}E.>o9G윸x~Q`:ϞWXx}ͼ{~⦆5i`M󞬉"CFQl`.~ <_ @]Q }Fi ͦIٴ66*TL';1E;<;A&W E8>1=H?,N崳<2uQ-R.iOeEBvWjz/+/ x=K{+~rK NX2Z*L-!Kel%]ϒ%#/X |* })v\UlSl}Mbc#?4esZ 4tU\q/Q]}IEcdOΔﰦ)[+ZW(7[sUͪ #s5oPtU]*60>kt&T Q?wQ=F*Nm %4N)h"/_WfWdkr6hvج o"nYo̠6ABmАc̿B$Q~<)p0EaWHiCxڰܰъ_({NV ^ ]dLk$d>=H(aAha^S}ZO#=vn4ݛjfWpj/s'Ϡ?FJ׀7GbCdr#H91Pf蛤^'Ygi3lz2 h8;8R}J_#6{܎~f췏l:lvژȉ醕1aRVtYFtbaʅ&-jiّ" )+G7Niq4%CrcG ;ғ=FYcP'pFnXoEF|O v"-6Q͠hfLΈIM=ߐe41zWCR[c@a [5{砚}>)8 |`BV `)-,5!Z>ʔULM7]?1nݗbWq\>r{c ;ғm|/#Y.h=?goÌX<5/e GAkТ!#@ Az@TBt]OZa]-3umn~L _|?~i扫t$))2k89ǹ0ՒJT2k7gk[=LڃYSL^&3iH$%QS{ Krٻ>5`:d1UKkR$iAzc~97⚣[XVu'4i^ԛ4#uNpK J?sYIjeC?14LӱظP\!?kԜsr2\ VAZwmꔌ5I^Z Iz-Y/(bkی8(bq1;¬Ay¤c> xc&;b|G:1SYQ1#:As9|ҩw X=|}鄓2v q~ x́GO4=ˠ5½ PBEE(z<(O=޷z]ɸ-w "N! t;< Ji7N}7PHI2$9CԿp;7qBƝIS0"@!tIeKo4pe" WX0/#tpL.#?o05w1cbzx;~~ 3 'MJpT,=/^`Q|9Y0y\t$o>r|O~|F!Dϵg/PdcE]cAnArKĂܑlX Y,?`/G|b‡hEE>{F)[6SDϣ̘.c x6o>&w -C}1<%ă=&YEyCp m49q42,&$ Ud=LZțNr qO?/ z%qx:)$D-"d% d+APg?u1q xk%w~AE?4tN"|G҉Xy8&>y;uvQ ?uR8ۃo>?p󎴡+7氪q9C41$[1jlδ4󥎝:Ӆ/ųܼ<;HT}Pem:X5$p 1$$"B"QmCToB ~ZC j]FҊ6\lU~\_qQBYOU"1J F* !zR}/&4w|kuWa\QƗ#.hVs|يs=1|Nw'#k"uqb  $?-2zp۸%Wb7;>ŹU8ӽz4Þ8ٳ'z^m8k:CO`kO]"_ǘ٧1-O$.E&꟏Q8ÑEOg`f_BfOr2lav lpxixm71Fd7w_AB> ' ]8\Q|L|4h9'6{6`ٮf:S-ڙLv.Yݤ]nnbkwrܺ!g5CV_>-È<&w銿6ZY=[|0,Ga_pҍ6 [tyجs0t%zmu:vMl*[/m[bJ,ѝ.ݒ6x,m!J? O?$[FM|@380J]b^q!ވ,fM\2]WʶUqKiB}YHҤ_%o5OW̸񢔐O%RkL!jy{Io$('ClH&$%IfQmNpM$2BZ P )Ҟs=n#ڌ2tŪh1hNMaf3sRNaC1,36 K5e0j*` G11E٫`Sg~+Ofz^b)K29sG1sӐc 7_k*ԘҐi:A/OL_LoWUPQ*L,Ch>rp:>iBzeE6l r1M4侍>'d[PJYҪ2 ܤW(6uy8ƓuE^W(6ҜN`g!XK- 5?OY=1#?ov` UyvΟ-R%(ZBe“LUQݭqZ>8,;9,?y™'ʝQxɷTd8GڳX@~*P`ڢQ3a6=$fb+ rٲWZPėX}5 + .ka][׫m]NVM_jUTXE gܤ:![G-^]4:u&rDiי; ^Q%k}j_ooUwj,\ub3^wY Gr`C3}Qye1LȸfnowKlE~F/zGn)\)\*ܮ6,x2Js KtNRS*4~$'j+텒x|Q䋃7q2 t7畖Kr!Yw]Q{;TiޣTďQV"_ <3:S P4vNO~%npUFQ9FXҘlRir* J$?IRF*ErVe*IXPT!*E9!{:;)`Tҝui />aB0H1șldBLf(5\ZO N$I2Cp0]<^PU T$ QSo&7h"i4L#UOs: {\?a0G!=p:c 066)a ~nL>\yTƟ3, ʦ0 '-Dk$F5O465"eE 8Hpj%&*.TӨ(1> &y{E 9^٬IθI&9]hBm^]u KY+ǢVwdX'!-'Y00g#YT:Gaf)r /lV&TƜҘXe\*T%R=PC_7f1&yeVr dia=H>}BR8Ο,$}oɽX{c?&ؾc~RĬvywR@Դ`5GQk׋WI%0PCi4K+MA/@t Cc4b嘆HG;rX/usRغv)XHk}/q ;z8x@Mi3_pz"©G3*ViDhe B*"r8*Ǣk$T͆U[U}V鳧0\$1θلyẳ&7<.=c6$z =08WO] Թԩy$&ߓBwp_F;~v[.vB-ӎxJd"%"SB ԩN 5j{q|˿C?N?D_/b"Od fRg>u p6Q)\s;SU[whWp}+\D ZBӅ9 H^!M?Ө3m&SǎXC56sjnݸX|8%:Uj- @oX ^zXHo2L77Z3X Ȧ 󸮥F5*phf,Nc'Y@*o1zuAS;hvcGbl ^;CQ T6`sQl n?Jp!! "',Y<8}hHBmcj"G:rĦ lZDB4zT픊51n(T{GUHOic{WT^o}kd4hg7Pih2X8 PbxņiuBT#'Ib9/a2a"axFq-ENcEv:Y=k=ן@|U߶^pĦXcBIXcզQ74QZek!0}$-3-rPe*S,1mU,65*N*$Pf)盅"JCơqs5>}{`%v,iȵ2j/e[&IK-Ŗ兖 y%[a)-%yjťeyޙ{D K] qDpFf`fD 5.Kq-5zXTkĜ4mz5m<96ij4Iۓd1w= |zeA6ҏ#ɳܱ1쳢ɄU&3-ֳ,Zѥڲ(γ<+1Vl y+6"SH"?7wg:xuH?6#<MXmE%4X2EZ S,7{2 ۼZ[b~^*6o]BeKa?LK^Ze}%s4kahEI٦*t۲mPj+KlbͫqֵRul:lsm/ԬkCzu]˸9Dq-빮l-#QW eʔ$#JLHY"8Xr]+~)W$/U~Q)ʅpEy'<[!܃Yż1t7|ۊQBRu&T@j:\L5IRԀXݭRYVxO^YՐLܢߗuJ@o/K} J#Pdc:9pHG#KPX&.q5َ,Gjo2;uq.,q3l>P/^0GO4l^\NGV G3 w><\$丌X]9bCJLWcqҦ6H&gltҥ^եOuo4gH꣰+y|'{X[rzTB^i$1qO➉ŞdyRaX,|!S$.TFO&ͽNkpoRrFIII>KB^ޠgS@-H zdW BVHX+' ; <)XTeʆUVU(ebNL,n{OKqޫ)ڸʐ6'.S8\>84ʕ] \n ~OFo }HYSs >Ź͚پSX[hbBڟ8tf`5 |?` 4HnX< S1?$0o.f0fi8Ycc 1Qu@fύC PD3I&s[1efƌhLoiqڪ3fL ((@Lс<؈ =x*)`|W ~KwQ{s+=o^[6 Q1LLjۢ0m,&MSX<`*30`1FkZن;aX"FԎG=a֐Qe۩BFT'%`^ v>ۣ0} ڣ1}t'i;w,ǠF ؂ h?[?CAzdݛX'$b_f1G Dqrº+RW,] Lz?]  |d8paD8vs 0CK77[7E. ̹3_oI}^3vi=EWGA a:-Dr:0 3G_l]BG>Z{#=`7ԧ__ DQԾI@!j{r aCя =aOpaȞߓ{G{]E Ybj٬5{#|Dc1=GO>g`|C x/y=dO4 rjbE 20*;o!"\>'ug_KH2kDT} ** EZnnhYDQA@B"2bM01rRV&NRV8ff\*5qܢo~T{=缤O~ld!Hu'3enDٍ^ӉYDdd"d3AvtS"oq?xW?" ~ 1 1tKlF3`'5ڨqssg#>mj O9z<&ȿ?eg7N&qdOT@EꬤF5j8s#5P{8g;V!}i_2:2G;C5ķQĝL%_AԌ3sӨCBjF%5jH-_'QB//} Moq~$7 /DÁc 9}r]*|=c\| urQDUԨF-5>V9wd4o鋫˴wi0Z"6;ٙ0eG'\;kBq5JN&gͣp y]U Dh9YВSG|kwqlCyeÆo$O^17x Ұ,\p9bu,ǙU85|z6S 9G#qGF^Qߠ1] sh!ȓx吻|!+ȍpy~.)DpM1lt-C[ :jtmD6toO$xm}qoc<6WL7OfRߛ70L.Ot%wW􎝆|=^ }`M.Ůk:-ScJ O9Sylv M=D+4xB y4O3 : ]&s6L*gsf2ϴaR4{bW*UY[Q?kP7S+}]s_\uS^})ZO.;v{{bs%}4h1' >ձͶ٭oᴥP[*oη3>G=6rޏ,P<\{-]~tS\ `*aRJ=ʔXLAҎ"eBY$,W ˔br+-]--YtI#e?!,CG߈.10vƲ1-Zָ. Uc6C}PUT:(PL!ᔥ^ 1ϳڄHb[+:#1&.{2<3I+s#kvxa>Y=DlvBP&-~,"d%ĞXVjI 5bԴc1ZiCvZ3\o1\r{y{lb>Kz 4&Vq.]#4"!RhX0&>'dӀ~M}̽5G%]3G%>4G%VhdeT>` 38E<gTJ&;iHbR48%LSh@jT6Q}Ҧ+:mҲ+3m),)tUShShdArCc#˰ Jsz2gکOzguStV_ٱ ώS ˙МSPE9kS+c͹,2L/RXݲ|އB}0 f8*]A , V@a Zƨe|,3mIU7"ue<-\GacFgWA+%r:!-;klql}Q3dcMW2UP #[yL@^RE7_W?7Hq؃R)`+5okTg/S |!adg,@PՑXuw\ xº2s/)kS ܍>iޖloaHa1~R=Ci}_CP o,^Ç<OXI-A GhFoz<^ÒsdwT2GvNI8Eag0?:Ǚg hrM@-H| -/:'֣?<ŕldllj֟%hMFg&9GEq\#dG(+t|+e`؛=vEHrsh@:st4CjQNFi-9c֋]DNg:ЙCGaoA:N:K(gJm5b>i-mP՝ U|ǴUl';cWC(NzM=~WO2|u{7W ?w1ԄZY?T}40VEq*  zM f*7h+;8WYEYy!GsC+-)%)a_ڸŵ7+x(0fl#Yik͊P- %,@=# ^+eOiJWZxR#2Q>_ h- ZE%Hy!@$ $BТmN!Zҭ͵{3nu;֞vNZ!~>Ͻ`͊O= S&',V iw$uLs0^5K>[R)G{Z 6g-=Xaڌ pŸQ ?|mX o^:"YDX\f!U<ຒX`d?|lΞH)EkӰ:;9:rLh)GCN9u]Q-\ʰQjIY̡TP/*IT80Tf?گ>8b팣E5yhV-O j Q`e<y [v&*w _4#2]Y&H4cO79rZM;렂Ʊ _39j&c6.N:tpQæ_/'EYQZ' ̆wd%["G+ ?Xu ;i& }60(Ӱ9lT4 a+,ƕ(5`1h(.z^ɊLC2iTVh#HEc[LyB~'Z$[s8ܦIpf bLa5eXX0QRBq*[`4(0zOd:yc/"ɴfIJG=L+s3Y&Pa0JR si:K0PTf̊ʽЗ?]yX}"z\loTBe(me-rA/{"z`-]c,Mb{,KQhO|+UA[YJ*WC][:l1pYUD+~g9 ۀ}M.G}\fN*KqC0TGB_]"hj!&y5*P9P:+ZlW3 tu WH=*gDjUO!wIBFs/QwZǀ'Ɇ5y0(Ȑ_{8CAGL V;V߈Vx2oR/#{Z$y HDGqKU(=C$ s[*e^ Oo*2}QHGZ"țRڔM*,o6`YUHj"ѿK['?m$4CB$!s;ڹ'Zg[#cR3 Hi@R$bi,i]G[Xܪ ;u Fl 11man% ¼"EB̺1q}~ux@s `3]9 ;v#%L-[Jpmcr60%&^JI$"|HL8x˥^ȩI @@ \*""^b2T@W=j>gmt]36v[NvݦsT|?D~;K NH#H3i#ϑm%1|I1G,Cy|G3y~g_2)ѐ,O"ƯgFCldbOajWL#>[_0o69aOƒ #5 &$dP/:jTι_72~w1N.~vp:kߤ0ڍ>$%qαRgrragaoj^ԓ24jZ}\ q>)貵p//ğ۝oG70޼8=谿͙ԓ3瑱<87+]Jjbf@FRcn)C\vV{k4Wy? C~9wyD)B8%3/ DQU^jM]c:ut='ye&I-`Sҋch"ڝQ1Y:9?"56q66ܲTܧγҰB<kW)hVub]X1eG;Kf ?6I:E1g ~s7ڧmFeV 5f4`Up>.6!QҌ%!X50<_EugxG|Lw d*g> Iǚl)X>#"BTGP\,SEsajTϭCFTmCyTG@Y̋ Qo O}؂ձ!|u iKd煕Q~X=u1cQl2jPkDe qN̏,Q⟠Hn (D •>.SL >{Hh%kS'F$ $Ơ\*C4 z$d(OB܉(L\|2dp:F87`O9Ia0x'29gIigk譞>'B>e`H![BIFlp&9H*F^r%K))w"KyUȢ(S`n:ظv``볎>VG-}+Ǣ$t(#R#O J٪\Rݰ#+F¤QsDyUd _Ads6x:ْ>(}T"O :X5)hĄLm6KaLAn6tۑ? HcNAF?V'.w/Zd=F.V}0,9ԋa+`ԧ!Ð }Bk\q=LH5|Q4@A4 " F'Aj?xK1#MQ2gLdL3a Yt ZL ԙyH!RU2d"9k^>d{|~y0Bc{?wp$(^ J5ři h!Pۢf"Ֆ UlRHqCSyRHoԾsGBl$va3#{/u+9Tq/𹼜<\z1:EPyCYH΋D# rGd $:m:!qAEk-b]g|A#% 9i?wQ{">9*VK!G%=B$A ;y @TQ `NQ#"7#xŠO!m9B!H@+9Κ~/;9_ 4s]QQXWeueߑE=-fQ(̸ `T 0q8QU bզAlVMM`L6{bCRc4how{ xmcb-fJM`PW`ŘՔhSE(4\ldZR[_yE`oجloCkiYΧ6B}3UXO|)uF(6VvЫ dά<Ȇ3D$ͭlJabWS2mzAWڄf_0'xni]' )vba'luPC!d|R[Yp156v)40wIwvjQ:jXG .@Z.Z}-Kbna14,ttN_tb\KK34@ o/uahj!j6pENc$\bq'-%r?= kgY,zA&Z@q.IX4iÁ=9]lix3o'3#MF{- ~FK.wuNĐv>Q@$M1p2 u1(}\4׸7qț|m‘3}ldIƿ>_{[4Ү)yWP(]%| [6]?>FC#c61qF./l~ `0)`(bJzآ~d|isY;}/\pedZ AwH0Ŵ}k1˰_}- :55u]|gu N|OCx̹7T} c ضa{.0.S0I v͏C8 Zנ"ZIJa/`߈"ih~1/Ƕ \M?Ч<~b*-a8k7刦NƠABc")}gcfcߪ^N*ȎSD2P-T+nKK_ϡ1L4ʓIg#?EhXrc;YvO^Ö}51%;JUhi#:cFg1v՜\; keҧ.]:6k 8qW:Dy{+ePvw9] ƧimZqGiV9hsV8s\ eJ]*TNuA2_T=z6k\FXᷔaw͆SUnZ=̣U9R%3EiI *4,\JhX|~C9>5fSvVfspN_FъpuQ7N :sh@ h;3bʹvK| ]9ʎ UVd21fF ֌=Vi)=MSf)kRb5)\c7+9Zh|qݚy};`sآ#;EXojz\kj|MV*%~&unS5Qr5.at_7W=hTbF&6jdѳm/uT@T@S2 0 ]`H䲨1 `y ^K$Zf*hY)=Zֶɶv:k%ִܓ?>y}}˚ƎL}%q4bb\9\0 -_EUG$+7ª\eGڔYQ5ʌ5EJTjl,5?NܛEra #NJ + q-z )?zrX͎1*#&U,*-ήԸjYR)JNإ2%Șx~)S'FNm[q88GE9^2LTaJ3D)Ր KB JI,Pr\%ͪiV'4˸Q2ː.;?^b911AaaV٦0QG%#dɔ$cRf%*1D ɏȐRfřE[*| w)<@75؇~gא2jSHdd8̓d4*yS~NC@SKoޖt/*zXlȤ,bI&XP,cR4QE *(M+NTV) M-Ճ%4CJɧ䔼K>y6&35‹J۸΅ܳ-ij҉ⲹ+>+)5I0=Ӷٵ&3S$իqO⻼ʳ<˳:8e ,\~Zʹ4\SHl2y1!P&JOոJ? HyU%ʳ*UcQe{"n[FVKիUF.wZVmhȠF΅ǩzr@LI1Z(7T:B(GFe遺 : ;лX_mQg?ߎI~%g#=Rb|J cʥUÛйM\\k1>$mIgiໝSQ;vMG'$]0P`C@uQN w+ }|7[ًO FwJ]#y‘PRa#> eԥ8 t4v71qzjiW|?-/҃ ܏WO1xNA^SIAN$'gR,Yhmy׵u/`ͅ35b%Ұ>Z ҅\Opn!p8>c"5ec,ýKKf+ų`ߐoO!|z-Kp\uCѫ 7RnWosܦHv;; PeP hfh(MEyEևb7:󺮢gKp>5H䲹$縿\,?Yu !yaMZ`{!`{9)E h̏Qh;:.iofp^'Ѻ7/}J3G~1`9U~ YKm@k6Ӣ?ڵzGOѺѩlS$8AQn<r_ w_pYX;|r"𓈏4-"el ֱc X:V;؎t^*ׅ5h 9$ V,a߆};plՐZ| -]ɳ|kyF;lݘ؀m@an_L b -M&kk^5SWUv6ҤjTiViӤݴnUNC}>}}.Wy%z"Y/_{Ob> ۻ3>wiJ>EOOUE79𓣛}!\+q~F6e;K 0"WҽMyޑ`HRsxx/Yڱ8]c~9Xze TtOҢQB|c29wxz8-RLSγhqyi'Ooi=lff1s c`4!F?јop4Vc:Wy,=|`oŔ>1 D`1*u`6ƎjLza"ΏnhF0pC LÒ{_CI"%M{MlbdK II%LTc,QcI%:0,APڀ!i H;0 EldcdsI^EwUtmDG{+3wLYfV 37C;1"##) /ՆCГք6tw`z?:GϘ2іyYwz ^ω?9B x6`uKlfiq'L) (R‚@v9NgѦUGޜ!4LE4?-xo s@Ïy uQD\, Nݿ{xmtMc[:oCxhdj2q@FV Z' ܨ-ZKg1TΡRav+(7~@N<_&-7p%~X Rud h,LGz}jTpp2Ԣ؄ c;E즣(3@y6uX-/>K%"Y=r`wps:T:&9&*Mp a7Qn.CŅRKlm$iXga]GQ"}opKcm*q-$ RG7u2VP֊&E&.wm  li&IX9㡭BS5uv۠T!ӆ^(Fp Ho"!R䳈=%.p$[;xuwIE덂99r(ݬ«CׂL:|Hu!7 yI$lBr ҖHlI-_Y̷۴?77s, ijڥZ Qn Y8H!ůܟd2pAф;! !3 OqF_|g|AfY㼓#VA}FK=J} io{eD$ B D !L`0!J{e7#bɽ6ɼ0Xa,L|qzJ] PSSm$;8D'!b8 -,FI> d0 1y7ȹf{5"Iq[\9 N98|_%~ / .) ._\Z!,8 ]u'0B(5wN FO3朜>лPgҤ}C¨匰ȯkK8??8=<<wrx\O &5y vh}q- t=! P Fj0ؔf/TdV [=v]Ku_}K7펝ץc+ XASZQvg+tB-l7?ckncgX>Ntho+|+{n* ^k踂?t\B{lum29wtt"w71pyG\Vx塿ۏa ]x: k %^i optDoq>!;p(cv;i w|-88,~>^rlWaد@Z=ZAXf8Z_m&:-D`kwp~ >szK?"'f)X~vcN^F[4Eт&tl2!'*,42"^q6Q{rר_\1a#bP Gcᨆc2pӜ.E(>;Fvf|¤n 3a#<H#8 -F"t)rkKwմZ)eZTmjKU}*{lVEσF]W=x2undy>уnOun5W&h{j3T힫qCU1Bc=U9^= y.RJxh~Km**qtS>TgYB*ݨ|V {Sy+0w^s6|;:rT ?Oj_J#5ߤb*ꛪa}sTw+?\Co50hv++2*3䞲B#u jv}L$7TA* 2 (F588CB)7P9!_) t21RJq%ڕP xwۜC^_IqD7g C"De(#<[JԈ DNRRl٣Zw}L֘Kp(щCp`<9k6d>B<̨~J2(-*F)QJ+):C ׀r%j"ǭٴ]&gzWq2}61dZʧyo":*1CБTCd3F*'k\T%b.TLje԰촳%ϷѰ|`jK0~a||}XzfXd/,`0oJfJj_5 TE WQ%+@3T.¤Vބ;@_Kڕ|VKH F7D`aLr_hvȣ<ȣ<iFF6wh es-**12eXI3b3Ism2Q"@zcn^NVN$)I&O/\T ypײ ~ h x Nw 8 ^o7h:9ϚQL3xm\|pZ+>V4X9np 9 %pb]79E|Fk.=tqߣp_ ~ @z! 8d %8b&qO, 7G;[s}F7}#8>oDX׏xobE.!}F'W\G8?#} y 7{//x8xB/?xxd!]ʥ?8 Jqq`2ϓ9cʚv鷈uXi<^^G~_['228}@-1/i z]@"b#v91::f)d̲%8 )=`A}`7x#vL*%x[fEA>Nlb=Ӊe2į~xVav];aA-63ڧamFnf:iyZG1cW6!~>gbE,C %F3QVXn8ױwl=>t 3mIB6wh=X)p1b8{V e5YЕ(އq#%Y/>`ݍ.F($ p< G 68jȣZӴ<G UJ\ #J7á{6h^b{?v[!{8v !J$D @2-Dʂ xPW`k,@9GY?[ԟ0G^m8rК.5~a_\0A O:YT W*N.gd m$VM{Mn+rޓ+}GXo|/DA]U9fy;kfTW5-hr,lSNCݚ;d\%X mh#aǕ~Iww[~8:ZڲE7*HFyb=41\ T3f(8NYɲGNWfd2"+Y&YMj:.,/>R+цhkknтҖQ|k9T(ƛm,S/My2̣d3[n\F)%fĬШW#^wh 8ӂ%mhY y>̠NSikTF.+_l# 0 3ΰl (0.D4Dwq;hc9&٬i&VLlkXSi&=iZcܲUt=}kPqQE! 0ԩ,+7lFSNx1WUJ3nUK)rF7r+%.^nrn-d߂?=#_<&0ҧzs+&OQA1#RVg&),3]Y *հI2dPp<(0C9?(8/<39AM֪lTi&Sy?;pMgq$*rkPHnȐP`~˿̖qHA>+#C *B ܼg9G0s%\*(EYX'btTP%b_qq-OI,WWҍ1 %gحNՠ:iV4x i|U<}/!㤀A+ Р2|ˌ)h`yr\rYX 0嘵rCƠSW.jB豉4/Ɩd%ӛ BM 0wE=\.BD."c'1!Mdb61;-s8KpG`O+yɇK*a@ȡ3$x \ \5\t5\@5д!`u+-M_M;"88Lum6{&P\ U jbibh[6ҋP@/DG=lyC2D-\X:` XX G} 35ã9p5XᲈXĢ.$ml||<[\ nm 5ʡ]ֱ@!H]/Y@ & VxҏVx£%RZq.|j&UL+q4+ZOX9HfF$|6K[w+(݋ < d۹xvzю(8r965]@:r;zgAK2>Ab{婋t} A===uh $߽V3u"o%9KɓFbvI9V#= u̐ǜc@E?eb(Ea.^zCU>_Z>QA\%!Կ_p55AGy1~ [/ g?>q&8Ǣ%Yzq]9@"g 57<Ǽ=f/΀w9Q|P5Xr*.S 8yP  q-M\׸p@E~_).: x~B>G"QUmpA0ҷx̯5c=U K+<.$;?1?R>@k?eέx ^?ni 53|5ezqA#_L ^.{8 3w𗿂8#=C=:n$2y?t,Y?8VrEr?أ8G:rXD^]M2m~A馲.= ݠ&救GZq+YȑLLV8DDRKX%_"6cvv'iP6Դl_+u:~G-rE.9ϢB1į DWc Ğ2 YNy: ߰Z_j%yWx=19v-{E'{Cf$Ilq1 BjrԑdkL76`0`n&&`CbH'@B(HB[Fi.K@%Ye (mfi6AZN]5mӺ}m6MӦM۪}ؤjڥ4G.S =z?y99『w f 8$7el{W('ߡܿ$xqÖ8 1Ua#f<ߦg3q;cX5#Df= MSw)h5졅p$v1iL.x 8K)gYBDim` $]v>K<n'2LY%u )tY='e*\v/q~J M5+ɢmIښQ{rڒ˵9%M)aES՜USj61m"Z~D XR(j ?R/1~ b:m:r"8+GS IږVQQU6`(VBZ7֫޸Qu6Mݪ5Ri3)yNU VUX>T3SKH'bCطEȓ&K"L3TgU\Z_5ZjUm(hک_Qgͪ,mUb{Sg;>S#{Lo&Yg{(C$;I!Qk,ekͭ*[*m媰W^2GJ[SI39OQsWޜw6 %33IcuKZ~vlF9{IW3SNʜ.*8'"WH>涩 Gyv?ʬQ5` Q)-[J&RVj0vƟ^Dw;X҃][K> 'dMSfI,kr@ ʨVz(PRB=J )1N0uR;HfbM ~f/w_ዾKax e"'q!a$|:xĞqbMG#a{i{sp mx AY2`͐ѐb: }0q8k]A(nbL4n"LvLavL"&i0bK4A<&?åC){1ǎJw ցJ9>c;cܘɋ9.?7FҳB_Hx| :;_ U:G;0\|Hv,bb,R(2 $y{8G^~;?oسEi㗩WH*_%p p Ǎ' 67%X,e 2X&8ҫ>_{Ŵna"r܄*_a |n]M>gVcB~PW Iʊt9c/ggTW6\ۏ_ݛ¸oo=^I/G!R6\{tƟ6%inmzK4IIKKEZ.E\1AAȠ ás)`e2q2&sӝYiOs~/<Yz,GG>ۇ;h {mf5*c?,ks51#ꋚ b԰>_8?@Gx76̶/2(䴡6ڦϱ-ҿu7g8?<7{{BGeER?.jK?wvT=:uч踂89,C%tz gz@{཮kz _>/߈M_p귪һܷtɜGG8qyqa6WqR6K'Hz0v]_p|ܟ>ݛ,::)tGsc88#8Zܬ}d/ _R@m!B#_y \b3e'"֯MzG=:t5R=±IJԹѽ(Sݰt*O.?䘲̘֤"f'QmG<4vPAo ɠy#ynsmEo  8,OUB$P]*,Od_ 2\G{?vX-s^tSsd+\x )c:h_P ~/k$?fOyF>OqmrѺ!.sSc>;\䱧"p᪇pMdptvZf^w@dG\ȝ -a4uAL&cjHָA9ʂ͞*P}LHuª4Z59_'`K0\RE-U$Fp+mw_ղqlI&&cqjHNQ8:CjU`b+4$JUI $5ȗ4VH%oUqOxBwU`BSDEOƮGm%#P1i(bPɨ!Ft94y4T*Rjܤbs *HW5r[)\ʱ\zD $#F#ϯw泥8!7#kȍߚ YJ-*RBK UX):Jn[rm3/T}RcxGi3-»[1nŌsJnFS'R*U`cO۞<{r%r9|I );AY㕙>MNgҝ+*{^2^5MlkH=Sl-~@ Fy24+iSө̌\P 93*=+4L={l]< K7#L_O̔zvx75RxeXՅ|vꤖz P#6(e3Ǣ49\#L*Yek.{LddHO*sLIs#>|o #c`;3 mcHrSCn|Ĥ* Y|vY ke,K)EmJ.+x U\Qy|;rȻ chiCG3#t27^RL%VJe,u) % VRYH 2*ۡXxK^n"/˴2K-pg]9]m jF_-CF2֓b$&@>*-JLx_b}^ SH~gCcc ~cUEp>4q*=NsaXFh11+)`bA MhPi`0MA C?Vj)x6{LzӐأVBV7q7 $K%l\xa0t\x ǸcBHuhcC걓zCON0yy@0"dF\1RkRivHMdM4pġӄ&45GoLLk.Khhh k\ni)![ 9<h#;?;: 6+Xy#tp 30hs1 ; 9tG7&4nrхU]Gy,AUEpܳ:^J<a<2h6ƺ gGI'M/uE賏FG.Y'ṿ; 1pa0p{Lߐ {%W@Ca!WқO c *r1@_RqpfLtLRl`ut^o$6hVӐq -8.sfp>rFqخR+_W.0Y āt0Rοgjs;pH}A#GGs"^@ aG>|Tp!X4T |pƲ~kg88K8G<N]zS'u/ >z:=;N*ңԞ<7U#` :._ORܠԍp/h=k!G!^7YJgz\hDt*bn 6^ 489x,؋h2GM>:p6Nv4#ԥY EfUR0we mXu8# teDt2!Ue/Z"\B.j(fmV]O{ jȭ7\~t \χc9)2xYŮC-Z@泳R\ ,F}9(48ĵ5xW:EiU5YJϨ.&j$ n1 BxS(fYjC(i>'G;}+l$95ٰ;\p%'/\p k4\5hr#{#PN. idgqedY1@3zMaL$?r2C&X5>ȡ1A.%jTPFgiD a!w+'tCV:7)5C)O( 1|!OwDt.Xm)1PANO!ǁ紆*dT^Ur .eGxGRZySbdS{< =ZQ1]!2YQ,jLN\r,rNi 9~LSeLȄ*W*,qB=9  NUHO]pwL,Xߕ|VLl)f9#'CNPEyLxl2{2yeLJUD0(-U3Ui0v|:ɮL1v ͥB+tr)D]᥊y ݸ~0)\*ָɽû{Xfmհ2V|ߵ=růĔTMT۩jEZWj^vqq*B˄ΆKZ[µo5c[_U`8,G bK^2ٓ:hh5i|1/jZVXA>ך_,N7Ѧ _\[=_iu`xD@yy_2%ʹx>r؏{Թr`jf>+Te$9 `cU: I ~%ٱ/袁/h _s)qqlK3[j ML_>7\;ֲc4QkTT((kx[w ሕKk4U@{.J1P╢4 ŗqE`ƎUn\ɼEi]l'${.yǵ1Ja} !Ϛ:mfG3m4I3]4E35q^'$;i츎[u r@ 1T<ȸѹm a-߉MKvǀz(j-|BL9~3p.Q3 xԭGn߶dN;|ܛ}6'Ѷ$3'qR<%&4S|qJ~DzR>ދx/9f |ʸ'yj= kâٱ ]0!,ڣp~ӳq0rN<Qٗc;ޥ`|<\^\e>F<?WOcq|xiorM_a{ u| =&RK忚6W$dv}*1?X߶i{#_\Y3Nmc} 6>|d)];__/9Գ 3%OlOI' 3d,mB=E;bW8{; ,g_^U*IltBtl x( $/g :{'iv6l`gv;8hûCQO)͠s'I=. \x)9)#+yJ9ۉxs'5ۆ Tx>)3tSI/ WB)t~-vk~ƻFvNZMsEp]z>Dk;ddI8,ybi|ENbWVf{crVրco5(Xe1/sSG j+GYvꎣ7b%8pTȊ*J3LJY–ٲ_h9 ukճ.?.7i<%oD,!`R8\)`. .jȥHB@H1%폎@TXb/&f:.cK4#1wsb=8|LfҖxxCCxt $2N(mt 5&j0T?CpmG2aEh9K(U/0q&{@AkX = =Y&zfͺ uЭ>HV^iPfPwމЋlxH9,4ٲ5f` ,x808!qM٠)]I l"10BTI##P$Ccba܍2Sc5#&F&G;Τ-gҖH#D >[3F5b( Ab${izз9&l^}p"F;b2!{asE D&x#8j$,byb!p,dLY]ّ!1CHlp\q .U%NLH-Rdch ^@D3Hvgxq|Dp*жhcHu}67jʌ ?R#3I3< PS,> ؞Eq\=-R'6;9IAzɆٜI6|XdA,@W־+Y?[ړC iBF-(ӊ -A[(oq@j ȡ^s8j$,AE$h~?Xhڊ>ǁ-•a0|!St+R)5D@*zmahCFnlV7qm͐pnyQњ+{O#Ok R>5y]Nbs0 ;P^84~EJcil)%dtUY#Wq€rFtGz](9dj_8`]భKJ7HKwsؗ1TT..(rۮѵ}4f>z{ϟࣵLAϻsƌzfzkfL(քC ~h?j}CJ3E%/c_TVJ*pT_xEy\_^Hڨ;Wi YA"ҭ[l!Iv^يR9$Vd2nqy>=/<y;s+Nw $ ӟmWy0\*c<0gלuN@B! +G[Yu?R|^rrH/坑,~$K]Kn`l=Z5[7q|gUnr"~F8ߛ-cY đ\ೖ-K1Es)`[>zyH]PF(볫ܤ;dqFV Lk-zPߔJK{wWy~P'C8d,ߴ. :J@7 dzqF@` V" 6X ##  ZeWŔԃN~a~qfu#E".lйy.?Xϊ ;m HK=`(tu4G!gn_:^!B@zhCLZ8l$@ + @ e!OAx C8~ⷎNs]=/I֣3ѡM*{q6ljK~!}9Ym!!_7Hlް(Qppj`0GXs,D`+/xGF@ҚSШ s=t##URuMT?|zq+[:sMnִ䂹33o\P7.B *OEtO1o,N4GO\ٞ~pc݌)GR0XQAl(f4 M)@<׹L"]NJYsr,'%hݹv  ݆/U)|JnPW x kFEQ`0|=t[ 1x}fpc3A&ŽpJ ~ 7%1,۰PRND,^HU0uf>7웻ñ]zQZVq6 S d`0XA#GVJ[(9 RWvHo^0x3 bx p`+gQ(^1ױ>9ږ騬*^x#qb ,Y2aHwcVMOb/f=-ȁ/} - `=瀾}k) 4`" C!)p3:mu@XoQv ngn3w:s+*qBV- M$NreO{}v R` 83JyMO4)XZGyQj{DM {_πY ̸Ӻ|)weUefᨈ.A]]dciI~\w<8/t Pg+e >*7E`S# 3\GHpχHn aKS[K 5uk;mɶcVރ iEHD_+߾U\'9GVXJ¬9M<~̨փI+qijL9%A0pcF"((`77Q#'q h[:-H,n#*Z_YXO =Vy!pLYzY*K;x2}{"w7er"Iw:GSy\V[<6'Rչn%:溬'5mDtbZL\&$ ܾ~vן{}߻<%E&gINDHJ"NƄdD] Q!c@ d *>7 8PW% \ h`3^l:93cM|;egA :܂8XJ[7XI|0|N7w[{EkvcJȬi%J-Q#u|FBѵ<~ԠVTw|_JvV{J,͓ɯ)l/` R|Vxfm 96pL1c3Y0ߜ,/NP[@Qt+eKTe9ۏ-p Ȯ|BpW$ %IHO޿y:~0?_(gD,rE}KcШ+)J_*=I,?!4l=Å[Pծ=Ğ [ }g OZO$o!xL=5dbBC) Oմ>RIr\r"#;@V2[kclzi5a#*Xm?;62.#:ĉ֙Li_8L+ endstream endobj 437 0 obj << /Type /XObject /Subtype /Image /Width 667 /Height 591 /BitsPerComponent 8 /ColorSpace /DeviceGray /Length 394198 >> stream endstream endobj 438 0 obj << /Type /XObject /Subtype /Image /Width 93 /Height 1123 /BitsPerComponent 8 /ColorSpace /DeviceGray /Length 104440 >> stream ΧΧգբ䢣ܠեͥΥեܥܥܥ奥ΥΥͥΥեΥΥܥܥեգգ endstream endobj 439 0 obj << /Type /XObject /Subtype /Image /Width 16 /Height 1123 /BitsPerComponent 8 /ColorSpace /DeviceGray /Length 17969 >> stream ΥΥΥեܥܥΥΥΥΥΥΥΥΥΥΥΥΥΥΥΥΥΥΥΥΥΥΥΥΥΥեեΥΥΥΥΥΥΥΥΥΥΥΥΥΥΥΥΥեΥΥΥΥΥΥܥΥΥեΥΥΥͥΥΥΥΥΥեΥΥΥΥΥΥΥΥΥΥΥΥΥΥΥΥΥΥΥΥΥΥΥܥΥΥΥΥեΥΥեΥΥΥΥ奥ΥΥΥΥΥΥΥΥΥΥΥΥΥΥΥΥΥΥܥΥΥΥܥΥΥΥΥΥΥΥΥΥΥΥΥΥΥΥΥΥΥΥΥΥͥΥΥΥΥΥΥΥΥΥΥΥΥΥΥΥΥΥΥΥΥΥΥΥΥΥΥΥΥΥͥΥΥΥΥΥΥΥΥΥΥΥΥΥΥΥΥΥ endstream endobj 440 0 obj << /Type /ExtGState /SA true /SM 0.02 /OP false /op false /OPM 1 /TR2 /Default >> endobj 1 0 obj << /Type /Page /Parent 390 0 R /Resources 2 0 R /Contents 3 0 R /MediaBox [ 0 0 595 842 ] /CropBox [ 0 0 595 842 ] /Rotate 0 >> endobj 2 0 obj << /ProcSet [ /PDF /Text ] /Font << /F2 337 0 R /F3 338 0 R >> /ExtGState << /GS1 434 0 R >> /ColorSpace << /DefaultCMYK 417 0 R /Cs6 416 0 R >> >> endobj 3 0 obj << /Length 770 >> stream q 1 i 0.015 737.008 510.221 -737.008 re W n /Cs6 cs 0 0 0 scn /GS1 gs 0.015 709.001 25.44 -0.284 re f Q /Cs6 cs 0 0 0 scn /GS1 gs 28.006 737.008 0.283 -25.455 re f 481.89 737.008 0.283 -25.455 re f 484.724 709.001 25.512 -0.284 re f 484.724 28.346 25.512 -0.283 re f 481.89 25.512 0.283 -25.512 re f q 1 i 0.015 737.008 510.221 -737.008 re W n 28.006 25.512 0.283 -25.512 re f 0.015 28.346 25.44 -0.283 re f Q BT /F2 1 Tf 9.5956 0 0 9.5956 214.696 120.1323 Tm 0 Tc 0 Tw [(ISBN)-251.4(92)-252.5(9036)-245.1(075)-254.7(5)]TJ -5.536 -1.0517 TD (Copyright)Tj /F3 1 Tf 4.6202 0 TD (#)Tj /F2 1 Tf 1.2466 0 TD [(by)-253.7(the)-249.6(Council)-253(for)-248.4(International)]TJ -5.5951 -1.0576 TD [(Organizations)-256.7(of)-249.4(Medical)-255.3(Sciences)-250.6(\(CIOMS\))]TJ ET endstream endobj 4 0 obj << /Type /Page /Parent 390 0 R /Resources 5 0 R /Contents 6 0 R /MediaBox [ 0 0 595 842 ] /CropBox [ 0 0 595 842 ] /Rotate 0 >> endobj 5 0 obj << /ProcSet [ /PDF /Text ] /Font << /F2 337 0 R /F4 339 0 R >> /ExtGState << /GS1 434 0 R >> /ColorSpace << /DefaultCMYK 417 0 R /Cs6 416 0 R >> >> endobj 6 0 obj << /Length 3929 >> stream q 1 i 0.015 737.008 510.221 -737.008 re W n /Cs6 cs 0 0 0 scn /GS1 gs 0.015 709.001 25.44 -0.284 re f Q /Cs6 cs 0 0 0 scn /GS1 gs 28.006 737.008 0.283 -25.455 re f 481.89 737.008 0.283 -25.455 re f 484.724 709.001 25.512 -0.284 re f 484.724 28.346 25.512 -0.283 re f 481.89 25.512 0.283 -25.512 re f q 1 i 0.015 737.008 510.221 -737.008 re W n 28.006 25.512 0.283 -25.512 re f 0.015 28.346 25.44 -0.283 re f Q BT /F4 1 Tf 19.9253 0 0 19.9253 212.1448 588.3589 Tm 0 Tc 0 Tw (Contents)Tj /F2 1 Tf 10.959 0 0 10.959 95.6409 542.8345 Tm -0.0001 Tc (ACKNOWLEDGEMENTS)Tj 12.8709 0 TD 0.118 Tc [(.....................................)-1376(5)]TJ -12.8709 -1.8779 TD 0 Tc (BACKGROUND)Tj 8.215 0 TD 0.118 Tc [(.................................................)-1376(7)]TJ -8.215 -1.8727 TD 0 Tc (INTRODUCTION)Tj 8.603 0 TD 0.118 Tc [(................................................)-874.3(1)118(1)]TJ -8.603 -1.8779 TD 0 Tc [(INTERNATIONAL)-300.8(INSTRUMENT)5.4(S)]TJ 1.2933 -1.226 TD [(AND)-301.9(GUIDELINES)]TJ 9.6376 0 TD 0.118 Tc [(..........................................)-874.3(1)118(5)]TJ -10.9309 -1.8779 TD 0 Tc [(GENERAL)-301.6(ETHICAL)-299.2(PRINCIPLES)]TJ 17.1387 0 TD 0.118 Tc [(..........................)-874.3(1)118(7)]TJ -17.1387 -1.8727 TD 0 Tc (PREAMBLE)Tj 6.2751 0 TD 0.118 Tc [(......................................................)-874.3(1)118(9)]TJ -6.2751 -1.8779 TD -0.0004 Tc [(THE)-303.7(GUIDELINES)]TJ 9.379 0 TD 0.118 Tc [(..............................................)-874.3(2)118(3)]TJ -7.5839 -1.8779 TD 0 Tc [(1.)-538.8(Ethical)-303.6(justification)-297.3(and)-299.7(scientific)-300.8(validity)]TJ 1.3088 -1.226 TD [(of)-299.7(biomedical)-299.1(research)-299.8(involving)-296.7(human)-296.7(subjects)]TJ 21.0186 0 TD 0.118 Tc [(........)-874.3(2)118(3)]TJ -22.3274 -1.8727 TD 0 Tc [(2.)-538.8(Ethical)-303.6(review)-300(committees)]TJ 13.0157 0 TD 0.118 Tc [(................................)-874.3(2)118(4)]TJ -13.0157 -1.8779 TD 0 Tc [(3.)-538.8(Ethical)-303.6(review)-300(of)-294.5(externally)-301.2(sponsored)-293.6(research)]TJ 21.9394 0 TD 0.118 Tc [(.........)-874.3(3)118(0)]TJ -21.9394 -1.8779 TD 0 Tc [(4.)-538.8(Individual)-299.5(informed)-297.7(consent)]TJ 13.7917 0 TD 0.118 Tc [(..............................)-874.3(3)118(2)]TJ -13.7917 -1.8727 TD 0 Tc [(5.)-538.8(Obtaining)-300(informed)-297.7(consent:)-299.8(Essential)-299.2(information)]TJ 1.3088 -1.226 TD [(for)-302.7(prospective)-297(research)-299.8(subjects)]TJ 14.4228 0 TD 0.118 Tc [(.........................)-874.3(3)118(7)]TJ -15.7316 -1.8779 TD 0 Tc [(6.)-538.8(Obtaining)-300(informed)-297.7(consent:)-299.8(Obligations)]TJ 1.3088 -1.226 TD [(of)-299.7(sponsors)-297.5(and)-299.7(investigators)]TJ 12.8708 0 TD 0.118 Tc [(.............................)-874.3(4)118(0)]TJ -14.1797 -1.8779 TD 0 Tc [(7.)-538.8(Inducement)-300.5(to)-299.7(participate)-299(in)-295.4(research)]TJ 17.6716 0 TD 0.118 Tc [(....................)-874.3(4)118(5)]TJ -17.6716 -1.8727 TD 0 Tc [(8.)-538.8(Benefits)-301.4(and)-299.7(risks)-299.2(of)-299.7(study)-295.7(participation)]TJ 18.8355 0 TD 0.118 Tc [(.................)-874.3(4)118(7)]TJ -18.8355 -1.8779 TD 0 Tc [(9.)-538.8(Special)-303.2(limitations)-295.5(on)-303.1(risk)-296.2(when)-301.7(research)-294.7(involves)]TJ 1.3088 -1.226 TD [(individuals)-298.5(who)-299(are)-302.4(not)-296(capable)-300.8(of)-299.7(giving)]TJ 0 -1.2312 TD [(informed)-302.8(consent)]TJ 7.827 0 TD 0.118 Tc [(..........................................)-874.3(4)118(9)]TJ -9.6376 -1.8727 TD 0 Tc [(10.)-540.6(Research)-302.8(in)-295.4(populations)-299.8(and)-294.6(communities)]TJ 1.8106 -1.226 TD [(with)-299.8(limited)-305.1(resources)]TJ 9.7669 0 TD 0.118 Tc [(.....................................)-874.3(5)118(1)]TJ -11.5776 -1.8779 TD 0 Tc [(11.)-540.6(Choice)-303.5(of)-299.7(control)-297.1(in)-300.6(clinical)-299.7(trials)]TJ 16.6214 0 TD 0.118 Tc [(........................)-874.3(5)118(4)]TJ ET endstream endobj 7 0 obj << /Type /Page /Parent 390 0 R /Resources 8 0 R /Contents 9 0 R /MediaBox [ 0 0 595 842 ] /CropBox [ 0 0 595 842 ] /Rotate 0 >> endobj 8 0 obj << /ProcSet [ /PDF /Text ] /Font << /F2 337 0 R /F5 340 0 R /F6 341 0 R /F7 342 0 R >> /ExtGState << /GS1 434 0 R >> /ColorSpace << /DefaultCMYK 417 0 R /Cs6 416 0 R >> >> endobj 9 0 obj << /Length 4615 >> stream q 1 i 0.015 737.008 510.221 -737.008 re W n /Cs6 cs 0 0 0 scn /GS1 gs 0.015 709.001 25.44 -0.284 re f Q /Cs6 cs 0 0 0 scn /GS1 gs 28.006 737.008 0.283 -25.455 re f 481.89 737.008 0.283 -25.455 re f 484.724 709.001 25.512 -0.284 re f 484.724 28.346 25.512 -0.283 re f 481.89 25.512 0.283 -25.512 re f q 1 i 0.015 737.008 510.221 -737.008 re W n 28.006 25.512 0.283 -25.512 re f 0.015 28.346 25.44 -0.283 re f Q BT /F2 1 Tf 10.959 0 0 10.959 109.8142 610.1857 Tm 0 Tc 0 Tw [(12.)-540.6(Equitable)-301.5(distribution)-296.6(of)-299.7(burdens)-299.4(and)-294.6(benefits)]TJ 1.8106 -1.226 TD [(in)-300.6(the)-302.4(selection)-300(of)-299.7(groups)-296.9(of)-294.5(subjects)-301.3(in)-300.6(research)]TJ 21.0186 0 TD 0.118 Tc [(........)-874.3(6)118(1)]TJ -22.8292 -1.7744 TD 0 Tc [(13.)-540.6(Research)-302.8(involving)-296.7(vulnerable)-294(persons)]TJ 18.5613 0 TD 0.118 Tc [(...................)-874.3(6)118(4)]TJ -18.5613 -1.7744 TD 0 Tc [(14.)-540.6(Research)-302.8(involving)-296.7(children)]TJ 13.9055 0 TD 0.118 Tc [(...............................)-874.3(6)118(6)]TJ -13.9055 -1.7692 TD 0 Tc [(15.)-540.6(Research)-302.8(involving)-296.7(individuals)-298.5(who)-299(by)-298.2(reason)]TJ 1.8106 -1.2312 TD [(of)-299.7(mental)-298.6(or)-299.4(behavioural)-299.8(disorders)-297.7(are)-297.2(not)-301.2(capable)]TJ 0 -1.226 TD [(of)-299.7(giving)-299.8(adequately)-297.1(informed)-297.7(consent)]TJ 16.7507 0 TD 0.118 Tc [(...................)-874.3(7)118(0)]TJ -18.5613 -1.7744 TD 0 Tc [(16.)-540.6(Women)-300.3(as)-299.7(research)-299.8(subjects)]TJ 14.2935 0 TD 0.118 Tc [(..............................)-874.3(7)118(2)]TJ -14.2935 -1.7692 TD 0 Tc [(17.)-540.6(Pregnant)-301.5(women)-297.1(as)-299.7(research)-294.7(subjects)]TJ 18.1734 0 TD 0.118 Tc [(....................)-874.3(7)118(4)]TJ -18.1734 -1.7744 TD 0 Tc [(18.)-540.6(Safeguarding)-295.5(confidentiality)]TJ 14.2935 0 TD 0.118 Tc [(..............................)-874.3(7)118(5)]TJ -14.2935 -1.7744 TD 0 Tc [(19.)-540.6(Right)-301.3(of)-299.7(injured)-298(subjects)-301.3(to)-299.7(treatment)]TJ 1.8106 -1.226 TD [(and)-299.7(compensation)]TJ 8.215 0 TD 0.118 Tc [(.........................................)-874.3(7)118(8)]TJ -10.0256 -1.7744 TD 0 Tc [(20.)-540.6(Strengthening)-299.4(capacity)-294(for)-302.7(ethical)-299.8(and)]TJ 1.8106 -1.226 TD [(scientific)-300.8(review)-300(and)-299.7(biomedical)-299.1(research)]TJ 17.9147 0 TD 0.118 Tc [(................)-874.3(8)118(0)]TJ -19.7253 -1.7692 TD 0 Tc [(21.)-540.6(Ethical)-303.6(obligation)-294.6(of)-299.7(external)-300.4(sponsors)-297.5(to)-299.7(provide)]TJ 1.8106 -1.2312 TD [(health-care)-297.6(services)]TJ 8.603 0 TD 0.118 Tc [(........................................)-874.3(8)118(1)]TJ -11.7069 -1.7692 TD 0 Tc [(Appendix)-300.2(1:)-694(Items)-302.2(to)-299.7(be)-299.1(included)-299.3(in)-300.6(a)-296.7(protocol)]TJ 5.9491 -1.2312 TD [(\(or)-302.7(associated)-294.6(documents\))-301(for)-297.5(biomedical)]TJ 0 -1.226 TD [(research)-299.8(involving)-296.7(human)-296.7(subjects.)]TJ 15.4574 0 TD 0.118 Tc [(...............)-874.3(8)118(3)]TJ -21.4066 -1.7744 TD 0 Tc [(Appendix)-300.2(2:)-694(The)-300.5(Declaration)-301.5(of)-294.5(Helsinki)]TJ 18.3027 0 TD 0.118 Tc [(.......................)-874.3(8)118(9)]TJ -18.3027 -1.7692 TD 0 Tc [(Appendix)-300.2(3:)-694(The)-300.5(Phases)-297.8(of)-299.7(Clinical)-303.2(Trials)]TJ 5.9491 -1.226 TD [(of)-299.7(Vaccines)-299.1(and)-299.7(Drugs)]TJ 10.0256 0 TD 0.118 Tc [(.............................)-874.3(9)118(7)]TJ -15.9748 -1.7744 TD 0 Tc [(Appendix)-300.2(4:)-694(Members)-302.3(of)-299.7(the)-297.2(Steering)-300.1(Committee)]TJ 21.7946 0 TD 0.118 Tc [(..............)-874.3(9)118(9)]TJ -21.7946 -1.7744 TD 0 Tc [(Appendix)-300.2(5:)-694(Consultation)-297.5(on)-297.9(Revising/Updating)-298.2(of)]TJ /F5 1 Tf 5.9491 -1.226 TD [(International)-298.3(Ethical)-298.7(Guidelines)-301.7(for)-297.7(Biomedical)]TJ T* [(Research)-298.2(Involving)-298.2(Human)-301.6(Subjects)]TJ /F2 1 Tf 0 -1.2312 TD [(\(March)-301.1(2000\):)-299.2(Participants)]TJ 11.9655 0 TD 0.118 Tc [(........................)-377.6(1)118(0)118(3)]TJ -17.9147 -1.7692 TD 0 Tc [(Appendix)-300.2(6:)-694(Commentators)-298(on)-297.9(draft)-302.5(guidelines)]TJ 5.9491 -1.226 TD [(\(Organizations)-298.3(and)-299.7(individuals\))]TJ 13.9055 0 TD 0.118 Tc [(...................)-377.6(1)118(0)118(9)]TJ ET 95.641 646.809 318.898 -0.51 re f BT /F6 1 Tf 7.9702 0 0 7.9702 191.1118 649.1337 Tm 0 Tc [(INTERNA)13.4(TIONAL)-327.4(ETHICAL)-327.5(GUIDELINES)-319.8(FOR)-332.5(BIOMED)13.7(ICAL)-331.1(RESEARCH)]TJ /F7 1 Tf 11.9551 0 0 11.9551 95.6409 649.1337 Tm (4)Tj ET endstream endobj 10 0 obj << /Type /Page /Parent 390 0 R /Resources 11 0 R /Contents 12 0 R /MediaBox [ 0 0 595 842 ] /CropBox [ 0 0 595 842 ] /Rotate 0 >> endobj 11 0 obj << /ProcSet [ /PDF /Text ] /Font << /F2 337 0 R /F4 339 0 R /F5 340 0 R >> /ExtGState << /GS1 434 0 R >> /ColorSpace << /DefaultCMYK 417 0 R /Cs6 416 0 R >> >> endobj 12 0 obj << /Length 5753 >> stream q 1 i 0.015 737.008 510.221 -737.008 re W n /Cs6 cs 0 0 0 scn /GS1 gs 0.015 709.001 25.44 -0.284 re f Q /Cs6 cs 0 0 0 scn /GS1 gs 28.006 737.008 0.283 -25.455 re f 481.89 737.008 0.283 -25.455 re f 484.724 709.001 25.512 -0.284 re f 484.724 28.346 25.512 -0.283 re f 481.89 25.512 0.283 -25.512 re f q 1 i 0.015 737.008 510.221 -737.008 re W n 28.006 25.512 0.283 -25.512 re f 0.015 28.346 25.44 -0.283 re f Q BT /F4 1 Tf 19.9253 0 0 19.9253 165.8267 588.3589 Tm 0 Tc 0 Tw [(Acknowledge)-5.2(ments)]TJ /F2 1 Tf 10.959 0 0 10.959 95.6409 542.9479 Tm [(The)-481.5(Council)-477.2(for)-483.7(International)-473.1(Organizations)-481.2(of)-475.6(Medical)-481.8(Sciences)]TJ 0 -1.2571 TD [(\(CIOMS\))-281(acknowledges)-274.5(the)-281.7(substantial)-272.2(financial)-278.7(contribution)-278.1(of)-279(the)]TJ T* [(Joint)-178.8(United)-174.2(Nations)-171.1(Programme)-176.6(on)-173.8(HIV/AIDS)-174.1(to)-175.5(the)-173.1(preparation)-175.9(of)]TJ 0 -1.2623 TD [(the)-499(2002)]TJ /F5 1 Tf 4.3144 0 TD [(International)-494.8(Ethical)-495.2(Guidelines)-493.1(for)-499.5(Biomedical)-491.2(Research)]TJ -4.3144 -1.2571 TD [(Involving)-525.8(Human)-524.1(Subjects)]TJ /F2 1 Tf 11.4017 0 TD (.)Tj 0.7967 0 TD [(The)-522.9(World)-526.6(Health)-521(Organization)-519.6(con-)]TJ -12.1983 -1.2623 TD [(tributed)-352.1(generously)-349.7(also,)-351(through)-345.3(the)-348.9(departments)-350.8(of)-346.2(Reproductive)]TJ 0 -1.2571 TD [(Health)-179.6(and)-170.4(Research,)-177.7(Essential)-175(Drugs)-170.2(and)-175.6(Medicines)-176.9(Policy,)-175.1(Vaccines)]TJ T* -0.0001 Tc [(and)-274(Biologicals,)-272.7(and)-268.8(HIV/AIDS/Sexually)-274.1(Transmitted)-269.4(Infections,)-274.2(as)]TJ 0 -1.2623 TD 0 Tc [(well)-229.4(as)-227.2(the)-224.8(Special)-220.4(Programme)-223.1(for)-225.1(Research)-225.2(and)-227.3(Training)-221.1(in)-228.2(Tropical)]TJ 0 -1.2571 TD [(Diseases.)-195.9(CIOMS)-186.6(was)-192.1(at)-191.3(all)-191.2(times)-189.6(free)-192.8(to)-191(avail)-189.7(itself)-191.3(of)-191(the)-188.6(services)-193.9(and)]TJ 0 -1.2623 TD [(facilities)-271.5(of)-268.6(the)-271.3(World)-268(Health)-267.5(Organization.)]TJ 1.2933 -1.3243 TD [(CIOMS)-321.1(acknowledge)7.8(s)-318.6(also)-315.7(with)-320.4(much)-316.7(appreciation)-314.3(the)-317.9(financial)]TJ -1.2933 -1.2571 TD 0.0102 Tc [(su)3.5(pp)3.5(ort)-613.8(t)1.8(o)-612.1(t)1.8(h)3.5(e)-613.3(pro)3.5(j)-4.3(ect)-613.8(fro)3.5(m)-611.1(th)]TJ 14.7642 0 TD 0.6238 Tc [(eG)623.8(o)606.2(v)616.8(e)610.7(r)615.6(n)617.1(m)612.9(e)615.9(n)611.9(to)]TJ 7.7184 0 TD 0.624 Tc [(fF)617.5(i)609.5(n)617.3(l)614.6(a)]TJ 3.2643 0 TD 0.0074 Tc [(nd,)-617.6(th)-4.5(e)]TJ -25.7469 -1.2623 TD 0 Tc [(Government)-221(of)-227.2(Switzerland,)-223.2(the)-219.6(Swiss)-224.9(Academy)-218.9(of)-227.2(Medical)-223.2(Sciences,)]TJ 0 -1.2571 TD [(the)-209.3(Fogarty)-206(International)-209.2(Center)-205.7(at)-212(the)-209.3(National)-205.1(Institutes)-209.8(of)-206.6(Health,)]TJ T* [(USA,)-270.9(and)-268.7(the)-271.3(Medical)-269.7(Research)-266.6(Council)-270.3(of)-268.6(the)-266.2(United)-272.4(Kingdom.)]TJ 1.2933 -1.3295 TD 0.6249 Tc [(An)613(u)618.2(m)614(b)613(e)617(ro)613(fi)]TJ 7.17 0 TD 0.0073 Tc [(ns)-6(ti)-7.2(tut)-6.3(i)-2.1(o)-4.6(n)0.6(s)-616.5(a)-4.8(nd)-620.2(or)-6(ga)-4.8(ni)-7.2(za)-4.8(tio)-4.6(n)0.6(s)-616.5(m)-3.6(a)-4.8(d)0.6(e)-616.2(v)-4.8(a)-4.8(l)-2(ua)-4.8(b)-4.6(l)-2.1(e)]TJ -8.4633 -1.2571 TD 0 Tc [(contributions)-239.7(by)-236.1(making)-239(their)-237.1(experts)-240.5(available)-236.1(at)-237.9(no)-241(cost)-238.1(to)-237.6(CIOMS)]TJ 0 -1.2623 TD [(for)-219.9(the)-214.4(three)-215(meetings)-216.4(held)-216.9(in)-217.8(relation)-213.6(to)-216.9(the)-214.4(revision)-218.5(project.)-214.5(This)-217(has)]TJ 0 -1.2571 TD [(been)-272.4(highly)-268.5(appreciated.)]TJ 1.2933 -1.3243 TD [(The)-497.1(task)-490.7(of)-491.1(finalizing)-495(the)-493.8(various)-487.6(drafts)-491.8(was)-492.2(in)-497.2(the)-488.6(hands)-495.7(of)]TJ -1.2933 -1.2623 TD [(Professor)-337.9(Robert)-328.4(J.)-338(Levine,)-334.1(who)-335.2(has)-332.2(been)-334.4(consultant)-329.6(to)-335.9(the)-333.4(project)]TJ 0 -1.2571 TD [(and)-258.4(chair)-251.2(of)-258.3(the)-250.7(steering)-255(committee,)-258.5(and)-253.2(whose)-253(profound)-253.4(knowledge)]TJ 0 -1.2623 TD [(and)-232.5(understanding)-230.7(of)-232.4(the)-235.1(field)-233.2(is)-234.8(remarkable.)-228.8(He)-236.1(was)-233.5(ably)-231.8(assisted)-229.4(by)]TJ 0 -1.2571 TD [(Dr)-334.6(James)-429.8(Gallagher)-430.3(of)-434.2(the)-431.7(CIOMS)-429.7(secretariat,)-428.8(who)-433.5(managed)-425.6(the)]TJ T* [(electronic)-297.6(discussion)-300.4(and)-294.6(endeavoured)-291.5(to)-299.7(accommodate)-294.9(or)-294.2(reflect)-301.2(in)]TJ 0 -1.2623 TD [(the)-173.1(text)-171.4(the)-173.1(numerous)-170.6(comments)-171.1(received.)-170.5(He)-168.8(also)-176.1(edited)-171.2(the)-167.9(final)-175.3(text.)]TJ 0 -1.2571 TD [(Special)-184.2(mention)-180.9(must)-179(be)-185.3(made)-177.3(of)-180.7(the)-183.4(informal)-180.4(drafting)-180.7(group)-180.1(set)-179.7(up)-184.1(to)]TJ T* [(bring)-369(the)-369.6(influence)-371(of)-366.9(various)-368.6(cultures)-368.6(to)-372.1(bear)-366(on)-370.4(the)-369.6(process.)-368.3(The)]TJ 0 -1.2623 TD [(group,)-215.3(with)-211.8(two)-212.8(members)-215.8(of)-211.7(the)-214.4(CIOMS)-212.4(secretariat,)-211.5(met)-213.5(for)-214.7(five)-213.7(days)]TJ 0 -1.2571 TD [(in)-336.8(New)-340.6(York)-332.8(in)-336.8(January)-334.9(2001)-333.1(and)-336(continued)-331(for)-338.9(several)-334.8(months)-337.3(to)]TJ 0 -1.2623 TD [(interact)-379.4(electronically)-376.8(with)-377.3(one)-378.3(another)-372.3(and)-377.3(with)-377.3(the)-380(secretariat)-378.1(to)]TJ 0 -1.2571 TD [(prepare)-295.7(the)-292(third)-292.9(draft,)-291.2(posted)-287.8(on)-292.8(the)-292(CIOMS)-295.2(website)-292.7(in)-290.2(June)-293(2001:)]TJ ET endstream endobj 13 0 obj << /Type /Page /Parent 390 0 R /Resources 14 0 R /Contents 15 0 R /MediaBox [ 0 0 595 842 ] /CropBox [ 0 0 595 842 ] /Rotate 0 >> endobj 14 0 obj << /ProcSet [ /PDF /Text ] /Font << /F2 337 0 R /F6 341 0 R /F7 342 0 R >> /ExtGState << /GS1 434 0 R >> /ColorSpace << /DefaultCMYK 417 0 R /Cs6 416 0 R >> >> endobj 15 0 obj << /Length 2653 >> stream q 1 i 0.015 737.008 510.221 -737.008 re W n /Cs6 cs 0 0 0 scn /GS1 gs 0.015 709.001 25.44 -0.284 re f Q /Cs6 cs 0 0 0 scn /GS1 gs 28.006 737.008 0.283 -25.455 re f 481.89 737.008 0.283 -25.455 re f 484.724 709.001 25.512 -0.284 re f 484.724 28.346 25.512 -0.283 re f 481.89 25.512 0.283 -25.512 re f q 1 i 0.015 737.008 510.221 -737.008 re W n 28.006 25.512 0.283 -25.512 re f 0.015 28.346 25.44 -0.283 re f Q BT /F2 1 Tf 10.959 0 0 10.959 95.6409 609.8455 Tm 0 Tc 0 Tw [(Fernando)-372(Lolas)-368.8(Stepke)-370.3(\(chair\),)-370.5(John)-374.6(Bryant,)-368.7(Leonardo)-366.8(de)-371.5(Castro,)]TJ 0 -1.2623 TD [(Kausar)-270.3(Khan,)-273.4(Robert)-271.5(Levine,)-266.8(Ruth)-271(Macklin,)-272.7(and)-268.7(Godfrey)-273.1(Tangwa.)]TJ 0 -1.2571 TD [(They)-173(continued)-170.6(from)-168.7(October)-170.8(2001,)-171.8(together)-169.9(with)-175.6(Florencia)-167.9(Luna)-171.8(and)]TJ 0 -1.2623 TD [(Rodolfo)-242(Saracci,)-239.2(and)-242.8(cooperated)-234.5(in)-243.7(preparing)-238.4(the)-240.3(fourth)-241.7(draft.)-239.5(Their)]TJ 0 -1.2571 TD [(contribution)-267.8(was)-269.7(invaluable.)]TJ 1.2933 -1.2571 TD 0.0099 Tc [(The)-603.3(i)9.9(nt)9.9(er)9.9(es)9.9(t)-606.8(a)2.9(n)9.9(d)-608.8(c)9.9(o)]TJ 9.291 0 TD 0 Tc [(mm)-11.4(en)-9.4(ts)-616.7(o)-6.7(f)-613.7(th)-10(e)-613.2(m)0(a)-12.7(n)0(y)-613.8(o)-6.7(rg)-10(a)-7(n)0(i)-10.9(z)0(a)-9.7(t)0(i)-7.4(o)-6.7(n)-6.7(s)-613.4(an)-8.5(d)]TJ -10.5843 -1.2623 TD [(individuals)-464(who)-464.6(responded)-458.8(to)-460(the)-462.8(several)-464.1(drafts)-460.7(of)-465.2(the)-462.8(guidelines)]TJ 0 -1.2571 TD [(posted)-546.4(on)-541.1(the)-540.4(CIOMS)-543.5(website)-541(or)-542.5(otherwise)-545.5(made)-539.4(available)-541.3(are)]TJ T* [(gratefully)-270.7(acknowledged)-267.9(\(Appendix)-262.1(6\).)]TJ 1.2933 -1.2623 TD [(At)-236.9(CIOMS,)-237.3(Sev)-233.7(Fluss)-235.5(was)-238.7(at)-232.7(all)-237.8(times)-236.2(ready)-233.3(and)-232.5(resourceful)-236.1(when)]TJ -1.2933 -1.2571 TD [(consulted,)-274.5(with)-273.9(advice)-273.4(and)-273.9(constructive)-269.2(comment,)-275.7(and)-273.9(Mrs)-274.1(Kathryn)]TJ 0 -1.2623 TD (C)Tj 0.7242 0 TD [(halaby)-7.5(-Am)-9.8(sler)-613(respon)-13.3(ded)-605.9(mo)-7.2(st)-606.3(com)-10(petent)-9.9(ly)-611.2(to)-610.1(the)-607.6(some)-7.8(ti)-7.4(mes)]TJ -0.7242 -1.2571 TD [(considerable)-449.5(demands)-447.2(made)-446.3(on)-448(her)-447(administrative)-445.5(and)-449.8(secretarial)]TJ T* (skills.)Tj ET 95.641 646.809 318.898 -0.51 re f BT /F6 1 Tf 7.9702 0 0 7.9702 191.1118 649.1337 Tm [(INTERNA)13.4(TIONAL)-327.4(ETHICAL)-327.5(GUIDELINES)-319.8(FOR)-332.5(BIOMED)13.7(ICAL)-331.1(RESEARCH)]TJ /F7 1 Tf 11.9551 0 0 11.9551 95.6409 649.1337 Tm (6)Tj ET endstream endobj 16 0 obj << /Type /Page /Parent 390 0 R /Resources 17 0 R /Contents 18 0 R /MediaBox [ 0 0 595 842 ] /CropBox [ 0 0 595 842 ] /Rotate 0 >> endobj 17 0 obj << /ProcSet [ /PDF /Text ] /Font << /F2 337 0 R /F4 339 0 R /F5 340 0 R >> /ExtGState << /GS1 434 0 R >> /ColorSpace << /DefaultCMYK 417 0 R /Cs6 416 0 R >> >> endobj 18 0 obj << /Length 5741 >> stream q 1 i 0.015 737.008 510.221 -737.008 re W n /Cs6 cs 0 0 0 scn /GS1 gs 0.015 709.001 25.44 -0.284 re f Q /Cs6 cs 0 0 0 scn /GS1 gs 28.006 737.008 0.283 -25.455 re f 481.89 737.008 0.283 -25.455 re f 484.724 709.001 25.512 -0.284 re f 484.724 28.346 25.512 -0.283 re f 481.89 25.512 0.283 -25.512 re f q 1 i 0.015 737.008 510.221 -737.008 re W n 28.006 25.512 0.283 -25.512 re f 0.015 28.346 25.44 -0.283 re f Q BT /F4 1 Tf 19.9253 0 0 19.9253 198.9354 588.3589 Tm 0.0004 Tc 0 Tw (Background)Tj /F2 1 Tf 10.959 0 0 10.959 95.6409 543.6849 Tm 0 Tc [(The)-481.5(Council)-477.2(for)-483.7(International)-473.1(Organizations)-481.2(of)-475.6(Medical)-481.8(Sciences)]TJ 0 -1.2571 TD 0.0076 Tc [(\(CIO)7.6(M)-7.8(S)0.9(\))-611.3(i)-1.8(s)-611(a)0.6(n)-614.7(i)-1.7(nternationa)-4.5(l)-612.2(nongov)-4.5(ernm)7.6(e)-6(n)-4.3(tal)-612.2(o)0.9(rganization)-614.7(i)-1.7(n)]TJ T* 0 Tc [(official)-470(relations)-470.1(with)-465.3(the)-467.9(World)-464.6(Health)-469.3(Organization)-462.7(\(WHO\).)-471.6(It)]TJ 0 -1.2622 TD [(was)-388.7(founded)-386.1(under)-388(the)-390.3(auspices)-387.8(of)-387.6(WHO)-388.4(and)-387.7(the)-390.3(United)-386.2(Nations)]TJ 0 -1.2571 TD [(Educational,)-521.1(Scientific)-521.8(and)-517(Cultural)-517.2(Organization)-519.6(\(UNESCO\))-519.4(in)]TJ 0 -1.2623 TD [(1949)-493.5(with)-496.3(among)-493.5(its)-496.7(mandates)-492.1(that)-496.1(of)-491.1(maintaining)-497.1(collaborative)]TJ 0 -1.2571 TD [(rel)-9.9(ations)-610.2(with)-610.1(the)-607.6(Unit)-9.5(ed)-604.3(Nation)-7.7(s)-608.2(and)-605(its)-610.5(speci)-9(aliz)-7.7(ed)-604.3(agenci)-9.6(es,)]TJ T* [(particularly)-271(with)-268.7(UNESCO)-269.7(and)-268.7(WHO.)]TJ 1.2933 -1.2623 TD [(CIOMS,)-185.6(in)-186.8(association)-183.7(with)-180.8(WHO,)-185.7(undertook)-183.7(its)-181.1(work)-183(on)-184.1(ethics)-188.1(in)]TJ -1.2933 -1.2571 TD [(relation)-270.5(to)-273.8(biomedical)-268.1(research)-268.8(in)-269.5(the)-271.3(late)-270.6(1970s.)-267.9(At)-267.9(that)-268.5(time,)-273.5(newly)]TJ 0 -1.2623 TD 0.0091 Tc [(in)9.1(de)9.1(pen)9.1(d)0.9(e)9.1(n)-0.3(t)-604.6(W)9.1(HO)]TJ 9.0944 0 TD 0 Tc [(Me)-12.2(mb)-7.2(e)-7.9(r)-613.4(St)-10(ate)-13(s)-613.4(w)-6.2(er)-10.9(e)-613.2(s)0(e)-10.9(t)0(t)-6.5(i)-9.4(ng)-613.8(u)-6.7(p)-612(h)-6.7(e)0(a)-9.7(l)0(t)-7.4(h)-6.7(-c)-11.2(ar)-10(e)]TJ -9.0944 -1.2571 TD [(systems.)-373.3(WHO)-367.7(was)-368(not)-368.5(then)-371.2(in)-367.8(a)-374.3(position)-367.4(to)-366.9(promote)-371.1(ethics)-369.2(as)-366.9(an)]TJ T* [(aspect)-268.5(of)-268.6(health)-268.5(care)-268.9(or)-268.4(research.)-267.8(It)-270.1(was)-264.5(thus)-268(that)-268.5(CIOMS)-269.3(set)-267.6(out,)-269.2(in)]TJ 0 -1.2623 TD [(cooperation)-330.6(with)-330.8(WHO,)-330.5(to)-330.7(prepare)-331.9(guidelines)-332.6(to)-328.7(indicate)-332.3(how)-330.1(the)]TJ 0 -1.2571 TD (e)Tj 0.4449 0 TD [(thi)-9(cal)-614(pri)-8.7(n)-6.7(c)0(i)-6.9(ple)-8.4(s)-608.2(tha)-6.6(t)-613.7(sho)-6.1(uld)-617.7(gui)-7.5(de)-614.7(the)-612.8(con)-11(duct)-614.3(o)-6.7(f)-608.5(bio)-7.2(me)-8.4(dic)-8.4(al)]TJ -0.4449 -1.2571 TD [(research)-274(involving)-276.1(human)-270.8(subjects,)-274.4(as)-273.8(set)-272.8(forth)-276.4(in)-274.7(the)-271.3(Declaration)-275.6(of)]TJ 0 -1.2623 TD [(Helsinki,)-553.7(could)-544.3(be)-547.4(effectively)-550(applied,)-544.2(particularly)-550.3(in)-548.9(developing)]TJ 0 -1.2571 TD [(countries,)-255.3(given)-255.2(their)-257.8(socioeconomic)-252.9(circumstances,)-254.2(laws)-253.2(and)-253.2(regula-)]TJ 0 -1.2623 TD [(tions,)-364.3(and)-356.6(executive)-359.7(and)-361.8(administrative)-357.5(arrangements.)-360(The)-362.6(World)]TJ 0 -1.2571 TD [(Medical)-295.6(Association)-291.4(had)-289.4(issued)-290.1(the)-292(original)-291.2(Declaration)-291.1(of)-294.5(Helsinki)]TJ T* [(in)-197.1(1964)-188.3(and)-191.1(an)-194.7(amended)-188.3(version)-193.7(in)-191.9(1975.)-192.5(The)-191.8(outcome)-189.8(of)-196.2(the)-193.8(CIOMS/)]TJ 0 -1.2623 TD [(WHO)-590.2(undertaking)-583.2(was,)-589.5(in)-590.3(1982,)]TJ /F5 1 Tf 15.6695 0 TD [(Proposed)-586.3(International)-582.8(Ethical)]TJ -15.6695 -1.2571 TD [(Guidelines)-270.6(for)-271.9(Biomedical)-268.7(Research)-267.2(Involving)-267.2(Human)-270.6(Subjects)]TJ /F2 1 Tf 25.8917 0 TD (.)Tj -24.5984 -1.2623 TD [(The)-471.2(period)-469.7(that)-470.3(followed)-464.9(saw)-471.5(the)-467.9(outbreak)-467(of)-470.4(the)-467.9(HIV/AIDS)]TJ -1.2933 -1.2571 TD [(pandemic)-208(and)-201.5(proposals)-202.2(to)-206.5(undertake)-200.7(large-scale)-207.1(trials)-205.6(of)-206.5(vaccine)-203.7(and)]TJ T* [(treatment)-203.2(drugs)-202.3(for)-199.2(the)-204.1(condition.)-202.1(These)-202.7(raised)-202.5(new)-201.9(ethical)-201.5(issues)-203.7(that)]TJ 0 -1.2623 TD [(had)-341.1(not)-337.4(been)-339.6(considered)-334.9(in)-342(the)-338.6(preparation)-336.3(of)]TJ /F5 1 Tf 20.3357 0 TD [(Proposed)-338(Guidelines)]TJ /F2 1 Tf 8.4943 0 TD (.)Tj -28.8301 -1.2571 TD [(There)-445.9(were)-444.1(other)-441.4(factors)-442.8(also)-445.1()-443.3(rapid)-441.4(advances)-441.1(in)-445.4(medicine)-444.4(and)]TJ 0 -1.2623 TD [(biotechnology,)-173.8(changing)-172.1(research)-170.5(practices)-175(such)-169.2(as)-175.5(multinational)-173.2(field)]TJ 0 -1.2571 TD [(trials,)-313.3(experimentation)-305.4(involving)-312.3(vulnerable)-304.4(population)-307.2(groups,)-311.4(and)]TJ T* [(also)-533(a)-534.6(changing)-529.1(view,)-531.3(in)-533.4(rich)-533.9(and)-527.4(poor)-535.3(countries,)-529.5(that)-532.3(research)]TJ 0 -1.2623 TD [(involving)-265.7(human)-265.6(subjects)-265.1(was)-264.5(largely)-267.8(beneficial)-266.8(and)-263.5(not)-265(threatening)]TJ /F5 1 Tf 28.8301 0 TD (.)Tj /F2 1 Tf -28.8301 -1.2571 TD [(The)-238.4(Declaration)-234.2(of)-237.6(Helsinki)-234(was)-238.7(revised)-236.2(twice)-236.4(in)-233.3(the)-240.3(1980s)-232.7()-236.4(i)0(n)-233.3(1983)]TJ ET endstream endobj 19 0 obj << /Type /Page /Parent 390 0 R /Resources 20 0 R /Contents 21 0 R /MediaBox [ 0 0 595 842 ] /CropBox [ 0 0 595 842 ] /Rotate 0 >> endobj 20 0 obj << /ProcSet [ /PDF /Text ] /Font << /F2 337 0 R /F5 340 0 R /F6 341 0 R /F7 342 0 R >> /ExtGState << /GS1 434 0 R >> /ColorSpace << /DefaultCMYK 417 0 R /Cs6 416 0 R >> >> endobj 21 0 obj << /Length 6644 >> stream q 1 i 0.015 737.008 510.221 -737.008 re W n /Cs6 cs 0 0 0 scn /GS1 gs 0.015 709.001 25.44 -0.284 re f Q /Cs6 cs 0 0 0 scn /GS1 gs 28.006 737.008 0.283 -25.455 re f 481.89 737.008 0.283 -25.455 re f 484.724 709.001 25.512 -0.284 re f 484.724 28.346 25.512 -0.283 re f 481.89 25.512 0.283 -25.512 re f q 1 i 0.015 737.008 510.221 -737.008 re W n 28.006 25.512 0.283 -25.512 re f 0.015 28.346 25.44 -0.283 re f Q BT /F2 1 Tf 10.959 0 0 10.959 95.6409 609.8455 Tm 0 Tc 0 Tw [(and)-253.2(1989.)-254.5(It)-249.4(was)-254.2(timely)-254.7(to)-253.1(revise)-250.2(and)-253.2(update)-250.4(the)-250.7(1982)-250.4(guidelines,)-254(and)]TJ 0 -1.2623 TD [(CIOMS,)-201.1(with)-196.3(the)-193.8(cooperation)-196.1(of)-196.2(WHO)-197(and)-196.3(its)-196.7(Global)-200(Programme)-192.1(on)]TJ 0 -1.2571 TD [(AIDS,)-201.5(undertook)-194.1(the)-198.9(task.)-200(The)-197(outcome)-200.1(was)-197.3(the)-198.9(issuing)-200.3(of)-196.2(two)-197.3(sets)-203.4(of)]TJ 0 -1.2623 TD [(guidelines:)-481.7(in)-476.5(1991,)]TJ /F5 1 Tf 9.022 0 TD [(International)-474.1(Guidelines)-477.5(for)-478.8(Ethical)-479.7(Review)-480.4(of)]TJ -9.022 -1.2571 TD [(Epidemiological)-215.2(Studies)]TJ /F2 1 Tf 9.9015 0 TD (;)Tj 0.4863 0 TD [(and,)-216(in)-217.8(1993,)]TJ /F5 1 Tf 5.6129 0 TD [(International)-210.3(Ethical)-215.9(Guidelines)]TJ -16.0006 -1.2571 TD [(for)-271.9(Biomedical)-268.7(Research)-267.2(Involving)-267.2(Human)-270.6(Subjects)]TJ /F2 1 Tf 21.3342 0 TD (.)Tj -20.0409 -1.2623 TD [(After)-307.9(1993,)-301.1(ethical)-299.8(issues)-307.1(arose)-301.7(for)-302.7(which)-300.8(the)-302.4(CIOMS)-305.5(Guidelines)]TJ -1.2933 -1.2571 TD [(had)-310.1(no)-308.3(specific)-308.9(provision.)-305.8(They)-307.5(related)-308.9(mainly)-303.7(to)-310(controlled)-305.6(clinical)]TJ T* [(trials,)-370.2(with)-361.8(external)-367.6(sponsors)-359.5(and)-361.8(investigators,)-365.2(carried)-365.6(out)-363.3(in)-362.7(low-)]TJ 0 -1.2623 TD [(resource)-491(countries)-494.2(and)-491.1(to)-491.1(the)-488.6(use)-493.5(of)-491.1(comparators)-489.3(other)-488(than)-489.2(an)]TJ 0 -1.2571 TD [(established)-552(effective)-549.2(intervention.)-552.8(The)-548.8(issue)-552.4(in)-548.9(question)-552.1(was)-549.1(the)]TJ 0 -1.2623 TD 0.0088 Tc [(per)8.8(c)-2.1(ei)8.8(ve)8.8(d)-611.1(n)8.8(eed)-603.2(i)]TJ 7.558 0 TD 0.612 Tc [(nt)603.6(h)612(o)]TJ 2.6176 0 TD 0 Tc [(se)-621.3(co)-9.4(u)-6.7(n)-6.7(t)0(r)-11.4(i)0(e)-12.1(s)-613.4(fo)-10(r)-613.4(l)-9.3(o)-6.7(w)-6.2(-c)-11.2(os)-9.7(t,)-623(te)-11.2(ch)-9.4(n)-6.7(o)0(l)-10.9(o)-6.7(gi)-11.2(ca)-9.7(ll)-13.5(y)]TJ -10.1756 -1.2571 TD [(appropriate,)-200.8(public-health)-204.7(solutions,)-203.8(and)-201.5(in)-202.3(particular)-202.9(for)-199.2(HIV/AIDS)]TJ T* [(treatment)-549.8(drugs)-543.7(or)-547.7(vaccines)-548.2(that)-542.7(poorer)-546.2(countries)-546(could)-544.3(afford.)]TJ 0 -1.2622 TD [(Commentators)-241.1(took)-240.7(opposing)-239.1(sides)-242(on)-246.2(this)-239.6(issue.)-246.2(One)-237.9(advocated,)-240.2(for)]TJ 0 -1.2571 TD [(low-resource)-532.1(countries,)-529.5(trials)-531.6(of)-527.3(interventions)-530.9(that)-527.2(might)-528.6(be)-531.9(less)]TJ 0 -1.2623 TD [(effective)-295.7(than)-287.5(the)-292(treatment)-285.9(available)-293(in)-290.2(the)-292(better-off)-286.5(countries,)-291.5(but)]TJ 0 -1.2571 TD [(also)-264(would)-258.2(be)-262.9(less)-261.2(expensive.)-259(All)-262.7(research)-258.5(efforts)-258(for)-261.3(public)-258.8(solutions)]TJ T* 0.0079 Tc [(approp)7.9(ria)7.9(t)-2.3(e)-610.4(t)7.9(o)-612.5(d)1.2(eve)7.9(l)-4.2(opi)7.9(ng)-609.5(c)7.9(o)-1.5(untr)7.9(i)-4.4(es)-605.5(shou)7.9(ld)-609.2(not)-605.8(be)-610.4(r)7.9(e)-3(je)7.9(cte)7.9(d)-612(as)]TJ 0 -1.2623 TD 0 Tc [(unethical,)-322.5(they)-319.7(claimed.)-316.8(The)-321.2(research)-315.4(context)-322.1(should)-313.4(be)-319.8(considered.)]TJ 0 -1.2571 TD [(Local)-182.3(decision-making)-175.8(should)-178.9(be)-185.3(the)-178.2(norm.)-181.5(Paternalism)-177.3(on)-179(the)-183.4(part)-180.3(of)]TJ T* [(the)-235.1(richer)-229.3(countries)-230.4(towards)-232.5(poorer)-230.6(countries)-230.4(should)-230.6(be)-231.9(avoided.)-231.4(The)]TJ 0 -1.2623 TD [(challenge)-240.5(was)-243.8(to)-237.6(encourage)-241.8(research)-237.8(for)-240.6(local)-242(solutions)-241(to)-237.6(the)-240.3(burden)]TJ 0 -1.2571 TD [(of)-346.2(disease)-344.9(in)-347.1(much)-347.8(of)-346.2(the)-343.8(world,)-346.6(while)-344.8(providing)-341.8(clear)-345.5(guidance)-343.8(on)]TJ 0 -1.2622 TD 0.0104 Tc [(protectin)3.7(g)-612.2(ag)3.4(ain)3.7(s)-2.9(t)-613.6(e)2.5(x)3.4(p)-1.5(loitatio)]TJ 13.4658 0 TD 0.6232 Tc [(no)616.5(fv)611.1(u)616.5(l)]TJ 4.0454 0 TD 0.0073 Tc [(ner)-6(a)0.3(b)-4.6(l)-2.1(e)-616.2(c)]TJ 4.2575 0 TD 0.0104 Tc [(ommunities)-613.4(and)]TJ -21.7687 -1.2571 TD 0 Tc (individuals.)Tj 1.2933 -1.2571 TD [(The)-559.1(other)-555.2(side)-559.8(argued)-555.6(that)-558.2(such)-557.1(trials)-557.4(constituted,)-555.2(or)-558.1(risked)]TJ -1.2933 -1.2623 TD [(constituting,)-180.8(exploitation)-181.6(of)-180.7(poor)-183.5(countries)-178.7(by)-184.4(rich)-182.1(countries)-178.7(and)-180.8(were)]TJ 0 -1.2571 TD [(inherently)-357.6(unethical.)-353.6(Economic)-357.6(factors)-354.8(should)-354.7(not)-358.1(influence)-355.5(ethical)]TJ 0 -1.2623 TD [(considerations.)-412.2(It)-409.8(was)-414.6(within)-408.9(the)-411(capacity)-413(of)-408.3(rich)-414.9(countries)-406.3(or)-413.2(the)]TJ 0 -1.2571 TD [(pharmaceutical)-586.9(industry)-583.7(to)-584.2(make)-586(established)-583(effective)-585.4(treatment)]TJ T* [(available)-401.7(for)-400.9(comparator)-403.6(purposes.)-399.7(Certain)-400.4(low-resource)-397.6(countries)]TJ 0 -1.2623 TD [(had)-465.3(already)-466.9(made)-467(available)-463.7(from)-468.7(their)-464.8(own)-464.6(resources)-468.1(established)]TJ 0 -1.2571 TD [(effective)-269.8(treatment)-270.4(for)-266.4(their)-273.4(HIV/AIDS)-267.3(patients.)]TJ 1.2933 -1.2571 TD [(This)-367(conflict)-370(complicated)-363(the)-369.6(revision)-363.4(and)-367(updating)-363.8(of)-366.9(the)-364.5(1993)]TJ -1.2933 -1.2623 TD [(Guidelines.)-475.2(Ultimately,)-475.6(it)-473(became)-472.5(clear)-469.7(that)-475.4(the)-473.1(conflicting)-470.6(views)]TJ 0 -1.2571 TD [(could)-347.8(not)-342.6(be)-350.9(reconciled,)-341.4(though)-347.5(the)-343.8(proponents)-341.9(of)-346.2(the)-343.8(former)-345.1(view)]TJ 0 -1.2623 TD [(claimed)-229.8(that)-232.3(the)-230(new)-227.8(draft)-230.1(guidelines)-229.2(had)-227.3(built)-226.8(in)-233.3(effective)-228.4(safeguards)]TJ ET 95.641 646.809 318.898 -0.51 re f BT /F6 1 Tf 7.9702 0 0 7.9702 191.1118 649.1337 Tm [(INTERNA)13.4(TIONAL)-327.4(ETHICAL)-327.5(GUIDELINES)-319.8(FOR)-332.5(BIOMED)13.7(ICAL)-331.1(RESEARCH)]TJ /F7 1 Tf 11.9551 0 0 11.9551 95.6409 649.1337 Tm (8)Tj ET endstream endobj 22 0 obj << /Type /Page /Parent 390 0 R /Resources 23 0 R /Contents 24 0 R /MediaBox [ 0 0 595 842 ] /CropBox [ 0 0 595 842 ] /Rotate 0 >> endobj 23 0 obj << /ProcSet [ /PDF /Text ] /Font << /F2 337 0 R /F5 340 0 R /F6 341 0 R /F7 342 0 R >> /ExtGState << /GS1 434 0 R >> /ColorSpace << /DefaultCMYK 417 0 R /Cs6 416 0 R >> >> endobj 24 0 obj << /Length 6134 >> stream q 1 i 0.015 737.008 510.221 -737.008 re W n /Cs6 cs 0 0 0 scn /GS1 gs 0.015 709.001 25.44 -0.284 re f Q /Cs6 cs 0 0 0 scn /GS1 gs 28.006 737.008 0.283 -25.455 re f 481.89 737.008 0.283 -25.455 re f 484.724 709.001 25.512 -0.284 re f 484.724 28.346 25.512 -0.283 re f 481.89 25.512 0.283 -25.512 re f q 1 i 0.015 737.008 510.221 -737.008 re W n 28.006 25.512 0.283 -25.512 re f 0.015 28.346 25.44 -0.283 re f Q BT /F2 1 Tf 10.959 0 0 10.959 95.6409 609.8455 Tm 0 Tc 0 Tw [(against)-426.1(exploitation.)-423.7(The)-424.6(commentary)-423(to)-423.8(the)-421.4(Guideline)-426.7(concerned)]TJ 0 -1.2623 TD [(\(11\))-268.8(recognizes)-269.1(the)-271.4(unresolved,)-265.7(or)-268.4(unresolvable,)-266.5(conflict.)]TJ 1.2933 -1.2571 TD [(The)-279.8(revision/updat)6.5(ing)-281.7(of)-273.8(the)-276.5(1993)-276.2(Guidelines)-279.6(began)-273.2(in)-279.9(December)]TJ -1.2933 -1.2623 TD [(1998,)-389(and)-387.7(a)-389.8(first)-389.2(draft)-390.5(prepared)-385.1(by)-391.3(the)-385.2(CIOMS)-388.3(consultant)-386.5(for)-390.6(the)]TJ 0 -1.2571 TD [(project)-251.8(was)-249(reviewed)-252.6(by)-246.5(the)-250.7(project)-251.8(steering)-249.8(committee,)-248.1(which)-249(met)-254.8(in)]TJ T* [(May)-214.8(1999.)-208(The)-212.5(committee)-212.9(proposed)-207.8(amendments)-210.6(and)-211.8(listed)-215.5(topics)-207.6(on)]TJ 0 -1.2623 TD [(which)-502.5(new)-502(or)-496(revised)-500.1(guidelines)-503.3(were)-501(indicated;)-498.4(it)-498.9(recommended)]TJ 0 -1.2571 TD [(papers)-437.8(to)-439.3(be)-444(commissione)5.5(d)-441.2(o)0(n)-437.6(the)-442.1(topics,)-439.4(as)-439.3(well)-436.4(as)-439.3(authors)-439.9(and)]TJ T* [(commentators,)-303.8(for)-297.5(presentation)-299.1(and)-299.7(discussion)-300.4(at)-299.9(a)-301.8(CIOMS)-300.4(interim)]TJ 0 -1.2623 TD [(consultation.)-241.2(It)-239(was)-238.7(considered)-241.8(that)-237.5(an)-241.3(interim)-241.9(consultation)-237(meeting,)]TJ 0 -1.2571 TD [(of)-356.6(members)-355.5(of)-356.6(the)-359.3(steering)-353.3(committee)-357.8(together)-356.1(with)-356.7(the)-354.1(authors)-357.1(of)]TJ 0 -1.2623 TD [(commissioned)-503(papers)-505(and)-501.5(designated)-505.2(commentators,)-500.4(followed)-501.1(by)]TJ 0 -1.2571 TD [(further)-406.3(redrafting)-408.9(and)-403.2(electronic)-406.2(distribution)-405.2(and)-408.4(feedback,)-404.8(would)]TJ T* [(better)-414.8(serve)-411.6(the)-411(purpose)-408(of)-413.5(the)-411(project)-406.9(than)-411.6(the)-411(process)-410.7(originally)]TJ 0 -1.2622 TD [(envisaged,)-170.1(which)-171.4(had)-170.4(been)-168.9(to)-170.3(complete)-169.3(the)-173.1(revision)-166.8(in)-171.2(one)-171.3(further)-168.3(step.)]TJ 0 -1.2571 TD [(The)-528.1(consultation)-521.5(was)-523.2(accordingly)-523.5(organized)-522.6(for)-525.1(March)-525.5(2000,)-523.5(in)]TJ 0 -1.2623 TD (Geneva.)Tj 1.2933 -1.2571 TD [(At)-407.6(the)-400.7(consultation,)-401.6(progress)-402.4(on)-406.6(the)-400.7(revision)-404.8(was)-404.2(reported)-402.1(and)]TJ -1.2933 -1.2571 TD [(contentious)-228.6(matters)-229.7(reviewed.)-230.9(Eight)-229.4(commissioned)-228.8(papers)-230.9(previously)]TJ 0 -1.2623 TD [(distributed)-469.5(were)-464.8(presented,)-465.9(commented)-462(upon,)-465.6(and)-465.3(discussed.)-467.1(The)]TJ 0 -1.2571 TD [(work)-343.4(of)-341(the)-338.6(consultation)-340.5(continued)-336.1(with)-341.1(ad)-339.6(hoc)-336.9(electronic)-344.2(working)]TJ T* [(groups)-271.1(over)-272.9(the)-276.5(following)-271.6(several)-272.7(weeks,)-273.9(and)-268.7(the)-276.5(outcome)-267.3(was)-274.9(made)]TJ 0 -1.2623 TD 0.0077 Tc [(avail)7.7(a)-3.5(ble)-610.6(f)7.7(or)-610.9(the)-610.6(p)7.7(reparat)7.7(i)-4.9(on)-609.4(of)-606(the)-610.6(t)-0.7(h)7.7(i)-3.2(rd)-609.4(dra)7.7(f)-2.5(t.)-606.9(The)-610.6(m)7.7(a)-5(t)-0.7(eri)7.7(a)-3.5(l)]TJ 0 -1.2571 TD 0 Tc [(commissioned)-218.4(for)-219.9(the)-219.6(consultation)-216.3(was)-218(made)-218.7(the)-219.6(subject)-220.7(of)-216.9(a)-219.1(CIOMS)]TJ 0 -1.2622 TD 0.0071 Tc [(publ)7.1(icat)7.1(ion:)]TJ /F5 1 Tf 5.7888 0 TD 0.0085 Tc [(Bi)8.5(om)8.5(edi)8.5(c)]TJ 3.8954 0 TD 0 Tc [(al)-621.6(Re)-9(s)-8.2(e)0(a)-9.7(r)0(c)-10.9(h)-612.2(E)-6.5(t)0(h)-10.2(i)-9.3(cs)-10.9(:)-613.7(U)0(p)-7.8(d)-7(a)-7(t)0(i)-7.4(n)-7(g)-612.2(I)-8.2(n)-7(t)0(e)-11.2(r)0(n)-10(a)0(t)-10.2(i)0(o)-11.2(n)-7(al)]TJ -9.6842 -1.2571 TD [(Guidelines.)-269.6(A)-270.1(Consultation)]TJ /F2 1 Tf 11.3913 0 TD [(\(December)-268.1(2000\).)]TJ -10.098 -1.2571 TD [(An)-359.3(informal)-351.1(redrafting)-357.2(group)-350.8(of)-356.6(eight,)-353.9(from)-354.9(Africa,)-356.2(Asia,)-355.4(Latin)]TJ -1.2933 -1.2623 TD [(America,)-299.3(the)-297.2(United)-298.3(States)-300.1(and)-294.6(the)-297.2(CIOMS)-300.4(secretariat,)-294.3(met)-301.4(in)-295.4(New)]TJ 0 -1.2571 TD [(York)-193.1(City)-186.2(in)-191.9(January)-184.9(2001,)-187.3(and)-191.1(subsequently)-183.6(interacted)-192.3(electronica)5.8(lly)]TJ 0 -1.2623 TD [(with)-191.1(one)-186.9(another)-180.9(and)-185.9(with)-185.9(the)-188.6(CIOMS)-186.6(secretariat.)-185.7(A)-187(revised)-184.5(draft)-188.7(was)]TJ 0 -1.2571 TD [(posted)-411.9(on)-411.7(the)-405.9(CIOMS)-409(website)-411.7(in)-414.4(June)-406.9(2001)-410.7(and)-408.4(otherwise)-411(widely)]TJ T* [(distributed.)-370.2(Many)-366.4(organization)7.3(s)-370.3(and)-367(individuals)-365.7(commented,)-362.8(some)]TJ 0 -1.2623 TD [(extensively,)-380.5(some)-380.3(critically.)-382.8(Views)-384.5(on)-375.5(certain)-381.3(positions,)-379.7(notably)-377.8(on)]TJ 0 -1.2571 TD [(placebo-controlled)-500.8(trials,)-509.9(were)-501(contradictory.)-501.7(For)-507.7(the)-504.1(subsequent)]TJ T* [(revision)-487.5(two)-487(members)-490(were)-485.5(added)-485.1(to)-485.9(the)-488.6(redrafting)-486.5(group,)-484.3(from)]TJ 0 -1.2623 TD [(Europe)-275.5(and)-279.1(Latin)-276(America.)-273.5(The)-274.6(consequent)-275.6(draft)-276.7(was)-274.9(posted)-272.2(on)-277.2(the)]TJ 0 -1.2571 TD [(website)-225.4(in)-223(January)-216(2002)-224.5(in)-223(preparation)-217.3(for)-219.9(the)-224.8(CIOMS)-217.6(Conference)-224.6(in)]TJ 0 -1.2623 TD [(February/)-268.3(March)-266.8(2002.)]TJ ET 95.641 646.809 318.898 -0.51 re f BT /F6 1 Tf 7.9702 0 0 7.9702 95.6409 649.1337 Tm (BACKGROUND)Tj /F7 1 Tf 11.9551 0 0 11.9551 407.9621 649.1337 Tm (9)Tj ET endstream endobj 25 0 obj << /Type /Page /Parent 390 0 R /Resources 26 0 R /Contents 27 0 R /MediaBox [ 0 0 595 842 ] /CropBox [ 0 0 595 842 ] /Rotate 0 >> endobj 26 0 obj << /ProcSet [ /PDF /Text ] /Font << /F2 337 0 R /F5 340 0 R /F6 341 0 R /F7 342 0 R /F8 343 0 R >> /ExtGState << /GS1 434 0 R >> /ColorSpace << /DefaultCMYK 417 0 R /Cs6 416 0 R >> >> endobj 27 0 obj << /Length 5397 >> stream q 1 i 0.015 737.008 510.221 -737.008 re W n /Cs6 cs 0 0 0 scn /GS1 gs 0.015 709.001 25.44 -0.284 re f Q /Cs6 cs 0 0 0 scn /GS1 gs 28.006 737.008 0.283 -25.455 re f 481.89 737.008 0.283 -25.455 re f 484.724 709.001 25.512 -0.284 re f 484.724 28.346 25.512 -0.283 re f 481.89 25.512 0.283 -25.512 re f q 1 i 0.015 737.008 510.221 -737.008 re W n 28.006 25.512 0.283 -25.512 re f 0.015 28.346 25.44 -0.283 re f Q BT /F2 1 Tf 10.959 0 0 10.959 109.8142 609.8455 Tm 0 Tc 0 Tw [(The)-357.4(CIOMS)-357.3(Conference)-353.9(was)-357.6(convened)-357.6(to)-356.6(discuss)-355.2(and,)-355.7(as)-356.6(far)-359.8(as)]TJ -1.2933 -1.2623 TD [(possible,)-191.4(endorse)-191.9(a)-188(final)-190.9(draft)-188.7(to)-191(be)-190.5(submitted)-187.1(for)-188.8(final)-190.9(approval)-187.9(to)-191(the)]TJ 0 -1.2571 TD [(CIOMS)-497(Executive)-498(Committee.)-494.8(Besides)-499.6(representation)-496.2(of)-496.2(member)]TJ 0 -1.2623 TD [(organizations)-275(of)-273.8(CIOMS,)-273.5(participants)-269.8(included)-273.4(experts)-271.5(in)-274.7(ethics)-276.1(and)]TJ 0 -1.2571 TD [(research)-532.6(from)-530.8(all)-527.5(continents.)-531.3(They)-529.9(reviewed)-526.7(the)-530(draft)-530.2(guidelines)]TJ T* [(seriatim)-234.8(and)-232.5(suggested)-233.5(modifications.)-234(Guideline)-230.1(11,)]TJ /F5 1 Tf 22.017 0 TD [(Choice)-231.6(of)-232.7(control)]TJ -22.017 -1.2623 TD [(in)-238.8(clinical)-232.7(trials)]TJ /F2 1 Tf 6.3371 0 TD (,)Tj 0.507 0 TD [(was)-233.5(redrafted)-229.8(at)-232.7(the)-235.1(conference)-231.4(in)-233.3(an)-236.1(effort)-229.1(to)-237.6(reduce)]TJ -6.8441 -1.2571 TD [(disagreement.)-436.5(The)-440.2(redrafted)-436.7(text)-435.2(of)-439.3(that)-434.1(guideline)-438.3(was)-440.4(intensively)]TJ T* [(discussed)-390.5(and)-387.7(generally)-385.9(well)-389.8(received.)-392.9(Some)-389.2(participant)7.4(s,)-390(however,)]TJ 0 -1.2623 TD [(continued)-237.8(to)-232.4(question)-236.6(the)-235.1(ethical)-232.5(acceptability)-237.5(of)-232.4(the)-240.3(exception)-234.1(to)-232.4(the)]TJ 0 -1.2571 TD [(general)-219.5(rule)-213.2(limiting)-220.5(the)-214.4(use)-219.4(of)-211.7(placebo)-217.8(to)-216.9(the)-214.4(conditions)-216.4(set)-215.9(out)-213.3(in)-217.8(the)]TJ 0 -1.2623 TD [(guideline;)-209.7(they)-205.9(argued)-209(that)-206.4(research)-206.7(subjects)-203(should)-209.9(not)-202.9(be)-211.2(exposed)-206.3(to)]TJ 0 -1.2571 TD [(risk)-477.3(of)-470.4(serious)-469(or)-475.3(irreversible)-470.6(harm)-472.5(when)-472.5(an)-468.9(established)-474.4(effective)]TJ T* [(intervention)-279.6(could)-280.5(prevent)-275.2(such)-277.8(harm,)-280.1(and)-279.1(that)-278.9(such)-277.8(exposure)-276.5(could)]TJ 0 -1.2622 TD [(constitute)-285.7(exploitation.)-284(Ultimately,)-284.2(the)-286.9(commentary)-283.3(of)-284.1(Guideline)-281.8(11)]TJ 0 -1.2571 TD [(reflects)-262.8(the)-261(opposing)-259.8(positions)-261.7(on)-261.7(use)-260.7(of)-258.3(a)-265.6(comparator)-258.7(other)-260.4(than)-256.4(an)]TJ 0 -1.2623 TD [(established)-272.6(effective)-264.6(intervention)-269.2(for)-271.6(control)-266.1(purposes.)]TJ 1.2933 -1.2571 TD [(The)-202.2(new)-196.7(text,)-196.3(the)-198.9(2002)-193.4(text,)-201.5(which)-197.3(supersedes)-195.5(that)-196.1(of)-196.2(1993,)-197.6(consists)]TJ -1.2933 -1.2571 TD [(of)-253.1(a)-250.1(statement)-244.6(of)-247.9(general)-250.6(ethical)-248(principles,)-250.1(a)-250.1(preamble)-245.7(and)-248(21)-251.9(guide-)]TJ 0 -1.2623 TD [(lines,)-268.1(with)-263.5(an)-262(introduction)-262.6(and)-263.5(a)-260.5(brief)-268.2(account)-258.3(of)-263.4(earlier)-264.7(instruments)]TJ 0 -1.2571 TD [(and)-548.1(guidelines.)-548.9(Like)-547.8(the)-550.7(1982)-545.2(and)-548.1(1993)-545.2(Guidelines,)-552.8(the)-545.5(present)]TJ T* [(publication)-472.9(is)-472.8(designed)-469.1(to)-470.4(be)-469.8(of)-470.4(use,)-471.8(particularly)-472.7(to)-470.4(low-resource)]TJ 0 -1.2623 TD [(countries,)-395(in)-398.9(defining)-393.2(national)-392.3(policies)-396.5(on)-391.1(the)-395.5(ethics)-395.1(of)-398(biomedical)]TJ 0 -1.2571 TD [(research,)-578.2(applying)-571.9(ethical)-573.9(standards)-574(in)-574.8(local)-573.1(circumstances,)-574.9(and)]TJ 0 -1.2622 TD [(establishing)-270.7(or)-268.4(redefining)-269.6(adequate)-265.2(mechanisms)-264.7(for)-271.6(ethical)-268.7(review)-269(of)]TJ 0 -1.2571 TD [(research)-268.8(involving)-270.9(human)-265.6(subjects.)]TJ ET 0.9 0.9 0.9 scn 95.641 235.276 318.898 -136.063 re f 0 0 0 scn 95.641 235.276 318.898 -0.737 re f 95.641 99.95 318.898 -0.737 re f 95.641 235.276 0.794 -136.063 re f 413.801 235.276 0.737 -136.063 re f BT /F8 1 Tf 10.959 0 0 10.959 146.2677 203.3008 Tm [(Comments)-263.3(on)-271.5(the)-270.5(Guidelines)-264.9(are)-269.9(welcome)]TJ -2.0227 -1.3605 TD [(and)-267.9(should)-264.3(be)-271.8(addressed)-262.8(to)-269(the)-270.5(Secretary-Gener)5.2(al,)]TJ -2.1262 -1.3657 TD [(Council)-268.3(for)-272(International)-265.8(Organizations)-270.7(of)-269(Medical)-268.3(Sciences,)]TJ 6.9062 -1.3605 TD [(c/o)-265.6(World)-267.7(Health)-272.2(Organizatio)6.3(n,)]TJ 2.4469 -1.3657 TD [(CH-1211)-265.7(Geneva)-266.9(27,)]TJ 1.821 -1.3657 TD (Switzerland;)Tj -4.2265 -1.3605 TD [(or)-268.1(by)-266.6(e-mail)-273.6(to)-269(cioms@who.i)6.6(nt)]TJ ET 95.641 646.809 318.898 -0.51 re f BT /F6 1 Tf 7.9702 0 0 7.9702 191.1118 649.1337 Tm [(INTERNA)13.4(TIONAL)-327.4(ETHICAL)-327.5(GUIDELINES)-319.8(FOR)-332.5(BIOMED)13.7(ICAL)-331.1(RESEARCH)]TJ /F7 1 Tf 11.9551 0 0 11.9551 95.6409 649.1337 Tm (10)Tj ET endstream endobj 28 0 obj << /Type /Page /Parent 392 0 R /Resources 29 0 R /Contents 30 0 R /MediaBox [ 0 0 595 842 ] /CropBox [ 0 0 595 842 ] /Rotate 0 >> endobj 29 0 obj << /ProcSet [ /PDF /Text ] /Font << /F2 337 0 R /F4 339 0 R >> /ExtGState << /GS1 434 0 R >> /ColorSpace << /DefaultCMYK 417 0 R /Cs6 416 0 R >> >> endobj 30 0 obj << /Length 5485 >> stream q 1 i 0.015 737.008 510.221 -737.008 re W n /Cs6 cs 0 0 0 scn /GS1 gs 0.015 709.001 25.44 -0.284 re f Q /Cs6 cs 0 0 0 scn /GS1 gs 28.006 737.008 0.283 -25.455 re f 481.89 737.008 0.283 -25.455 re f 484.724 709.001 25.512 -0.284 re f 484.724 28.346 25.512 -0.283 re f 481.89 25.512 0.283 -25.512 re f q 1 i 0.015 737.008 510.221 -737.008 re W n 28.006 25.512 0.283 -25.512 re f 0.015 28.346 25.44 -0.283 re f Q BT /F4 1 Tf 19.9253 0 0 19.9253 194.6834 588.3589 Tm 0 Tc 0 Tw [(Introductio)-7(n)]TJ /F2 1 Tf 10.959 0 0 10.959 95.6409 542.7211 Tm [(This)-367(is)-369.3(the)-364.5(third)-370.5(in)-362.7(the)-369.6(series)-365.2(of)-366.9(international)-365.6(ethical)-367(guidelines)-363.7(for)]TJ 0 -1.2571 TD [(biomedical)-294(research)-289.5(involving)-286.4(human)-291.5(subjects)-291(issued)-290.1(by)-287.9(the)-292(Council)]TJ 0 -1.2623 TD [(for)-318.2(International)-312.7(Organizations)-310.5(of)-315.2(Medical)-311.1(Sciences)-316(\(CIOMS\))-312.1(since)]TJ 0 -1.2571 TD [(1982.)-151.1(Its)-148.9(scope)-151.2(and)-144.5(preparation)-144.9(reflect)-151.2(well)-151.8(the)-147.2(transformation)-147.1(that)-149.5(has)]TJ 0 -1.2623 TD [(occurred)-292.9(in)-290.2(the)-292(field)-290.1(of)-289.3(research)-289.5(ethics)-291.6(in)-290.2(the)-292(almost)-288.5(quarter)-291(century)]TJ 0 -1.2571 TD [(since)-355.6(CIOMS)-357.3(first)-352.9(undertook)-349.3(to)-356.6(make)-353.2(this)-353.4(contribution)-350.6(to)-356.6(medical)]TJ T* [(sciences)-203.7(and)-201.5(the)-198.9(ethics)-203.7(of)-201.4(research.)-200.6(The)-202.2(CIOMS)-196.9(Guidelines,)-201(with)-201.5(their)]TJ 0 -1.2623 TD [(stated)-331.1(concern)-331.3(for)-328.5(the)-328.3(application)-328.3(of)-330.7(the)-333.4(Declaration)-327.3(of)-330.7(Helsinki)-332.3(in)]TJ 0 -1.2571 TD [(developing)-256.4(countries,)-255.3(necessarily)-258.3(reflect)-259.8(the)-255.8(conditions)-252.6(and)-258.4(the)-255.8(needs)]TJ 0 -1.2623 TD [(of)-377.3(biomedical)-376.7(research)-372.3(in)-378.2(those)-374.2(countries,)-374.3(and)-372.2(the)-374.8(implications)-374.1(for)]TJ 0 -1.2571 TD [(multinational)-157.7(or)-154.5(transnational)-156.6(research)-155(in)-155.7(which)-155.9(they)-159.3(may)-154.2(be)-159.5(partners.)]TJ 1.2933 -1.3502 TD [(An)-173.1(issue,)-173.8(mainly)-174.4(for)-173.3(those)-172.4(countries)-173.5(and)-170.4(perhaps)-170.3(less)-173.3(pertinent)-173.8(now)]TJ -1.2933 -1.2571 TD [(than)-334(in)-336.8(the)-333.4(past,)-334.5(has)-332.2(been)-334.4(the)-333.4(extent)-330.9(to)-335.9(which)-331.8(ethical)-336(principles)-333.8(are)]TJ T* [(considered)-210.7(universal)-204.8(or)-206.3(as)-206.5(culturally)-209.3(relative)-204.7()-210.5(the)-204.1(universalist)-210.1(versus)]TJ 0 -1.2623 TD [(the)-261(pluralist)-259.5(view.)-262.3(The)-259.1(challenge)-256(to)-263.4(international)-257(research)-258.5(ethics)-260.6(is)-260.7(to)]TJ 0 -1.2571 TD 0.0122 Tc [(apply)-615.6(universal)-617.9(ethical)-617.9(p)0.3(rinciples)-616.7(t)-1.4(o)-615.3(b)0.3(iomedical)-617.9(r)-1.1(esearch)-615.3(i)-2.3(n)-615.3(a)]TJ 0 -1.2623 TD 0 Tc [(multicultural)-423.9(world)-414.8(with)-423.9(a)-415.7(multiplicity)-423.6(of)-418.6(health-care)-416.5(systems)-420.8(and)]TJ 0 -1.2571 TD [(considerable)-397.8(variation)-400.7(in)-398.9(standards)-392.9(of)-398(health)-397.9(care.)-402.4(The)-398.8(Guidelines)]TJ T* [(take)-381.8(the)-385.2(position)-377.7(that)-382.3(research)-382.6(involving)-379.5(human)-379.4(subjects)-384.1(must)-380.8(not)]TJ 0 -1.2623 TD [(violate)-226.4(any)-227.6(universally)-221.1(applicable)-222.8(ethical)-227.3(standards,)-221.2(but)-228.8(acknowledge)]TJ 0 -1.2571 TD [(that,)-345.1(in)-347.1(superficial)-347.7(aspects,)-343(the)-343.8(application)-343.8(of)-346.2(the)-343.8(ethical)-346.3(principles,)]TJ T* [(e.g.,)-260.2(in)-259.2(relation)-255(to)-258.3(individual)-254.1(autonomy)-256.7(and)-253.2(informed)-256.3(consent,)-258.5(needs)]TJ 0 -1.2623 TD [(to)-418.6(take)-412.8(account)-413.5(of)-413.5(cultural)-415.4(values,)-412.4(while)-412(respecting)-414.5(absolutely)-413.5(the)]TJ 0 -1.2571 TD [(ethical)-273.9(standards.)]TJ 1.2933 -1.3502 TD [(Related)-172.2(to)-170.3(this)-172.3(issue)-169.6(is)-172.7(that)-170.2(of)-170.3(the)-173.1(human)-167.3(rights)-172(of)-170.3(research)-170.5(subjects,)]TJ -1.2933 -1.2571 TD [(as)-532.5(well)-529.5(as)-527.3(of)-527.3(health)-527.2(professionals)-525.7(as)-527.3(researchers)-525.8(in)-528.2(a)-529.5(variety)-530.7(of)]TJ 0 -1.2623 TD [(sociocultural)-195.6(contexts,)-189.6(and)-191.1(the)-193.8(contribution)-190.2(that)-190.9(international)-189.7(human)]TJ 0 -1.2571 TD (r)Tj 0.3932 0 TD [(igh)-7.5(ts)-616.7(ins)-8.7(tr)-11.4(um)-7.2(ent)-7.5(s)-613.4(can)-616.5(ma)-7.5(ke)-614.7(in)-611(th)-10(e)-608(a)-7(ppl)-7.3(ic)-12.1(ati)-9.2(on)-613.5(of)-615.2(the)-618(gen)-6.1(e)-7.9(ral)]TJ -0.3932 -1.2571 TD [(principles)-339(of)-341.1(ethics)-338.2(to)-335.9(research)-336.1(involving)-338.1(human)-338(subjects.)-336.5(The)-336.7(issue)]TJ 0 -1.2623 TD [(concerns)-339.5(largely,)-339.2(though)-337.1(not)-337.4(exclusively,)-340.1(two)-337(principles:)-338(respect)-339.7(for)]TJ 0 -1.2571 TD [(autonomy)-401.5(and)-398(protection)-402.9(of)-398(dependent)-401.9(or)-397.7(vulnerable)-402.7(persons)-399.1(and)]TJ 0 -1.2623 TD [(populations.)-578.2(In)-573.6(the)-576.6(preparation)-574.3(of)-579(the)-576.6(Guidelines)-574.5(the)-576.6(potential)]TJ 0 -1.2571 TD [(contribution)-205.7(in)-207.5(these)-204.6(respects)-208.2(of)-206.5(human)-203.5(rights)-208.2(instruments)-203.5(and)-206.6(norms)]TJ ET endstream endobj 31 0 obj << /Type /Page /Parent 392 0 R /Resources 32 0 R /Contents 33 0 R /MediaBox [ 0 0 595 842 ] /CropBox [ 0 0 595 842 ] /Rotate 0 >> endobj 32 0 obj << /ProcSet [ /PDF /Text ] /Font << /F2 337 0 R /F5 340 0 R /F6 341 0 R /F7 342 0 R >> /ExtGState << /GS1 434 0 R >> /ColorSpace << /DefaultCMYK 417 0 R /Cs6 416 0 R >> >> endobj 33 0 obj << /Length 6900 >> stream q 1 i 0.015 737.008 510.221 -737.008 re W n /Cs6 cs 0 0 0 scn /GS1 gs 0.015 709.001 25.44 -0.284 re f Q /Cs6 cs 0 0 0 scn /GS1 gs 28.006 737.008 0.283 -25.455 re f 481.89 737.008 0.283 -25.455 re f 484.724 709.001 25.512 -0.284 re f 484.724 28.346 25.512 -0.283 re f 481.89 25.512 0.283 -25.512 re f q 1 i 0.015 737.008 510.221 -737.008 re W n 28.006 25.512 0.283 -25.512 re f 0.015 28.346 25.44 -0.283 re f Q BT /F2 1 Tf 10.959 0 0 10.959 95.6409 609.8455 Tm 0 Tc 0 Tw [(was)-223.1(discussed,)]TJ 8.2191 0 0 7.3052 161.9716 614.7211 Tm (1)Tj 10.959 0 0 10.959 168.4913 609.8455 Tm [(and)-222.1(the)-219.6(Guideline)-219.7(drafters)-223.3(have)-220(represented)-219.2(the)-219.6(views)]TJ -6.6475 -1.2623 TD 0.0107 Tc [(of)-613.3(comm)10.7(e)-8.1(n)4(tators)-613.1(on)-611.6(safegu)4(arding)-611.9(th)4(e)-612.8(c)-2.4(o)4(r)-2.6(resp)4(on)4(ding)-611.9(righ)4(ts)-613.1(o)4(f)]TJ 0 -1.2571 TD 0 Tc (subjects.)Tj 1.2933 -1.3036 TD [(Certain)-581.5(areas)-581.4(of)-579(biomedical)-578.5(research)-579.2(are)-581.7(not)-580.5(represented)-576.1(by)]TJ -1.2933 -1.2623 TD [(specific)-562.3(guidelines.)-564.4(One)-558.6(such)-562.3(is)-560.7(human)-560.5(genetics.)-559(It)-564.9(is,)-559.7(however,)]TJ 0 -1.2571 TD [(considered)-417.7(in)-419.6(Guideline)-416.3(18)-422.6(Commentary)-411(under)]TJ /F5 1 Tf 21.1479 0 TD [(Issues)-420(of)-413.7(confiden-)]TJ -21.1479 -1.2571 TD [(tiality)-410.7(in)-409.5(genetics)-405(research)]TJ /F2 1 Tf 11.2361 0 TD (.)Tj 0.6777 0 TD [(The)-403.9(ethics)-410.6(of)-408.3(genetics)-404.8(research)-408.5(was)-404.2(the)]TJ -11.9138 -1.2623 TD [(subject)-272.4(of)-268.6(a)-270.8(commissione)5.5(d)-270.5(paper)-269.3(and)-268.7(commentary.)]TJ 8.2191 0 0 7.3052 332.7873 517.6062 Tm (2)Tj 10.959 0 0 10.959 109.8142 498.444 Tm [(Another)-304.1(unrepresented)-305(area)-304.2(is)-302(research)-305(with)-304.9(products)-302.6(of)-304.8(concep-)]TJ -1.2933 -1.2571 TD [(tion)-196.7(\(embryo)-195.5(and)-196.3(fetal)-196.3(research,)-195.4(and)-196.3(fetal)-196.3(tissue)-193.6(research\).)-198.7(An)-193.7(attempt)]TJ 0 -1.2623 TD [(to)-315.2(craft)-308.9(a)-312.2(guideline)-308.9(on)-308.3(the)-312.7(topic)-308.1(proved)-312.2(unfeasible.)-310(At)-309.3(issue)-309.3(was)-311.1(the)]TJ 0 -1.2571 TD [(moral)-264.5(status)-264.2(of)-263.5(embryos)-257.3(and)-263.5(fetuses)-262.6(and)-263.5(the)-261(degree)-262.8(to)-263.4(which)-264.5(risks)-263(to)]TJ 0 -1.2623 TD [(the)-271.3(life)-273(or)-268.4(well-being)-270.4(of)-268.6(these)-266.7(entities)-273.2(are)-266.2(ethically)-269.5(permissible.)]TJ 8.2191 0 0 7.3052 383.9243 448.1007 Tm (3)Tj 10.959 0 0 10.959 109.8142 428.9385 Tm [(In)-340.8(relation)-337.8(to)-335.9(the)-338.6(use)-338.3(of)-335.9(comparators)-334.1(in)-342(controls,)-335.3(commentators)]TJ -1.2933 -1.2571 TD [(have)-307.9(raised)-300.8(the)-307.6(the)-307.6(question)-298.7(of)-304.8(standard)-307.2(of)-304.8(care)-305.1(to)-304.8(be)-304.3(provided)-302.4(to)-304.8(a)]TJ 0 -1.2623 TD [(control)-312.6(group.)-308.5(They)-307.5(emphasize)-310.5(that)-309.9(standard)-307.2(of)-310(care)-310.3(refers)-312.6(to)-310(more)]TJ 0 -1.2571 TD [(than)-375.4(the)-374.8(comparator)-372.5(drug)-370(or)-371.8(other)-374.2(intervention,)-371.7(and)-377.3(that)-372(research)]TJ T* [(subjects)-549.6(in)-554.1(the)-550.7(poorer)-546.2(countries)-546(do)-551.4(not)-549.5(usually)-550.9(enjoy)-544.6(the)-550.7(same)]TJ 0 -1.2623 TD [(standard)-167.5(of)-170.3(all-round)-172.6(care)-165.4(enjoyed)-171.2(by)-168.9(subjects)-172(in)-171.3(richer)-167.2(countries.)-172.5(This)]TJ 0 -1.2571 TD [(issue)-273.1(is)-271(not)-265(addressed)-269.2(specifically)-269.1(in)-269.5(the)-271.4(Guidelines.)]TJ 1.2933 -1.3036 TD [(In)-299.4(one)-290.3(respect)-293.1(the)-297.2(Guidelines)-295.1(depart)-293.2(from)-292.8(the)-297.2(terminolog)6.7(y)-296.7(o)0(f)-294.5(the)]TJ -1.2933 -1.2623 TD [(Declaration)-296.3(of)-299.7(Helsinki.)-295.1(Best)-299(current)-297.1(interventio)6.5(n)-300.6(is)-296.9(the)-297.2(term)-294(most)]TJ 0 -1.2571 TD [(commonly)-397.2(used)-396.8(to)-398(describe)-393.9(the)-400.7(active)-394.1(comparator)-393.2(that)-397.9(is)-400.3(ethically)]TJ T* [(preferred)-230.4(in)-233.3(controlled)-228(clinical)-232.4(trials.)-235.7(For)-228.3(many)-228.1(indications,)-230.2(however,)]TJ 0 -1.2623 TD [(there)-328.8(is)-322.7(more)-323.4(than)-323.7(one)-326.5(established)-319.2(current)-326.2(intervention)-321(and)-325.6(expert)]TJ 0 -1.2571 TD [(clinicians)-216.3(do)-210(not)-213.3(agree)-208.6(on)-215.2(which)-212.8(is)-208.9(superior.)-216.1(In)-211.4(other)-208.6(circumstances)-213.8(in)]TJ 0 -1.2623 TD [(which)-554.2(there)-556.4(are)-550.7(several)-557.2(established)-552(current)-553.8(interventions,)-550.6(some)]TJ 0 -1.2571 TD [(expert)-185.8(clinicians)-185.2(recognize)-183.3(one)-186.9(as)-180.7(superior)-186(to)-185.9(the)-183.4(rest;)-186.9(some)-183.7(commonly)]TJ ET 95.641 206.589 92.126 -0.51 re f BT 6.7246 0 0 5.9768 95.6409 196.8378 Tm (1)Tj 8.9663 0 0 8.9663 106.9795 192.8692 Tm [(Andreopoulos,)-555.3(GJ.)-544.9(2000.)-550(Declarations)-551.1(and)-545.8(covenants)-544.8(of)-550.3(human)-550.2(rights)-546.8(and)]TJ 0 -1.2203 TD 0.0158 Tc [(in)5.1(ternational)-618.4(c)3.9(ode)3.9(s)-617.2(o)-1.3(f)-618.6(r)2.5(e)3.9(s)-3.9(e)3.9(a)-2.7(rc)3.9(h)-620.9(e)3.9(th)]TJ 16.5344 0 TD 0.014 Tc [(ic)-4.2(s,)-620.2(pp.)-620.2(1)1.8(8)-4.5(12)-4.5(03)-4.5(;)-620.2(a)1.8(nd)-616.4(An-Na)-4.5(im)-618.3(AA)-6.4(,)]TJ -16.5344 -1.2266 TD 0 Tc [(Commentary,)-501.5(pp.)-497.6(204206.)-498(In:)-500.2(Levine,)-497.4(RJ,)-495.8(Gorovitz,)-501.1(S,)-499.5(Gallagher,)-495.4(J.)-500.7(\(eds.\))]TJ /F5 1 Tf 0 -1.2203 TD [(Biomedical)-406.7(Research)-399.4(Ethics:)-401.9(Updating)-401.3(International)-404.1(Guidelines.)-406.5(A)-401.2(Consultation.)]TJ /F2 1 Tf T* [(Geneva,)-275.8(Council)-272(for)-272.8(International)-272(Organizations)-272.7(of)-272.1(Medical)-269.2(Sciences.)]TJ 6.7246 0 0 5.9768 95.6409 139.0677 Tm (2)Tj 8.9663 0 0 8.9663 106.9795 135.0992 Tm [(Clayton)-273.9(EW.)-269.1(2000.)-265.5(Genetics)-266.2(research:)-271.3(towards)-267.6(international)-273.2(guidelines,)-272.5(pp.)-263.6(152)]TJ 0 -1.2266 TD [(169;)-272.3(and)-273.9(Qiu,)-268.8(Ren-Zong,)-274.6(Commentary,)-273.9(pp.)-270(170177.)]TJ /F5 1 Tf 22.8067 0 TD (ibid)Tj /F2 1 Tf 1.5428 0 TD (.)Tj 6.7246 0 0 5.9768 95.6409 114.1795 Tm (3)Tj 8.9663 0 0 8.9663 106.9795 110.1543 Tm [(Macklin)-179.5(R.)-174(2000.)-177(Reproductive)-179.2(biology)-174.1(and)-179.1(technology,)-172.9(pp.)-175.1(208224;)-175.5(and)-179.1(Luna)-170.7(F,)]TJ 0 -1.2203 TD [(Commentary,)-273.9(pp.)-276.3(225229.)]TJ /F5 1 Tf 11.8555 0 TD (ibid)Tj /F2 1 Tf 1.5365 0 TD (.)Tj ET 95.641 646.809 318.898 -0.51 re f BT /F6 1 Tf 7.9702 0 0 7.9702 191.1118 649.1337 Tm [(INTERNA)13.4(TIONAL)-327.4(ETHICAL)-327.5(GUIDELINES)-319.8(FOR)-332.5(BIOMED)13.7(ICAL)-331.1(RESEARCH)]TJ /F7 1 Tf 11.9551 0 0 11.9551 95.6409 649.1337 Tm (12)Tj ET endstream endobj 34 0 obj << /Type /Page /Parent 392 0 R /Resources 35 0 R /Contents 36 0 R /MediaBox [ 0 0 595 842 ] /CropBox [ 0 0 595 842 ] /Rotate 0 >> endobj 35 0 obj << /ProcSet [ /PDF /Text ] /Font << /F2 337 0 R /F6 341 0 R /F7 342 0 R >> /ExtGState << /GS1 434 0 R >> /ColorSpace << /DefaultCMYK 417 0 R /Cs6 416 0 R >> >> endobj 36 0 obj << /Length 3052 >> stream q 1 i 0.015 737.008 510.221 -737.008 re W n /Cs6 cs 0 0 0 scn /GS1 gs 0.015 709.001 25.44 -0.284 re f Q /Cs6 cs 0 0 0 scn /GS1 gs 28.006 737.008 0.283 -25.455 re f 481.89 737.008 0.283 -25.455 re f 484.724 709.001 25.512 -0.284 re f 484.724 28.346 25.512 -0.283 re f 481.89 25.512 0.283 -25.512 re f q 1 i 0.015 737.008 510.221 -737.008 re W n 28.006 25.512 0.283 -25.512 re f 0.015 28.346 25.44 -0.283 re f Q BT /F2 1 Tf 10.959 0 0 10.959 95.6409 609.8455 Tm 0 Tc 0 Tw [(prescribe)-381.4(another)-377.5(because)-378.2(the)-380(superior)-377.4(intervention)-377.9(may)-376.6(be)-381.9(locally)]TJ 0 -1.2623 TD [(unavailable,)-186.5(for)-178.5(example,)-185(or)-185.6(prohibitive)6.7(ly)-187(expensive)-182.4(or)-180.4(unsuited)-184.8(to)-180.7(the)]TJ 0 -1.2571 TD [(capability)-259.8(of)-263.4(particular)-259.8(patients)-259.3(to)-258.3(adhere)-261.6(to)-258.3(a)-260.5(complex)-263.4(and)-258.4(rigorous)]TJ 0 -1.2623 TD [(regimen.)-579.4(Establishe)5.5(d)-575.8(effective)-575(intervention)-573.5(is)-576.2(the)-571.4(term)-573.4(used)-577.8(in)]TJ 0 -1.2571 TD [(Guideline)-255.9(11)-257.1(to)-258.3(refer)-252.7(to)-258.3(all)-253.3(such)-257.1(interventions,)-255.7(including)-250.8(the)-255.8(best)-258.8(and)]TJ T* [(the)-338.6(various)-332.4(alternatives)-333.3(to)-330.7(the)-333.4(best.)-335.4(In)-335.6(some)-333.7(cases)-334(an)-334.4(ethical)-336(review)]TJ 0 -1.2623 TD [(committee)-430.2(may)-433.5(determine)-425.7(that)-428.9(it)-431.6(is)-431.4(ethically)-429.9(acceptable)-428.5(to)-434.2(use)-426.3(an)]TJ 0 -1.2571 TD [(established)-184.7(effective)-181.9(intervention)-181.3(as)-185.9(a)-182.9(comparator,)-180.1(even)-184.7(in)-181.6(cases)-184(where)]TJ T* [(such)-272.6(an)-267.2(intervention)-269.2(is)-271(not)-265(considered)-267.6(the)-271.4(best)-269.2(current)-266.1(intervention.)]TJ 1.2933 -1.2623 TD [(The)-202.2(mere)-200.4(formulation)-197.1(of)-196.2(ethical)-201.5(guidelines)-198.1(for)-199.2(biomedical)-200.8(research)]TJ -1.2933 -1.2571 TD [(involving)-203.6(human)-198.4(subjects)-203(will)-205(hardly)-200.1(resolve)-200(all)-206.7(the)-198.9(moral)-202.5(doubts)-203.8(that)]TJ 0 -1.2623 TD [(can)-223.3(arise)-221.6(in)-217.8(association)-220(with)-222.2(much)-218.4(research,)-221.3(but)-218.4(the)-224.8(Guidelines)-217.6(can)-223.3(at)]TJ 0 -1.2571 TD [(least)-268.4(draw)-266.1(the)-261(attention)-266.2(of)-263.5(sponsors,)-265.4(investigators)-262.7(and)-263.5(ethical)-268.7(review)]TJ T* [(committees)-174.5(to)-175.5(the)-173.1(need)-168.9(to)-175.5(consider)-170.2(carefully)-175.2(the)-173.1(ethical)-170.4(implications)-177.5(of)]TJ 0 -1.2622 TD [(research)-274(protocols)-270.6(and)-273.9(the)-271.4(conduct)-273.5(of)-273.8(research,)-267.8(and)-273.9(thus)-273.2(conduce)-273(to)]TJ 0 -1.2571 TD [(high)-272.9(scientific)-269.7(and)-268.7(ethical)-268.7(standards)-263.6(of)-268.6(biomedical)-273.3(research.)]TJ ET 95.641 646.809 318.898 -0.51 re f BT /F6 1 Tf 7.9702 0 0 7.9702 95.6409 649.1337 Tm [(INTRODUCTI)11.9(ON)]TJ /F7 1 Tf 11.9551 0 0 11.9551 401.3857 649.1337 Tm (13)Tj ET endstream endobj 37 0 obj << /Type /Page /Parent 392 0 R /Resources 38 0 R /Contents 39 0 R /MediaBox [ 0 0 595 842 ] /CropBox [ 0 0 595 842 ] /Rotate 0 >> endobj 38 0 obj << /ProcSet [ /PDF ] /ExtGState << /GS1 434 0 R >> /ColorSpace << /DefaultCMYK 417 0 R /Cs6 416 0 R >> >> endobj 39 0 obj << /Length 412 >> stream q 1 i 0.015 737.008 510.221 -737.008 re W n /Cs6 cs 0 0 0 scn /GS1 gs 0.015 709.001 25.44 -0.284 re f Q /Cs6 cs 0 0 0 scn /GS1 gs 28.006 737.008 0.283 -25.455 re f 481.89 737.008 0.283 -25.455 re f 484.724 709.001 25.512 -0.284 re f 484.724 28.346 25.512 -0.283 re f 481.89 25.512 0.283 -25.512 re f q 1 i 0.015 737.008 510.221 -737.008 re W n 28.006 25.512 0.283 -25.512 re f 0.015 28.346 25.44 -0.283 re f Q endstream endobj 40 0 obj << /Type /Page /Parent 392 0 R /Resources 41 0 R /Contents 42 0 R /MediaBox [ 0 0 595 842 ] /CropBox [ 0 0 595 842 ] /Rotate 0 >> endobj 41 0 obj << /ProcSet [ /PDF /Text ] /Font << /F2 337 0 R /F4 339 0 R /F5 340 0 R >> /ExtGState << /GS1 434 0 R >> /ColorSpace << /DefaultCMYK 417 0 R /Cs6 416 0 R >> >> endobj 42 0 obj << /Length 5245 >> stream q 1 i 0.015 737.008 510.221 -737.008 re W n /Cs6 cs 0 0 0 scn /GS1 gs 0.015 709.001 25.44 -0.284 re f Q /Cs6 cs 0 0 0 scn /GS1 gs 28.006 737.008 0.283 -25.455 re f 481.89 737.008 0.283 -25.455 re f 484.724 709.001 25.512 -0.284 re f 484.724 28.346 25.512 -0.283 re f 481.89 25.512 0.283 -25.512 re f q 1 i 0.015 737.008 510.221 -737.008 re W n 28.006 25.512 0.283 -25.512 re f 0.015 28.346 25.44 -0.283 re f Q BT /F4 1 Tf 19.9253 0 0 19.9253 131.6409 588.3589 Tm 0 Tc 0 Tw [(Internatio)-7(nal)-250.3(Instruments)]TJ 2.7628 -1.1979 TD [(and)-252.4(Guidelines)]TJ /F2 1 Tf 10.959 0 0 10.959 95.6409 518.1164 Tm [(The)-316(first)-311.6(international)-313.9(instrument)-309.1(on)-313.5(the)-312.7(ethics)-312.3(of)-310(medical)-312.6(research,)]TJ 0 -1.2571 TD [(the)-292(Nuremberg)-286.4(Code,)-290.4(was)-285.2(promulgated)-287.3(in)-290.2(1947)-286.6(as)-289.3(a)-286.3(consequence)-288.1(of)]TJ T* [(the)-566.2(trial)-569.9(of)-563.5(physicians)-563.3(\(the)-569.5(Doctors)-563(Trial\))-566.1(who)-568(had)-563.6(conducted)]TJ 0 -1.2623 TD 0.007 Tc (at)Tj 0.84 0 TD 0.0062 Tc (ro)Tj 0.9432 0 TD (c)Tj 0.4464 0 TD 0 Tc [(iou)-7.2(s)-613.4(exp)-11.2(eri)-9.9(me)-8.4(nts)-618.2(on)-613.5(unc)-11(ons)-6.1(e)-7.9(nti)-9(ng)-613.8(pri)-8.7(s)-8.2(oner)-14(s)-608.3(a)0(n)-8.5(d)-606.8(d)-6.7(eta)-7.8(in)-10.9(ees)]TJ -2.2296 -1.2571 TD [(during)-463.7(the)-457.6(second)-457.9(world)-461.4(war.)-460.1(The)-460.8(Code,)-461.1(designed)-458.8(to)-460(protect)-457.8(the)]TJ 0 -1.2623 TD [(integrity)-413.7(of)-413.5(the)-411(research)-413.7(subject,)-411.1(set)-412.5(out)-415(conditions)-407.8(for)-411.3(the)-416.2(ethical)]TJ 0 -1.2571 TD [(conduct)-496(of)-496.2(research)-496.4(involving)-493.3(human)-493.2(subjects,)-496.9(emphasizing)-491.2(their)]TJ T* [(voluntary)-268.8(consent)-269.8(to)-268.6(research.)]TJ 1.2933 -1.4123 TD [(The)-290.1(Universal)-286.6(Declaration)-286(of)-284.1(Human)-285.3(Rights)-288.8(was)-285.2(adopted)-282.9(by)-287.9(the)]TJ -1.2933 -1.2571 TD [(General)-570(Assembly)-560.8(of)-568.7(the)-561(United)-567.3(Nations)-564.2(in)-564.4(1948.)-564.9(To)-566.8(give)-564(the)]TJ 0 -1.2622 TD [(Declaration)-534.3(legal)-537.2(as)-532.5(well)-539.8(as)-532.5(moral)-533.5(force,)-534.7(the)-535.2(General)-533.8(Assembly)]TJ 0 -1.2571 TD [(adopted)-386.4(in)-388.5(1966)-384.9(the)-385.2(International)-385.1(Covenant)-382.6(on)-385.9(Civil)-387.9(and)-387.7(Political)]TJ 0 -1.2623 TD [(Rights.)-267.1(Article)-264(7)-260.5(o)0(f)-263.5(the)-266.2(Covenant)-258.4(states)-260.2()]TJ /F5 1 Tf 17.5888 0 TD [(No)-261.3(one)-265(shall)-263.3(be)-263.2(subjected)-262(to)]TJ -17.5888 -1.2571 TD [(torture)-293(or)-294.5(to)-294.8(cruel,)-298(inhuman)-288.2(or)-294.5(degrading)-289.7(treatment)-291.7(or)-294.5(punishment.)-296.2(In)]TJ T* [(particular,)-249(no)-241.6(one)-244.3(shall)-247.8(be)-242.5(subjected)-246.5(without)-245.1(his)-246.9(free)-244.5(consent)-244.7(to)-243(medical)]TJ 0 -1.2623 TD [(or)-216.9(scientific)-213.1(experiment)6.5(ation.)]TJ /F2 1 Tf 12.7312 0 TD [(It)-213.2(is)-208.9(through)-210.8(this)-213.7(statement)-213.5(that)-206.4(society)]TJ -12.7312 -1.2571 TD [(expresses)-421.8(the)-421.4(fundamental)-416.9(human)-420.8(value)-420.7(that)-418.5(is)-421(held)-418.7(to)-423.8(govern)-415.9(all)]TJ T* [(research)-232.6(involving)-234.7(human)-229.4(subjects)-234.1()-231.2(the)-235.1(protection)-232.2(of)-232.4(the)-235.1(rights)-234(and)]TJ 0 -1.2623 TD [(welfare)-272.3(of)-268.6(all)-268.8(human)-270.8(subjects)-265.1(of)-268.6(scientific)-274.9(experimentat)7.1(ion.)]TJ 1.2933 -1.4123 TD 0.0082 Tc [(The)-610.1(D)8.2(e)-5.4(c)0.3(l)8.2(a)-3(rati)8.2(on)-614.1(of)-605.5(He)8.2(l)-3.9(s)0(inki)8.2(,)-615.8(i)-1.2(ssue)8.2(d)-611.7(by)-609.2(the)-610.1(W)-1.2(or)8.2(l)-4.1(d)-608.9(Me)8.2(dical)]TJ -1.2933 -1.2571 TD 0 Tc [(Association)-384.5(in)-383.4(1964,)-383.9(is)-384.8(the)-380(fundamental)-380.7(international)-381.1(document)-382.7(in)]TJ T* [(the)-488.6(field)-486.6(of)-485.9(ethics)-488.2(in)-486.8(biomedical)-485.4(research)-486.1(and)-486(has)-482.3(influenced)-486.4(the)]TJ 0 -1.2623 TD [(formulation)-398.8(of)-398(international,)-395.7(regional)-398.4(and)-392.9(national)-397.5(legislation)-399.7(and)]TJ 0 -1.2571 TD [(codes)-477.1(of)-480.7(conduct.)-474.3(The)-476.4(Declaration,)-476.4(amended)-472.8(several)-474.5(times,)-478.3(most)]TJ T* [(recently)-353(in)-347.1(2000)-348.6(\(Appendix)-350(2\),)-350.7(is)-348.6(a)-353.6(comprehensi)6(ve)-351.1(statement)-348(of)-351.4(the)]TJ 0 -1.2623 TD [(ethics)-581.3(of)-584.2(research)-579.2(involving)-581.3(human)-576(subjects.)-579.7(It)-585.6(sets)-581(out)-580.6(ethical)]TJ 0 -1.2571 TD [(guidelines)-456.8(for)-457.9(physicians)-454.7(engaged)-453.7(in)-455.8(both)-452.8(clinical)-460.1(and)-454.9(nonclinical)]TJ 0 -1.2623 TD [(biomedical)-273.3(research.)]TJ 1.2933 -1.4071 TD [(Since)-509.3(the)-504.1(publication)-503.9(of)-506.6(the)-509.3(CIOMS)-502.1(1993)-503.8(Guidelines,)-506.3(several)]TJ -1.2933 -1.2623 TD [(international)-360.5(organizations)-363(have)-359.6(issued)-362.6(ethical)-361.8(guidance)-359.3(on)-360(clinical)]TJ 0 -1.2571 TD [(trials.)-416.8(This)-408.4(has)-409.8(included,)-412.1(from)-411.8(the)-411(World)-407.7(Health)-412.4(Organization,)-410(in)]TJ ET endstream endobj 43 0 obj << /Type /Page /Parent 392 0 R /Resources 44 0 R /Contents 45 0 R /MediaBox [ 0 0 595 842 ] /CropBox [ 0 0 595 842 ] /Rotate 0 >> endobj 44 0 obj << /ProcSet [ /PDF /Text ] /Font << /F2 337 0 R /F5 340 0 R /F6 341 0 R /F7 342 0 R >> /ExtGState << /GS1 434 0 R >> /ColorSpace << /DefaultCMYK 417 0 R /Cs6 416 0 R >> >> endobj 45 0 obj << /Length 4982 >> stream q 1 i 0.015 737.008 510.221 -737.008 re W n /Cs6 cs 0 0 0 scn /GS1 gs 0.015 709.001 25.44 -0.284 re f Q /Cs6 cs 0 0 0 scn /GS1 gs 28.006 737.008 0.283 -25.455 re f 481.89 737.008 0.283 -25.455 re f 484.724 709.001 25.512 -0.284 re f 484.724 28.346 25.512 -0.283 re f 481.89 25.512 0.283 -25.512 re f q 1 i 0.015 737.008 510.221 -737.008 re W n 28.006 25.512 0.283 -25.512 re f 0.015 28.346 25.44 -0.283 re f Q BT /F2 1 Tf 10.959 0 0 10.959 95.6409 609.8455 Tm 0 Tc 0 Tw (1995,)Tj /F5 1 Tf 2.5711 0 TD [(Guidelines)-296.5(for)-297.8(Good)-301.4(Clinical)-298.3(Practice)-301.1(for)-297.8(Trials)-296.9(on)-298.5(Pharmaceu-)]TJ -2.5711 -1.2623 TD [(tical)-207.6(Products)]TJ /F2 1 Tf 5.7215 0 TD (;)Tj 0.4708 0 TD [(and)-201.5(from)-204.9(the)-198.9(International)-198.9(Conference)-203.9(on)-199.6(Harmonisa-)]TJ -6.1923 -1.2571 TD [(tion)-295(of)-289.3(Technical)-291.8(Requirement)6.5(s)-292.7(for)-292.3(Registration)-289.7(of)-289.3(Pharmaceuticals)]TJ 0 -1.2623 TD [(for)-292.3(Human)-290.5(Use)-285.6(\(ICH\))]TJ /F5 1 Tf 9.6221 0 TD (,)Tj /F2 1 Tf 0.5639 0 TD [(in)-290.2(1996,)]TJ /F5 1 Tf 3.6678 0 TD [(Guideline)-288.3(on)-293.3(Good)-285.8(Clinical)-293.1(Practice)]TJ /F2 1 Tf 14.9763 0 TD (,)Tj -28.8301 -1.2571 TD [(des)-7.3(igned)-606.7(to)-604.9(ensure)-609.4(that)-604.8(data)-608.5(generated)-610.8(from)-608.4(clinical)-610.1(tria)-7.1(ls)-602.1(are)]TJ T* [(mutually)-205.1(acceptable)-200.9(to)-206.5(regulatory)-200.5(authorities)-200.7(in)-207.5(the)-198.9(European)-201.2(Union,)]TJ 0 -1.2623 TD [(Japan)-319.8(and)-315.3(the)-317.9(United)-319(States)-315.6(of)-315.2(America.)-320(The)-316(Joint)-318.5(United)-319(Nations)]TJ 0 -1.2571 TD [(Programme)-207.6(on)-204.8(HIV/AIDS)-205.2(published)-202.8(in)-207.5(2000)-203.8(the)-209.3(UNAIDS)-203.6(Guidance)]TJ T* (Document)Tj /F5 1 Tf 5.0232 0 TD [(Ethical)-515.9(Considerations)-516.3(in)-518.1(HIV)-516.8(Preventive)-513.5(Vaccine)-518.8(Re-)]TJ -5.0232 -1.2623 TD (search)Tj /F2 1 Tf 2.6435 0 TD (.)Tj -1.3502 -1.2571 TD [(In)-201.1(2001)-198.6(the)-198.9(Council)-197.8(of)-196.2(Ministers)-199.8(of)-196.2(the)-198.9(European)-196.1(Union)-200.7(adopted)-195(a)]TJ -1.2933 -1.2623 TD [(Directive)-314.8(on)-313.5(clinical)-315.2(trials,)-313.3(which)-311.1(will)-313.7(be)-314.6(binding)-311.2(on)-308.3(Member)-314.8(States)]TJ 0 -1.2571 TD [(from)-567(2004.)-564.9(The)-564.3(Council)-560(of)-563.5(Europe,)-564.2(with)-563.6(44)-567.5(member)-564.6(States,)-562.9(is)]TJ T* [(developing)-463.3(a)-457(Protocol)-458.8(on)-463.5(Biomedical)-459.3(Research,)-457(which)-461.1(will)-463.7(be)-459.5(an)]TJ 0 -1.2622 TD [(additional)-444.6(protocol)-438.3(to)-444.5(the)-442.1(Councils)-443(1997)-441.8(Convention)-439.8(on)-442.8(Human)]TJ 0 -1.2571 TD [(Rights)-273.2(and)-268.7(Biomedicine.)]TJ 1.2933 -1.2623 TD [(Not)-517.5(specifically)-512.2(concerned)-511.5(with)-517(biomedical)-511.2(research)-511.9(involving)]TJ -1.2933 -1.2571 TD [(human)-400.1(subjects)-404.8(but)-399.5(clearly)-403.2(pertinent,)-400.4(as)-403.1(noted)-398.6(above,)-401.6(are)-400.7(interna-)]TJ T* [(tional)-476.9(human)-472.5(rights)-472(instruments.)-476.6(These)-471.7(are)-473.1(mainly)-474.5(the)-473.1(Universal)]TJ 0 -1.2623 TD [(Declaration)-539.4(of)-537.6(Human)-538.8(Rights,)-541.3(which,)-537.7(particularly)-540(in)-538.6(its)-538.1(science)]TJ 0 -1.2571 TD [(provisions,)-588.2(was)-580.1(highly)-584.1(influenced)-584.6(by)-582.7(the)-586.9(Nuremberg)-581.3(Code;)-585.3(the)]TJ T* (I)Tj 0.3932 0 TD [(nte)-12.7(rn)-9.7(ati)-9.2(o)-6.7(n)0(a)-8.5(l)-609.4(C)-6.2(o)0(v)-8.5(e)0(n)-9.4(a)0(n)-8.5(t)-608.5(o)-6.7(n)-612(Civ)-12.2(il)-618.8(an)-8.5(d)-606.8(P)-6.4(ol)-10.9(it)-7.4(ic)-12.1(al)-616.4(Rig)-12(ht)-10(s;)-612.4(a)-7(n)0(d)-613.5(t)-8.4(he)]TJ -0.3932 -1.2623 TD [(International)-405.8(Covenant)-403.3(on)-401.4(Economic,)-408.3(Social)-404(and)-403.2(Cultural)-403.4(Rights.)]TJ 0 -1.2571 TD [(Since)-297.2(the)-292(Nuremberg)-291.6(experience,)-293.7(human)-286.3(rights)-296.1(law)-291.6(has)-290.9(expanded)-294.6(to)]TJ 0 -1.2622 TD [(include)-292.6(the)-292(protection)-289.1(of)-294.5(women)-291.9(\(Convention)-287.8(on)-292.8(the)-292(Elimination)-292.1(of)]TJ 0 -1.2571 TD [(All)-397.2(Forms)-392.2(of)-392.8(Discrimination)-388(Against)-394(Women\))-391.5(and)-387.7(children)-393.9(\(Con-)]TJ T* [(vention)-321.8(on)-318.6(the)-323.1(Rights)-319.8(of)-315.2(the)-323.1(Child\).)-320(All)-319.6(endorse)-321.3(in)-321.3(terms)-317.7(of)-320.4(human)]TJ 0 -1.2623 TD 0.011 Tc [(righ)4.3(ts)-612.8(the)-612.5(g)-1.1(eneral)-614(ethical)-614(p)-0.9(rin)4.3(c)-2.1(iples)-612.8(t)2.6(hat)-613(u)4.3(nd)4.3(erlie)-612.5(t)-2.6(h)4.3(e)-612.5(CIOMS)]TJ 0 -1.2571 TD 0 Tc [(International)-271.3(Ethical)-267.3(Guidelines.)]TJ ET 95.641 646.809 318.898 -0.51 re f BT /F6 1 Tf 7.9702 0 0 7.9702 191.1118 649.1337 Tm [(INTERNA)13.4(TIONAL)-327.4(ETHICAL)-327.5(GUIDELINES)-319.8(FOR)-332.5(BIOMED)13.7(ICAL)-331.1(RESEARCH)]TJ /F7 1 Tf 11.9551 0 0 11.9551 95.6409 649.1337 Tm (16)Tj ET endstream endobj 46 0 obj << /Type /Page /Parent 392 0 R /Resources 47 0 R /Contents 48 0 R /MediaBox [ 0 0 595 842 ] /CropBox [ 0 0 595 842 ] /Rotate 0 >> endobj 47 0 obj << /ProcSet [ /PDF /Text ] /Font << /F2 337 0 R /F4 339 0 R /F9 344 0 R >> /ExtGState << /GS1 434 0 R >> /ColorSpace << /DefaultCMYK 417 0 R /Cs6 416 0 R >> >> endobj 48 0 obj << /Length 5202 >> stream q 1 i 0.015 737.008 510.221 -737.008 re W n /Cs6 cs 0 0 0 scn /GS1 gs 0.015 709.001 25.44 -0.284 re f Q /Cs6 cs 0 0 0 scn /GS1 gs 28.006 737.008 0.283 -25.455 re f 481.89 737.008 0.283 -25.455 re f 484.724 709.001 25.512 -0.284 re f 484.724 28.346 25.512 -0.283 re f 481.89 25.512 0.283 -25.512 re f q 1 i 0.015 737.008 510.221 -737.008 re W n 28.006 25.512 0.283 -25.512 re f 0.015 28.346 25.44 -0.283 re f Q BT /F4 1 Tf 19.9253 0 0 19.9253 131.2441 588.3589 Tm 0 Tc 0 Tw [(General)-254.5(Ethical)-251.4(Princip)-5.4(les)]TJ /F2 1 Tf 10.7396 0 0 10.959 95.6409 542.2676 Tm 0.0124 Tc [(All)-615(r)1.5(esearch)-612.8(i)2.6(nvo)4.8(l)-2.7(ving)-612(h)4.8(u)-0.4(man)-612.8(s)1.5(ub)4.8(jec)6(t)-3(s)-610.9(s)1.5(hou)4.8(ld)-612.8(b)4.8(e)-616.9(co)4.8(ndu)4.8(cte)6(d)-618.1(in)]TJ 0 -1.2571 TD 0 Tc [(accordance)-532.1(with)-528.9(three)-532.4(basic)-532.4(ethical)-532(principles,)-529.3(namely)-535(respect)-528.6(for)]TJ T* [(persons,)-541.4(beneficence)-535.1(and)-539.2(justice.)-535.3(It)-543.6(is)-538(generally)-535.7(agreed)-535.8(that)-541.4(these)]TJ 0 -1.2623 TD [(principles,)-439.6(which)-432.4(in)-434.4(the)-435.9(abstract)-433.9(have)-428.7(equal)-434(moral)-437.7(force,)-431.3(guide)-434(the)]TJ 0 -1.2571 TD [(conscientious)-203.6(preparation)-202.8(of)-202.4(proposals)-200.9(for)-202.8(scientific)-208.8(studies.)-199.8(In)-208.5(varying)]TJ 0 -1.2623 TD [(circumstances)-397.4(they)-395.1(may)-395.1(be)-399.3(expressed)-390.6(differently)-396.5(and)-396.7(given)-396.3(different)]TJ 0 -1.2571 TD [(moral)-284.6(weight,)-287.9(and)-280.6(their)-287.6(application)-279.7(may)-284.3(lead)-283.9(to)-286.9(different)-284.9(decisions)-282.8(or)]TJ T* [(courses)-213.8(of)-218.3(action.)-211.1(The)-213.7(present)-213(guidelines)-214.5(are)-214.1(directed)-213(at)-212.2(the)-214.1(application)]TJ 0 -1.2623 TD [(of)-271.1(these)-268.4(principles)-271.5(to)-265.8(research)-272.2(involving)-262.4(human)-268.5(subjects.)]TJ /F9 1 Tf 10.959 0 0 10.959 95.6409 404.7306 Tm [(Respect)-457(for)-458.1(persons)]TJ /F2 1 Tf 8.9237 0 TD [(incorporates)-454(at)-455.1(least)-459.9(two)-455.9(fundament)8.1(al)-461.2(ethical)]TJ -8.9237 -1.2571 TD [(considerations,)-267.3(namely:)]TJ 1.2933 -1.3916 TD (a\))Tj 10.7396 0 0 10.959 126.822 375.7039 Tm [(respect)-185.5(for)-176.4(autonomy,)-181.3(which)-179.1(requires)-181.3(that)-182.4(those)-179.8(who)-178.7(are)-182.5(capable)]TJ 0 -1.2571 TD [(of)-355.5(deliberation)-348.3(about)-345.8(their)-351(personal)-352.5(choices)-350.7(should)-346.5(be)-351.8(treated)]TJ T* -0.0001 Tc [(with)-254.5(respect)-243.6(for)-250.4(their)-250.8(capacity)-245.5(for)-250.4(self-determination;)-252.7(and)]TJ 10.959 0 0 10.959 109.8142 332.9007 Tm 0 Tc [(b\))-667(protection)-263.3(of)-263.5(persons)-259.5(with)-258.4(impaired)-262.6(or)-263.2(diminished)-262.9(autonomy,)]TJ 1.552 -1.2571 TD [(which)-269.7(requires)-270(that)-268.5(those)-270.7(who)-268(are)-271.3(dependent)-262.3(or)-273.5(vulnerable)-263(be)]TJ T* [(afforded)-272.1(security)-265.4(against)-270.9(harm)-265.5(or)-268.4(abuse.)]TJ /F9 1 Tf -2.8452 -2.4831 TD (Beneficence)Tj /F2 1 Tf 5.1059 0 TD [(refers)-214.3(to)-216.9(the)-214.4(ethical)-217(obligation)-211.8(to)-216.9(maximize)-209.9(benefit)-215.8(and)-217(to)]TJ -5.1059 -1.2571 TD [(minimize)-305.1(harm.)-300.8(This)-299.8(principle)-299.8(gives)-298(rise)-302.6(to)-299.7(norms)-299.3(requiring)-297.7(that)-299.6(the)]TJ T* [(risks)-335.4(of)-330.7(research)-325.7(be)-330.2(reasonable)-329.1(in)-331.6(the)-328.3(light)-330.5(of)-330.7(the)-333.4(expected)-329.4(benefits,)]TJ 0 -1.2623 TD [(that)-496.1(the)-499(research)-496.4(design)-495.9(be)-495.7(sound,)-494.4(and)-496.3(that)-496.1(the)-499(investigato)7.1(rs)-497.4(be)]TJ 0 -1.2571 TD [(competent)-247.5(both)-251(to)-247.9(conduct)-247.7(the)-250.7(research)-248.1(and)-248(to)-247.9(safeguard)-248.1(the)-245.5(welfare)]TJ T* [(of)-247.9(the)-240.3(research)-242.9(subjects.)-248.6(Beneficence)-240.3(further)-245.9(proscribes)-238.3(the)-245.5(deliberate)]TJ 0 -1.2623 TD [(infliction)-247.9(of)-242.8(harm)-244.8(on)-246.2(persons;)-242.9(this)-244.8(aspect)-247.8(of)-242.8(beneficence)-245.7(is)-245.1(sometimes)]TJ 0 -1.2571 TD [(expressed)-270.3(as)-268.6(a)-270.8(separate)-268.2(principle,)]TJ /F9 1 Tf 14.3245 0 TD (nonmaleficence)Tj /F2 1 Tf 6.5958 0 TD [(\(do)-270.2(no)-266.9(harm\).)]TJ /F9 1 Tf -20.9203 -2.478 TD (Justice)Tj /F2 1 Tf 3.466 0 TD [(refers)-607.4(to)-599.7(the)-607.6(ethical)-605(obligation)-599.8(to)-604.9(treat)-603.8(each)-603.7(person)-603.1(in)]TJ -3.466 -1.2623 TD [(accordance)-508.4(with)-511.9(what)-504.3(is)-514.1(morally)-508.5(right)-505.2(and)-511.8(proper,)-509(to)-506.6(give)-507.1(each)]TJ 0 -1.2571 TD [(person)-292.7(what)-292.2(is)-291.7(due)-290.3(to)-289.3(him)-296(or)-289.1(her.)-290.8(In)-294.2(the)-292(ethics)-291.6(of)-289.3(research)-289.5(involving)]TJ 0 -1.2623 TD [(human)-374.3(subjects)-378.9(the)-374.8(principle)-372.2(refers)-374.6(primarily)-376(to)]TJ /F9 1 Tf 21.2048 0 TD [(distributive)-372.2(justice,)]TJ /F2 1 Tf -21.2048 -1.2571 TD [(which)-243.8(requires)-239(the)-240.3(equitable)-240.8(distribution)-239.7(of)-242.8(both)-235.5(the)-240.3(burdens)-242.5(and)-237.7(the)]TJ ET endstream endobj 49 0 obj << /Type /Page /Parent 392 0 R /Resources 50 0 R /Contents 51 0 R /MediaBox [ 0 0 595 842 ] /CropBox [ 0 0 595 842 ] /Rotate 0 >> endobj 50 0 obj << /ProcSet [ /PDF /Text ] /Font << /F2 337 0 R /F6 341 0 R /F7 342 0 R >> /ExtGState << /GS1 434 0 R >> /ColorSpace << /DefaultCMYK 417 0 R /Cs6 416 0 R >> >> endobj 51 0 obj << /Length 5662 >> stream q 1 i 0.015 737.008 510.221 -737.008 re W n /Cs6 cs 0 0 0 scn /GS1 gs 0.015 709.001 25.44 -0.284 re f Q /Cs6 cs 0 0 0 scn /GS1 gs 28.006 737.008 0.283 -25.455 re f 481.89 737.008 0.283 -25.455 re f 484.724 709.001 25.512 -0.284 re f 484.724 28.346 25.512 -0.283 re f 481.89 25.512 0.283 -25.512 re f q 1 i 0.015 737.008 510.221 -737.008 re W n 28.006 25.512 0.283 -25.512 re f 0.015 28.346 25.44 -0.283 re f Q BT /F2 1 Tf 10.959 0 0 10.959 95.6409 609.8455 Tm 0 Tc 0 Tw [(benefits)-410.2(of)-408.3(participation)-407(in)-404(research.)-407.5(Differences)-407.3(in)-409.2(distribution)-410.4(of)]TJ 0 -1.2623 TD [(burdens)-258(and)-258.4(benefits)-260.2(are)-255.8(justifiable)-261.5(only)-257.4(if)-260.9(they)-257.6(are)-255.8(based)-258.9(on)-256.6(morally)]TJ 0 -1.2571 TD 0.0148 Tc [(relevant)-619.6(d)-2.2(isti)-4.9(ncti)-4.9(on)]TJ 8.841 0 TD 0.6341 Tc [(sb)617.1(e)621(t)615.3(w)622.7(e)]TJ 3.5747 0 TD 0.0129 Tc [(en)-624.9(pe)-5.3(rs)-5.6(o)-4.1(n)1(s)-5.6(;)-622.4(on)-4.1(e)-621(s)-5.6(uc)-5.3(h)-619.8(d)-4.1(is)-5.6(ti)-6.8(nc)-5.3(tio)-4.1(n)-619.8(i)-6.8(s)]TJ -12.4156 -1.2623 TD 0 Tc [(vulnerability.)-448.6(Vulnerability)-450.1(refers)-447.1(to)-449.7(a)-446.7(substantial)-448.1(incapacity)-449.8(to)]TJ 0 -1.2571 TD [(protect)-421.5(ones)-416.5(own)-418(interests)-414.7(owing)-418.8(to)-418.6(such)-412.3(impediments)-418.9(as)-418.7(lack)-418.9(of)]TJ T* [(capability)-466.7(to)-460(give)-465.8(informed)-458(consent,)-465.4(lack)-460.3(of)-465.2(alternative)-459.7(means)-464.8(of)]TJ 0 -1.2623 TD [(obtaining)-176.6(medical)-183.2(care)-175.8(or)-180.4(other)-177.6(expensive)-177.2(necessities,)-176.9(or)-180.4(being)-177.3(a)-177.7(junior)]TJ 0 -1.2571 TD [(or)-268.4(subordinat)8.1(e)-266.6(member)-264.6(of)-263.5(a)-260.5(hierarchical)-266.2(group.)-261.9(Accordingly,)-262.8(special)]TJ T* [(provision)-208.5(must)-210.1(be)-206(made)-208.4(for)-209.5(the)-209.3(protection)-206.3(of)-206.5(the)-209.3(rights)-208.2(and)-206.6(welfare)-210.2(of)]TJ 0 -1.2623 TD [(vulnerable)-268.2(persons.)]TJ 1.2933 -1.2571 TD [(Sponsors)-332.2(of)-330.7(research)-330.9(or)-335.6(investigato)7.1(rs)-337.1(cannot,)-327(in)-331.6(general,)-332.3(be)-335.3(held)]TJ -1.2933 -1.2623 TD [(accountable)-366.8(for)-364.7(unjust)-361.6(conditions)-361.3(where)-368(the)-364.5(research)-361.9(is)-369.3(conducted,)]TJ 0 -1.2571 TD [(but)-290.9(they)-288.7(must)-282.5(refrain)-288.5(from)-287.7(practices)-288.8(that)-289.2(are)-286.9(likely)-287.6(to)-289.3(worsen)-287(unjust)]TJ T* [(conditions)-294(or)-294.2(contribute)-294.3(to)-294.5(new)-295(inequities.)-291.7(Neither)-297.3(should)-292.7(they)-293.8(take)]TJ 0 -1.2622 TD [(advantage)-587.1(of)-589.4(the)-586.9(relative)-587.5(inability)-590.5(of)-589.4(low-resource)-583.8(countries)-587.4(or)]TJ 0 -1.2571 TD [(vulnerable)-288.9(populations)-284.3(to)-284.1(protect)-287(their)-288.9(own)-283.5(interests,)-289.5(by)-287.9(conducting)]TJ 0 -1.2623 TD [(research)-361.9(inexpensively)-354.5(and)-361.8(avoiding)-354.6(complex)-356.5(regulatory)-360.9(systems)-358.7(of)]TJ 0 -1.2571 TD [(industrialized)-236(countries)-230.4(in)-233.3(order)-234.2(to)-232.4(develop)-228.1(products)-235.4(for)-230.2(the)-235.1(lucrative)]TJ T* [(markets)-269.3(of)-268.6(those)-270.7(countries.)]TJ 1.2933 -1.2623 TD [(In)-175.2(general,)-166.8(the)-173.1(research)-170.5(project)-169(should)-168.5(leave)-173.6(low-resource)-164.8(countries)]TJ -1.2933 -1.2571 TD [(or)-227(communities)-222.3(better)-223.4(off)-220.2(than)-220.2(previously)-221.9(or,)-226(at)-222.3(least,)-226.1(no)-220.3(worse)-223.4(off.)-224.3(It)]TJ T* [(should)-308.2(be)-309.5(responsive)-309.5(to)-304.8(their)-309.6(health)-309.9(needs)-306.4(and)-310.1(priorities)-309.9(in)-305.8(that)-309.9(any)]TJ 0 -1.2623 TD [(product)-196.2(developed)-196.2(is)-198.6(made)-198(reasonably)-193.6(available)-194.7(to)-196.2(them,)-198.5(and)-196.3(as)-196.2(far)-199.5(as)]TJ 0 -1.2571 TD [(possible)-316.6(leave)-308.1(the)-312.7(population)-312.3(in)-310.9(a)-312.2(better)-316.5(position)-310.5(to)-310(obtain)-313.9(effective)]TJ 0 -1.2622 TD [(health)-268.5(care)-274.1(and)-263.5(protect)-271.5(its)-269.1(own)-268(health.)]TJ 1.2933 -1.2571 TD [(Justice)-304.7(requires)-295.9(also)-300.2(that)-299.6(the)-302.4(research)-294.7(be)-299.1(responsive)-299.2(to)-299.7(the)-302.4(health)]TJ -1.2933 -1.2571 TD [(conditions)-511.3(or)-511.5(needs)-513.3(of)-511.8(vulnerable)-511.3(subjects.)-512.4(The)-507.4(subjects)-513.4(selected)]TJ 0 -1.2623 TD [(should)-189.2(be)-185.3(the)-188.6(least)-185.7(vulnerable)-185.4(necessary)-182.7(to)-185.9(accomplish)-189.3(the)-183.4(purposes)-188.6(of)]TJ 0 -1.2571 TD [(the)-178.2(research.)-179.9(Risk)-175.1(to)-180.7(vulnerable)-175(subjects)-177.1(is)-177.9(most)-173.9(easily)-178.1(justified)-177.9(when)-177.6(it)]TJ 0 -1.2623 TD [(arises)-369.5(from)-365.3(interventions)-365.4(or)-366.6(procedures)-364.7(that)-366.8(hold)-365.7(out)-363.3(for)-369.9(them)-365(the)]TJ 0 -1.2571 TD [(prospect)-267.6(of)-268.6(direct)-270.9(health-related)-265.2(benefit.)-266.5(Risk)-268.2(that)-268.5(does)-267.4(not)-265(hold)-267.4(out)]TJ T* [(such)-484.7(prospect)-479.7(must)-484.3(be)-485.4(justified)-483.1(by)-484.4(the)-478.3(anticipated)-483.8(benefit)-484.8(to)-480.7(the)]TJ 0 -1.2623 TD [(population)-255.4(of)-253.1(which)-259.4(the)-255.8(individual)-254.1(research)-253.3(subject)-256.9(is)-255.5(representative.)]TJ ET 95.641 646.809 318.898 -0.51 re f BT /F6 1 Tf 7.9702 0 0 7.9702 191.1118 649.1337 Tm [(INTERNA)13.4(TIONAL)-327.4(ETHICAL)-327.5(GUIDELINES)-319.8(FOR)-332.5(BIOMED)13.7(ICAL)-331.1(RESEARCH)]TJ /F7 1 Tf 11.9551 0 0 11.9551 95.6409 649.1337 Tm (18)Tj ET endstream endobj 52 0 obj << /Type /Page /Parent 392 0 R /Resources 53 0 R /Contents 54 0 R /MediaBox [ 0 0 595 842 ] /CropBox [ 0 0 595 842 ] /Rotate 0 >> endobj 53 0 obj << /ProcSet [ /PDF /Text ] /Font << /F2 337 0 R /F4 339 0 R /F10 345 0 R >> /ExtGState << /GS1 434 0 R >> /ColorSpace << /DefaultCMYK 417 0 R /Cs6 416 0 R >> >> endobj 54 0 obj << /Length 5238 >> stream q 1 i 0.015 737.008 510.221 -737.008 re W n /Cs6 cs 0 0 0 scn /GS1 gs 0.015 709.001 25.44 -0.284 re f Q /Cs6 cs 0 0 0 scn /GS1 gs 28.006 737.008 0.283 -25.455 re f 481.89 737.008 0.283 -25.455 re f 484.724 709.001 25.512 -0.284 re f 484.724 28.346 25.512 -0.283 re f 481.89 25.512 0.283 -25.512 re f q 1 i 0.015 737.008 510.221 -737.008 re W n 28.006 25.512 0.283 -25.512 re f 0.015 28.346 25.44 -0.283 re f Q BT /F4 1 Tf 19.9253 0 0 19.9253 212.5417 588.3589 Tm 0 Tc 0 Tw (Preamble)Tj /F2 1 Tf 10.959 0 0 10.959 95.6409 543.3447 Tm [(The)-197(term)-190.6(research)-192.4(refers)-193.6(to)-196.2(a)-193.2(class)-190.6(of)-191(activity)-193.7(designed)-189.8(to)-196.2(develop)-191.9(or)]TJ 0 -1.2622 TD [(contribute)-599.5(to)-599.7(generalizable)-598.8(knowledge.)-597.1(Generaliza)5.8(ble)-603.4(knowledge)]TJ 0 -1.2571 TD [(consists)-182.6(of)-180.7(theories,)-176.2(principles)-183.8(or)-180.4(relationships)5.9(,)-180.1(o)0(r)-180.4(the)-183.4(accumulation)-177.4(of)]TJ T* [(information)-367.8(on)-360(which)-368(they)-361.1(are)-364.5(based,)-366.6(that)-361.6(can)-363(be)-366.4(corroborated)-358.3(by)]TJ 0 -1.2623 TD [(accepted)-526(scientific)-523.2(methods)-521.1(of)-522.1(observation)-522.5(and)-522.2(inference.)-525.2(In)-521.8(the)]TJ 0 -1.2571 TD [(present)-410.9(context)-410(research)-414.9(includes)-409.4(both)-411.4(medical)-410.9(and)-408.4(behavioural)]TJ 0 -1.2623 TD [(studies)-189.9(pertaining)-180.8(to)-185.9(human)-182.8(health.)-184.8(Usually)-187.8(research)-187.2(is)-183.1(modified)-185(by)]TJ 0 -1.2571 TD [(the)-271.3(adjective)-268.1(biomedical)-269.3(to)-273.8(indicate)-265.1(its)-269.1(relation)-270.5(to)-268.6(health.)]TJ 1.2933 -1.2933 TD [(Progress)-272.8(in)-274.7(medical)-271.2(care)-268.9(and)-273.9(disease)-267.3(prevention)-272.2(depends)-268.1(upon)-270(an)]TJ -1.2933 -1.2571 TD (u)Tj 0.5742 0 TD 0.0178 Tc [(nderstanding)-625.5(of)-621.8(physio)-4.4(l)3.3(o)-4.4(g)0.5(ical)-622.7(and)-620(p)-4.4(athological)-622.7(proc)-5.6(esses)-621.5(o)0.8(r)]TJ -0.5742 -1.2623 TD 0.0185 Tc [(epidemiological)-627.2(f)4.9(indings,)-622(and)-619.3(r)0(equires)-620.8(a)1.2(t)-621.1(s)0(ome)-620.5(t)-0.3(ime)-625.7(r)0(esearch)]TJ 0 -1.2571 TD 0 Tc [(involving)-234.7(human)-234.6(subjects.)-238.2(The)-233.2(collection,)-239.7(analysis)-233.4(and)-232.5(interpretation)]TJ T* [(of)-589.4(information)-585.1(obtained)-582(from)-587.7(research)-584.4(involving)-586.4(human)-586.4(beings)]TJ 0 -1.2623 TD [(contribute)-268.4(significantly)-270.2(to)-268.6(the)-271.3(improvement)-266.5(of)-268.6(human)-265.6(health.)]TJ 1.2933 -1.2933 TD [(Research)-271.8(involving)-265.7(human)-265.6(subjects)-270.3(includes:)]TJ /F10 1 Tf 0 -1.2881 TD (7)Tj /F2 1 Tf 1.2933 0 TD [(studies)-231.3(of)-232.4(a)-229.4(physiological,)-229.6(biochemical)-229.4(or)-232.1(pathological)-226.7(process,)]TJ 0 -1.2623 TD [(or)-190.8(of)-185.9(the)-183.4(response)-184.6(to)-185.9(a)-188(specific)-184.7(intervention)-186.5()-184.7(whether)-186.6(physical,)]TJ 0 -1.2571 TD [(chemical)-273.9(or)-268.4(psychological)-265.3()-267.4(i)0(n)-269.5(healthy)-270.3(subjects)-270.3(or)-268.4(patients;)]TJ /F10 1 Tf -1.2933 -1.2933 TD (7)Tj /F2 1 Tf 1.2933 0 TD 0.0136 Tc [(controlled)-619.1(t)0(rials)-620.5(o)1.7(f)-615.6(d)]TJ 10.0308 0 TD [(iagnostic,)-621.8(preventive)-615.2(or)-620.6(therapeutic)]TJ -10.0308 -1.2571 TD 0 Tc [(measures)-266.6(in)-269.5(larger)-264.8(groups)-265.9(of)-263.5(persons,)-268.8(designed)-262.2(to)-268.6(demonstrate)]TJ 0 -1.2623 TD (a)Tj 0.9001 0 TD [(specific)-402(generalizable)-397(response)-396.7(to)-398(these)-401.2(measures)-396(against)-400.2(a)]TJ -0.9001 -1.2571 TD [(background)-266.9(of)-268.6(individual)-269.6(biological)-265.6(variation;)]TJ /F10 1 Tf -1.2933 -1.2933 TD (7)Tj /F2 1 Tf 1.2933 0 TD [(studies)-262.4(designed)-262.2(to)-263.4(determine)-260.2(the)-261(consequences)-260.1(for)-261.3(individuals)]TJ 0 -1.2623 TD [(and)-170.4(communities)-165.4(of)-170.3(specific)-169.2(preventive)-165(or)-164.9(therapeutic)-168(measures;)]TJ 0 -1.2571 TD (and)Tj /F10 1 Tf -1.2933 -1.2933 TD (7)Tj /F2 1 Tf 1.2933 0 TD [(studies)-221(concerning)-214.7(human)-213.9(health-related)-213.4(behaviour)-216.2(in)-217.8(a)-213.9(variety)]TJ 0 -1.2571 TD [(of)-273.8(circumstance)6.5(s)-272(and)-268.7(environments.)]TJ -1.2933 -1.2933 TD [(Research)-178.7(involving)-172.6(human)-172.5(subjects)-177.1(may)-174.9(employ)-177.9(either)-172.6(observation)]TJ -1.2933 -1.2571 TD [(or)-227(physical,)-221.5(chemical)-222.2(or)-221.8(psychological)-218.8(intervention;)-221.7(it)-224.7(may)-221.4(also)-222.6(either)]TJ 0 -1.2623 TD 0.0198 Tc [(generate)-624.4(recor)-3.9(d)2.8(s)-624.7(o)2.8(r)-624.7(m)-1.4(ake)-624.4(u)2.8(se)-624.4(of)-624.9(exis)-3.9(ting)-623.5(records)-624.7(c)1.6(ontaining)]TJ 0 -1.2571 TD 0 Tc [(biomedical)-288.8(or)-283.9(other)-281.1(information)-285(about)-283.9(individuals)-283(who)-283.5(may)-283.5(or)-289.1(may)]TJ 0 -1.2623 TD [(not)-290.9(be)-288.8(identifiable)-293.8(from)-287.7(the)-286.9(records)-291.7(or)-289(information.)-289.2(The)-290.1(use)-286.6(of)-289.3(such)]TJ 0 -1.2571 TD [(records)-421(and)-413.6(the)-421.4(protection)-413.3(of)-418.6(the)-416.2(confidentiality)-419.4(of)-418.6(data)-417.1(obtained)]TJ ET endstream endobj 55 0 obj << /Type /Page /Parent 392 0 R /Resources 56 0 R /Contents 57 0 R /MediaBox [ 0 0 595 842 ] /CropBox [ 0 0 595 842 ] /Rotate 0 >> endobj 56 0 obj << /ProcSet [ /PDF /Text ] /Font << /F2 337 0 R /F5 340 0 R /F6 341 0 R /F7 342 0 R >> /ExtGState << /GS1 434 0 R >> /ColorSpace << /DefaultCMYK 417 0 R /Cs6 416 0 R >> >> endobj 57 0 obj << /Length 6318 >> stream q 1 i 0.015 737.008 510.221 -737.008 re W n /Cs6 cs 0 0 0 scn /GS1 gs 0.015 709.001 25.44 -0.284 re f Q /Cs6 cs 0 0 0 scn /GS1 gs 28.006 737.008 0.283 -25.455 re f 481.89 737.008 0.283 -25.455 re f 484.724 709.001 25.512 -0.284 re f 484.724 28.346 25.512 -0.283 re f 481.89 25.512 0.283 -25.512 re f q 1 i 0.015 737.008 510.221 -737.008 re W n 28.006 25.512 0.283 -25.512 re f 0.015 28.346 25.44 -0.283 re f Q BT /F2 1 Tf 10.959 0 0 10.959 95.6409 609.8455 Tm 0 Tc 0 Tw [(from)-184.2(those)-177.6(records)-183(are)-178.2(discussed)-183.6(in)]TJ /F5 1 Tf 14.6711 0 TD [(Internation)7.8(al)-181.9(Guidelines)-182.7(for)-178.8(Ethical)]TJ -14.6711 -1.2623 TD [(Review)-273.4(of)-268.9(Epidemiological)-267(Studies)]TJ /F2 1 Tf 14.5625 0 TD [(\(CIOMS,)-271.6(1991\).)]TJ -13.2692 -1.2571 TD [(The)-528.1(research)-527.5(may)-526.6(be)-526.7(concerned)-527(with)-527.4(the)-524.8(social)-529.6(environment)6.7(,)]TJ -1.2933 -1.2623 TD [(manipulating)-607.3(environmental)-609.8(factors)-608.3(in)-600.6(a)-607.1(way)-604.8(that)-599.6(could)-606.4(affect)]TJ 0 -1.2571 TD [(incidentally-exposed)-232.8(individuals.)-235.4(It)-233.9(is)-234.8(defined)-234.8(in)-233.3(broad)-231.8(terms)-235(in)-233.3(order)]TJ T* [(to)-242.8(embrace)-237.5(field)-238.3(studies)-236.5(of)-242.8(pathogenic)-234.7(organisms)-237.7(and)-237.7(toxic)-236(chemicals)]TJ 0 -1.2623 TD [(under)-269(investigation)-267.6(for)-271.6(health-related)-265.2(purposes.)]TJ 10.7396 0 0 10.959 109.8142 513.2408 Tm [(Biomedical)-186.1(research)-182.5(with)-185.8(human)-178.8(subjects)-185.8(is)-184.3(to)-181.3(be)-182.9(distinguished)-180.9(from)]TJ -1.3197 -1.2571 TD [(the)-266.9(practice)-265(of)-265.8(medicine,)-265.8(public)-265.1(health)-264.7(and)-264.7(other)-264.3(forms)-262.7(of)-265.8(health)-264.7(care,)]TJ 0 -1.2623 TD [(which)-274.1(is)-279.4(designed)-268.9(to)-276.4(contribute)-268.8(directly)-273.7(to)-276.3(the)-272.2(health)-275.2(of)-271.1(individuals)-273.3(or)]TJ 0 -1.2571 TD [(communities.)-215.6(Prospective)-212.7(subjects)-212.2(may)-215.6(find)-214.5(it)-215.2(confusing)-211.5(when)-211.5(research)]TJ 0 -1.2623 TD [(and)-317.5(practice)-317.8(are)-319.7(to)-318.6(be)-314.9(conducted)-315.3(simultaneously,)-318.1(as)-318.6(when)-317.1(research)-314.5(is)]TJ 0 -1.2571 TD [(designed)-379.7(to)-381.9(obtain)-376.6(new)-378.1(information)-379.6(about)-377.4(the)-377.8(efficacy)-379.6(of)-381.9(a)-381.6(drug)-375.9(or)]TJ T* [(other)-269.6(therapeutic,)-268.4(diagnostic)-268(or)-266.6(preventive)-268.8(modality.)]TJ 10.959 0 0 10.959 109.8142 416.6361 Tm [(As)-278(stated)-274.2(in)-279.9(Paragraph)-271(32)-277.8(of)-273.8(the)-276.5(Declaration)-275.6(of)-273.8(Helsinki,)-279.5(In)-276.7(the)]TJ -1.2933 -1.2571 TD [(treatment)-410.1(of)-408.3(a)-410.5(patient,)-410.5(where)-404.2(proven)-410.5(prophylactic,)-406.5(diagnostic)-408.4(and)]TJ 0 -1.2623 TD [(therapeutic)-597.3(methods)-598.7(do)-598(not)-596.1(exist)-599.5(or)-599.4(have)-597.6(been)-593.1(ineffective,)-600.4(the)]TJ 0 -1.2571 TD [(physician,)-202.4(with)-201.5(informed)-194.2(consent)-202.5(from)-199.7(the)-198.9(patient,)-198.4(must)-199.7(be)-200.8(free)-197.9(to)-201.4(use)]TJ T* [(unproven)-263.5(or)-268.4(new)-264(prophylactic,)-261.6(diagnostic)-263.5(and)-268.7(therapeutic)-261.1(measures,)]TJ 0 -1.2623 TD [(if)-529.9(in)-523(the)-524.8(physicians)-526.1(judgement)-521.7(it)-529.9(offers)-523.7(hope)-524.6(of)-522.1(saving)-526.3(life,)-525.5(re-)]TJ 0 -1.2571 TD [(establishing)-498.3(health)-496.1(or)-496(alleviating)-497(suffering.)-499.2(Where)-495.3(possible,)-496.6(these)]TJ T* [(measures)-235.6(should)-235.8(be)-237(made)-239.4(the)-235.1(object)-238.4(of)-232.4(research,)-236.8(designed)-236.3(to)-237.6(evaluate)]TJ 0 -1.2623 TD [(their)-449.2(safety)-440(and)-444.6(efficacy.)-445.7(In)-444.2(all)-444.7(cases,)-446.8(new)-445.1(information)-440.2(should)-442.7(be)]TJ 0 -1.2571 TD [(recorded)-567.1(and,)-562.6(where)-569.8(appropriate,)-562.9(published.)-564(The)-564.3(other)-565.6(relevant)]TJ 0 -1.2622 TD [(guidelines)-270.5(of)-268.6(this)-270.6(Declaration)-270.4(should)-266.8(be)-268.1(followed.)]TJ 1.2933 -1.2571 TD [(Professionals)-453(whose)-454.8(roles)-454.1(combine)-449.3(investigation)-453.8(and)-449.8(treatment)]TJ -1.2933 -1.2571 TD [(have)-442.4(a)-441.5(special)-444.3(obligation)-439.4(to)-444.5(protect)-437.1(the)-442.1(rights)-441(and)-444.6(welfare)-443(of)-439.3(the)]TJ 0 -1.2623 TD [(patient-subjects.)-497.8(An)-499(investigator)-492.5(who)-500.8(agrees)-496.2(to)-496.2(act)-499.2(as)-496.2(physician-)]TJ 0 -1.2571 TD 0.0217 Tc [(in)4.7(vestiga)4.4(t)-2.2(o)4.7(r)-622.8(un)4.7(dertak)4.7(es)-622.8(some)-622.5(o)4.7(r)-622.8(all)-624(o)-0.5(f)-623(t)2.9(h)4.7(e)-622.5(lega)4.4(l)-623.9(a)-0.8(n)4.6(d)-621.3(ethica)4.4(l)]TJ 0 -1.2623 TD 0 Tc [(responsibilities)-477.1(of)-480.7(the)-473.1(subjects)-476.2(primary-care)-479.4(physician.)-471.4(In)-480.5(such)-474.4(a)]TJ 0 -1.2571 TD [(case,)-319.6(if)-323(the)-317.9(subject)-319(withdraws)-315.3(from)-318.7(the)-317.9(research)-320.5(owing)-315.3(to)-320.4(complica-)]TJ T* [(tions)-220.4(related)-221(to)-216.9(the)-219.6(research)-217.1(or)-216.6(in)-223(the)-214.4(exercise)-219.5(of)-222.1(the)-214.4(right)-220.7(to)-216.9(withdraw)]TJ 0 -1.2623 TD [(without)-228.5(loss)-229(of)-227.2(benefit,)-225.2(the)-230(physician)-224.1(has)-228.8(an)-225.8(obligation)-227.3(to)-227.2(continue)-226(to)]TJ 0 -1.2571 TD [(provide)-259.5(medical)-255.7(care,)-257.6(or)-258(to)-253.1(see)-256.8(that)-258.2(the)-255.8(subject)-256.9(receives)-255.7(the)-255.8(necessary)]TJ T* [(care)-196.5(in)-191.9(the)-193.8(health-care)-194.1(system,)-189.2(or)-195.9(to)-191(offer)-194.8(assistance)-192.6(in)-191.9(finding)-193.9(another)]TJ 0 -1.2623 TD (physician.)Tj 1.2933 -1.2571 TD [(Research)-333.9(with)-330.8(human)-332.9(subjects)-332.3(should)-328.9(be)-330.2(carried)-334.5(out)-327.1(only)-335(by,)-328.3(or)]TJ -1.2933 -1.2623 TD [(strictly)-190.9(supervised)-185.4(by,)-188.6(suitably)-186.8(qualified)-190.5(and)-185.9(experienced)-187.6(investigators)]TJ ET 95.641 646.809 318.898 -0.51 re f BT /F6 1 Tf 7.9702 0 0 7.9702 191.1118 649.1337 Tm [(INTERNA)13.4(TIONAL)-327.4(ETHICAL)-327.5(GUIDELINES)-319.8(FOR)-332.5(BIOMED)13.7(ICAL)-331.1(RESEARCH)]TJ /F7 1 Tf 11.9551 0 0 11.9551 95.6409 649.1337 Tm (20)Tj ET endstream endobj 58 0 obj << /Type /Page /Parent 393 0 R /Resources 59 0 R /Contents 60 0 R /MediaBox [ 0 0 595 842 ] /CropBox [ 0 0 595 842 ] /Rotate 0 >> endobj 59 0 obj << /ProcSet [ /PDF /Text ] /Font << /F2 337 0 R /F6 341 0 R /F7 342 0 R >> /ExtGState << /GS1 434 0 R >> /ColorSpace << /DefaultCMYK 417 0 R /Cs6 416 0 R >> >> endobj 60 0 obj << /Length 2358 >> stream q 1 i 0.015 737.008 510.221 -737.008 re W n /Cs6 cs 0 0 0 scn /GS1 gs 0.015 709.001 25.44 -0.284 re f Q /Cs6 cs 0 0 0 scn /GS1 gs 28.006 737.008 0.283 -25.455 re f 481.89 737.008 0.283 -25.455 re f 484.724 709.001 25.512 -0.284 re f 484.724 28.346 25.512 -0.283 re f 481.89 25.512 0.283 -25.512 re f q 1 i 0.015 737.008 510.221 -737.008 re W n 28.006 25.512 0.283 -25.512 re f 0.015 28.346 25.44 -0.283 re f Q BT /F2 1 Tf 10.959 0 0 10.959 95.6409 609.8455 Tm 0 Tc 0 Tw [(and)-299.7(in)-300.6(accordance)-301.5(with)-299.8(a)-296.7(protocol)-298.7(that)-299.6(clearly)-304.9(states:)-300.6(the)-297.2(aim)-301.4(of)-299.7(the)]TJ 0 -1.2623 TD [(research;)-195.4(the)-188.6(reasons)-187.3(for)-194(proposing)-185.2(that)-190.9(it)-193.7(involve)-188.5(human)-188(subjects;)-191.7(the)]TJ 0 -1.2571 TD [(nature)-189.7(and)-191.1(degree)-190.4(of)-191(any)-186.2(known)-188.3(risks)-190.6(to)-191(the)-188.6(subjects;)-191.7(the)-188.6(sources)-188.2(from)]TJ 0 -1.2623 TD [(which)-290.4(it)-292(is)-291.7(proposed)-285.4(to)-289.3(recruit)-289.4(subjects;)-290(and)-289.4(the)-292(means)-289(proposed)-285.4(for)]TJ 0 -1.2571 TD [(ensuring)-531.4(that)-527.2(subjects)-527.9(consent)-528.5(will)-530.9(be)-526.7(adequately)-524.7(informed)-530.5(and)]TJ T* 0.0142 Tc [(voluntary.)-621.1(The)-619.6(p)2.3(rotocol)-621.1(s)0.9(hould)-618.5(b)-2.8(e)-614.5(s)-4.3(cientifically)-618.7(and)-618.5(e)1.1(thical)-5.5(ly)]TJ 0 -1.2623 TD 0.0109 Tc [(ap)4.2(pra)3.9(i)1.5(sed)-611.4(b)4.2(y)-611.7(o)-1(n)4.2(e)]TJ 8.6961 0 TD 0.0089 Tc [(or)-614.9(more)-614.6(suitably)-613.7(consti)-5.6(tuted)-613.4(r)0.7(evi)-5.6(e)1(w)-613(b)2.2(odies,)]TJ -8.6961 -1.2571 TD 0 Tc [(independent)-268(of)-268.6(the)-271.3(investigators.)]TJ 1.2933 -1.2571 TD [(New)-459.6(vaccines)-455(and)-454.9(medicinal)-458(drugs,)-454.8(before)-459.7(being)-451.5(approved)-455.2(for)]TJ -1.2933 -1.2623 TD [(general)-291.9(use,)-296(must)-292.9(be)-294(tested)-290.7(on)-292.8(human)-291.5(subjects)-291(in)-290.2(clinical)-294.5(trials;)-292.6(such)]TJ 0 -1.2571 TD [(trials)-391.9(constitute)-384(a)-389.8(substantial)-386(part)-387.2(of)-387.6(all)-387.8(research)-387.8(involving)-384.7(human)]TJ 0 -1.2623 TD (subjects.)Tj ET 95.641 646.809 318.898 -0.51 re f BT /F6 1 Tf 7.9702 0 0 7.9702 95.6409 649.1337 Tm (PREAMBLE)Tj /F7 1 Tf 11.9551 0 0 11.9551 401.3857 649.1337 Tm (21)Tj ET endstream endobj 61 0 obj << /Type /Page /Parent 393 0 R /Resources 62 0 R /Contents 63 0 R /MediaBox [ 0 0 595 842 ] /CropBox [ 0 0 595 842 ] /Rotate 0 >> endobj 62 0 obj << /ProcSet [ /PDF ] /ExtGState << /GS1 434 0 R >> /ColorSpace << /DefaultCMYK 417 0 R /Cs6 416 0 R >> >> endobj 63 0 obj << /Length 412 >> stream q 1 i 0.015 737.008 510.221 -737.008 re W n /Cs6 cs 0 0 0 scn /GS1 gs 0.015 709.001 25.44 -0.284 re f Q /Cs6 cs 0 0 0 scn /GS1 gs 28.006 737.008 0.283 -25.455 re f 481.89 737.008 0.283 -25.455 re f 484.724 709.001 25.512 -0.284 re f 484.724 28.346 25.512 -0.283 re f 481.89 25.512 0.283 -25.512 re f q 1 i 0.015 737.008 510.221 -737.008 re W n 28.006 25.512 0.283 -25.512 re f 0.015 28.346 25.44 -0.283 re f Q endstream endobj 64 0 obj << /Type /Page /Parent 393 0 R /Resources 65 0 R /Contents 66 0 R /MediaBox [ 0 0 595 842 ] /CropBox [ 0 0 595 842 ] /Rotate 0 >> endobj 65 0 obj << /ProcSet [ /PDF /Text ] /Font << /F2 337 0 R /F4 339 0 R /F5 340 0 R /F8 343 0 R /F11 346 0 R >> /ExtGState << /GS1 434 0 R >> /ColorSpace << /DefaultCMYK 417 0 R /Cs6 416 0 R >> >> endobj 66 0 obj << /Length 4985 >> stream q 1 i 0.015 737.008 510.221 -737.008 re W n /Cs6 cs 0 0 0 scn /GS1 gs 0.015 709.001 25.44 -0.284 re f Q /Cs6 cs 0 0 0 scn /GS1 gs 28.006 737.008 0.283 -25.455 re f 481.89 737.008 0.283 -25.455 re f 484.724 709.001 25.512 -0.284 re f 484.724 28.346 25.512 -0.283 re f 481.89 25.512 0.283 -25.512 re f q 1 i 0.015 737.008 510.221 -737.008 re W n 28.006 25.512 0.283 -25.512 re f 0.015 28.346 25.44 -0.283 re f Q 1 1 1 scn 95.641 533.877 14.173 -2.835 re f 0 0 0 scn 95.641 554.06 318.898 -20.183 re f 1 1 1 scn 95.641 497.367 14.173 -2.835 re f 0.8 0.8 0.8 scn 95.641 531.042 318.898 -33.676 re f BT /F4 1 Tf 19.9253 0 0 19.9253 186.6897 588.3589 Tm 0 0 0 scn 0 Tc 0 Tw [(The)-252.4(Guidelines)]TJ /F11 1 Tf 11.9551 0 3.5865 11.9551 218.8913 539.4329 Tm 1 1 1 scn [(Guideline)-278.6(1)]TJ 11.9551 0 0 11.9551 113.3291 516.529 Tm 0 0 0 scn [(Ethical)-276.5(justif)-9.7(ication)-276.4(and)-273.5(scientific)-279(validity)-277.6(of)]TJ -0.128 -1.1381 TD [(biomedical)-278.7(research)-275.6(invol)-9.2(ving)-269.6(human)-276.8(beings)]TJ /F8 1 Tf 10.7396 0 0 10.959 95.6409 481.3227 Tm [(The)-214.3(ethical)-219.5(justification)-213.6(of)-214.2(biomedical)-216.2(research)-210.5(involving)-215.1(human)]TJ 0 -1.2571 TD [(subjects)-310.1(is)-307.7(the)-306.3(prospect)-301.5(of)-309.3(discovering)-305.3(new)-307(ways)-303.2(of)-309.3(benefiting)]TJ 0 -1.2623 TD [(peoples)-215.1(health.)-215(Such)-218.7(research)-210.5(can)-213.5(be)-216.5(ethically)-215.7(justifiable)-215.8(only)-213.5(if)]TJ 0 -1.2571 TD [(it)-273.7(is)-270.7(carried)-263.2(out)-270.1(in)-266.2(ways)-271.5(that)-264(respect)-271.2(and)-267.1(protect,)-263.7(and)-267.1(are)-268.9(fair)-271.1(to,)]TJ T* [(the)-295.7(subjects)-289(of)-298.7(that)-290.4(research)-289.7(and)-293.5(are)-290(morally)-293.3(acceptable)-293.6(within)]TJ 0 -1.2623 TD [(the)-248.2(communiti)7.5(es)-247.4(in)-245.1(which)-240.6(the)-242.9(research)-242.2(is)-244.3(carried)-242.1(out.)-242.9(Moreover,)]TJ 0 -1.2571 TD [(because)-519(scientifically)-514.4(invalid)-520.4(research)-516.7(is)-518.8(unethical)-516(in)-519.6(that)-517.4(it)]TJ 0 -1.2623 TD [(exposes)-476.8(research)-479.7(subjects)-473.8(to)-483.5(risks)-476.2(without)-484.3(possible)-473.8(benefit,)]TJ 0 -1.2571 TD [(investigators)-283.4(and)-277.6(sponsors)-278.1(must)-281.7(ensure)-282.6(that)-279.9(proposed)-278.9(studies)]TJ T* 0.0184 Tc [(involving)-623.4(human)-618.1(subjects)-622.6(c)0.3(onform)-622.2(t)2.6(o)-623.4(g)-0.5(enerally)-622.6(accepted)]TJ 0 -1.2623 TD 0 Tc [(scientific)-384.7(principles)-383.6(and)-383.2(are)-385(based)-382.5(on)-386.2(adequate)-382.6(knowledge)-378(of)]TJ 0 -1.2571 TD [(the)-269.3(pertinent)-272(scientific)-268.5(literature.)]TJ 9.9626 0 2.9888 9.9626 95.6409 296.7306 Tm [(Comm)-9.3(ent)-7.2(ary)-269.4(on)-277.2(Guidelin)-10.9(e)-267.4(1)]TJ /F2 1 Tf 10.959 0 0 10.959 95.6409 278.6456 Tm [(Among)-290.8(the)-286.9(essential)-290.2(features)-290.3(of)-289.3(ethically)-290.2(justified)-291.7(research)-284.3(involving)]TJ T* [(human)-265.6(subjects,)-264.1(including)-261.2(research)-263.6(with)-263.5(identifiable)-262.7(human)-260.4(tissue)-266(or)]TJ T* [(data,)-281.6(are)-286.9(that)-278.9(the)-281.7(research)-284.3(offers)-280.6(a)-281.2(means)-283.8(of)-284.1(developing)-277.1(information)]TJ 0 -1.2623 TD [(not)-146(otherwise)-142(obtainable,)-142.1(that)-139.2(the)-142(design)-144.1(of)-144.5(the)-142(research)-139.5(is)-146.8(scientifically)]TJ 0 -1.2571 TD [(sound,)-375.4(and)-377.3(that)-372(the)-374.8(investigators)-371.3(and)-377.3(other)-374.2(research)-372.3(personnel)-373.5(are)]TJ 0 -1.2623 TD [(competent.)-422.4(The)-424.6(methods)-417.6(to)-423.8(be)-418.1(used)-422.6(should)-422(be)-423.3(appropriate)-413.9(to)-423.8(the)]TJ 0 -1.2571 TD [(objectives)-384.6(of)-382.4(the)-380(research)-382.6(and)-382.5(the)-380(field)-383.2(of)-382.4(study.)-382.6(Investigators)-380.5(and)]TJ T* [(sponsors)-157.8(must)-158.4(also)-160.5(ensure)-154.2(that)-159.9(all)-155(who)-159.3(participate)-159.3(in)-155.7(the)-157.5(conduct)-154.5(of)-160(the)]TJ 0 -1.2623 TD [(research)-305(are)-302.4(qualified)-299.1(by)-303.4(virtue)-301(of)-299.7(their)-304.4(education)-300.2(and)-299.7(experience)-305(to)]TJ 0 -1.2571 TD [(perform)-357(competently)-346.6(in)-357.5(their)-351(roles.)-354.9(These)-352.8(considerations)-351.1(should)-349.6(be)]TJ 0 -1.2623 TD [(adequately)-188.5(reflected)-191.7(in)-186.8(the)-188.6(research)-191.2(protocol)-184.8(submitted)-187.1(for)-188.8(review)-191.4(and)]TJ 0 -1.2571 TD [(clearance)-230.1(to)-232.4(scientific)-228.3(and)-227.3(ethical)-227.3(review)-232.8(committees)-226.3(\(Appendix)-231(1\).)]TJ 1.2933 -1.2571 TD [(Scientific)-547.6(review)-543.2(is)-540(discussed)-540.5(further)-546(in)-543.7(the)-540.4(Commentaries)-543.2(to)]TJ -1.2933 -1.2623 TD [(Guidelines)-336.5(2)-338.1(and)-330.8(3:)]TJ /F5 1 Tf 8.7634 0 TD [(Ethical)-334.9(review)-337.4(committees)]TJ /F2 1 Tf 11.2879 0 TD (and)Tj /F5 1 Tf 1.9399 0 TD [(Ethical)-334.9(review)-337.4(of)]TJ ET endstream endobj 67 0 obj << /Type /Page /Parent 393 0 R /Resources 68 0 R /Contents 69 0 R /MediaBox [ 0 0 595 842 ] /CropBox [ 0 0 595 842 ] /Rotate 0 >> endobj 68 0 obj << /ProcSet [ /PDF /Text ] /Font << /F2 337 0 R /F5 340 0 R /F6 341 0 R /F7 342 0 R /F8 343 0 R /F11 346 0 R >> /ExtGState << /GS1 434 0 R >> /ColorSpace << /DefaultCMYK 417 0 R /Cs6 416 0 R >> >> endobj 69 0 obj << /Length 5443 >> stream q 1 i 0.015 737.008 510.221 -737.008 re W n /Cs6 cs 0 0 0 scn /GS1 gs 0.015 709.001 25.44 -0.284 re f Q /Cs6 cs 0 0 0 scn /GS1 gs 28.006 737.008 0.283 -25.455 re f 481.89 737.008 0.283 -25.455 re f 484.724 709.001 25.512 -0.284 re f 484.724 28.346 25.512 -0.283 re f 481.89 25.512 0.283 -25.512 re f q 1 i 0.015 737.008 510.221 -737.008 re W n 28.006 25.512 0.283 -25.512 re f 0.015 28.346 25.44 -0.283 re f Q 1 1 1 scn 95.641 503.376 14.173 -2.835 re f 0 0 0 scn 95.641 523.559 318.898 -20.183 re f 1 1 1 scn 95.641 480.359 14.173 -2.835 re f 0.8 0.8 0.8 scn 95.641 500.542 318.898 -20.183 re f BT /F5 1 Tf 10.959 0 0 10.959 95.6409 609.8455 Tm 0 0 0 scn 0 Tc 0 Tw [(externally)-384(sponsored)-382.8(research.)]TJ /F2 1 Tf 13.1606 0 TD [(Other)-383.8(ethical)-382.5(aspects)-380.2(of)-382.4(research)-382.6(are)]TJ -13.1606 -1.2623 TD [(discussed)-385.3(in)-378.2(the)-385.2(remaining)-378.3(guidelines)-384.3(and)-377.3(their)-382(commentaries)]TJ /F5 1 Tf 26.797 0 TD (.)Tj /F2 1 Tf 0.6518 0 TD (The)Tj -27.4489 -1.2571 TD [(protocol)-179.7(designed)-179.4(for)-178.5(submission)-174.1(for)-178.5(review)-181(and)-175.6(clearance)-178.4(to)-180.7(scientific)]TJ 0 -1.2623 TD [(and)-460.1(ethical)-455(review)-460.4(committees)-453.9(should)-458.2(include,)-457.2(when)-456.9(relevant,)-454.6(the)]TJ 0 -1.2571 TD [(items)-381(specified)-372.5(in)-378.2(Appendix)-372.6(1,)-378.5(and)-372.2(should)-375.4(be)-376.7(carefully)-377(followed)-377(in)]TJ T* [(conducting)-270.7(the)-266.2(research.)]TJ /F11 1 Tf 11.9551 0 3.5865 11.9551 218.8913 508.9888 Tm 1 1 1 scn [(Guideline)-278.6(2)]TJ 11.9551 0 0 11.9551 168.7181 485.9715 Tm 0 0 0 scn [(Ethical)-276.5(review)-275.6(committee)-10.8(s)]TJ /F8 1 Tf 10.959 0 0 10.959 95.6409 464.3716 Tm [(All)-381.9(proposals)-373.8(to)-377.6(conduct)-374.2(research)-371.9(involving)-377.6(human)-372.3(subjects)]TJ T* [(must)-187.4(be)-183.9(submitted)-184.1(for)-189.2(review)-183.3(of)-186.2(their)-184.6(scientific)-188.2(merit)-183(and)-185.1(ethical)]TJ 0 -1.2623 TD [(acceptability)-192.5(to)-191.4(one)-190.3(or)-190.5(more)-191.7(scientific)-188.2(review)-193.6(and)-190.3(ethical)-188.9(review)]TJ 0 -1.2571 TD [(committees.)-385(The)-381.7(review)-385.1(committees)-380.8(must)-384(be)-385.6(independent)-377.3(of)]TJ 0 -1.2623 TD [(the)-394.7(research)-387.4(team,)-388.4(and)-392.1(any)-392.3(direct)-387.9(financial)-390.9(or)-392.2(other)-388.6(material)]TJ 0 -1.2571 TD [(benefit)-581.5(they)-577.3(may)-582.1(derive)-576.9(from)-582(the)-575.8(research)-578.8(should)-574.7(not)-580.7(be)]TJ T* [(contingent)-440.5(on)-437.1(the)-436.1(outcome)-434.6(of)-439.7(their)-438.1(review.)-435.8(The)-438.6(investigat)6.2(or)]TJ 0 -1.2623 TD [(must)-228.8(obtain)-230.7(their)-226(approval)-227.7(or)-226.7(clearance)-224.6(before)-229.8(undertaking)-223.8(the)]TJ 0 -1.2571 TD [(research.)-220.9(The)-221.3(ethical)-219.9(review)-219.5(committee)-218.9(should)-217.7(conduct)-219(further)]TJ 0 -1.2623 TD [(reviews)-303.8(as)-303.1(necessary)-299.5(in)-305.5(the)-301.6(course)-299.8(of)-305.2(the)-301.6(research,)-303.6(including)]TJ 0 -1.2571 TD [(monitoring)-269.6(of)-269(its)-273.5(progress.)]TJ 9.9626 0 2.9888 9.9626 95.6409 291.685 Tm [(Comm)-9.3(ent)-7.2(ary)-269.4(on)-277.2(Guidelin)-10.9(e)-267.4(2)]TJ /F2 1 Tf 10.959 0 0 10.959 95.6409 273.7133 Tm [(Ethical)-401.9(review)-403.5(committees)-397(may)-397.3(function)-402.4(at)-398.2(the)-400.7(institutional,)-398.6(local,)]TJ 0 -1.2467 TD [(regional,)-195.7(or)-190.8(national)-190.6(level,)-190.5(and)-191.1(in)-191.9(some)-188.9(cases)-194.3(at)-191.3(the)-188.6(international)-189.7(level.)]TJ 0 -1.2416 TD [(The)-321.2(regulatory)-319.5(or)-314.9(other)-322.4(governmen)8.7(tal)-319.6(authorities)-319.7(concerned)-314.9(should)]TJ 0 -1.2467 TD [(promote)-221.1(uniform)-217.3(standards)-211.9(across)-216.8(committees)-221.1(within)-217.5(a)-213.9(country,)-221.3(and,)]TJ T* [(under)-284.5(all)-289.5(systems,)-285.3(sponsors)-282(of)-284.1(research)-284.3(and)-284.2(institutions)-287.9(in)-285.1(which)-285.2(the)]TJ T* [(investigators)-252.4(are)-255.8(employed)-254.6(should)-251.3(allocate)-255(sufficient)-252.1(resources)-256(to)-253.1(the)]TJ 0 -1.2416 TD [(review)-243.1(process.)-239(Ethical)-241.5(review)-243.1(committees)-241.8(may)-242.1(receive)-237.2(money)-240.9(for)-240.6(the)]TJ 0 -1.2467 TD [(activity)-493.8(of)-496.2(reviewing)-493.8(protocols,)-492.1(but)-492.6(under)-491.4(no)-494.5(circumstances)-493.2(may)]TJ T* [(payment)-240.8(be)-242.2(offered)-240.5(or)-237.3(accepted)-241.5(for)-240.6(a)-239.8(review)-243.1(committees)-240.8(approval)-239.6(or)]TJ T* [(clearance)-271.5(of)-268.6(a)-270.8(protocol.)]TJ /F5 1 Tf 0 -2.152 TD [(Scientific)-433.8(review.)]TJ /F2 1 Tf 7.6563 0 TD [(According)-423.4(to)-429(the)-431.7(Declaration)-425.6(of)-429(Helsinki)-430.6(\()]TJ /F5 1 Tf 19.0631 0 TD (Para-)Tj -26.7194 -1.2467 TD [(graph)-330.9(11)]TJ /F2 1 Tf 3.7143 0 TD [(\),)-581.7(medical)-576.4(research)-579.2(involving)-576.1(humans)-573.8(must)-577.4(conform)-578(to)]TJ -3.7143 -1.2467 TD [(generally)-318.6(accepted)-319.1(scientific)-316.3(principles,)-322.5(and)-315.3(be)-319.8(based)-315.8(on)-318.6(a)-317.4(thorough)]TJ ET 95.641 646.809 318.898 -0.51 re f BT /F6 1 Tf 7.9702 0 0 7.9702 191.1118 649.1337 Tm [(INTERNA)13.4(TIONAL)-327.4(ETHICAL)-327.5(GUIDELINES)-319.8(FOR)-332.5(BIOMED)13.7(ICAL)-331.1(RESEARCH)]TJ /F7 1 Tf 11.9551 0 0 11.9551 95.6409 649.1337 Tm (24)Tj ET endstream endobj 70 0 obj << /Type /Page /Parent 393 0 R /Resources 71 0 R /Contents 72 0 R /MediaBox [ 0 0 595 842 ] /CropBox [ 0 0 595 842 ] /Rotate 0 >> endobj 71 0 obj << /ProcSet [ /PDF /Text ] /Font << /F2 337 0 R /F5 340 0 R /F6 341 0 R /F7 342 0 R >> /ExtGState << /GS1 434 0 R >> /ColorSpace << /DefaultCMYK 417 0 R /Cs6 416 0 R >> >> endobj 72 0 obj << /Length 6192 >> stream q 1 i 0.015 737.008 510.221 -737.008 re W n /Cs6 cs 0 0 0 scn /GS1 gs 0.015 709.001 25.44 -0.284 re f Q /Cs6 cs 0 0 0 scn /GS1 gs 28.006 737.008 0.283 -25.455 re f 481.89 737.008 0.283 -25.455 re f 484.724 709.001 25.512 -0.284 re f 484.724 28.346 25.512 -0.283 re f 481.89 25.512 0.283 -25.512 re f q 1 i 0.015 737.008 510.221 -737.008 re W n 28.006 25.512 0.283 -25.512 re f 0.015 28.346 25.44 -0.283 re f Q BT /F2 1 Tf 10.959 0 0 10.959 95.6409 609.9589 Tm 0 Tc 0 Tw [(knowledge)-592.9(of)-594.5(the)-592.1(scientific)-590.5(literature,)-592.5(other)-591.4(relevant)-595.3(sources)-591.7(of)]TJ 0 -1.2416 TD [(information,)-320.3(and)-315.3(adequate)-317(laboratory)-318.3(and,)-319.4(where)-316.3(indicated,)-317.4(animal)]TJ 0 -1.2467 TD [(experimentation.)-237.1(Scientific)-237.2(review)-237.9(must)-236(consider,)-241.7(inter)-237.1(alia,)-238.6(the)-235.1(study)]TJ T* [(design,)-293.1(including)-287.1(the)-286.9(provisions)-284(for)-292.3(avoiding)-282.2(or)-289.1(minimizing)-289.2(risk)-291(and)]TJ T* [(for)-256.1(monitoring)-245.6(safety.)-252.8(Committees)-250.5(competent)-252.6(to)-253.1(review)-248.3(and)-253.2(approve)]TJ 0 -1.2416 TD [(scientific)-274.9(aspects)-266.3(of)-268.6(research)-268.8(proposals)-269.4(must)-267(be)-268.1(multidisciplinary.)]TJ /F5 1 Tf 10.7396 0 0 10.959 95.6409 517.2093 Tm 0.0127 Tc [(Ethic)-4.3(a)0.7(l)-593.6(r)-3.5(eview)]TJ /F2 1 Tf 6.3769 0 TD 0.6063 Tc (.T)Tj 1.5573 0 TD 0.013 Tc [(he)-595.2(ethical)-593.3(r)-3.2(eview)-599.3(c)1.3(ommittee)-595.2(is)-594.4(responsible)-595.2(for)]TJ -7.9341 -1.2364 TD 0 Tc [(safeguarding)-240.5(the)-240.5(rights,)-240(safety,)-240.4(and)-243.6(well-being)-237.8(of)-244.7(the)-240.5(research)-240.6(subjects.)]TJ T* [(Scientific)-300.4(review)-298.9(and)-296.4(ethical)-294.4(review)-298.9(cannot)-294.1(be)-299(separated:)-294.4(scientifically)]TJ T* [(unsound)-161.9(research)-161.4(involving)-162.1(humans)-163.3(as)-160.2(subjects)-164.7(is)-163.2(ipso)-162.5(facto)-162.4(unethical)-161.7(in)]TJ T* [(that)-229.9(it)-225.8(may)-226.2(expose)-225.1(them)-226.2(to)-228.8(risk)-229.2(or)-224.4(inconvenience)-222.9(to)-228.8(no)-226.3(purpose;)-226.6(even)-222.5(if)]TJ T* [(there)-289.6(is)-289.9(no)-289.6(risk)-292.6(of)-286.9(injury,)-289.1(wasting)-289.4(of)-286.9(subjects)-290.6(and)-285.8(researchers)-289.1(time)-291.8(in)]TJ T* [(unproductive)-148.6(activities)-155.5(represents)-151.5(loss)-150(of)-154.9(a)-149.3(valuable)-151.2(resource.)-150.8(Normally,)]TJ T* [(therefore,)-218.2(an)-214.9(ethical)-215.2(review)-214.4(committee)-218.2(considers)-215.3(both)-212.3(the)-219.4(scientific)-214(and)]TJ T* [(the)-377.8(ethical)-373.6(aspects)-370.6(of)-371.4(proposed)-372.2(research.)-371.7(It)-374.7(must)-373.2(either)-373.2(carry)-369.1(out)-373.6(or)]TJ T* [(arrange)-240.9(for)-245(a)-239(proper)-241(scientific)-240.4(review)-246.1(or)-240.2(verify)-240.8(that)-240.5(a)-244.3(competent)-237.9(expert)]TJ T* [(body)-314.5(has)-315.6(determined)-311.8(that)-309.1(the)-314.4(research)-314.5(is)-316.3(scientifically)-310.5(sound.)-314.9(Also,)-313.3(it)]TJ T* [(considers)-252.3(provisions)-247.7(for)-245(monitoring)-248(of)-250(data)-247.7(and)-248.9(safety.)]TJ 1.3197 -1.2364 TD [(If)-137.2(the)-140.2(ethical)-136(review)-135.3(committee)-133.8(finds)-135.7(a)-138.7(research)-135(proposal)-132(scientifically)]TJ -1.3197 -1.2364 TD [(sound,)-167.1(or)-166.3(verifies)-166.2(that)-166.6(a)-165.1(competent)-164(expert)-164.4(body)-166.7(has)-162.5(found)-167.1(it)-167.7(so,)-165.5(it)-167.7(should)]TJ T* [(then)-290.3(consider)-288.9(whether)-286.5(any)-285(known)-283.5(or)-293(possible)-286.9(risks)-287.6(to)-286.9(the)-288.1(subjects)-286.1(are)]TJ T* [(justified)-351.3(by)-346.9(the)-346.1(expected)-342.8(benefits,)-347.9(direct)-346.8(or)-351(indirect,)-347.6(and)-343.9(whether)-344.6(the)]TJ T* [(proposed)-256.1(research)-261.7(methods)-252.2(will)-261.5(minimize)-258.6(harm)-259(and)-259.4(maximize)-260.1(benefit.)]TJ T* [(\(See)-136.1(Guideline)-129.7(8:)]TJ /F5 1 Tf 7.0895 0 TD [(Benefits)-133.6(and)-131.2(risks)-129.2(of)-133(study)-131.1(participation)]TJ /F2 1 Tf 15.8207 0 TD [(.\))-136(If)-131.9(the)-129.7(proposal)]TJ -22.9102 -1.2364 TD [(is)-142.1(sound)-141.5(and)-138(the)-140.2(balance)-135.8(of)-144.4(risks)-139.8(to)-139.1(anticipated)-136.4(benefits)-137.5(is)-142.1(reasonable,)-138(the)]TJ T* [(committee)-207.7(should)-204(then)-205.9(determine)-209.2(whether)-202(the)-208.9(procedures)-203.7(proposed)-203.3(for)]TJ T* [(obtaining)-200.2(informed)-204(consent)-199.1(are)-203.6(satisfactory)-196.9(and)-201.4(those)-201(proposed)-198(for)-202.8(the)]TJ T* [(selection)-233.4(of)-228.8(subjects)-228.1(are)-230(equitable.)]TJ /F5 1 Tf 10.959 0 0 10.959 95.6409 208.1763 Tm [(Ethical)-386.6(review)-389.2(of)-382.7(emergency)-387.4(compassionate)-382.3(use)-385.2(of)-382.7(an)-386.4(investigational)]TJ T* (therapy.)Tj /F2 1 Tf 4.0196 0 TD [(In)-294.2(some)-297.5(countries,)-296.7(drug)-297.6(regulatory)-293.6(authorities)-293.8(require)-298(that)]TJ -4.0196 -1.2364 TD [(the)-193.8(so-called)-185.3(compassionate)-189.5(or)-185.6(humanitarian)-187.1(use)-188.3(of)-191(an)-189.6(investigational)]TJ T* [(treatment)-151.4(be)-149.1(reviewed)-149.1(by)-148.2(an)-153.4(ethical)-149.7(review)-150(committee)-145.7(as)-149.6(though)-150.9(it)-147.1(were)]TJ T* [(research.)-355.8(Exceptionally,)-347.2(a)-353.6(physician)-348.2(may)-350.8(undertake)-350.7(the)-348.9(compassio-)]TJ T* [(nate)-164.5(use)-167.6(of)-165.2(an)-163.7(investigational)-165(therapy)-160.5(before)-164.8(obtaining)-161.1(the)-167.9(approval)-162(or)]TJ T* [(clearance)-297.4(of)-299.7(an)-293(ethical)-294.6(review)-300(committee,)-294.7(provided)-297.2(three)-292.6(criteria)-299(are)]TJ T* [(met:)-300.4(a)-301.8(patient)-297.7(needs)-296(emergency)-298.9(treatment,)-300.5(there)-297.8(is)-302(some)-297.5(evidence)-299.3(of)]TJ T* [(possible)-233.8(effectiveness)-233.5(of)-227.2(the)-235.1(investigational)-227(treatment,)-233.2(and)-227.3(there)-235.7(is)-229.6(no)]TJ ET 95.641 646.809 318.898 -0.51 re f BT /F6 1 Tf 7.9702 0 0 7.9702 95.6409 649.1337 Tm [(THE)-330.8(GUIDELINES)]TJ /F7 1 Tf 11.9551 0 0 11.9551 401.3857 649.1337 Tm (25)Tj ET endstream endobj 73 0 obj << /Type /Page /Parent 393 0 R /Resources 74 0 R /Contents 75 0 R /MediaBox [ 0 0 595 842 ] /CropBox [ 0 0 595 842 ] /Rotate 0 >> endobj 74 0 obj << /ProcSet [ /PDF /Text ] /Font << /F2 337 0 R /F5 340 0 R /F6 341 0 R /F7 342 0 R /F10 345 0 R >> /ExtGState << /GS1 434 0 R >> /ColorSpace << /DefaultCMYK 417 0 R /Cs6 416 0 R >> >> endobj 75 0 obj << /Length 6454 >> stream q 1 i 0.015 737.008 510.221 -737.008 re W n /Cs6 cs 0 0 0 scn /GS1 gs 0.015 709.001 25.44 -0.284 re f Q /Cs6 cs 0 0 0 scn /GS1 gs 28.006 737.008 0.283 -25.455 re f 481.89 737.008 0.283 -25.455 re f 484.724 709.001 25.512 -0.284 re f 484.724 28.346 25.512 -0.283 re f 481.89 25.512 0.283 -25.512 re f q 1 i 0.015 737.008 510.221 -737.008 re W n 28.006 25.512 0.283 -25.512 re f 0.015 28.346 25.44 -0.283 re f Q BT /F2 1 Tf 10.959 0 0 10.959 95.6409 609.8455 Tm 0 Tc 0 Tw [(other)-420.7(treatment)-420.4(available)-422.4(that)-418.5(is)-421(known)-421.1(to)-418.6(be)-423.3(equally)-416.1(effective)-419.8(or)]TJ 0 -1.2623 TD [(superior.)-231.6(Informed)-234.4(consent)-228.4(should)-230.6(be)-231.9(obtained)-230.2(according)-227.8(to)-232.4(the)-230(legal)]TJ 0 -1.2571 TD [(requirements)-309.1(and)-310.1(cultural)-311.9(standards)-305(of)-310(the)-312.7(community)-307.4(in)-310.9(which)-311.1(the)]TJ 0 -1.2623 TD [(intervention)-186.5(is)-193.4(carried)-184.5(out.)-186.4(Within)-189.7(one)-186.9(week)-189.1(the)-183.4(physician)-187.8(must)-189.4(report)]TJ 0 -1.2571 TD [(to)-279(the)-271.3(ethical)-279.1(review)-274.2(committee)-275(the)-276.5(details)-274.2(of)-273.8(the)-276.5(case)-274.1(and)-273.9(the)-276.5(action)]TJ T* [(taken,)-304.7(and)-299.7(an)-298.2(independent)-299(health-care)-297.6(professional)-300.3(must)-303.2(confirm)-301.3(in)]TJ 0 -1.2623 TD [(writing)-572.6(to)-573.8(the)-571.4(ethical)-573.9(review)-569(committee)-569.9(the)-571.4(treating)-575.1(physicians)]TJ 0 -1.2571 TD [(judgment)-229.2(that)-232.3(the)-224.8(use)-229.7(of)-232.4(the)-230(investigation)6.6(al)-233.6(intervention)-227.9(was)-228.3(justified)]TJ T* [(according)-553.7(to)-553.1(the)-550.7(three)-556.4(specified)-553.5(criteria.)-551.5(\(See)-553.4(also)-553.7(Guideline)-550.8(13)]TJ 0 -1.2623 TD [(Commentary)-250.6(section:)]TJ /F5 1 Tf 9.3531 0 TD [(Other)-249.6(vulnerable)-249.2(groups)]TJ /F2 1 Tf 9.9273 0 TD (.\))Tj /F5 1 Tf -19.2804 -2.3797 TD [(National)-221.4(\(centralized\))-220.8(or)-216.9(local)-221.6(review.)]TJ /F2 1 Tf 16.0161 0 TD [(Ethical)-220.8(review)-222.4(committees)-221.1(may)]TJ -16.0161 -1.2571 TD [(be)-221.5(created)-219.5(under)-217.3(the)-219.6(aegis)-215.3(of)-222.1(national)-216.4(or)-216.6(local)-221.4(health)-216.8(administrations,)]TJ 0 -1.2623 TD [(national)-200.9(\(or)-204.4(centralized)5.8(\))-205(medical)-198.8(research)-201.6(councils)-202.5(or)-201.1(other)-198.3(nationally)]TJ 0 -1.2571 TD 0.008 Tc [(representa)8(tive)-610.3(bodies)8(.)-614.8(I)-0.2(n)-609.1(a)-609.4(highly)-609.4(c)8(e)-2.6(ntrali)8(z)-4.1(e)0.1(d)-609.1(a)1(dm)8(i)-7.1(n)1.3(istr)8(ation)-609.1(a)]TJ T* 0 Tc [(national,)-437.9(or)-433.9(centralized,)-432.9(review)-439.7(committee)-430.2(may)-438.7(be)-433.6(constituted)-432.1(for)]TJ 0 -1.2623 TD [(both)-395.9(the)-400.7(scientific)-393.9(and)-398(the)-395.5(ethical)-398.1(review)-398.3(of)-398(research)-393(protocols.)-393.8(In)]TJ 0 -1.2571 TD [(countries)-194.2(where)-186.9(medical)-193.6(research)-186(is)-193.4(not)-192.6(centrally)-185.6(administered,)-194.6(ethical)]TJ T* [(review)-310.4(is)-307.2(more)-307.8(effectively)-306.8(and)-304.9(conveniently)-308.9(undertaken)-300.5(at)-310.3(a)-307(local)-304.1(or)]TJ 0 -1.2623 TD [(regional)-258.7(level.)-262.9(The)-259.1(authority)-259.9(of)-258.3(a)-260.5(local)-257.6(ethical)-258.4(review)-263.8(committee)-259.5(may)]TJ 0 -1.2571 TD [(be)-262.9(confined)-257(to)-263.4(a)-260.5(single)-260.6(institution)-259.1(or)-258(may)-262.8(extend)-256.7(to)-263.4(all)-258.5(institutions)-262.1(in)]TJ 0 -1.2623 TD [(which)-176.6(biomedical)-169.8(research)-170.5(is)-177.9(carried)-169(out)-171.9(within)-176.1(a)-172.5(defined)-172.7(geographical)]TJ 0 -1.2571 TD [(area.)-272.2(The)-269.4(basic)-266.7(responsibilities)-270.2(of)-268.6(ethical)-268.7(review)-269(committees)-272.8(are:)]TJ /F10 1 Tf 1.2933 -1.2881 TD (7)Tj /F2 1 Tf 1.2933 0 TD [(to)-372.1(determine)-368.8(that)-366.8(all)-367.1(proposed)-368.2(interventions,)-364.4(particularly)-369.3(the)]TJ 0 -1.2571 TD [(administration)-449.2(of)-454.9(drugs)-445.4(and)-449.8(vaccines)-449.9(or)-449.4(the)-452.4(use)-452.1(of)-449.7(medical)]TJ 0 -1.2623 TD [(devices)-318.7(or)-314.9(procedures)-313(under)-310.4(development,)-312.8(are)-317.9(acceptably)-313.8(safe)]TJ 0 -1.2571 TD [(to)-191(be)-185.3(undertaken)-186.7(in)-186.8(humans)-191(or)-185.6(to)-185.9(verify)-192.7(that)-185.7(another)-186.1(competent)]TJ 0 -1.2623 TD [(expert)-268.5(body)-270.2(has)-270.2(done)-266(so;)]TJ /F10 1 Tf -1.2933 -1.2881 TD (7)Tj /F2 1 Tf 1.2933 0 TD [(to)-299.7(determine)-296.4(that)-294.4(the)-297.2(proposed)-290.6(research)-299.8(is)-296.9(scientifically)-297.2(sound)]TJ 0 -1.2571 TD [(or)-273.5(to)-268.6(verify)-270.2(that)-268.5(another)-263.7(competent)-268.2(expert)-268.5(body)-265.1(has)-270.2(done)-271.2(so;)]TJ /F10 1 Tf -1.2933 -1.2881 TD (7)Tj /F2 1 Tf 1.2933 0 TD [(to)-227.2(ensure)-221.4(that)-227.1(all)-222.3(other)-224.2(ethical)-227.3(concerns)-220.5(arising)-226.4(from)-225.6(a)-224.2(protocol)]TJ 0 -1.2571 TD [(are)-271.3(satisfactorily)-268.6(resolved)-268.8(both)-266.5(in)-269.5(principle)-268.7(and)-268.7(in)-269.5(practice;)]TJ /F10 1 Tf -1.2933 -1.2881 TD (7)Tj /F2 1 Tf 1.2933 0 TD [(to)-449.7(consider)-444.4(the)-447.2(qualifications)-447.4(of)-449.7(the)-447.2(investigators)6.3(,)-449.1(including)]TJ 0 -1.2623 TD 0.0073 Tc [(edu)7.3(c)]TJ 2.002 0 TD 0 Tc [(at)-10.2(io)-10.9(n)-612(i)0(n)-621.3(t)0(h)-10(e)-613.2(p)-6.7(r)0(i)-7.2(n)-6.7(c)-7.9(i)0(p)-10.9(l)0(e)-6.9(s)-618.6(of)-615.2(r)-8.2(e)0(s)-10.9(e)0(a)-9.7(r)0(c)-10.9(h)-612(p)-6.7(r)0(a)-10(c)0(t)-11.2(i)0(c)-12.1(e)0(,)-617.3(a)-7(nd)-618.7(th)-10(e)]TJ -2.002 -1.2571 TD [(conditions)-283.7(of)-284.1(the)-281.7(research)-284.3(site)-282.2(with)-284.2(a)-286.3(view)-284(to)-284.1(ensuring)-278(the)-286.9(safe)]TJ 0 -1.2623 TD [(conduct)-268.3(of)-268.6(the)-271.3(trial;)-268.9(and)]TJ /F10 1 Tf -1.2933 -1.2881 TD (7)Tj /F2 1 Tf 1.2933 0 TD [(to)-247.9(keep)-241.3(records)-245.1(of)-242.8(decisions)-241.7(and)-242.8(take)-242.1(measures)-245.9(to)-242.8(follow)-243.4(up)-241(on)]TJ 0 -1.2571 TD [(the)-271.3(conduct)-268.3(of)-268.6(ongoing)-267.4(research)-268.8(projects.)]TJ ET 95.641 646.809 318.898 -0.51 re f BT /F6 1 Tf 7.9702 0 0 7.9702 191.1118 649.1337 Tm [(INTERNA)13.4(TIONAL)-327.4(ETHICAL)-327.5(GUIDELINES)-319.8(FOR)-332.5(BIOMED)13.7(ICAL)-331.1(RESEARCH)]TJ /F7 1 Tf 11.9551 0 0 11.9551 95.6409 649.1337 Tm (26)Tj ET endstream endobj 76 0 obj << /Type /Page /Parent 393 0 R /Resources 77 0 R /Contents 78 0 R /MediaBox [ 0 0 595 842 ] /CropBox [ 0 0 595 842 ] /Rotate 0 >> endobj 77 0 obj << /ProcSet [ /PDF /Text ] /Font << /F2 337 0 R /F5 340 0 R /F6 341 0 R /F7 342 0 R >> /ExtGState << /GS1 434 0 R >> /ColorSpace << /DefaultCMYK 417 0 R /Cs6 416 0 R >> >> endobj 78 0 obj << /Length 6376 >> stream q 1 i 0.015 737.008 510.221 -737.008 re W n /Cs6 cs 0 0 0 scn /GS1 gs 0.015 709.001 25.44 -0.284 re f Q /Cs6 cs 0 0 0 scn /GS1 gs 28.006 737.008 0.283 -25.455 re f 481.89 737.008 0.283 -25.455 re f 484.724 709.001 25.512 -0.284 re f 484.724 28.346 25.512 -0.283 re f 481.89 25.512 0.283 -25.512 re f q 1 i 0.015 737.008 510.221 -737.008 re W n 28.006 25.512 0.283 -25.512 re f 0.015 28.346 25.44 -0.283 re f Q BT /F5 1 Tf 10.959 0 0 10.959 95.6409 609.8455 Tm 0 Tc 0 Tw [(Committee)-310.4(membership.)]TJ /F2 1 Tf 10.4136 0 TD [(National)-308.5(or)-309.7(local)-309.3(ethical)-310.1(review)-310.4(committees)]TJ -10.4136 -1.2623 TD [(should)-173.7(be)-175(so)-170.1(composed)-170.3(as)-175.5(to)-170.3(be)-175(able)-170.6(to)-175.5(provide)-171.5(complete)-169.3(and)-170.4(adequate)]TJ 0 -1.2571 TD [(review)-377.6(of)-372.1(the)-374.8(research)-372.3(proposals)-372.9(submitted)-373.4(to)-372.1(them.)-374.4(It)-373.5(is)-374.5(generally)]TJ 0 -1.2623 TD [(presumed)-239(that)-242.7(their)-242.3(membershi)6.1(p)-244.7(should)-235.8(include)-240.9(physicians,)-241.6(scientists)]TJ 0 -1.2571 TD [(and)-175.6(other)-177.6(professionals)-168.8(such)-179.5(as)-170.3(nurses,)-179.3(lawyers,)-171.8(ethicists)-177.9(and)-175.6(clergy,)-175.6(as)]TJ T* [(well)-193.2(as)-191(lay)-188.8(persons)-187(qualified)-190.5(to)-191(represent)-183.9(the)-193.8(cultural)-187.8(and)-185.9(moral)-192.1(values)]TJ 0 -1.2623 TD [(of)-191(the)-193.8(community)-188.4(and)-185.9(to)-191(ensure)-190.4(that)-190.9(the)-188.6(rights)-187.5(of)-191(the)-188.6(research)-191.2(subjects)]TJ 0 -1.2571 TD [(will)-303.3(be)-299.1(respected.)-296.4(They)-302.3(should)-297.8(include)-297.8(both)-297.6(men)-299.7(and)-294.6(women.)-301.3(When)]TJ T* [(uneducated)-222.7(or)-221.8(illiterate)-224.9(persons)-218.1(form)-225.6(the)-219.6(focus)-224.2(of)-222.1(a)-224.2(study)-218.1(they)-221.4(should)]TJ 0 -1.2623 TD [(also)-315.7(be)-314.6(considered)-314.2(for)-313(membership)-316.2(or)-314.9(invited)-314.1(to)-315.2(be)-314.6(represented)-312.3(and)]TJ 0 -1.2571 TD [(have)-271.7(their)-268.2(views)-271.4(expressed.)]TJ 1.2933 -1.2623 TD (A)Tj 0.9519 0 TD [(number)-181.6(of)-180.7(members)-179.6(should)-184(be)-180.1(replaced)-180.6(periodically)-178.2(with)-180.8(the)-183.4(aim)]TJ -2.2452 -1.2571 TD 0.0102 Tc [(of)-613.8(b)3.5(l)-4.3(end)3.5(i)0.8(ng)-612.4(the)-613.3(a)3.2(dvan)3.5(tages)-613.6(o)3.5(f)-613.8(e)-2.9(xperience)-613.3(w)-1.2(ith)-612.1(t)-3.4(h)3.5(o)-1.7(se)-613.3(o)3.5(f)-613.8(fresh)]TJ 0 -1.2623 TD 0 Tc (perspectives.)Tj 1.2933 -1.2571 TD (A)Tj 1.3347 0 TD [(national)-563(or)-563.2(local)-562.8(ethical)-563.6(review)-563.9(committee)-564.7(responsible)-561.8(for)]TJ -2.628 -1.2623 TD [(reviewing)-235.1(and)-227.3(approving)-230.8(proposals)-228(for)-230.2(externally)-228.8(sponsored)-231.5(research)]TJ 0 -1.2571 TD [(should)-478.9(have)-483.8(among)-478(its)-481.2(members)-479.6(or)-480.5(consultants)-477.4(persons)-476.7(who)-480.1(are)]TJ 0 -1.2623 TD [(thoroughly)-192.4(familiar)-188.5(with)-191.1(the)-193.8(customs)-191.5(and)-191.1(traditions)-187.7(of)-191(the)-193.8(population)]TJ 0 -1.2571 TD [(or)-273.5(community)-266(concerned)-268.3(and)-268.7(sensitive)-269.5(to)-268.6(issues)-265.7(of)-268.6(human)-270.8(dignity.)]TJ 1.2933 -1.2623 TD [(Committees)-591.9(that)-594.4(often)-591.7(review)-589.7(research)-594.7(proposals)-585(directed)-595.9(at)]TJ -1.2933 -1.2571 TD [(specific)-355.4(diseases)-353(or)-356.3(impairmen)5.8(ts,)-357(such)-350.2(as)-356.6(HIV/AIDS)-350(or)-356.3(paraplegia,)]TJ T* [(should)-297.8(invite)-297(or)-299.4(hear)-293.6(the)-297.2(views)-297.3(of)-299.7(individuals)-293.3(or)-299.4(bodies)-293.9(representing)]TJ 0 -1.2623 TD [(patients)-393.8(with)-398(such)-391.6(diseases)-394.4(or)-397.7(impairments.)-392.6(Similarly,)-396.9(for)-395.8(research)]TJ 0 -1.2571 TD [(involving)-555.4(such)-546.8(subjects)-554.8(as)-553.1(children,)-548.1(students,)-551.7(elderly)-553(persons)-549.2(or)]TJ 0 -1.2623 TD [(employees,)-568.1(committees)-562.5(should)-561.7(invite)-566(or)-563.2(hear)-567.8(the)-561(views)-566.3(of)-563.5(their)]TJ 0 -1.2571 TD [(representatives)-267.9(or)-273.5(advocates.)]TJ 1.2933 -1.2623 TD 0.0065 Tc [(To)-605.5(m)6.5(a)]TJ 3.166 0 TD 0 Tc [(int)-9(a)-7(i)0(n)-616.1(the)-618(rev)-12.7(ie)-6.9(w)-611.5(c)0(o)-9.4(mmi)-10.4(tt)-6.5(e)-7.9(e)0()-6.9(s)-608.2(i)-9.3(nde)-11(pen)-11(den)-11(ce)-615.9(fr)-6.3(om)-612.5(t)-8.4(h)0(e)]TJ -4.4593 -1.2571 TD [(investigators)-495.5(and)-496.3(sponsors)-494.1(and)-496.3(to)-496.2(avoid)-497.1(conflict)-494.2(of)-496.2(interest,)-498.6(any)]TJ 0 -1.2623 TD [(member)-342.2(with)-336(a)-338.1(special)-340.9(or)-335.6(particular,)-336.4(direct)-338.2(or)-340.8(indirect,)-337.7(interest)-339.2(in)-336.8(a)]TJ 0 -1.2571 TD [(proposal)-292.3(should)-292.7(not)-290.9(take)-293.8(part)-288.9(in)-295.4(its)-295(assessment)-288.4(if)-292(that)-294.4(interest)-292.7(could)]TJ T* [(subvert)-254.8(the)-250.7(members)-251(objective)-252.3(judgment.)-248.9(Members)-250.6(of)-253.1(ethical)-253.2(review)]TJ 0 -1.2623 TD [(committees)-453.9(should)-447.9(be)-454.3(held)-449.7(to)-449.7(the)-452.4(same)-447.8(standard)-452(of)-449.7(disclosure)-451.6(as)]TJ 0 -1.2571 TD [(scientific)-274.9(and)-263.5(medical)-271.2(research)-268.8(staff)-268.1(with)-268.7(regard)-267.3(to)-268.6(financial)-268.3(or)-268.4(other)]TJ T* [(interests)-316.4(that)-315.1(could)-311.6(be)-314.6(construed)-310.5(as)-310(conflicts)-316.1(of)-315.2(interest.)-312.4(A)-316.4(practical)]TJ 0 -1.2623 TD [(way)-242.7(of)-242.8(avoiding)-240.8(such)-241.6(conflict)-240.7(of)-242.8(interest)-240.9(is)-245.1(for)-240.6(the)-245.5(committee)-238.8(to)-242.8(insist)]TJ 0 -1.2571 TD [(on)-220.3(a)-219.1(declaration)-219.7(of)-222.1(possible)-218.3(conflict)-220(of)-216.9(interest)-220.3(by)-220.6(any)-217.2(of)-222.1(its)-217.4(members.)]TJ 0 -1.2623 TD (A)Tj 1.0139 0 TD [(member)-238.7(who)-236.9(makes)-237.2(such)-236.4(a)-239.8(declaration)-235.2(should)-240.9(then)-236.7(withdraw,)-238.9(if)-240.2(to)]TJ -1.0139 -1.2571 TD [(do)-251.4(so)-247.7(is)-245.1(clearly)-248(the)-245.5(appropriate)-248.4(action)-242.7(to)-247.9(take,)-246.3(either)-250.2(at)-248.2(the)-245.5(members)]TJ ET 95.641 646.809 318.898 -0.51 re f BT /F6 1 Tf 7.9702 0 0 7.9702 95.6409 649.1337 Tm [(THE)-330.8(GUIDELINES)]TJ /F7 1 Tf 11.9551 0 0 11.9551 401.3857 649.1337 Tm (27)Tj ET endstream endobj 79 0 obj << /Type /Page /Parent 393 0 R /Resources 80 0 R /Contents 81 0 R /MediaBox [ 0 0 595 842 ] /CropBox [ 0 0 595 842 ] /Rotate 0 >> endobj 80 0 obj << /ProcSet [ /PDF /Text ] /Font << /F2 337 0 R /F5 340 0 R /F6 341 0 R /F7 342 0 R >> /ExtGState << /GS1 434 0 R >> /ColorSpace << /DefaultCMYK 417 0 R /Cs6 416 0 R >> >> endobj 81 0 obj << /Length 6415 >> stream q 1 i 0.015 737.008 510.221 -737.008 re W n /Cs6 cs 0 0 0 scn /GS1 gs 0.015 709.001 25.44 -0.284 re f Q /Cs6 cs 0 0 0 scn /GS1 gs 28.006 737.008 0.283 -25.455 re f 481.89 737.008 0.283 -25.455 re f 484.724 709.001 25.512 -0.284 re f 484.724 28.346 25.512 -0.283 re f 481.89 25.512 0.283 -25.512 re f q 1 i 0.015 737.008 510.221 -737.008 re W n 28.006 25.512 0.283 -25.512 re f 0.015 28.346 25.44 -0.283 re f Q BT /F2 1 Tf 10.959 0 0 10.959 95.6409 609.8455 Tm 0 Tc 0 Tw [(own)-557.7(discretion)-555.3(or)-552.9(at)-553.4(the)-555.9(request)-555.8(of)-553.1(the)-555.9(other)-555.2(members.)-556.3(Before)]TJ 0 -1.2623 TD [(withdrawing,)-262(the)-266.2(member)-259.4(should)-261.6(be)-262.9(permitted)-265.9(to)-263.5(offer)-262.1(comments)-259(on)]TJ 0 -1.2571 TD [(the)-271.3(protocol)-267.6(or)-268.4(to)-268.6(respond)-268.3(to)-268.6(questions)-270.6(of)-268.6(other)-265.5(members.)]TJ /F5 1 Tf 10.7396 0 0 10.959 95.6409 555.8172 Tm [(Multi-centre)-577.5(research.)]TJ /F2 1 Tf 10.1196 0 TD [(Some)-577.3(research)-573.1(projects)-581.8(are)-578.4(designed)-575(to)-577.2(be)]TJ -10.1196 -1.2571 TD [(conducted)-183.3(in)-181(a)-186.3(number)-178.8(of)-181.3(centres)-185.5(in)-181(different)-184.6(communitie)5.7(s)-185.1(o)0(r)-182.1(countries.)]TJ T* [(Generally,)-355.5(to)-350.3(ensure)-350.7(that)-351.3(the)-356.7(results)-351.7(will)-351.3(be)-357.1(valid,)-351.3(the)-351.4(study)-349.1(must)-352.1(be)]TJ 0 -1.2622 TD [(conducted)-436.7(in)-444.9(an)-436.6(identical)-438.4(way)-441.1(at)-439.2(each)-438.9(centre.)-437.7(Such)-440.9(studies)-438.1(include)]TJ 0 -1.2571 TD [(clinical)-409.4(trials,)-405.9(research)-398.9(designed)-406.1(for)-403.4(the)-404.2(evaluation)-401.1(of)-403(health)-407.2(service)]TJ 0 -1.2623 TD [(programmes,)-265.4(and)-270(various)-266.1(kinds)-265.1(of)-271.1(epidemio)6.8(logical)-268(research.)-271.4(For)-265.7(such)]TJ 0 -1.2571 TD [(studies,)-315.9(local)-320.1(ethical)-310.3(or)-319.4(scientific)-314.3(review)-314.7(committees)-313.6(are)-319.7(not)-310.3(normally)]TJ T* [(authorized)-281.3(to)-286.9(change)-279.1(doses)-286.2(of)-281.6(drugs,)-285.8(to)-281.6(change)-279.1(inclusion)-282.8(or)-287.7(exclusion)]TJ 0 -1.2623 TD [(criteria,)-313.2(or)-308.8(to)-308(make)-307.3(other)-306.5(similar)-312.8(modification)5.8(s.)-311(They)-310.2(should)-304.3(be)-309.6(fully)]TJ 0 -1.2571 TD [(empowered)-540(to)-545.6(prevent)-536.2(a)-545.2(study)-539.1(that)-541.4(they)-542.9(believe)-538.8(to)-540.3(be)-541.9(unethical.)]TJ 0 -1.2623 TD [(Moreover,)-154.2(changes)-152.7(that)-150.7(local)-156.5(review)-151.1(committees)-155.3(believe)-153.5(are)-150.8(necessary)-152.3(to)]TJ 0 -1.2571 TD [(protect)-196.4(the)-198.3(research)-193(subjects)-196.4(should)-193.5(be)-198.7(documented)-195.4(and)-190.8(reported)-194.2(to)-197.2(the)]TJ T* [(research)-509.8(institution)-507.3(or)-509.4(sponsor)-506.4(responsible)-507.1(for)-503.7(the)-509.8(whole)-506.3(research)]TJ 0 -1.2623 TD [(programme)-297.5(for)-303.1(considerati)6.5(on)-300.2(and)-296.4(due)-301.3(action,)-300.8(to)-297.5(ensure)-297.9(that)-298.5(all)-300.8(other)]TJ 0 -1.2571 TD [(subjects)-196.4(can)-200.2(be)-193.5(protected)-194.5(and)-196.1(that)-192.9(the)-198.3(research)-193(will)-203.5(be)-193.5(valid)-199(across)-190.8(sites.)]TJ 10.959 0 0 10.959 109.8142 348.2078 Tm [(To)-282.2(ensure)-283.5(the)-281.7(validity)-281.4(of)-284.1(multi-centre)-281.2(research,)-278.2(any)-284.5(change)-281.1(in)-279.9(the)]TJ -1.2933 -1.2571 TD [(protocol)-262.4(should)-261.6(be)-262.9(made)-260.1(at)-258.5(every)-265.5(collaborati)6.5(ng)-262(centre)-264.3(or)-263.2(institution,)]TJ 0 -1.2623 TD [(or,)-220.8(failing)-217.5(this,)-217.9(explicit)-216(inter-centre)-215(comparability)-213.2(procedures)-214.7(must)-215.3(be)]TJ 0 -1.2571 TD [(introduced;)-250.2(changes)-247.9(made)-249.7(at)-248.2(some)-245.8(but)-249.5(not)-249.5(all)-248.1(will)-251.6(defeat)-248.1(the)-250.7(purpose)]TJ T* [(of)-227.2(multi-centre)-224.3(research.)-221.3(For)-228.3(some)-225.1(multi-centr)6(e)-225.2(studies,)-225.2(scientific)-228.4(and)]TJ 0 -1.2623 TD [(ethical)-480.8(review)-475.9(may)-474.9(be)-475(facilitated)-472.6(by)-474.1(agreement)-475.4(among)-472.8(centres)-479.4(to)]TJ 0 -1.2571 TD [(accept)-454.5(the)-447.2(conclusions)-446.5(of)-454.9(a)-446.7(single)-452(review)-450(committee;)-449.9(its)-450.1(members)]TJ T* [(could)-228.8(include)-225.3(a)-229.4(representative)-223.5(of)-227.2(the)-230(ethical)-227.3(review)-227.6(committee)-228.4(at)-222.3(each)]TJ 0 -1.2623 TD [(of)-392.8(the)-390.3(centres)-386.3(at)-387.9(which)-388.7(the)-390.3(research)-387.8(is)-390(to)-387.6(be)-392.2(conducted,)-385.4(as)-387.6(well)-395(as)]TJ 0 -1.2571 TD [(individuals)-314(competent)-309.6(to)-315.2(conduct)-309.7(scientific)-316.3(review.)-309.4(In)-314.9(other)-312.1(circum-)]TJ 0 -1.2623 TD [(stances,)-348.1(a)-343.2(centralized)-346(review)-346.6(may)-340.4(be)-345.7(complemented)-346.3(by)-344.8(local)-345.5(review)]TJ 0 -1.2571 TD [(relating)-307(to)-310(the)-302.4(local)-309.3(participating)-303.8(investigators)-304.1(and)-304.9(institutions.)-307.6(The)]TJ T* [(central)-231.3(committee)-223.3(could)-228.8(review)-227.6(the)-224.8(study)-228.4(from)-225.6(a)-229.4(scientific)-228.3(and)-227.3(ethical)]TJ 0 -1.2623 TD [(standpoint,)-208.4(and)-206.6(the)-204.1(local)-211(committees)-205.6(could)-208.1(verify)-208.2(the)-204.1(practicability)-210.9(of)]TJ 0 -1.2571 TD [(the)-209.3(study)-207.7(in)-212.6(their)-206.1(communities,)-211(including)-204.3(the)-209.3(infrastructures,)-210.5(the)-204.1(state)]TJ 0 -1.2623 TD [(of)-273.8(training,)-268.6(and)-268.7(ethical)-268.7(considerations)-263.2(of)-268.6(local)-273.1(significance.)]TJ 1.5416 -1.314 TD [(In)-242.5(a)-244.9(large)-246.3(multi-centre)-245(trial,)-243(individual)-243.8(investigators)-242(will)-246.4(not)-244.3(have)]TJ -1.5416 -1.2623 TD [(authority)-415.1(to)-408.3(act)-416.5(independentl)7.2(y,)-414.7(with)-413.6(regard)-412.2(to)-408.3(data)-411.9(analysis)-414.5(or)-413.2(to)]TJ 0 -1.2571 TD [(preparation)-217.3(and)-217(publication)-214.3(of)-222.1(manuscripts,)-216.5(for)-214.7(instance.)-216.4(Such)-219.4(a)-219.1(trial)]TJ ET 95.641 646.809 318.898 -0.51 re f BT /F6 1 Tf 7.9702 0 0 7.9702 191.1118 649.1337 Tm [(INTERNA)13.4(TIONAL)-327.4(ETHICAL)-327.5(GUIDELINES)-319.8(FOR)-332.5(BIOMED)13.7(ICAL)-331.1(RESEARCH)]TJ /F7 1 Tf 11.9551 0 0 11.9551 95.6409 649.1337 Tm (28)Tj ET endstream endobj 82 0 obj << /Type /Page /Parent 393 0 R /Resources 83 0 R /Contents 84 0 R /MediaBox [ 0 0 595 842 ] /CropBox [ 0 0 595 842 ] /Rotate 0 >> endobj 83 0 obj << /ProcSet [ /PDF /Text ] /Font << /F2 337 0 R /F5 340 0 R /F6 341 0 R /F7 342 0 R >> /ExtGState << /GS1 434 0 R >> /ColorSpace << /DefaultCMYK 417 0 R /Cs6 416 0 R >> >> endobj 84 0 obj << /Length 6407 >> stream q 1 i 0.015 737.008 510.221 -737.008 re W n /Cs6 cs 0 0 0 scn /GS1 gs 0.015 709.001 25.44 -0.284 re f Q /Cs6 cs 0 0 0 scn /GS1 gs 28.006 737.008 0.283 -25.455 re f 481.89 737.008 0.283 -25.455 re f 484.724 709.001 25.512 -0.284 re f 484.724 28.346 25.512 -0.283 re f 481.89 25.512 0.283 -25.512 re f q 1 i 0.015 737.008 510.221 -737.008 re W n 28.006 25.512 0.283 -25.512 re f 0.015 28.346 25.44 -0.283 re f Q BT /F2 1 Tf 10.959 0 0 10.959 95.6409 609.8455 Tm 0 Tc 0 Tw [(usually)-214.6(has)-213.3(a)-219.1(set)-210.7(of)-216.9(committees)-215.9(which)-212.8(operate)-213.2(under)-212.1(the)-214.4(direction)-210.9(of)-216.9(a)]TJ 0 -1.2623 TD [(st)-6.3(eering)-610.9(committee)-611.2(and)-610.1(are)-607.6(responsibl)-10.7(e)-602.8(for)-607.9(such)-608.9(functio)-7.7(ns)-604.6(and)]TJ 0 -1.2571 TD [(decisions.)-271.7(The)-264.3(function)-262.7(of)-268.6(the)-266.2(ethical)-268.7(review)-269(committee)-264.6(in)-269.5(such)-262.3(cases)]TJ 0 -1.2623 TD [(is)-271(to)-268.6(review)-274.2(the)-266.2(relevant)-269.3(plans)-270.7(with)-268.7(the)-266.2(aim)-270.4(of)-268.6(avoiding)-266.7(abuses.)]TJ /F5 1 Tf 0 -2.4314 TD (Sanctions.)Tj /F2 1 Tf 4.599 0 TD [(Ethical)-298.4(review)-300(committees)-303.9(generally)-297.9(have)-297.6(no)-297.9(authority)-301.3(to)]TJ -4.599 -1.2623 TD [(impose)-282.5(sanctions)-281.2(on)-277.2(researchers)-277.5(who)-283.5(violate)-278.2(ethical)-279.1(standards)-279.1(in)-279.9(the)]TJ 0 -1.2571 TD [(conduct)-195.9(of)-196.2(research)-196.4(involving)-193.3(humans.)-195.2(They)-193.6(may,)-194.6(however,)-194.5(withdraw)]TJ 0 -1.2623 TD [(ethical)-186(approval)-187.9(of)-180.7(a)-188(research)-186(project)-184.5(if)-188.5(judged)-184(necessary)]TJ /F5 1 Tf 23.4448 0 TD (.)Tj /F2 1 Tf 0.4552 0 TD [(They)-183.3(should)]TJ -23.9001 -1.2571 TD [(be)-288.8(required)-284.1(to)-289.3(monitor)-284.6(the)-286.9(implementati)5.7(on)-287.6(of)-284.1(an)-287.9(approved)-284.5(protocol)]TJ T* [(and)-372.2(its)-367.4(progression,)-367.3(and)-372.2(to)-366.9(report)-366.8(to)-372.1(institutional)-368.5(or)-366.6(governmental)]TJ 0 -1.2623 TD [(authorities)-433.5(any)-429.3(serious)-432.8(or)-433.9(continuing)-427.3(non-compliance)-429.7(with)-434.3(ethical)]TJ 0 -1.2571 TD [(standards)-180.8(as)-180.7(they)-180(are)-178.2(reflected)-181.3(in)-176.4(protocols)-182.7(that)-175.4(they)-180(have)-178.6(approved)-181(or)]TJ T* [(in)-414.4(the)-411(conduct)-408(of)-413.5(the)-411(studies.)-411.4(Failure)-411.9(to)-408.3(submit)-412.4(a)-410.5(protocol)-412.5(to)-408.3(the)]TJ 0 -1.2623 TD [(committee)-497.4(should)-494.4(be)-500.9(considered)-490.1(a)-498.4(clear)-495.5(and)-496.3(serious)-494.9(violation)-500(of)]TJ 0 -1.2571 TD [(ethical)-273.9(standards.)]TJ 10.7396 0 0 10.959 109.8142 389.0267 Tm [(Sanctions)-327.6(imposed)-325.8(by)-331.1(governmental)6.9(,)-331.8(institutional,)-322.5(professional)-327.6(or)]TJ -1.3197 -1.2623 TD [(other)-169.3(authorities)-171.4(possessing)-168.5(disciplinary)-166.9(power)-169.6(should)-167.1(be)-172.3(employed)-164.4(as)-170.8(a)]TJ 0 -1.2571 TD [(last)-486.3(resort.)-478.4(Preferred)-484.5(methods)-479.2(of)-482.2(control)-477(include)-482.7(cultivation)-482.9(of)-476.9(an)]TJ T* [(atmosphere)-255.2(of)-250(mutual)-254.5(trust,)-254.7(and)-248.9(education)-254.5(and)-248.9(support)-252.2(to)-255.2(promote)-252.2(in)]TJ 0 -1.2623 TD [(researchers)-179.1(and)-180.3(in)-181(sponsors)-174.2(the)-182.5(capacity)-176.8(for)-181.7(ethical)-178.3(conduct)-179.9(of)-176(research.)]TJ 10.6302 0 0 10.959 109.8142 319.0676 Tm [(Should)-324.6(sanctions)-321.9(become)-325.6(necessary,)-325.2(they)-321.9(should)-320.9(be)-328.3(directed)-324.9(at)-324.3(the)]TJ -1.3333 -1.2571 TD [(non-compliant)-512.2(researchers)-506.9(or)-513.6(sponsors.)-509.9(They)-506.3(may)-513.9(include)-508.6(fines)-513.6(or)]TJ 0 -1.2623 TD [(suspension)-369.9(of)-368.3(eligibility)-372.6(to)-373.6(receive)-366.2(research)-369.9(funding,)-370.9(to)-368.3(use)-370(investiga-)]TJ 0 -1.2571 TD [(tional)-205.6(interventions,)-198.5(or)-199(to)-203(practise)-199.6(medicine.)-203.6(Unless)-199.6(there)-202.6(are)-203.3(persuasive)]TJ T* [(reasons)-291.9(to)-293.6(do)-288(otherwise,)-290.2(editors)-291.3(should)-288.9(refuse)-292.3(to)-293.6(publish)-290.9(the)-288.6(results)-292.9(of)]TJ 0 -1.2623 TD 0.0106 Tc [(re)10.6(s)-4.7(e)10.6(arc)10.6(h)-589.7(co)10.6(nd)]TJ 6.2878 0 TD 0 Tc [(uc)-13.6(te)-14(d)-594.6(u)-8(n)-8(e)0(t)-14(h)0(i)-10(c)-11(a)-6.7(l)-7.3(l)-7.3(y)-6.7(,)-599.3(a)-6.7(nd)-602.6(re)-10(t)-8.3(r)-9.7(a)-6.7(c)0(t)-600.6(a)-6.7(n)-8(y)-598.6(a)-6.7(r)0(t)-12.6(i)-7.3(cl)-18.3(es)-602(t)-8.3(h)-8(at)-601.6(a)-6.6(r)0(e)]TJ -6.2878 -1.2571 TD [(subsequently)-359.5(found)-354.9(to)-363(contain)-355.9(falsified)-361.9(or)-359(fabricated)-362.2(data)-354.9(or)-359(to)-363(have)]TJ T* [(been)-341.9(based)-336.6(on)-336(unethical)-336.9(research.)-339.9(Drug)-338.3(regulatory)-332.5(authorities)-337.5(should)]TJ 0 -1.2623 TD [(consider)-579.2(refusal)-577.9(to)-581.6(accept)-578.6(unethically)-574.9(obtained)-577.2(data)-578.9(submitted)-574.5(in)]TJ 0 -1.2571 TD [(support)-278.2(of)-277.6(an)-276(application)-278.5(for)-276.6(authorization)-275.8(to)-277.6(market)-277.6(a)-278.6(product.)-270.9(Such)]TJ 0 -1.2623 TD [(sanctions,)-163.9(however,)-154.2(may)-161.9(deprive)-157.6(of)-160.3(benefit)-163.3(not)-157.6(only)-157.9(the)-160.6(errant)-159.9(researcher)]TJ 0 -1.2571 TD [(or)-225.6(sponsor)-220.9(but)-221.6(also)-223.6(that)-223.3(segment)-224.6(of)-224.3(society)-221.9(intended)-224.2(to)-224.3(benefit)-221.9(from)-222.6(the)]TJ T* [(research;)-249.2(such)-249.9(possible)-250.2(consequence)7.5(s)-249.6(merit)-248.9(careful)-248.6(consideration.)]TJ /F5 1 Tf 0 -2.4366 TD [(Potential)-430.9(conflicts)-433.6(of)-431(interest)-429.2(related)-428.6(to)-431(project)-433.9(support.)]TJ /F2 1 Tf 24.5593 0 TD (Increasingly,)Tj -24.5593 -1.2623 TD 0.0133 Tc (bi)Tj 0.8426 0 TD 0.0086 Tc [(ome)8.6(d)-10.4(ical)-590.7(stud)-4.7(ies)-593(r)8.6(e)-6.7(c)-2.4(e)8.6(i)-9.7(ve)-594.4(funding)-590(from)-593.4(com)8.6(m)-6(erc)8.6(i)-9.7(al)-596(firms.)-590.7(Such)]TJ -0.8426 -1.2571 TD 0 Tc [(sponsors)-502.6(have)-506.9(good)-499.9(reasons)-499.9(to)-507(support)-502.2(research)-503.2(methods)-500.2(that)-505.9(are)]TJ ET 95.641 646.809 318.898 -0.51 re f BT /F6 1 Tf 7.9702 0 0 7.9702 95.6409 649.1337 Tm [(THE)-330.8(GUIDELINES)]TJ /F7 1 Tf 11.9551 0 0 11.9551 401.3857 649.1337 Tm (29)Tj ET endstream endobj 85 0 obj << /Type /Page /Parent 393 0 R /Resources 86 0 R /Contents 87 0 R /MediaBox [ 0 0 595 842 ] /CropBox [ 0 0 595 842 ] /Rotate 0 >> endobj 86 0 obj << /ProcSet [ /PDF /Text ] /Font << /F2 337 0 R /F5 340 0 R /F6 341 0 R /F7 342 0 R /F8 343 0 R /F11 346 0 R >> /ExtGState << /GS1 434 0 R >> /ColorSpace << /DefaultCMYK 417 0 R /Cs6 416 0 R >> >> endobj 87 0 obj << /Length 5845 >> stream q 1 i 0.015 737.008 510.221 -737.008 re W n /Cs6 cs 0 0 0 scn /GS1 gs 0.015 709.001 25.44 -0.284 re f Q /Cs6 cs 0 0 0 scn /GS1 gs 28.006 737.008 0.283 -25.455 re f 481.89 737.008 0.283 -25.455 re f 484.724 709.001 25.512 -0.284 re f 484.724 28.346 25.512 -0.283 re f 481.89 25.512 0.283 -25.512 re f q 1 i 0.015 737.008 510.221 -737.008 re W n 28.006 25.512 0.283 -25.512 re f 0.015 28.346 25.44 -0.283 re f Q 1 1 1 scn 95.641 383.074 14.173 -2.835 re f 0 0 0 scn 95.641 403.257 318.898 -20.183 re f 1 1 1 scn 95.641 346.224 14.173 -2.835 re f 0.8 0.8 0.8 scn 95.641 380.239 318.898 -34.016 re f BT /F2 1 Tf 10.6302 0 0 10.959 95.6409 609.8455 Tm 0 0 0 scn 0 Tc 0 Tw [(ethically)-206.9(and)-209.3(scientifically)-207.9(acceptable,)-202.9(but)-205.6(cases)-207.9(have)-208.3(arisen)-206.9(in)-207.3(which)-206.9(the)]TJ 0 -1.2623 TD [(conditions)-302.2(of)-299(funding)-299.6(could)-298.3(have)-298.9(introduced)-300.5(bias.)-300.3(It)-300.6(may)-300.6(happen)-300.2(that)]TJ 0 -1.2571 TD [(investigators)-187.2(have)-181.6(little)-188.3(or)-183(no)-186.6(input)-183.6(into)-186.3(trial)-188.6(design,)-185.9(limited)-181.9(access)-186.9(to)-187(the)]TJ 0 -1.2623 TD [(raw)-402.3(data,)-399.6(or)-401.6(limited)-400.6(participation)-397.8(in)-404.6(data)-397.6(interpretation,)-398.8(or)-401.6(that)-399.3(the)]TJ 0 -1.2571 TD [(results)-191.6(of)-181.6(a)-188(clinical)-188.6(trial)-188.6(may)-183.3(not)-184.3(be)-189.6(published)-181.9(if)-186.3(they)-188.6(are)-187.3(unfavourable)-181.5(to)]TJ T* [(the)-166(sponsors)-163.2(product.)-164.2(This)-164.3(risk)-162.6(of)-165.6(bias)-165(may)-167.3(also)-165(be)-163(associated)-160.9(with)-164.3(other)]TJ 0 -1.2623 TD [(sources)-248.2(of)-245.6(support,)-248.2(such)-244.6(as)-245.6(government)-241.9(or)-247(foundations.)-244.9(As)-247.6(the)-246(persons)]TJ 0 -1.2571 TD [(directly)-309.2(responsible)-305.5(for)-308.6(their)-310.9(work,)-306.9(investigato)8.1(rs)-312.6(should)-304.9(not)-307(enter)-309.3(into)]TJ T* [(agreements)-321.2(that)-319.3(interfere)-318.9(unduly)-317.9(with)-318.9(their)-321.6(access)-314.9(to)-320.3(the)-320.6(data)-317.6(or)-321.6(their)]TJ 0 -1.2623 TD [(ability)-243.6(to)-240.3(analyse)-242.6(the)-240.6(data)-237.6(independently,)-240.5(to)-240.3(prepare)-239.9(manuscripts,)-242.2(or)-241.6(to)]TJ 0 -1.2571 TD [(publish)-413.6(them.)-417.9(Investigators)-408.2(must)-414.6(also)-415.6(disclose)-413.2(potential)-408.9(or)-417.6(apparent)]TJ 0 -1.2623 TD [(conflicts)-297.6(of)-293.6(interest)-297.2(on)-293.3(their)-300.3(part)-293.9(to)-293.6(the)-294(ethical)-299.6(review)-292.9(committee)-298.2(or)-295(to)]TJ 0 -1.2571 TD [(other)-354.3(institutional)-347.9(committees)-350.5(designed)-352.2(to)-352.3(evaluate)-348.2(and)-347.9(manage)-352.9(such)]TJ T* [(conflicts.)-283.6(Ethical)-278.6(review)-282.3(committee)5.8(s)-281.6(should)-278.3(therefore)-282.2(ensure)-275.9(that)-282(these)]TJ 0 -1.2622 TD [(conditions)-248.9(are)-251.3(met.)-249.9(See)-248.6(also)]TJ /F5 1 Tf 12.0157 0 TD [(Multi-centre)-247.9(research)]TJ /F2 1 Tf 8.9384 0 TD (,)Tj 0.5173 0 TD (above.)Tj /F11 1 Tf 11.9551 0 3.5865 11.9551 218.8913 388.6298 Tm 1 1 1 scn [(Guideline)-278.6(3)]TJ 11.9551 0 0 11.9551 166.8472 365.6125 Tm 0 0 0 scn [(Ethical)-276.5(revie)-8(w)-267.5(o)0(f)-272.1(externally)]TJ 2.0154 -1.1523 TD [(sponsore)-9.1(d)-268.2(research)]TJ /F8 1 Tf 10.6302 0 0 10.959 95.6409 330.2361 Tm [(An)-192.6(external)-189.6(sponsoring)-190.2(organization)-187.5(and)-191.9(individual)-189.2(investigators)]TJ 0 -1.2623 TD [(should)-441.9(submit)-437.6(the)-441.9(research)-436.6(protocol)-433.6(for)-443.6(ethical)-440.6(and)-437.3(scientific)]TJ 0 -1.2571 TD [(review)-422.9(in)-422(the)-420.6(country)-419.6(of)-418(the)-426(sponsoring)-414.2(organization,)-418.8(and)-421.3(the)]TJ T* [(ethical)-317.9(standards)-312.9(applied)-314.6(should)-319.2(be)-316(no)-317.3(less)-313.9(stringent)-312.9(than)-317.9(they)]TJ 0 -1.2623 TD [(would)-449.2(be)-449.3(for)-454.3(research)-441.9(carried)-449.2(out)-448.6(in)-448.6(that)-450.6(country.)-448.2(The)-447.9(health)]TJ 0 -1.2571 TD [(authorities)-152.2(of)-156.6(the)-148.6(host)-152.6(country,)-149.6(as)-154.6(well)-153.9(as)-149.3(a)-157.3(national)-147.2(or)-152.3(local)-151.9(ethical)]TJ 0 -1.2622 TD [(review)-310.9(committee,)-311.2(should)-308.6(ensure)-308.2(that)-311.9(the)-314(proposed)-306.9(research)-303.2(is)]TJ 0 -1.2571 TD [(responsive)-250.2(to)-252.6(the)-255.3(health)-253.3(needs)-250.6(and)-250.6(priorities)-249.9(of)-258(the)-250(host)-253.9(country)]TJ T* [(and)-250.6(meets)-246.3(the)-250(requisite)-246.2(ethical)-248.6(standards.)]TJ 9.9626 0 2.9888 9.9626 95.6409 185.9527 Tm [(Comm)-9.3(ent)-7.2(ary)-269.4(on)-277.2(Guidelin)-10.9(e)-267.4(3)]TJ /F5 1 Tf 10.959 0 0 10.959 95.6409 168.0378 Tm (Definition.)Tj /F2 1 Tf 4.7697 0 TD [(The)-316(term)]TJ /F5 1 Tf 4.2627 0 TD [(externally)-311.5(sponsored)-310.4(research)]TJ /F2 1 Tf 12.6794 0 TD [(refers)-312.6(to)-315.2(research)]TJ -21.7118 -1.2467 TD [(undertaken)-197.1(in)-202.3(a)-198.4(host)-200.7(country)-196.5(but)-197.7(sponsored,)-199.5(financed,)-194.2(and)-201.5(sometimes)]TJ T* [(wholly)-288.5(or)-289.1(partly)-284.6(carried)-288(out)-285.7(by)-287.9(an)-287.9(external)-290(internation)7.7(al)-290.5(or)-289.1(national)]TJ T* [(organization)-349.6(or)-351.1(pharmaceutica)7(l)-356(company)-347.7(with)-346.3(the)-354.1(collaborati)6.5(on)-349.7(or)]TJ 0 -1.2416 TD [(agreement)-304.6(of)-304.8(the)-302.4(appropriate)-305.3(authorities,)-303.2(institutions)-303.5(and)-299.7(personnel)]TJ 0 -1.2467 TD [(of)-273.8(the)-266.2(host)-268(country.)]TJ ET 95.641 646.809 318.898 -0.51 re f BT /F6 1 Tf 7.9702 0 0 7.9702 191.1118 649.1337 Tm [(INTERNA)13.4(TIONAL)-327.4(ETHICAL)-327.5(GUIDELINES)-319.8(FOR)-332.5(BIOMED)13.7(ICAL)-331.1(RESEARCH)]TJ /F7 1 Tf 11.9551 0 0 11.9551 95.6409 649.1337 Tm (30)Tj ET endstream endobj 88 0 obj << /Type /Page /Parent 394 0 R /Resources 89 0 R /Contents 90 0 R /MediaBox [ 0 0 595 842 ] /CropBox [ 0 0 595 842 ] /Rotate 0 >> endobj 89 0 obj << /ProcSet [ /PDF /Text ] /Font << /F2 337 0 R /F5 340 0 R /F6 341 0 R /F7 342 0 R >> /ExtGState << /GS1 434 0 R >> /ColorSpace << /DefaultCMYK 417 0 R /Cs6 416 0 R >> >> endobj 90 0 obj << /Length 6410 >> stream q 1 i 0.015 737.008 510.221 -737.008 re W n /Cs6 cs 0 0 0 scn /GS1 gs 0.015 709.001 25.44 -0.284 re f Q /Cs6 cs 0 0 0 scn /GS1 gs 28.006 737.008 0.283 -25.455 re f 481.89 737.008 0.283 -25.455 re f 484.724 709.001 25.512 -0.284 re f 484.724 28.346 25.512 -0.283 re f 481.89 25.512 0.283 -25.512 re f q 1 i 0.015 737.008 510.221 -737.008 re W n 28.006 25.512 0.283 -25.512 re f 0.015 28.346 25.44 -0.283 re f Q BT /F5 1 Tf 10.7396 0 0 10.959 95.6409 609.8455 Tm 0 Tc 0 Tw [(Ethical)-391.9(and)-384.6(scientific)-392.7(review.)]TJ /F2 1 Tf 12.6059 0 TD [(Committees)-391.6(in)-386.9(both)-386.5(the)-388.3(country)-389.5(of)-387.2(the)]TJ -12.6059 -1.2623 TD [(sponsor)-290(and)-285.8(the)-288.1(host)-284.3(country)-283.9(have)-286.2(responsibility)-289.1(for)-287.3(conducting)-283.2(both)]TJ 0 -1.2571 TD [(scientific)-514.9(and)-507.5(ethical)-510.8(review,)-509.3(as)-513.9(well)-511.6(as)-508.6(the)-509.8(authority)-510(to)-508.6(withhold)]TJ 0 -1.2623 TD [(approval)-174.5(of)-170.8(research)-171.9(proposals)-174.6(that)-171.8(fail)-173.7(to)-176.1(meet)-172.3(their)-176.8(scientific)-171.8(or)-171.6(ethical)]TJ 0 -1.2571 TD [(standards.)-210.3(As)-217.5(far)-212.6(as)-213(possible,)-212.2(there)-210.4(must)-214.9(be)-214.6(assurance)-206.2(that)-214.1(the)-214.2(review)-209.2(is)]TJ T* [(independent)-179.6(and)-180.3(that)-177.1(there)-178.7(is)-184.3(no)-178.8(conflict)-178.6(of)-181.3(interest)-177.9(that)-177.1(might)-183.5(affect)-176.7(the)]TJ 0 -1.2623 TD [(judgement)-417.4(of)-418.9(members)-414.8(of)-418.9(the)-420(review)-415(committees)-419.2(in)-418.5(relation)-417.3(to)-418.9(any)]TJ 0 -1.2571 TD [(aspect)-322.7(of)-323.9(the)-319.7(research.)-324.2(When)-320.6(the)-319.7(external)-323.4(sponsor)-321.6(is)-321.6(an)-320.5(international)]TJ T* [(organization,)-223.5(its)-226.1(review)-225(of)-223.6(the)-224.7(research)-224.7(protocol)-220.6(must)-225.4(be)-225.1(in)-223.2(accordance)]TJ 0 -1.2623 TD [(with)-254.4(its)-247.3(own)-247.3(independent)-248.2(ethical-review)-249.8(procedures)-245.9(and)-248.9(standards.)]TJ 10.959 0 0 10.959 109.8142 471.7983 Tm [(Committees)-390.2(in)-388.5(the)-385.2(external)-383.2(sponsoring)-384.8(country)-387.9(or)-387.3(international)]TJ -1.2933 -1.2571 TD [(organization)-349.6(have)-349.3(a)-353.6(special)-346.1(responsibility)-350(to)-351.4(determine)-353.3(whether)-346.9(the)]TJ T* [(scientific)-254.2(methods)-246.9(are)-250.7(sound)-247.1(and)-248(suitable)-249.8(to)-253.1(the)-250.7(aims)-247.5(of)-253.1(the)-250.7(research;)]TJ 0 -1.2623 TD [(whether)-233.1(the)-235.1(drugs,)-232.3(vaccines,)-231.6(devices)-230.8(or)-232.1(procedures)-230.2(to)-232.4(be)-231.9(studied)-229.9(meet)]TJ 0 -1.2571 TD [(adequate)-260.1(standards)-253.3(of)-258.3(safety;)-258(whether)-259(there)-256.4(is)-260.7(sound)-257.4(justification)-255.9(for)]TJ 0 -1.2623 TD [(conducting)-208.6(the)-204.1(research)-206.7(in)-207.5(the)-204.1(host)-205.9(country)-206.8(rather)-206.7(than)-204.7(in)-207.5(the)-204.1(country)]TJ 0 -1.2571 TD [(of)-516.9(the)-514.5(external)-512.5(sponsor)-506.6(or)-516.7(in)-512.7(another)-512(country;)-511(and)-511.8(whether)-512.5(the)]TJ T* [(proposed)-295.7(research)-294.7(is)-302(in)-295.4(compliance)-297.7(with)-294.6(the)-297.2(ethical)-299.8(standards)-294.6(of)-294.5(the)]TJ 0 -1.2623 TD [(external)-269.3(sponsoring)-265.8(country)-268.9(or)-268.4(international)-267.3(organization.)]TJ 1.2933 -1.2623 TD [(Committees)-390.2(in)-388.5(the)-385.2(host)-387(country)-387.9(have)-385.5(a)-384.6(special)-387.4(responsibility)-391.4(to)]TJ -1.2933 -1.2571 TD [(determine)-229.2(whether)-222.8(the)-230(objectives)-224.2(of)-227.2(the)-224.8(research)-222.2(are)-230(responsive)-221.6(to)-227.2(the)]TJ T* [(health)-330.6(needs)-327.1(and)-325.6(priorities)-325.5(of)-330.7(that)-325.4(country.)-324.8(The)-326.3(ability)-331.3(to)-325.5(judge)-327.3(the)]TJ 0 -1.2623 TD [(ethical)-201.5(acceptability)-201.3(of)-201.4(various)-197.9(aspects)-199.1(of)-201.4(a)-198.4(research)-201.6(proposal)-199.2(requires)]TJ 0 -1.2571 TD (a)Tj 0.7708 0 TD [(thorough)-269.2(understanding)-266.9(of)-268.6(a)-270.8(communitys)-268(customs)-269.1(and)-268.7(traditions.)]TJ -0.7708 -1.2623 TD [(The)-171.1(ethical)-175.6(review)-170.7(committee)-171.5(in)-171.3(the)-167.9(host)-169.7(country,)-169.6(therefore,)-172.8(must)-168.7(have)]TJ 0 -1.2571 TD [(as)-242.8(either)-234.7(members)-236.5(or)-237.3(consultants)-234.3(persons)-238.8(with)-237.7(such)-236.4(understanding;)-234.9(it)]TJ T* [(will)-246.4(then)-236.7(be)-242.2(in)-238.5(a)-239.8(favourable)-235.3(position)-238(to)-242.8(determine)-239.5(the)-235.1(acceptability)-242.7(of)]TJ 0 -1.2623 TD [(the)-421.4(proposed)-414.7(means)-413.1(of)-418.6(obtaining)-414.5(informed)-416.6(consent)-414.6(and)-413.6(otherwise)]TJ 0 -1.2571 TD [(respecting)-331.7(the)-328.3(rights)-327.2(of)-330.7(prospective)-328.1(subjects)-332.3(as)-325.5(well)-332.9(as)-330.7(of)-325.5(the)-333.4(means)]TJ T* [(proposed)-213(to)-216.9(protect)-209.4(the)-214.4(welfare)-215.3(of)-211.7(the)-214.4(research)-211.9(subjects.)-212.4(Such)-214.3(persons)]TJ 0 -1.2623 TD [(should)-458.2(be)-459.5(able,)-459.3(for)-457.9(example,)-459.2(to)-454.9(indicate)-456.5(suitable)-461.9(members)-453.8(of)-460(the)]TJ 0 -1.2571 TD [(community)-550.5(to)-548(serve)-551.2(as)-548(intermediaries)-550.5(between)-548.4(investigators)-547.2(and)]TJ 0 -1.2623 TD [(subjects,)-310.7(and)-299.7(to)-310(advise)-304.7(on)-303.1(whether)-305.6(material)-306(benefits)-306.7(or)-304.6(inducements)]TJ 0 -1.2571 TD [(may)-361.1(be)-356(regarded)-354.4(as)-356.6(appropriate)-351.8(in)-357.5(the)-359.3(light)-356.4(of)-356.6(a)-358.7(communitys)-355.9(gift-)]TJ T* [(exchange)-270.1(and)-268.7(other)-265.5(customs)-269.1(and)-268.7(traditions.)]TJ 1.2933 -1.2623 TD [(When)-289.4(a)-291.5(sponsor)-289.3(or)-289(investigator)-290.7(in)-290.2(one)-290.3(country)-289.6(proposes)-286.9(to)-289.3(carry)]TJ -1.2933 -1.2623 TD [(out)-430.5(research)-429.2(in)-429.9(another,)-428.3(the)-431.7(ethical)-429.1(review)-434.5(committees)-428(in)-429.9(the)-431.7(two)]TJ 0 -1.2571 TD [(countries)-214.9(may,)-210.1(by)-210.3(agreement,)-210.5(undertake)-211.1(to)-211.7(review)-212.1(different)-211.7(aspects)-214.6(of)]TJ ET 95.641 646.809 318.898 -0.51 re f BT /F6 1 Tf 7.9702 0 0 7.9702 95.6409 649.1337 Tm [(THE)-330.8(GUIDELINES)]TJ /F7 1 Tf 11.9551 0 0 11.9551 401.3857 649.1337 Tm (31)Tj ET endstream endobj 91 0 obj << /Type /Page /Parent 394 0 R /Resources 92 0 R /Contents 93 0 R /MediaBox [ 0 0 595 842 ] /CropBox [ 0 0 595 842 ] /Rotate 0 >> endobj 92 0 obj << /ProcSet [ /PDF /Text ] /Font << /F2 337 0 R /F5 340 0 R /F6 341 0 R /F7 342 0 R /F8 343 0 R /F11 346 0 R >> /ExtGState << /GS1 434 0 R >> /ColorSpace << /DefaultCMYK 417 0 R /Cs6 416 0 R >> >> endobj 93 0 obj << /Length 5836 >> stream q 1 i 0.015 737.008 510.221 -737.008 re W n /Cs6 cs 0 0 0 scn /GS1 gs 0.015 709.001 25.44 -0.284 re f Q /Cs6 cs 0 0 0 scn /GS1 gs 28.006 737.008 0.283 -25.455 re f 481.89 737.008 0.283 -25.455 re f 484.724 709.001 25.512 -0.284 re f 484.724 28.346 25.512 -0.283 re f 481.89 25.512 0.283 -25.512 re f q 1 i 0.015 737.008 510.221 -737.008 re W n 28.006 25.512 0.283 -25.512 re f 0.015 28.346 25.44 -0.283 re f Q 1 1 1 scn 95.641 384.491 14.173 -2.835 re f 0 0 0 scn 95.641 404.674 318.898 -20.183 re f 1 1 1 scn 95.641 361.474 14.173 -2.835 re f 0.8 0.8 0.8 scn 95.641 381.657 318.898 -20.183 re f BT /F2 1 Tf 10.959 0 0 10.959 95.6409 609.8455 Tm 0 0 0 scn 0 Tc 0 Tw [(the)-209.3(research)-201.6(protocol.)-204.6(In)-206.3(short,)-207.9(in)-202.3(respect)-205.2(of)-206.5(host)-205.9(countries)-204.6(either)-208.8(with)]TJ 0 -1.2623 TD [(developed)-170.3(capacity)-169.9(for)-173.3(independent)-169.7(ethical)-170.4(review)-170.7(or)-175.2(in)-171.3(which)-171.4(external)]TJ 0 -1.2571 TD [(sponsors)-504.4(and)-506.7(investigato)7.1(rs)-507.8(are)-504.1(contributing)-500.8(substantially)-505.8(to)-501.4(such)]TJ 0 -1.2623 TD [(capacity,)-349.9(ethical)-346.3(review)-346.6(in)-347.1(the)-348.9(external,)-345.9(sponsoring)-343.4(country)-346.5(may)-345.6(be)]TJ 0 -1.2571 TD [(limited)-237.9(to)-232.4(ensuring)-231.4(compliance)-235.6(with)-232.5(broadly)-232.7(stated)-232.8(ethical)-232.5(standards.)]TJ T* [(The)-285(ethical)-289.4(review)-284.5(committee)-285.3(in)-285.1(the)-281.7(host)-288.7(country)-279.2(can)-285.4(be)-283.6(expected)-288(to)]TJ 0 -1.2623 TD 0.0132 Tc [(have)-615.5(greater)-615.7(c)0.1(ompete)]TJ 10.0049 0 TD 0.0122 Tc [(nce)-616.5(f)-1.4(or)-621.9(reviewing)-615.6(t)-1.4(he)-616.5(d)-4.9(e)-0.9(ta)-5.1(iled)-620.5(plans)-616.7(f)-1.4(or)]TJ -10.0049 -1.2571 TD 0 Tc [(compliance,)-369.1(in)-367.8(view)-366.7(of)-372.1(its)-367.4(better)-368.3(understanding)-360.1(of)-366.9(the)-369.6(cultural)-368.8(and)]TJ T* [(moral)-238.7(values)-237.5(of)-237.6(the)-235.1(population)-234.7(in)-238.5(which)-233.5(it)-240.2(is)-240(proposed)-233.7(to)-237.6(conduct)-232.1(the)]TJ 0 -1.2623 TD [(research;)-547.2(it)-550.6(is)-545.2(also)-548.5(likely)-546.3(to)-548(be)-542.3(in)-548.9(a)-545(better)-549.3(position)-543.3(to)-548(monitor)]TJ 0 -1.2571 TD [(compliance)-189(in)-191.9(the)-188.6(course)-190.4(of)-185.9(a)-193.2(study.)-186(However,)-188.3(in)-191.9(respect)-189.7(of)-185.9(research)-191.2(in)]TJ 0 -1.2623 TD [(host)-573.2(countries)-571.8(with)-568.8(inadequate)-571(capacity)-568.2(for)-571.7(independent)-573.2(ethical)]TJ 0 -1.2571 TD [(review,)-402.5(full)-401.1(review)-398.3(by)-396.5(the)-400.7(ethical)-398.1(review)-398.3(committee)-399.1(in)-398.9(the)-400.7(external)]TJ T* [(sponsoring)-271(country)-263.7(or)-268.4(international)-267.3(agency)-271.1(is)-271(necessary.)]TJ /F11 1 Tf 11.9551 0 3.5865 11.9551 218.8913 390.0471 Tm 1 1 1 scn [(Guideline)-278.6(4)]TJ 11.9551 0 0 11.9551 165.3165 367.0298 Tm 0 0 0 scn [(Individual)-277.6(informed)-275.6(consent)]TJ /F8 1 Tf 10.959 0 0 10.959 95.6409 345.4298 Tm [(For)-279.7(all)-273.7(biomedical)-274.1(research)-273.6(involving)-274.2(humans)-275.5(the)-275.7(investigat)6.2(or)]TJ T* [(must)-239.1(obtain)-235.9(the)-239.5(voluntary)-236.8(informed)-233.3(consent)-234.8(of)-238(the)-239.5(prospective)]TJ T* [(subject)-351.5(or,)-349.9(in)-352(the)-353.3(case)-347.6(of)-351.8(an)-349.4(individual)-345.6(who)-349.9(is)-352.3(not)-353.1(capable)-349.1(of)]TJ 0 -1.2623 TD [(giving)-205.1(informed)-202.3(consent,)-197.6(the)-203.3(permission)-200.5(of)-201.8(a)-203.3(legally)-199.5(authorized)]TJ 0 -1.2571 TD [(representative)-445.1(in)-450.3(accordance)-445.4(with)-449.9(applicable)-446.7(law.)-445.3(Waiver)-450.9(of)]TJ 0 -1.2623 TD 0.0176 Tc [(in)-4.4(formed)-620(c)-4.6(ons)-4.6(ent)-622.6(i)-2.1(s)-625.4(t)-1.8(o)-620(b)-4.4(e)-620.2(r)-0.9(e)-4.6(g)0.8(arde)-4.6(d)-620(a)0.6(s)-625.4(u)0.8(n)-4.4(c)0.6(ommo)-4.4(n)-620(a)0.6(n)-4.3(d)]TJ 0 -1.2571 TD 0 Tc [(exceptional,)-353.9(and)-345.5(must)-352.9(in)-352(all)-351.3(cases)-349.1(be)-349.4(approved)-348.9(by)-349.4(an)-349.4(ethical)]TJ T* [(review)-271.2(committee.)]TJ 9.9626 0 2.9888 9.9626 95.6409 214.1291 Tm [(Comm)-9.3(ent)-7.2(ary)-269.4(on)-277.2(Guidelin)-10.9(e)-267.4(4)]TJ /F5 1 Tf 10.959 0 0 10.959 95.6409 196.1008 Tm [(General)-172.5(considerations.)]TJ /F2 1 Tf 9.7618 0 TD [(Informed)-167.1(consent)-171.5(is)-167.5(a)-172.5(decision)-171.4(to)-170.3(participate)-169.7(in)]TJ -9.7618 -1.2623 TD [(research,)-516.1(taken)-507.5(by)-515.5(a)-513.9(competent)-511.3(individual)-507.6(who)-511.1(has)-513.3(received)-512.9(the)]TJ 0 -1.2571 TD [(necessary)-270.6(information;)-268.5(who)-268(has)-270.2(adequately)-266.1(understood)-269.5(the)-271.4(informa-)]TJ T* [(tion;)-407.9(and)-403.2(who,)-401.5(after)-407.2(considering)-400.2(the)-405.9(information,)-403(has)-399.5(arrived)-406(at)-403.4(a)]TJ 0 -1.2623 TD [(decision)-285.2(without)-285.4(having)-281.7(been)-282.7(subjected)-281.9(to)-284.1(coercion,)-288(undue)-277.9(influence)]TJ 0 -1.2571 TD [(or)-273.5(inducement,)-264.5(or)-273.5(intimidatio)6(n.)]TJ 1.2933 -1.2623 TD 0.0075 Tc [(Inf)7.5(o)]TJ 1.8468 0 TD 0 Tc [(rm)-8.7(e)-7.9(d)-612(c)-7.9(o)-6.7(ns)-9.7(en)-9.4(t)-613.7(i)-9.3(s)-613.4(b)-6.7(as)-10(ed)-619.9(on)-618.7(th)-10(e)-613.2(p)-6.7(ri)-12.3(n)-6.7(c)0(i)-12.1(p)0(l)-10.9(e)-613.2(th)-10(a)-7(t)-613.7(co)-9.4(mp)-12.4(et)-11.2(en)-9.4(t)]TJ -3.1401 -1.2571 TD [(individuals)-453.7(are)-452.4(entitled)-452.8(to)-454.9(choose)-447.6(freely)-452.2(whether)-455.6(to)-449.7(participate)-454.2(in)]TJ ET 95.641 646.809 318.898 -0.51 re f BT /F6 1 Tf 7.9702 0 0 7.9702 191.1118 649.1337 Tm [(INTERNA)13.4(TIONAL)-327.4(ETHICAL)-327.5(GUIDELINES)-319.8(FOR)-332.5(BIOMED)13.7(ICAL)-331.1(RESEARCH)]TJ /F7 1 Tf 11.9551 0 0 11.9551 95.6409 649.1337 Tm (32)Tj ET endstream endobj 94 0 obj << /Type /Page /Parent 394 0 R /Resources 95 0 R /Contents 96 0 R /MediaBox [ 0 0 595 842 ] /CropBox [ 0 0 595 842 ] /Rotate 0 >> endobj 95 0 obj << /ProcSet [ /PDF /Text ] /Font << /F2 337 0 R /F5 340 0 R /F6 341 0 R /F7 342 0 R >> /ExtGState << /GS1 434 0 R >> /ColorSpace << /DefaultCMYK 417 0 R /Cs6 416 0 R >> >> endobj 96 0 obj << /Length 5608 >> stream q 1 i 0.015 737.008 510.221 -737.008 re W n /Cs6 cs 0 0 0 scn /GS1 gs 0.015 709.001 25.44 -0.284 re f Q /Cs6 cs 0 0 0 scn /GS1 gs 28.006 737.008 0.283 -25.455 re f 481.89 737.008 0.283 -25.455 re f 484.724 709.001 25.512 -0.284 re f 484.724 28.346 25.512 -0.283 re f 481.89 25.512 0.283 -25.512 re f q 1 i 0.015 737.008 510.221 -737.008 re W n 28.006 25.512 0.283 -25.512 re f 0.015 28.346 25.44 -0.283 re f Q BT /F2 1 Tf 10.959 0 0 10.959 95.6409 609.8455 Tm 0 Tc 0 Tw [(research.)-567.9(Informed)-565.5(consent)-569.8(protects)-564.2(the)-566.2(individuals)-566.5(freedom)-568.8(of)]TJ 0 -1.2623 TD [(choice)-501.7(and)-501.5(respects)-503.1(the)-499(individuals)-499.2(autonomy.)-498.8(As)-505.6(an)-500(additional)]TJ 0 -1.2571 TD [(safeguard,)-355.7(it)-359.2(must)-354.9(always)-360.3(be)-356(complemented)-356.7(by)-355.1(independent)-355.9(ethical)]TJ 0 -1.2623 TD [(review)-227.6(of)-227.2(research)-222.2(proposals.)-221.9(This)-227.3(safeguard)-222.2(of)-222.1(independent)-221.4(review)-227.6(is)]TJ 0 -1.2571 TD [(particularly)-607.2(important)-605.2(as)-604.9(many)-600.6(individuals)-608.9(are)-602.4(limited)-605.2(in)-605.8(their)]TJ T* [(capacity)-521.6(to)-516.9(give)-522.7(adequate)-513.6(informed)-520.1(consent;)-517.1(they)-521.5(include)-520.2(young)]TJ 0 -1.2623 TD [(children,)-455(adults)-455(with)-454.9(severe)-455.7(mental)-453.8(or)-454.6(behavioural)-449.8(disorders,)-457(and)]TJ 0 -1.2571 TD [(persons)-394(who)-387(are)-390.3(unfamiliar)-393.3(with)-387.7(medical)-395.3(concepts)-386.3(and)-392.9(technology)]TJ T* [(\(See)-274.1(Guidelines)-269.3(13,)-266.4(14,)-271.6(15\).)]TJ /F5 1 Tf 0 -2.5245 TD (Process.)Tj /F2 1 Tf 3.735 0 TD [(Obtaining)-269(informed)-266.6(consent)-264.6(is)-265.8(a)-270.8(process)-265.8(that)-268.5(is)-271(begun)-262.6(when)]TJ -3.735 -1.2571 TD [(initial)-525.1(contact)-518.6(is)-519.3(made)-518.8(with)-517(a)-524.3(prospective)-514.3(subject)-520.8(and)-517(continues)]TJ T* [(throughout)-424(the)-421.4(course)-423.2(of)-423.8(the)-421.4(study.)-424(By)-422.2(informing)-425.1(the)-421.4(prospective)]TJ 0 -1.2623 TD [(subjects,)-264.1(by)-256.8(repetition)-260.7(and)-258.4(explanation,)-257.7(by)-256.8(answering)-258.6(their)-257.8(questions)]TJ 0 -1.2571 TD [(as)-284.1(they)-283.5(arise,)-282.7(and)-279(by)-282.7(ensuring)-283.1(that)-278.9(each)-283(individual)-280(understands)-277.9(each)]TJ 0 -1.2623 TD [(procedure,)-246.9(investigators)-242(elicit)-248.9(their)-247.5(informed)-240.8(consent)-249.1(and)-242.8(in)-243.7(so)-247.7(doing)]TJ 0 -1.2571 TD [(manifest)-454.9(respect)-448.3(for)-452.7(their)-449.2(dignity)-447.7(and)-449.8(autonomy.)-447.1(Each)-452.3(individual)]TJ T* [(must)-215.3(be)-211.2(given)-213.8(as)-211.7(much)-213.3(time)-212.5(as)-216.9(is)-214.1(needed)-209.4(to)-216.9(reach)-208.4(a)-213.9(decision,)-211.8(including)]TJ 0 -1.2623 TD [(time)-274.5(for)-266.4(consultation)-268.1(with)-273.9(family)-269.3(members)-267.5(or)-268.4(others.)-272.7(Adequate)-269.4(time)]TJ 0 -1.2571 TD [(and)-268.7(resources)-271.5(should)-266.8(be)-268.1(set)-272.8(aside)-266.7(for)-271.6(informed-c)6.7(onsent)-272.3(procedures.)]TJ /F5 1 Tf 0 -2.5193 TD (Language.)Tj /F2 1 Tf 4.8162 0 TD [(Informing)-439.4(the)-447.2(individual)-440.3(subject)-443.2(must)-442.9(not)-440.9(be)-444(simply)-444.6(a)]TJ -4.8162 -1.2623 TD [(ritual)-349(recitation)-343.8(of)-346.2(the)-343.8(contents)-340.3(of)-346.2(a)-343.2(written)-344.9(document.)-345.5(Rather,)-343.2(the)]TJ 0 -1.2571 TD [(investigator)-580.4(must)-582.6(convey)-581.2(the)-581.7(information,)-578.9(whether)-584.9(orally)-580.4(or)-583.9(in)]TJ 0 -1.2623 TD [(writing,)-235.3(in)-228.2(language)-229.3(that)-232.3(suits)-227.1(the)-230(individuals)-230.2(level)-232.9(of)-232.4(understanding.)]TJ 0 -1.2571 TD [(The)-440.2(investigator)-435.6(must)-442.9(bear)-433.3(in)-440.3(mind)-442.3(that)-434.1(the)-442.1(prospective)-436.7(subjects)]TJ T* [(ability)-476.2(to)-470.4(understand)-466.4(the)-473.1(information)-471.3(necessary)-467.2(to)-470.4(give)-470.9(informed)]TJ 0 -1.2623 TD [(consent)-207.7(depends)-206(on)-204.8(that)-201.3(individuals)-209.5(maturity,)-204.6(intelligence,)-205.5(education)]TJ 0 -1.2571 TD [(and)-377.3(belief)-380.7(system.)-380.6(It)-378.7(depends)-371.5(also)-383(on)-375.5(the)-380(investigato)7.1(rs)-382.6(ability)-377.9(and)]TJ T* [(willingness)-274.5(to)-268.6(communicate)-266.3(with)-268.7(patience)-268.8(and)-268.7(sensitivity.)]TJ /F5 1 Tf 0 -2.5245 TD (Comprehension.)Tj /F2 1 Tf 6.9683 0 TD [(The)-295.3(investigator)-295.9(must)-298(then)-298.7(ensure)-293.9(that)-299.6(the)-297.2(prospec-)]TJ -6.9683 -1.2571 TD 0.0178 Tc [(tiv)-4.7(e)-621.2(subjec)-5.6(t)-621.8(h)0.8(as)-626.7(adequ)-4.4(a)0.5(tely)-620.3(un)-4.4(derstood)-625.2(t)-1(he)-626.4(in)-4.4(forma)-4.7(t)-1(ion.)-622.7(The)]TJ T* 0 Tc [(investigator)-352.8(should)-349.6(give)-346.8(each)-350.2(one)-352.4(full)-354.6(opportunit)8.1(y)-353.6(t)0(o)-351.4(ask)-347.8(questions)]TJ 0 -1.2623 TD [(and)-232.5(should)-230.6(answer)-230.4(them)-230.5(honestly,)-230.7(promptly)-234.7(and)-227.3(completely.)-231.2(In)-232.1(some)]TJ 0 -1.2571 TD [(instances)-266.9(the)-266.2(investigator)-270.1(may)-262.8(administer)-268.9(an)-267.2(oral)-264(or)-268.4(a)-265.6(written)-267.3(test)-270.9(or)]TJ 0 -1.2623 TD [(otherwise)-416.2(determine)-415.4(whether)-414.2(the)-416.2(information)-414.4(has)-415(been)-417.2(adequately)]TJ 0 -1.2571 TD (understood.)Tj ET 95.641 646.809 318.898 -0.51 re f BT /F6 1 Tf 7.9702 0 0 7.9702 95.6409 649.1337 Tm [(THE)-330.8(GUIDELINES)]TJ /F7 1 Tf 11.9551 0 0 11.9551 401.3857 649.1337 Tm (33)Tj ET endstream endobj 97 0 obj << /Type /Page /Parent 394 0 R /Resources 98 0 R /Contents 99 0 R /MediaBox [ 0 0 595 842 ] /CropBox [ 0 0 595 842 ] /Rotate 0 >> endobj 98 0 obj << /ProcSet [ /PDF /Text ] /Font << /F2 337 0 R /F5 340 0 R /F6 341 0 R /F7 342 0 R >> /ExtGState << /GS1 434 0 R >> /ColorSpace << /DefaultCMYK 417 0 R /Cs6 416 0 R >> >> endobj 99 0 obj << /Length 6298 >> stream q 1 i 0.015 737.008 510.221 -737.008 re W n /Cs6 cs 0 0 0 scn /GS1 gs 0.015 709.001 25.44 -0.284 re f Q /Cs6 cs 0 0 0 scn /GS1 gs 28.006 737.008 0.283 -25.455 re f 481.89 737.008 0.283 -25.455 re f 484.724 709.001 25.512 -0.284 re f 484.724 28.346 25.512 -0.283 re f 481.89 25.512 0.283 -25.512 re f q 1 i 0.015 737.008 510.221 -737.008 re W n 28.006 25.512 0.283 -25.512 re f 0.015 28.346 25.44 -0.283 re f Q BT /F5 1 Tf 10.959 0 0 10.959 95.6409 609.8455 Tm 0 Tc 0 Tw [(Documentation)-282.1(of)-279.2(consent.)]TJ /F2 1 Tf 11.3862 0 TD [(Consent)-278.5(may)-283.5(be)-278.4(indicated)-282.1(in)-279.9(a)-286.3(number)-279.9(of)]TJ -11.3862 -1.2623 TD [(ways.)-342.9(The)-336.7(subject)-339.7(may)-340.4(imply)-338.2(consent)-337.1(by)-339.6(voluntary)-336(actions,)-337.8(express)]TJ 0 -1.2571 TD [(consent)-285.3(orally,)-284.5(or)-283.9(sign)-284.7(a)-286.3(consent)-285.3(form.)-281.5(As)-288.3(a)-281.1(general)-286.8(rule,)-284.6(the)-281.7(subject)]TJ 0 -1.2623 TD [(should)-323.7(sign)-320.9(a)-322.5(consent)-321.5(form,)-322.9(or,)-319.1(in)-321.3(the)-323.1(case)-320.6(of)-325.5(incompetenc)6(e,)-327.6(a)-317.4(legal)]TJ 0 -1.2571 TD [(guardian)-322.4(or)-320.1(other)-317.3(duly)-319.4(authorized)-318.7(representative)-321.8(should)-318.5(do)-318.6(so.)-324.3(The)]TJ T* [(ethical)-227.3(review)-227.6(committee)-223.3(may)-226.6(approve)-220.9(waiver)-226.7(of)-222.1(the)-224.8(requirement)-223.3(of)-227.2(a)]TJ 0 -1.2623 TD [(signed)-226.9(consent)-228.4(form)-225.6(if)-224.7(the)-230(research)-222.2(carries)-227.3(no)-225.5(more)-225.1(than)-225.4(minimal)-229.1(risk)]TJ 0 -1.2571 TD ()Tj 1.1847 0 TD [(that)-185.7(is,)-187.2(risk)-182.4(that)-185.7(is)-183.1(no)-184.1(more)-183.7(likely)-189.3(and)-180.8(not)-182.2(greater)-183.8(than)-184(that)-185.7(attached)]TJ -1.1847 -1.2571 TD [(to)-594.5(routine)-592(medical)-586.7(or)-594.3(psychological)-586.1(examination)-588.8()-593.3(and)-589.4(if)-592(the)]TJ 0 -1.2623 TD [(procedures)-271.6(to)-268.6(be)-268.1(used)-267.4(are)-266.2(only)-272.9(those)-265.5(for)-271.6(which)-264.5(signed)-268.3(consent)-269.8(forms)]TJ 0 -1.2571 TD [(are)-545.5(not)-544.3(customarily)-539.7(required)-542.7(outside)-540.3(the)-545.5(research)-543(context.)-538.3(Such)]TJ 0 -1.2623 TD [(waivers)-172.8(may)-174.9(also)-170.9(be)-175(approved)-165.5(when)-172.4(existence)-174.7(of)-170.3(a)-172.5(signed)-170(consent)-171.5(form)]TJ 0 -1.2571 TD -0.0001 Tc [(would)-201.4(be)-195.8(an)-200(unjustified)-196.6(threat)-196.7(to)-196.3(the)-199(subjects)-202.1(confidentiality.)-200.9(I)-0.1(n)-196(some)]TJ T* 0 Tc [(cases,)-193.3(particularly)-193.4(when)-187.9(the)-193.8(information)-186.7(is)-193.4(complicated,)-191.3(it)-193.7(is)-188.2(advisable)]TJ 0 -1.2622 TD [(to)-470.4(give)-460.6(subjects)-466.8(information)-460.9(sheets)-466.3(to)-465.2(retain;)-465.6(these)-468.5(may)-464.6(resemble)]TJ 0 -1.2571 TD [(consent)-290.5(forms)-290.7(in)-290.2(all)-289.5(respects)-291(except)-289(that)-289.2(subjects)-285.8(are)-292(not)-290.9(required)-289.2(to)]TJ 0 -1.2623 TD [(sign)-439.9(them.)-431.3(Their)-437(wording)-433.7(should)-432.3(be)-438.8(cleared)-432.5(by)-437.9(the)-431.7(ethical)-439.4(review)]TJ 0 -1.2571 TD [(committee.)-253.3(When)-242.8(consent)-249.1(has)-244.3(been)-246.5(obtained)-245.7(orally,)-248.3(investigators)-247.2(are)]TJ T* [(responsible)-272.1(for)-266.4(providing)-269.4(documentation)-265.7(or)-268.4(proof)-269.5(of)-268.6(consent.)]TJ /F5 1 Tf 0 -2.5711 TD [(Waiver)-251.5(of)-253.4(the)-250.9(consent)-249.9(requirement.)]TJ /F2 1 Tf 14.697 0 TD [(Investigators)-246(should)-251.3(never)-249.8(initiate)]TJ -14.697 -1.2571 TD [(research)-336.1(involving)-338.1(human)-332.9(subjects)-337.5(without)-337.1(obtaining)-331.8(each)-339.9(subjects)]TJ T* [(informed)-204.5(consent,)-201.6(unless)-202.2(they)-205.9(have)-199.3(received)-202.5(explicit)-205.7(approval)-203.4(to)-201.4(do)-204.8(so)]TJ 0 -1.2623 TD [(from)-199.7(an)-199.9(ethical)-196.3(review)-201.7(committee.)-196.4(However,)-198.7(when)-198.3(the)-193.8(research)-201.5(design)]TJ 0 -1.2571 TD [(involves)-289.8(no)-282.4(more)-287.1(than)-287.5(minimal)-286(risk)-285.9(and)-284.2(a)-291.5(requirement)-285.4(of)-284.1(individual)]TJ T* [(informed)-245.9(consent)-243.9(would)-242.7(make)-244.6(the)-245.5(conduct)-242.5(of)-242.8(the)-245.5(research)-242.9(impractic-)]TJ 0 -1.2623 TD [(able)-331(\(for)-326.6(example,)-329.9(where)-331.8(the)-328.3(research)-325.7(involves)-326(only)-329.8(excerpting)-325.3(data)]TJ 0 -1.2571 TD [(from)-215.3(subjects)-207.2(records\),)-211.2(the)-214.4(ethical)-206.6(review)-212.1(committee)-212.9(may)-211.1(waive)-208.2(some)]TJ 0 -1.2623 TD [(or)-273.5(all)-268.8(of)-268.6(the)-271.3(elements)-269(of)-268.6(informed)-266.6(consent.)]TJ /F5 1 Tf 0 -2.4728 TD [(Renewing)-271(consent.)]TJ /F2 1 Tf 7.9253 0 TD [(When)-268.7(material)-264.6(changes)-268.6(occur)-265(in)-269.5(the)-266.2(conditions)-268.2(or)]TJ -7.9253 -1.2623 TD [(the)-266.2(procedures)-261.3(of)-263.5(a)-265.6(study,)-263.6(and)-258.4(also)-264(periodically)-266.2(in)-264.4(long-term)-259.8(studies,)]TJ 0 -1.2571 TD [(the)-359.3(investigator)-358(should)-359.9(once)-355.1(again)-357.7(seek)-361.8(informed)-354.6(consent)-357.7(from)-360.1(the)]TJ T* [(subjects.)-176.2(For)-166.2(example,)-174.7(new)-170.9(information)-166(may)-169.7(have)-173.4(come)-167.9(to)-170.3(light,)-174.3(either)]TJ 0 -1.2623 TD [(from)-318.7(the)-312.7(study)-311.2(or)-314.9(from)-313.5(other)-312.1(sources,)-316.6(about)-309.7(the)-312.7(risks)-314.7(or)-314.9(benefits)-317.1(of)]TJ 0 -1.2571 TD [(products)-287.1(being)-280.8(tested)-285.5(or)-283.9(about)-283.9(alternatives)-286.8(to)-284.1(them.)-286.4(Subjects)-279.2(should)]TJ 0 -1.2623 TD [(be)-180.1(given)-177.6(such)-174.3(information)-176.4(promptly.)-176.8(In)-175.2(many)-176.4(clinical)-180.7(trials,)-178.8(results)-175.9(are)]TJ 0 -1.2571 TD [(not)-171.9(disclosed)-169.3(to)-170.3(subjects)-172(and)-165.2(investigators)-169.6(until)-169.9(the)-167.9(study)-171.5(is)-172.7(concluded.)]TJ ET 95.641 646.809 318.898 -0.51 re f BT /F6 1 Tf 7.9702 0 0 7.9702 191.1118 649.1337 Tm [(INTERNA)13.4(TIONAL)-327.4(ETHICAL)-327.5(GUIDELINES)-319.8(FOR)-332.5(BIOMED)13.7(ICAL)-331.1(RESEARCH)]TJ /F7 1 Tf 11.9551 0 0 11.9551 95.6409 649.1337 Tm (34)Tj ET endstream endobj 100 0 obj << /Type /Page /Parent 394 0 R /Resources 101 0 R /Contents 102 0 R /MediaBox [ 0 0 595 842 ] /CropBox [ 0 0 595 842 ] /Rotate 0 >> endobj 101 0 obj << /ProcSet [ /PDF /Text ] /Font << /F2 337 0 R /F5 340 0 R /F6 341 0 R /F7 342 0 R >> /ExtGState << /GS1 434 0 R >> /ColorSpace << /DefaultCMYK 417 0 R /Cs6 416 0 R >> >> endobj 102 0 obj << /Length 6213 >> stream q 1 i 0.015 737.008 510.221 -737.008 re W n /Cs6 cs 0 0 0 scn /GS1 gs 0.015 709.001 25.44 -0.284 re f Q /Cs6 cs 0 0 0 scn /GS1 gs 28.006 737.008 0.283 -25.455 re f 481.89 737.008 0.283 -25.455 re f 484.724 709.001 25.512 -0.284 re f 484.724 28.346 25.512 -0.283 re f 481.89 25.512 0.283 -25.512 re f q 1 i 0.015 737.008 510.221 -737.008 re W n 28.006 25.512 0.283 -25.512 re f 0.015 28.346 25.44 -0.283 re f Q BT /F2 1 Tf 10.959 0 0 10.959 95.6409 609.8455 Tm 0 Tc 0 Tw [(This)-610.1(is)-602.1(ethically)-611(acceptable)-609.6(if)-607.5(an)-603.4(ethical)-605(review)-610.4(committee)-606.1(has)]TJ 0 -1.2623 TD [(approved)-269(their)-268.2(non-disclosure.)]TJ /F5 1 Tf 10.7396 0 0 10.959 95.6409 571.0109 Tm [(Cultural)-340.6(consideratio)7.4(ns)]TJ /F2 1 Tf 9.7131 0 TD 0.3371 Tc (.I)Tj 0.9921 0 TD (n)Tj 0.8925 0 TD 0 Tc [(some)-337.9(cultures)-333.6(an)-336.3(investigator)-335.8(may)-337.1(enter)-337.1(a)]TJ -11.5976 -1.2364 TD [(community)-328(to)-329.1(conduct)-322.4(research)-325(or)-329.9(approach)-325.1(prospective)-322.7(subjects)-328.4(for)]TJ T* [(th)-7.1(e)-6.4(i)0(r)-611.9(i)0(n)-6.8(d)0(i)-6.8(v)-6.8(i)0(d)-6.8(ual)-615.3(co)-8.7(nse)-9.1(nt)-614.2(onl)-9.1(y)-608.6(a)0(f)-6.3(ter)-618.7(obt)-9.4(ain)-8.3(in)-6.8(g)-608.6(p)0(e)-8.7(r)0(m)-7.1(iss)-10.5(io)-6.8(n)-609.4(fro)-12.8(m)-608.6(a)]TJ T* [(community)-201.3(leader,)-200.2(a)-202.1(council)-197.6(of)-202.4(elders,)-204.3(or)-198(another)-199.4(designated)-201.3(authority.)]TJ T* [(Such)-578.1(customs)-577.6(must)-573.8(be)-578.8(respected.)-573.5(In)-578(no)-580(case,)-573.5(however,)-578(may)-574.6(the)]TJ T* [(permission)-415.5(of)-413.6(a)-408(community)-412.5(leader)-412.1(or)-414.4(other)-406.8(authority)-409.7(substitute)-413.1(for)]TJ T* [(individual)-241.3(informed)-240.9(consent.)-240.6(In)-240.2(some)-242.8(populations)-235.3(the)-240.5(use)-241.3(of)-239.4(a)-244.3(number)]TJ T* [(of)-276.4(local)-272.6(languages)-269.9(may)-273.7(complicate)-267.7(the)-277.5(communicatio)7.2(n)-276.8(o)0(f)-271.1(information)]TJ T* [(to)-345(potential)-334.4(subjects)-344.2(and)-338.6(the)-335.6(ability)-340.3(of)-339.7(an)-341.6(investigator)-335.8(to)-345(ensure)-334.9(that)]TJ T* [(they)-384.6(truly)-383(understand)-378.6(it.)-388.6(Many)-378.2(people)-383.2(in)-386.9(all)-385.3(cultures)-381.2(are)-383.1(unfamiliar)]TJ T* [(with,)-253.6(or)-245.5(do)-247.4(not)-247(readily)-248(understand,)-245.8(scientific)-251(concepts)-247.8(such)-243.6(as)-250(those)-248.5(of)]TJ T* [(placebo)-263.2(or)-261.3(randomization.)-262.7(Sponsors)-260.6(and)-259.4(investigators)-262.2(should)-262.1(develop)]TJ T* 0.0064 Tc (cu)Tj 0.9954 0 TD 0.0068 Tc (lt)Tj 0.6098 0 TD (u)Tj 0.5591 0 TD 0 Tc [(rall)-10.8(y)-608.6(app)-11.3(ropr)-10.6(iat)-10.8(e)-608.2(w)0(a)-6.7(y)0(s)-608.9(t)0(o)-614.2(com)-10.2(muni)-10.6(ca)-7.9(te)-613.1(in)-6.8(for)-7.5(mat)-7.8(io)-6.8(n)-609.3(t)0(h)-7.1(a)0(t)-613.4(i)0(s)]TJ -2.1643 -1.2364 TD [(necessary)-506(for)-503.7(adherence)-504.2(to)-503.3(the)-504.5(standard)-501(required)-505.3(in)-503(the)-509.8(informed)]TJ T* [(consent)-278.3(process.)-271.1(Also,)-276.3(they)-273.7(should)-277.9(describe)-271.9(and)-275.3(justify)-276.2(in)-276(the)-272.2(research)]TJ T* [(protocol)-220.6(the)-214.2(procedure)-219.2(they)-215.6(plan)-216.4(to)-218.3(use)-220.2(in)-217.9(communicating)-216(information)]TJ T* [(to)-482.2(subjects.)-480.7(For)-482.2(collaborative)-481(research)-478.1(in)-481.9(developing)-477.4(countries)-478.5(the)]TJ T* [(research)-219.4(project)-211.9(should,)-213.8(if)-220.5(necessary,)-214.9(include)-213.5(the)-214.1(provision)-215.6(of)-218.3(resources)]TJ T* [(to)-360.8(ensure)-361.3(that)-356.6(informed)-357(consent)-357.5(can)-358.6(indeed)-356.8(be)-362.4(obtained)-353.7(legitimately)]TJ T* [(within)-271.7(different)-269.1(linguistic)-268(and)-270(cultural)-269.5(settings.)]TJ /F5 1 Tf 10.959 0 0 10.959 95.6409 288.5102 Tm [(Consent)-398.3(to)-398.2(use)-400.7(for)-396(research)-398.4(purposes)-396.6(biological)-400.9(materials)-397.2(\(including)]TJ 0 -1.2416 TD [(genetic)-226.2(material\))-225.3(from)-226.1(subjects)-224.2(in)-223.3(clinical)-227.5(trials.)]TJ /F2 1 Tf 19.8288 0 TD [(Consent)-226.8(forms)-223.4(for)-225.1(the)]TJ -19.8288 -1.2416 TD [(research)-336.1(protocol)-329.7(should)-328.9(include)-334(a)-332.9(separate)-330.2(section)-329.3(for)-333.7(clinical-trial)]TJ T* [(subjects)-197.8(who)-195.6(are)-198.9(requested)-192.7(to)-196.2(provide)-192.2(their)-200.9(consent)-192.2(for)-194(the)-198.9(use)-193.5(of)-196.2(their)]TJ T* [(biological)-374.3(specimens)-368.6(for)-375.1(research.)-366.1(Separate)-370.2(consent)-373.3(may)-366.3(be)-371.5(appro-)]TJ T* [(priate)-218.3(in)-217.8(some)-214.7(cases)-215(\(e.g.,)-216.9(if)-219.5(investigato)7.1(rs)-218.1(are)-214.4(requesting)-216.7(permission)-216.6(to)]TJ T* [(conduct)-356.3(basic)-354.7(research)-351.6(which)-357.7(is)-353.8(not)-358.1(a)-353.6(necessary)-353.4(part)-351(of)-356.6(the)-354.1(clinical)]TJ T* [(trial\),)-442.9(but)-435.7(not)-435.7(in)-435.1(others)-439.2(\(e.g.,)-439.4(the)-436.9(clinical)-439.4(trial)-435.4(requires)-435.5(the)-436.9(use)-441.8(of)]TJ T* [(subjects)-269.3(biological)-270.8(materials\).)]TJ /F5 1 Tf 10.7396 0 0 10.959 95.6409 153.1842 Tm [(Use)-334.8(of)-328.4(medical)-326.4(records)-328.4(and)-326.5(biological)-332.8(specimens.)]TJ /F2 1 Tf 20.8515 0 TD [(Medical)-324.7(records)-329.9(and)]TJ -20.8515 -1.2312 TD [(biological)-197.9(specimens)-188.9(taken)-191.5(in)-196.8(the)-193(course)-192.3(of)-197.2(clinical)-193(care)-194.2(may)-194.5(be)-193.5(used)-190.8(for)]TJ T* [(research)-272.2(without)-274.4(the)-272.2(consent)-267.7(of)-271.1(the)-272.2(patients/subjects)-270.5(only)-274.5(if)-273.3(an)-267.7(ethical)]TJ T* [(review)-230.3(committee)-228.8(has)-225.8(determined)-227.4(that)-229.9(the)-230(research)-224.7(poses)-228.1(minimal)-231.4(risk,)]TJ T* [(that)-224.6(the)-219.4(rights)-219.7(or)-224.3(interests)-220.4(of)-218.3(the)-224.7(patients)-217.1(will)-224.6(not)-220.6(be)-219.9(violated,)-222.4(that)-219.3(their)]TJ ET 95.641 646.809 318.898 -0.51 re f BT /F6 1 Tf 7.9702 0 0 7.9702 95.6409 649.1337 Tm [(THE)-330.8(GUIDELINES)]TJ /F7 1 Tf 11.9551 0 0 11.9551 401.3857 649.1337 Tm (35)Tj ET endstream endobj 103 0 obj << /Type /Page /Parent 394 0 R /Resources 104 0 R /Contents 105 0 R /MediaBox [ 0 0 595 842 ] /CropBox [ 0 0 595 842 ] /Rotate 0 >> endobj 104 0 obj << /ProcSet [ /PDF /Text ] /Font << /F2 337 0 R /F5 340 0 R /F6 341 0 R /F7 342 0 R >> /ExtGState << /GS1 434 0 R >> /ColorSpace << /DefaultCMYK 417 0 R /Cs6 416 0 R >> >> endobj 105 0 obj << /Length 6361 >> stream q 1 i 0.015 737.008 510.221 -737.008 re W n /Cs6 cs 0 0 0 scn /GS1 gs 0.015 709.001 25.44 -0.284 re f Q /Cs6 cs 0 0 0 scn /GS1 gs 28.006 737.008 0.283 -25.455 re f 481.89 737.008 0.283 -25.455 re f 484.724 709.001 25.512 -0.284 re f 484.724 28.346 25.512 -0.283 re f 481.89 25.512 0.283 -25.512 re f q 1 i 0.015 737.008 510.221 -737.008 re W n 28.006 25.512 0.283 -25.512 re f 0.015 28.346 25.44 -0.283 re f Q BT /F2 1 Tf 10.7396 0 0 10.959 95.6409 610.129 Tm 0 Tc 0 Tw [(privacy)-429.8(and)-423.1(confidentiality)-427(or)-424.9(anonymity)-428.6(are)-425.3(assured,)-424.5(and)-428.4(that)-425.2(the)]TJ 0 -1.2312 TD [(research)-377.8(is)-379.7(designed)-374.4(to)-376.6(answer)-375.1(an)-373.3(important)-372.8(question)-373.7(and)-375.6(would)-375.5(be)]TJ T* [(impracticable)-511.6(if)-505.6(the)-509.8(requirement)-507.5(for)-509(informed)-504.9(consent)-505.3(were)-509.3(to)-508.6(be)]TJ T* [(imposed.)-240.6(Patients)-233.7(have)-238.7(a)-239(right)-235.2(to)-239.4(know)-239(that)-235.2(their)-240.1(records)-234.9(or)-240.2(specimens)]TJ 0 -1.2364 TD [(may)-247.3(be)-241(used)-243.6(for)-245(research.)-239.8(Refusal)-242.3(or)-245.5(reluctance)-242.1(of)-244.7(individuals)-241.6(to)-244.7(agree)]TJ 0 -1.2312 TD [(to)-355.5(participate)-350.9(would)-354.4(not)-352.5(be)-351.8(evidence)-353(of)-355.5(impracticab)6.1(ility)-357.7(sufficient)-352.8(to)]TJ T* 0.0188 Tc [(warrant)-619.5(w)-2.2(aiving)-626.7(in)-4.6(formed)-622.2(consent.)-624.4(Records)-620.3(a)-3.8(nd)-622.2(specimens)-620.3(o)0.7(f)]TJ T* 0 Tc [(individuals)-384.2(who)-384.6(have)-386.5(specifically)-380.3(rejected)-386.1(such)-386.1(uses)-384.2(in)-381.6(the)-388.3(past)-383.8(may)]TJ T* [(be)-214.6(used)-211.9(only)-211.2(in)-217.9(the)-208.9(case)-215.3(of)-213(public)-212.3(health)-211.9(emergencies.)-210.8(\(See)-215.3(Guideline)-208.9(18)]TJ T* (Commentary,)Tj /F5 1 Tf 6.1604 0 TD [(Confidentiality)-264.3(between)-269.1(physician)-266.1(and)-268.4(patient\).)]TJ -6.1604 -2.3745 TD [(Secondary)-208.5(use)-208.9(of)-206.9(research)-208.1(records)-206.9(or)-213(biological)-206.1(specimens.)]TJ /F2 1 Tf 24.1824 0 TD (Investigators)Tj -24.1824 -1.2364 TD 0.0169 Tc [(ma)10.1(y)-591.7(w)6.4(a)4.9(n)4.1(t)-589.7(t)1.5(o)-587.2(u)4.1(s)6(e)-591.3(r)]TJ 9.1113 0 TD 0.0115 Tc [(ecords)-595.9(o)3.9(r)-595.9(b)-1.3(iologic)-5.5(a)4.7(l)-600.1(s)0.6(pecimens)-601.2(that)-595.1(anothe)-5.5(r)]TJ -9.1113 -1.2364 TD 0 Tc [(investigator)-277.7(has)-278.6(used)-280.6(or)-277.1(collected)-276.4(for)-282(use,)-277.5(in)-281.3(another)-273.3(institution)-280.4(in)-276(the)]TJ T* [(same)-205.1(or)-203.2(another)-204.7(country.)-203.9(This)-201.6(raises)-203.5(the)-203.6(issue)-209.2(of)-202.4(whether)-202(the)-203.6(records)-203.2(or)]TJ T* [(specimens)-584.8(contain)-578.4(personal)-579.5(identifiers,)-584.3(or)-583.3(can)-580.3(be)-584.1(linked)-581.8(to)-582.5(such)]TJ T* 0.0089 Tc [(id)-3.9(entifiers)8.9(,)-597.7(and)-589.9(b)1.3(y)-594.4(w)-1.6(hom.)-592.1(\()-1.2(See)-588.8(a)-3.1(ls)8.9(o)-600.8(G)2.1(uideline)-588.8(1)-3.2(8:)]TJ /F5 1 Tf 24.0716 0 TD 0.0074 Tc [(Sa)-4.6(f)7.4(e)-9.2(gua)]TJ 3.4365 0 TD 0 Tc [(rd)-17.7(i)-9.8(n)-6.8(g)]TJ -27.5081 -1.2364 TD (confidentiality)Tj /F2 1 Tf 5.9545 0 TD 0.4905 Tc (\)I)Tj 1.2085 0 TD (f)Tj 0.8291 0 TD 0 Tc [(informed)-489(consent)-489.4(or)-493.6(permission)-494.7(was)-492.7(required)-489.4(to)]TJ -7.9922 -1.2364 TD [(authorize)-199.8(the)-203.6(original)-200.9(collection)-197.6(or)-203.2(use)-199.1(of)-202.4(such)-201.4(records)-198(or)-203.2(specimens)-199.5(for)]TJ T* [(research)-446.4(purposes,)-443.4(secondary)-440.4(uses)-442.3(are)-446.4(generally)-440.7(constrained)-445.3(by)-441.9(the)]TJ T* [(conditions)-185.1(specified)-185.9(in)-186.3(the)-187.8(original)-185.1(consent.)-182.5(Consequently,)-182.4(it)-188.8(is)-189.6(essential)]TJ T* [(that)-346(the)-351.4(original)-343.4(consent)-346.9(process)-345.8(anticipate,)-344.5(to)-345(the)-346.1(extent)-348.3(that)-346(this)-344.6(is)]TJ T* [(feasible,)-177.9(any)-174.2(foreseeable)-173.8(plans)-174.6(for)-171.1(future)-174.1(use)-172.7(of)-176.1(the)-177.2(records)-171.6(or)-176.8(specimens)]TJ T* [(for)-181.7(research.)-176.4(Thus,)-182.8(in)-181(the)-177.2(original)-179.8(process)-176.8(of)-181.3(seeking)-176.8(informed)-177.6(consent)-178(a)]TJ T* [(member)-219.1(of)-213(the)-214.1(research)-214.2(team)-214.9(should)-214.6(discuss)-211.9(with,)-216.7(and,)-216.4(when)-211.5(indicated,)]TJ T* [(request)-250(the)-251.1(permission)-246.6(of,)-249.2(prospective)-248.8(subjects)-249.2(as)-244.7(to:)]TJ 10.959 0 0 10.959 109.8142 256.8188 Tm [(i\))-949(whether)-362.5(there)-359.8(will)-365.4(or)-361.5(could)-358.1(be)-361.2(any)-362.1(secondary)-355.9(use)-364.2(and,)-360.8(if)-359.2(so,)]TJ 1.552 -1.2364 TD [(whether)-295.2(such)-293.3(secondary)-288.7(use)-291.8(will)-298.1(be)-294(limited)-294.8(with)-294.6(regard)-288(to)-294.5(the)]TJ T* [(type)-273.2(of)-268.6(study)-264.6(that)-268.5(may)-268(be)-273.3(performed)-268.2(on)-266.9(such)-267.4(materials;)]TJ -1.552 -1.4692 TD [(ii\))-679(the)-390.3(conditions)-387.1(under)-382.8(which)-388.7(investigators)-386.9(will)-391.3(be)-387.1(required)-387.5(to)]TJ 1.552 -1.2364 TD [(contact)-322.1(the)-323.1(research)-320.5(subjects)-316.8(for)-323.3(additional)-320.4(authorization)-316.4(for)]TJ T* [(secondary)-268(use;)]TJ -1.552 -1.4692 TD [(iii\))-409(the)-183.4(investigators)-184.1(plans,)-181.8(if)-188.5(any,)-180(to)-185.9(destroy)-177.2(or)-185.6(to)-185.9(strip)-180.5(of)-185.9(personal)]TJ 1.552 -1.2364 TD [(identifiers)-271.5(the)-271.3(records)-265.8(or)-268.4(specimens;)-269.3(and)]TJ -1.552 -1.4847 TD [(iv\))-449(the)-276.5(rights)-275.4(of)-273.8(subjects)-275.4(to)-273.8(request)-271.3(destruction)-276.6(or)-273.5(anonymization)]TJ 1.552 -1.2571 TD [(of)-315.2(biological)-317.4(specimens)-311.7(or)-314.9(of)-315.2(records)-312.4(or)-314.9(parts)-312.6(of)-310(records)-317.6(that)]TJ 0 -1.2623 TD [(they)-562.9(might)-554.5(consider)-558.2(particularly)-560.7(sensitive,)-558.2(such)-557.1(as)-558.3(photo-)]TJ 0 -1.2571 TD [(graphs,)-270.3(videotapes)-267.2(or)-268.4(audiotapes.)]TJ ET 95.641 646.809 318.898 -0.51 re f BT /F6 1 Tf 7.9702 0 0 7.9702 191.1118 649.1337 Tm [(INTERNA)13.4(TIONAL)-327.4(ETHICAL)-327.5(GUIDELINES)-319.8(FOR)-332.5(BIOMED)13.7(ICAL)-331.1(RESEARCH)]TJ /F7 1 Tf 11.9551 0 0 11.9551 95.6409 649.1337 Tm (36)Tj ET endstream endobj 106 0 obj << /Type /Page /Parent 394 0 R /Resources 107 0 R /Contents 108 0 R /MediaBox [ 0 0 595 842 ] /CropBox [ 0 0 595 842 ] /Rotate 0 >> endobj 107 0 obj << /ProcSet [ /PDF /Text ] /Font << /F2 337 0 R /F5 340 0 R /F6 341 0 R /F7 342 0 R /F8 343 0 R /F11 346 0 R >> /ExtGState << /GS1 434 0 R >> /ColorSpace << /DefaultCMYK 417 0 R /Cs6 416 0 R >> >> endobj 108 0 obj << /Length 5203 >> stream q 1 i 0.015 737.008 510.221 -737.008 re W n /Cs6 cs 0 0 0 scn /GS1 gs 0.015 709.001 25.44 -0.284 re f Q /Cs6 cs 0 0 0 scn /GS1 gs 28.006 737.008 0.283 -25.455 re f 481.89 737.008 0.283 -25.455 re f 484.724 709.001 25.512 -0.284 re f 484.724 28.346 25.512 -0.283 re f 481.89 25.512 0.283 -25.512 re f q 1 i 0.015 737.008 510.221 -737.008 re W n 28.006 25.512 0.283 -25.512 re f 0.015 28.346 25.44 -0.283 re f Q 1 1 1 scn 95.641 534.841 14.173 -2.835 re f 0 0 0 scn 95.641 555.023 318.898 -20.183 re f 1 1 1 scn 95.641 484.214 14.173 -2.835 re f 0.8 0.8 0.8 scn 95.641 532.006 318.898 -47.792 re f BT /F2 1 Tf 10.959 0 0 10.959 109.8142 609.8455 Tm 0 0 0 scn 0 Tc 0 Tw [(\(See)-574.1(also)-574.4(Guidelines)-574.5(5:)]TJ /F5 1 Tf 11.0809 0 TD [(Obtaining)-575(informed)-572.9(consent:)-573.9(Essential)]TJ -12.3742 -1.2623 TD [(information)-395(for)-390.9(prospective)-391.9(research)-393.2(subjects;)]TJ /F2 1 Tf 19.7098 0 TD (6:)Tj /F5 1 Tf 1.164 0 TD [(Obtaining)-393.9(informed)]TJ -20.8738 -1.2571 TD [(consent:)-284.2(Obligations)-282.1(of)-284.4(sponsors)-283(and)-284.8(investigators;)]TJ /F2 1 Tf 21.3652 0 TD [(and)-284.2(7:)]TJ /F5 1 Tf 2.9384 0 TD (Inducement)Tj -24.3036 -1.2623 TD [(to)-274.1(participate)-263.3(in)-269.8(research.\))]TJ /F11 1 Tf 11.9551 0 3.5865 11.9551 218.8913 540.3967 Tm 1 1 1 scn [(Guideline)-278.6(5)]TJ 11.9551 0 0 11.9551 163.6724 517.3794 Tm 0 0 0 scn [(Obtaining)-277.4(inf)-7(ormed)-273.4(consent:)]TJ 1.8874 -1.1523 TD [(Essential)-277.8(information)]TJ -3.3195 -1.1523 TD [(for)-271.3(prospe)-8.1(ctive)-273.6(research)-275.6(subjects)]TJ /F8 1 Tf 10.959 0 0 10.959 95.6409 468.3967 Tm [(Before)-540(requesting)-538.1(an)-535.6(individuals)-537.6(consent)-540(to)-538(participate)-540(in)]TJ 0 -1.2364 TD 0.0435 Tc [(re)-4.6(search,)-648.7(t)-1.8(he)-646.1(investigator)-647.5(must)-648.4(provide)-646.1(t)-1.8(he)-651.2(following)]TJ T* 0 Tc [(information,)-453.8(in)-450.3(language)-448.4(or)-454.3(another)-448.3(form)-447.5(of)-455.2(communication)]TJ T* [(that)-274.5(the)-265.4(individual)-268(can)-268.2(understand:)]TJ 1.7951 -1.5313 TD [(1\))-434.8(that)-367.6(the)-368.8(individual)-366.3(is)-367.8(invited)-364.5(to)-372.5(participate)-364.1(in)-367.6(research,)]TJ 1.3088 -1.2364 TD [(the)-389.5(reasons)-379(for)-385.8(considering)-384.4(the)-384.4(individual)-387(suitable)-381.5(for)]TJ T* [(the)-270.5(research,)-267.4(and)-267.9(that)-269.3(participation)-271(is)-269.5(voluntary;)]TJ -1.3088 -1.2364 TD [(2\))-434.8(that)-238.2(the)-234.3(individual)-231.8(is)-233.3(free)-237.6(to)-232.8(refuse)-235.2(to)-232.8(participate)-234.8(and)-231.7(will)]TJ 1.3088 -1.2364 TD [(be)-194.2(free)-191(to)-191.4(withdraw)-192.7(from)-188.8(the)-192.9(research)-185.6(at)-196.9(any)-190.6(time)-190.3(without)]TJ 0 -1.2312 TD [(penalty)-444.6(or)-444(loss)-443.1(of)-444.9(benefits)-443.4(to)-444.9(which)-443.6(he)-447.7(or)-444(she)-438.9(would)]TJ 0 -1.2364 TD [(otherwise)-272.5(be)-266.6(entitled;)]TJ -1.3088 -1.2364 TD [(3\))-434.8(the)-177.4(purpose)-171.5(of)-170.7(the)-172.3(research,)-174.3(the)-172.3(procedures)-167.2(to)-175.9(be)-173.5(carried)]TJ 1.3088 -1.2364 TD 0.0333 Tc [(out)-637.9(b)1(y)-635.6(t)-1.7(he)-635.6(investigator)-637(and)-635.3(t)-1.6(he)-635.6(subject,)-638.2(a)0.7(nd)-640.5(an)]TJ T* 0 Tc [(explanation)-494.3(of)-491.5(how)-494.8(the)-493(research)-490.9(differs)-495.3(from)-494.1(routine)]TJ T* [(medical)-272.5(care;)]TJ -1.3088 -1.2364 TD [(4\))-434.8(for)-437.5(controlled)-437.3(trials,)-436.4(an)-437.3(explanation)-432.2(of)-434.6(features)-437.3(of)-434.6(the)]TJ 1.3088 -1.2364 TD -0.0001 Tc [(research)-346.1(design)-347.4(\(e.g.,)-345.3(randomization,)-346(double-blinding\),)]TJ T* 0 Tc [(and)-474.8(that)-476.2(the)-472.3(subject)-475.7(will)-473.8(not)-477.2(be)-473.6(told)-476.2(of)-475.9(the)-472.3(assigned)]TJ T* [(treatment)-392.7(until)-392.5(the)-389.5(study)-387.2(has)-392.3(been)-388.4(completed)-383.4(and)-392.1(the)]TJ T* [(blind)-270.8(has)-268.2(been)-269.4(broken;)]TJ -1.3088 -1.2364 TD [(5\))-434.8(the)-425.7(expected)-422.8(duration)-426.4(of)-424.2(the)-425.7(individuals)-423.8(participation)]TJ 1.3088 -1.2364 TD [(\(including)-246.8(number)-245.9(and)-247.2(duration)-245.3(of)-248.3(visits)-249.7(to)-248.3(the)-244.7(research)]TJ T* [(centre)-261.1(and)-257.6(the)-260.2(total)-258(time)-262.7(involved\))-253.5(and)-257.6(the)-260.2(possibility)-261.8(of)]TJ T* 0.0104 Tc [(ea)3.7(rly)-611.9(t)1.3(ermin)4(a)3.7(tio)4(n)]TJ 9.053 0 TD 0.0079 Tc [(of)-616.8(the)-614.4(t)-1.2(ria)-4(l)-611.9(o)-3.7(r)-610.7(of)-616.8(th)-3.7(e)-609.2(i)-1.5(n)-3.7(d)1.5(iv)-4(idua)-4(ls)]TJ -9.053 -1.2364 TD 0 Tc [(participation)-271(in)-269.3(it;)]TJ -1.3088 -1.2364 TD [(6\))-434.8(whether)-266.8(money)-263.9(or)-268.1(other)-264.5(forms)-262.8(of)-269(material)-262.6(goods)-265.3(will)-266.8(be)]TJ 1.3088 -1.2364 TD [(provided)-170.5(in)-171(return)-164(for)-173.7(the)-167.1(individuals)-170.3(participation)-167.6(and,)-168.6(if)]TJ T* [(so,)-270.8(the)-270.5(kind)-266.9(and)-267.9(amount;)]TJ ET 95.641 646.809 318.898 -0.51 re f BT /F6 1 Tf 7.9702 0 0 7.9702 95.6409 649.1337 Tm [(THE)-330.8(GUIDELINES)]TJ /F7 1 Tf 11.9551 0 0 11.9551 401.3857 649.1337 Tm (37)Tj ET endstream endobj 109 0 obj << /Type /Page /Parent 394 0 R /Resources 110 0 R /Contents 111 0 R /MediaBox [ 0 0 595 842 ] /CropBox [ 0 0 595 842 ] /Rotate 0 >> endobj 110 0 obj << /ProcSet [ /PDF /Text ] /Font << /F6 341 0 R /F7 342 0 R /F8 343 0 R >> /ExtGState << /GS1 434 0 R >> /ColorSpace << /DefaultCMYK 417 0 R /Cs6 416 0 R >> >> endobj 111 0 obj << /Length 5801 >> stream q 1 i 0.015 737.008 510.221 -737.008 re W n /Cs6 cs 0 0 0 scn /GS1 gs 0.015 709.001 25.44 -0.284 re f Q /Cs6 cs 0 0 0 scn /GS1 gs 28.006 737.008 0.283 -25.455 re f 481.89 737.008 0.283 -25.455 re f 484.724 709.001 25.512 -0.284 re f 484.724 28.346 25.512 -0.283 re f 481.89 25.512 0.283 -25.512 re f q 1 i 0.015 737.008 510.221 -737.008 re W n 28.006 25.512 0.283 -25.512 re f 0.015 28.346 25.44 -0.283 re f Q BT /F8 1 Tf 10.959 0 0 10.959 115.3134 609.8455 Tm 0 Tc 0 Tw [(7\))-434.8(that,)-335.5(after)-334.6(the)-332.6(completion)-330.4(of)-336.3(the)-332.6(study,)-329.3(subjects)-332.3(will)-334.1(be)]TJ 1.3088 -1.2623 TD [(informed)-290.2(of)-284.5(the)-286.1(findings)-287.9(of)-284.5(the)-291.2(research)-283.9(in)-284.8(general,)-287.5(and)]TJ 0 -1.2571 TD [(individual)-340.4(subjects)-337.5(will)-344.4(be)-339.1(informed)-336.8(of)-341.4(any)-335.4(finding)-343.3(that)]TJ 0 -1.2623 TD [(relates)-270.7(to)-269(their)-272.5(particular)-268.5(health)-267.2(status;)]TJ -1.3088 -1.2571 TD [(8\))-434.8(that)-377.9(subjects)-368.6(have)-373.2(the)-374(right)-375.7(of)-372.5(access)-371.3(to)-372.5(their)-376(data)-370.4(on)]TJ 1.3088 -1.2571 TD [(demand,)-212.4(even)-212.8(if)-209.8(these)-211.5(data)-215.2(lack)-210.5(immediate)-208.8(clinical)-214(utility)]TJ 0 -1.2623 TD [(\(u)-10.3(nle)-7(ss)-608.3(th)-10.3(e)-606.8(eth)-6.7(ica)-7.2(l)-609.4(r)0(e)-9.7(vie)-7.2(w)-606.1(c)0(o)-8(mmi)-8.6(tte)-9.4(e)-606.8(has)-614.8(appr)-7.1(ov)-8(ed)]TJ 0 -1.2571 TD 0.0072 Tc [(tem)7.2(p)-4(orar)7.2(y)-612.9(o)0.8(r)-611.4(p)0.8(e)7.2(r)-2.5(m)7.2(a)-4.3(nent)-607.1(non-di)7.2(sclos)7.2(u)-0.8(re)-609.9(of)-607.1(data,)-607.4(i)-2.1(n)]TJ T* 0 Tc [(which)-562.6(case)-559.7(the)-560.2(subject)-558.4(should)-559.1(be)-561.5(informed)-559.2(of,)-562.9(and)]TJ 0 -1.2623 TD [(given,)-272.6(the)-265.4(reasons)-270.3(for)-266.8(such)-269.4(non-disclosu)6.5(re\);)]TJ -1.3088 -1.2571 TD [(9\))-434.8(a)-32.6(n)-27.1(y)-663.7(f)-29.8(o)-27.1(r)]TJ 5.137 0 TD (e)Tj 0.5846 0 TD 0.0282 Tc [(see)-4.4(able)-635.5(ris)-4.4(ks,)-638.1(pain)-635.2(or)-637(dis)-4.4(c)0.8(omfort)-6.8(,)-633(o)1.1(r)-637(i)-1.8(n-)]TJ -4.4127 -1.2623 TD 0 Tc [(convenience)-535.8(to)-543.2(the)-539.6(individual)-537(\(or)-541(others\))-538.9(associated)]TJ 0 -1.2571 TD [(with)-289.5(participation)-281.4(in)-284.8(the)-280.9(research,)-283(including)-284.3(risks)-280.8(to)-284.5(the)]TJ T* [(health)-272.4(or)-268.1(well-being)-267.3(of)-269(a)-270.5(subjects)-269.3(spouse)-267.1(or)-268.1(partner;)]TJ -1.8106 -1.2622 TD [(10\))-384.6(the)-265.4(direct)-268.9(benefits,)-261.3(if)-266.8(any,)-267.2(expected)-257.3(to)-269(result)-263.7(to)-263.8(subjects)]TJ 1.8106 -1.2571 TD [(from)-271.6(participating)-265.8(in)-274.4(the)-265.4(research;)]TJ -1.8106 -1.2623 TD [(11\))-384.6(the)-280.9(expected)-278(benefits)-277.8(of)-284.5(the)-275.7(research)-278.8(to)-279.4(the)-280.9(community)]TJ 1.8106 -1.2571 TD [(or)-588.8(to)-589.7(society)-584.6(at)-584.8(large,)-589.9(or)-583.7(contributions)-583.4(to)-589.7(scientific)]TJ T* (knowledge;)Tj -1.8106 -1.2623 TD [(12\))-384.6(whether,)-369.3(when)-361.8(and)-366.2(how)-365.5(any)-366.5(products)-361.7(or)-366.4(interventions)]TJ 1.8106 -1.2571 TD [(proven)-335.8(by)-339.1(the)-337.8(research)-335.7(to)-341.4(be)-333.9(safe)-339.6(and)-335.2(effective)-339.2(will)-339.3(be)]TJ T* [(made)-417.8(available)-419.8(to)-419(subjects)-420.3(after)-417.4(they)-422.1(have)-414.6(completed)]TJ 0 -1.2623 TD [(their)-257(participation)-255.5(in)-253.8(the)-255(research,)-251.9(and)-257.6(whether)-251.3(they)-256.6(will)]TJ 0 -1.2571 TD [(be)-271.8(expected)-267.6(to)-269(pay)-268.2(for)-266.8(them;)]TJ -1.8106 -1.2622 TD [(13\))-384.6(a)-17(n)-16.8(y)-632.7(c)-11.9(u)-16.8(r)-13.3(r)-13.3(e)-17(n)-11.6(t)-14.3(l)-19.7(y)]TJ 9.1617 0 TD 0.0135 Tc [(av)-3.5(ail)-6.2(a)1.6(ble)-619.2(a)1.6(lt)-5.9(er)-5(na)-3.5(tiv)-3.5(e)-619.2(int)-5.9(e)1.6(rv)-3.5(entions)-619.2(o)-3.3(r)]TJ -7.3511 -1.2571 TD 0 Tc [(courses)-270.3(of)-269(treatment;)]TJ -1.8106 -1.2571 TD [(14\))-384.6(the)-192.9(provisions)-191.8(that)-191.7(will)-194.4(be)-189(made)-190.2(to)-191.4(ensure)-191.2(respect)-185(for)-194.4(the)]TJ 1.8106 -1.2623 TD [(privacy)-226.7(of)-232.8(subjects)-223.7(and)-226.5(for)-230.6(the)-224(confidentiality)-231.1(of)-227.6(records)]TJ 0 -1.2571 TD [(in)-274.4(which)-267.7(subjects)-265.1(are)-269.9(identified;)]TJ -1.8106 -1.2623 TD [(15\))-384.6(the)-348.1(limits,)-347.7(legal)-349(or)-345.7(other,)-346.2(to)-351.8(the)-343(investigators)-345.2(ability)-346.7(to)]TJ 1.8106 -1.2571 TD 0.0208 Tc [(sa)3.8(fe)]TJ 2.0537 0 TD 0.0173 Tc [(guard)-620.3(co)-4.7(nfid)-4.7(entia)-4.9(l)2.8(ity,)-623.2(and)-625.4(t)3(h)-4.7(e)-620.5(possible)-620.5(c)0.3(o)-4.7(n)0.5(se-)]TJ -2.0537 -1.2571 TD 0 Tc [(quences)-268.6(of)-269(breaches)-266.7(of)-269(confidentiality;)]TJ -1.8106 -1.2623 TD [(16\))-384.6(policy)-314(with)-315.4(regard)-311.6(to)-315.6(the)-317.1(use)-314.7(of)-310.4(results)-317(of)-315.6(genetic)-310.1(tests)]TJ 1.8106 -1.2571 TD [(and)-283.4(familial)-287.2(genetic)-284.2(information,)-283.1(and)-283.4(the)-286.1(precautions)-281(in)]TJ T* [(place)-294.6(to)-294.9(prevent)-288.2(disclosure)-290.3(of)-294.9(the)-291.2(results)-291.1(of)-294.9(a)-291.2(subjects)]TJ 0 -1.2623 TD [(genetic)-330.8(tests)-328(to)-331.1(immediate)-327.8(family)-330.5(relatives)-328.2(or)-330.2(to)-325.9(others)]TJ 0 -1.2571 TD [(\(e.g.,)-443.5(insurance)-431(companies)-432.8(or)-438.8(employers\))-438.4(without)-435.7(the)]TJ 0 -1.2623 TD [(consent)-271(of)-269(the)-270.5(subject;)]TJ ET 95.641 646.809 318.898 -0.51 re f BT /F6 1 Tf 7.9702 0 0 7.9702 191.1118 649.1337 Tm [(INTERNA)13.4(TIONAL)-327.4(ETHICAL)-327.5(GUIDELINES)-319.8(FOR)-332.5(BIOMED)13.7(ICAL)-331.1(RESEARCH)]TJ /F7 1 Tf 11.9551 0 0 11.9551 95.6409 649.1337 Tm (38)Tj ET endstream endobj 112 0 obj << /Type /Page /Parent 394 0 R /Resources 113 0 R /Contents 114 0 R /MediaBox [ 0 0 595 842 ] /CropBox [ 0 0 595 842 ] /Rotate 0 >> endobj 113 0 obj << /ProcSet [ /PDF /Text ] /Font << /F6 341 0 R /F7 342 0 R /F8 343 0 R >> /ExtGState << /GS1 434 0 R >> /ColorSpace << /DefaultCMYK 417 0 R /Cs6 416 0 R >> >> endobj 114 0 obj << /Length 5690 >> stream q 1 i 0.015 737.008 510.221 -737.008 re W n /Cs6 cs 0 0 0 scn /GS1 gs 0.015 709.001 25.44 -0.284 re f Q /Cs6 cs 0 0 0 scn /GS1 gs 28.006 737.008 0.283 -25.455 re f 481.89 737.008 0.283 -25.455 re f 484.724 709.001 25.512 -0.284 re f 484.724 28.346 25.512 -0.283 re f 481.89 25.512 0.283 -25.512 re f q 1 i 0.015 737.008 510.221 -737.008 re W n 28.006 25.512 0.283 -25.512 re f 0.015 28.346 25.44 -0.283 re f Q BT /F8 1 Tf 10.959 0 0 10.959 109.8142 609.8455 Tm 0 Tc 0 Tw [(17\))-384.6(the)-265.4(sponsors)-261(of)-269(the)-265.4(research,)-262.3(the)-265.4(institutional)-264.2(affiliation)]TJ 1.8106 -1.2623 TD [(of)-558.7(the)-555.1(investigators,)-552.2(and)-557.6(the)-555.1(nature)-555.7(and)-552.4(sources)-554.9(of)]TJ 0 -1.2571 TD [(funding)-267.9(for)-272(the)-270.5(research;)]TJ -1.8106 -1.2623 TD [(18\))-384.6(the)-322.3(possible)-316.8(research)-315(uses,)-315.3(direct)-320.6(or)-319.8(secondary,)-313.5(of)-320.7(the)]TJ 1.8106 -1.2571 TD [(subjects)-336.5(medical)-329.4(records)-333.9(and)-330(of)-336.3(biological)-330.1(specimens)]TJ T* [(taken)-185.7(in)-186.5(the)-182.6(course)-180.9(of)-186.2(clinical)-183(care)-183.5(\(See)-184.2(also)-184.4(Guidelines)-182.1(4)]TJ 0 -1.2623 TD [(and)-273.1(18)-266.9(Commentaries\))7(;)]TJ -1.8106 -1.2571 TD [(19\))-384.6(whether)-173.7(it)-173.6(is)-176.4(planned)-167.5(that)-176.2(biological)-169.7(specimens)-169.2(collected)]TJ 1.8106 -1.2571 TD [(in)-196.8(the)-192.9(research)-185.7(will)-194.4(be)-194.2(destroyed)-187.6(at)-196.9(its)-190.7(conclusion,)-189(and,)-194.5(if)]TJ 0 -1.2623 TD [(not,)-465.9(details)-463(about)-459.3(their)-464(storage)-458.9(\(where,)-461.1(how,)-462.8(for)-458.2(how)]TJ 0 -1.2571 TD [(long,)-250.1(and)-252.4(final)-247.9(disposition\))-252.2(and)-247.2(possible)-249.6(future)-247.7(use,)-251.7(and)]TJ 0 -1.2623 TD [(that)-274.5(subjects)-265.1(have)-269.7(the)-265.4(right)-272.3(to)-269(decide)-270(about)-267.9(such)-269.4(future)]TJ 0 -1.2571 TD 0.0277 Tc [(use,)-628.3(to)-625.4(re)5.5(fuse)-625.6(stora)5.5(g)0.6(e,)-628.3(and)-625.4(t)-2.1(o)-625.4(h)0.6(ave)-625.7(the)-625.6(m)2.2(ate)5.5(r)-1.2(ial)]TJ T* 0 Tc [(destroyed)-270.3(\(See)-267(Guideline)-268.5(4)-270.5(Commentary\))7.6(;)]TJ -1.8106 -1.2622 TD [(20\))-384.6(whether)-375.5(commercial)-375(products)-372(may)-370(be)-375.3(developed)-372.4(from)]TJ 1.8106 -1.2571 TD [(biological)-397.3(specimens,)-390.7(and)-392.1(whether)-391(the)-394.7(participant)-394.9(will)]TJ 0 -1.2623 TD (r)Tj 0.3932 0 TD [(ecei)-8.8(ve)-613.5(mon)-7.3(eta)-7(ry)-609.8(o)-6.4(r)-608.2(oth)-6.4(er)-615(bene)-10.8(fits)-618.8(fr)-6.9(om)-611.3(the)-612(d)-6.4(evel)-8.8(-)]TJ -0.3932 -1.2571 TD [(opment)-267.5(of)-274.2(such)-264.3(products;)]TJ -1.8106 -1.2571 TD (21\))Tj 10.7396 0 0 10.959 129.6567 361.4739 Tm [(whether)-186(the)-179.6(investigator)-180.8(is)-181(serving)-181.5(only)-181.8(as)-184(an)-179.6(investigator)]TJ 0 -1.2623 TD [(or)-251.5(as)-247.4(both)-252(investiga)7.4(tor)-251.5(and)-251.2(the)-248.2(subjects)-246(physician;)]TJ 10.959 0 0 10.959 109.8142 333.8645 Tm [(22\))-384.6(the)-275.7(extent)-267.2(of)-274.2(the)-270.5(investigators)-267.7(responsibility)-267.6(to)-274.2(provide)]TJ 1.8106 -1.2571 TD [(medical)-272.5(services)-264.7(to)-269(the)-270.5(participant;)]TJ -1.8106 -1.2623 TD (23\))Tj 10.7396 0 0 10.959 129.6567 306.255 Tm [(that)-195.4(treatment)-196.9(will)-193.7(be)-195.4(provided)-190.6(free)-195(of)-193.1(charge)-192.8(for)-198.8(specified)]TJ 0 -1.2571 TD [(ty)-7.6(pes)-609.4(of)-604.9(rese)-7.2(arch-)-8(related)-611.3(in)-7.6(jury)-612(or)-605.2(for)-610.5(compli)-8.7(cati)-9.1(ons)]TJ 0 -1.2622 TD [(associated)-304.1(with)-309.2(the)-306.3(research,)-299.5(the)-306.3(nature)-306.7(and)-304(duration)-304.5(of)]TJ 0 -1.2571 TD [(such)-243(care,)-238.7(the)-242.9(name)-241.8(of)-240.6(the)-242.9(organization)-236.6(or)-246.3(individual)-240.7(that)]TJ T* [(will)-584.3(provide)-578.2(the)-580.8(treatment,)-581.5(and)-578.5(whether)-576.6(there)-583.4(is)-576.9(any)]TJ 0 -1.2623 TD [(uncertainty)-271.3(regarding)-264.9(funding)-268(of)-267(such)-269.4(treatment.)]TJ 10.959 0 0 10.959 109.8142 223.4834 Tm [(24\))-384.6(in)-207.2(what)-204.1(way,)-199.5(and)-200.6(by)-204.6(what)-204.1(organization,)-201.4(the)-203.3(subject)-201.5(or)-200.8(the)]TJ 1.8106 -1.2623 TD [(subjects)-274.4(family)-273.6(or)-268.1(dependants)-269.9(will)-277.2(be)-271.8(compensated)-264.6(for)]TJ 0 -1.2571 TD [(disability)-333(or)-330.2(death)-330.3(resulting)-327.4(from)-333.7(such)-326.3(injury)-331(\(or,)-333.1(when)]TJ T* 0.0079 Tc [(ind)7.9(i)]TJ 1.7744 0 TD 0 Tc [(ca)-8.2(t)-9.1(e)0(d)-8(,)-614.6(th)-10.4(a)-6.7(t)-614.3(t)-9.1(h)0(e)-8(r)0(e)-620.1(a)0(r)-9.7(e)-612(n)-6.4(o)-616.9(pl)-10.6(an)-8(s)-617.1(t)0(o)-615.6(p)-6.4(r)-8.2(o)0(v)-8(i)0(d)-10.6(e)-617.1(su)-8(c)-6.7(h)]TJ -1.7744 -1.2623 TD (compensation\);)Tj -1.8106 -1.2571 TD [(25\))-384.6(whether)-308.2(or)-304.3(not,)-305.5(in)-305.5(the)-306.8(country)-303.5(in)-305.5(which)-303.9(the)-306.8(prospective)]TJ 1.8106 -1.2571 TD [(subject)-310.1(is)-305.8(invited)-307.6(to)-310.4(participate)-307.2(in)-305.5(research,)-303.6(the)-311.9(right)-303.3(to)]TJ 0 -1.2623 TD [(compensation)-268.5(is)-269.5(legally)-266.7(guaranteed;)]TJ -1.8106 -1.2571 TD [(26\))-384.6(t)-14.3(h)-11.6(a)-11.9(t)]TJ 4.273 0 TD 0.0116 Tc [(an)-610.4(eth)5.2(i)-2.9(ca)4.9(l)-618.5(r)3.4(eview)-615.2(c)4.9(o)0(mmittee)-610.7(has)-610.7(a)-0.3(pproved)-610.4(or)]TJ -2.4624 -1.2623 TD 0 Tc [(cleared)-268.1(the)-270.5(research)-268.4(protocol.)]TJ ET 95.641 646.809 318.898 -0.51 re f BT /F6 1 Tf 7.9702 0 0 7.9702 95.6409 649.1337 Tm [(THE)-330.8(GUIDELINES)]TJ /F7 1 Tf 11.9551 0 0 11.9551 401.3857 649.1337 Tm (39)Tj ET endstream endobj 115 0 obj << /Type /Page /Parent 394 0 R /Resources 116 0 R /Contents 117 0 R /MediaBox [ 0 0 595 842 ] /CropBox [ 0 0 595 842 ] /Rotate 0 >> endobj 116 0 obj << /ProcSet [ /PDF /Text ] /Font << /F2 337 0 R /F6 341 0 R /F7 342 0 R /F8 343 0 R /F10 345 0 R /F11 346 0 R >> /ExtGState << /GS1 434 0 R >> /ColorSpace << /DefaultCMYK 417 0 R /Cs6 416 0 R >> >> endobj 117 0 obj << /Length 5504 >> stream q 1 i 0.015 737.008 510.221 -737.008 re W n /Cs6 cs 0 0 0 scn /GS1 gs 0.015 709.001 25.44 -0.284 re f Q /Cs6 cs 0 0 0 scn /GS1 gs 28.006 737.008 0.283 -25.455 re f 481.89 737.008 0.283 -25.455 re f 484.724 709.001 25.512 -0.284 re f 484.724 28.346 25.512 -0.283 re f 481.89 25.512 0.283 -25.512 re f q 1 i 0.015 737.008 510.221 -737.008 re W n 28.006 25.512 0.283 -25.512 re f 0.015 28.346 25.44 -0.283 re f Q 1 1 1 scn 95.641 603.439 14.173 -2.835 re f 0 0 0 scn 95.641 623.622 318.898 -20.183 re f 1 1 1 scn 95.641 566.646 14.173 -2.835 re f 0.8 0.8 0.8 scn 95.641 600.605 318.898 -33.959 re f BT /F11 1 Tf 11.9551 0 3.5865 11.9551 218.8913 608.9951 Tm 1 1 1 scn 0 Tc 0 Tw [(Guideline)-278.6(6)]TJ 11.9551 0 0 11.9551 125.1779 585.9778 Tm 0 0 0 scn [(Obtaining)-277.4(inf)-7(ormed)-273.4(consent:)-276.8(Obligation)-12.3(s)]TJ 2.9212 -1.1523 TD [(of)-272.1(sponsors)-279.7(and)-273.5(investigators)]TJ /F8 1 Tf 10.959 0 0 10.959 95.6409 550.6014 Tm [(Sponsors)-266(and)-273.1(investigat)6.2(ors)-269.6(have)-269.7(a)-270.5(duty)-266.6(to:)]TJ /F10 1 Tf 1.2933 -1.7434 TD (7)Tj /F8 1 Tf 1.2933 0 TD [(refrain)-468.5(from)-463(unjustified)-463.1(deception,)-461.7(undue)-467(influence,)-459.4(or)]TJ 0 -1.2623 TD (intimidation;)Tj /F10 1 Tf -1.2933 -1.2571 TD (7)Tj /F8 1 Tf 1.2933 0 TD [(seek)-244.1(consent)-245.1(only)-246.2(after)-241.5(ascertaining)-244(that)-248.6(the)-244.7(prospective)]TJ 0 -1.2571 TD [(subject)-237.7(has)-237.1(adequate)-236.3(understandin)7.7(g)-239.2(o)0(f)-238(the)-239.5(relevant)-235.8(facts)]TJ 0 -1.2623 TD [(and)-428.3(of)-424.2(the)-430.9(conseque)9.5(nces)-424.9(of)-429.4(participation)-426.2(and)-423.1(has)-428.5(had)]TJ 0 -1.2571 TD [(sufficient)-270.4(opportunity)-262.1(to)-269(consider)-263.9(whether)-266.8(to)-269(participate;)]TJ /F10 1 Tf -1.2933 -1.2623 TD (7)Tj /F8 1 Tf 10.7396 0 0 10.959 123.9874 448.6676 Tm [(as)-316(a)-319(general)-313.5(rule,)-315.6(obtain)-311.6(from)-316.7(each)-316.1(prospectiv)8.5(e)-319(subject)-313.1(a)]TJ 0 -1.2571 TD [(signed)-372(form)-369.5(as)-368.8(evidence)-365.2(of)-367.3(informed)-366.6(consent)]TJ /F2 1 Tf 22.2451 0 TD ()Tj /F8 1 Tf 1.3672 0 TD (investi-)Tj -23.6123 -1.2571 TD [(gators)-380.6(should)-378(justify)-380.9(any)-377.2(exceptions)-378.8(to)-377.9(this)-379.4(general)-382.1(rule)]TJ 0 -1.2623 TD [(and)-399.1(obtain)-401.4(the)-396(approval)-401(of)-399(the)-396(ethical)-399(review)-397.8(committee)]TJ 0 -1.2571 TD [(\(See)-177.9(Guideline)-170.5(4)-176.5(Commentary)9.4(,)]TJ 10.7396 0 3.2219 10.959 276.0944 393.5054 Tm [(Documentatio)6.3(n)-177.3(o)0(f)-172(consent)]TJ 10.7396 0 0 10.959 407.6219 393.5054 Tm (\);)Tj /F10 1 Tf 10.959 0 0 10.959 109.8142 379.6723 Tm (7)Tj /F8 1 Tf 1.2933 0 TD [(renew)-339.2(the)-332.6(informed)-336.8(consent)-333.1(of)-336.3(each)-337(subject)-330.8(if)-339.2(there)-337.2(are)]TJ 0 -1.2571 TD [(significant)-184(changes)-180.7(in)-181.3(the)-182.6(conditions)-176.9(or)-185.3(procedures)-177.6(of)-181.1(the)]TJ T* [(research)-454.7(or)-454.3(if)-458.2(new)-453.7(information)-454.8(becomes)-448(available)-456(that)]TJ 0 -1.2623 TD [(could)-449.2(affect)-445.7(the)-446.4(willingness)-445(of)-444.9(subjects)-441(to)-450.1(continue)-445.6(to)]TJ 0 -1.2571 TD [(participate;)-269.8(and,)]TJ /F10 1 Tf -1.2933 -1.2571 TD (7)Tj /F8 1 Tf 1.2933 0 TD [(renew)-261.6(the)-265.4(informed)-259.2(consent)-260.6(of)-263.8(each)-259.4(subject)-263.6(in)-264.1(long-term)]TJ 0 -1.2623 TD [(studies)-341.2(at)-336.5(pre-determined)-334.1(intervals,)-337.3(even)-337(if)-339.2(there)-337.2(are)-337.1(no)]TJ 0 -1.2571 TD [(changes)-268.6(in)-269.3(the)-270.5(design)-264.5(or)-273.3(objectives)-265.6(of)-269(the)-270.5(research.)]TJ 9.9626 0 2.9888 9.9626 95.6409 242.7023 Tm [(Comm)-9.3(ent)-7.2(ary)-269.4(on)-277.2(Guidelin)-10.9(e)-267.4(6)]TJ /F2 1 Tf 10.959 0 0 10.959 95.6409 224.6739 Tm [(The)-222.9(investigato)7.1(r)-220.3(i)0(s)-219.3(responsible)-215.2(for)-219.9(ensuring)-215.9(the)-219.6(adequacy)-212.1(of)-216.9(informed)]TJ 0 -1.2623 TD [(consent)-357.7(from)-354.9(each)-360.6(subject.)-354.2(The)-357.4(person)-354.7(obtaining)-357.6(informed)-354.6(consent)]TJ 0 -1.2571 TD [(should)-173.7(be)-175(knowledgeable)-173.8(about)-170(the)-173.1(research)-175.7(and)-170.4(capable)-171.5(of)-175.5(answering)]TJ T* [(questions)-399.9(from)-396.3(prospective)-395.3(subjects.)-398.6(Investigators)-390.8(in)-398.9(charge)-396.4(of)-398(the)]TJ 0 -1.2623 TD [(study)-445.7(must)-442.9(make)-441.2(themselves)-444.5(available)-443(to)-439.3(answer)-442.5(questions)-441.3(at)-444.8(the)]TJ 0 -1.2571 TD [(request)-323(of)-325.5(subjects.)-321(Any)-324.9(restrictions)-319.9(on)-323.8(the)-323.1(subjects)-326.2(opportunit)8.1(y)-327.7(t)0(o)]TJ 0 -1.2623 TD [(ask)-503(questions)-498.2(and)-496.3(receive)-501(answers)-497.2(before)-501.1(or)-501.2(during)-499.9(the)-499(research)]TJ 0 -1.2571 TD [(undermines)-270.6(the)-266.2(validity)-271.1(of)-268.6(the)-271.3(informed)-266.6(consent.)]TJ 1.2933 -1.2571 TD [(In)-609.8(some)-607.9(types)-607.2(of)-604.9(research,)-614.4(potential)-608.6(subject)-8.6(s)-603.1(should)-608.2(receive)]TJ -1.2933 -1.2623 TD [(counselling)-587.6(about)-583.9(risks)-583.7(of)-584.2(acquiring)-586.2(a)-586.4(disease)-582.8(unless)-585(they)-588.7(take)]TJ ET 95.641 646.809 318.898 -0.51 re f BT /F6 1 Tf 7.9702 0 0 7.9702 191.1118 649.1337 Tm [(INTERNA)13.4(TIONAL)-327.4(ETHICAL)-327.5(GUIDELINES)-319.8(FOR)-332.5(BIOMED)13.7(ICAL)-331.1(RESEARCH)]TJ /F7 1 Tf 11.9551 0 0 11.9551 95.6409 649.1337 Tm (40)Tj ET endstream endobj 118 0 obj << /Type /Page /Parent 395 0 R /Resources 119 0 R /Contents 120 0 R /MediaBox [ 0 0 595 842 ] /CropBox [ 0 0 595 842 ] /Rotate 0 >> endobj 119 0 obj << /ProcSet [ /PDF /Text ] /Font << /F2 337 0 R /F5 340 0 R /F6 341 0 R /F7 342 0 R >> /ExtGState << /GS1 434 0 R >> /ColorSpace << /DefaultCMYK 417 0 R /Cs6 416 0 R >> >> endobj 120 0 obj << /Length 6204 >> stream q 1 i 0.015 737.008 510.221 -737.008 re W n /Cs6 cs 0 0 0 scn /GS1 gs 0.015 709.001 25.44 -0.284 re f Q /Cs6 cs 0 0 0 scn /GS1 gs 28.006 737.008 0.283 -25.455 re f 481.89 737.008 0.283 -25.455 re f 484.724 709.001 25.512 -0.284 re f 484.724 28.346 25.512 -0.283 re f 481.89 25.512 0.283 -25.512 re f q 1 i 0.015 737.008 510.221 -737.008 re W n 28.006 25.512 0.283 -25.512 re f 0.015 28.346 25.44 -0.283 re f Q BT /F2 1 Tf 10.959 0 0 10.959 95.6409 609.8455 Tm 0 Tc 0 Tw [(precautions.)-186.2(This)-185.9(is)-188.2(especially)-184.1(true)-186.4(of)-185.9(HIV/AIDS)-184.5(vaccine)-183(research)-186(\(see)]TJ 0 -1.2623 TD [(the)-447.2(UNAIDS)-446.7(Guidance)-446(Document)]TJ /F5 1 Tf 15.9075 0 TD [(Ethical)-448.7(Considerations)-443.9(in)-445.7(HIV)]TJ -15.9075 -1.2571 TD [(Preventive)-270.4(Vaccine)-270.5(Research)]TJ /F2 1 Tf 11.9759 0 TD (,)Tj 0.538 0 TD [(Guidance)-270.1(Point)-332.5(14\).)]TJ /F5 1 Tf -12.5139 -2.4107 TD [(Withholding)-512(information)-514(and)-512.4(deception.)]TJ /F2 1 Tf 17.7285 0 TD [(Sometimes,)-510.5(to)-516.9(ensure)-511.1(the)]TJ -17.7285 -1.2571 TD [(validity)-234.9(of)-232.4(research,)-231.6(investigators)-231.7(withhold)-230.9(certain)-231.3(information)-228.1(in)-233.3(the)]TJ T* [(consent)-254.3(process.)-249.3(In)-252.8(biomedical)-252.6(research,)-252.3(this)-255.1(typically)-253.1(takes)-250.3(the)-250.7(form)]TJ 0 -1.2622 TD [(of)-227.2(withholding)-223(information)-228.1(about)-221.8(the)-224.8(purpose)-227(of)-222.1(specific)-226.1(procedures.)]TJ 0 -1.2571 TD [(For)-176.6(example,)-174.7(subjects)-172(in)-176.4(clinical)-175.5(trials)-174.6(are)-178.2(often)-172.7(not)-171.9(told)-176.1(the)-173.1(purpose)-175.2(of)]TJ 0 -1.2623 TD [(tests)-185.9(performed)-180.2(to)-185.9(monitor)-181.1(their)-185.4(compliance)-183.9(with)-180.8(the)-183.4(protocol,)-183.9(since)-184.9(if)]TJ 0 -1.2571 TD [(they)-283.5(knew)-275.9(their)-283.7(compliance)-277(was)-280.1(being)-280.8(monitored)-278.5(they)-278.3(might)-280.3(modify)]TJ T* [(their)-294(behaviour)-288.7(and)-289.4(hence)-295.8(invalidate)-285.7(results.)-293.9(In)-294.2(most)-287.7(such)-293.3(cases,)-291.6(the)]TJ 0 -1.2623 TD [(prospective)-198.7(subjects)-197.8(are)-193.8(asked)-196.8(to)-196.2(consent)-197.4(to)-196.2(remain)-194.8(uninformed)-197.3(of)-196.2(the)]TJ 0 -1.2571 TD [(purpose)-247.6(of)-253.1(some)-245.8(procedures)-245.7(until)-252.7(the)-250.7(research)-248.1(is)-250.3(completed;)-247.4(after)-246.8(the)]TJ 0 -1.2623 TD [(conclusion)-365.9(of)-366.9(the)-369.6(study)-362.9(they)-366.3(are)-369.6(given)-363.8(the)-364.5(omitted)-368.8(information.)-366.8(In)]TJ 0 -1.2571 TD [(other)-534.5(cases,)-534.7(because)-528.2(a)-534.6(request)-529.9(for)-530.3(permission)-532.2(to)-532.5(withhold)-531(some)]TJ T* [(information)-197.1(would)-196.1(jeopardize)-191.5(the)-198.9(validity)-193.5(of)-196.2(the)-198.9(research,)-195.4(subjects)-192.7(are)]TJ 0 -1.2623 TD [(not)-301.2(told)-305.4(that)-299.6(some)-297.5(information)-300.6(has)-301.2(been)-298.2(withheld)-304.6(until)-299.2(the)-302.4(research)]TJ 0 -1.2571 TD [(has)-404.7(been)-396.5(completed.)-402.6(Any)-397.3(such)-401.9(procedure)-397.9(must)-401.5(receive)-397.5(the)-400.7(explicit)]TJ T* [(approval)-270.7(of)-268.6(the)-266.2(ethical)-273.9(review)-269(committee.)]TJ 1.2933 -1.3192 TD [(Active)-419(deception)-414.9(of)-413.5(subjects)-415.1(is)-415.8(considerably)-412.4(more)-416.5(controversial)]TJ -1.2933 -1.2623 TD [(than)-339.2(simply)-341.1(withholding)-341.9(certain)-340(information.)-335.8(Lying)-341.8(to)-341(subjects)-337.5(is)-343.4(a)]TJ 0 -1.2571 TD [(tactic)-411.1(not)-409.8(commonly)-407.6(employed)-404.6(in)-414.4(biomedical)-407.8(research.)-407.5(Social)-409.1(and)]TJ T* [(behavioural)-470.5(scientists,)-469.6(however,)-468.6(sometimes)-471.6(deliberately)-468.2(misinform)]TJ 0 -1.2623 TD [(subjects)-172(to)-170.3(study)-166.3(their)-169.9(attitudes)-169.4(and)-165.2(behaviour.)-168.7(For)-171.4(example,)-169.5(scientists)]TJ 0 -1.2571 TD [(have)-323.4(pretended)-315.4(to)-320.4(be)-319.8(patients)-316.2(to)-320.4(study)-321.5(the)-317.9(behaviour)-319.7(of)-320.4(health-care)]TJ T* [(professionals)-272.2(and)-263.5(patients)-269.6(in)-269.5(their)-268.2(natural)-270.6(settings.)]TJ 1.2933 -1.3192 TD [(Some)-316.7(people)-319.5(maintain)-313.7(that)-315.1(active)-316.5(deception)-311.5(is)-317.6(never)-317(permissible.)]TJ -1.2933 -1.2623 TD [(Others)-423(would)-418.5(permit)-418.7(it)-416.1(in)-419.6(certain)-422.7(circumstances.)-414.6(Deception)-419.1(is)-421(not)]TJ 0 -1.2571 TD [(permissible,)-422.8(however,)-422.1(in)-419.6(cases)-416.7(in)-424.7(which)-419.7(the)-416.2(deception)-420.1(itself)-424.1(would)]TJ T* [(disguise)-420.3(the)-416.2(possibility)-420.4(of)-413.5(the)-421.4(subject)-417.3(being)-415.3(exposed)-413.2(to)-418.6(more)-416.5(than)]TJ 0 -1.2623 TD [(minimal)-187.7(risk.)-181.4(When)-180.8(deception)-182.1(is)-183.1(deemed)-177.3(indispensable)-183.5(to)-180.7(the)-183.4(methods)]TJ 0 -1.2571 TD [(of)-382.4(a)-384.6(study)-378.4(the)-380(investigators)-381.7(must)-380.8(demonstrate)-376.7(to)-382.4(an)-381(ethical)-382.5(review)]TJ T* 0.0101 Tc [(comm)10.1(i)-10.1(t)1.7(t)-3.5(e)2.2(e)-613.4(t)-3.5(hat)-613.9(n)-1.8(o)-612.2(o)-1.8(ther)-613.7(research)-612.2(method)-617.4(would)-612.2(s)-3.2(uf)-3.5(fice;)-614.9(that)]TJ 0 -1.2623 TD 0 Tc [(significant)-253.9(advances)-254.9(could)-249.5(result)-255.7(from)-251.5(the)-255.8(research;)-252.3(and)-253.2(that)-253(nothing)]TJ 0 -1.2571 TD [(has)-265(been)-262(withheld)-263.2(that,)-262.4(if)-260.9(divulged,)-261.5(would)-263.4(cause)-260.1(a)-265.6(reasonable)-261.8(person)]TJ 0 -1.2623 TD 0.0127 Tc [(to)-609.6(re)4.8(fu)6(se)-610.8(t)4.3(o)-614.8(p)6(a)0.6(r)4.5(t)-0.9(ic)4.8(ip)6(at)4.3(e.)-612.3(Th)6(e)-610.8(e)]TJ 14.5728 0 TD 0.0104 Tc [(thical)-614.6(review)-611.4(commi)-4.1(ttee)-613.1(s)2.2(houl)-4.1(d)]TJ -14.5728 -1.2571 TD 0 Tc [(determine)-399.9(the)-400.7(consequences)-394.6(for)-400.9(the)-400.7(subject)-396.6(of)-403.1(being)-394.6(deceived,)-401.8(and)]TJ ET 95.641 646.809 318.898 -0.51 re f BT /F6 1 Tf 7.9702 0 0 7.9702 95.6409 649.1337 Tm [(THE)-330.8(GUIDELINES)]TJ /F7 1 Tf 11.9551 0 0 11.9551 401.3857 649.1337 Tm (41)Tj ET endstream endobj 121 0 obj << /Type /Page /Parent 395 0 R /Resources 122 0 R /Contents 123 0 R /MediaBox [ 0 0 595 842 ] /CropBox [ 0 0 595 842 ] /Rotate 0 >> endobj 122 0 obj << /ProcSet [ /PDF /Text ] /Font << /F2 337 0 R /F5 340 0 R /F6 341 0 R /F7 342 0 R >> /ExtGState << /GS1 434 0 R >> /ColorSpace << /DefaultCMYK 417 0 R /Cs6 416 0 R >> >> endobj 123 0 obj << /Length 6351 >> stream q 1 i 0.015 737.008 510.221 -737.008 re W n /Cs6 cs 0 0 0 scn /GS1 gs 0.015 709.001 25.44 -0.284 re f Q /Cs6 cs 0 0 0 scn /GS1 gs 28.006 737.008 0.283 -25.455 re f 481.89 737.008 0.283 -25.455 re f 484.724 709.001 25.512 -0.284 re f 484.724 28.346 25.512 -0.283 re f 481.89 25.512 0.283 -25.512 re f q 1 i 0.015 737.008 510.221 -737.008 re W n 28.006 25.512 0.283 -25.512 re f 0.015 28.346 25.44 -0.283 re f Q BT /F2 1 Tf 10.959 0 0 10.959 95.6409 609.8455 Tm 0 Tc 0 Tw [(whether)-595.3(and)-589.4(how)-593.9(deceived)-589(subjects)-591(should)-592.7(be)-594(informed)-587.4(of)-594.5(the)]TJ 0 -1.2623 TD 0.0213 Tc [(decep)4.3(t)-2.6(io)4.3(n)-626.9(u)4.3(pon)-621.7(comp)4.3(letion)-621.7(o)4.2(f)-623.4(th)4.2(e)-628.1(r)2.8(esearch.)-619.2(Such)-621.7(i)-3.6(n)4.3(f)-2.6(o)4.3(r)-2.4(ming,)]TJ 0 -1.2571 TD 0 Tc [(co)-9.4(mmonl)-8.3(y)-607.1(cal)-8.7(le)-6.9(d)-606.8()0()-8.4(debr)-8.8(ie)-6.9(fing)-9.8(,)-613.6(ord)-6.1(ina)-7.5(ri)-7.2(ly)-611.2(ent)-7.5(ails)-613.2(exp)-6.1(lai)-10.2(nin)-7.2(g)-607.1(the)]TJ 0 -1.2623 TD [(reasons)-259.7(for)-256.1(the)-255.8(deception.)-253.6(A)-259.5(subject)-251.7(who)-257.6(disapproves)-253.3(of)-258.3(having)-250.6(been)]TJ 0 -1.2571 TD [(deceived)-449.3(should)-447.9(be)-449.1(offered)-447.4(an)-448.2(opportunity)-448.9(to)-444.5(refuse)-450.8(to)-449.7(allow)-447.3(the)]TJ T* [(investigator)-539.1(to)-532.5(use)-534.9(information)-538.5(thus)-531.8(obtained.)-534.4(Investigators)-535.7(and)]TJ 0 -1.2623 TD [(ethical)-398.1(review)-393.1(committees)-391.8(should)-391(be)-397.4(aware)-388(that)-392.7(deceiving)-395.7(research)]TJ 0 -1.2571 TD [(subjects)-296.1(may)-293.8(wrong)-293.5(them)-292.6(as)-294.5(well)-296.7(as)-294.5(harm)-296.6(them;)-291.6(subjects)-296.1(may)-293.8(resent)]TJ T* [(not)-208.1(having)-198.9(been)-205.1(informed)-204.5(when)-203.5(they)-200.7(learn)-204.6(that)-206.4(they)-200.7(have)-204.4(participated)]TJ 0 -1.2623 TD [(in)-533.4(a)-529.5(study)-528.4(under)-527.6(false)-532.3(pretences.)-529.2(In)-532.2(some)-525.1(studies)-531.4(there)-530.6(may)-526.6(be)]TJ 0 -1.2571 TD [(justification)-364.6(for)-359.6(deceiving)-359.5(persons)-357.7(other)-358.7(than)-359.9(the)-359.3(subjects)-358.2(by)-360.3(either)]TJ 0 -1.2623 TD [(withholding)-347.1(or)-340.8(disguising)-342.3(elements)-346.6(of)-341(information.)-346.1(Such)-343.6(tactics)-341.7(are)]TJ 0 -1.2571 TD [(often)-338.2(proposed,)-336.1(for)-338.9(example,)-340.2(for)-333.7(studies)-340(of)-335.9(the)-338.6(abuse)-336.5(of)-341(spouses)-331.9(or)]TJ T* [(children.)-346.3(An)-348.9(ethical)-341.2(review)-346.6(committee)-347.4(must)-344.6(review)-341.4(and)-346.3(approve)-339.8(all)]TJ 0 -1.2622 TD [(proposals)-419.4(to)-423.8(deceive)-421.9(persons)-419.8(other)-420.7(than)-416.8(the)-421.4(subjects.)-424.5(Subjects)-418.8(are)]TJ 0 -1.2571 TD [(entitled)-282.1(to)-279(prompt)-280.4(and)-273.9(honest)-277.4(answers)-280(to)-279(their)-278.5(questions;)-280(the)-281.7(ethical)]TJ 0 -1.2623 TD [(review)-248.3(committee)-244(must)-246.3(determine)-239.5(for)-245.8(each)-246.7(study)-238.7(whether)-243.5(others)-247.8(who)]TJ 0 -1.2571 TD [(are)-271.3(to)-268.6(be)-268.1(deceived)-268.3(are)-271.4(similarly)-270(entitled.)]TJ /F5 1 Tf 0 -2.4366 TD [(Intimidation)-187.1(and)-181.3(undue)-180.7(influence.)]TJ /F2 1 Tf 13.9417 0 TD [(Intimidation)-185.8(in)-181.6(any)-186.2(form)-184.2(invalidates)]TJ -13.9417 -1.2623 TD [(informed)-209.7(consent.)-201.6(Prospective)-208.8(subjects)-203(who)-205.9(are)-204.1(patients)-207.5(often)-203.7(depend)]TJ 0 -1.2571 TD -0.0001 Tc [(for)-323.4(medical)-323(care)-315.6(upon)-321.8(the)-318(physician/investigator,)-324.4(who)-319.8(consequently)]TJ T* 0 Tc [(has)-280.5(a)-276(certain)-272.7(credibility)-276.4(in)-279.9(their)-278.5(eyes,)-273.1(and)-279(whose)-273.7(influence)-277.9(over)-272.9(them)]TJ 0 -1.2623 TD 0.0084 Tc [(may)-609(b)-3.5(e)-609.9(c)0.5(onsiderable,)-611.4(p)1.7(articul)8.4(a)]TJ 14.2676 0 TD 0.0078 Tc [(rly)-609.6(i)-1.6(f)-611.1(t)-0.6(he)-610.5(s)-5.5(t)]TJ 5.7079 0 TD 0.0136 Tc [(ud)6.9(y)-603.8(p)6.9(r)5.4(o)1.7(t)5.2(o)6.9(c)5.7(o)6.9(l)-606.2(h)6.9(as)-605(a)]TJ -19.9755 -1.2571 TD 0 Tc [(therapeutic)-318(component.)-310.8(They)-312.6(may)-314.5(fear,)-315(for)-318.2(example,)-314.4(that)-315.1(refusal)-314.4(to)]TJ T* [(participate)-221.4(would)-216.8(damage)-217.1(the)-219.6(therapeutic)-214.5(relationship)-218.7(or)-221.8(result)-219.4(in)-217.8(the)]TJ 0 -1.2623 TD -0.0001 Tc [(withholding)-171.3(of)-170.4(health)-170.3(services.)-172.3(The)-166.1(physician/investigator)-170.2(must)-174(assure)]TJ 0 -1.2571 TD 0 Tc [(them)-292.6(that)-289.2(their)-288.9(decision)-285.2(on)-287.6(whether)-290(to)-289.3(participate)-288.7(will)-287.8(not)-290.9(affect)-286(the)]TJ 0 -1.2623 TD [(therapeutic)-183.5(relationship)-177.3(or)-185.6(other)-177.6(benefits)-182.6(to)-180.7(which)-181.8(they)-180(are)-183.4(entitled.)-182.8(In)]TJ 0 -1.2571 TD [(this)-244.8(situation)-236.4(the)-240.3(ethical)-237.7(review)-243.1(committee)-238.8(should)-240.9(consider)-237.5(whether)-238.3(a)]TJ T* [(neutral)-271.5(third)-267(party)-270.1(should)-266.8(seek)-268.6(informed)-266.6(consent.)]TJ 1.2933 -1.3502 TD [(The)-310.8(prospective)-307.4(subject)-308.7(must)-308.4(not)-306.4(be)-309.5(exposed)-309.7(to)-310(undue)-303.7(influence.)]TJ -1.2933 -1.2571 TD [(The)-264.3(borderline)-263.9(between)-263.9(justifiable)-261.5(persuasion)-261.8(and)-263.5(undue)-262.4(influence)-262.4(is)]TJ T* [(imprecise,)-582.3(however.)-577.3(The)-574.7(researcher)-579.7(should)-572(give)-579.6(no)-577.3(unjustifiable)]TJ 0 -1.2623 TD [(assurances)-215.5(about)-211.4(the)-214.4(benefits,)-212.6(risks)-216.4(or)-216.6(inconveniences)-210.4(of)-216.9(the)-214.4(research,)]TJ 0 -1.2571 TD [(for)-442.3(example,)-443.7(or)-439.1(induce)-438.4(a)-441.5(close)-443.5(relative)-442.7(or)-439.1(a)-441.5(community)-436.7(leader)-445.3(to)]TJ 0 -1.2623 TD [(influence)-567.6(a)-560.5(prospective)-566(subjects)-564.1(decision.)-563.6(See)-560.5(also)-564(Guideline)-566.3(4:)]TJ /F5 1 Tf 0 -1.2571 TD [(Individual)-270.4(informed)-267.7(consent.)]TJ ET 95.641 646.809 318.898 -0.51 re f BT /F6 1 Tf 7.9702 0 0 7.9702 191.1118 649.1337 Tm [(INTERNA)13.4(TIONAL)-327.4(ETHICAL)-327.5(GUIDELINES)-319.8(FOR)-332.5(BIOMED)13.7(ICAL)-331.1(RESEARCH)]TJ /F7 1 Tf 11.9551 0 0 11.9551 95.6409 649.1337 Tm (42)Tj ET endstream endobj 124 0 obj << /Type /Page /Parent 395 0 R /Resources 125 0 R /Contents 126 0 R /MediaBox [ 0 0 595 842 ] /CropBox [ 0 0 595 842 ] /Rotate 0 >> endobj 125 0 obj << /ProcSet [ /PDF /Text ] /Font << /F2 337 0 R /F5 340 0 R /F6 341 0 R /F7 342 0 R >> /ExtGState << /GS1 434 0 R >> /ColorSpace << /DefaultCMYK 417 0 R /Cs6 416 0 R >> >> endobj 126 0 obj << /Length 6296 >> stream q 1 i 0.015 737.008 510.221 -737.008 re W n /Cs6 cs 0 0 0 scn /GS1 gs 0.015 709.001 25.44 -0.284 re f Q /Cs6 cs 0 0 0 scn /GS1 gs 28.006 737.008 0.283 -25.455 re f 481.89 737.008 0.283 -25.455 re f 484.724 709.001 25.512 -0.284 re f 484.724 28.346 25.512 -0.283 re f 481.89 25.512 0.283 -25.512 re f q 1 i 0.015 737.008 510.221 -737.008 re W n 28.006 25.512 0.283 -25.512 re f 0.015 28.346 25.44 -0.283 re f Q BT /F5 1 Tf 10.959 0 0 10.959 95.6409 609.8455 Tm 0 Tc 0 Tw (Risks.)Tj /F2 1 Tf 2.8556 0 TD [(Investigators)-292.5(should)-292.7(be)-288.8(completely)-294.2(objective)-293.7(in)-295.4(discussing)-290.3(the)]TJ -2.8556 -1.2623 TD [(details)-232.8(of)-232.4(the)-230(experimental)-226.6(intervention,)-232(the)-230(pain)-231.5(and)-227.3(discomfort)-231.5(that)]TJ 0 -1.2571 TD [(it)-447.2(may)-443.9(entail,)-446.1(and)-444.6(known)-441.8(risks)-444.1(and)-444.6(possible)-445.9(hazards.)-443.8(In)-444.2(complex)]TJ 0 -1.2623 TD [(research)-361.9(projects)-358.2(it)-359.2(may)-361.1(be)-356(neither)-360.4(feasible)-359.7(nor)-357.8(desirable)-360.9(to)-356.6(inform)]TJ 0 -1.2571 TD [(prospective)-343.6(participants)-342.2(fully)-340.9(about)-340.8(every)-343.1(possible)-342.4(risk.)-341.8(They)-343.7(must,)]TJ T* [(however,)-365.2(be)-361.2(informed)-359.7(of)-366.9(all)-361.9(risks)-361.3(that)-361.6(a)-363.9(reasonable)-359.1(person)-364.1(would)]TJ 0 -1.2623 TD [(consider)-263.4(material)-259.5(to)-263.4(making)-259.7(a)-265.6(decision)-259.4(about)-258(whether)-264.2(to)-258.3(participate,)]TJ 0 -1.2571 TD [(including)-369.8(risks)-366.5(to)-372.1(a)-369.1(spouse)-365.1(or)-366.6(partner)-368.6(associated)-367(with)-367(trials)-371.2(of,)-365.9(for)]TJ T* (e)Tj 0.4552 0 TD 0.0129 Tc [(xample,)-617.2(psycho)-4.1(tro)-4.1(p)1(ic)-615.8(or)-616(genital-tract)-616.3(m)2(edicaments.)-617.2(\()-0.7(See)-615.8(a)0.8(lso)]TJ -0.4552 -1.2623 TD 0 Tc [(Guideline)-271.5(8)-270.8(Commentary,)]TJ /F5 1 Tf 11.3603 0 TD [(Risks)-271.7(to)-268.9(groups)-266.7(of)-268.9(persons.)]TJ /F2 1 Tf 11.1637 0 TD (\))Tj /F5 1 Tf -22.524 -2.5245 TD [(Exception)-605.8(to)-605.1(the)-602.7(requirement)-602.1(for)-603(informed)-604(consent)-601.7(in)-606.1(studies)-599.2(of)]TJ 0 -1.2571 TD [(emergency)-454.7(situations)-452.3(in)-450.9(which)-456.8(the)-452.7(researcher)-450.7(anticipates)-454.8(that)-449.8(many)]TJ 0 -1.2623 TD [(subjects)-317.4(will)-319.1(be)-320.1(unable)-314.2(to)-320.6(consent.)]TJ /F2 1 Tf 14.4694 0 TD [(Research)-313.2(protocols)-317.2(are)-317.9(sometimes)]TJ -14.4694 -1.2571 TD [(designed)-251.8(to)-253.1(address)-254.5(conditions)-252.6(occurring)-249.6(suddenly)-250.6(and)-253.2(rendering)-249.7(the)]TJ 0 -1.2623 TD [(patients/subjects)-232.8(incapable)-234.1(of)-232.4(giving)-237.8(informed)-230.4(consent.)-232.6(Examples)-234.2(are)]TJ 0 -1.2571 TD [(head)-328.3(trauma,)-321.3(cardiopulmonary)-322(arrest)-322(and)-325.6(stroke.)-324.4(The)-326.3(investigation)]TJ T* [(cannot)-276.2(be)-273.3(done)-271.2(with)-273.9(patients)-274.8(who)-273.2(can)-269.9(give)-274.3(informed)-271.8(consent)-275(in)-274.7(time)]TJ 0 -1.2623 TD [(and)-263.5(there)-261.5(may)-262.8(not)-265(be)-262.9(time)-259(to)-263.4(locate)-264.5(a)-260.5(person)-261.6(having)-261(the)-261(authority)-265(to)]TJ 0 -1.2571 TD [(give)-201.9(permission.)-200.1(In)-201.1(such)-200.2(circumstances)-198.3(it)-198.8(is)-203.8(often)-198.5(necessary)-198.2(to)-201.4(proceed)]TJ T* [(with)-522.2(the)-519.7(research)-517.1(interventions)-520.5(very)-516.3(soon)-519.7(after)-521(the)-519.7(onset)-519(of)-516.9(the)]TJ 0 -1.2623 TD [(condition)-208.3(in)-202.3(order)-208.4(to)-201.4(evaluate)-206.1(an)-205.1(investigation)6.6(al)-207.7(treatment)-203.2(or)-206.3(develop)]TJ 0 -1.2571 TD [(the)-333.4(desired)-329.1(knowledge.)-333.2(As)-329.7(this)-332.7(class)-330.3(of)-330.7(emergency)-330(exception)-332.4(can)-326.8(be)]TJ 0 -1.2623 TD [(anticipated,)-229.3(the)-230(researcher)-228(must)-230.8(secure)-227.8(the)-230(review)-227.6(and)-232.5(approval)-224.1(of)-227.2(an)]TJ 0 -1.2571 TD [(ethical)-361.8(review)-356.9(committee)-352.6(before)-356.2(initiating)-355.8(the)-359.3(study.)-356.7(If)-352.9(possible,)-357(an)]TJ T* [(attempt)-435.4(should)-432.3(be)-428.5(made)-430.8(to)-434.2(identify)-431.2(a)-436.3(population)-426.2(that)-434.1(is)-431.4(likely)-437.6(to)]TJ 0 -1.2623 TD [(develop)-393.7(the)-385.2(condition)-389.3(to)-392.8(be)-387.1(studied.)-389.2(This)-392.9(can)-388.9(be)-392.2(done)-385(readily,)-390.7(for)]TJ 0 -1.2571 TD [(example,)-210.9(if)-204(the)-209.3(condition)-203.1(is)-208.9(one)-202.4(that)-206.4(recurs)-207.4(periodically)-204.1(in)-207.5(individuals;)]TJ 0 -1.2623 TD [(examples)-178.7(include)-178.8(grand)-175.2(mal)-182.4(seizures)-178.1(and)-175.6(alcohol)-177.9(binges.)-179.3(In)-175.2(such)-179.5(cases,)]TJ 0 -1.2571 TD [(prospective)-576.4(subjects)-580.7(should)-577.2(be)-578.5(contacted)-574.6(while)-577.6(fully)-578.8(capable)-580.2(of)]TJ T* [(informed)-452.9(consent,)-449.9(and)-449.8(invited)-453.8(to)-449.7(consent)-450.9(to)-449.7(their)-454.4(involvement)-450(as)]TJ 0 -1.2623 TD [(research)-294.7(subjects)-291(during)-287.8(future)-294.7(periods)-291.7(of)-289.3(incapacitation.)-288.6(If)-295.9(they)-288.7(are)]TJ 0 -1.2571 TD [(patients)-523.1(of)-522.1(an)-525.8(independent)-521.5(physician)-518.9(who)-521.5(is)-524.5(also)-522.7(the)-524.8(physician-)]TJ T* [(researcher,)-206.3(the)-204.1(physician)-203.4(should)-204.7(likewise)-209.8(seek)-201.4(their)-206.1(consent)-202.5(while)-210.3(they)]TJ 0 -1.2623 TD [(are)-255.8(fully)-258.1(capable)-254.3(of)-253.1(informed)-251.1(consent.)-253.3(In)-258(all)-253.3(cases)-256.4(in)-254(which)-254.2(approved)]TJ 0 -1.2571 TD 0.0119 Tc [(research)-610.4(has)-617(b)0(egun)-615.6(without)-612.1(prior)-617(c)4(onsen)5.2(t)-617.3(o)0(f)-612.1(p)0(atients/subjects)]TJ 0 -1.2623 TD 0 Tc [(incapable)-296.2(of)-294.5(giving)-294.7(informed)-292.5(consent)-290.5(because)-295.4(of)-294.5(suddenly)-292(occurring)]TJ 0 -1.2571 TD [(conditions,)-308.6(they)-304.2(should)-303(be)-309.5(given)-306.9(all)-305(relevant)-305.6(information)-305.7(as)-304.8(soon)-307.6(as)]TJ ET 95.641 646.809 318.898 -0.51 re f BT /F6 1 Tf 7.9702 0 0 7.9702 95.6409 649.1337 Tm [(THE)-330.8(GUIDELINES)]TJ /F7 1 Tf 11.9551 0 0 11.9551 401.3857 649.1337 Tm (43)Tj ET endstream endobj 127 0 obj << /Type /Page /Parent 395 0 R /Resources 128 0 R /Contents 129 0 R /MediaBox [ 0 0 595 842 ] /CropBox [ 0 0 595 842 ] /Rotate 0 >> endobj 128 0 obj << /ProcSet [ /PDF /Text ] /Font << /F2 337 0 R /F5 340 0 R /F6 341 0 R /F7 342 0 R >> /ExtGState << /GS1 434 0 R >> /ColorSpace << /DefaultCMYK 417 0 R /Cs6 416 0 R >> >> endobj 129 0 obj << /Length 6555 >> stream q 1 i 0.015 737.008 510.221 -737.008 re W n /Cs6 cs 0 0 0 scn /GS1 gs 0.015 709.001 25.44 -0.284 re f Q /Cs6 cs 0 0 0 scn /GS1 gs 28.006 737.008 0.283 -25.455 re f 481.89 737.008 0.283 -25.455 re f 484.724 709.001 25.512 -0.284 re f 484.724 28.346 25.512 -0.283 re f 481.89 25.512 0.283 -25.512 re f q 1 i 0.015 737.008 510.221 -737.008 re W n 28.006 25.512 0.283 -25.512 re f 0.015 28.346 25.44 -0.283 re f Q BT /F2 1 Tf 10.959 0 0 10.959 95.6409 609.8455 Tm 0 Tc 0 Tw [(they)-505.9(are)-504.1(in)-502.3(a)-503.6(state)-500.3(to)-506.6(receive)-501(it,)-503.1(and)-501.5(their)-506.1(consent)-502.6(to)-501.4(continued)]TJ 0 -1.2623 TD [(participation)-267.3(should)-272(be)-268.1(obtained)-266.4(as)-268.6(soon)-266.3(as)-273.8(is)-265.8(reasonably)-271.2(possible.)]TJ 1.2933 -1.3399 TD [(Before)-293.9(proceeding)-292.3(without)-290.6(prior)-292.6(informed)-292.5(consent,)-294.7(the)-292(investiga-)]TJ -1.2933 -1.2623 TD [(tor)-256.1(must)-251.5(make)-249.7(reasonable)-251.5(efforts)-247.6(to)-253.1(locate)-254.2(an)-251.6(individual)-248.9(who)-252.5(has)-249.5(the)]TJ 0 -1.2571 TD [(authority)-259.9(to)-263.4(give)-258.8(permission)-258(on)-261.7(behalf)-258.2(of)-263.5(an)-256.8(incapacitated)-260.7(patient.)-260.5(If)]TJ 0 -1.2623 TD [(such)-453.7(a)-446.7(person)-447.9(can)-451(be)-449.1(located)-447.1(and)-449.8(refuses)-448.6(to)-449.7(give)-450.2(permission,)-448.4(the)]TJ 0 -1.2571 TD [(patient)-225.2(may)-221.4(not)-223.6(be)-226.7(enrolled)-223.2(as)-222.1(a)-224.2(subject.)-224.9(The)-222.9(risks)-226.8(of)-222.1(all)-227.4(interventions)]TJ T* [(and)-341.1(procedures)-333.7(will)-339.5(be)-340.5(justified)-338.2(as)-341(required)-335.8(by)-339.6(Guideline)-338.7(9)-338.1(\()]TJ /F5 1 Tf 26.0831 0 TD (Special)Tj -26.0831 -1.2623 TD [(limitations)-472.2(on)-469.2(risks)-470.2(when)-462.9(research)-470.8(involves)-468(individuals)-466(who)-470.5(are)-467.9(not)]TJ 0 -1.2571 TD [(capable)-451.4(of)-450(giving)-451(consent.\).)]TJ /F2 1 Tf 12.3846 0 TD [(The)-450.5(researcher)-450.4(and)-449.8(the)-447.2(ethical)-455(review)]TJ -12.3846 -1.2623 TD [(committee)-399.1(should)-391(agree)-400(to)-392.8(a)-395(maximum)-393.8(time)-398.7(of)-398(involvement)-393.1(of)-392.8(an)]TJ 0 -1.2571 TD [(individual)-228.2(without)-228.5(obtaining)-228.3(either)-229.5(the)-224.8(individuals)-230.2(informed)-225.2(consent)]TJ T* [(or)-206.3(authorization)-197.4(according)-201.9(to)-201.4(the)-204.1(applicable)-196.9(legal)-206.1(system)-200.6(if)-204(the)-204.1(person)]TJ 0 -1.2623 TD [(is)-405.5(not)-404.7(able)-403.4(to)-408.3(give)-403.7(consent.)-403.3(If)-404.6(by)-401.7(that)-403(time)-409(the)-400.7(researcher)-403.9(has)-404.7(not)]TJ 0 -1.2571 TD [(obtained)-281.9(either)-286.4(consent)-285.3(or)-283.9(permission)-283.9()-282.9(owing)-279.1(either)-286.4(to)-284.1(a)-286.3(failure)-284.5(to)]TJ T* [(contact)-208.3(a)-208.7(representative)-208(or)-206.3(a)-208.7(refusal)-210.9(of)-206.5(either)-208.8(the)-209.3(patient)-204.5(or)-211.5(the)-209.3(person)]TJ 0 -1.2623 TD [(or)-423.6(body)-420.3(authorized)-417(to)-418.6(give)-424.4(permission)-418.4()-422.6(the)-416.2(participation)-422.5(of)-418.6(the)]TJ 0 -1.2571 TD [(patient)-194.2(as)-191(a)-188(subject)-189.7(must)-194.6(be)-190.5(discontinued.)-188.7(The)-191.8(patient)-189(or)-190.8(the)-188.6(person)-194.4(or)]TJ 0 -1.2623 TD [(body)-384.1(providing)-388.4(authorizati)7.4(on)-385.9(should)-385.8(be)-387.1(offered)-385.3(an)-381(opportunity)-386.8(to)]TJ 0 -1.2571 TD [(forbid)-309.9(the)-307.6(use)-307.3(of)-310(data)-303.3(derived)-307.2(from)-308.4(participation)-308.7(of)-304.8(the)-312.7(patient)-302.8(as)-310(a)]TJ T* [(subject)-272.4(without)-264.7(consent)-269.8(or)-268.4(permission.)]TJ 10.7396 0 0 10.959 109.8142 318.2173 Tm [(Where)-346.2(appropriate,)-339.3(plans)-343.5(to)-345(conduct)-338.3(emergency)-344.3(research)-340.8(without)]TJ -1.3197 -1.2623 TD [(prior)-173.4(consent)-167.4(of)-176.1(the)-166.6(subjects)-175.3(should)-167.1(be)-172.3(publicized)-168.6(within)-171.4(the)-171.9(community)]TJ 0 -1.2571 TD [(in)-186.3(which)-184.3(it)-188.8(will)-182.4(be)-188.2(carried)-185.5(out.)-182.8(In)-182.1(the)-187.8(design)-181(and)-185.5(conduct)-179.9(of)-186.6(the)-182.5(research,)]TJ T* [(the)-208.9(ethical)-204.7(review)-209.2(committee,)-206.9(the)-208.9(investigato)7.7(rs)-211.9(and)-201.4(the)-208.9(sponsors)-205.9(should)]TJ 0 -1.2623 TD [(be)-325.4(responsive)-322.4(to)-329.1(the)-325(concerns)-322.4(of)-323.9(the)-325(community.)-322(If)-327.2(there)-321.2(is)-326.9(cause)-323.2(for)]TJ 0 -1.2571 TD [(concern)-206(about)-197.9(the)-203.6(acceptability)-199.3(of)-202.4(the)-203.6(research)-203.6(in)-202.1(the)-203.6(community,)-200.5(there)]TJ T* [(should)-235.7(be)-235.7(a)-233.8(formal)-231.4(consultation)-233.7(with)-233.3(representatives)-233.6(designated)-233(by)-230.8(the)]TJ 0 -1.2623 TD [(community.)-263.9(The)-266.5(research)-261.7(should)-262.1(not)-262.8(be)-262.1(carried)-264.7(out)-262.8(if)-268(it)-262.7(does)-264.7(not)-262.8(have)]TJ 0 -1.2571 TD [(substantial)-467.4(support)-468.7(in)-466(the)-467.5(community)-465.3(concerned.)-467.3(\(See)-468.7(Guideline)-467.6(8)]TJ 0 -1.2623 TD (Commentary,)Tj /F5 1 Tf 6.1604 0 TD [(Risks)-271.3(to)-265(groups)-270.6(of)-265(persons)]TJ /F2 1 Tf 10.8903 0 TD (.\))Tj /F5 1 Tf -17.0507 -2.421 TD [(Exception)-223.4(to)-228.1(the)-223.9(requirement)-224.6(of)-228.1(informed)-221.9(consent)-223.1(for)-228.4(inclusion)-221.6(in)-227.7(clinical)]TJ 0 -1.2467 TD [(trials)-433.1(of)-433.9(persons)-429(rendered)-430.9(incapable)-430.5(of)-428.6(informed)-427.8(consent)-434.3(by)-430.6(an)-430.6(acute)]TJ T* (condition.)Tj /F2 1 Tf 4.392 0 TD [(Certain)-315.4(patients)-312.1(with)-312.5(an)-309.9(acute)-311.8(condition)-311.5(that)-314.4(renders)-314.1(them)]TJ -4.392 -1.2416 TD [(incapable)-253.4(of)-250(giving)-248(informed)-246.2(consent)-251.9(may)-247.3(be)-251.5(eligible)-251.1(for)-250.3(inclusion)-251.1(in)-249.6(a)]TJ 0 -1.2467 TD [(clinical)-166.6(trial)-163.5(in)-159.9(which)-163.2(the)-161.4(majority)-163.5(of)-160.2(prospective)-164.4(subjects)-159.4(will)-166.5(be)-161.8(capable)]TJ T* [(of)-191.9(informed)-193.4(consent.)-187.8(Such)-192.7(a)-191.5(trial)-189.9(would)-190.8(relate)-193(to)-191.9(a)-191.5(new)-193.4(treatment)-191.4(for)-187(an)]TJ ET 95.641 646.809 318.898 -0.51 re f BT /F6 1 Tf 7.9702 0 0 7.9702 191.1118 649.1337 Tm [(INTERNA)13.4(TIONAL)-327.4(ETHICAL)-327.5(GUIDELINES)-319.8(FOR)-332.5(BIOMED)13.7(ICAL)-331.1(RESEARCH)]TJ /F7 1 Tf 11.9551 0 0 11.9551 95.6409 649.1337 Tm (44)Tj ET endstream endobj 130 0 obj << /Type /Page /Parent 395 0 R /Resources 131 0 R /Contents 132 0 R /MediaBox [ 0 0 595 842 ] /CropBox [ 0 0 595 842 ] /Rotate 0 >> endobj 131 0 obj << /ProcSet [ /PDF /Text ] /Font << /F2 337 0 R /F5 340 0 R /F6 341 0 R /F7 342 0 R /F8 343 0 R /F11 346 0 R >> /ExtGState << /GS1 434 0 R >> /ColorSpace << /DefaultCMYK 417 0 R /Cs6 416 0 R >> >> endobj 132 0 obj << /Length 5602 >> stream q 1 i 0.015 737.008 510.221 -737.008 re W n /Cs6 cs 0 0 0 scn /GS1 gs 0.015 709.001 25.44 -0.284 re f Q /Cs6 cs 0 0 0 scn /GS1 gs 28.006 737.008 0.283 -25.455 re f 481.89 737.008 0.283 -25.455 re f 484.724 709.001 25.512 -0.284 re f 484.724 28.346 25.512 -0.283 re f 481.89 25.512 0.283 -25.512 re f q 1 i 0.015 737.008 510.221 -737.008 re W n 28.006 25.512 0.283 -25.512 re f 0.015 28.346 25.44 -0.283 re f Q 1 1 1 scn 95.641 408.812 14.173 -2.835 re f 0 0 0 scn 95.641 428.995 318.898 -20.183 re f 1 1 1 scn 95.641 385.795 14.173 -2.835 re f 0.8 0.8 0.8 scn 95.641 405.978 318.898 -20.183 re f BT /F2 1 Tf 10.7396 0 0 10.959 95.6409 609.9589 Tm 0 0 0 scn 0 Tc 0 Tw [(acute)-380.4(condition)-374.8(such)-375.6(as)-376.6(sepsis,)-383(stroke)-375.5(or)-377.4(myocardial)-374.7(infarction.)-376.2(The)]TJ 0 -1.2416 TD [(investigational)-242.6(treatment)-238.9(would)-238.3(hold)-243.6(out)-241.7(the)-240.5(prospect)-236.4(of)-244.7(direct)-241.3(benefit)]TJ 0 -1.2467 TD [(and)-444.2(would)-444.1(be)-441.6(justified)-446.3(accordingly,)-439.2(though)-437.8(the)-446.4(investigation)-442.5(might)]TJ T* [(involve)-455.8(certain)-459.2(procedures)-451.8(or)-456.6(interventions)-454.6(that)-456.9(were)-456.6(not)-452.8(of)-455.8(direct)]TJ T* [(benefit)-190(but)-188.9(carried)-185.5(no)-189.3(more)-184.8(than)-185.1(minimal)-189.2(risk;)-191.5(an)-183.3(example)-187.8(would)-185.5(be)-188.2(the)]TJ 0 -1.2416 TD [(process)-451.4(of)-450.6(randomization)-448.3(or)-451.3(the)-451.7(collection)-445.7(of)-450.5(additional)-452.8(blood)-446.5(for)]TJ 0 -1.2467 TD [(research)-393.6(purposes.)-385.4(For)-392.4(such)-391.4(cases)-389.9(the)-388.4(initial)-390.9(protocol)-389.5(submitted)-388.3(for)]TJ T* [(approval)-301.2(to)-308(the)-303.9(ethical)-299.7(review)-304.2(committee)-302.7(should)-304.3(anticipate)-303(that)-303.8(some)]TJ T* [(patients)-401.8(may)-395.1(be)-399.3(incapable)-395.9(of)-397.8(consent,)-398.9(and)-396.7(should)-394.1(propose)-396.3(for)-398.1(such)]TJ 0 -1.2416 TD [(patients)-222.4(a)-223.2(form)-225.4(of)-223.6(proxy)-219.1(consent,)-219.4(such)-222.5(as)-223.6(permission)-225.4(of)-218.3(the)-224.7(responsible)]TJ 0 -1.2467 TD [(relative.)-340.7(When)-336.4(the)-335.6(ethical)-336.6(review)-341.1(committee)-334.4(has)-336.7(approved)-335.6(or)-335.2(cleared)]TJ T* [(such)-555.1(a)-555.8(protocol,)-547.1(an)-552.8(investigator)-552.2(may)-553.5(seek)-553.9(the)-552(permission)-552.7(of)-550.8(the)]TJ T* [(responsible)-248.5(relative)-251.8(and)-248.9(enrol)-248.1(such)-248.9(a)-249.6(patient.)]TJ /F11 1 Tf 11.9551 0 3.5865 11.9551 218.8913 414.3684 Tm 1 1 1 scn [(Guideline)-278.6(7)]TJ 11.9551 0 0 11.9551 132.8882 391.3511 Tm 0 0 0 scn [(Induceme)-10.9(nt)-272.2(to)-267.5(parti)-9.1(cipate)-275.9(in)-268.7(research)]TJ /F8 1 Tf 10.6302 0 0 10.959 95.6409 369.8078 Tm [(Subjects)-325.9(may)-325.6(be)-321.3(reimbursed)-324.2(for)-326.3(lost)-321.3(earnings,)-321.5(travel)-326.9(costs)-324.6(and)]TJ 0 -1.2519 TD [(other)-279.6(expenses)-269.2(incurred)-278.6(in)-278(taking)-274.6(part)-275.6(in)-278(a)-280(study;)-275.9(they)-273.9(may)-277.6(also)]TJ T* [(receive)-360.9(free)-364.9(medical)-362.9(services.)-360.2(Subjects,)-359.9(particularly)-361.9(those)-363.3(who)]TJ T* [(receive)-472.9(no)-472(direct)-477.6(benefit)-469.9(from)-475.9(research,)-465.2(may)-474.9(also)-469.9(be)-476(paid)-471.3(or)]TJ 0 -1.2571 TD [(otherwise)-343.5(compensate)8.5(d)-340(for)-342.3(inconvenience)-333.1(and)-341.3(time)-344.3(spent.)-338.6(The)]TJ 0 -1.2519 TD [(payments)-582.2(should)-575.2(not)-581.9(be)-582.6(so)-582.6(large,)-582.9(however,)-574.9(or)-584.3(the)-580.6(medical)]TJ T* [(services)-587.6(so)-582.6(extensive)-585.2(as)-581.3(to)-583.3(induce)-584.6(prospective)-584.2(subjects)-583.9(to)]TJ T* 0.0187 Tc (co)Tj 1.184 0 TD 0.0136 Tc [(nsent)-597.7(t)-5.7(o)-593(p)-1(articipate)-602.4(in)-598.4(the)-597(r)-1.4(esearch)-598.4(against)-597.7(t)-5.7(he)-5.1(ir)-598.7(better)]TJ -1.184 -1.2519 TD 0 Tc [(judgment)-242.9(\(undue)-239.2(inducement)7.8(\).)-244(All)-240.6(payments,)-237.5(reimbursements)]TJ T* [(and)-341.3(medical)-341.6(services)-342.2(provided)-336.9(to)-343.3(research)-340.5(subjects)-338.6(must)-340.9(have)]TJ T* [(been)-247.9(approved)-246.9(by)-246.6(an)-252(ethical)-248.6(review)-246.9(committee.)]TJ 9.9626 0 2.9888 9.9626 95.6409 199.729 Tm [(Comm)-9.3(ent)-7.2(ary)-269.4(on)-277.2(Guidelin)-10.9(e)-267.4(7)]TJ /F5 1 Tf 10.959 0 0 10.959 95.6409 181.7574 Tm [(Acceptable)-174.9(recompense.)]TJ /F2 1 Tf 9.9739 0 TD [(Research)-173.5(subjects)-172(may)-174.9(be)-175(reimbursed)-168.6(for)-173.3(their)]TJ -9.9739 -1.2467 TD [(transport)-218.5(and)-217(other)-219(expenses,)-214.6(including)-214.6(lost)-218.9(earnings,)-220.3(associated)-217(with)]TJ 0 -1.2416 TD [(their)-366.5(participation)-360.5(in)-362.7(research.)-360.9(Those)-361.9(who)-361.1(receive)-361.3(no)-365.2(direct)-358.8(benefit)]TJ 0 -1.2467 TD [(from)-567(the)-566.2(research)-563.7(may)-562.9(also)-564(receive)-568.2(a)-565.7(small)-562.1(sum)-563.8(of)-568.7(money)-561.7(for)]TJ T* [(inconvenience)-290.1(due)-290.3(to)-289.3(their)-294(participation)-288(in)-290.2(the)-292(research.)-288.5(All)-293.7(subjects)]TJ T* [(may)-505.9(receive)-501(medical)-504(services)-499.1(unrelated)-503.4(to)-501.4(the)-504.1(research)-496.4(and)-501.5(have)]TJ 0 -1.2416 TD [(procedures)-271.6(and)-263.5(tests)-273.9(performed)-268.2(free)-265.2(of)-268.6(charge.)]TJ ET 95.641 646.809 318.898 -0.51 re f BT /F6 1 Tf 7.9702 0 0 7.9702 95.6409 649.1337 Tm [(THE)-330.8(GUIDELINES)]TJ /F7 1 Tf 11.9551 0 0 11.9551 401.3857 649.1337 Tm (45)Tj ET endstream endobj 133 0 obj << /Type /Page /Parent 395 0 R /Resources 134 0 R /Contents 135 0 R /MediaBox [ 0 0 595 842 ] /CropBox [ 0 0 595 842 ] /Rotate 0 >> endobj 134 0 obj << /ProcSet [ /PDF /Text ] /Font << /F2 337 0 R /F5 340 0 R /F6 341 0 R /F7 342 0 R >> /ExtGState << /GS1 434 0 R >> /ColorSpace << /DefaultCMYK 417 0 R /Cs6 416 0 R >> >> endobj 135 0 obj << /Length 5905 >> stream q 1 i 0.015 737.008 510.221 -737.008 re W n /Cs6 cs 0 0 0 scn /GS1 gs 0.015 709.001 25.44 -0.284 re f Q /Cs6 cs 0 0 0 scn /GS1 gs 28.006 737.008 0.283 -25.455 re f 481.89 737.008 0.283 -25.455 re f 484.724 709.001 25.512 -0.284 re f 484.724 28.346 25.512 -0.283 re f 481.89 25.512 0.283 -25.512 re f q 1 i 0.015 737.008 510.221 -737.008 re W n 28.006 25.512 0.283 -25.512 re f 0.015 28.346 25.44 -0.283 re f Q BT /F5 1 Tf 10.959 0 0 10.959 95.6409 609.8455 Tm 0 Tc 0 Tw [(Unacceptable)-281.7(recompense.)]TJ /F2 1 Tf 11.2361 0 TD [(Payments)-279.8(in)-279.9(money)-282.3(or)-278.7(in)-279.9(kind)-283(to)-279(research)]TJ -11.2361 -1.2623 TD [(subjects)-187.5(should)-184(not)-182.2(be)-185.3(so)-180.4(large)-184.2(as)-185.9(to)-185.9(persuade)-183.4(them)-183.9(to)-180.7(take)-185.2(undue)-179.6(risks)]TJ 0 -1.2571 TD [(or)-247.7(volunteer)-244.7(against)-245(their)-247.5(better)-249.3(judgment.)-243.8(Payments)-243.6(or)-247.7(rewards)-248.9(that)]TJ 0 -1.2623 TD [(undermine)-547(a)-545(persons)-543(capacity)-547.5(to)-542.8(exercise)-545.4(free)-549.7(choice)-543.1(invalidate)]TJ 0 -1.2571 TD [(consent.)-387.8(It)-383.9(may)-387(be)-387.1(difficult)-385.1(to)-382.4(distinguish)-386.7(between)-382.9(suitable)-384.3(recom-)]TJ T* [(pense)-228.8(and)-227.3(undue)-226.1(influence)-226.2(to)-227.2(participate)-226.6(in)-228.2(research.)-226.4(An)-224.8(unemployed)]TJ 0 -1.2623 TD [(person)-277.1(or)-273.5(a)-276(student)-270.3(may)-273.2(view)-278.8(promised)-271.5(recompense)-270.4(differently)-274.6(from)]TJ 0 -1.2571 TD [(an)-231(employed)-233.9(person.)-229.6(Someone)-229.4(without)-228.5(access)-233.2(to)-232.4(medical)-229.8(care)-232.7(may)-231.8(or)]TJ T* [(may)-402.5(not)-399.5(be)-402.6(unduly)-400.1(influenced)-398.4(to)-403.1(participate)-397.3(in)-404(research)-398.1(simply)-403.2(to)]TJ 0 -1.2623 TD [(receive)-206.1(such)-205.4(care.)-205.8(A)-207.7(prospective)-203.9(subject)-205.2(may)-205.9(be)-206(induced)-202(to)-206.5(participate)]TJ 0 -1.2571 TD [(in)-233.3(order)-229.1(to)-227.2(obtain)-231.1(a)-229.4(better)-228.6(diagnosis)-229.5(or)-232.1(access)-228.1(to)-227.2(a)-229.4(drug)-230.3(not)-228.8(otherwise)]TJ 0 -1.2623 TD [(available;)-235.1(local)-231.7(ethical)-227.3(review)-232.8(committees)-231.4(may)-231.8(find)-227.8(such)-231.2(inducements)]TJ 0 -1.2571 TD [(acceptable.)-427.5(Monetary)-423.4(and)-423.9(in-kind)-426.4(recompense)-425.6(must,)-426.4(therefore,)-421.1(be)]TJ T* [(evaluated)-331.8(in)-331.6(the)-333.4(light)-335.7(of)-330.7(the)-333.4(traditions)-327.3(of)-335.9(the)-333.4(particular)-327.1(culture)-334.5(and)]TJ 0 -1.2622 TD [(population)-477.9(in)-471.3(which)-476.6(they)-474.9(are)-478.3(offered,)-472.3(to)-475.6(determine)-477.5(whether)-476.3(they)]TJ 0 -1.2571 TD 0.0129 Tc [(co)-4.1(nstitute)-615.8(undue)-615.8(influence.)-612.1(The)-615.8(e)-0.2(thical)-617.2(review)-614.1(committee)-615.8(w)1.5(ill)]TJ 0 -1.2623 TD 0 Tc [(ordinarily)-321.6(be)-325(the)-323.1(best)-320.9(judge)-322.2(of)-320.4(what)-318.1(constitutes)-324.9(reasonable)-318.7(material)]TJ 0 -1.2571 TD [(recompense)-218.6(in)-217.8(particular)-213.2(circumstances.)-212.8(When)-217(research)-217.1(interventions)]TJ T* [(or)-428.7(procedures)-426.8(that)-428.9(do)-427.3(not)-425.4(hold)-427.8(out)-425.4(the)-431.7(prospect)-422.8(of)-429(direct)-426.1(benefit)]TJ 0 -1.2623 TD [(present)-214.3(more)-209.5(than)-209.9(minimal)-213.6(risk,)-212.5(all)-211.9(parties)-210.9(involved)-210.7(in)-207.5(the)-214.4(research)-206.7()]TJ 0 -1.2571 TD [(sponsors,)-487.9(investigators)-485.1(and)-486(ethical)-486(review)-486.3(committees)-490.1()-484.7(i)0(n)-486.8(both)]TJ T* [(funding)-227.5(and)-227.3(host)-226.6(countries)-230.4(should)-225.4(be)-226.7(careful)-231.3(to)-227.2(avoid)-228.1(undue)-226.1(material)]TJ 0 -1.2623 TD (inducement.)Tj /F5 1 Tf 0 -2.3486 TD [(Incompetent)-548.2(persons.)]TJ /F2 1 Tf 9.5859 0 TD [(Incompetent)-541.7(persons)-549.2(may)-542.2(be)-547.4(vulnerable)-547.5(to)]TJ -9.5859 -1.2571 TD [(exploitation)-424.7(for)-421.6(financial)-423.5(gain)-418(by)-422.4(guardians.)-422.7(A)-419.8(guardian)-420.7(asked)-424.4(to)]TJ 0 -1.2623 TD [(give)-569.2(permission)-568.4(on)-566.9(behalf)-568.6(of)-568.7(an)-567.2(incompetent)-563.6(person)-566.8(should)-566.8(be)]TJ 0 -1.2571 TD [(offered)-468.1(no)-463.5(recompense)-461.8(other)-462.1(than)-463.4(a)-467.4(refund)-458.5(of)-465.2(travel)-466.8(and)-460.1(related)]TJ 0 -1.2623 TD (expenses.)Tj /F5 1 Tf 0 -2.3486 TD [(Withdrawal)-239.5(from)-236.5(a)-234.6(study.)]TJ /F2 1 Tf 10.8326 0 TD (A)Tj 1.0088 0 TD [(subject)-236.2(who)-236.9(withdraws)-232.6(from)-241.1(research)-232.6(for)]TJ -11.8414 -1.2571 TD [(reasons)-378.7(related)-376.2(to)-377.3(the)-374.8(study,)-377.4(such)-376.1(as)-377.3(unacceptable)-374.7(side-effects)-377.1(of)-377.3(a)]TJ 0 -1.2623 TD [(study)-197.4(drug,)-198.3(or)-201.1(who)-195.6(is)-198.6(withdrawn)-194.9(on)-199.6(health)-196.1(grounds,)-194(should)-199.5(be)-195.7(paid)-200.5(or)]TJ 0 -1.2571 TD [(recompensed)-313.3(as)-315.2(if)-312.7(full)-313.2(participation)-313.9(had)-310.1(taken)-316.1(place.)-312(A)-316.4(subject)-313.8(who)]TJ T* [(withdraws)-305(for)-307.8(any)-305.2(other)-306.9(reason)-303.3(should)-303(be)-304.3(paid)-309.1(in)-305.8(proportion)-302(to)-304.8(the)]TJ 0 -1.2623 TD [(amount)-253.4(of)-253.1(participation.)-256(An)-250.7(investigator)-254.5(who)-252.5(must)-251.5(remove)-255.5(a)-250.1(subject)]TJ 0 -1.2571 TD [(from)-179(the)-183.4(study)-176.7(for)-178.5(wilful)-178.8(noncompliance)-178.1(is)-177.9(entitled)-178.6(to)-180.7(withhold)-179.2(part)-180.3(or)]TJ 0 -1.2623 TD [(all)-274(of)-268.6(the)-266.2(payment.)]TJ ET 95.641 646.809 318.898 -0.51 re f BT /F6 1 Tf 7.9702 0 0 7.9702 191.1118 649.1337 Tm [(INTERNA)13.4(TIONAL)-327.4(ETHICAL)-327.5(GUIDELINES)-319.8(FOR)-332.5(BIOMED)13.7(ICAL)-331.1(RESEARCH)]TJ /F7 1 Tf 11.9551 0 0 11.9551 95.6409 649.1337 Tm (46)Tj ET endstream endobj 136 0 obj << /Type /Page /Parent 395 0 R /Resources 137 0 R /Contents 138 0 R /MediaBox [ 0 0 595 842 ] /CropBox [ 0 0 595 842 ] /Rotate 0 >> endobj 137 0 obj << /ProcSet [ /PDF /Text ] /Font << /F2 337 0 R /F5 340 0 R /F6 341 0 R /F7 342 0 R /F8 343 0 R /F10 345 0 R /F11 346 0 R >> /ExtGState << /GS1 434 0 R >> /ColorSpace << /DefaultCMYK 417 0 R /Cs6 416 0 R >> >> endobj 138 0 obj << /Length 6634 >> stream q 1 i 0.015 737.008 510.221 -737.008 re W n /Cs6 cs 0 0 0 scn /GS1 gs 0.015 709.001 25.44 -0.284 re f Q /Cs6 cs 0 0 0 scn /GS1 gs 28.006 737.008 0.283 -25.455 re f 481.89 737.008 0.283 -25.455 re f 484.724 709.001 25.512 -0.284 re f 484.724 28.346 25.512 -0.283 re f 481.89 25.512 0.283 -25.512 re f q 1 i 0.015 737.008 510.221 -737.008 re W n 28.006 25.512 0.283 -25.512 re f 0.015 28.346 25.44 -0.283 re f Q 1 1 1 scn 95.641 601.285 14.173 -2.835 re f 0 0 0 scn 95.641 621.468 318.898 -20.183 re f 1 1 1 scn 95.641 578.268 14.173 -2.835 re f 0.8 0.8 0.8 scn 95.641 598.45 318.898 -20.183 re f BT /F11 1 Tf 11.9551 0 3.5865 11.9551 218.8913 606.8975 Tm 1 1 1 scn 0 Tc 0 Tw [(Guideline)-278.6(8)]TJ 11.9551 0 0 11.9551 126.5952 583.8802 Tm 0 0 0 scn [(Benefi)-10.5(ts)-267.8(and)-273.5(risks)-274(of)-272.1(study)-276.1(participation)]TJ /F8 1 Tf 10.959 0 0 10.959 95.6409 562.4503 Tm [(For)-543.5(all)-542.7(biomedical)-537.9(research)-542.6(involving)-538(human)-543(subjects,)-538.3(the)]TJ 0 -1.2364 TD [(investigator)-334.4(must)-332.3(ensure)-330.9(that)-336.5(potential)-333.5(benefits)-329.5(and)-335.1(risks)-332.5(are)]TJ T* [(reasonably)-267(balanced)-267.6(and)-267.9(risks)-270.4(are)-264.7(minimized.)]TJ /F10 1 Tf 8.9663 0 0 8.9663 95.6409 520.5542 Tm (.)Tj /F8 1 Tf 10.959 0 0 10.959 116.5606 519.7038 Tm [(Interventions)-325.3(or)-330.2(procedures)-327.6(that)-331.4(hold)-328.7(out)-327.2(the)-327.4(prospect)-330.9(of)]TJ -1.9089 -1.2364 TD [(direct)-569(diagnostic,)-559(therapeutic)-563(or)-563(preventive)-564.5(benefit)-560.8(for)-566.9(the)]TJ T* [(individual)-200.8(subject)-201.5(must)-202.9(be)-199.4(justified)-201.9(by)-204.6(the)-198.1(expectation)-199.4(that)-202(they)]TJ T* [(will)-225.5(be)-214.9(at)-222.7(least)-214.5(as)-220.3(advantageous)-216.1(to)-217.3(the)-218.8(individual)-216.3(subject,)-221.2(in)-217.5(the)]TJ T* 0.0121 Tc [(light)-617.8(of)-612.6(foreseeable)-615.4(risks)-610.2(and)-615.1(b)0.5(enefits,)-618(as)-615.4(any)-615.4(available)]TJ T* 0.0407 Tc [(al)5.5(te)3(rn)3.2(a)3(t)0.6(i)]TJ 4.1799 0 TD 0.0387 Tc [(ve.)-643.2(Risks)-640.5(of)-642.9(such)-640.2(beneficial)-643.2(interventions)-640.5(o)1.2(r)]TJ -4.1799 -1.2364 TD 0 Tc [(procedures)-374.2(must)-373.6(be)-375.3(justified)-377.8(in)-372.7(relation)-377.8(to)-372.5(expected)-376.3(benefits)]TJ T* [(to)-274.2(the)-265.4(individual)-268(subject.)]TJ /F10 1 Tf 8.9663 0 0 8.9663 95.6409 410.0031 Tm (.)Tj /F8 1 Tf 10.959 0 0 10.959 116.5606 409.1526 Tm [(Risks)-268.5(of)-274.2(interventions)-268.4(that)-269.3(do)-271.5(not)-270.3(hold)-271.8(out)-270.3(the)-270.5(prospect)-263.6(of)]TJ -1.9089 -1.2364 TD [(direct)-569(diagnostic,)-559(therapeutic)-563(or)-563(preventive)-564.5(benefit)-560.8(for)-566.9(the)]TJ T* [(individual)-257.7(must)-259.8(be)-256.3(justified)-253.6(in)-258.9(relation)-258.8(to)-258.7(the)-255(expected)-257.3(benefits)]TJ T* [(to)-367.3(society)-356.9(\(generalizable)-358.7(knowledge\).)-364.2(The)-361(risks)-358.4(presented)-358.3(by)]TJ T* (s)Tj 0.5587 0 TD [(uch)-614.5(int)-9.4(e)-6.7(rve)-6.1(n)-6.4(t)0(i)-8.1(ons)-614.5(mu)-6.1(st)-615.9(be)-613.2(rea)-6.1(so)-8(nab)-9.2(le)-611(in)-615.9(rel)-8.7(a)-6.7(t)0(i)-8.1(o)0(n)-613(t)0(o)-610.4(t)0(h)-10.3(e)]TJ -0.5587 -1.2364 TD [(importance)-267.4(of)-269(the)-270.5(knowledge)-268.2(to)-269(be)-266.6(gained.)]TJ 9.9626 0 2.9888 9.9626 95.6409 318.6141 Tm [(Comm)-9.3(ent)-7.2(ary)-269.4(on)-277.2(Guidelin)-10.9(e)-267.4(8)]TJ /F2 1 Tf 10.959 0 0 10.959 95.6409 301.3228 Tm [(The)-207.4(Declaration)-198(of)-206.5(Helsinki)-202.9(in)-202.3(several)-205.5(paragraphs)-196.7(deals)-204.6(with)-206.6(the)-198.9(well-)]TJ 0 -1.226 TD 0.0225 Tc [(being)-620.8(o)0.3(f)-622.2(r)4(esea)5.2(rc)4.3(h)-625.7(s)4(ub)5.5(je)4.3(cts)-622(a)0(nd)]TJ 15.3333 0 TD 0.0213 Tc [(the)-622.9(a)-1.2(voidan)4.3(ce)-622.9(of)-623.4(risk.)-624.3(T)4.4(hus,)]TJ -15.3333 -1.226 TD 0 Tc [(considerations)-273.5(related)-272.7(to)-279(the)-271.3(well-being)-275.5(of)-273.8(the)-276.5(human)-270.8(subject)-272.4(should)]TJ 10.7396 0 0 10.959 95.6409 260.9574 Tm [(take)-210.4(precedence)-209.4(over)-211.2(the)-214.1(interests)-209.9(of)-207.7(science)-212.3(and)-211.9(society)]TJ /F5 1 Tf 23.4487 0 TD [(\(Paragraph)-210.9(5)]TJ /F2 1 Tf 5.6431 0 TD (\);)Tj 10.959 0 0 10.959 95.6409 247.5212 Tm [(clinical)-351.4(testing)-345.7(must)-349.8(be)-345.7(preceded)-344.4(by)-349.9(adequate)-342.8(laboratory)-344.2(or)-346(animal)]TJ 0 -1.226 TD [(experimentation)-326.1(to)-330.7(demonstrate)-325(a)-327.7(reasonable)-323.9(probability)-328.6(of)-325.5(success)]TJ T* [(without)-259.5(undue)-257.2(risk)-260(\()]TJ /F5 1 Tf 8.6547 0 TD [(Paragraph)-256.1(11)]TJ /F2 1 Tf 5.6905 0 TD [(\);)-260.9(every)-255.2(project)-256.9(should)-256.5(be)-262.9(preceded)]TJ -14.3452 -1.2312 TD [(by)-236.1(careful)-231.3(assessment)-226.3(of)-232.4(predictable)-231(risks)-232(and)-232.5(burdens)-227(in)-233.3(comparison)]TJ 0 -1.226 TD [(with)-320.4(foreseeable)-318.9(benefits)-322.3(to)-320.4(the)-317.9(subject)-319(or)-320.1(to)-320.4(others)-320.3(\()]TJ /F5 1 Tf 22.7464 0 TD [(Paragraph)-318.2(16)]TJ /F2 1 Tf 5.7526 0 TD (\);)Tj -28.499 -1.226 TD [(physician-researchers)-287.6(must)-282.5(be)-288.8(confident)-286.1(that)-284(the)-286.9(risks)-288.9(involved)-283.1(have)]TJ T* [(been)-365.5(adequately)-364.3(assessed)-362.2(and)-361.8(can)-368.2(be)-361.2(satisfactorily)-366.9(managed)-363.5(\()]TJ /F5 1 Tf 26.7194 0 TD (Para-)Tj -26.7194 -1.226 TD [(graph)-186.1(17)]TJ /F2 1 Tf 3.5695 0 TD [(\);)-188.5(and)-185.9(the)-188.6(risks)-185.4(and)-185.9(burdens)-185.6(to)-185.9(the)-188.6(subject)-184.5(must)-184.2(be)-190.5(minimized,)]TJ -3.5695 -1.2312 TD [(and)-320.4(reasonable)-318.7(in)-316.1(relation)-322.3(to)-315.2(the)-323.1(importance)-317.7(of)-315.2(the)-317.9(objective)-319.5(or)-320.1(the)]TJ 0 -1.226 TD [(knowledge)-267(to)-273.8(be)-268.1(gained)-267.1(\()]TJ /F5 1 Tf 10.6619 0 TD [(Paragraph)-266.5(18)]TJ /F2 1 Tf 5.7008 0 TD (\).)Tj 10.7396 0 0 10.959 109.8142 112.989 Tm [(Biomedical)-455.4(research)-446.4(often)-453.5(employs)-446.4(a)-455.5(variety)-448.2(of)-450.6(interventions)-449.4(of)]TJ -1.3197 -1.2364 TD 0.009 Tc [(wh)9(ich)-589.8(s)9(ome)-588.7(hol)9(d)-594.3(o)9(ut)-587.1(th)]TJ 11.4476 0 TD 0.5999 Tc [(ep)592.3(r)599.9(o)]TJ 2.5467 0 TD 0 Tc [(sp)-13.2(e)-6.4(c)-6.4(t)-596.1(o)-7.6(f)-596.1(di)-12.1(re)-12.1(c)-6.4(t)-596.1(t)-10.1(h)0(e)-14(r)0(a)-12.4(p)0(e)-8.7(u)-7.6(ti)-14.6(c)-597.7(b)0(e)-14(n)0(e)-8.7(f)-10.1(it)]TJ ET 95.641 646.809 318.898 -0.51 re f BT /F6 1 Tf 7.9702 0 0 7.9702 95.6409 649.1337 Tm [(THE)-330.8(GUIDELINES)]TJ /F7 1 Tf 11.9551 0 0 11.9551 401.3857 649.1337 Tm (47)Tj ET endstream endobj 139 0 obj << /Type /Page /Parent 395 0 R /Resources 140 0 R /Contents 141 0 R /MediaBox [ 0 0 595 842 ] /CropBox [ 0 0 595 842 ] /Rotate 0 >> endobj 140 0 obj << /ProcSet [ /PDF /Text ] /Font << /F2 337 0 R /F5 340 0 R /F6 341 0 R /F7 342 0 R >> /ExtGState << /GS1 434 0 R >> /ColorSpace << /DefaultCMYK 417 0 R /Cs6 416 0 R >> >> endobj 141 0 obj << /Length 6571 >> stream q 1 i 0.015 737.008 510.221 -737.008 re W n /Cs6 cs 0 0 0 scn /GS1 gs 0.015 709.001 25.44 -0.284 re f Q /Cs6 cs 0 0 0 scn /GS1 gs 28.006 737.008 0.283 -25.455 re f 481.89 737.008 0.283 -25.455 re f 484.724 709.001 25.512 -0.284 re f 484.724 28.346 25.512 -0.283 re f 481.89 25.512 0.283 -25.512 re f q 1 i 0.015 737.008 510.221 -737.008 re W n 28.006 25.512 0.283 -25.512 re f 0.015 28.346 25.44 -0.283 re f Q BT /F2 1 Tf 10.7396 0 0 10.959 95.6409 609.8455 Tm 0 Tc 0 Tw [(\(beneficial)-259.7(interventions\))-258.9(and)-259.4(others)-259.4(are)-261.7(administered)-253.7(solely)-262.4(to)-260.5(answer)]TJ 0 -1.2623 TD [(the)-372.5(research)-362(question)-368.4(\(non-beneficial)-366.4(interventions\).)-363.7(Beneficial)-367.8(inter-)]TJ 0 -1.2571 TD [(ventions)-240.9(are)-235.3(justified)-240.4(as)-239.4(they)-236.8(are)-240.5(in)-239.1(medical)-238.3(practice)-238.6(by)-241.3(the)-235.3(expectation)]TJ 0 -1.2623 TD [(that)-156(they)-147(will)-156(be)-151.2(at)-154.1(least)-149.6(as)-154.9(advantageous)-144.4(to)-154.9(the)-150.8(individuals)-151.9(concerned,)-150.5(in)]TJ 0 -1.2571 TD [(the)-288.1(light)-286.8(of)-286.9(both)-286.2(risks)-282.4(and)-285.8(benefits,)-289.9(as)-281.6(any)-285(available)-286.8(alternative.)-286(Non-)]TJ T* [(beneficial)-323.5(interventions)-322.7(are)-325(assessed)-324.2(differently;)-321.8(they)-321.2(may)-321.2(be)-325.4(justified)]TJ 0 -1.2623 TD [(only)-200.6(by)-199.1(appeal)-198(to)-202.4(the)-198.3(knowledge)-196.8(to)-197.2(be)-204(gained.)-197.2(In)-198(assessing)-197.1(the)-203.6(risks)-197.9(and)]TJ 0 -1.2571 TD [(benefits)-327.6(that)-324.9(a)-328.8(protocol)-320.9(presents)-324.2(to)-329.1(a)-323.5(population,)-323.9(it)-326.1(is)-326.9(appropriate)-324.2(to)]TJ T* [(consider)-251.9(the)-245.8(harm)-248.5(that)-251(could)-244.8(result)-251(from)-251.8(forgoing)-246.5(the)-245.8(research.)]TJ 10.959 0 0 10.959 109.8142 485.0078 Tm [(Paragraphs)-180.9(5)-177.7(and)-180.8(18)-174.3(of)-180.7(the)-183.4(Declaration)-177.3(of)-180.7(Helsinki)-177.1(do)-179(not)-182.2(preclude)]TJ -1.2933 -1.2623 TD [(well-informed)-514.9(volunteers,)-505.4(capable)-512.9(of)-506.6(fully)-511.6(appreciating)-511.2(risks)-511.3(and)]TJ 0 -1.2571 TD (b)Tj 0.5587 0 TD [(ene)-7(fits)-613.8(of)-610.1(an)-613.8(inv)-7.5(esti)-8(gat)-6.9(ion)-7.2(,)-609.4(f)0(r)-6.2(o)0(m)-607.3(par)-6.3(ti)-7.4(ci)-6.9(pat)-6.6(ing)-612.8(in)-611(res)-8.7(ear)-7.5(ch)-609.5(for)]TJ -0.5587 -1.2571 TD [(altruistic)-274.3(reasons)-264.9(or)-268.4(for)-271.6(modest)-266.1(remuneration.)]TJ /F5 1 Tf 0 -2.4107 TD 0.0184 Tc [(Min)-4.1(i)-1.3(mizin)-4.1(g)-619.7(risk)-624.9(ass)-5.3(o)1.1(ciated)-624.9(wit)-5.5(h)-619.7(pa)-4.1(rticipa)-4.1(t)-0.4(ion)-619.7(i)-6.5(n)-619.7(a)-624.9(rand)-4.1(omiz)-5(ed)]TJ 0 -1.2571 TD 0 Tc [(controlled)-404.9(trial.)]TJ /F2 1 Tf 6.9631 0 TD [(In)-402.9(randomized)-398.8(controlled)-398.7(trials)-402.2(subjects)-404.8(risk)-399.7(being)]TJ -6.9631 -1.2623 TD [(allocated)-504.9(to)-506.6(receive)-506.2(the)-509.3(treatment)-503.2(that)-506.5(proves)-499.9(inferior.)-508.7(They)-504(are)]TJ 0 -1.2571 TD [(allocated)-401.4(by)-396.5(chance)-395.9(to)-398(one)-393.8(of)-398(two)-399(or)-397.7(more)-395.8(intervention)-398.6(arms)-396.3(and)]TJ T* [(followed)-190.8(to)-185.9(a)-188(predetermi)5.8(ned)-186.9(end-point.)-185.7(\(Interventions)-186.4(are)-183.4(understood)]TJ 0 -1.2623 TD 0.0177 Tc [(to)-620.1(include)-621.3(new)-624.8(o)0.7(r)-621.6(e)4.6(stablished)-620.1(therapies,)-622.8(diagnostic)-621.3(t)4.1(ests)-621.6(and)]TJ 0 -1.2571 TD 0 Tc [(preventive)-346(measures.\))-341.3(An)-338.6(intervention)-341.7(is)-343.4(evaluated)-342.1(by)-344.8(comparing)-339.4(it)]TJ 0 -1.2623 TD [(with)-423.9(another)-418.9(intervention)-414.1(\(a)-424.1(control\),)-418.4(which)-419.7(is)-421(ordinarily)-419.9(the)-421.4(best)]TJ 0 -1.2571 TD [(current)-566.1(method,)-563.7(selected)-560.9(from)-567(the)-561(safe)-564.3(and)-563.6(effective)-564.7(treatments)]TJ T* [(available)-443(globally,)-439.1(unless)-440.2(some)-437.2(other)-441.4(control)-442(interventio)6.5(n)-441.3(such)-443.3(as)]TJ 0 -1.2623 TD [(placebo)-269.5(can)-269.9(be)-268.1(justified)-271(ethically)-269.5(\(See)-268.9(Guideline)-266.3(11\).)]TJ 1.2933 -1.314 TD 0.0121 Tc [(To)-610.2(minimize)-616.6(risk)-615.4(when)-615.4(the)-616.6(i)-2.4(ntervention)-610.2(t)-1.5(o)-615.4(b)0.2(e)-616.6(t)3.7(ested)-615.4(i)-2.4(n)-615.4(a)]TJ -1.2933 -1.2623 TD 0 Tc [(randomized)-466(controlled)-460.8(trial)-466.5(is)-462.4(designed)-463.9(to)-465.2(prevent)-461.5(or)-464.9(postpone)-461.5(a)]TJ 0 -1.2571 TD [(lethal)-193.6(or)-190.8(disabling)-189.3(outcome,)-188.8(the)-193.8(investigator)-187.3(must)-189.4(not,)-191.6(for)-194(purposes)-188.6(of)]TJ 0 -1.2623 TD [(conducting)-219(the)-214.4(trial,)-217.2(withhold)-215.4(therapy)-217.4(that)-216.8(is)-219.3(known)-214.1(to)-216.9(be)-216.4(superior)-217.1(to)]TJ 0 -1.2571 TD [(the)-297.2(intervention)-289.9(being)-296.3(tested,)-294.9(unless)-290.1(the)-297.2(withholding)-290.2(can)-295.8(be)-294(justified)]TJ T* [(by)-215.4(the)-214.4(standards)-206.7(set)-215.9(forth)-214.3(in)-212.6(Guideline)-214.6(11.)-209.5(Also,)-215.5(the)-214.4(investigator)-208(must)]TJ 0 -1.2623 TD [(provide)-290.5(in)-290.2(the)-292(research)-284.3(protocol)-288.3(for)-292.3(the)-286.9(monitoring)-292.1(of)-289.3(research)-284.3(data)]TJ 0 -1.2571 TD [(by)-308.6(an)-303.4(independent)-299(board)-304.3(\(Data)-305.5(and)-299.7(Safety)-304.1(Monitoring)-301(Board\);)-306.4(one)]TJ T* [(function)-438.6(of)-439.3(such)-438.2(a)-436.3(board)-438.8(is)-436.5(to)-439.3(protect)-437.1(the)-436.9(research)-439.5(subjects)-435.8(from)]TJ 0 -1.2623 TD [(previously)-449.5(unknown)-439.7(adverse)-446(reactions)-448(or)-444.2(unnecessarily)-447.6(prolonged)]TJ 0 -1.2571 TD 0.0086 Tc [(expos)8.6(ure)-604.6(t)0.2(o)-603.4(a)1.6(n)-608.5(i)8.6(nfer)8.6(io)8.6(r)-611.5(t)0.2(h)8.6(e)-0.8(ra)8.6(py)]TJ 14.7849 0 TD 0.6146 Tc [(.N)603.7(o)614.6(r)]TJ 2.6642 0 TD 0 Tc [(ma)-12.7(ll)-13.5(y)-612.2(a)-7(t)-618.9(t)0(h)-10(e)-618.3(ou)-8.2(t)-8.4(s)0(e)-10.9(t)-618.9(of)-620.4(a)]TJ -17.4491 -1.2623 TD [(randomized)-248.7(controlled)-253.8(trial,)-248.2(criteria)-252.5(are)-250.7(established)-246.7(for)-250.9(its)-253.6(premature)]TJ 0 -1.2571 TD [(termination)-270.7(\(stopping)-264.8(rules)-273.1(or)-268.4(guidelines\).)]TJ ET 95.641 646.809 318.898 -0.51 re f BT /F6 1 Tf 7.9702 0 0 7.9702 191.1118 649.1337 Tm [(INTERNA)13.4(TIONAL)-327.4(ETHICAL)-327.5(GUIDELINES)-319.8(FOR)-332.5(BIOMED)13.7(ICAL)-331.1(RESEARCH)]TJ /F7 1 Tf 11.9551 0 0 11.9551 95.6409 649.1337 Tm (48)Tj ET endstream endobj 142 0 obj << /Type /Page /Parent 395 0 R /Resources 143 0 R /Contents 144 0 R /MediaBox [ 0 0 595 842 ] /CropBox [ 0 0 595 842 ] /Rotate 0 >> endobj 143 0 obj << /ProcSet [ /PDF /Text ] /Font << /F2 337 0 R /F5 340 0 R /F6 341 0 R /F7 342 0 R /F8 343 0 R /F11 346 0 R >> /ExtGState << /GS1 434 0 R >> /ColorSpace << /DefaultCMYK 417 0 R /Cs6 416 0 R >> >> endobj 144 0 obj << /Length 6072 >> stream q 1 i 0.015 737.008 510.221 -737.008 re W n /Cs6 cs 0 0 0 scn /GS1 gs 0.015 709.001 25.44 -0.284 re f Q /Cs6 cs 0 0 0 scn /GS1 gs 28.006 737.008 0.283 -25.455 re f 481.89 737.008 0.283 -25.455 re f 484.724 709.001 25.512 -0.284 re f 484.724 28.346 25.512 -0.283 re f 481.89 25.512 0.283 -25.512 re f q 1 i 0.015 737.008 510.221 -737.008 re W n 28.006 25.512 0.283 -25.512 re f 0.015 28.346 25.44 -0.283 re f Q 1 1 1 scn 95.641 354.898 14.173 -2.835 re f 0 0 0 scn 95.641 375.08 318.898 -20.183 re f 1 1 1 scn 95.641 304.271 14.173 -2.835 re f 0.8 0.8 0.8 scn 95.641 352.063 318.898 -47.792 re f BT /F5 1 Tf 10.7396 0 0 10.959 95.6409 610.0156 Tm 0 0 0 scn 0.0096 Tc 0 Tw [(Risks)-613.7(t)-0.5(o)-609.5(g)-2.4(r)9.6(o)-8.1(up)]TJ 6.852 0 TD 0.6229 Tc [(so)616.1(fp)610.9(e)611.2(r)622.9(s)606.3(o)610.9(n)616.1(s)]TJ /F2 1 Tf 5.6325 0 TD 0.6206 Tc [(.R)609.3(e)608.9(s)620.6(e)603.3(a)608.6(r)620.6(c)603.3(hi)605.5(nc)608.9(e)614.2(r)609.7(t)610.5(a)608.6(i)610.8(n)0.7(f)610.5(i)610.8(e)608.9(l)610.8(d)613(s)609.7(,)-6.8(s)620.6(u)602.1(c)614.2(h)-4.6(a)613.8(s)]TJ -12.4845 -1.2416 TD 0 Tc [(epidemiology,)-282(genetics)-280.9(or)-282.4(sociology,)-278.2(may)-284.3(present)-281.6(risks)-282.4(to)-281.6(the)-277.5(interests)]TJ T* [(of)-487.5(communities,)-484.8(societies,)-484(or)-488.3(racially)-484(or)-483(ethnically)-482.2(defined)-488.3(groups.)]TJ T* [(Information)-502.1(might)-505.6(be)-504.9(published)-502.3(that)-499.1(could)-503.4(stigmatize)-506.2(a)-503(group)-499.6(or)]TJ T* -0.0001 Tc [(expose)-272.7(its)-268.5(members)-272.3(to)-271.2(discrimination.)-273.1(Such)-266.8(information,)-268(for)-271.5(example,)]TJ T* 0 Tc [(could)-371.5(indicate,)-369.8(rightly)-373.2(or)-366.9(wrongly,)-370.5(that)-367.2(the)-372.5(group)-367.7(has)-368.4(a)-371(higher)-371(than)]TJ T* [(average)-177.5(prevalence)-180.6(of)-176.1(alcoholism,)-182.4(mental)-179.4(illness)-176(or)-182.1(sexually)-175.6(transmitted)]TJ T* [(disease,)-232.2(or)-229.6(is)-226.6(particularly)-229.8(susceptible)-225.4(to)-228.8(certain)-226.9(genetic)-227.7(disorders.)-229.6(Plans)]TJ T* [(to)-244.7(conduct)-238(such)-238.3(research)-240.6(should)-241(be)-241(sensitive)-242.3(to)-239.4(such)-238.3(considerations,)-240.5(to)]TJ T* [(the)-251.1(need)-249.7(to)-250(maintain)-249.9(confidentiality)-247.5(during)-250.7(and)-248.9(after)-250.2(the)-251.1(study,)-248(and)-248.9(to)]TJ T* [(the)-277.5(need)-270.8(to)-271.1(publish)-271.9(the)-272.2(resulting)-269.9(data)-274.1(in)-270.7(a)-270.7(manner)-273(that)-272.1(is)-274.1(respectful)-271(of)]TJ 0 -1.2467 TD [(the)-208.9(interests)-204.6(of)-207.7(all)-205.8(concerned,)-203.3(or)-208.5(in)-202.1(certain)-205.8(circumstances)-207.3(not)-204.7(to)-202.4(publish)]TJ 0 -1.2416 TD [(them.)-262.4(The)-255.9(ethical)-262.7(review)-256.7(committee)-260.5(should)-256.8(ensure)-255.7(that)-256.3(the)-261.7(interests)-257.4(of)]TJ T* [(all)-274.4(concerned)-267.4(are)-272.2(given)-264.3(due)-269.6(consideration;)-271.8(often)-268.8(it)-268(will)-272.1(be)-272.6(advisable)-267.6(to)]TJ T* [(have)-270.4(individual)-267.7(consent)-267.7(supplemented)-263.6(by)-273(community)-264.7(consultation.)]TJ 10.959 0 0 10.959 109.8142 405.8644 Tm [([The)-175.3(ethical)-170.4(basis)-173.9(for)-173.3(the)-173.1(justification)-168(of)-175.5(risk)-172.1(is)-172.7(elaborated)-168.9(further)-173.5(in)]TJ -1.2933 -1.2416 TD [(Guideline)-271.5(9])]TJ /F11 1 Tf 11.9551 0 3.5865 11.9551 218.8913 360.4534 Tm 1 1 1 scn [(Guideline)-278.6(9)]TJ 11.9551 0 0 11.9551 121.9464 337.4361 Tm 0 0 0 scn [(Special)-279.9(limitations)-277.6(on)-270.9(risk)-275.7(when)-275.5(research)]TJ 0.2466 -1.1523 TD [(involves)-274(individual)-13.4(s)-268.6(who)-272.8(are)-274.9(not)-270.1(capab)-8.5(le)]TJ 3.7368 -1.1523 TD [(of)-272.1(giving)-277.4(informed)-275.6(conse)-8.9(nt)]TJ /F8 1 Tf 10.959 0 0 10.959 95.6409 288.2834 Tm [(When)-469(there)-466.5(is)-466.1(ethical)-468.2(and)-469.7(scientific)-467.5(justification)-466.3(to)-465.6(conduct)]TJ 0 -1.2623 TD 0.0317 Tc [(re)4.3(se)4.3(arch)-631.7(with)-631.7(ind)4.6(i)-3.5(v)4.3(i)1.7(du)4.6(als)-632(i)1.7(nca)4.3(p)-0.6(a)4.3(b)-0.6(le)-632(o)4.6(f)-634.4(givin)4.6(g)-631.7(in)4.6(formed)]TJ 0 -1.2571 TD 0 Tc [(consent,)-295.9(the)-296.4(risk)-299.9(from)-292.3(research)-294.3(interventions)-294.2(that)-295.2(do)-297.4(not)-296.1(hold)]TJ 0 -1.2623 TD [(out)-472(the)-472.3(prospect)-470.6(of)-470.8(direct)-470.7(benefit)-467.7(for)-473.8(the)-472.3(individual)-469.8(subject)]TJ 0 -1.2571 TD [(should)-238.4(be)-235.6(no)-235.3(more)-233(likely)-234.4(and)-236.9(not)-234.1(greater)-233(than)-235.6(the)-239.5(risk)-232.7(attached)]TJ T* 0.0079 Tc [(to)-609(rou)7.9(t)-2.5(in)7.9(e)-610.5(m)7.9(edica)7.9(l)-613.4(or)-605.5(psychol)7.9(ogica)7.9(l)-613.4(exa)7.9(mi)7.9(nati)7.9(on)-609(of)-606.4(such)]TJ 0 -1.2623 TD 0 Tc [(persons.)-429.4(Slight)-430(or)-428.5(minor)-428.4(increases)-426.3(above)-426.2(such)-429.8(risk)-429.3(may)-426.9(be)]TJ 0 -1.2571 TD [(permitted)-491(when)-491.2(there)-487.2(is)-492(an)-489.1(overriding)-482.9(scientific)-493.4(or)-490.5(medical)]TJ 0 -1.2623 TD 0.0076 Tc [(rat)7.6(i)-5.7(ona)7.6(le)-604.4(for)-605.8(s)0.9(uch)-604.1(i)-1.7(nc)7.6(reas)7.6(es)]TJ 14.8936 0 TD 0 Tc [(an)-8(d)-616.9(w)0(h)-12.4(e)-6.7(n)-611.7(a)-6.7(n)-616.9(e)0(t)-10.6(h)-6.4(ic)-10.9(a)-6.7(l)-614.6(r)-8.2(e)-6.7(vi)-10.9(e)-6.7(w)]TJ -14.8936 -1.2571 TD [(committee)-270.6(has)-268.2(approved)-266.2(them.)]TJ 9.9626 0 2.9888 9.9626 95.6409 131.244 Tm [(Comm)-9.3(ent)-7.2(ary)-269.4(on)-277.2(Guidelin)-10.9(e)-267.4(9)]TJ /F5 1 Tf 10.959 0 0 10.959 95.6409 113.159 Tm [(The)-197.3(low-risk)-188.1(standard:)]TJ /F2 1 Tf 9.4566 0 TD [(Certain)-193.5(individuals)-189.8(or)-190.8(groups)-193.5(may)-190.4(have)-188.9(limited)]TJ -9.4566 -1.2571 TD [(capacity)-382(to)-377.3(give)-383(informed)-375.3(consent)-378.4(either)-379.5(because,)-377.2(as)-382.4(in)-378.2(the)-380(case)-382.7(of)]TJ ET 95.641 646.809 318.898 -0.51 re f BT /F6 1 Tf 7.9702 0 0 7.9702 95.6409 649.1337 Tm [(THE)-330.8(GUIDELINES)]TJ /F7 1 Tf 11.9551 0 0 11.9551 401.3857 649.1337 Tm (49)Tj ET endstream endobj 145 0 obj << /Type /Page /Parent 395 0 R /Resources 146 0 R /Contents 147 0 R /MediaBox [ 0 0 595 842 ] /CropBox [ 0 0 595 842 ] /Rotate 0 >> endobj 146 0 obj << /ProcSet [ /PDF /Text ] /Font << /F2 337 0 R /F6 341 0 R /F7 342 0 R >> /ExtGState << /GS1 434 0 R >> /ColorSpace << /DefaultCMYK 417 0 R /Cs6 416 0 R >> >> endobj 147 0 obj << /Length 6373 >> stream q 1 i 0.015 737.008 510.221 -737.008 re W n /Cs6 cs 0 0 0 scn /GS1 gs 0.015 709.001 25.44 -0.284 re f Q /Cs6 cs 0 0 0 scn /GS1 gs 28.006 737.008 0.283 -25.455 re f 481.89 737.008 0.283 -25.455 re f 484.724 709.001 25.512 -0.284 re f 484.724 28.346 25.512 -0.283 re f 481.89 25.512 0.283 -25.512 re f q 1 i 0.015 737.008 510.221 -737.008 re W n 28.006 25.512 0.283 -25.512 re f 0.015 28.346 25.44 -0.283 re f Q BT /F2 1 Tf 10.959 0 0 10.959 95.6409 609.8455 Tm 0 Tc 0 Tw [(prisoners,)-415.7(their)-413(autonomy)-406.7(is)-410.7(limited,)-418(or)-408(because)-414.4(they)-407.7(have)-411.4(limited)]TJ 0 -1.2623 TD [(cognitive)-251.4(capacity.)-246.5(For)-243.8(research)-248.1(involving)-250.2(persons)-243.9(who)-247.3(are)-245.5(unable)-251.3(to)]TJ 0 -1.2571 TD [(consent,)-227.4(or)-221.8(whose)-222(capacity)-221.6(to)-222.1(make)-223.9(an)-225.8(informed)-220.1(choice)-222.4(may)-226.6(not)-223.6(fully)]TJ 0 -1.2623 TD [(meet)-417.9(the)-411(standard)-415.8(of)-413.5(informed)-411.5(consent,)-413.7(ethical)-413.6(review)-413.8(committees)]TJ 0 -1.2571 TD [(must)-277.3(distinguish)-272.9(between)-269.1(intervention)-274.4(risks)-273.3(that)-268.5(do)-277.2(not)-270.2(exceed)-272.9(those)]TJ T* [(associated)-211.8(with)-217(routine)-209.2(medical)-214.3(or)-211.5(psychological)-208.4(examination)-211.2(of)-211.7(such)]TJ 0 -1.2623 TD [(persons)-269.8(and)-268.7(risks)-268.2(in)-269.5(excess)-269.5(of)-268.6(those.)]TJ 10.7396 0 0 10.959 109.8142 513.2408 Tm [(When)-225.6(the)-224.7(risks)-224.3(of)-223.6(such)-222.5(interventio)7.3(ns)-224.3(do)-226.3(not)-220.6(exceed)-224.8(those)-222.1(associated)]TJ -1.3197 -1.2623 TD [(with)-391.6(routine)-392.5(medical)-391.4(or)-393.3(psychologic)7.9(al)-396.6(examination)-386.8(of)-392.5(such)-386.1(persons,)]TJ 0 -1.2571 TD [(there)-215.7(is)-216(no)-210.4(requirement)-211.9(for)-213.4(special)-216(substantive)-210.6(or)-213.8(procedural)-213.4(protective)]TJ 0 -1.2623 TD [(measures)-219.8(apart)-216.3(from)-220.1(those)-216.8(generally)-213.7(required)-220.2(for)-218.6(all)-216.4(research)-219.4(involving)]TJ 0 -1.2571 TD [(members)-214.2(of)-207.7(the)-214.1(particular)-208(class)-213.7(of)-207.7(persons.)-214.2(When)-209.7(the)-208.9(risks)-213.7(are)-208.9(in)-212.7(excess)]TJ T* [(of)-239.4(those,)-237.1(the)-240.5(ethical)-236.3(review)-240.8(committee)-234.1(must)-241.3(find:)-234.8(1\))-238.6(that)-240.5(the)-235.3(research)-235.3(is)]TJ 0 -1.2623 TD [(designed)-517(to)-519.2(be)-515.5(responsive)-517.7(to)-519.2(the)-515(disease)-518(affecting)-517.5(the)-515(prospective)]TJ 0 -1.2571 TD [(subjects)-412.8(or)-409.1(to)-408.3(conditions)-406.8(to)-408.3(which)-406(they)-411(are)-409.5(particularly)-404(susceptible;)]TJ T* [(2\))-333.6(that)-298.5(the)-298.6(risks)-298.2(of)-297.5(the)-298.6(research)-298.6(interventions)-296.3(are)-298.6(only)-295.6(slightly)-298.5(greater)]TJ 0 -1.2623 TD [(than)-285.4(those)-285.4(associated)-283.8(with)-286.1(routine)-286.9(medical)-285.8(or)-287.7(psychologic)7.9(al)-291.1(examina-)]TJ 0 -1.2571 TD [(tion)-309.5(of)-302.7(such)-307(persons)-299.4(for)-308.4(the)-303.9(condition)-300.9(or)-308.8(set)-302(of)-308(clinical)-303.8(circumstances)]TJ 0 -1.2623 TD [(under)-277.6(investigation;)-278.1(3\))-280.8(that)-277.4(the)-277.5(objective)-276.7(of)-281.6(the)-277.5(research)-277.5(is)-279.4(sufficiently)]TJ 0 -1.2571 TD [(important)-172.2(to)-170.8(justify)-170.6(exposure)-169.7(of)-170.8(the)-171.9(subjects)-170(to)-170.8(the)-171.9(increased)-167.8(risk;)-175.6(and)-169.7(4\))]TJ T* [(that)-346(the)-340.8(interventions)-338.5(are)-340.8(reasonably)-339.7(commensura)6.8(te)-343.8(with)-344.1(the)-340.8(clinical)]TJ 0 -1.2623 TD [(interventions)-243.5(that)-245.7(the)-245.8(subjects)-243.9(have)-244(experienced)-245.9(or)-245.5(may)-242(be)-246.3(expected)-242.5(to)]TJ 0 -1.2571 TD [(experience)-248.9(in)-249.6(relation)-248.4(to)-250(the)-251.1(condition)-248.1(under)-245.9(investigation.)]TJ 10.959 0 0 10.959 109.8142 292.422 Tm [(If)-373.5(such)-370.9(research)-372.3(subjects,)-372.7(including)-369.8(children,)-377.4(become)-368.7(capable)-373.3(of)]TJ -1.2933 -1.2571 TD [(giving)-605.1(independent)-604.2(informed)-608.1(consent)-600.9(during)-603.3(the)-607.6(research,)-604.1(their)]TJ 0 -1.2623 TD [(consent)-269.8(to)-268.6(continued)-268.9(participation)-267.3(should)-266.8(be)-268.1(obtained.)]TJ 1.2933 -1.2571 TD [(There)-202.7(is)-203.7(no)-204.8(international)6.8(ly)-202.6(agreed,)-204(precise)-200.9(definition)-203.8(of)-201.4(a)-198.4(slight)-207.4(or)]TJ -1.2933 -1.2623 TD [(minor)-357.4(increase)-361.1(above)-350.8(the)-359.3(risks)-356.1(associated)-356.6(with)-356.7(routine)-354(medical)-359.1(or)]TJ 0 -1.2571 TD [(psychological)-374(examinatio)7.7(n)-374(o)0(f)-372.1(such)-370.9(persons.)-367.1(Its)-376.5(meaning)-365.9(is)-374.5(inferred)]TJ 0 -1.2623 TD [(from)-225.6(what)-225(various)-218.6(ethical)-227.3(review)-222.4(committees)-221.1(have)-225.1(reported)-221.1(as)-222.1(having)]TJ 0 -1.2571 TD [(met)-306.6(the)-297.2(standard.)-301(Examples)-301.5(include)-297.8(additional)-299.7(lumbar)-302.3(punctures)-300.2(or)]TJ T* [(bone-marrow)-285.4(aspirations)-287.5(in)-290.2(children)-285.2(with)-289.4(conditions)-288.9(for)-287.1(which)-285.2(such)]TJ 0 -1.2623 TD 0.0176 Tc [(examinations)-621.7(are)-616.2(r)-0.9(egularly)-620.5(indicated)-625.4(i)3.1(n)-620.2(c)-0.6(linical)-622.9(practice.)-622.9(The)]TJ 0 -1.2571 TD 0 Tc [(requirement)-476.8(that)-480.6(the)-478.3(objective)-474.7(of)-480.7(the)-478.3(research)-475.7(be)-475(relevant)-481.4(to)-475.6(the)]TJ T* [(disease)-179.3(or)-175.2(condition)-177.2(affecting)-174.6(the)-173.1(prospective)-178(subjects)-172(rules)-180(out)-171.9(the)-178.2(use)]TJ 0 -1.2623 TD [(of)-273.8(such)-267.4(interventions)-267.1(in)-269.5(healthy)-265.2(children.)]TJ 10.7396 0 0 10.959 109.8142 112.989 Tm [(The)-551.6(requireme)6.4(nt)-550.9(that)-546.6(the)-546.7(research)-546.7(interventio)7.3(ns)-551.6(be)-547.1(reasonably)]TJ -1.3197 -1.2571 TD [(commensurate)-595.7(with)-597.5(clinical)-594.2(interventions)-597.2(that)-594.1(subjects)-592.3(may)-595.7(have)]TJ ET 95.641 646.809 318.898 -0.51 re f BT /F6 1 Tf 7.9702 0 0 7.9702 191.1118 649.1337 Tm [(INTERNA)13.4(TIONAL)-327.4(ETHICAL)-327.5(GUIDELINES)-319.8(FOR)-332.5(BIOMED)13.7(ICAL)-331.1(RESEARCH)]TJ /F7 1 Tf 11.9551 0 0 11.9551 95.6409 649.1337 Tm (50)Tj ET endstream endobj 148 0 obj << /Type /Page /Parent 396 0 R /Resources 149 0 R /Contents 150 0 R /MediaBox [ 0 0 595 842 ] /CropBox [ 0 0 595 842 ] /Rotate 0 >> endobj 149 0 obj << /ProcSet [ /PDF /Text ] /Font << /F2 337 0 R /F5 340 0 R /F6 341 0 R /F7 342 0 R /F8 343 0 R /F10 345 0 R /F11 346 0 R >> /ExtGState << /GS1 434 0 R >> /ColorSpace << /DefaultCMYK 417 0 R /Cs6 416 0 R >> >> endobj 150 0 obj << /Length 5833 >> stream q 1 i 0.015 737.008 510.221 -737.008 re W n /Cs6 cs 0 0 0 scn /GS1 gs 0.015 709.001 25.44 -0.284 re f Q /Cs6 cs 0 0 0 scn /GS1 gs 28.006 737.008 0.283 -25.455 re f 481.89 737.008 0.283 -25.455 re f 484.724 709.001 25.512 -0.284 re f 484.724 28.346 25.512 -0.283 re f 481.89 25.512 0.283 -25.512 re f q 1 i 0.015 737.008 510.221 -737.008 re W n 28.006 25.512 0.283 -25.512 re f 0.015 28.346 25.44 -0.283 re f Q 1 1 1 scn 95.641 466.866 14.173 -2.835 re f 0 0 0 scn 95.641 487.049 318.898 -20.183 re f 1 1 1 scn 95.641 430.016 14.173 -2.835 re f 0.8 0.8 0.8 scn 95.641 464.031 318.898 -34.016 re f BT /F2 1 Tf 10.7396 0 0 10.959 95.6409 609.8455 Tm 0 0 0 scn 0.0076 Tc 0 Tw [(ex)7.6(pe)7.6(r)]TJ 2.3333 0 TD 0 Tc [(ien)-13.2(ce)-7.6(d)-609.3(o)0(r)-615(a)0(r)-7.1(e)-613.5(li)-9(kel)-7.9(y)-613.8(t)0(o)-614.2(e)0(x)-7.9(p)0(e)-8.7(rie)-11.3(nc)-8.7(e)-608.2(f)0(o)-7.1(r)-612.7(th)-7.1(e)-613.5(con)-11(di)-6.8(ti)-9.3(on)-611.6(un)-9.8(der)]TJ -2.3333 -1.2623 TD [(investigation)-189.1(is)-194.9(intended)-189.7(to)-191.9(enable)-187.1(them)-194.5(to)-186.6(draw)-194.1(on)-189.3(personal)-188.9(experience)]TJ 0 -1.2571 TD [(as)-381.9(they)-379.3(decide)-376.7(whether)-376.2(to)-376.6(accept)-376.3(or)-382.7(reject)-377.4(additional)-373.6(procedures)-377.9(for)]TJ 0 -1.2623 TD [(research)-203.6(purposes.)-195.3(Their)-197.5(choices)-202.9(will,)-202.7(therefore,)-197.1(be)-198.7(more)-200.6(informed)-198.7(even)]TJ 0 -1.2571 TD [(though)-268.9(they)-268.4(may)-268.4(not)-268.1(fully)-271(meet)-267.3(the)-272.2(standard)-263.5(of)-271.1(informed)-267.3(consent.)]TJ 10.959 0 0 10.959 109.8142 540.8503 Tm [(\(See)-346.5(also)-346.8(Guidelines)-346.9(4:)]TJ /F5 1 Tf 10.1705 0 TD [(Individual)-342.8(informed)-345.3(consent)]TJ /F2 1 Tf 11.6086 0 TD (;)Tj 0.6156 0 TD (13:)Tj /F5 1 Tf 1.614 0 TD (Research)Tj -25.302 -1.2623 TD [(involving)-314.9(vulnerable)-311.3(persons;)]TJ /F2 1 Tf 12.2811 0 TD (14:)Tj /F5 1 Tf 1.583 0 TD [(Research)-313.7(involving)-309.7(children;)]TJ /F2 1 Tf 12.0535 0 TD [(and)-310.1(15:)]TJ /F5 1 Tf -25.9176 -1.2571 TD [(Research)-282.7(involving)-278.7(individuals)-279.8(who)-279.1(by)-277.8(reason)-283.1(of)-279.2(mental)-278.4(or)-279(behavioural)]TJ T* [(disorders)-272.6(are)-266.2(not)-270.7(capable)-265.2(of)-268.9(giving)-270(adequately)-266.9(informed)-267.7(consent)]TJ /F2 1 Tf 26.2642 0 TD (.\))Tj /F11 1 Tf 11.9551 0 3.5865 11.9551 214.8661 472.4219 Tm 1 1 1 scn [(Guideline)-278.6(10)]TJ 11.9551 0 0 11.9551 120.0189 449.4046 Tm 0 0 0 scn [(Research)-274.6(in)-273.4(populatio)-11.4(ns)-271.2(and)-273.5(communities)]TJ 5.2685 -1.1523 TD [(with)-269.9(limited)-276.9(reso)-7.6(urces)]TJ /F8 1 Tf 10.959 0 0 10.959 95.6409 414.0282 Tm [(Before)-188.2(undertaking)-182.4(research)-185.6(in)-186.5(a)-187.8(population)-181.8(or)-190.5(community)-179.8(with)]TJ 0 -1.2623 TD [(limited)-231(resources,)-222.1(the)-229.2(sponsor)-223.2(and)-226.5(the)-224(investigator)-225.7(must)-228.8(make)]TJ 0 -1.2571 TD [(every)-267.8(effort)-271(to)-269(ensure)-268.8(that:)]TJ /F10 1 Tf 1.2933 -1.5519 TD (7)Tj /F8 1 Tf 1.2933 0 TD [(the)-384.4(research)-382.2(is)-383.4(responsive)-380.8(to)-382.8(the)-384.4(health)-381(needs)-384.8(and)-381.7(the)]TJ 0 -1.2571 TD [(priorities)-260.8(of)-258.7(the)-255(population)-259.4(or)-257.7(community)-252.2(in)-258.9(which)-257.4(it)-261.6(is)-259.2(to)]TJ 0 -1.2623 TD [(be)-271.8(carried)-269.5(out;)-269(and)]TJ /F10 1 Tf -1.2933 -1.2571 TD (7)Tj /F8 1 Tf 1.2933 0 TD [(any)-542.3(intervention)-541(or)-542.3(product)-536(developed,)-536.9(or)-542.3(knowledge)]TJ 0 -1.2571 TD [(generated,)-574.6(will)-572.1(be)-571.8(made)-567.8(reasonably)-572.2(available)-569.9(for)-572(the)]TJ 0 -1.2623 TD [(benefit)-271.1(of)-269(that)-269.3(population)-269.7(or)-268.1(community.)]TJ 9.9626 0 2.9888 9.9626 95.6409 266.8535 Tm [(Comm)-9.3(ent)-7.2(ary)-269.4(on)-277.2(Guidelin)-10.9(e)-267.4(1)0(0)]TJ /F2 1 Tf 10.959 0 0 10.959 95.6409 248.7684 Tm [(This)-325.6(guideline)-319.3(is)-322.7(concerned)-320.1(with)-325.6(countries)-318.4(or)-320.1(communities)-325.8(in)-321.3(which)]TJ 0 -1.2571 TD [(resources)-209.5(are)-204.1(limited)-206.8(to)-206.5(the)-204.1(extent)-206.7(that)-201.3(they)-205.9(are,)-208.3(or)-206.3(may)-205.9(be,)-205(vulnerable)]TJ 0 -1.2623 TD [(to)-501.4(exploitation)-492(by)-500(sponsors)-494(and)-496.3(investigators)-495.5(from)-499.8(the)-493.8(relatively)]TJ 0 -1.2571 TD [(wealthy)-269.9(countries)-266.6(and)-268.7(communities.)]TJ /F5 1 Tf 10.6302 0 0 10.959 95.6409 182.6078 Tm [(Responsiveness)-427.8(of)-425.6(research)-427.2(to)-425.6(health)-425.3(needs)-423.6(and)-425.3(priorities)]TJ /F2 1 Tf 24.426 0 TD (.)Tj 0.6986 0 TD [(The)-424.9(ethical)]TJ -25.1247 -1.2571 TD [(requirement)-475.2(that)-473.9(research)-471.2(be)-477.6(responsive)-472.9(to)-475(the)-470(health)-475.9(needs)-474.3(of)-475(the)]TJ 0 -1.2623 TD [(population)-205.5(or)-204.3(community)-199.9(in)-207.3(which)-201.6(it)-207.6(is)-203.6(carried)-207.3(out)-200.3(calls)-207.3(for)-207.3(decisions)-202.6(on)]TJ 0 -1.2571 TD [(what)-350.3(is)-353(needed)-350.2(to)-352.3(fulfil)-350.6(the)-352.6(requirement.)-349.2(It)-354(is)-353(not)-349.6(sufficient)-348.6(simply)-352.9(to)]TJ T* [(determine)-265.6(that)-265.9(a)-268(disease)-260.6(is)-267.6(prevalent)-263.2(in)-266(the)-267.3(population)-258.9(and)-262.6(that)-265.9(new)-266.3(or)]TJ 0 -1.2623 TD [(further)-270.9(research)-268.6(is)-273(needed:)-266.9(the)-267.3(ethical)-272.9(requirement)-267.2(of)-267(responsiveness)]TJ 0 -1.2571 TD [(can)-276.3(be)-269.6(fulfilled)-275.6(only)-269.9(if)-271.6(successful)-274.9(interventions)-271.2(or)-268.3(other)-274.3(kinds)-270.3(of)-272.3(health)]TJ ET 95.641 646.809 318.898 -0.51 re f BT /F6 1 Tf 7.9702 0 0 7.9702 95.6409 649.1337 Tm [(THE)-330.8(GUIDELINES)]TJ /F7 1 Tf 11.9551 0 0 11.9551 401.3857 649.1337 Tm (51)Tj ET endstream endobj 151 0 obj << /Type /Page /Parent 396 0 R /Resources 152 0 R /Contents 153 0 R /MediaBox [ 0 0 595 842 ] /CropBox [ 0 0 595 842 ] /Rotate 0 >> endobj 152 0 obj << /ProcSet [ /PDF /Text ] /Font << /F2 337 0 R /F6 341 0 R /F7 342 0 R >> /ExtGState << /GS1 434 0 R >> /ColorSpace << /DefaultCMYK 417 0 R /Cs6 416 0 R >> >> endobj 153 0 obj << /Length 6771 >> stream q 1 i 0.015 737.008 510.221 -737.008 re W n /Cs6 cs 0 0 0 scn /GS1 gs 0.015 709.001 25.44 -0.284 re f Q /Cs6 cs 0 0 0 scn /GS1 gs 28.006 737.008 0.283 -25.455 re f 481.89 737.008 0.283 -25.455 re f 484.724 709.001 25.512 -0.284 re f 484.724 28.346 25.512 -0.283 re f 481.89 25.512 0.283 -25.512 re f q 1 i 0.015 737.008 510.221 -737.008 re W n 28.006 25.512 0.283 -25.512 re f 0.015 28.346 25.44 -0.283 re f Q BT /F2 1 Tf 10.6302 0 0 10.959 95.6409 609.8455 Tm 0 Tc 0 Tw [(benefit)-157.9(are)-160.6(made)-152.9(available)-158.2(to)-155(the)-160.6(population.)-154.2(This)-153.6(is)-161(applicable)-155.9(especially)]TJ 0 -1.2623 TD [(to)-165.6(research)-161.9(conducted)-155.9(in)-164.6(countries)-160.9(where)-158.9(governments)-160.9(lack)-161(the)-160.6(resources)]TJ 0 -1.2571 TD [(to)-165.6(make)-163.6(such)-164.6(products)-161.2(or)-167(benefits)-162.2(widely)-164.9(available.)-165.6(Even)-164.9(when)-162.3(a)-166.6(product)]TJ 0 -1.2623 TD [(to)-293.6(be)-291(tested)-296.3(in)-292.6(a)-289.3(particular)-290.6(country)-288.9(is)-294.3(much)-292.9(cheaper)-289.2(than)-292.3(the)-288.6(standard)]TJ 0 -1.2571 TD [(treatment)-187.9(in)-191.3(some)-187.9(other)-188.9(countries,)-184.2(the)-192.6(government)-183.2(or)-188.3(individuals)-185.5(in)-191.3(that)]TJ T* [(country)-171.6(may)-172.6(still)-173.3(be)-173.6(unable)-171.6(to)-176.3(afford)-166.3(it.)-177.6(If)-172.6(the)-171.3(knowledge)-171.2(gained)-170.3(from)-174.6(the)]TJ 0 -1.2623 TD [(research)-161.9(in)-164.6(such)-159.3(a)-161.3(country)-155.6(is)-166.3(used)-159.3(primarily)-163.2(for)-159.3(the)-160.6(benefit)-163.3(of)-160.3(populations)]TJ 0 -1.2571 TD 0.0124 Tc [(th)4.4(at)-566.6(can)-571.6(a)5.7(f)4.1(f)-1.3(o)4.4(r)]TJ 6.5758 0 TD 0.584 Tc [(dt)575.7(h)576(e)-3(t)575.7(e)573(s)574.3(t)575.7(e)573(d)]TJ 6.1705 0 TD 0.0098 Tc [(pro)-3.5(duct,)-573.5(t)-3.9(h)1.8(e)-571.8(r)0.1(esearc)9.8(h)-579.8(m)-0.2(ay)-572.8(right)-3.9(l)2.5(y)-572.8(b)1.8(e)]TJ -12.7463 -1.2571 TD 0 Tc [(characterized)-231.2(as)-224.3(exploitative)-229.9(and,)-227.3(therefore,)-230.9(unethical.)]TJ 10.959 0 0 10.959 109.8142 485.5747 Tm [(When)-289.4(an)-293(investigational)-289.1(interventio)6.5(n)-291.2(has)-290.9(important)-289.7(potential)-287.9(for)]TJ -1.2933 -1.2571 TD [(health)-459.9(care)-460.3(in)-455.8(the)-457.6(host)-459.4(country,)-454.1(the)-457.6(negotiation)-456.7(that)-459.9(the)-457.6(sponsor)]TJ T* [(should)-251.3(undertake)-247.3(to)-247.9(determine)-249.8(the)-245.5(practical)-252.8(implications)-244.8(of)-253.1(respon-)]TJ 0 -1.2623 TD 0.0097 Tc [(siveness,)-615.3(a)-2.4(s)-614.1(w)-1.7(ell)-615.3(a)-2.4(s)-614.1(reasonabl)]TJ 15.0591 0 TD 0.6235 Tc [(ea)611.4(v)616.5(a)611.4(i)614.1(l)]TJ 3.1556 0 TD 0.011 Tc [(ability,)-614(s)2.8(ho)4.3(uld)-611.3(i)1.6(nclu)4.3(de)]TJ -18.2147 -1.2571 TD 0 Tc [(representatives)-273.1(of)-279(stakeholders)-267.8(in)-274.7(the)-276.5(host)-273.2(country;)-273.1(these)-277.1(include)-271.9(the)]TJ T* [(national)-169.9(government,)-169.5(the)-173.1(health)-170.2(ministry,)-170.5(local)-169.6(health)-175.4(authorities,)-168.7(and)]TJ 0 -1.2623 TD [(concerned)-180.4(scientific)-187(and)-180.8(ethics)-183(groups,)-182.1(as)-180.7(well)-182.9(as)-185.9(representativ)6.8(es)-186.8(of)-180.7(the)]TJ 0 -1.2571 TD [(communities)-320.6(from)-323.9(which)-316.3(subjects)-322(are)-323.1(drawn)-314.2(and)-320.4(non-governmental)]TJ 0 -1.2623 TD [(organizations)-595.8(such)-598.5(as)-599.7(health)-599.6(advocacy)-595.1(groups.)-596(The)-595.3(negotiation)]TJ 0 -1.2571 TD [(should)-494.4(cover)-492.9(the)-488.6(health-care)-494.1(infrastructur)6.3(e)-494.2(required)-491(for)-494.1(safe)-491.9(and)]TJ T* [(rational)-352.4(use)-353.9(of)-356.6(the)-348.9(intervention,)-356.2(the)-348.9(likelihood)-353(of)-356.6(authorization)-347.5(for)]TJ 0 -1.2623 TD [(distribution,)-331.8(and)-336(decisions)-329.6(regarding)-331.8(payments,)-330.8(royalties,)-329.7(subsidies,)]TJ 0 -1.2571 TD [(technology)-421(and)-418.7(intellectual)-419.1(property,)-415.7(as)-418.6(well)-420.8(as)-423.8(distribution)-415.5(costs,)]TJ 0 -1.2623 TD [(when)-374.2(this)-374.1(economic)-374.5(information)-373(is)-374.5(not)-373.6(proprietary.)-373(In)-371.8(some)-375.1(cases,)]TJ 0 -1.2571 TD 0.0187 Tc [(satisfactory)-624.6(discussion)-624.3(of)-626(the)]TJ 14.4694 0 TD [(availability)-624.5(a)1.5(nd)-619(di)-6.1(stribution)-624.2(of)]TJ -14.4694 -1.2571 TD 0 Tc [(successful)-441.5(products)-437.1(will)-443(necessarily)-439.3(engage)-436.6(international)-438(organiza-)]TJ 0 -1.2623 TD 0.0113 Tc [(tions,)-613.7(don)4.6(or)-612.5(govern)4.6(men)4.6(t)-2.3(s)-612.5(a)-0.8(n)4.6(d)-616.2(bila)]TJ 16.3731 0 TD 0.0126 Tc [(te)4.7(ra)5.6(l)-612.4(age)4.7(ncie)4.7(s,)-612.4(in)5.9(te)4.7(rn)5.9(ation)5.9(a)0.5(l)]TJ -16.3731 -1.2571 TD 0 Tc [(nongovernmental)-377.7(organizations,)-382.7(and)-377.3(the)-380(private)-380.4(sector.)-382.5(The)-383.2(devel-)]TJ T* [(opment)-409.5(of)-403.1(a)-405.3(health-care)-406.2(infrastructure)-405.1(should)-406.5(be)-402.6(facilitated)-410.6(at)-403.4(the)]TJ 0 -1.2623 TD [(onset)-312.1(so)-309.7(that)-309.9(it)-312.7(can)-311.3(be)-309.5(of)-310(use)-312.5(during)-308.5(and)-310.1(beyond)-310.7(the)-307.6(conduct)-309.7(of)-310(the)]TJ 0 -1.2571 TD (research.)Tj 1.2933 -1.2623 TD [(Additionally,)-474.5(if)-467.8(an)-474.1(investigation)6.6(al)-471.6(drug)-468.3(has)-471.9(been)-468.9(shown)-469.1(to)-470.4(be)]TJ -1.2933 -1.2623 TD [(beneficial,)-327.9(the)-323.1(sponsor)-325.5(should)-323.7(continue)-324.3(to)-325.5(provide)-321.5(it)-328.2(to)-325.5(the)-323.1(subjects)]TJ 0 -1.2571 TD [(after)-257.2(the)-261(conclusion)-252.1(of)-258.3(the)-255.8(study,)-258.4(and)-253.2(pending)-258(its)-253.6(approval)-255.2(by)-256.8(a)-255.3(drug)]TJ T* [(regulatory)-345.4(authority.)-346.8(The)-347(sponsor)-346.2(is)-348.6(unlikely)-347.6(to)-346.2(be)-350.9(in)-347.1(a)-348.4(position)-346.7(to)]TJ 0 -1.2623 TD [(make)-332.5(a)-327.7(beneficial)-328.9(investigational)-330.5(interventio)6.5(n)-332.6(generally)-329(available)-329.2(to)]TJ 0 -1.2571 TD [(the)-255.8(community)-250.5(or)-252.8(population)-250.3(until)-257.8(some)-250.9(time)-253.8(after)-252(the)-255.8(conclusion)-252.1(of)]TJ 0 -1.2623 TD [(the)-209.3(study,)-206.7(as)-201.4(it)-209.2(may)-205.9(be)-206(in)-207.5(short)-203.7(supply)-205(and)-206.6(in)-207.5(any)-201.7(case)-206.8(cannot)-203.8(be)-206(made)]TJ 0 -1.2571 TD [(generally)-173.8(available)-168.9(before)-170(a)-172.5(drug)-173.4(regulatory)-169.5(authority)-166.8(has)-171.9(approved)-170.7(it.)]TJ ET 95.641 646.809 318.898 -0.51 re f BT /F6 1 Tf 7.9702 0 0 7.9702 191.1118 649.1337 Tm [(INTERNA)13.4(TIONAL)-327.4(ETHICAL)-327.5(GUIDELINES)-319.8(FOR)-332.5(BIOMED)13.7(ICAL)-331.1(RESEARCH)]TJ /F7 1 Tf 11.9551 0 0 11.9551 95.6409 649.1337 Tm (52)Tj ET endstream endobj 154 0 obj << /Type /Page /Parent 396 0 R /Resources 155 0 R /Contents 156 0 R /MediaBox [ 0 0 595 842 ] /CropBox [ 0 0 595 842 ] /Rotate 0 >> endobj 155 0 obj << /ProcSet [ /PDF /Text ] /Font << /F2 337 0 R /F5 340 0 R /F6 341 0 R /F7 342 0 R >> /ExtGState << /GS1 434 0 R >> /ColorSpace << /DefaultCMYK 417 0 R /Cs6 416 0 R >> >> endobj 156 0 obj << /Length 6195 >> stream q 1 i 0.015 737.008 510.221 -737.008 re W n /Cs6 cs 0 0 0 scn /GS1 gs 0.015 709.001 25.44 -0.284 re f Q /Cs6 cs 0 0 0 scn /GS1 gs 28.006 737.008 0.283 -25.455 re f 481.89 737.008 0.283 -25.455 re f 484.724 709.001 25.512 -0.284 re f 484.724 28.346 25.512 -0.283 re f 481.89 25.512 0.283 -25.512 re f q 1 i 0.015 737.008 510.221 -737.008 re W n 28.006 25.512 0.283 -25.512 re f 0.015 28.346 25.44 -0.283 re f Q BT /F2 1 Tf 10.959 0 0 10.959 109.8142 609.8455 Tm 0 Tc 0 Tw [(For)-440.4(minor)-440.2(research)-434.3(studies)-438.3(and)-439.4(when)-436.2(the)-436.9(outcome)-438.1(is)-441.7(scientific)]TJ -1.2933 -1.2623 TD [(knowledge)-215.2(rather)-211.9(than)-209.9(a)-213.9(commercial)-210.2(product,)-210.7(such)-215.7(complex)-211.6(planning)]TJ 0 -1.2571 TD [(or)-413.2(negotiation)-405(is)-405.5(rarely,)-408.7(if)-410.9(ever,)-407.6(needed.)-410.1(There)-404.5(must)-411.8(be)-407.8(assurance,)]TJ 0 -1.2623 TD [(however,)-261.7(that)-258.2(the)-261(scientific)-259.4(knowledge)-256.6(developed)-258.3(will)-261.9(be)-257.7(used)-257.1(for)-261.3(the)]TJ 0 -1.2571 TD [(benefit)-272.7(of)-268.6(the)-266.2(population.)]TJ /F5 1 Tf 0 -2.3486 TD [(Reasonable)-550.4(availability)]TJ /F2 1 Tf 9.917 0 TD (.)Tj 0.8225 0 TD [(The)-548.8(issue)-552.4(of)-553.2(reasonable)-549.5(availability)-550.1(is)]TJ -10.7395 -1.2623 TD [(complex)-459.9(and)-454.9(will)-458.5(need)-458.6(to)-454.9(be)-459.5(determined)-453.1(on)-458.3(a)-457(case-by-case)-454.6(basis.)]TJ 0 -1.2571 TD [(Relevant)-474.1(considerations)-464.9(include)-473.7(the)-467.9(length)-470.3(of)-475.5(time)-471.1(for)-468.2(which)-471.5(the)]TJ T* [(intervention)-372.7(or)-377(product)-372.1(developed,)-371.1(or)-371.8(other)-374.2(agreed)-375.7(benefit,)-370(will)-375.7(be)]TJ 0 -1.2623 TD 0.0109 Tc [(made)-612.6(available)-617.8(t)2.5(o)-611.4(r)-2.4(esearch)-611.4(s)-2.4(ub)4.2(jects,)-614.1(o)4.2(r)-618(to)-611.4(the)-612.6(c)3(ommun)4.2(i)-3.6(ty)-611.7(or)]TJ 0 -1.2571 TD 0 Tc [(population)-327.9(concerned;)-324.3(the)-323.1(severity)-327.7(of)-325.5(a)-322.5(subjects)-326.2(medical)-328.1(condition;)]TJ T* [(the)-240.3(effect)-240.4(of)-242.8(withdrawing)-237.1(the)-240.3(study)-233.6(drug)-240.7(\(e.g.,)-242.8(death)-238.5(of)-237.6(a)-239.8(subject\);)-238.5(the)]TJ 0 -1.2623 TD [(cost)-496.8(to)-496.2(the)-493.8(subject)-489.7(or)-496(health)-491(service;)-495.1(and)-496.3(the)-493.8(question)-490.1(of)-496.2(undue)]TJ 0 -1.2571 TD [(inducement)-270.6(if)-271.3(an)-267.2(intervention)-269.2(is)-271(provided)-266.2(free)-270.4(of)-268.6(charge.)]TJ 1.2933 -1.2623 TD [(In)-527(general,)-528.9(if)-524.8(there)-525.4(is)-529.7(good)-523.7(reason)-520.6(to)-527.3(believe)-526.8(that)-527.2(a)-524.3(product)]TJ -1.2933 -1.2571 TD [(developed)-522.1(or)-516.7(knowledge)-520.5(generated)-517.7(by)-515.5(research)-517.1(is)-524.5(unlikely)-518.3(to)-516.9(be)]TJ T* [(reasonably)-209.2(available)-205.1(to,)-205.6(or)-211.5(applied)-203.7(to)-206.5(the)-209.3(benefit)-205.5(of,)-210.7(the)-204.1(population)-208.9(of)]TJ 0 -1.2623 TD (a)Tj 0.8691 0 TD [(proposed)-363(host)-366.3(country)-362(or)-366.6(community)-364.3(after)-360.6(the)-369.6(conclusion)-360.7(of)-366.9(the)]TJ -0.8691 -1.2571 TD [(research,)-386.8(it)-385.1(is)-384.8(unethical)-385.6(to)-382.4(conduct)-382.2(the)-385.2(research)-382.6(in)-383.4(that)-387.5(country)-382.7(or)]TJ 0 -1.2623 TD [(community.)-544.3(This)-542.9(should)-541(not)-544.3(be)-542.3(construed)-543.3(as)-542.8(precluding)-536.9(studies)]TJ 0 -1.2571 TD [(designed)-251.8(to)-247.9(evaluate)-252.6(novel)-249.7(therapeutic)-245.6(concepts.)-250.8(As)-252.1(a)-250.1(rare)-248.5(exception,)]TJ T* [(for)-204.4(example,)-205.7(research)-201.6(may)-200.7(be)-200.8(designed)-205.3(to)-201.4(obtain)-200.1(preliminary)-204.4(evidence)]TJ 0 -1.2623 TD [(that)-185.7(a)-182.9(drug)-183.8(or)-185.6(a)-182.9(class)-185.4(of)-180.7(drugs)-181.6(has)-187.4(a)-182.9(beneficial)-184.1(effect)-183.5(in)-186.8(the)-183.4(treatment)-182.5(of)]TJ 0 -1.2571 TD (a)Tj 0.7242 0 TD [(disease)-220.7(that)-222(occurs)-221.4(only)-221.2(in)-223(regions)-219.5(with)-222.2(extremely)-224.5(limited)-222.4(resources,)]TJ -0.7242 -1.2571 TD [(and)-372.2(it)-369.6(could)-368.5(not)-373.6(be)-366.4(carried)-370.7(out)-368.5(reasonably)-369.5(well)-369.1(in)-373(more)-369.9(developed)]TJ 0 -1.2623 TD [(communities.)-267.9(Such)-271.2(research)-263.6(may)-268(be)-268.1(justified)-265.8(ethically)-269.5(even)-267.4(if)-271.3(there)-266.7(is)]TJ 0 -1.2571 TD [(no)-246.2(plan)-241.8(in)-243.7(place)-240.6(to)-242.8(make)-239.4(a)-244.9(product)-242.7(available)-241.3(to)-242.8(the)-240.3(population)-239.9(of)-242.8(the)]TJ 0 -1.2623 TD [(host)-190.4(country)-191.3(or)-190.8(community)-188.4(at)-191.3(the)-188.6(conclusion)-190(of)-191(the)-193.8(preliminary)-188.9(phase)]TJ 0 -1.2571 TD [(of)-366.9(its)-367.4(development)6.9(.)-366.3(I)0(f)-368.4(the)-364.5(concept)-362.6(is)-364.1(found)-361.2(to)-366.9(be)-361.2(valid,)-369.5(subsequent)]TJ T* [(phases)-313.6(of)-315.2(the)-317.9(research)-315.4(could)-311.6(result)-317.7(in)-316.1(a)-312.2(product)-315.2(that)-309.9(could)-316.7(be)-314.6(made)]TJ 0 -1.2623 TD [(reasonably)-271.2(available)-267.2(at)-268.9(its)-269.1(conclusion.)]TJ 1.2933 -1.2571 TD [(\(See)-543.1(also)-538.2(Guidelines)-538.3(3:)]TJ /F5 1 Tf 10.9413 0 TD [(Ethical)-536.6(review)-539.2(of)-543.1(externally)-534(sponsored)]TJ -12.2346 -1.2623 TD [(res)-8.7(ear)-7.5(ch;)]TJ /F2 1 Tf 4.4282 0 TD (12:)Tj /F5 1 Tf 1.883 0 TD [(Equi)-9.1(table)-613.9(dis)-9(tr)-6.2(ibuti)-10.1(on)-608.9(of)-610.3(bur)-6.6(den)-6.3(s)-608.2(and)-610.7(ben)-6.3(efit)-8.3(s;)]TJ /F2 1 Tf 21.5152 0 TD (20:)Tj /F5 1 Tf -27.8265 -1.2571 TD [(Strengthening)-264(capacity)-258.1(for)-266.7(ethical)-263.8(and)-258.9(scientific)-264.8(review)-265(and)-264.1(biomedical)]TJ T* [(research;)-412(and)-414.1(21:)-410.4(Ethical)-412.5(obligation)-409.4(of)-413.7(external)-409(sponsors)-412.3(to)-408.6(provide)]TJ 0 -1.2623 TD [(health-care)-272.2(services)]TJ /F2 1 Tf 8.0753 0 TD (.\))Tj ET 95.641 646.809 318.898 -0.51 re f BT /F6 1 Tf 7.9702 0 0 7.9702 95.6409 649.1337 Tm [(THE)-330.8(GUIDELINES)]TJ /F7 1 Tf 11.9551 0 0 11.9551 401.3857 649.1337 Tm (53)Tj ET endstream endobj 157 0 obj << /Type /Page /Parent 396 0 R /Resources 158 0 R /Contents 159 0 R /MediaBox [ 0 0 595 842 ] /CropBox [ 0 0 595 842 ] /Rotate 0 >> endobj 158 0 obj << /ProcSet [ /PDF /Text ] /Font << /F2 337 0 R /F5 340 0 R /F6 341 0 R /F7 342 0 R /F8 343 0 R /F10 345 0 R /F11 346 0 R >> /ExtGState << /GS1 434 0 R >> /ColorSpace << /DefaultCMYK 417 0 R /Cs6 416 0 R >> >> endobj 159 0 obj << /Length 6000 >> stream q 1 i 0.015 737.008 510.221 -737.008 re W n /Cs6 cs 0 0 0 scn /GS1 gs 0.015 709.001 25.44 -0.284 re f Q /Cs6 cs 0 0 0 scn /GS1 gs 28.006 737.008 0.283 -25.455 re f 481.89 737.008 0.283 -25.455 re f 484.724 709.001 25.512 -0.284 re f 484.724 28.346 25.512 -0.283 re f 481.89 25.512 0.283 -25.512 re f q 1 i 0.015 737.008 510.221 -737.008 re W n 28.006 25.512 0.283 -25.512 re f 0.015 28.346 25.44 -0.283 re f Q 1 1 1 scn 95.641 603.439 14.173 -2.835 re f 0 0 0 scn 95.641 623.622 318.898 -20.183 re f 1 1 1 scn 95.641 580.422 14.173 -2.835 re f 0.8 0.8 0.8 scn 95.641 600.605 318.898 -20.183 re f BT /F11 1 Tf 11.9551 0 3.5865 11.9551 214.8661 608.9951 Tm 1 1 1 scn 0 Tc 0 Tw [(Guideline)-278.6(11)]TJ 11.9551 0 0 11.9551 148.8755 585.9778 Tm 0 0 0 scn [(Choice)-274.9(of)-272.1(control)-275.2(in)-273.4(clinical)-278(trials)]TJ /F8 1 Tf 10.959 0 0 10.959 95.6409 564.3778 Tm [(As)-328.5(a)-322.3(general)-324.7(rule,)-324.6(research)-320.2(subjects)-322(in)-326.2(the)-327.4(control)-321.7(group)-323.6(of)-325.9(a)]TJ 0 -1.2571 TD [(trial)-497.9(of)-496.6(a)-493(diagnostic,)-491.7(therapeutic,)-494.7(or)-495.7(preventive)-492.1(intervention)]TJ T* [(should)-357.4(receive)-351.1(an)-359.7(established)-349.7(effective)-359.9(intervention.)-353.8(In)-357.2(some)]TJ 0 -1.2623 TD 0.0165 Tc [(circu)4.9(m)1.4(s)4.6(t)2.2(an)4.9(ce)4.6(s)-616.2(i)2(t)-613.4(m)1.4(ay)-611(be)-616.2(e)4.6(t)]TJ 14.3297 0 TD 0.0136 Tc [(hica)-3.4(lly)-619.1(acc)-3.4(eptable)-619.1(t)-0.7(o)-618.8(u)2(se)-619.1(a)-3.4(n)]TJ -14.3297 -1.2571 TD 0 Tc [(alternative)-271.3(comparator,)-265.3(such)-269.4(as)-266.9(placebo)-266.1(or)-268.1(no)-269.6(treatment)]TJ 0 -1.5519 TD [(Placebo)-271.3(may)-266.5(be)-266.6(used:)]TJ /F10 1 Tf 1.2933 -1.552 TD (7)Tj /F8 1 Tf 1.2933 0 TD [(when)-268.7(there)-269.9(is)-269.5(no)-271.5(established)-261.7(effective)-271.9(intervention;)]TJ /F10 1 Tf -1.2933 -1.2571 TD (7)Tj /F8 1 Tf 1.2933 0 TD [(when)-449.8(withholding)-443.9(an)-447.7(established)-448(effective)-447.8(intervention)]TJ 0 -1.2571 TD [(would)-231.2(expose)-226(subjects)-228.9(to,)-226.6(at)-227.9(most,)-233(temporary)-223.6(discomfort)]TJ 0 -1.2623 TD [(or)-273.3(delay)-268.7(in)-269.3(relief)-266.7(of)-274.2(symptoms;)]TJ /F10 1 Tf -1.2933 -1.2571 TD (7)Tj /F8 1 Tf 1.2933 0 TD [(when)-573.9(use)-578.6(of)-574.2(an)-571.8(established)-577.3(effective)-572(intervention)-572.1(as)]TJ 0 -1.2623 TD [(comparator)-307.6(would)-303.7(not)-306.5(yield)-307.6(scientifically)-308.2(reliable)-305.9(results)]TJ 0 -1.2571 TD [(and)-304.1(use)-304.4(of)-305.2(placebo)-302.3(would)-303.7(not)-301.3(add)-304.1(any)-304.4(risk)-305.1(of)-305.2(serious)-298.8(or)]TJ T* [(irreversible)-268.4(harm)-269.2(to)-269(the)-270.5(subjects.)]TJ 9.9626 0 2.9888 9.9626 95.6409 352.0629 Tm [(Comm)-9.3(ent)-7.2(ary)-269.4(on)-277.2(Guidelin)-10.9(e)-267.4(1)0(1)]TJ /F5 1 Tf 10.959 0 0 10.959 95.6409 334.0345 Tm [(General)-208.7(considerations)-202.4(for)-209.8(controlled)-203.2(clinical)-206.8(trials.)]TJ /F2 1 Tf 21.1065 0 TD [(The)-202.2(design)-206.2(of)-206.5(trials)]TJ -21.1065 -1.2623 TD [(of)-284.1(investigational)-278.8(diagnostic,)-283.2(therapeutic)-281.8(or)-278.7(preventive)-284(interventions)]TJ 0 -1.2571 TD [(raises)-369.5(interrelated)-365(scientific)-373.2(and)-361.8(ethical)-372.2(issues)-364(for)-369.9(sponsors,)-363.7(investi-)]TJ 0 -1.2623 TD [(gators)-511(and)-511.8(ethical)-506.7(review)-512.1(committees.)-509.8(To)-509.8(obtain)-510.5(reliable)-510.6(results,)]TJ 0 -1.2571 TD [(investigators)-242(must)-246.3(compare)-241.5(the)-245.5(effects)-243.4(of)-242.8(an)-246.5(investigation)6.6(al)-249.1(interven-)]TJ T* [(tion)-201.9(on)-199.6(subjects)-197.8(assigned)-195.5(to)-201.4(the)-198.9(investigation)6.6(al)-202.6(arm)-196.7(\(or)-199.2(arms\))-197.8(of)-201.4(a)-198.4(trial)]TJ 0 -1.2623 TD [(with)-206.6(the)-198.9(effects)-202(that)-201.3(a)-198.4(control)-204(interventio)6.5(n)-203.3(produces)-198.6(in)-202.3(subjects)-203(drawn)]TJ 0 -1.2571 TD 0.0226 Tc [(fro)-4.8(m)-624.6(the)-626.8(s)-1.1(a)-5.1(m)1.4(e)-626.8(pop)-4.8(ulatio)-4.8(n)-625.6(a)0.1(nd)-630.8(assig)-5.1(n)0.4(ed)-625.6(to)-625.6(its)-627(c)-0.8(on)-4.8(tro)-4.8(l)-628.2(arm.)]TJ T* 0 Tc [(Randomization)-285.7(is)-286.5(the)-286.9(preferred)-287.3(method)-280.1(for)-287.1(assigning)-286.7(subjects)-285.8(to)-284.1(the)]TJ 0 -1.2623 TD [(various)-466.9(arms)-468.7(of)-470.4(the)-462.8(clinical)-470.4(trial)-471.7(unless)-466(another)-465.5(method,)-465.4(such)-469.2(as)]TJ 0 -1.2571 TD [(historical)-479.5(or)-480.5(literature)-474.6(controls,)-480.2(can)-476.8(be)-480.2(justified)-477.9(scientifically)-478.3(and)]TJ 0 -1.2623 TD 0.0094 Tc [(eth)2.7(i)0.1(c)1.5(a)2.4(lly)2.4(.)-615.6(A)9.4(s)-4.7(si)]TJ 6.3837 0 TD 0.0088 Tc [(gnm)8.8(e)-4.8(nt)-610.1(to)-608.3(treatm)8.8(e)-10(n)2.1(t)-610.1(a)1.8(rms)-609.8(b)-3.1(y)-608.6(r)0.6(andomization,)-616.2(in)]TJ -6.3837 -1.2571 TD 0 Tc [(addition)-417.9(to)-418.6(its)-424.3(usual)-415.6(scientific)-419.8(superiority,)-421.9(offers)-415.1(the)-421.4(advantage)-416.4(of)]TJ T* [(tending)-363.2(to)-361.7(render)-361.1(equivalent)-356.4(to)-361.7(all)-361.9(subjects)-363.4(the)-359.3(foreseeable)-360.3(benefits)]TJ 0 -1.2623 TD [(and)-268.7(risks)-273.4(of)-268.6(participation)-267.3(in)-269.5(a)-270.8(trial.)]TJ 1.2933 -1.2571 TD (A)Tj 1.0812 0 TD [(clinical)-315.2(trial)-311.3(cannot)-307.3(be)-309.5(justified)-312.4(ethically)-310.9(unless)-305.7(it)-312.7(is)-312.4(capable)-311.2(of)]TJ -2.3745 -1.2623 TD [(producing)-521.2(scientifically)-519.7(reliable)-521(results.)-521.5(When)-522.2(the)-519.7(objective)-521.3(is)-524.5(to)]TJ 0 -1.2571 TD [(establish)-144.2(the)-142(effectiveness)-140.4(and)-139.4(safety)-140(of)-139.3(an)-143(investigational)-139.1(intervention,)]TJ ET 95.641 646.809 318.898 -0.51 re f BT /F6 1 Tf 7.9702 0 0 7.9702 191.1118 649.1337 Tm [(INTERNA)13.4(TIONAL)-327.4(ETHICAL)-327.5(GUIDELINES)-319.8(FOR)-332.5(BIOMED)13.7(ICAL)-331.1(RESEARCH)]TJ /F7 1 Tf 11.9551 0 0 11.9551 95.6409 649.1337 Tm (54)Tj ET endstream endobj 160 0 obj << /Type /Page /Parent 396 0 R /Resources 161 0 R /Contents 162 0 R /MediaBox [ 0 0 595 842 ] /CropBox [ 0 0 595 842 ] /Rotate 0 >> endobj 161 0 obj << /ProcSet [ /PDF /Text ] /Font << /F2 337 0 R /F5 340 0 R /F6 341 0 R /F7 342 0 R >> /ExtGState << /GS1 434 0 R >> /ColorSpace << /DefaultCMYK 417 0 R /Cs6 416 0 R >> >> endobj 162 0 obj << /Length 6741 >> stream q 1 i 0.015 737.008 510.221 -737.008 re W n /Cs6 cs 0 0 0 scn /GS1 gs 0.015 709.001 25.44 -0.284 re f Q /Cs6 cs 0 0 0 scn /GS1 gs 28.006 737.008 0.283 -25.455 re f 481.89 737.008 0.283 -25.455 re f 484.724 709.001 25.512 -0.284 re f 484.724 28.346 25.512 -0.283 re f 481.89 25.512 0.283 -25.512 re f q 1 i 0.015 737.008 510.221 -737.008 re W n 28.006 25.512 0.283 -25.512 re f 0.015 28.346 25.44 -0.283 re f Q BT /F2 1 Tf 10.959 0 0 10.959 95.6409 609.9022 Tm 0 Tc 0 Tw [(the)-240.3(use)-240(of)-237.6(a)-234.6(placebo)-238.5(control)-235(is)-240(often)-239.9(much)-234(more)-240.6(likely)-235.9(than)-235.8(that)-237.5(of)-237.6(an)]TJ 0 -1.2467 TD [(active)-223.4(control)-219.5(to)-222.1(produce)-221.5(a)-224.2(scientifically)-219.6(reliable)-226.1(result.)-223.6(In)-221.8(many)-217.8(cases)]TJ 0 -1.2519 TD 0.0183 Tc [(the)-620.7(a)6.2(bilit)4.7(y)-619.8(of)-616.1(a)-619.8(t)-0.5(r)5(i)-1.4(al)-617(to)-614.4(dis)5(t)-0.5(in)6.4(guis)5(h)-619.5(e)0.1(f)4.7(f)-0.5(ec)5.2(tiv)6.2(e)-620.7(fr)5(om)-618.5(in)6.4(eff)4.7(ect)4.7(ive)]TJ T* 0 Tc [(interventions)-546.4(\(its)-546.5(assay)-549.4(sensitivity\))-543.2(cannot)-545.2(be)-547.4(assured)-544.2(unless)-548.8(the)]TJ 0 -1.2467 TD [(control)-193.7(is)-198.6(a)-193.2(placebo.)-190.9(If,)-196.7(however,)-194.5(an)-189.6(effect)-193.8(of)-196.2(using)-193.1(a)-193.2(placebo)-191.9(would)-190.9(be)]TJ 0 -1.2519 TD [(to)-470.4(deprive)-467.6(subjects)-466.8(in)-466.1(the)-467.9(control)-467.8(arm)-465.7(of)-470.4(an)-463.7(established)-469.2(effective)]TJ 0 -1.2467 TD [(intervention,)-185.5(and)-180.8(thereby)-176.9(to)-185.9(expose)-178.9(them)-183.9(to)-180.7(serious)-179.3(harm,)-181.8(particularly)]TJ 0 -1.2519 TD [(if)-271.3(it)-271.3(is)-271(irreversible,)-267.8(it)-271.3(would)-268.5(obviously)-269.4(be)-268.1(unethical)-266.6(to)-268.6(use)-271.1(a)-270.8(placebo.)]TJ /F5 1 Tf 10.7396 0 0 10.959 95.6409 489.3731 Tm [(Placebo)-158.2(control)-152.6(in)-159.1(the)-155.3(absence)-156.1(of)-159.4(a)-154.6(current)-153.4(effective)-156.7(alternative.)]TJ /F2 1 Tf 25.4705 0 TD [(The)-155.6(use)-156.9(of)]TJ -25.4705 -1.2519 TD [(placebo)-178.8(in)-175.7(the)-171.9(control)-176.1(arm)-177.6(of)-176.1(a)-175.7(clinical)-177.2(trial)-174.1(is)-179.1(ethically)-173.7(acceptable)-174.6(when,)]TJ 0 -1.2467 TD [(as)-360.8(stated)-358.1(in)-360.5(the)-362(Declaration)-358.1(of)-360.8(Helsinki)-358.9(\(Paragraph)-357(29\),)-355.5(no)-362(proven)]TJ 0 -1.2519 TD [(prophylactic,)-212.6(diagnostic)-215.2(or)-213.8(therapeutic)-211.1(method)-214.9(exists.)-216.2(Usually,)-210.7(in)-217.9(this)]TJ 0 -1.2467 TD [(case,)-240.9(a)-239(placebo)-236.8(is)-237.1(scientifically)-236.6(preferable)-241.3(to)-234.1(no)-236.8(intervention.)-237.1(In)-240.2(certain)]TJ 0 -1.2519 TD [(circumstances,)-164.3(however,)-166.2(an)-162.1(alternative)-165.4(design)-165.1(may)-162.9(be)-167.1(both)-159.5(scientifically)]TJ T* [(and)-196.1(ethically)-189.6(acceptable,)-194.9(and)-190.8(preferable;)-193(an)-193.8(example)-187.8(would)-196(be)-193.5(a)-191.5(clinical)]TJ 0 -1.2467 TD [(trial)-168.8(of)-160.2(a)-165.1(surgical)-163.9(intervention,)-163.2(because,)-162.2(for)-165.9(many)-159.9(surgical)-163.9(interventions,)]TJ 0 -1.2519 TD [(either)-204.3(it)-199.4(is)-200.2(not)-199.4(possible)-197.2(or)-203.2(it)-199.4(is)-200.2(ethically)-200.1(unacceptable)-195(to)-202.4(devise)-195.7(a)-202.1(suitable)]TJ T* [(placebo;)-299.4(for)-297.8(another)-294.5(example,)-297.8(in)-297.1(certain)-300.8(vaccine)-298.3(trials)-295.8(an)-299.4(investigator)]TJ 0 -1.2467 TD [(might)-246.9(choose)-241.8(to)-244.7(provide)-241.3(for)-245(those)-237.9(in)-244.3(the)-245.8(control)-243.1(arm)-246.2(a)-239(vaccine)-245.5(that)-240.5(is)]TJ 0 -1.2519 TD [(unrelated)-247.3(to)-250(the)-251.1(investigational)-247.9(vaccine.)]TJ /F5 1 Tf 10.6302 0 0 10.959 95.6409 315.0424 Tm 0.0121 Tc [(Pla)5.4(c)-4.2(ebo-co)5.4(ntrolled)-575.9(t)-1.6(rials)-578.9(t)3.8(hat)-577.5(entail)-576.5(only)-575.9(m)3.5(inor)-573.5(risks.)]TJ /F2 1 Tf 24.9273 0 TD 0.59 Tc [(Ap)582(l)577.3(a)578(c)579(e)573.7(b)582(o)576.7(-)]TJ -24.9273 -1.2519 TD 0 Tc (c)Tj 0.448 0 TD [(ont)-13.6(ro)-12.3(l)-7.3(l)0(e)-7.6(d)-578.6(de)-8.3(si)-11.6(g)-6.7(n)-573.3(ma)-11.3(y)-572(b)-8(e)-576.3(e)0(t)-8.6(h)-8(i)-7.3(c)0(a)-7(l)-7.3(l)-7.3(y)-572(a)-6.7(c)0(c)-11.3(e)0(p)-13.6(t)0(a)-9.6(b)0(l)-10(e)0(,)-583.6(a)-6.7(nd)-576(p)-8(r)0(e)-10(f)0(e)-14(r)0(a)-11(b)0(l)-10(e)-576.3(on)]TJ -0.448 -1.2519 TD [(scientific)-345.2(grounds,)-337.2(when)-338.3(the)-336.6(condition)-340.6(for)-340.6(which)-340.3(patients/su)8.1(bjects)-343.3(are)]TJ 0 -1.2467 TD [(randomly)-528.2(assigned)-525.6(to)-528.3(placebo)-529.2(or)-529.6(active)-525.6(treatment)-529.2(is)-529(only)-525.9(a)-529.3(small)]TJ 0 -1.2519 TD [(deviation)-300.6(in)-298(physiological)-299.2(measuremen)6.5(ts,)-302.6(such)-297.9(as)-299(slightly)-301.2(raised)-297.6(blood)]TJ 0 -1.2467 TD [(pressure)-327.2(or)-321.6(a)-321.3(modest)-321.6(increase)-324.9(in)-324.6(serum)-325.6(cholesterol;)-319.9(and)-321.3(if)-325(delaying)-322.9(or)]TJ 0 -1.2519 TD [(omitting)-159.9(available)-158.2(treatment)-155.9(may)-162(cause)-158.3(only)-157.9(temporary)-152.5(discomfort)-157.5(\(e.g.,)]TJ T* [(common)-332.2(headache\))-334.5(and)-332(no)-330.6(serious)-329.9(adverse)-334.6(consequence)7.5(s.)-337(The)-334.3(ethical)]TJ 0 -1.2467 TD [(review)-207.6(committee)-207.6(must)-206.6(be)-205.6(fully)-208.3(satisfied)-204.2(that)-207.3(the)-203.3(risks)-209.6(of)-203(withholding)-206.9(an)]TJ 0 -1.2519 TD [(established)-228.2(effective)-232.2(intervention)-224.2(are)-230(truly)-226.6(minor)-229.6(and)-230.6(short-lived.)]TJ /F5 1 Tf 10.959 0 0 10.959 95.6409 168.0945 Tm [(Placebo)-290.6(control)-287.6(when)-281.9(active)-291.6(control)-287.6(would)-285.1(not)-286.2(yield)-288.9(reliable)-288.4(results.)]TJ /F2 1 Tf 28.3335 0 TD (A)Tj -28.3335 -1.2519 TD [(related)-293.4(but)-285.7(distinct)-287.5(rationale)-287.9(for)-287.1(using)-291.4(a)-286.3(placebo)-290.2(control)-286.8(rather)-284.3(than)]TJ T* [(an)-443.1(established)-438.2(effective)-435.3(intervention)-440(is)-436.5(that)-439.2(the)-442.1(documented)-433.5(expe-)]TJ 0 -1.2467 TD [(rience)-353.1(with)-351.5(the)-348.9(established)-345(effective)-352.6(intervention)-346.8(is)-348.6(not)-352.9(sufficient)-350.4(to)]TJ 0 -1.2519 TD [(provide)-512.9(a)-513.9(scientifically)-514.5(reliable)-515.8(comparison)-512.8(with)-511.9(the)-514.5(intervention)]TJ 0 -1.2467 TD [(being)-420.5(investigated;)-413.6(it)-421.3(is)-421(then)-412.6(difficult,)-420.3(or)-418.4(even)-417.5(impossible,)-418.6(without)]TJ ET 95.641 646.809 318.898 -0.51 re f BT /F6 1 Tf 7.9702 0 0 7.9702 95.6409 649.1337 Tm [(THE)-330.8(GUIDELINES)]TJ /F7 1 Tf 11.9551 0 0 11.9551 401.3857 649.1337 Tm (55)Tj ET endstream endobj 163 0 obj << /Type /Page /Parent 396 0 R /Resources 164 0 R /Contents 165 0 R /MediaBox [ 0 0 595 842 ] /CropBox [ 0 0 595 842 ] /Rotate 0 >> endobj 164 0 obj << /ProcSet [ /PDF /Text ] /Font << /F2 337 0 R /F5 340 0 R /F6 341 0 R /F7 342 0 R >> /ExtGState << /GS1 434 0 R >> /ColorSpace << /DefaultCMYK 417 0 R /Cs6 416 0 R >> >> endobj 165 0 obj << /Length 6499 >> stream q 1 i 0.015 737.008 510.221 -737.008 re W n /Cs6 cs 0 0 0 scn /GS1 gs 0.015 709.001 25.44 -0.284 re f Q /Cs6 cs 0 0 0 scn /GS1 gs 28.006 737.008 0.283 -25.455 re f 481.89 737.008 0.283 -25.455 re f 484.724 709.001 25.512 -0.284 re f 484.724 28.346 25.512 -0.283 re f 481.89 25.512 0.283 -25.512 re f q 1 i 0.015 737.008 510.221 -737.008 re W n 28.006 25.512 0.283 -25.512 re f 0.015 28.346 25.44 -0.283 re f Q BT /F2 1 Tf 10.959 0 0 10.959 95.6409 609.9022 Tm 0 Tc 0 Tw [(using)-343.1(a)-338.1(placebo,)-341(to)-341(design)-340.7(a)-343.2(scientifically)-338.6(reliable)-345.1(study.)-336.1(This)-341.1(is)-343.4(not)]TJ 0 -1.2467 TD [(always,)-323.1(however,)-323.8(an)-318.9(ethically)-321.3(acceptable)-319.9(basis)-323.9(for)-323.3(depriving)-317.2(control)]TJ 0 -1.2519 TD [(subjects)-259.9(of)-263.5(an)-256.8(established)-257.1(effective)-259.5(intervention)-258.9(in)-259.2(clinical)-263.5(trials;)-261.6(only)]TJ T* [(when)-301.7(doing)-300.3(so)-304.6(would)-299.6(not)-301.2(add)-304.9(any)-300(risk)-301.4(of)-299.7(serious)-303.5(harm,)-300.8(particularly)]TJ 0 -1.2467 TD [(irreversible)-191.2(harm,)-186.9(to)-185.9(the)-183.4(subjects)-187.5(would)-185.8(it)-188.5(be)-185.3(ethically)-186.8(acceptable)-185.4(to)-185.9(do)]TJ 0 -1.2519 TD [(so.)-189.8(In)-190.8(some)-188.9(cases,)-188.1(the)-188.6(condition)-187.6(at)-186.1(which)-186.9(the)-188.6(intervention)-186.5(is)-193.4(aimed)-186.7(\(for)]TJ 0 -1.2467 TD [(example,)-252.3(cancer)-247.3(or)-247.7(HIV/AIDS\))-249.8(will)-251.6(be)-247.4(too)-249.5(serious)-246.6(to)-253.1(deprive)-245.1(control)]TJ 0 -1.2519 TD [(subjects)-270.3(of)-268.6(an)-272.3(established)-267.4(effective)-269.8(interventio)6.5(n.)]TJ 1.2933 -1.3812 TD [(This)-351.5(latter)-344.1(rationale)]TJ /F5 1 Tf 8.9755 0 TD [(\(when)-340.6(active)-348.5(control)-349.7(would)-342(not)-348.3(yield)-345.8(reliable)]TJ -10.2687 -1.2623 TD (results\))Tj /F2 1 Tf 3.4505 0 TD [(differs)-253.7(from)-256.6(the)-250.7(former)]TJ /F5 1 Tf 10.036 0 TD [(\(trials)-254(that)-253.3(entail)-255.9(only)-252.7(minor)-254.7(risks\))]TJ /F2 1 Tf 14.7953 0 TD (in)Tj -28.2817 -1.2571 TD [(emphasis.)-529.5(In)-521.8(trials)-526.4(that)-527.2(entail)-524.7(only)-526.4(minor)-522.9(risks)-526.8(the)-524.8(investigative)]TJ T* [(interventions)-391.2(are)-390.3(aimed)-393.6(at)-387.9(relatively)-391.8(trivial)-394.9(conditions,)-391.3(such)-386.4(as)-392.8(the)]TJ 0 -1.2623 TD [(common)-261.9(cold)-263.5(or)-263.2(hair)-264(loss;)-264.2(forgoing)-261.8(an)-262(established)-262.3(effective)-264.6(interven-)]TJ 0 -1.2571 TD [(tion)-227.8(for)-219.9(the)-224.8(duration)-220.1(of)-222.1(a)-224.2(trial)-223.3(deprives)-222.2(control)-224.7(subjects)-218.5(of)-227.2(only)-221.2(minor)]TJ T* [(benefits.)-274.7(It)-275.3(is)-276.2(for)-271.6(this)-275.8(reason)-272.2(that)-273.7(it)-271.3(is)-276.2(not)-275.3(unethical)-271.8(to)-273.8(use)-271.1(a)-276(placebo-)]TJ 0 -1.2623 TD [(control)-364.4(design.)-360.4(Even)-359.2(if)-359.2(it)-364.4(were)-361.3(possible)-357.9(to)-361.7(design)-361.4(a)-358.7(so-called)-361.2(non-)]TJ 0 -1.2571 TD [(inferiority,)-288.3(or)-283.9(equivalency,)-285.4(trial)-285.4(using)-286.2(an)-282.7(active)-285.5(control,)-285.8(it)-286.8(would)]TJ 0 -1.2622 TD [(still)-293(not)-285.7(be)-288.8(unethical)-287.3(in)-285.1(these)-287.4(circumstances)-286.2(to)-289.3(use)-286.6(a)-286.3(placebo-control)]TJ 0 -1.2571 TD [(design.)-381.1(In)-377(any)-382.8(event,)-378.4(the)-374.8(researcher)-378(must)-380.8(satisfy)-377.2(the)-380(ethical)-382.5(review)]TJ T* [(committee)-181.9(that)-175.4(the)-178.2(safety)-176.2(and)-175.6(human)-172.5(rights)-177.1(of)-175.5(the)-178.2(subjects)-177.2(will)-179.2(be)-180.1(fully)]TJ 0 -1.2623 TD [(protected,)-512.8(that)-506.5(prospective)-509.1(subjects)-508.2(will)-510.2(be)-511.2(fully)-506.4(informed)-509.8(about)]TJ 0 -1.2571 TD [(alternative)-294.1(treatments,)-287.9(and)-294.6(that)-289.2(the)-292(purpose)-289(and)-289.4(design)-294.1(of)-289.3(the)-292(study)]TJ 0 -1.2623 TD [(are)-421.4(scientifically)-421.4(sound.)-422(The)-419.5(ethical)-423.9(acceptability)-418.5(of)-418.6(such)-422.6(placebo-)]TJ 0 -1.2571 TD [(controlled)-253.8(studies)-246.8(increases)-252.3(as)-247.9(the)-250.7(period)-247.3(of)-253.1(placebo)-248.8(use)-250.4(is)-250.3(decreased,)]TJ T* [(and)-584.3(when)-581.1(the)-586.9(study)-580.2(design)-583.8(permits)-582.1(change)-581.2(to)-584.2(active)-580.4(treatment)]TJ 0 -1.2623 TD [(\(escape)-269.3(treatment\))-271.7(if)-271.3(intolerable)-268.6(symptoms)-268.7(occur.)]TJ /F5 1 Tf 10.7396 0 0 10.959 95.6409 237.2031 Tm [(Exceptional)-477.5(use)-483.4(of)-476.2(a)-481.9(comparator)-474.1(other)-479.2(than)-479.1(an)-478.1(established)-476.8(effective)]TJ T* (intervention.)Tj /F2 1 Tf 5.5903 0 TD [(An)-420(exception)-417(to)-418.9(the)-420(general)-418.9(rule)-420(is)-416.6(applicable)-416.3(in)-423.8(some)]TJ -5.5903 -1.2571 TD [(studies)-459.2(designed)-458.9(to)-461.1(develop)-453.3(a)-460.8(therapeutic,)-458.4(preventive)-453.6(or)-461.9(diagnostic)]TJ T* [(intervention)-216.7(for)-218.6(use)-220.2(in)-217.9(a)-217.9(country)-215.3(or)-219.1(community)-217.2(in)-217.9(which)-216(an)-220.2(established)]TJ 0 -1.2623 TD [(effective)-363(intervention)-359.3(is)-358.5(not)-363.1(available)-355.5(and)-359.7(unlikely)-360.8(in)-360.5(the)-362(foreseeable)]TJ 0 -1.2571 TD [(future)-348.3(to)-350.3(become)-347.3(available,)-349.4(usually)-349.5(for)-345.3(economic)-348.8(or)-351(logistic)-345.6(reasons.)]TJ T* [(The)-277.1(purpose)-274.9(of)-271.1(such)-275.3(a)-276(study)-275.2(is)-274.1(to)-276.4(make)-270.4(available)-276.3(to)-276.3(the)-272.2(population)-271.9(of)]TJ 0 -1.2623 TD [(the)-404.2(country)-394.8(or)-398.6(community)-401.9(an)-394.4(effective)-399.9(alternative)-397.6(to)-403(an)-399.7(established)]TJ 0 -1.2571 TD [(effective)-553(intervention)-549.3(that)-546.6(is)-548.6(locally)-553.1(unavailable.)-544(Accordingly,)-549.3(the)]TJ 0 -1.2623 TD [(proposed)-245.5(investigational)-242.6(interventio)7.3(n)-245.1(must)-246.5(be)-246.3(responsive)-237.9(to)-244.7(the)-245.8(health)]TJ 0 -1.2571 TD [(needs)-255.3(of)-250(the)-256.4(population)-245.5(from)-251.8(which)-253(the)-251.1(research)-251.1(subjects)-254.5(are)-251.1(recruited)]TJ ET 95.641 646.809 318.898 -0.51 re f BT /F6 1 Tf 7.9702 0 0 7.9702 191.1118 649.1337 Tm [(INTERNA)13.4(TIONAL)-327.4(ETHICAL)-327.5(GUIDELINES)-319.8(FOR)-332.5(BIOMED)13.7(ICAL)-331.1(RESEARCH)]TJ /F7 1 Tf 11.9551 0 0 11.9551 95.6409 649.1337 Tm (56)Tj ET endstream endobj 166 0 obj << /Type /Page /Parent 396 0 R /Resources 167 0 R /Contents 168 0 R /MediaBox [ 0 0 595 842 ] /CropBox [ 0 0 595 842 ] /Rotate 0 >> endobj 167 0 obj << /ProcSet [ /PDF /Text ] /Font << /F2 337 0 R /F5 340 0 R /F6 341 0 R /F7 342 0 R /F10 345 0 R >> /ExtGState << /GS1 434 0 R >> /ColorSpace << /DefaultCMYK 417 0 R /Cs6 416 0 R >> >> endobj 168 0 obj << /Length 6483 >> stream q 1 i 0.015 737.008 510.221 -737.008 re W n /Cs6 cs 0 0 0 scn /GS1 gs 0.015 709.001 25.44 -0.284 re f Q /Cs6 cs 0 0 0 scn /GS1 gs 28.006 737.008 0.283 -25.455 re f 481.89 737.008 0.283 -25.455 re f 484.724 709.001 25.512 -0.284 re f 484.724 28.346 25.512 -0.283 re f 481.89 25.512 0.283 -25.512 re f q 1 i 0.015 737.008 510.221 -737.008 re W n 28.006 25.512 0.283 -25.512 re f 0.015 28.346 25.44 -0.283 re f Q BT /F2 1 Tf 10.7396 0 0 10.959 95.6409 609.8455 Tm 0 Tc 0 Tw [(and)-233(there)-226.2(must)-230.7(be)-225.1(assurance)-227.3(that,)-229.1(if)-231.1(it)-231.1(proves)-229.6(to)-228.8(be)-225.1(safe)-229.6(and)-227.8(effective,)-230.2(it)]TJ 0 -1.2623 TD [(will)-594.1(be)-589.4(made)-592.4(reasonably)-587.8(available)-587.7(to)-587.8(that)-594.1(population.)-587.8(Also,)-587.7(the)]TJ 0 -1.2571 TD [(scientific)-493.8(and)-486.4(ethical)-489.7(review)-494.2(committees)-487.8(must)-489.4(be)-489.1(satisfied)-488.9(that)-488.6(the)]TJ 0 -1.2623 TD 0.0083 Tc [(es)8.3(t)-7.5(a)8.3(bl)8.3(i)-6(s)8.3(h)-4.9(e)8.3(d)-607.5(e)1.9(ff)8.3(ect)8.3(i)-1(ve)]TJ 9.5283 0 TD [(in)8.2(ter)8.2(v)1.1(ent)8.2(i)-1.1(on)-606.4(can)8.2(n)-1.6(ot)-603.7(be)-605.3(us)8.2(ed)-606.4(as)-604.5(com)8.2(p)-0.9(ar)8.2(at)8.2(or)]TJ -9.5283 -1.2571 TD 0 Tc [(because)-242.1(its)-247.3(use)-241.3(would)-243.5(not)-241.7(yield)-246.2(scientifically)-241.9(reliable)-241.6(results)-246.1(that)-240.5(would)]TJ T* [(be)-504.9(relevant)-497.6(to)-503.3(the)-504.5(health)-496.9(needs)-503.4(of)-503.3(the)-499.2(study)-502.2(population.)-498.1(In)-504.1(these)]TJ 0 -1.2623 TD [(circumstances)-275.9(an)-278.3(ethical)-278.6(review)-277.8(committee)-276.3(can)-274.1(approve)-275.3(a)-276(clinical)-277.5(trial)]TJ 0 -1.2571 TD 0.0083 Tc [(in)-611.6(whi)8.3(c)-7.9(h)-606.3(t)-1.8(he)-610.5(compar)8.3(ator)-609.7(is)-609.7(other)-609.7(t)-1.8(han)-611.6(a)1.5(n)-611.6(e)1.9(s)8.3(t)-7.5(abli)8.3(s)-7.1(h)0.7(ed)-611.6(eff)8.3(e)-8.3(cti)8.3(v)-8.3(e)]TJ T* 0 Tc [(intervention,)-268.7(such)-270(as)-271.1(placebo)-263.2(or)-271.9(no)-268.5(treatment)-265.3(or)-271.9(a)-270.7(local)-267.3(remedy.)]TJ 10.959 0 0 10.959 109.8142 485.3479 Tm [(However,)-286.6(some)-282(people)-283.2(strongly)-278.8(object)-285(to)-284.1(the)-281.7(exceptional)-281.5(use)-281.4(of)-284.1(a)]TJ -1.2933 -1.2571 TD [(comparator)-196.6(other)-198.3(than)-194.4(an)-194.7(established)-200.2(effective)-192.2(intervention)-196.8(because)-197.1(it)]TJ T* [(could)-306.4(result)-307.4(in)-305.8(exploitation)-300.5(of)-304.8(poor)-307.6(and)-299.7(disadvantaged)-302.5(populations.)]TJ 0 -1.2623 TD [(The)-269.4(objection)-271.5(rests)-268.4(on)-266.9(three)-271.9(arguments:)]TJ /F10 1 Tf 8.9663 0 0 8.9663 109.8142 430.7527 Tm (.)Tj /F2 1 Tf 10.959 0 0 10.959 123.9874 429.9023 Tm [(Placebo)-186.5(control)-183.3(could)-182.2(expose)-184(research)-186(subjects)-182.3(to)-185.9(risk)-187.6(of)-180.7(serious)]TJ 0 -1.2571 TD [(or)-392.5(irreversible)-393(harm)-389.7(when)-394.9(the)-390.3(use)-390.1(of)-392.8(an)-391.3(established)-391.6(effective)]TJ 0 -1.2623 TD [(intervention)-269.2(as)-268.6(comparator)-269(could)-265(avoid)-269.5(the)-271.3(risk.)]TJ /F10 1 Tf 8.9663 0 0 8.9663 109.8142 389.0834 Tm (.)Tj /F2 1 Tf 10.959 0 0 10.959 123.9874 388.233 Tm [(Not)-196.7(all)-196.4(scientific)-197.3(experts)-193.9(agree)-193.1(about)-195.9(conditions)-190.6(under)-196.6(which)-192.1(an)]TJ 0 -1.2571 TD [(established)-314(effective)-311.2(intervention)-310.6(used)-314(as)-310(a)-312.2(comparator)-310.4(would)]TJ 0 -1.2623 TD [(not)-270.2(yield)-273.1(scientifically)-266.2(reliable)-272.6(results.)]TJ /F10 1 Tf 8.9663 0 0 8.9663 109.8142 347.4141 Tm (.)Tj /F2 1 Tf 10.959 0 0 10.959 123.9874 346.5637 Tm [(An)-411(economic)-410.7(reason)-411.9(for)-411.3(the)-411(unavailability)-405.1(of)-413.5(an)-412(established)]TJ 0 -1.2571 TD [(effective)-249.1(intervention)-243.4(cannot)-240(justify)-243.7(a)-244.9(placebo-controlled)-242.1(study)]TJ 0 -1.2623 TD [(in)-259.2(a)-255.3(country)-253.4(of)-253.1(limited)-258.6(resources)-250.8(when)-255.2(it)-255.8(would)-258.2(be)-252.6(unethical)-256.3(to)]TJ 0 -1.2571 TD [(conduct)-439.1(a)-436.3(study)-435.3(with)-434.3(the)-436.9(same)-437.4(design)-433.8(in)-440.3(a)-436.3(population)-436.5(with)]TJ 0 -1.2623 TD [(general)-271.3(access)-269.4(to)-268.6(the)-271.3(effective)-264.6(intervention)-269.2(outside)-266.1(the)-271.3(study.)]TJ /F5 1 Tf -2.5866 -2.3745 TD [(Pla)-7.3(cebo)-609.1(control)-608.3(when)-607.8(an)-608.9(establi)-10.6(shed)-604.2(effec)-9.5(tive)-607.8(interve)-10.1(ntion)-607.8(is)-607.3(not)]TJ 0 -1.2571 TD [(available)-377(in)-378.4(the)-380.3(host)-372(country.)]TJ /F2 1 Tf 12.7519 0 TD [(The)-378.1(question)-376.3(addressed)-372.6(here)-377.3(is:)-378.6(when)]TJ -12.7519 -1.2571 TD [(should)-225.4(an)-220.6(exception)-223.8(be)-226.7(allowed)-224(to)-222.1(the)-224.8(general)-219.5(rule)-228.7(that)-222(subjects)-223.7(in)-223(the)]TJ 0 -1.2623 TD [(control)-317.8(arm)-315.7(of)-315.2(a)-317.4(clinical)-315.2(trial)-316.5(should)-313.4(receive)-314.7(an)-318.9(established)-314(effective)]TJ 0 -1.2571 TD (intervention?)Tj 1.2933 -1.2829 TD [(The)-217.7(usual)-213.8(reason)-215.3(for)-214.7(proposing)-211.1(the)-219.6(exception)-213.4(is)-214.1(that,)-215.8(for)-214.7(economic)]TJ -1.2933 -1.2623 TD [(or)-485.6(logistic)-485.3(reasons,)-481.2(an)-484.4(established)-484.7(effective)-481.9(intervention)-481.3(is)-483.1(not)-487.4(in)]TJ 0 -1.2571 TD [(general)-416.1(use)-410.8(or)-413.2(available)-406.8(in)-414.4(the)-411(country)-408.6(in)-414.4(which)-414.6(the)-411(study)-409.5(will)-412(be)]TJ 0 -1.2623 TD [(conducted,)-375.1(whereas)-378(the)-374.8(investigational)-377.1(intervention)-372.7(could)-378.8(be)-376.7(made)]TJ 0 -1.2571 TD [(available,)-271.3(given)-270.7(the)-266.2(finances)-269.1(and)-268.7(infrastructure)-265.4(of)-268.6(the)-271.3(country.)]TJ 1.2933 -1.2829 TD [(Another)-350.7(reason)-349.8(that)-351.3(may)-350.8(be)-356(advanced)-346.6(for)-349.2(proposing)-350.7(a)-353.6(placebo-)]TJ -1.2933 -1.2623 TD [(controlled)-176.2(trial)-176.8(is)-177.9(that)-175.4(using)-172.4(an)-174(established)-174.3(effective)-176.7(intervention)-171(as)-175.5(the)]TJ 0 -1.2571 TD [(control)-286.8(would)-289.2(not)-285.7(produce)-283.6(scientifically)-292.1(reliable)-288.2(data)-282.6(relevant)-284.9(to)-289.3(the)]TJ ET 95.641 646.809 318.898 -0.51 re f BT /F6 1 Tf 7.9702 0 0 7.9702 95.6409 649.1337 Tm [(THE)-330.8(GUIDELINES)]TJ /F7 1 Tf 11.9551 0 0 11.9551 401.3857 649.1337 Tm (57)Tj ET endstream endobj 169 0 obj << /Type /Page /Parent 396 0 R /Resources 170 0 R /Contents 171 0 R /MediaBox [ 0 0 595 842 ] /CropBox [ 0 0 595 842 ] /Rotate 0 >> endobj 170 0 obj << /ProcSet [ /PDF /Text ] /Font << /F2 337 0 R /F6 341 0 R /F7 342 0 R /F10 345 0 R /F12 347 0 R >> /ExtGState << /GS1 434 0 R >> /ColorSpace << /DefaultCMYK 417 0 R /Cs6 416 0 R >> >> endobj 171 0 obj << /Length 6257 >> stream q 1 i 0.015 737.008 510.221 -737.008 re W n /Cs6 cs 0 0 0 scn /GS1 gs 0.015 709.001 25.44 -0.284 re f Q /Cs6 cs 0 0 0 scn /GS1 gs 28.006 737.008 0.283 -25.455 re f 481.89 737.008 0.283 -25.455 re f 484.724 709.001 25.512 -0.284 re f 484.724 28.346 25.512 -0.283 re f 481.89 25.512 0.283 -25.512 re f q 1 i 0.015 737.008 510.221 -737.008 re W n 28.006 25.512 0.283 -25.512 re f 0.015 28.346 25.44 -0.283 re f Q BT /F2 1 Tf 10.959 0 0 10.959 95.6409 609.8455 Tm 0 Tc 0 Tw [(country)-248.2(in)-248.8(which)-249(the)-250.7(trial)-249.2(is)-250.3(to)-247.9(be)-252.6(conducted.)-245.7(Existing)-248.7(data)-246.4(about)-247.6(the)]TJ 0 -1.2623 TD [(effectiveness)-295.6(and)-289.4(safety)-295.2(of)-294.5(the)-292(established)-293.3(effective)-290.5(intervention)-295.1(may)]TJ 0 -1.2571 TD [(have)-530.4(been)-531(accumulated)-526.2(under)-527.6(circumstances)-529.4(unlike)-533(those)-529.4(of)-527.3(the)]TJ 0 -1.2623 TD [(population)-229.6(in)-228.2(which)-228.3(it)-229.9(is)-229.6(proposed)-223.3(to)-227.2(conduct)-227(the)-230(trial)]TJ /F12 1 Tf 22.6947 0 TD (;)Tj /F2 1 Tf 0.4966 0 TD [(this,)-228.2(it)-229.9(may)-231.8(be)]TJ -23.1913 -1.2571 TD [(argued,)-233.9(could)-228.8(make)-234.2(their)-232(use)-229.7(in)-233.3(the)-235.1(trial)-228.5(unreliable.)-233.3(One)-232.7(reason)-230.9(could)]TJ T* [(be)-221.5(that)-222(the)-219.6(disease)-220.7(or)-216.6(condition)-218.6(manifests)-219.9(itself)-222.4(differently)-217.7(in)-223(different)]TJ 0 -1.2623 TD [(populations,)-231.6(or)-232.1(other)-229.3(uncontrolled)-225.9(factors)-230.7(could)-228.8(invalidate)-228.8(the)-230(use)-234.9(of)]TJ 0 -1.2571 TD [(existing)-270.8(data)-267.1(for)-271.6(comparative)-268.1(purposes.)]TJ 1.2933 -1.3036 TD [(The)-491.9(use)-488.4(of)-485.9(placebo)-486.8(control)-488.5(in)-486.8(these)-489.2(circumstances)-488(is)-488.3(ethically)]TJ -1.2933 -1.2571 TD [(controversial,)-271.2(for)-266.4(the)-271.3(following)-266.4(reasons:)]TJ /F10 1 Tf 8.9663 0 0 8.9663 109.8142 471.7416 Tm (.)Tj /F2 1 Tf 10.959 0 0 10.959 123.9874 470.8912 Tm [(Sponsors)-254.6(of)-253.1(research)-253.3(might)-254.5(use)-255.6(poor)-255.9(countries)-251.1(or)-258(communities)]TJ 0 -1.2623 TD [(as)-548(testing)-547.4(grounds)-541.6(for)-551(research)-543(that)-547.9(would)-542.7(be)-547.4(difficult)-550.6(or)]TJ 0 -1.2571 TD [(impossible)-486.8(in)-486.8(countries)-483.9(where)-487(there)-484(is)-488.3(general)-483.4(access)-481.6(to)-485.9(an)]TJ T* 0.0123 Tc [(established)-615.2(e)-0.8(ffective)-616.4(i)-2.2(ntervention;)-612.7(and)-615.2(t)-1.3(he)-616.4(investigational)]TJ 0 -1.2623 TD 0 Tc [(in)-10.9(ter)-9(ven)-6.1(ti)-7.4(on)-8.2(,)-609.4(i)0(f)-612.7(pro)-11.2(ven)-611.3(sa)-10(fe)-611.2(and)-615.3(eff)-9.2(ect)-8.7(ive)-8.7(,)-609.4(i)0(s)-617.6(l)0(i)-8.4(kel)-8.4(y)-607.1(t)0(o)-615.2(b)0(e)]TJ 0 -1.2571 TD 0.0178 Tc [(marketed)-620(in)-620(countries)-621.5(in)-620(which)-620(a)0.5(n)-620(e)-0.4(stablished)-620(effective)]TJ T* 0 Tc [(intervention)-279.6(is)-281.3(already)-280.7(available)-277.5(and)-279.1(not)-275.3(likely)-282.4(to)-279(be)-278.4(marketed)]TJ 0 -1.2623 TD [(in)-274.7(the)-266.2(host)-268(country.)]TJ /F10 1 Tf 8.9663 0 0 8.9663 109.8142 360.8503 Tm (.)Tj /F2 1 Tf 10.959 0 0 10.959 123.9874 359.9999 Tm [(The)-419.5(research)-413.7(subjects,)-414.1(both)-411.4(active-arm)-413.1(and)-413.6(control-arm,)-413.4(are)]TJ 0 -1.2571 TD [(patients)-507.6(who)-511.1(may)-505.9(have)-509.7(a)-508.8(serious,)-504.2(possibly)-507(life-threatening,)]TJ T* [(illness.)-446(They)-436.8(do)-437.6(not)-440.9(normally)-437.6(have)-437.2(access)-435(to)-439.3(an)-443.1(established)]TJ 0 -1.2623 TD [(effective)-316.4(intervention)-315.8(currently)-313.5(available)-313.7(to)-315.2(similar)-315.8(patients)-316.2(in)]TJ 0 -1.2571 TD [(many)-517.8(other)-513.8(countries.)-513.9(According)-511.3(to)-516.9(the)-514.5(requirements)-510.9(of)-516.9(a)]TJ 0 -1.2623 TD [(scientifically)-550.7(reliable)-541.6(trial,)-548.3(investigators,)-546.2(who)-542.2(may)-547.3(be)-542.3(their)]TJ 0 -1.2571 TD [(attending)-233.7(physicians,)-226.1(would)-232.3(be)-231.9(expected)-226(to)-232.4(enrol)-230.2(some)-230.2(of)-232.4(those)]TJ T* [(patients/subjects)-170.7(in)-171.3(the)-173.1(placebo-control)-166.4(arm.)-169.9(This)-170.4(would)-170.2(appear)]TJ 0 -1.2623 TD [(to)-263.4(be)-262.9(a)-260.5(violation)-256.8(of)-263.5(the)-261(physicians)-257.1(fiduciary)-262(duty)-261.6(of)-258.3(undivided)]TJ 0 -1.2571 TD [(loyalty)-437.6(to)-439.3(the)-436.9(patient,)-441.5(particularly)-436.5(in)-435.1(cases)-437.4(in)-440.3(which)-435.2(known)]TJ 0 -1.2623 TD [(effective)-269.8(therapy)-269.1(could)-270.2(be)-268.1(made)-270.4(available)-267.2(to)-268.6(the)-266.2(patients.)]TJ -2.5866 -2.39 TD [(An)-359.3(argument)-352.5(for)-359.6(exceptional)-353.9(use)-359(of)-356.6(placebo)-352.3(control)-359.2(may)-355.9(be)-356(that)-356.5(a)]TJ 0 -1.2623 TD 0.0197 Tc [(he)-3.7(al)-5.2(th)-628.5(aut)-4.2(h)2.7(or)-4(ity)-628.7(i)0(n)-628.5(a)-623.6(c)-3.7(o)2.7(untr)-4(y)-623.6(wher)-4(e)-624.5(a)-2.8(n)-623.3(e)-3.7(s)-4(t)0.9(abl)-5.2(i)0(s)-4(h)-2.5(ed)-628.5(ef)-4.2(fe)-3.7(ct)-4.2(ive)]TJ 0 -1.2571 TD 0 Tc [(intervention)-300.3(is)-296.9(not)-296(generally)-297.9(available)-298.2(or)-294.2(affordable,)-297.8(and)-294.6(unlikely)-301(to)]TJ T* [(become)-436(available)-432.7(or)-433.9(affordable)-433.3(in)-435.1(the)-431.7(foreseeable)-432.7(future,)-433.3(seeks)-437.2(to)]TJ 0 -1.2623 TD [(develop)-316.1(an)-313.7(affordable)-314.3(intervention)-315.8(specifically)-315.7(for)-313(a)-317.4(health)-315.1(problem)]TJ 0 -1.2571 TD [(affecting)-340.1(its)-341.5(population.)-337.2(There)-337.2(may)-340.4(then)-340.1(be)-340.5(less)-338.8(reason)-339.5(for)-338.9(concern)]TJ 0 -1.2623 TD [(that)-320.3(a)-317.4(placebo)-316.1(design)-314.8(is)-322.7(exploitative,)-316.5(and)-315.3(therefore)-318.6(unethical,)-317.4(as)-315.2(the)]TJ 0 -1.2571 TD [(health)-361.6(authority)-358.2(has)-363.3(responsibility)-360.4(for)-359.6(the)-359.3(populations)-360.9(health,)-360.7(and)]TJ ET 95.641 646.809 318.898 -0.51 re f BT /F6 1 Tf 7.9702 0 0 7.9702 191.1118 649.1337 Tm [(INTERNA)13.4(TIONAL)-327.4(ETHICAL)-327.5(GUIDELINES)-319.8(FOR)-332.5(BIOMED)13.7(ICAL)-331.1(RESEARCH)]TJ /F7 1 Tf 11.9551 0 0 11.9551 95.6409 649.1337 Tm (58)Tj ET endstream endobj 172 0 obj << /Type /Page /Parent 396 0 R /Resources 173 0 R /Contents 174 0 R /MediaBox [ 0 0 595 842 ] /CropBox [ 0 0 595 842 ] /Rotate 0 >> endobj 173 0 obj << /ProcSet [ /PDF /Text ] /Font << /F2 337 0 R /F5 340 0 R /F6 341 0 R /F7 342 0 R >> /ExtGState << /GS1 434 0 R >> /ColorSpace << /DefaultCMYK 417 0 R /Cs6 416 0 R >> >> endobj 174 0 obj << /Length 6440 >> stream q 1 i 0.015 737.008 510.221 -737.008 re W n /Cs6 cs 0 0 0 scn /GS1 gs 0.015 709.001 25.44 -0.284 re f Q /Cs6 cs 0 0 0 scn /GS1 gs 28.006 737.008 0.283 -25.455 re f 481.89 737.008 0.283 -25.455 re f 484.724 709.001 25.512 -0.284 re f 484.724 28.346 25.512 -0.283 re f 481.89 25.512 0.283 -25.512 re f q 1 i 0.015 737.008 510.221 -737.008 re W n 28.006 25.512 0.283 -25.512 re f 0.015 28.346 25.44 -0.283 re f Q BT /F2 1 Tf 10.959 0 0 10.959 95.6409 609.8455 Tm 0 Tc 0 Tw [(there)-406.4(are)-411(valid)-401.5(health)-408.2(grounds)-401.9(for)-406.1(testing)-407.7(an)-406.8(apparently)-400.8(beneficial)]TJ 0 -1.2623 TD [(intervention.)-252.7(In)-247.7(such)-251.9(circumstances)-250(an)-246.5(ethical)-253.2(review)-248.3(committee)-254.3(may)]TJ 0 -1.2571 TD [(determine)-187.8(that)-180.6(the)-183.4(proposed)-181.9(trial)-182(is)-183.1(ethically)-186.8(acceptable,)-179.2(provided)-183.4(that)]TJ 0 -1.2623 TD [(the)-271.3(rights)-270.3(and)-268.7(safety)-264.2(of)-273.8(subjects)-265.1(are)-271.3(safeguarded.)]TJ 1.2933 -1.314 TD [(Ethical)-194.9(review)-191.4(committees)-190(will)-189.5(need)-189.6(to)-191(engage)-188.3(in)-191.9(careful)-189.9(analysis)-192(of)]TJ -1.2933 -1.2623 TD [(the)-193.8(circumstances)-193.1(to)-191(determine)-187.8(whether)-191.7(the)-193.8(use)-193.5(of)-191(placebo)-191.9(rather)-191.2(than)]TJ 0 -1.2571 TD [(an)-256.8(established)-257.1(effective)-259.5(intervention)-253.7(is)-255.5(ethically)-259.2(acceptable.)-256.8(They)-255.7(will)]TJ T* [(need)-298.2(to)-294.5(be)-299.1(satisfied)-295.9(that)-294.4(an)-293(established)-293.3(effective)-300.8(interventio)6.5(n)-296.4(i)0(s)-296.9(truly)]TJ 0 -1.2623 TD [(unlikely)-218.3(to)-211.7(become)-213.5(available)-215.4(and)-211.8(implementable)-212.6(in)-217.8(that)-211.6(country.)-216.2(This)]TJ 0 -1.2571 TD [(may)-516.3(be)-516.4(difficult)-519.6(to)-511.8(determine,)-517.9(however,)-515.2(as)-516.9(it)-514.4(is)-519.3(clear)-516.2(that,)-515.8(with)]TJ 0 -1.2623 TD [(sufficient)-283.1(persistence)-278.7(and)-273.9(ingenuity,)-280.2(ways)-276.7(may)-278.3(be)-283.6(found)-273.2(of)-279(accessing)]TJ 0 -1.2571 TD [(previously)-397.8(unattainable)-396.5(medicinal)-395.9(products,)-394.8(and)-398(thus)-397.3(avoiding)-396(the)]TJ T* [(ethical)-273.9(issue)-267.9(raised)-269.7(by)-267.2(the)-271.3(use)-265.9(of)-268.6(placebo)-269.5(control.)]TJ 10.7396 0 0 10.959 109.8142 429.1653 Tm [(When)-325.9(the)-330.3(rationale)-323.8(of)-329.1(proposing)-324.3(a)-323.5(placebo-controlled)-325.4(trial)-327.1(is)-326.9(that)]TJ -1.3197 -1.2571 TD [(the)-214.1(use)-214.9(of)-213(an)-209.6(established)-210(effective)-215.2(intervention)-206.2(as)-213(the)-214.1(control)-213(would)-211.9(not)]TJ 0 -1.2623 TD [(yield)-272.6(scientifically)-268.3(reliable)-268(data)-263.5(relevant)-270.6(to)-265.8(the)-266.9(proposed)-266.7(host)-268.4(country,)]TJ 0 -1.2571 TD [(the)-272.2(ethical)-268(review)-267.2(committee)-265.7(in)-270.7(that)-266.9(country)-268.1(has)-268.1(the)-266.9(option)-266.6(of)-265.8(seeking)]TJ 0 -1.2623 TD [(expert)-190.8(opinion)-189.3(as)-191.9(to)-186.6(whether)-191.5(use)-188.5(of)-191.9(an)-188.5(established)-188.8(effective)-188.8(intervention)]TJ 0 -1.2571 TD [(in)-270.7(the)-272.2(control)-265.8(arm)-267.3(would)-269.9(invalidate)-266.1(the)-272.2(results)-267.2(of)-271.1(the)-266.9(research.)]TJ /F5 1 Tf 10.959 0 0 10.959 95.6409 333.8078 Tm [(An)-334(equivalency)-336.7(trial)-335.2(as)-330.7(an)-334.7(alternative)-331.5(to)-336.1(a)-332.9(placebo-contro)6.9(lled)-333.6(trial.)]TJ /F2 1 Tf 0 -1.2623 TD [(An)-447.2(alternative)-449.3(to)-444.5(a)-446.7(placebo-control)-445.8(design)-444.1(in)-445.4(these)-447.8(circumstances)]TJ 0 -1.2571 TD [(would)-258.2(be)-257.7(an)-256.8(equivalency)-257.4(trial,)-256.6(which)-259.4(would)-253(compare)-257(an)-256.8(investiga-)]TJ 0 -1.2623 TD [(tional)-513.1(intervention)-507.2(with)-506.7(an)-510.3(established)-505.4(effective)-512.9(intervention)-507.2(and)]TJ 0 -1.2571 TD [(produce)-262.9(scientifically)-266.2(reliable)-267.5(data.)-260.9(An)-266.2(equivalency)-259.3(trial)-264.7(in)-264.4(a)-265.6(country)]TJ T* [(in)-528.2(which)-528.4(no)-525.6(established)-526.1(effective)-523.3(intervention)-527.9(is)-524.5(available)-525.8(is)-529.7(not)]TJ 0 -1.2623 TD [(designed)-505.3(to)-501.4(determine)-503.3(whether)-502.1(the)-504.1(investigational)-501.2(intervention)-502(is)]TJ 0 -1.2571 TD 0.0082 Tc [(su)8.2(pe)8.2(r)8.2(i)]TJ 2.6125 0 TD 0 Tc [(or)-615(to)-615.2(a)-7(n)-612(est)-9(a)-7(b)0(l)-10.9(i)0(s)-7.2(h)-6.7(ed)-614.7(ef)-11.2(fec)-8.7(t)-8.4(ive)-619.1(in)-10.9(ter)-14.1(ve)-9.7(nti)-14.1(on)-613.5(cu)-9.4(rre)-13.9(nt)-10(ly)-616.4(use)-12.4(d)]TJ -2.6125 -1.2623 TD [(somewhere)-277.5(in)-279.9(the)-276.5(world;)-279.3(its)-274.3(purpose)-278.7(is,)-275.2(rather,)-278.2(to)-279(determine)-275.7(whether)]TJ 0 -1.2571 TD 0.0122 Tc [(the)-616.5(i)-2.3(nv)5.2(estigational)-617.9(i)-2.3(n)5.5(t)-1.4(erve)4.3(ntion)-615.3(i)2.9(s,)-617.9(in)-615.3(effectiveness)-611.6(a)0.1(nd)-615.3(safety,)]TJ T* 0 Tc [(equivalent)-584(to,)-588.4(or)-583.9(almost)-583.4(equivalent)-584(to,)-583.2(the)-586.9(established)-583(effective)]TJ 0 -1.2623 TD [(intervention.)-371.7(It)-373.5(would)-366.8(be)-371.6(hazardous)-365.1(to)-372.1(conclude,)-369.3(however,)-370.4(that)-366.8(an)]TJ 0 -1.2571 TD [(intervention)-274.4(demonstrated)-269.6(to)-273.8(be)-273.3(equivalent,)-272.6(or)-273.5(almost)-278.1(equivalent,)-272.6(to)]TJ T* [(an)-210.3(established)-205.4(effective)-202.6(intervention)-207.2(is)-208.9(better)-202.7(than)-204.7(nothing)-206.8(or)-206.3(superior)]TJ 0 -1.2623 TD [(to)-408.3(whatever)-400.7(intervention)-403.7(is)-405.5(available)-406.8(in)-404(the)-405.8(country;)-402.4(there)-406.4(may)-402.5(be)]TJ 0 -1.2571 TD [(substantial)-386(differences)-387.6(between)-388.1(the)-385.2(results)-388(of)-387.6(superficially)-389.9(identical)]TJ 0 -1.2623 TD [(clinical)-485.9(trials)-479.8(carried)-479.4(out)-482.3(in)-481.6(different)-480.7(countries.)-482.9(If)-482.2(there)-478.8(are)-478.3(such)]TJ 0 -1.2571 TD 0.0138 Tc [(diffe)-4.4(rences)-4.7(,)-616.3(i)-0.7(t)-620.6(w)-2.8(oul)-5.9(d)-613.7(b)-3.3(e)-620(s)0.5(cie)-4.4(n)1.9(tif)-5(i)-0.7(call)-5.9(y)-614(a)-3.5(cce)-4.4(ptable)-620(and)-618.9(e)0.7(thical)-5.9(ly)]TJ ET 95.641 646.809 318.898 -0.51 re f BT /F6 1 Tf 7.9702 0 0 7.9702 95.6409 649.1337 Tm 0 Tc [(THE)-330.8(GUIDELINES)]TJ /F7 1 Tf 11.9551 0 0 11.9551 401.3857 649.1337 Tm (59)Tj ET endstream endobj 175 0 obj << /Type /Page /Parent 396 0 R /Resources 176 0 R /Contents 177 0 R /MediaBox [ 0 0 595 842 ] /CropBox [ 0 0 595 842 ] /Rotate 0 >> endobj 176 0 obj << /ProcSet [ /PDF /Text ] /Font << /F2 337 0 R /F5 340 0 R /F6 341 0 R /F7 342 0 R >> /ExtGState << /GS1 434 0 R >> /ColorSpace << /DefaultCMYK 417 0 R /Cs6 416 0 R >> >> endobj 177 0 obj << /Length 6401 >> stream q 1 i 0.015 737.008 510.221 -737.008 re W n /Cs6 cs 0 0 0 scn /GS1 gs 0.015 709.001 25.44 -0.284 re f Q /Cs6 cs 0 0 0 scn /GS1 gs 28.006 737.008 0.283 -25.455 re f 481.89 737.008 0.283 -25.455 re f 484.724 709.001 25.512 -0.284 re f 484.724 28.346 25.512 -0.283 re f 481.89 25.512 0.283 -25.512 re f q 1 i 0.015 737.008 510.221 -737.008 re W n 28.006 25.512 0.283 -25.512 re f 0.015 28.346 25.44 -0.283 re f Q BT /F2 1 Tf 10.959 0 0 10.959 95.6409 609.8455 Tm 0 Tc 0 Tw [(preferable)-176.5(to)-180.7(conduct)-175.2(such)-174.3(equivalency)-179.8(trials)-174.6(in)-181.6(countries)-173.5(in)-176.4(which)-176.6(an)]TJ 0 -1.2623 TD [(established)-272.6(effective)-264.6(intervention)-269.2(is)-271(already)-265.2(available.)]TJ 1.2933 -1.3036 TD [(If)-208(there)-204.6(are)-204.1(substantial)-205(grounds)-200.2(for)-209.5(the)-204.1(ethical)-201.5(review)-206.9(committee)-207.7(to)]TJ -1.2933 -1.2571 TD [(conclude)-375.5(that)-372(an)-370.6(established)-370.9(effective)-373.3(intervention)-372.7(will)-370.6(not)-373.6(become)]TJ T* [(available)-184.4(and)-180.8(implementable,)-180.5(the)-183.4(committee)-181.9(should)-178.9(obtain)-184.6(assurances)]TJ 0 -1.2623 TD [(from)-179(the)-178.2(parties)-174.7(concerned)-175.2(that)-175.4(plans)-177.6(have)-178.6(been)-174.1(agreed)-179.1(for)-173.3(making)-176.9(the)]TJ 0 -1.2571 TD [(investigational)-289.1(interventio)6.5(n)-286.1(reasonably)-286.7(available)-282.7(in)-290.2(the)-286.9(host)-283.5(country)]TJ 0 -1.2623 TD [(or)-232.1(community)-229.8(once)-236.1(its)-232.9(effectiveness)-228.3(and)-232.5(safety)-227.9(have)-230.3(been)-231(established.)]TJ 0 -1.2571 TD [(Moreover,)-226.5(when)-219(the)-224.8(study)-223.2(has)-218.4(external)-222.8(sponsorship,)-221(approval)-219(should)]TJ T* [(usually)-199.1(be)-195.7(dependent)-195(on)-194.5(the)-198.9(sponsors)-194(and)-196.3(the)-198.9(health)-196.1(authorities)-195.5(of)-196.2(the)]TJ 0 -1.2623 TD [(host)-185.2(country)-175.8(having)-183.4(engaged)-179.5(in)-181.6(a)-177.7(process)-183(of)-180.7(negotiation)-177.4(and)-180.8(planning,)]TJ 0 -1.2571 TD [(including)-271.5(justifying)-266.7(the)-271.3(study)-264.6(in)-269.5(regard)-272.5(to)-268.6(local)-267.9(health-care)-266.5(needs.)]TJ /F5 1 Tf 0 -2.3952 TD [(Means)-401.6(of)-398.2(minimizing)-393.8(harm)-400.6(to)-398.2(placebo-contro)6.9(l)-402.5(subjects.)]TJ /F2 1 Tf 24.2932 0 TD [(Even)-395.4(when)]TJ -24.2932 -1.2571 TD [(placebo)-419.6(controls)-424.3(are)-416.2(justified)-421(on)-422.1(one)-419.7(of)-423.8(the)-416.2(bases)-420.7(set)-422.8(forth)-421.3(in)-419.6(the)]TJ 0 -1.2623 TD [(guideline,)-178.6(there)-178.8(are)-178.2(means)-180.3(of)-175.5(minimizing)-180.6(the)-178.2(possibly)-176(harmful)-181.4(effect)-178.3(of)]TJ 0 -1.2571 TD [(being)-270.4(in)-269.5(the)-271.3(control)-266.1(arm.)]TJ 1.2933 -1.3036 TD [(First,)-298.3(a)-291.5(placebo-control)-290.6(group)-288.8(need)-293(not)-290.9(be)-294(untreated.)-289.4(An)-292(add-on)]TJ -1.2933 -1.2571 TD [(design)-480.4(may)-480.1(be)-480.2(employed)-477(when)-477.6(the)-478.3(investigational)-475.3(therapy)-481.2(and)-475.6(a)]TJ 0 -1.2623 TD 0.0126 Tc [(standard)-614.9(treatment)-616.6(h)0.7(av)-4.7(e)-616.1(d)0.7(ifferent)-621.8(mechanisms)-621.5(of)-616.6(action.)-617.5(T)0.9(he)]TJ 0 -1.2571 TD 0 Tc [(treatment)-430.8(to)-434.2(be)-428.5(tested)-430.3(and)-429.1(placebo)-429.9(are)-431.7(each)-427.8(added)-428.2(to)-434.2(a)-431.2(standard)]TJ T* [(treatment.)-481.5(Such)-478.1(studies)-479.6(have)-478.6(a)-477.7(particular)-477.1(place)-478.6(when)-477.6(a)-482.9(standard)]TJ 0 -1.2623 TD [(treatment)-182.5(is)-188.2(known)-177.9(to)-185.9(decrease)-180.6(mortality)-183.9(or)-180.4(irreversible)-186.1(morbidity)-181.9(but)]TJ 0 -1.2571 TD (a)Tj 0.7242 0 TD [(trial)-223.3(with)-222.2(standard)-219.2(treatment)-218.7(as)-222.1(the)-219.6(active)-223.4(control)-219.5(cannot)-219.3(be)-221.5(carried)]TJ -0.7242 -1.2623 TD [(out)-425.4(or)-423.6(would)-423.7(be)-423.3(difficult)-426.5(to)-423.8(interpret)-418.4([)]TJ /F5 1 Tf 17.1646 0 TD [(International)-417.2(Conference)-422(on)]TJ -17.1646 -1.2571 TD (Harmonisation)Tj /F2 1 Tf 6.4458 0 TD (\()Tj /F5 1 Tf 0.3311 0 TD [(ICH\))-213.3(Guideline:)-208.8(Choice)-210.9(of)-206.8(Control)-208.3(Group)-211.2(and)-207.2(Related)]TJ -6.7769 -1.2571 TD [(Issues)-326.9(in)-321.5(Clinical)-324.2(Trials,)-326.9(2000)]TJ /F2 1 Tf 12.5243 0 TD [(].)-323.9(In)-320.1(testing)-325(for)-323.4(improved)-322.1(treatment)-322.2(of)]TJ -12.5243 -1.2623 TD [(life-threatening)-277.8(diseases)-275.4(such)-277.8(as)-273.8(cancer,)-277.4(HIV/AIDS,)-276.6(or)-273.5(heart)-276.1(failure,)]TJ 0 -1.2571 TD [(add-on)-357.8(designs)-359.2(are)-354.1(a)-358.7(particularly)-358.9(useful)-357.7(means)-356.2(of)-356.6(finding)-354.3(improve-)]TJ T* [(ments)-523.2(in)-523(interventio)6.5(ns)-521.8(that)-522(are)-519.7(not)-518.5(fully)-521.9(effective)-523.3(or)-516.7(may)-521.5(cause)]TJ 0 -1.2623 TD [(intolerable)-227.2(side-effects.)-226.1(They)-224.7(have)-225.1(a)-224.2(place)-225.1(also)-222.6(in)-228.2(respect)-225.9(of)-222.1(treatment)]TJ 0 -1.2571 TD [(for)-509.6(epilepsy,)-501.8(rheumatism)-503.2(and)-506.7(osteoporosis,)-499.6(for)-504.4(example,)-505.8(because)]TJ 0 -1.2623 TD [(withholding)-321.2(of)-325.5(established)-319.2(effective)-321.5(therapy)-320.9(could)-321.9(result)-322.9(in)-321.3(progres-)]TJ 0 -1.2571 TD [(sive)-270.4(disability,)-271.8(unacceptable)-266.1(discomfort)-267.7(or)-268.4(both.)]TJ 10.7396 0 0 10.959 109.8142 140.5984 Tm 0.0121 Tc [(Seco)4.5(nd,)-594.2(a)5.3(s)-595.3(in)4.5(dicated)-592(i)2.3(n)-597.2(G)0(u)4.5(i)2.3(delin)4.5(e)-596.1(8)-591.2(C)1.6(ommen)4.5(t)2(ary,)-594.2(whe)5.7(n)-597.2(the)]TJ -1.3197 -1.2571 TD 0 Tc [(intervention)-338.1(to)-334.4(be)-336(tested)-336.6(in)-334.1(a)-334.1(randomized)-336(controlled)-331.8(trial)-337.7(is)-337.4(designed)]TJ 0 -1.2623 TD [(to)-286.9(prevent)-277.5(or)-282.4(postpone)-281.7(a)-281.3(lethal)-282.7(or)-282.4(disabling)-282.4(outcome,)-283.9(the)-282.8(investigator)]TJ 0 -1.2571 TD [(minimizes)-169.2(harmful)-165.1(effects)-160.9(of)-165.5(placebo-control)-164.4(studies)-163.6(by)-162.1(providing)-164(in)-165.1(the)]TJ ET 95.641 646.809 318.898 -0.51 re f BT /F6 1 Tf 7.9702 0 0 7.9702 191.1118 649.1337 Tm [(INTERNA)13.4(TIONAL)-327.4(ETHICAL)-327.5(GUIDELINES)-319.8(FOR)-332.5(BIOMED)13.7(ICAL)-331.1(RESEARCH)]TJ /F7 1 Tf 11.9551 0 0 11.9551 95.6409 649.1337 Tm (60)Tj ET endstream endobj 178 0 obj << /Type /Page /Parent 397 0 R /Resources 179 0 R /Contents 180 0 R /MediaBox [ 0 0 595 842 ] /CropBox [ 0 0 595 842 ] /Rotate 0 >> endobj 179 0 obj << /ProcSet [ /PDF /Text ] /Font << /F2 337 0 R /F5 340 0 R /F6 341 0 R /F7 342 0 R /F8 343 0 R /F11 346 0 R >> /ExtGState << /GS1 434 0 R >> /ColorSpace << /DefaultCMYK 417 0 R /Cs6 416 0 R >> >> endobj 180 0 obj << /Length 5770 >> stream q 1 i 0.015 737.008 510.221 -737.008 re W n /Cs6 cs 0 0 0 scn /GS1 gs 0.015 709.001 25.44 -0.284 re f Q /Cs6 cs 0 0 0 scn /GS1 gs 28.006 737.008 0.283 -25.455 re f 481.89 737.008 0.283 -25.455 re f 484.724 709.001 25.512 -0.284 re f 484.724 28.346 25.512 -0.283 re f 481.89 25.512 0.283 -25.512 re f q 1 i 0.015 737.008 510.221 -737.008 re W n 28.006 25.512 0.283 -25.512 re f 0.015 28.346 25.44 -0.283 re f Q 1 1 1 scn 95.641 270.765 14.173 -2.835 re f 0 0 0 scn 95.641 290.948 318.898 -20.183 re f 1 1 1 scn 95.641 233.178 14.173 -2.835 re f 0.8 0.8 0.8 scn 95.641 267.194 318.898 -34.016 re f BT /F2 1 Tf 10.7396 0 0 10.959 95.6409 609.8455 Tm 0 0 0 scn 0 Tc 0 Tw [(research)-156.1(protocol)-157.2(for)-155.3(the)-156.1(monitoring)-153(of)-154.9(research)-156.1(data)-152.6(by)-156.9(an)-151.6(independent)]TJ 0 -1.2623 TD [(Data)-310.2(and)-301.7(Safety)-306.4(Monitoring)-302.7(Board)-306.4(\(DSMB\).)-305.6(One)-305(function)-304.2(of)-308(such)-307(a)]TJ 0 -1.2571 TD [(board)-431(is)-432.4(to)-429.4(protect)-433.9(the)-430.6(research)-425.3(subjects)-433.9(from)-431.3(previously)-427.2(unknown)]TJ 0 -1.2623 TD [(adverse)-171.9(reactions;)-165.4(another)-167.8(is)-168.5(to)-170.8(avoid)-165.1(unnecessarily)-165.9(prolonged)-166.7(exposure)]TJ 0 -1.2571 TD [(to)-223.6(an)-220.2(inferior)-220.9(therapy.)-219(The)-219(board)-219.8(fulfils)-221.2(the)-219.4(latter)-223.1(function)-219.8(by)-220.2(means)-217.9(of)]TJ T* [(interim)-177.5(analyses)-171.5(of)-176.1(the)-177.2(data)-173.8(pertaining)-173(to)-170.8(efficacy)-173.7(to)-176.1(ensure)-176.5(that)-171.8(the)-171.9(trial)]TJ 0 -1.2623 TD [(does)-206.7(not)-199.4(continue)-205.5(beyond)-201.8(the)-203.6(point)-200.9(at)-201.7(which)-205.5(an)-204.4(investigational)-200.4(therapy)]TJ 0 -1.2571 TD [(is)-184.3(demonstrated)-172.6(to)-176.1(be)-182.9(effective.)-177.4(Normally,)-175.2(at)-180.5(the)-177.2(outset)-179.4(of)-176(a)-181(randomized)]TJ T* [(controlled)-331.8(trial,)-331.7(criteria)-335.1(are)-330.3(established)-331.4(for)-329.5(its)-331.7(premature)-332.1(termination)]TJ 0 -1.2623 TD [(\(stopping)-246.9(rules)-251.5(or)-250.7(guidelines\).)]TJ 10.959 0 0 10.959 109.8142 471.118 Tm [(In)-314.9(some)-313(cases)-313.3(the)-307.6(DSMB)-312.9(is)-312.4(called)-312(upon)-311.4(to)-315.2(perform)-310.5(conditional)]TJ -1.2933 -1.2571 TD [(power)-444.4(calculation)6.7(s,)-444.9(designed)-438.1(to)-439.3(determine)-441.3(the)-442.1(probability)-437.2(that)-439.2(a)]TJ 0 -1.2623 TD [(particular)-570.2(clinical)-573.9(trial)-569.9(could)-570.2(ever)-568.9(show)-571(that)-568.6(the)-571.4(investigational)]TJ 0 -1.2571 TD [(therapy)-383(is)-384.8(effective.)-387.8(If)-383.9(that)-382.3(probability)-385.5(is)-384.8(very)-381.8(small,)-385.2(the)-385.2(DSMB)-385.3(is)]TJ 0 -1.2623 TD [(expected)-376(to)-377.3(recommend)-373.8(termination)-374.2(of)-377.3(the)-374.8(clinical)-377.3(trial,)-377.5(because)-378.2(it)]TJ 0 -1.2571 TD [(would)-268.5(be)-273.3(unethical)-266.6(to)-268.6(continue)-267.4(it)-271.3(beyond)-264.2(that)-268.5(point.)]TJ 1.2933 -1.3243 TD 0.0175 Tc [(In)-620.3(most)-622.1(cases)-621.8(o)0.5(f)-616.9(r)-1(esearch)-620.3(i)-2.2(nvolving)-620.6(human)-620.3(s)-1(ubjects,)-623(it)-616.9(is)]TJ -1.2933 -1.2623 TD 0 Tc [(unnecessary)-242.6(to)-247.9(appoint)-243(a)-244.9(DSMB.)-244.7(To)-246(ensure)-242.1(that)-242.7(research)-242.9(is)-250.3(carefully)]TJ 0 -1.2571 TD [(monitored)-195.7(for)-194(the)-188.6(early)-194.6(detection)-194.2(of)-191(adverse)-192.5(events,)-195.1(the)-193.8(sponsor)-191(or)-190.8(the)]TJ T* [(principal)-417.8(investigator)-420.1(appoints)-416.7(an)-417.2(individual)-414.5(to)-418.6(be)-418.1(responsible)-416.9(for)]TJ 0 -1.2623 TD [(advising)-299.2(on)-303.1(the)-297.2(need)-298.2(to)-304.8(consider)-294.4(changing)-301.4(the)-297.2(system)-298.8(of)-299.7(monitoring)]TJ 0 -1.2571 TD [(for)-416.5(adverse)-409.7(events)-413.4(or)-413.2(the)-416.2(process)-410.7(of)-413.5(informed)-416.6(consent,)-408.5(or)-413.2(even)-417.5(to)]TJ 0 -1.2623 TD [(consider)-268.5(terminating)-271(the)-266.2(study.)]TJ /F11 1 Tf 11.9551 0 3.5865 11.9551 214.8661 276.3212 Tm 1 1 1 scn [(Guideline)-278.6(12)]TJ 11.9551 0 0 11.9551 101.3102 252.5669 Tm 0 0 0 scn [(Equi)-8.6(table)-259(distribution)-262.1(of)-257.8(burdens)-262.1(and)-254.5(benefit)-9.5(s)-254.3(i)0(n)]TJ 0.3936 -1.1523 TD [(the)-270.1(se)-5.6(lection)-276.4(of)-272.1(groups)-273.7(of)-272.1(subjects)-277.2(in)-273.4(research)]TJ /F8 1 Tf 10.959 0 0 10.959 95.6409 216.737 Tm [(Groups)-210.9(or)-211.2(communitie)7.5(s)-213.6(t)0(o)-206.9(b)0(e)-209.7(invited)-209.3(to)-212.1(be)-209.7(subjects)-208.2(of)-206.9(research)]TJ 0 -1.2312 TD [(should)-222.9(be)-220.1(selected)-218.8(in)-217.5(such)-222.9(a)-218.8(way)-221.2(that)-222.7(the)-218.8(burdens)-218.1(and)-221.3(benefits)]TJ 0 -1.226 TD [(of)-481.1(the)-477.5(research)-475.3(will)-478.9(be)-478.7(equitably)-475.9(distributed.)-476.4(The)-480(exclusion)]TJ T* [(of)-651.8(groups)-645.9(or)-650.9(communities)-645.9(that)-652.1(might)-651.7(benefit)-648.8(from)-649.3(study)]TJ T* [(participation)-452.1(must)-446.1(be)-447.7(justified.)]TJ 9.9626 0 2.9888 9.9626 95.6409 131.811 Tm [(Comm)-9.3(ent)-7.2(ary)-269.4(on)-277.2(Guidelin)-10.9(e)-267.4(1)0(2)]TJ /F5 1 Tf 10.959 0 0 10.959 95.6409 112.989 Tm [(General)-467.4(considerations:)]TJ /F2 1 Tf 10.4136 0 TD [(Equity)-463.7(requires)-461.4(that)-465.1(no)-468.7(group)-459.5(or)-464.9(class)-469.9(of)]TJ -10.4136 -1.2571 TD [(persons)-523.3(should)-520.3(bear)-521.2(more)-525.1(than)-520.3(its)-522.6(fair)-524.4(share)-519(of)-522.1(the)-524.8(burdens)-521.8(of)]TJ ET 95.641 646.809 318.898 -0.51 re f BT /F6 1 Tf 7.9702 0 0 7.9702 95.6409 649.1337 Tm [(THE)-330.8(GUIDELINES)]TJ /F7 1 Tf 11.9551 0 0 11.9551 401.3857 649.1337 Tm (61)Tj ET endstream endobj 181 0 obj << /Type /Page /Parent 397 0 R /Resources 182 0 R /Contents 183 0 R /MediaBox [ 0 0 595 842 ] /CropBox [ 0 0 595 842 ] /Rotate 0 >> endobj 182 0 obj << /ProcSet [ /PDF /Text ] /Font << /F2 337 0 R /F6 341 0 R /F7 342 0 R >> /ExtGState << /GS1 434 0 R >> /ColorSpace << /DefaultCMYK 417 0 R /Cs6 416 0 R >> >> endobj 183 0 obj << /Length 6633 >> stream q 1 i 0.015 737.008 510.221 -737.008 re W n /Cs6 cs 0 0 0 scn /GS1 gs 0.015 709.001 25.44 -0.284 re f Q /Cs6 cs 0 0 0 scn /GS1 gs 28.006 737.008 0.283 -25.455 re f 481.89 737.008 0.283 -25.455 re f 484.724 709.001 25.512 -0.284 re f 484.724 28.346 25.512 -0.283 re f 481.89 25.512 0.283 -25.512 re f q 1 i 0.015 737.008 510.221 -737.008 re W n 28.006 25.512 0.283 -25.512 re f 0.015 28.346 25.44 -0.283 re f Q BT /F2 1 Tf 10.959 0 0 10.959 95.6409 609.8455 Tm 0 Tc 0 Tw [(participation)-313.9(in)-310.9(research.)-314.4(Similarly,)-314.1(no)-313.5(group)-309.4(should)-308.2(be)-314.6(deprived)-313.9(of)]TJ 0 -1.2623 TD [(its)-217.4(fair)-214(share)-213.8(of)-216.9(the)-209.3(benefits)-213.6(of)-216.9(research,)-210.9(short-term)-216.5(or)-211.5(long-term;)-212.3(such)]TJ 0 -1.2571 TD [(benefits)-451.6(include)-453(the)-452.4(direct)-452(benefits)-451.6(of)-454.9(participation)-448.4(as)-449.7(well)-457.1(as)-449.7(the)]TJ 0 -1.2623 TD [(benefits)-296.4(of)-294.5(the)-297.2(new)-289.9(knowledge)-292.8(that)-294.4(the)-297.2(research)-289.5(is)-296.9(designed)-293.2(to)-294.5(yield.)]TJ 0 -1.2571 TD 0.0074 Tc [(When)-635.6(burdens)-637.1(or)-642.2(be)7.4(nefi)7.4(t)-5.2(s)-642.2(of)-637.3(res)7.4(e)-3.5(arch)-635.6(are)-636.8(t)-1(o)-640.8(b)0.7(e)-636.8(a)0.4(pport)7.4(i)-5.2(oned)]TJ T* 0 Tc [(unequally)-383(among)-379.7(individuals)-386.4(or)-382.2(groups)-379.7(of)-382.4(persons,)-382.6(the)-385.2(criteria)-381.8(for)]TJ 0 -1.2623 TD [(unequal)-278.7(distribution)-281(should)-277.1(be)-283.6(morally)-280.9(justifiable)-277(and)-279.1(not)-280.5(arbitrary.)]TJ 0 -1.2571 TD [(In)-263.2(other)-265.5(words,)-262.6(unequal)-258(allocation)-264.7(must)-261.8(not)-265(be)-262.9(inequitable.)-261(Subjects)]TJ T* [(should)-546.2(be)-547.4(drawn)-547(from)-546.3(the)-550.7(qualifying)-543.1(population)-545.1(in)-548.9(the)-545.5(general)]TJ 0 -1.2623 TD [(geographic)-633.1(area)-630.1(of)-635.9(the)-633.5(trial)-632(without)-632(regard)-629.5(to)-635.9(race,)-630(ethnicity,)]TJ 0 -1.2571 TD [(economic)-374.5(status)-378(or)-371.8(gender)-375.4(unless)-372.9(there)-375.4(is)-374.5(a)-379.4(sound)-371.3(scientific)-378.4(reason)]TJ 0 -1.2623 TD [(to)-299.7(do)-303.1(otherwise.)]TJ 1.2933 -1.2571 TD [(In)-237.3(the)-230(past,)-231(groups)-229.7(of)-232.4(persons)-233.6(were)-232(excluded)-230.9(from)-230.8(participation)-231.1(in)]TJ -1.2933 -1.2623 TD 0.0222 Tc [(re)4(s)3.7(e)4(ar)3.7(c)4(h)-620.8(for)-617.1(w)0.4(h)5.2(a)-0.3(t)-617.4(w)]TJ 9.7928 0 TD 0.018 Tc [(ere)-626.2(t)-0.8(h)-4.2(e)-0.2(n)-625(c)-0.2(on)-4.2(side)-5.4(re)]TJ 8.6961 0 TD 0.6441 Tc [(dg)626.8(o)621.9(o)627.1(dr)625.6(e)620.7(a)626.8(s)625.6(o)627.1(n)621.9(s)625.6(.A)627.8(sa)]TJ -18.4889 -1.2571 TD 0 Tc [(consequence)-453.7(of)-460(such)-453.7(exclusions,)-454.6(information)-455.7(about)-449.4(the)-457.6(diagnosis,)]TJ 0 -1.2623 TD [(prevention)-411.8(and)-408.4(treatment)-410.1(of)-408.3(diseases)-409.9(in)-409.2(such)-412.3(groups)-410.7(of)-408.3(persons)-409.5(is)]TJ 0 -1.2571 TD [(limited.)-335.2(This)-336(has)-332.2(resulted)-332.3(in)-336.8(a)-332.9(serious)-334.5(class)-330.3(injustice.)-336.7(If)-332.2(information)]TJ T* [(about)-459.7(the)-462.8(management)-458(of)-460(diseases)-456.5(is)-462.4(considered)-459(a)-462.2(benefit)-458.9(that)-459.9(is)]TJ 0 -1.2623 TD [(distributed)-190.1(within)-186.5(a)-182.9(society,)-188.9(it)-188.5(is)-188.2(unjust)-185.8(to)-185.9(deprive)-183(groups)-188.3(of)-185.9(persons)-187(of)]TJ 0 -1.2571 TD [(that)-289.2(benefit.)-282.1(Such)-286.7(documents)-282.2(as)-284.1(the)-286.9(Declaration)-286(of)-284.1(Helsinki)-285.7(and)-284.2(the)]TJ 0 -1.2623 TD 0.0085 Tc [(UNA)8.5(I)-5.6(D)-2.4(S)-613.8(G)8.5(u)-3.9(i)-0.8(d)-3.4(a)1.5(nce)-615(D)8.5(o)-9.1(c)0.6(ument)-615.5(E)2(thic)-4.6(al)-611.3(Consid)-3.4(eratio)-3.4(ns)-610.1(in)-613.8(HIV)]TJ 0 -1.2571 TD 0 Tc [(Preventive)-532(Vaccine)-528.9(Research,)-529.5(and)-527.4(the)-530(policies)-531(of)-532.5(many)-528.2(national)]TJ T* [(governments)-240.7(and)-242.8(professional)-243.4(societies,)-243.6(recognize)-240.2(the)-240.3(need)-241.3(to)-242.8(redress)]TJ 0 -1.2623 TD 0.008 Tc [(these)-610.3(i)8(njusti)8(c)-4.1(e)0.1(s)-610.6(b)1.3(y)-609.4(e)0.1(nc)8(ouraging)-609.4(t)8(h)-2(e)-610.3(p)1.3(arti)8(c)-4.1(i)-1.4(pati)8(on)-609.1(of)-610.9(previ)8(o)-2.9(usly)]TJ 0 -1.2571 TD 0 Tc [(excluded)-272.3(groups)-265.9(in)-269.5(basic)-266.7(and)-268.7(applied)-271(biomedical)-268.1(research.)]TJ 1.2933 -1.2623 TD [(Members)-302.3(of)-304.8(vulnerable)-299.2(groups)-296.9(also)-305.4(have)-297.6(the)-302.4(same)-302.9(entitlement)-304.1(to)]TJ -1.2933 -1.2571 TD [(access)-554(to)-553.1(the)-555.9(benefits)-555.1(of)-553.2(investigation)6.6(al)-554.3(interventions)-551.6(that)-553(show)]TJ 0 -1.2623 TD [(promise)-285.5(of)-284.1(therapeutic)-281.8(benefit)-277.9(as)-284.1(persons)-285.3(not)-280.5(considered)-283.1(vulnerable,)]TJ 0 -1.2571 TD [(particularly)-183(when)-177.6(no)-179(superior)-180.9(or)-175.2(equivalent)-180.5(approaches)-176.4(to)-180.7(therapy)-176(are)]TJ T* (available.)Tj 1.2933 -1.2623 TD [(There)-399.3(has)-399.5(been)-396.5(a)-400.1(perception,)-396.2(sometimes)-399.1(correct)-396.6(and)-398(sometimes)]TJ -1.2933 -1.2623 TD [(incorrect,)-525.5(that)-522(certain)-521(groups)-524.5(of)-522.1(persons)-523.3(have)-520(been)-520.7(overused)-524.8(as)]TJ 0 -1.2571 TD [(research)-294.7(subjects.)-300.3(In)-294.2(some)-292.3(cases)-297.8(such)-293.3(overuse)-295.7(has)-296(been)-293(based)-295.1(on)-292.8(the)]TJ T* [(administrative)-243.7(availability)-241.7(of)-237.6(the)-245.5(populations.)-236.8(Research)-240.8(hospitals)-241.3(are)]TJ 0 -1.2623 TD [(often)-286.5(located)-281.6(in)-285.1(places)-285(where)-280.1(members)-283.1(of)-284.1(the)-286.9(lowest)-284.8(socio-economi)5.2(c)]TJ 0 -1.2571 TD [(classes)-356.7(reside,)-357.6(and)-351.5(this)-353.4(has)-352.9(resulted)-353(in)-357.5(an)-349.9(apparent)-353.5(overuse)-352.6(of)-351.4(such)]TJ 0 -1.2623 TD [(persons.)-418.8(Other)-420(groups)-415.9(that)-413.4(may)-418(have)-416.5(been)-417.2(overused)-416.2(because)-419.5(they)]TJ 0 -1.2571 TD 0.008 Tc [(we)-5.1(re)-625.8(co)-3.9(nv)-4.1(en)-3.9(ie)-5.1(ntl)-6.5(y)-624.9(av)-4.1(ail)-6.5(a)1(b)-3.9(l)-1.4(e)-625.8(t)-0.4(o)-624.7(r)-0.2(e)-5.1(s)-0.2(e)-5.1(a)1(r)-5.3(c)0.1(h)-3.9(e)0.1(rs)-626.1(in)-3.9(cl)-6.5(ud)-3.9(e)-625.9(s)-0.2(tu)-3.9(de)-5.1(nt)-5.6(s)-626.1(i)-1.3(n)]TJ ET 95.641 646.809 318.898 -0.51 re f BT /F6 1 Tf 7.9702 0 0 7.9702 191.1118 649.1337 Tm 0 Tc [(INTERNA)13.4(TIONAL)-327.4(ETHICAL)-327.5(GUIDELINES)-319.8(FOR)-332.5(BIOMED)13.7(ICAL)-331.1(RESEARCH)]TJ /F7 1 Tf 11.9551 0 0 11.9551 95.6409 649.1337 Tm (62)Tj ET endstream endobj 184 0 obj << /Type /Page /Parent 397 0 R /Resources 185 0 R /Contents 186 0 R /MediaBox [ 0 0 595 842 ] /CropBox [ 0 0 595 842 ] /Rotate 0 >> endobj 185 0 obj << /ProcSet [ /PDF /Text ] /Font << /F2 337 0 R /F5 340 0 R /F6 341 0 R /F7 342 0 R >> /ExtGState << /GS1 434 0 R >> /ColorSpace << /DefaultCMYK 417 0 R /Cs6 416 0 R >> >> endobj 186 0 obj << /Length 5875 >> stream q 1 i 0.015 737.008 510.221 -737.008 re W n /Cs6 cs 0 0 0 scn /GS1 gs 0.015 709.001 25.44 -0.284 re f Q /Cs6 cs 0 0 0 scn /GS1 gs 28.006 737.008 0.283 -25.455 re f 481.89 737.008 0.283 -25.455 re f 484.724 709.001 25.512 -0.284 re f 484.724 28.346 25.512 -0.283 re f 481.89 25.512 0.283 -25.512 re f q 1 i 0.015 737.008 510.221 -737.008 re W n 28.006 25.512 0.283 -25.512 re f 0.015 28.346 25.44 -0.283 re f Q BT /F2 1 Tf 10.959 0 0 10.959 95.6409 609.8455 Tm 0.0094 Tc 0 Tw [(inv)9.4(e)-0.3(st)9.4(ig)9.4(at)]TJ 4.1437 0 TD 0 Tc [(or)-9.7(s)-8.2()-625(c)-7.9(l)0(a)-11.2(s)0(s)-11.2(e)-7.9(s,)-628(r)-8.2(e)-7.9(si)-12.3(de)-9.4(n)-6.7(t)0(s)-632.2(o)-6.7(f)-624(l)0(o)-10.9(n)-6.7(g)-7(-)0(t)-11.7(e)0(r)-10.9(m)-626.5(ca)-9.7(r)-8.2(e)-623.5(f)-8.4(a)0(c)-9.7(i)0(l)-13.5(i)0(t)-12.6(i)0(e)-12.1(s)-623.8(a)-7(n)-6.7(d)]TJ -4.1437 -1.2623 TD 0.0081 Tc [(subo)8.1(rdi)8.1(n)-2.8(at)8.1(e)-618.7(m)8.1(e)-5.5(m)8.1(b)-4.3(e)8.1(rs)-615.7(of)-615.9(hi)8.1(e)-4(r)-0.1(a)8.1(r)-1.9(ch)8.1(ic)]TJ 16.0496 0 TD 0.0096 Tc [(al)-615.4(in)9.6(st)9.6(it)9.6(uti)9.6(o)-1.3(ns)]TJ 6.2593 0 TD 0.628 Tc [(.I)619.8(m)628(p)]TJ 2.6775 0 TD 0 Tc [(ov)-8.5(e)-7.9(r)0(i)-12.3(s)0(h)-9.7(e)-7.9(d)]TJ -24.9864 -1.2571 TD [(groups)-374.5(have)-370(been)-370.6(overused)-374.8(because)-367.8(of)-377.3(their)-371.6(willingness)-372.8(to)-372.1(serve)-375.4(as)]TJ 0 -1.2623 TD [(subjects)-218.5(in)-217.8(exchange)-208.1(for)-219.9(relatively)-215.9(small)-215.5(stipends.)-216.4(Prisoners)-214.6(have)-209.6(been)]TJ 0 -1.2571 TD [(considered)-397(ideal)-397.2(subjects)-399.6(for)-395.8(Phase)-393.1(I)-396.1(drug)-395.9(studies)-396.9(because)-398.9(of)-392.8(their)]TJ T* [(highly)-563.4(regimented)-562(lives)-564.2(and,)-562.6(in)-564.4(many)-564.4(cases,)-565.8(their)-563.1(conditions)-563(of)]TJ 0 -1.2623 TD [(economic)-281.3(deprivation)-275.4(\(Appendix)-277.6(3\).)]TJ 1.2933 -1.2571 TD [(Overuse)-207(of)-201.4(certain)-205.5(groups,)-202.8(such)-200.2(as)-206.5(the)-204.1(poor)-204.2(or)-201.1(the)-204.1(administratively)]TJ -1.2933 -1.2571 TD [(available,)-193.7(is)-193.4(unjust)-190.9(for)-188.8(several)-189.9(reasons.)-191.5(It)-192.5(is)-193.4(unjust)-190.9(to)-191(selectively)-193.7(recruit)]TJ 0 -1.2623 TD [(impoverished)-209.4(people)-210.8(to)-211.7(serve)-204.6(as)-211.7(research)-211.9(subjects)-208.2(simply)-206.6(because)-212.6(they)]TJ 0 -1.2571 TD [(can)-502.7(be)-500.9(more)-499.2(easily)-504(induced)-496.9(to)-501.4(participate)-500.8(in)-502.3(exchange)-497.8(for)-499.2(small)]TJ 0 -1.2623 TD [(payments.)-299.7(In)-299.4(most)-303.2(cases,)-296.8(these)-302.9(people)-298.8(would)-299.6(be)-299.1(called)-301.7(upon)-295.8(to)-299.7(bear)]TJ 0 -1.2571 TD [(the)-266.2(burdens)-258(of)-263.5(research)-263.6(so)-263.2(that)-263.3(others)-263.4(who)-257.6(are)-266.2(better)-259.6(off)-266.7(could)-259.8(enjoy)]TJ T* [(the)-317.9(benefits.)-316.1(However,)-317.6(although)-312.1(the)-317.9(burdens)-314.9(of)-315.2(research)-315.4(should)-313.4(not)]TJ 0 -1.2622 TD [(fall)-251.4(disproportionately)-246.9(on)-246.2(socio-economically)-247.5(disadvantaged)-245.6(groups,)]TJ 0 -1.2571 TD [(neither)-339.7(should)-334.1(such)-339.9(groups)-333.1(be)-340.5(categorically)-335.8(excluded)-334.3(from)-339.4(research)]TJ 0 -1.2623 TD (protocols)Tj /F5 1 Tf 4.0196 0 TD (.)Tj /F2 1 Tf 0.5173 0 TD [(It)-244.2(would)-242.7(not)-244.3(be)-247.4(unjust)-242.7(to)-247.9(selectively)-245.4(recruit)-242.9(poor)-245.6(people)-247(to)]TJ -4.5369 -1.2571 TD [(serve)-365(as)-361.7(subjects)-363.4(in)-362.7(research)-361.9(designed)-360.5(to)-361.7(address)-363.2(problems)-359.5(that)-361.6(are)]TJ T* (p)Tj 0.5587 0 TD [(rev)-7.5(ale)-8.7(nt)-610.1(in)-616.1(the)-7.5(ir)-612.4(gro)-6.3(u)-6.7(p)-606.8()-608.9(maln)-13.2(utr)-7.8(it)-7.4(ion)-7.2(,)-609.4(for)-613(ex)-9.7(ampl)-8.1(e.)-612.2(S)-6.7(imi)-8.9(lar)]TJ -0.5587 -1.2623 TD -0.0001 Tc [(considerations)-578.8(apply)-580(to)-579.1(institutionalized)-581.3(groups)-576.4(or)-578.8(those)-581.2(whose)]TJ 0 -1.2571 TD 0 Tc [(availability)-314.1(to)-315.2(the)-312.7(investigators)-309.3(is)-312.4(for)-313(other)-312.1(reasons)-311.4(administratively)]TJ T* (convenient.)Tj 1.2933 -1.2623 TD [(Not)-320.9(only)-319.4(may)-314.5(certain)-319.3(groups)-317.6(within)-315.8(a)-317.4(society)-319.3(be)-319.8(inappropriat)7.3(ely)]TJ -1.2933 -1.2571 TD [(overused)-204.1(as)-206.5(research)-206.7(subjects,)-202(but)-208.1(also)-201.9(entire)-203.7(communities)-206.8(or)-206.3(societies)]TJ 0 -1.2622 TD [(may)-562.9(be)-563(overused.)-560(This)-558.4(has)-559.9(been)-562(particularly)-560.7(likely)-561.8(to)-558.3(occur)-565(in)]TJ 0 -1.2571 TD [(countries)-318.4(or)-314.9(communities)-315.5(with)-320.4(insufficiently)-315.5(well-developed)-315.1(systems)]TJ T* [(for)-545.8(the)-540.4(protection)-537.4(of)-542.8(the)-540.4(rights)-544.4(and)-537.7(welfare)-541.3(of)-542.8(human)-539.8(research)]TJ 0 -1.2623 TD [(subjects.)-176.2(Such)-172.9(overuse)-171.5(is)-177.9(especially)-173.7(questionab)8.4(le)-177.6(when)-172.4(the)-173.1(populations)]TJ 0 -1.2571 TD [(or)-573.6(communities)-568.9(concerned)-573.6(bear)-567.8(the)-571.4(burdens)-573.6(of)-568.7(participation)-572.5(in)]TJ 0 -1.2623 TD [(research)-284.3(but)-285.7(are)-286.9(extremely)-281.4(unlikely)-285.5(ever)-284.4(to)-284.1(enjoy)-286(the)-286.9(benefits)-280.9(of)-289.3(new)]TJ 0 -1.2571 TD [(knowledge)-339.4(and)-341.1(products)-333.7(developed)-341(as)-335.9(a)-343.2(result)-338.4(of)-341.1(the)-338.6(research.)-340.2(\(See)]TJ T* [(Guideline)-385.3(10:)]TJ /F5 1 Tf 6.1975 0 TD [(Research)-381(in)-383.6(populations)-379(and)-377.9(communities)-384.1(with)-377.9(limited)]TJ -6.1975 -1.2623 TD (resources)Tj /F2 1 Tf 3.854 0 TD (.\))Tj ET 95.641 646.809 318.898 -0.51 re f BT /F6 1 Tf 7.9702 0 0 7.9702 95.6409 649.1337 Tm [(THE)-330.8(GUIDELINES)]TJ /F7 1 Tf 11.9551 0 0 11.9551 401.3857 649.1337 Tm (63)Tj ET endstream endobj 187 0 obj << /Type /Page /Parent 397 0 R /Resources 188 0 R /Contents 189 0 R /MediaBox [ 0 0 595 842 ] /CropBox [ 0 0 595 842 ] /Rotate 0 >> endobj 188 0 obj << /ProcSet [ /PDF /Text ] /Font << /F2 337 0 R /F5 340 0 R /F6 341 0 R /F7 342 0 R /F8 343 0 R /F10 345 0 R /F11 346 0 R >> /ExtGState << /GS1 434 0 R >> /ColorSpace << /DefaultCMYK 417 0 R /Cs6 416 0 R >> >> endobj 189 0 obj << /Length 5826 >> stream q 1 i 0.015 737.008 510.221 -737.008 re W n /Cs6 cs 0 0 0 scn /GS1 gs 0.015 709.001 25.44 -0.284 re f Q /Cs6 cs 0 0 0 scn /GS1 gs 28.006 737.008 0.283 -25.455 re f 481.89 737.008 0.283 -25.455 re f 484.724 709.001 25.512 -0.284 re f 484.724 28.346 25.512 -0.283 re f 481.89 25.512 0.283 -25.512 re f q 1 i 0.015 737.008 510.221 -737.008 re W n 28.006 25.512 0.283 -25.512 re f 0.015 28.346 25.44 -0.283 re f Q 1 1 1 scn 95.641 603.439 14.173 -2.835 re f 0 0 0 scn 95.641 623.622 318.898 -20.183 re f 1 1 1 scn 95.641 580.422 14.173 -2.835 re f 0.8 0.8 0.8 scn 95.641 600.605 318.898 -20.183 re f BT /F11 1 Tf 11.9551 0 3.5865 11.9551 214.8661 608.9951 Tm 1 1 1 scn 0 Tc 0 Tw [(Guideline)-278.6(13)]TJ 11.9551 0 0 11.9551 130.7338 585.9778 Tm 0 0 0 scn [(Research)-274.6(involvin)-10.6(g)-268.2(v)0(u)-5.6(lnerable)-274.3(person)-8.1(s)]TJ /F8 1 Tf 10.959 0 0 10.959 95.6409 564.6046 Tm 0.0355 Tc [(Special)-636(j)-4.9(ust)-4.6(i)0.3(fication)-633.1(i)-4.9(s)-633.4(requ)]TJ 14.7798 0 TD 0.0353 Tc [(ired)-638.5(for)-640.2(i)0.1(nviting)-638.5(v)2.7(ulnerable)]TJ -14.7798 -1.2364 TD 0 Tc [(individuals)-564.4(to)-558.7(serve)-562.7(as)-556.6(research)-558.1(subjects)-560(and,)-561.8(if)-561.6(they)-561.8(are)]TJ T* [(selected,)-238.5(the)-234.3(means)-233.1(of)-232.8(protecting)-235.3(their)-236.3(rights)-232.4(and)-236.9(welfare)-233.8(must)]TJ T* [(be)-271.8(strictly)-266.9(applied.)]TJ 9.9626 0 2.9888 9.9626 95.6409 492.8314 Tm [(Comm)-9.3(ent)-7.2(ary)-269.4(on)-277.2(Guidelin)-10.9(e)-267.4(1)0(3)]TJ /F2 1 Tf 10.959 0 0 10.959 95.6409 474.9731 Tm [(Vulnerable)-577.8(persons)-575(are)-571.4(those)-575.9(who)-578.4(are)-571.4(relatively)-578(\(or)-576.8(absolutely\))]TJ T* [(incapable)-254.8(of)-258.3(protecting)-253.2(their)-257.8(own)-257.6(interests.)-253.3(More)-254.7(formally,)-257.3(they)-257.6(may)]TJ T* [(have)-338.9(insufficient)-335.4(power,)-334.8(intelligence,)-334.8(education,)-335.4(resources,)-337.8(strength,)]TJ T* [(or)-273.5(other)-265.5(needed)-271.4(attributes)-265.5(to)-268.6(protect)-271.5(their)-268.2(own)-268(interests.)]TJ /F5 1 Tf 10.7396 0 0 10.959 95.6409 411.8172 Tm [(General)-485.2(considerations.)]TJ /F2 1 Tf 10.3888 0 TD [(The)-482.9(central)-485.6(problem)-484.2(presented)-480.4(by)-484.1(plans)-486(to)]TJ -10.3888 -1.2364 TD [(involve)-281.6(vulnerable)-274.9(persons)-278.3(as)-276.4(research)-277.5(subjects)-280.9(is)-279.4(that)-277.4(such)-275.3(plans)-280.1(may)]TJ T* [(entail)-166.6(an)-162.1(inequitable)-163.2(distribution)-156.7(of)-165.5(the)-161.4(burdens)-164.1(and)-159.1(benefits)-163.9(of)-160.2(research)]TJ T* [(participation.)-236.6(Classes)-240.4(of)-234.1(individuals)-236.3(conventionally)-237.1(considered)-234.2(vulner-)]TJ T* [(able)-220.6(are)-219.4(those)-222.1(with)-217.4(limited)-223.9(capacity)-219(or)-219.1(freedom)-219.4(to)-218.3(consent)-214.9(or)-224.4(to)-218.3(decline)]TJ T* [(to)-250(consent.)-240.6(They)-246.9(are)-245.8(the)-245.8(subject)-243.5(of)-244.7(specific)-246.9(guidelines)-246.2(in)-244.3(this)-249.5(document)]TJ T* [(\(Guidelines)-330.2(14,15\))-326.8(and)-328.1(include)-329.6(children,)-329.2(and)-328.1(persons)-325.8(who)-331.8(because)-326.6(of)]TJ T* [(mental)-517.3(or)-509.4(behavioural)-515(disorders)-510.1(are)-515(incapable)-512.1(of)-508.6(giving)-517.3(informed)]TJ T* [(consent.)-235.3(Ethical)-229.1(justification)-232.4(of)-234.1(their)-234.8(involvement)-228.1(usually)-233.3(requires)-228.9(that)]TJ T* [(investigators)-251.7(satisfy)-244.9(ethical)-252.2(review)-246.1(committees)-250.3(that:)]TJ /F10 1 Tf 10.959 0 0 10.959 109.8142 276.0944 Tm (7)Tj /F2 1 Tf 1.2933 0 TD [(the)-436.9(research)-434.3(could)-435.7(not)-435.7(be)-433.6(carried)-438(out)-435.7(equally)-431.6(well)-441.5(with)-434.3(less)]TJ 0 -1.2364 TD [(vulnerable)-268.2(subjects;)]TJ /F10 1 Tf -1.2933 -1.2519 TD (7)Tj /F2 1 Tf 1.2933 0 TD [(the)-328.3(research)-320.5(is)-322.7(intended)-324.3(to)-320.4(obtain)-324.2(knowledge)-318.7(that)-325.4(will)-324(lead)-325.8(to)]TJ 0 -1.2364 TD [(improved)-487.6(diagnosis,)-482(prevention)-484.2(or)-485.6(treatment)-487.7(of)-485.9(diseases)-482.4(or)]TJ T* [(other)-565.6(health)-563.4(problems)-566.4(characteris)6.5(tic)-568.9(of,)-562.5(or)-563.2(unique)-566.6(to,)-562.5(the)]TJ T* [(vulnerable)-283.7(class)-283.7()-277.8(either)-281.3(the)-281.7(actual)-284.3(subjects)-280.6(or)-283.9(other)-281.1(similarly)]TJ T* [(situated)-269.6(members)-267.5(of)-273.8(the)-266.2(vulnerable)-268.2(class;)]TJ /F10 1 Tf -1.2933 -1.2519 TD (7)Tj /F2 1 Tf 10.7396 0 0 10.959 123.9874 180.907 Tm [(research)-198.3(subjects)-191.1(and)-196.1(other)-195.7(members)-193.1(of)-197.2(the)-193(vulnerable)-195.7(class)-192.6(from)]TJ 0 -1.2364 TD [(which)-194.9(subjects)-196.4(are)-193(recruited)-192.3(will)-198.2(ordinarily)-187.7(be)-198.7(assured)-187.8(reasonable)]TJ T* [(access)-232.6(to)-228.8(any)-227(diagnostic,)-225(preventive)-231.8(or)-224.3(therapeutic)-226.9(products)-227(that)]TJ T* [(will)-272.1(become)-268.2(available)-271(as)-265.8(a)-270.7(consequence)-265.6(of)-271.1(the)-266.9(research;)]TJ /F10 1 Tf 10.959 0 0 10.959 109.8142 126.5385 Tm (7)Tj /F2 1 Tf 10.6302 0 0 10.959 123.9874 126.5385 Tm [(the)-219.3(risks)-214.9(attached)-217.2(to)-213.6(interventions)-212.5(or)-215(procedures)-216.5(that)-212.6(do)-218.6(not)-216.3(hold)]TJ T* [(out)-344.3(the)-342(prospect)-340.2(of)-341.6(direct)-343.3(health-related)-338.2(benefit)-339.2(will)-344(not)-344.3(exceed)]TJ T* [(those)-268.9(associated)-262.2(with)-265.6(routine)-268.2(medical)-263.9(or)-268.3(psychologica)8.5(l)-268.7(examina-)]TJ ET 95.641 646.809 318.898 -0.51 re f BT /F6 1 Tf 7.9702 0 0 7.9702 191.1118 649.1337 Tm [(INTERNA)13.4(TIONAL)-327.4(ETHICAL)-327.5(GUIDELINES)-319.8(FOR)-332.5(BIOMED)13.7(ICAL)-331.1(RESEARCH)]TJ /F7 1 Tf 11.9551 0 0 11.9551 95.6409 649.1337 Tm (64)Tj ET endstream endobj 190 0 obj << /Type /Page /Parent 397 0 R /Resources 191 0 R /Contents 192 0 R /MediaBox [ 0 0 595 842 ] /CropBox [ 0 0 595 842 ] /Rotate 0 >> endobj 191 0 obj << /ProcSet [ /PDF /Text ] /Font << /F2 337 0 R /F5 340 0 R /F6 341 0 R /F7 342 0 R /F10 345 0 R >> /ExtGState << /GS1 434 0 R >> /ColorSpace << /DefaultCMYK 417 0 R /Cs6 416 0 R >> >> endobj 192 0 obj << /Length 6187 >> stream q 1 i 0.015 737.008 510.221 -737.008 re W n /Cs6 cs 0 0 0 scn /GS1 gs 0.015 709.001 25.44 -0.284 re f Q /Cs6 cs 0 0 0 scn /GS1 gs 28.006 737.008 0.283 -25.455 re f 481.89 737.008 0.283 -25.455 re f 484.724 709.001 25.512 -0.284 re f 484.724 28.346 25.512 -0.283 re f 481.89 25.512 0.283 -25.512 re f q 1 i 0.015 737.008 510.221 -737.008 re W n 28.006 25.512 0.283 -25.512 re f 0.015 28.346 25.44 -0.283 re f Q BT /F2 1 Tf 10.6302 0 0 10.959 123.9874 610.0723 Tm 0 Tc 0 Tw [(tion)-143.6(of)-144.3(such)-137.9(persons,)-140.6(unless)-144.3(an)-142.6(ethical)-139.6(review)-143.6(committee)-143.5(authorizes)]TJ 0 -1.2364 TD (a)Tj 0.7306 0 TD [(slight)-228.6(increase)-228.9(over)-227.3(this)-230.6(level)-229.9(of)-229.6(risk)-232(\(Guideline)-224.9(9\);)-230.3(and,)]TJ /F10 1 Tf 10.959 0 0 10.959 109.8142 582.2928 Tm (7)Tj /F2 1 Tf 1.2933 0 TD 0.0101 Tc [(when)-612.2(the)-613.4(p)-1.8(rospect)-3.5(i)0.7(ve)-618.6(subj)-4.4(ects)-613.7(ar)-3.2(e)-613.4(e)2.2(i)-4.4(t)1.7(her)-613.7(i)-4.4(ncom)10.1(p)-7.5(e)-3(tent)-613.9(or)]TJ 0 -1.2571 TD 0 Tc [(otherwise)-317.9(substantial)7.1(ly)-316.4(unable)-313.4(to)-310(give)-315.7(informed)-313.2(consent,)-310.2(their)]TJ 0 -1.2622 TD [(agreement)-211.5(will)-210.2(be)-211.2(supplemented)-207.9(by)-210.3(the)-209.3(permission)-211.4(of)-211.7(their)-206.1(legal)]TJ 0 -1.2571 TD [(guardians)-268.5(or)-268.4(other)-270.7(appropriate)-263.9(representatives.)]TJ /F5 1 Tf -2.5866 -2.3952 TD [(Other)-399.6(vulnerable)-399.2(groups.)]TJ /F2 1 Tf 10.8999 0 TD [(The)-398.8(quality)-395.9(of)-403.1(the)-395.5(consent)-399.1(of)-398(prospective)]TJ -10.8999 -1.2623 TD [(subjects)-425.5(who)-423.2(are)-421.4(junior)-419.5(or)-423.6(subordinate)-418.8(members)-422.7(of)-423.8(a)-420.8(hierarchical)]TJ 0 -1.2571 TD [(group)-252.5(requires)-254.5(careful)-257.2(consideration,)-248.8(as)-258.3(their)-252.7(agreement)-252.9(to)-253.1(volunteer)]TJ T* [(may)-195.6(be)-190.5(unduly)-188(influenced,)-190.5(whether)-191.7(justified)-193.4(or)-190.8(not,)-191.6(by)-194.7(the)-188.6(expectation)]TJ 0 -1.2623 TD [(of)-366.9(preferential)-370.2(treatment)-363.5(if)-364.4(they)-366.3(agree)-369(or)-366.6(by)-365.5(fear)-362.6(of)-366.9(disapproval)-362.2(or)]TJ 0 -1.2571 TD [(retaliation)-341.9(if)-338.5(they)-340.4(refuse.)-341.2(Examples)-337.7(of)-341(such)-334.7(groups)-338.3(are)-343.8(medical)-338.4(and)]TJ T* [(nursing)-518.4(students,)-515.5(subordinate)-517.1(hospital)-517.7(and)-517(laboratory)-514.9(personnel,)]TJ 0 -1.2623 TD [(employees)-269.1(of)-273.8(pharmaceutica)7(l)-273.2(companies,)-266.9(and)-268.7(members)-272.7(of)-268.6(the)-271.3(armed)]TJ 0 -1.2571 TD [(forces)-176.6(or)-180.4(police.)-176.3(Because)-176.2(they)-174.9(work)-172.7(in)-176.4(close)-179.7(proximity)-171.9(to)-180.7(investigato)7.1(rs,)]TJ 0 -1.2623 TD [(they)-190.4(tend)-184.9(to)-191(be)-190.5(called)-187.9(upon)-187.2(more)-183.7(often)-188.2(than)-189.2(others)-185.8(to)-191(serve)-184(as)-191(research)]TJ 0 -1.2571 TD [(subjects,)-543.5(and)-537.7(this)-539.6(could)-539.2(result)-540.2(in)-538.5(inequitable)-536.2(distribution)-539.7(of)-537.6(the)]TJ T* [(burdens)-268.3(and)-268.7(benefits)-270.5(of)-268.6(research.)]TJ 1.2933 -1.3088 TD [(Elderly)-598.2(persons)-590.5(are)-592.1(commonly)-593.8(regarded)-592.3(as)-589.4(vulnerable.)-593.1(With)]TJ -1.2933 -1.2571 TD [(advancing)-194.6(age,)-191.6(people)-195.3(are)-193.8(increasingly)-187.7(likely)-194.5(to)-196.2(acquire)-193.4(attributes)-193.1(that)]TJ T* [(define)-181.5(them)-178.8(as)-175.5(vulnerable.)-179.2(They)-178.1(may,)-179(for)-178.5(example,)-179.9(be)-175(institutionalized)]TJ 0 -1.2623 TD [(or)-185.6(develop)-181.6(varying)-181.5(degrees)-183(of)-180.7(dementia.)-182.9(If)-182.1(and)-180.8(when)-182.8(they)-185.2(acquire)-183(such)]TJ 0 -1.2571 TD [(vulnerability-defining)-297.7(attributes,)-300.7(and)-299.7(not)-296(before,)-303.5(it)-297.1(is)-302(appropriate)-300.1(to)]TJ T* [(consider)-268.5(them)-271.9(vulnerable)-268.2(and)-268.7(to)-268.6(treat)-267.5(them)-266.7(accordingly.)]TJ 1.2933 -1.3088 TD [(Other)-306.2(groups)-296.9(or)-304.6(classes)-299.8(may)-304.2(also)-300.2(be)-299.1(considered)-303.8(vulnerable.)-298.2(They)]TJ -1.2933 -1.2571 TD [(include)-282.3(residents)-278.4(of)-279(nursing)-275.2(homes,)-282.5(people)-278.1(receiving)-278.2(welfare)-277.4(benefits)]TJ T* [(or)-496(social)-493.4(assistance)-492.6(and)-496.3(other)-493.2(poor)-493.9(people)-490.2(and)-496.3(the)-493.8(unemployed,)]TJ 0 -1.2623 TD [(patients)-202.4(in)-207.5(emergency)-200.6(rooms,)-200(some)-204.4(ethnic)-202.2(and)-201.5(racial)-203.9(minority)-201.1(groups,)]TJ 0 -1.2571 TD [(homeless)-298.6(persons,)-294.7(nomads,)-293.5(refugees)-294.9(or)-294.2(displaced)-292.2(persons,)-294.7(prisoners,)]TJ 0 -1.2623 TD 0.0076 Tc [(pati)7.6(e)-4.5(n)0.9(ts)-605.8(wit)7.6(h)-612.8(inc)7.6(u)-1.8(rabl)7.6(e)-614.9(d)0.9(i)7.6(s)-4.7(eas)7.6(e)-3.3(,)-607(i)-1.8(ndi)7.6(vidu)7.6(als)-605.8(w)1.4(ho)-609.5(are)-605.6(pol)7.6(i)-5.9(t)-0.8(i)7.6(c)-4.5(al)7.6(l)-5.9(y)]TJ 0 -1.2571 TD 0 Tc [(powerless,)-477(and)-475.6(members)-474.5(of)-475.6(communities)-470.7(unfamiliar)-476.1(with)-475.6(modern)]TJ T* [(medical)-229.8(concepts.)-230.2(To)-230.5(the)-230(extent)-227.4(that)-227.1(these)-230.5(and)-227.3(other)-229.3(classes)-227.3(of)-232.4(people)]TJ 0 -1.2623 TD [(have)-173.4(attributes)-172.4(resembling)-170.1(those)-167.2(of)-175.5(classes)-170.4(identified)-174(as)-170.3(vulnerable,)-168.9(the)]TJ 0 -1.2571 TD [(need)-479.3(for)-478.5(special)-480.6(protection)-475.4(of)-475.6(their)-480.3(rights)-477.2(and)-475.6(welfare)-479.2(should)-473.7(be)]TJ T* [(reviewed)-273.3(and)-263.5(applied,)-270(where)-269.7(relevant.)]TJ 10.7396 0 0 10.959 109.8142 112.989 Tm -0.0001 Tc [(Persons)-310.8(who)-316(have)-307.4(serious,)-311.5(potentially)-314.1(disabling)-308.8(or)-314.2(life-threatening)]TJ -1.3197 -1.2571 TD 0 Tc [(diseases)-185.8(are)-187.8(highly)-185.5(vulnerable.)-184.3(Physicians)-185.1(sometimes)-181.3(treat)-186.9(such)-185.5(patients)]TJ ET 95.641 646.809 318.898 -0.51 re f BT /F6 1 Tf 7.9702 0 0 7.9702 95.6409 649.1337 Tm [(THE)-330.8(GUIDELINES)]TJ /F7 1 Tf 11.9551 0 0 11.9551 401.3857 649.1337 Tm (65)Tj ET endstream endobj 193 0 obj << /Type /Page /Parent 397 0 R /Resources 194 0 R /Contents 195 0 R /MediaBox [ 0 0 595 842 ] /CropBox [ 0 0 595 842 ] /Rotate 0 >> endobj 194 0 obj << /ProcSet [ /PDF /Text ] /Font << /F2 337 0 R /F5 340 0 R /F6 341 0 R /F7 342 0 R /F8 343 0 R /F10 345 0 R /F11 346 0 R >> /ExtGState << /GS1 434 0 R >> /ColorSpace << /DefaultCMYK 417 0 R /Cs6 416 0 R >> >> endobj 195 0 obj << /Length 6061 >> stream q 1 i 0.015 737.008 510.221 -737.008 re W n /Cs6 cs 0 0 0 scn /GS1 gs 0.015 709.001 25.44 -0.284 re f Q /Cs6 cs 0 0 0 scn /GS1 gs 28.006 737.008 0.283 -25.455 re f 481.89 737.008 0.283 -25.455 re f 484.724 709.001 25.512 -0.284 re f 484.724 28.346 25.512 -0.283 re f 481.89 25.512 0.283 -25.512 re f q 1 i 0.015 737.008 510.221 -737.008 re W n 28.006 25.512 0.283 -25.512 re f 0.015 28.346 25.44 -0.283 re f Q 1 1 1 scn 95.641 292.989 14.173 -2.835 re f 0 0 0 scn 95.641 313.172 318.898 -20.183 re f 1 1 1 scn 95.641 269.972 14.173 -2.835 re f 0.8 0.8 0.8 scn 95.641 290.154 318.898 -20.183 re f BT /F2 1 Tf 10.7396 0 0 10.959 95.6409 610.0723 Tm 0 0 0 scn 0 Tc 0 Tw [(with)-328.3(drugs)-328.8(or)-324.6(other)-327.6(therapies)-324.6(not)-331.4(yet)-324.2(licensed)-328.8(for)-324.2(general)-329.1(availability)]TJ 0 -1.2364 TD [(because)-252.7(studies)-248(designed)-247.8(to)-250(establish)-248.8(their)-245.4(safety)-251.7(and)-248.9(efficacy)-247.6(have)-249.2(not)]TJ T* [(been)-318.3(completed.)-310.7(This)-317.7(is)-316.3(compatible)-316.3(with)-312.5(the)-314.4(Declaration)-315.9(of)-313.3(Helsinki,)]TJ T* [(which)-421.9(states)-419.5(in)-418.5(Paragraph)-410.2(32:)]TJ /F5 1 Tf 13.5614 0 TD [(In)-422.6(the)-419.2(treatment)-416.8(of)-418.1(a)-418.5(patient,)-415(where)]TJ -13.5614 -1.2364 TD [(proven...therapeutic)-371.9(methods)-375.8(do)-372.5(not)-372.1(exist)-377.4(or)-371.4(have)-374.8(been)-374.8(ineffective,)-373.1(the)]TJ T* [(physician,)-360.3(with)-358.4(informed)-353.9(consent)-360.4(from)-355.8(the)-355.9(patient,)-356.9(must)-361.1(be)-356.3(free)-361.2(to)-354.7(use)]TJ T* [(unproven)-194.9(or)-191.9(new...)-194.8(therapeutic)-187.6(measures,)-196.3(if)-194.1(in)-190.8(the)-197.5(physicians)-191.8(judgement)-187.2(it)]TJ T* [(offers)-250.6(hope)-243.2(of)-243.9(saving)-248(life,)-246.5(re-establishing)-245.2(health)-242(or)-250(alleviating)-242.3(suffering)]TJ /F2 1 Tf 29.4243 0 TD (.)Tj -29.4243 -1.2364 TD [(Such)-256.1(treatment,)-254(commonly)-254.5(called)-257.9(compassionate)-252.2(use,)-255.6(is)-258.2(not)-257.5(properly)]TJ T* [(regarded)-221.7(as)-223.6(research,)-218.7(but)-220.6(it)-225.8(can)-221.4(contribute)-221.3(to)-218.3(ongoing)-222.5(research)-219.4(into)-219.8(the)]TJ T* [(safety)-272.8(and)-264.7(efficacy)-268.7(of)-271.1(the)-266.9(interventions)-269.9(used.)]TJ 1.3197 -1.2364 TD [(Although,)-384.1(on)-379.4(the)-383.1(whole,)-384.2(investigators)-378.4(must)-383.8(study)-380.8(less)-381.2(vulnerable)]TJ -1.3197 -1.2364 TD [(groups)-457.8(before)-455.5(involving)-452.4(those)-454.3(who)-458.5(may)-453.2(be)-457.4(more)-454(vulnerable,)-458.8(some)]TJ T* [(exceptions)-211.5(are)-208.9(justified.)-213.2(In)-208.5(general,)-212.2(children)-208.5(are)-208.9(not)-210(suitable)-211.4(for)-213.4(Phase)-208.9(I)]TJ T* [(drug)-354.8(trials)-348.6(or)-356.3(for)-350.6(Phase)-351.5(I)-348.8(o)0(r)-351(I)0(I)-354.4(vaccine)-351.1(trials,)-353.1(but)-352.5(such)-349.2(trials)-353.9(may)-347.6(be)]TJ T* [(permissible)-440(after)-440.3(studies)-438.1(in)-439.6(adults)-438.1(have)-439.3(shown)-434.7(some)-438.2(therapeutic)-438.1(or)]TJ T* [(preventive)-194.9(effect.)-191.4(For)-191.8(example,)-197.5(a)-191.5(Phase)-193.1(II)-190.8(vaccine)-192.7(trial)-195.2(seeking)-192.7(evidence)]TJ T* [(of)-176.1(immunogenicity)-167.7(in)-175.7(infants)-168.4(may)-173.4(be)-172.3(justified)-177.1(when)-169.3(a)-170.4(vaccine)-176.8(has)-167.8(shown)]TJ T* [(evidence)-168.2(of)-170.8(preventing)-169.6(or)-166.3(slowing)-168.4(progression)-165.5(of)-170.8(an)-167.4(infectious)-170.7(disease)-169.6(in)]TJ T* [(adults,)-162.8(or)-155.7(Phase)-156.2(I)-158.7(research)-161.4(with)-159.4(children)-155.7(may)-157.6(be)-156.5(appropriate)-155.3(because)-157.7(the)]TJ T* [(disease)-180.2(to)-176.1(be)-177.6(treated)-174.5(does)-180.3(not)-173.1(occur)-176.1(in)-181(adults)-174.1(or)-176.8(is)-179.1(manifested)-177.5(differently)]TJ T* [(in)-254.9(children)-245.5(\(Appendix)-248.8(3:)]TJ /F5 1 Tf 10.563 0 TD [(Phases)-246.8(of)-249.2(clinical)-250.3(trials)]TJ /F2 1 Tf 9.5494 0 TD (.\))Tj /F11 1 Tf 11.9551 0 3.5865 11.9551 214.8661 298.6015 Tm 1 1 1 scn [(Guideline)-278.6(14)]TJ 11.9551 0 0 11.9551 165.7133 275.5842 Tm 0 0 0 scn [(Resear)-8.5(ch)-270.9(involving)-278.8(children)]TJ /F8 1 Tf 10.959 0 0 10.959 95.6409 254.1543 Tm 0.0643 Tc [(Before)-671.8(underta)-4.5(k)0.7(ing)-666.4(r)-0.8(es)-4.5(earch)-671.5(in)-4.2(volving)-671.6(c)0.7(hildren)-4.2(,)-669.3(the)]TJ 0 -1.2364 TD 0 Tc [(investigator)-272.3(must)-265(ensure)-268.8(that:)]TJ /F10 1 Tf 1.2933 -1.5468 TD (7)Tj /F8 1 Tf 10.7396 0 0 10.959 123.9874 223.6535 Tm [(the)-448.8(research)-442.8(might)-445.4(not)-444.3(equally)-449.6(well)-444.9(be)-443.5(carried)-448(out)-444.3(with)]TJ 0 -1.2364 TD (adults;)Tj /F10 1 Tf 10.959 0 0 10.959 109.8142 196.3842 Tm (7)Tj /F8 1 Tf 1.2933 0 TD [(the)-601.6(purpose)-595.7(of)-594.9(the)-601.6(research)-594.3(is)-595.5(to)-600.1(obtain)-598(knowledge)]TJ 0 -1.2364 TD [(relevant)-272(to)-269(the)-270.5(health)-267.2(needs)-265.8(of)-269(children;)]TJ /F10 1 Tf -1.2933 -1.2519 TD (7)Tj /F8 1 Tf 1.2933 0 TD (a)Tj 0.9105 0 TD [(parent)-348.8(or)-356(legal)-354.1(representat)7(ive)-353.8(of)-357(each)-352.5(child)-348.7(has)-356.1(given)]TJ -0.9105 -1.2364 TD (permission;)Tj /F10 1 Tf -1.2933 -1.2571 TD (7)Tj /F8 1 Tf 1.2933 0 TD [(the)-192.9(agreement)-185.9(\(assent\))-189.9(of)-191.4(each)-192.1(child)-188.3(has)-190.6(been)-186.7(obtained)-192.1(to)]TJ 0 -1.2364 TD [(the)-270.5(extent)-267.2(of)-274.2(the)-265.4(childs)-271.6(capabilities;)-267.6(and,)]TJ /F10 1 Tf -1.2933 -1.2519 TD (7)Tj /F8 1 Tf 1.2933 0 TD (a)Tj 0.7915 0 TD [(childs)-230.3(refusal)-234.2(to)-238(participate)-229.6(or)-237.1(continue)-233.5(in)-233.1(the)-234.3(research)]TJ -0.7915 -1.2364 TD [(will)-272(be)-271.8(respected.)]TJ ET 95.641 646.809 318.898 -0.51 re f BT /F6 1 Tf 7.9702 0 0 7.9702 191.1118 649.1337 Tm [(INTERNA)13.4(TIONAL)-327.4(ETHICAL)-327.5(GUIDELINES)-319.8(FOR)-332.5(BIOMED)13.7(ICAL)-331.1(RESEARCH)]TJ /F7 1 Tf 11.9551 0 0 11.9551 95.6409 649.1337 Tm (66)Tj ET endstream endobj 196 0 obj << /Type /Page /Parent 397 0 R /Resources 197 0 R /Contents 198 0 R /MediaBox [ 0 0 595 842 ] /CropBox [ 0 0 595 842 ] /Rotate 0 >> endobj 197 0 obj << /ProcSet [ /PDF /Text ] /Font << /F2 337 0 R /F5 340 0 R /F6 341 0 R /F7 342 0 R /F8 343 0 R >> /ExtGState << /GS1 434 0 R >> /ColorSpace << /DefaultCMYK 417 0 R /Cs6 416 0 R >> >> endobj 198 0 obj << /Length 6482 >> stream q 1 i 0.015 737.008 510.221 -737.008 re W n /Cs6 cs 0 0 0 scn /GS1 gs 0.015 709.001 25.44 -0.284 re f Q /Cs6 cs 0 0 0 scn /GS1 gs 28.006 737.008 0.283 -25.455 re f 481.89 737.008 0.283 -25.455 re f 484.724 709.001 25.512 -0.284 re f 484.724 28.346 25.512 -0.283 re f 481.89 25.512 0.283 -25.512 re f q 1 i 0.015 737.008 510.221 -737.008 re W n 28.006 25.512 0.283 -25.512 re f 0.015 28.346 25.44 -0.283 re f Q BT /F8 1 Tf 9.9626 0 2.9888 9.9626 95.6409 609.8455 Tm 0 Tc 0 Tw [(Comm)-9.3(ent)-7.2(ary)-269.4(on)-277.2(Guidelin)-10.9(e)-267.4(1)0(4)]TJ /F5 1 Tf 10.959 0 0 10.959 95.6409 591.4203 Tm [(Justification)-249.2(of)-248.2(the)-245.8(involvement)-251.2(of)-248.2(children)-244.7(in)-249.1(biomedical)-248.5(research.)]TJ /F2 1 Tf 27.4489 0 TD (The)Tj -27.4489 -1.2622 TD [(participation)-241.5(of)-237.6(children)-238.7(is)-245.1(indispensable)-235.2(for)-240.6(research)-237.8(into)-243.3(diseases)-239.2(of)]TJ 0 -1.2571 TD 0.0286 Tc (ch)Tj 1.0398 0 TD 0.0236 Tc [(ildhoo)-3.8(d)-624.6(a)1.1(n)-3.8(d)-624.6(con)-3.8(d)1.4(itions)-631.2(to)-624.6(which)-624.6(c)0.2(h)-3.8(ildren)-624.6(a)-4.1(re)-625.8(par)-5.3(t)-0.3(icularly)]TJ -1.0398 -1.2571 TD 0 Tc [(susceptible)-371.8(\(cf.)-375.5(vaccine)-369.3(trials\),)-373.5(as)-372.1(well)-374.3(as)-372.1(for)-369.9(clinical)-377.3(trials)-371.2(of)-372.1(drugs)]TJ 0 -1.2623 TD [(that)-227.1(are)-230(designed)-220.8(for)-230.2(children)-223.2(as)-227.2(well)-229.4(as)-227.2(adults.)-226.4(In)-227(the)-224.8(past,)-225.9(many)-228.1(new)]TJ 0 -1.2571 TD [(products)-499.2(were)-501(not)-497.8(tested)-502.8(for)-499.2(children)-497.3(though)-497.5(they)-500.8(were)-501(directed)]TJ 0 -1.2622 TD [(towards)-237.6(diseases)-228.9(also)-238.1(occurring)-229(in)-238.5(childhood;)-231.4(thus)-231.8(children)-233.5(either)-234.7(did)]TJ 0 -1.2571 TD [(not)-177(benefit)-179.6(from)-173.9(these)-178.8(new)-176(drugs)-176.4(or)-180.4(were)-175.1(exposed)-175.2(to)-175.5(them)-178.8(though)-176.7(little)]TJ T* [(was)-249(known)-245.2(about)-247.6(their)-247.5(specific)-246.8(effects)-248.6(or)-247.7(safety)-243.5(in)-248.8(children.)-248(Now)-246.3(it)-250.6(is)]TJ 0 -1.2623 TD [(widely)-579.4(agreed)-577.5(that,)-577.9(as)-573.8(a)-581.2(general)-576.5(rule,)-574.3(the)-576.6(sponsor)-579(of)-573.8(any)-579.4(new)]TJ 0 -1.2571 TD [(therapeutic,)-492.9(diagnostic)-496.3(or)-490.8(preventive)-496.1(product)-491.1(that)-491(is)-498.6(likely)-494.5(to)-491.1(be)]TJ T* [(indicated)-458(for)-452.7(use)-452.1(in)-455.8(children)-456(is)-452.1(obliged)-457.2(to)-454.9(evaluate)-449.2(its)-455.3(safety)-455.6(and)]TJ 0 -1.2623 TD [(efficacy)-270.8(for)-271.6(children)-264.6(before)-268.3(it)-271.3(is)-271(released)-270(for)-266.4(general)-271.3(distribution.)]TJ /F5 1 Tf 0 -2.3693 TD [(Assent)-387.3(of)-382.7(the)-385.4(child.)]TJ /F2 1 Tf 8.6495 0 TD [(The)-383.2(willing)-383.3(cooperation)-382.3(of)-387.6(the)-380(child)-386.6(should)-380.6(be)]TJ -8.6495 -1.2467 TD [(sought,)-223.8(after)-221(the)-224.8(child)-226.3(has)-218.4(been)-225.8(informed)-220.1(to)-222.1(the)-224.8(extent)-222.2(that)-222(the)-224.8(childs)]TJ T* [(maturity)-334.9(and)-325.6(intelligence)-335.8(permit.)-329.8(The)-331.5(age)-332.2(at)-331(which)-331.8(a)-327.7(child)-334.9(becomes)]TJ T* [(legally)-543.2(competent)-542.3(to)-542.8(give)-538.2(consent)-544(differs)-538.3(substantially)-542(from)-541.2(one)]TJ 0 -1.2416 TD 0.0139 Tc [(ju)7.2(r)5.7(i)4.5(sd)7.2(i)4.5(c)0.8(t)5.5(i)4.6(o)7.2(n)]TJ 5.556 0 TD 0.0106 Tc [(to)-611.7(an)3.9(oth)3.9(e)-2.5(r;)-609.2(in)-606.5(so)3.9(me)-612.9(co)3.9(un)3.9(tries)-613.2(t)2.2(h)3.9(e)-612.9(age)-612.9(o)3.9(f)-613.4(c)2.7(on)3.9(sen)3.9(t)]TJ -5.556 -1.2467 TD 0 Tc [(established)-583(in)-579.9(their)-578.6(different)-579(provinces,)-579.7(states)-575.7(or)-578.8(other)-581.1(political)]TJ T* [(subdivisions)-419(varies)-420(considerab)7.5(ly.)-424(Often)-415.1(children)-419.7(who)-418(have)-416.5(not)-415(yet)]TJ T* [(reached)-435.1(the)-431.7(legally)-429.4(established)-433(age)-430.5(of)-429(consent)-430.2(can)-430.3(understand)-430.1(the)]TJ 0 -1.2416 TD [(implications)-555.2(of)-558.3(informed)-551.1(consent)-554.3(and)-553.2(go)-556.9(through)-547(the)-555.9(necessary)]TJ 0 -1.2467 TD [(procedures;)-317.2(they)-314.5(can)-316.5(therefore)-313.5(knowingly)-314.1(agree)-317.3(to)-315.2(serve)-318.5(as)-315.2(research)]TJ T* [(subjects.)-217.5(Such)-214.3(knowing)-215(agreement,)-215.7(sometimes)-212.9(referred)-213.4(to)-216.9(as)-216.9(assent,)-216.1(is)]TJ T* [(insufficient)-438.9(to)-434.2(permit)-439.4(participation)-432.9(in)-435.1(research)-439.5(unless)-435(it)-436.8(is)-436.5(supple-)]TJ 0 -1.2416 TD [(mented)-271(by)-267.2(the)-266.2(permission)-268.4(of)-268.6(a)-270.8(parent,)-266.3(a)-265.6(legal)-268.2(guardian)-265.5(or)-268.4(other)-270.7(duly)]TJ 0 -1.2467 TD [(authorized)-267(representative.)]TJ 1.2933 -1.2778 TD [(Some)-306.4(children)-305.9(who)-309.4(are)-302.4(too)-306.4(immature)-307.3(to)-304.8(be)-309.5(able)-305.1(to)-304.8(give)-310.6(knowing)]TJ -1.2933 -1.2467 TD [(agreement,)-262.3(or)-258(assent,)-262.6(may)-257.6(be)-262.9(able)-258.6(to)-263.4(register)-261.6(a)-260.5(deliberate)-259.5(objection,)]TJ 0 -1.2416 TD [(an)-236.1(expression)-231.9(of)-232.4(disapproval)-232.8(or)-232.1(refusal)-231.6(of)-232.4(a)-234.6(proposed)-233.7(procedure.)-231.4(The)]TJ 0 -1.2467 TD 0.0151 Tc [(deliberate)-618.7(o)3.2(b)3.2(j)0.6(ection)]TJ 9.6428 0 TD 0.0128 Tc [(of)-621.6(an)-619.9(old)-4.2(e)-0.3(r)-621.3(c)-0.3(hil)-6.9(d)0.9(,)-622.5(f)-0.8(or)-621.3(exa)-4.5(m)1.9(p)-4.3(l)-1.7(e,)-622.5(is)-621.3(to)-619.9(be)]TJ -9.6428 -1.2467 TD 0 Tc [(distinguished)-370.3(from)-365.3(the)-369.6(behaviour)-366.3(of)-366.9(an)-370.6(infant,)-366.4(who)-366.3(is)-369.3(likely)-370.4(to)-366.9(cry)]TJ T* [(or)-258(withdraw)-250.3(in)-254(response)-251.8(to)-253.1(almost)-252.3(any)-253.5(stimulus.)-253(Older)-255.4(children,)-253.2(who)]TJ 0 -1.2416 TD [(are)-271.3(more)-266.5(capable)-269.8(of)-268.6(giving)-268.8(assent,)-267.8(should)-266.8(be)-268.1(selected)-271.2(before)-268.3(younger)]TJ 0 -1.2467 TD [(children)-269.7(or)-263.2(infants,)-265.9(unless)-264.3(there)-266.7(are)-266.2(valid)-267(scientific)-264.6(reasons)-264.9(related)-267.5(to)]TJ T* [(age)-270.2(for)-271.6(involving)-265.7(younger)-267.4(children)-269.7(first.)]TJ ET 95.641 646.809 318.898 -0.51 re f BT /F6 1 Tf 7.9702 0 0 7.9702 95.6409 649.1337 Tm [(THE)-330.8(GUIDELINES)]TJ /F7 1 Tf 11.9551 0 0 11.9551 401.3857 649.1337 Tm (67)Tj ET endstream endobj 199 0 obj << /Type /Page /Parent 397 0 R /Resources 200 0 R /Contents 201 0 R /MediaBox [ 0 0 595 842 ] /CropBox [ 0 0 595 842 ] /Rotate 0 >> endobj 200 0 obj << /ProcSet [ /PDF /Text ] /Font << /F2 337 0 R /F5 340 0 R /F6 341 0 R /F7 342 0 R >> /ExtGState << /GS1 434 0 R >> /ColorSpace << /DefaultCMYK 417 0 R /Cs6 416 0 R >> >> endobj 201 0 obj << /Length 6264 >> stream q 1 i 0.015 737.008 510.221 -737.008 re W n /Cs6 cs 0 0 0 scn /GS1 gs 0.015 709.001 25.44 -0.284 re f Q /Cs6 cs 0 0 0 scn /GS1 gs 28.006 737.008 0.283 -25.455 re f 481.89 737.008 0.283 -25.455 re f 484.724 709.001 25.512 -0.284 re f 484.724 28.346 25.512 -0.283 re f 481.89 25.512 0.283 -25.512 re f q 1 i 0.015 737.008 510.221 -737.008 re W n 28.006 25.512 0.283 -25.512 re f 0.015 28.346 25.44 -0.283 re f Q BT /F2 1 Tf 10.959 0 0 10.959 109.8142 609.8455 Tm 0 Tc 0 Tw (A)Tj 1.0191 0 TD [(deliberate)-244.9(objection)-245.7(by)-246.5(a)-250.1(child)-246.9(to)-247.9(taking)-241.7(part)-247.6(in)-248.8(research)-248.1(should)]TJ -2.3124 -1.2623 TD [(always)-262(be)-257.7(respected)-256(even)-257.1(if)-260.9(the)-255.8(parents)-260(have)-256.2(given)-260.4(permission)5.8(,)-262.8(unless)]TJ 0 -1.2571 TD [(the)-292(child)-288.3(needs)-285.7(treatment)-285.9(that)-289.2(is)-286.5(not)-285.7(available)-287.9(outside)-286.8(the)-286.9(context)-291(of)]TJ 0 -1.2623 TD [(research,)-236.8(the)-235.1(investigation)6.6(al)-238.8(intervention)-233(shows)-232.6(promise)-233.8(of)-232.4(therapeu-)]TJ 0 -1.2571 TD [(tic)-320.6(benefit,)-323.5(and)-315.3(there)-318.5(is)-322.7(no)-318.6(acceptable)-314.7(alternative)-320(therapy.)-314.7(In)-320.1(such)-319.2(a)]TJ T* [(case,)-288.6(particularly)-291.7(if)-286.8(the)-286.9(child)-288.3(is)-291.7(very)-288.7(young)-282.4(or)-289(immature,)-285.6(a)-291.5(parent)-288(or)]TJ 0 -1.2623 TD [(guardian)-244.8(may)-247.3(override)-242.9(the)-250.7(childs)-243.8(objections.)-247.7(If)-244.2(the)-245.5(child)-247(is)-250.3(older)-245.8(and)]TJ 0 -1.2571 TD [(more)-390.6(nearly)-382.3(capable)-383.6(of)-387.6(independent)-381.8(informed)-385.6(consent,)-382.6(the)-385.2(investi-)]TJ T* [(gator)-311.4(should)-303(seek)-310(the)-307.6(specific)-308.9(approval)-306.9(or)-309.7(clearance)-307.7(of)-304.8(the)-312.7(scientific)]TJ 0 -1.2623 TD [(and)-367(ethical)-367(review)-367.3(committees)-365.9(for)-369.9(initiating)-366.2(or)-366.6(continuing)-365.3(with)-367(the)]TJ 0 -1.2571 TD 0.0122 Tc [(investigational)-612.8(t)-1.4(reatment.)-612.8(I)-1.1(f)-617(c)]TJ 13.9624 0 TD [(hild)-610.1(subjects)-616.7(become)-616.5(capable)-616.5(o)0.3(f)]TJ -13.9624 -1.2623 TD 0 Tc [(independent)-418(informed)-416.6(consent)-419.8(during)-417.1(the)-416.2(research,)-417.8(their)-418.2(informed)]TJ 0 -1.2571 TD [(cons)-8.8(ent)-607.6(to)-610.1(conti)-8.1(nued)-607.4(par)-6.3(tici)-9.2(patio)-7.1(n)-601.6(sho)-6.1(uld)-607.3(be)-609.5(sou)-6.1(ght)-606.7(and)-610.1(their)]TJ T* [(decision)-269.7(respected.)]TJ 1.2933 -1.3192 TD (A)Tj 1.1433 0 TD [(child)-371.1(with)-367(a)-369.1(likely)-370.4(fatal)-371.3(illness)-369.4(may)-366.3(object)-372.9(or)-366.6(refuse)-368(assent)-372.3(to)]TJ -2.4366 -1.2571 TD [(continuation)-416.6(of)-418.6(a)-420.8(burdensome)-412.8(or)-418.4(distressing)-419.2(intervention.)-413.1(In)-418.4(such)]TJ 0 -1.2623 TD [(circumstances)-384.5(parents)-379(may)-381.8(press)-380.5(an)-381(investigator)-383.9(to)-382.4(persist)-377.6(with)-382.5(an)]TJ 0 -1.2571 TD [(investigational)-408.1(intervention)-408.9(against)-405.4(the)-405.9(childs)-409.3(wishes.)-407.7(The)-409.1(investi-)]TJ 0 -1.2623 TD [(gator)-533.9(may)-531.8(agree)-529.4(to)-532.5(do)-530.7(so)-532.2(if)-535.1(the)-530(intervention)-527.9(shows)-532.6(promise)-533.8(of)]TJ 0 -1.2571 TD [(preserving)-366.7(or)-366.6(prolonging)-364.1(life)-366.1(and)-361.8(there)-370.2(is)-364.1(no)-365.2(acceptable)-366.5(alternative)]TJ T* [(treatment.)-445.3(In)-439.1(such)-438.2(cases,)-441.6(the)-442.1(investigator)-440.8(should)-437.5(seek)-439.4(the)-442.1(specific)]TJ 0 -1.2623 TD [(approval)-213.8(or)-216.6(clearance)-209.5(of)-216.9(the)-214.4(ethical)-217(review)-212.1(committee)-212.9(before)-216.5(agreeing)]TJ 0 -1.2571 TD [(to)-273.8(override)-268.8(the)-266.2(wishes)-269(of)-268.6(the)-271.3(child.)]TJ /F5 1 Tf 0 -2.4107 TD [(Permission)-289.7(of)-289.6(a)-291.5(parent)-288.6(or)-289.3(guardian.)]TJ /F2 1 Tf 15.1005 0 TD [(The)-290.1(investigator)-290.7(must)-287.7(obtain)-288(the)]TJ -15.1005 -1.2571 TD [(permission)-299.4(of)-299.7(a)-296.7(parent)-298.4(or)-299.4(guardian)-291.4(in)-300.6(accordance)-296.3(with)-299.8(local)-299(laws)-294.6(or)]TJ T* [(established)-251.9(procedures.)-249.9(It)-254.6(may)-252.5(be)-252.6(assumed)-252.1(that)-247.8(children)-254.2(over)-252.2(the)-250.7(age)]TJ 0 -1.2623 TD [(of)-522.1(12)-520.9(or)-516.7(13)-520.9(years)-519.3(are)-519.7(usually)-514.7(capable)-518.1(of)-522.1(understanding)-515.3(what)-519.8(is)]TJ 0 -1.2571 TD [(necessary)-472.4(to)-475.5(give)-470.9(adequately)-467.8(informed)-473.6(consent,)-470.6(but)-471.9(their)-475.1(consent)]TJ 0 -1.2623 TD [(\(assent\))-399.5(should)-396.1(normally)-396.2(be)-397.4(complemented)-392.9(by)-396.5(the)-395.5(permission)-397.7(of)-397.9(a)]TJ 0 -1.2571 TD [(parent)-531.2(or)-532.2(guardian,)-533.5(even)-531.3(when)-529.4(local)-531.7(law)-534.7(does)-531.3(not)-528.8(require)-530.8(such)]TJ T* 0.0176 Tc [(permission.)-617.7(Eve)4.5(n)-620.2(when)-615.1(the)-616.2(l)-2.1(a)5.5(w)-619.8(req)5.7(u)0.6(ir)4.3(es)-616.5(pare)4.5(ntal)-617.7(pe)4.5(rmis)4.3(sion,)]TJ 0 -1.2623 TD 0 Tc [(however,)-272.1(the)-266.2(assent)-268.8(of)-268.6(the)-271.3(child)-267.6(must)-272.2(be)-268.1(obtained.)]TJ 1.2933 -1.314 TD [(In)-252.8(some)-250.9(jurisdictions,)-248.9(some)-250.9(individuals)-246.8(who)-247.3(are)-250.7(below)-249(the)-250.7(general)]TJ -1.2933 -1.2623 TD [(age)-347.8(of)-341(consent)-342.2(are)-343.8(regarded)-344(as)-341(emancipated)-346.3(or)-340.8(mature)-345.2(minors)]TJ 0 -1.2571 TD [(and)-429.1(are)-426.5(authorized)-422.2(to)-423.8(consent)-425(without)-425.1(the)-426.5(agreement)-423.6(or)-428.7(even)-422.6(the)]TJ 0 -1.2623 TD [(awareness)-413.8(of)-413.5(their)-418.2(parents)-410(or)-418.4(guardians.)-412.4(They)-410.9(may)-412.8(be)-418.1(married)-415.1(or)]TJ 0 -1.2571 TD [(pregnant)-643.2(or)-646(be)-645.7(already)-642.8(parents)-642.8(or)-640.8(living)-648.8(independentl)7.2(y.)-647.5(Some)]TJ ET 95.641 646.809 318.898 -0.51 re f BT /F6 1 Tf 7.9702 0 0 7.9702 191.1118 649.1337 Tm [(INTERNA)13.4(TIONAL)-327.4(ETHICAL)-327.5(GUIDELINES)-319.8(FOR)-332.5(BIOMED)13.7(ICAL)-331.1(RESEARCH)]TJ /F7 1 Tf 11.9551 0 0 11.9551 95.6409 649.1337 Tm (68)Tj ET endstream endobj 202 0 obj << /Type /Page /Parent 397 0 R /Resources 203 0 R /Contents 204 0 R /MediaBox [ 0 0 595 842 ] /CropBox [ 0 0 595 842 ] /Rotate 0 >> endobj 203 0 obj << /ProcSet [ /PDF /Text ] /Font << /F2 337 0 R /F5 340 0 R /F6 341 0 R /F7 342 0 R >> /ExtGState << /GS1 434 0 R >> /ColorSpace << /DefaultCMYK 417 0 R /Cs6 416 0 R >> >> endobj 204 0 obj << /Length 5329 >> stream q 1 i 0.015 737.008 510.221 -737.008 re W n /Cs6 cs 0 0 0 scn /GS1 gs 0.015 709.001 25.44 -0.284 re f Q /Cs6 cs 0 0 0 scn /GS1 gs 28.006 737.008 0.283 -25.455 re f 481.89 737.008 0.283 -25.455 re f 484.724 709.001 25.512 -0.284 re f 484.724 28.346 25.512 -0.283 re f 481.89 25.512 0.283 -25.512 re f q 1 i 0.015 737.008 510.221 -737.008 re W n 28.006 25.512 0.283 -25.512 re f 0.015 28.346 25.44 -0.283 re f Q BT /F2 1 Tf 10.959 0 0 10.959 95.6409 609.8455 Tm 0 Tc 0 Tw [(studies)-443.4(involve)-436.8(investigation)-438.3(of)-439.3(adolescents)-435.7(beliefs)-440.6(and)-439.4(behaviour)]TJ 0 -1.2623 TD [(regarding)-574.9(sexuality)-577.8(or)-573.6(use)-576.3(of)-573.8(recreational)-575.7(drugs;)-573.7(other)-575.9(research)]TJ 0 -1.2571 TD [(addresses)-487.9(domestic)-479.9(violence)-487(or)-485.6(child)-484.9(abuse.)-485.5(For)-481.8(studies)-484.8(on)-484.2(these)]TJ 0 -1.2623 TD [(topics,)-336(ethical)-336(review)-331.1(committees)-334.9(may)-335.2(waive)-332.3(parental)-330.2(permission)-335.6(if,)]TJ 0 -1.2571 TD [(for)-266.4(example,)-262.6(parental)-257.8(knowledge)-261.8(of)-263.5(the)-261(subject)-262.1(matter)-262.9(may)-262.8(place)-261.3(the)]TJ T* [(adolescents)-266(at)-263.7(some)-261.3(risk)-265.2(of)-263.5(questioning)-259.6(or)-263.2(even)-267.4(intimidation)-259.4(by)-262(their)]TJ 0 -1.2623 TD (parents.)Tj 1.2933 -1.2571 TD [(Because)-243.5(of)-237.6(the)-240.3(issues)-239.9(inherent)-237.8(in)-238.5(obtaining)-238.7(assent)-237.8(from)-241.1(children)-238.7(in)]TJ -1.2933 -1.2571 TD [(institutions,)-390.4(such)-386.4(children)-383.5(should)-385.8(only)-386.7(exceptionally)-385.8(be)-387.1(subjects)-389.2(of)]TJ 0 -1.2623 TD [(research.)-273(In)-268.4(the)-271.3(case)-268.9(of)-268.6(institutionalized)-271.1(children)-269.7(without)-269.9(parents,)-264.2(or)]TJ 0 -1.2571 TD [(whose)-434.1(parents)-430.7(are)-431.7(not)-430.5(legally)-429.4(authorized)-432.5(to)-429(grant)-430.4(permission,)-432.9(the)]TJ 0 -1.2623 TD [(ethical)-413.6(review)-413.8(committee)-414.7(may)-412.8(require)-411.9(sponsors)-411.3(or)-413.2(investigators)-412.7(to)]TJ 0 -1.2571 TD [(provide)-456(it)-452.3(with)-449.8(the)-452.4(opinion)-455.8(of)-449.7(an)-453.4(independent,)-448(concerned,)-453.6(expert)]TJ T* -0.0001 Tc [(advocate)-327.7(for)-328.6(institutionalized)-332.7(children)-326.7(as)-325.6(to)-330.8(the)-323.2(propriety)-327.9(of)-330.8(under-)]TJ 0 -1.2622 TD 0 Tc [(taking)-272.8(the)-266.2(research)-268.8(with)-268.7(such)-267.4(children.)]TJ /F5 1 Tf 0 -2.3486 TD [(Observation)-233.8(of)-232.7(research)-227.7(by)-231.2(a)-234.6(parent)-231.7(or)-232.4(guardian.)]TJ /F2 1 Tf 20.134 0 TD (A)Tj 1.0036 0 TD [(parent)-231.1(or)-232.1(guardian)]TJ -21.1376 -1.2571 TD [(who)-283.5(gives)-277.3(permission)-278.7(for)-282(a)-281.1(child)-278(to)-284.1(participate)-278.3(in)-279.9(research)-279.1(should)-277.1(be)]TJ 0 -1.2623 TD [(given)-234.5(the)-235.1(opportunity,)-230.7(to)-232.4(a)-234.6(reasonable)-230.8(extent,)-231.6(to)-232.4(observe)-233.6(the)-235.1(research)]TJ 0 -1.2571 TD [(as)-284.1(it)-281.6(proceeds,)-281.6(so)-278.7(as)-279(to)-284.1(be)-278.4(able)-284.4(to)-279(withdraw)-281.3(the)-281.7(child)-278(if)-281.6(the)-281.7(parent)-282.9(or)]TJ 0 -1.2623 TD [(guardian)-270.7(decides)-266.7(it)-271.3(is)-271(in)-269.5(the)-266.2(childs)-274.8(best)-269.2(interests)-264.6(to)-273.8(do)-266.9(so.)]TJ /F5 1 Tf 0 -2.3486 TD 0.0074 Tc [(Psyc)7.4(hol)7.4(o)-3.8(gi)7.4(c)-4.7(a)0.4(l)-607.2(a)0.4(n)7.4(d)]TJ 8.5513 0 TD 0 Tc [(me)-13.9(di)-11.2(ca)-9.7(l)-614.6(s)-8.2(u)-7(p)0(p)-8.8(o)-7(rt)-11.4(.)]TJ /F2 1 Tf 7.8632 0 TD [(Re)-13.9(s)-8.2(e)0(a)-9.7(r)-8.2(ch)-619.9(in)-10.9(v)-7(o)-6.7(lv)-11.2(in)-10.9(g)-612.2(c)-7.9(h)-6.7(i)0(l)-13.5(d)-6.7(re)-10.9(n)]TJ -16.4145 -1.2571 TD [(should)-401.3(be)-397.4(conducted)-396.8(in)-404(settings)-395.2(in)-398.9(which)-399(the)-400.7(child)-402.1(and)-398(the)-400.7(parent)]TJ 0 -1.2623 TD [(can)-569.9(obtain)-567.4(adequate)-565.3(medical)-566.1(and)-568.7(psychologica)7.8(l)-573.2(support.)-562.8(As)-567.7(an)]TJ 0 -1.2571 TD 0.0119 Tc [(additional)-613.1(p)0(rotection)-615.6(f)-1.7(or)-611.9(children,)-618.2(a)-0.2(n)-615.6(i)2.6(nvestigator)-617(m)1(ay,)-613.1(when)]TJ T* 0 Tc [(possible,)-222.4(obtain)-220.8(the)-219.6(advice)-221.7(of)-222.1(a)-224.2(childs)-217.9(family)-222.7(physician,)-223.1(paediatrician)]TJ 0 -1.2623 TD [(or)-568.4(other)-560.4(health-care)-561.4(provider)-562.5(on)-566.9(matters)-560.8(concerning)-561.3(the)-566.2(childs)]TJ 0 -1.2571 TD [(participation)-267.3(in)-274.7(the)-266.2(research.)]TJ 0 -2.3486 TD [(\(See)-543.1(also)-543.3(Guidelines)-543.5(8:)]TJ /F5 1 Tf 10.9568 0 TD [(Benefits)-544.8(and)-538.2(risks)-542.7(of)-543.1(study)-544.5(participation)]TJ /F2 1 Tf 17.8733 0 TD (;)Tj -28.8301 -1.2623 TD (9:)Tj /F5 1 Tf 1.1071 0 TD [(Special)-313.6(limitations)-317(on)-319.2(risks)-315(when)-318.1(subjects)-312.2(are)-317.9(not)-317.3(capable)-316.9(of)-315.4(giving)]TJ -1.1071 -1.2571 TD (consent)Tj /F2 1 Tf 3.0936 0 TD (;)Tj 0.538 0 TD [(and)-268.7(13:)]TJ /F5 1 Tf 3.4143 0 TD [(Research)-267.2(involving)-268.3(vulnerable)-269.9(persons)]TJ /F2 1 Tf 15.6126 0 TD (.\))Tj ET 95.641 646.809 318.898 -0.51 re f BT /F6 1 Tf 7.9702 0 0 7.9702 95.6409 649.1337 Tm [(THE)-330.8(GUIDELINES)]TJ /F7 1 Tf 11.9551 0 0 11.9551 401.3857 649.1337 Tm (69)Tj ET endstream endobj 205 0 obj << /Type /Page /Parent 397 0 R /Resources 206 0 R /Contents 207 0 R /MediaBox [ 0 0 595 842 ] /CropBox [ 0 0 595 842 ] /Rotate 0 >> endobj 206 0 obj << /ProcSet [ /PDF /Text ] /Font << /F2 337 0 R /F5 340 0 R /F6 341 0 R /F7 342 0 R /F8 343 0 R /F10 345 0 R /F11 346 0 R >> /ExtGState << /GS1 434 0 R >> /ColorSpace << /DefaultCMYK 417 0 R /Cs6 416 0 R >> >> endobj 207 0 obj << /Length 5236 >> stream q 1 i 0.015 737.008 510.221 -737.008 re W n /Cs6 cs 0 0 0 scn /GS1 gs 0.015 709.001 25.44 -0.284 re f Q /Cs6 cs 0 0 0 scn /GS1 gs 28.006 737.008 0.283 -25.455 re f 481.89 737.008 0.283 -25.455 re f 484.724 709.001 25.512 -0.284 re f 484.724 28.346 25.512 -0.283 re f 481.89 25.512 0.283 -25.512 re f q 1 i 0.015 737.008 510.221 -737.008 re W n 28.006 25.512 0.283 -25.512 re f 0.015 28.346 25.44 -0.283 re f Q 1 1 1 scn 95.641 603.439 14.173 -2.835 re f 0 0 0 scn 95.641 623.622 318.898 -20.183 re f 1 1 1 scn 95.641 539.036 14.173 -2.835 re f 0.8 0.8 0.8 scn 95.641 600.605 318.898 -61.568 re f BT /F11 1 Tf 11.9551 0 3.5865 11.9551 214.8661 608.9951 Tm 1 1 1 scn 0 Tc 0 Tw [(Guideline)-278.6(15)]TJ 11.9551 0 0 11.9551 142.0724 585.9778 Tm 0 0 0 scn [(Research)-274.6(involvin)-10.6(g)-268.2(indivi)-9.7(duals)-272.2(who)]TJ 0.1517 -1.1523 TD [(by)-271.2(reason)-273.7(of)-272.1(mental)-278.6(or)-267.5(behav)-8.9(ioural)]TJ 2.428 -1.1523 TD [(disorders)-276.5(are)-274.9(not)-270.1(capable)]TJ -3.4286 -1.1571 TD [(of)-272.1(giving)-272.7(adequ)-8.5(ately)-273.6(informed)-275.6(consent)]TJ /F8 1 Tf 10.959 0 0 10.959 95.6409 522.992 Tm [(Before)-596.9(undertaking)-591.1(research)-594.3(involving)-594.9(individuals)-595.5(who)-593.1(by)]TJ 0 -1.2571 TD [(reason)-341.2(of)-341.4(mental)-343.1(or)-340.5(behavioural)-338.1(disorders)-339.3(are)-342.3(not)-337.5(capable)-343.9(of)]TJ T* [(giving)-556.9(adequately)-552.4(informed)-548.9(consent,)-554.5(the)-555.1(investigator)-551.6(must)]TJ 0 -1.2623 TD [(ensure)-268.8(that:)]TJ /F10 1 Tf 1.2933 -1.7434 TD (7)Tj /F8 1 Tf 1.2933 0 TD [(such)-285(persons)-275.2(will)-287.5(not)-280.6(be)-282.2(subjects)-280.6(of)-279.4(research)-278.8(that)-284.8(might)]TJ 0 -1.2623 TD [(equally)-248.3(well)-253.8(be)-245.9(carried)-248.8(out)-249.6(on)-250.8(persons)-244.2(whose)-249.6(capacity)-249.8(to)]TJ 0 -1.2571 TD [(give)-272.4(adequately)-262.7(informed)-269.5(consent)-265.8(is)-269.5(not)-270.3(impaired;)]TJ /F10 1 Tf -1.2933 -1.2571 TD (7)Tj /F8 1 Tf 1.2933 0 TD [(the)-601.6(purpose)-595.7(of)-594.9(the)-601.6(research)-594.3(is)-595.5(to)-600.1(obtain)-598(knowledge)]TJ 0 -1.2623 TD [(relevant)-416.8(to)-413.9(the)-415.4(particular)-413.4(health)-412(needs)-415.8(of)-413.9(persons)-409.7(with)]TJ 0 -1.2571 TD [(mental)-270.7(or)-268.1(behavioural)-265.7(disorders;)]TJ /F10 1 Tf -1.2933 -1.2623 TD (7)Tj /F8 1 Tf 1.2933 0 TD [(the)-456.8(consent)-446.9(of)-455.2(each)-450.8(subject)-455(has)-449.2(been)-450.5(obtained)-450.8(to)-455.2(the)]TJ 0 -1.2571 TD [(extent)-468.9(of)-465.6(that)-471(persons)-460.5(capabilities,)-464.4(and)-469.7(a)-467.1(prospective)]TJ T* [(subjects)-574.5(refusal)-570.5(to)-579.4(participate)-571(in)-574.5(research)-568.5(is)-574.8(always)]TJ 0 -1.2623 TD [(respected,)-238.6(unless,)-232.8(in)-243.4(exception)7.8(al)-238.5(circumstances,)-235.1(there)-238.9(is)]TJ 0 -1.2571 TD [(no)-328.4(reasonable)-329.1(medical)-324.3(alternative)-328.2(and)-324.8(local)-328.3(law)-332.4(permits)]TJ T* [(overriding)-270.8(the)-270.5(objection;)-267.5(and,)]TJ /F10 1 Tf -1.2933 -1.2623 TD (7)Tj /F8 1 Tf 1.2933 0 TD [(in)-527.9(cases)-519.8(where)-520.3(prospective)-519.2(subjects)-523.7(lack)-520.9(capacity)-524(to)]TJ 0 -1.2571 TD 0.0076 Tc [(consent,)-607(perm)7.6(i)-6.6(ssi)7.6(on)-609.3(is)-609.5(obt)7.6(ained)-609.3(f)7.6(r)-4.5(o)1.2(m)-607.6(a)-609.5(responsi)7.6(b)-3(le)]TJ 0 -1.2623 TD 0 Tc [(family)-371.9(member)-363.5(or)-366.4(a)-368.8(legally)-365(authorized)-362.5(representative)-367.5(in)]TJ 0 -1.2571 TD [(accordance)-264.3(with)-274(applicable)-265.6(law.)]TJ 9.9626 0 2.9888 9.9626 95.6409 214.2991 Tm [(Comm)-9.3(ent)-7.2(ary)-269.4(on)-277.2(Guidelin)-10.9(e)-267.4(1)0(5)]TJ /F5 1 Tf 10.959 0 0 10.959 95.6409 196.2141 Tm [(General)-281.1(considerations.)]TJ /F2 1 Tf 9.979 0 TD [(Most)-281.1(individuals)-277.8(with)-279.1(mental)-283.1(or)-278.7(behavioural)]TJ -9.979 -1.2571 TD [(disorders)-375.3(are)-374.8(capable)-373.3(of)-377.3(giving)-372.3(informed)-375.3(consent;)-372.3(this)-379.3(Guideline)-374.9(is)]TJ 0 -1.2623 TD [(concerned)-263.2(only)-262.5(with)-263.5(those)-265.5(who)-257.6(are)-266.2(not)-259.8(capable)-264.6(or)-263.2(who)-262.8(because)-259.2(their)]TJ 0 -1.2571 TD [(condition)-404.8(deteriorates)-405.2(become)-405(temporarily)-405.2(incapable.)-403.9(They)-400.6(should)]TJ 0 -1.2623 TD [(never)-218.7(be)-211.2(subjects)-218.5(of)-211.7(research)-217.1(that)-211.6(might)-218.3(equally)-214.3(well)-213.9(be)-216.4(carried)-215.5(out)-213.3(on)]TJ 0 -1.2571 TD [(persons)-202.5(in)-202.3(full)-199.4(possession)-200.9(of)-201.4(their)-200.9(mental)-200.3(faculties,)-201.6(but)-197.7(they)-200.7(are)-204.1(clearly)]TJ T* [(the)-276.5(only)-272.9(subjects)-270.3(suitable)-275.7(for)-271.6(a)-276(large)-272.2(part)-273.4(of)-273.8(research)-268.8(into)-274.3(the)-271.3(origins)]TJ 0 -1.2623 TD [(and)-268.7(treatment)-270.4(of)-268.6(certain)-267.5(severe)-269.4(mental)-267.5(or)-273.5(behavioural)-263.6(disorders.)]TJ ET 95.641 646.809 318.898 -0.51 re f BT /F6 1 Tf 7.9702 0 0 7.9702 191.1118 649.1337 Tm [(INTERNA)13.4(TIONAL)-327.4(ETHICAL)-327.5(GUIDELINES)-319.8(FOR)-332.5(BIOMED)13.7(ICAL)-331.1(RESEARCH)]TJ /F7 1 Tf 11.9551 0 0 11.9551 95.6409 649.1337 Tm (70)Tj ET endstream endobj 208 0 obj << /Type /Page /Parent 398 0 R /Resources 209 0 R /Contents 210 0 R /MediaBox [ 0 0 595 842 ] /CropBox [ 0 0 595 842 ] /Rotate 0 >> endobj 209 0 obj << /ProcSet [ /PDF /Text ] /Font << /F2 337 0 R /F5 340 0 R /F6 341 0 R /F7 342 0 R >> /ExtGState << /GS1 434 0 R >> /ColorSpace << /DefaultCMYK 417 0 R /Cs6 416 0 R >> >> endobj 210 0 obj << /Length 6181 >> stream q 1 i 0.015 737.008 510.221 -737.008 re W n /Cs6 cs 0 0 0 scn /GS1 gs 0.015 709.001 25.44 -0.284 re f Q /Cs6 cs 0 0 0 scn /GS1 gs 28.006 737.008 0.283 -25.455 re f 481.89 737.008 0.283 -25.455 re f 484.724 709.001 25.512 -0.284 re f 484.724 28.346 25.512 -0.283 re f 481.89 25.512 0.283 -25.512 re f q 1 i 0.015 737.008 510.221 -737.008 re W n 28.006 25.512 0.283 -25.512 re f 0.015 28.346 25.44 -0.283 re f Q BT /F5 1 Tf 10.959 0 0 10.959 95.6409 609.8455 Tm 0 Tc 0 Tw [(Consent)-181(of)-180.9(the)-178.5(individual.)]TJ /F2 1 Tf 10.486 0 TD [(The)-181.5(investigator)-176.9(must)-179.1(obtain)-179.4(the)-183.4(approval)-177.6(of)]TJ -10.486 -1.2623 TD [(an)-365.5(ethical)-367(review)-362.1(committee)-368.1(to)-361.7(include)-365(in)-362.7(research)-367.1(persons)-362.9(who)-361.1(by)]TJ 0 -1.2571 TD [(reason)-313.6(of)-310(mental)-308.9(or)-309.7(behavioural)-310.2(disorders)-308(are)-307.6(not)-311.6(capable)-311.2(of)-310(giving)]TJ 0 -1.2623 TD [(informed)-240.8(consent.)-237.8(The)-238.4(willing)-238.4(cooperation)-237.5(of)-237.6(such)-236.4(persons)-238.8(should)-235.8(be)]TJ 0 -1.2571 TD [(sought)-209.2(to)-206.5(the)-204.1(extent)-206.7(that)-206.4(their)-206.1(mental)-205.5(state)-205.4(permits,)-208.7(and)-206.6(any)-201.7(objection)]TJ T* [(on)-401.4(their)-397.5(part)-392.4(to)-398(taking)-396.9(part)-397.6(in)-398.9(any)-393.1(study)-399.1(that)-392.7(has)-399.5(no)-396.2(components)]TJ 0 -1.2623 TD [(designed)-412.2(to)-408.3(benefit)-407.2(them)-411.6(directly)-411.4(should)-406.5(always)-412(be)-407.8(respected.)-410.2(The)]TJ 0 -1.2571 TD [(objection)-457.8(of)-460(such)-458.9(an)-458.6(individual)-455.9(to)-460(an)-458.6(investigation)6.6(al)-461.2(intervention)]TJ T* [(intended)-241.5(to)-242.8(be)-247.4(of)-242.8(therapeutic)-240.4(benefit)-241.7(should)-240.9(be)-242.2(respected)-240.5(unless)-243.6(there)]TJ 0 -1.2623 TD [(is)-255.5(no)-251.4(reasonable)-246.3(medical)-255.7(alternative)-247.5(and)-253.2(local)-247.2(law)-255.4(permits)-251(overriding)]TJ 0 -1.2571 TD [(the)-178.2(objection.)-177.4(The)-176.3(agreement)-175.3(of)-180.7(an)-174(immediate)-176.7(family)-181.3(member)-176.6(or)-175.2(other)]TJ 0 -1.2623 TD [(person)-178.9(with)-175.6(a)-177.7(close)-174.5(personal)-174.5(relationship)-177.3(with)-175.6(the)-173.1(individual)-176.5(should)-173.7(be)]TJ 0 -1.2571 TD [(sought,)-254.8(but)-249.5(it)-255.7(should)-251.3(be)-252.6(recognized)-252.1(that)-253(these)-251.2(proxies)-250.6(may)-252.5(have)-251(their)]TJ T* [(own)-464.6(interests)-466.4(that)-465.1(may)-464.6(call)-468.1(their)-464.8(permission)-464.9(into)-465.8(question.)-463.2(Some)]TJ 0 -1.2622 TD [(relatives)-342.2(may)-340.4(not)-342.6(be)-340.5(primarily)-345(concerned)-335.6(with)-346.3(protecting)-336(the)-343.8(rights)]TJ 0 -1.2571 TD [(and)-170.4(welfare)-174(of)-170.3(the)-167.9(patients.)-170.3(Moreover,)-169.6(a)-172.5(close)-169.4(family)-171(member)-171.4(or)-170.1(friend)]TJ 0 -1.2623 TD [(may)-216.2(wish)-211.5(to)-211.7(take)-211.1(advantage)-204.3(of)-211.7(a)-213.9(research)-211.9(study)-207.7(in)-212.6(the)-214.4(hope)-209.1(that)-211.6(it)-214.4(will)]TJ 0 -1.2571 TD [(succeed)-301.5(in)-300.6(curing)-295.3(the)-302.4(condition.)-295.2(Some)-301.2(jurisdictions)-296.5(do)-297.9(not)-301.2(permit)]TJ T* [(third-party)-224.7(permission)-221.8(for)-225.1(subjects)-223.7(lacking)-224.7(capacity)-221.6(to)-227.2(consent.)-222.2(Legal)]TJ 0 -1.2623 TD [(authorization)-316.4(may)-314.5(be)-314.6(necessary)-317.2(to)-315.2(involve)-317.8(in)-316.1(research)-315.4(an)-313.7(individual)]TJ 0 -1.2571 TD [(who)-273.2(has)-265(been)-272.4(committed)-268.6(to)-268.6(an)-267.2(institution)-269.4(by)-267.2(a)-270.8(court)-265.5(order.)]TJ /F5 1 Tf 0 -2.4366 TD [(Serious)-173(illness)-173.1(in)-171.5(persons)-167.1(who)-170.5(because)-171.8(of)-170.6(mental)-169.8(or)-170.3(behavioural)-172.5(disorders)]TJ 0 -1.2623 TD [(are)-266.2(unable)-262.4(to)-268.9(give)-264.9(adequately)-261.7(informed)-262.5(consent.)]TJ /F2 1 Tf 20.1547 0 TD [(Persons)-264.4(who)-262.8(because)]TJ -20.1547 -1.2571 TD [(of)-444.5(mental)-443.4(or)-444.2(behavioural)-439.5(disorders)-442.5(are)-442.1(unable)-442.7(to)-444.5(give)-445.1(adequately)]TJ T* [(informed)-178.7(consent)-176.7(and)-180.8(who)-180(have,)-177.6(or)-175.2(are)-178.2(at)-181(risk)-177.2(of,)-179.7(serious)-179.3(illnesses)-183.7(such)]TJ 0 -1.2623 TD [(as)-346.2(HIV)-346(infection,)-344.7(cancer)-345.6(or)-340.8(hepatitis)-346.2(should)-344.4(not)-342.6(be)-345.7(deprived)-339.8(of)-346.2(the)]TJ 0 -1.2571 TD [(possible)-435.5(benefits)-430.9(of)-434.2(investigation)6.6(al)-435.4(drugs,)-434.1(vaccines)-429.2(or)-433.9(devices)-432.5(that)]TJ 0 -1.2623 TD [(show)-260.6(promise)-264.8(of)-258.3(therapeutic)-261.1(or)-258(preventive)-258.1(benefit,)-261.4(particularly)-260.6(when)]TJ 0 -1.2571 TD [(no)-375.5(superior)-367.1(or)-371.8(equivalent)-371.9(therapy)-367.4(or)-371.8(prevention)-370.4(is)-374.5(available.)-369.6(Their)]TJ T* [(entitlement)-583.5(to)-579(access)-579.8(to)-584.2(such)-577.8(therapy)-579.5(or)-583.9(prevention)-577.4(is)-581.4(justified)]TJ 0 -1.2623 TD [(ethically)-574.8(on)-572.1(the)-571.4(same)-571.9(grounds)-567.5(as)-568.7(is)-576.2(such)-567.5(entitlement)-573.1(for)-571.7(other)]TJ 0 -1.2571 TD [(vulnerable)-268.2(groups.)]TJ 1.2933 -1.345 TD [(Persons)-342(who)-345.6(are)-338.6(unable)-344.4(to)-341(give)-341.6(adequately)-338.5(informed)-344.2(consent)-337.1(by)]TJ -1.2933 -1.2623 TD [(reason)-210.2(of)-206.5(mental)-210.6(or)-206.3(behavioural)-206.7(disorders)-209.7(are,)-208.3(in)-207.5(general,)-208.2(not)-208.1(suitable)]TJ 0 -1.2571 TD [(for)-338.9(participation)-334.6(in)-331.6(formal)-335.1(clinical)-341.1(trials)-335(except)-335.5(those)-332.8(trials)-335(that)-335.8(are)]TJ 0 -1.2623 TD [(designed)-272.5(to)-268.6(be)-268.1(responsive)-268.2(to)-268.6(their)-268.2(particular)-265(health)-268.5(needs)-270.2(and)-268.7(can)-264.7(be)]TJ 0 -1.2571 TD [(carried)-272.4(out)-270.2(only)-267.7(with)-268.7(them.)]TJ ET 95.641 646.809 318.898 -0.51 re f BT /F6 1 Tf 7.9702 0 0 7.9702 95.6409 649.1337 Tm [(THE)-330.8(GUIDELINES)]TJ /F7 1 Tf 11.9551 0 0 11.9551 401.3857 649.1337 Tm (71)Tj ET endstream endobj 211 0 obj << /Type /Page /Parent 398 0 R /Resources 212 0 R /Contents 213 0 R /MediaBox [ 0 0 595 842 ] /CropBox [ 0 0 595 842 ] /Rotate 0 >> endobj 212 0 obj << /ProcSet [ /PDF /Text ] /Font << /F2 337 0 R /F5 340 0 R /F6 341 0 R /F7 342 0 R /F8 343 0 R /F11 346 0 R >> /ExtGState << /GS1 434 0 R >> /ColorSpace << /DefaultCMYK 417 0 R /Cs6 416 0 R >> >> endobj 213 0 obj << /Length 5980 >> stream q 1 i 0.015 737.008 510.221 -737.008 re W n /Cs6 cs 0 0 0 scn /GS1 gs 0.015 709.001 25.44 -0.284 re f Q /Cs6 cs 0 0 0 scn /GS1 gs 28.006 737.008 0.283 -25.455 re f 481.89 737.008 0.283 -25.455 re f 484.724 709.001 25.512 -0.284 re f 484.724 28.346 25.512 -0.283 re f 481.89 25.512 0.283 -25.512 re f q 1 i 0.015 737.008 510.221 -737.008 re W n 28.006 25.512 0.283 -25.512 re f 0.015 28.346 25.44 -0.283 re f Q 1 1 1 scn 95.641 540.51 14.173 -2.835 re f 0 0 0 scn 95.641 560.693 318.898 -20.183 re f 1 1 1 scn 95.641 517.493 14.173 -2.835 re f 0.8 0.8 0.8 scn 95.641 537.675 318.898 -20.183 re f BT /F2 1 Tf 10.959 0 0 10.959 109.8142 609.8455 Tm 0 0 0 scn 0 Tc 0 Tw [(\(See)-393.1(also)-393.3(Guidelines)-393.4(8:)]TJ /F5 1 Tf 10.3515 0 TD [(Benefits)-394.8(and)-388.2(risks)-392.6(of)-393(study)-394.5(participation;)]TJ /F2 1 Tf -11.6448 -1.2623 TD (9:)Tj /F5 1 Tf 1.1071 0 TD [(Special)-313.6(limitations)-317(on)-319.2(risks)-315(when)-318.1(subjects)-312.2(are)-317.9(not)-317.3(capable)-316.9(of)-315.4(giving)]TJ -1.1071 -1.2571 TD (consent;)Tj /F2 1 Tf 3.6936 0 TD [(and)-268.7(13:)]TJ /F5 1 Tf 3.4143 0 TD [(Research)-267.2(involving)-268.3(vulnerable)-269.9(persons)]TJ /F2 1 Tf 15.6126 0 TD (.\))Tj /F11 1 Tf 11.9551 0 3.5865 11.9551 214.8661 546.1227 Tm 1 1 1 scn [(Guideline)-278.6(16)]TJ 11.9551 0 0 11.9551 162.2551 523.1054 Tm 0 0 0 scn [(Women)-274.7(as)-271.2(research)-275.6(subjects)]TJ /F8 1 Tf 10.959 0 0 10.959 95.6409 501.5054 Tm [(Investigators,)-386.6(sponsors)-385.1(or)-381.9(ethical)-385.5(review)-385.1(committees)-386(should)]TJ 0 -1.2623 TD [(not)-647.9(exclude)-638.8(women)-640.8(of)-641.5(reproductive)-640.9(age)-640.6(from)-644.1(biomedical)]TJ 0 -1.2571 TD [(research.)-298.5(The)-293.8(potential)-297.3(for)-297.9(becoming)-296.5(pregnant)-294.4(during)-296.8(a)-296.4(study)]TJ T* [(should)-445.3(not,)-450.4(in)-445.2(itself,)-447.6(be)-447.7(used)-445.3(as)-448(a)-446.4(reason)-444.7(for)-447.9(precluding)-439.8(or)]TJ 0 -1.2623 TD [(limiting)-250.4(participation.)-249.3(However,)-247.7(a)-249.8(thorough)-247.3(discussion)-247.2(of)-248.3(risks)]TJ 0 -1.2571 TD [(to)-377.6(the)-379.2(pregnant)-372(woman)-377(and)-376.5(to)-377.6(her)-373.1(fetus)-379.5(is)-378.2(a)-374(prerequisite)-374.8(for)]TJ T* [(the)-384.4(womans)-377.5(ability)-382.9(to)-382.8(make)-381.9(a)-379.2(rational)-383(decision)-378.9(to)-382.8(enrol)-378.5(in)-383.1(a)]TJ 0 -1.2623 TD 0.0115 Tc [(clinical)-675.5(s)4.8(t)-2.8(ud)5.1(y.)-675.5(In)-672.6(this)-672.9(dis)4.8(c)-0.4(us)4.8(sio)5.1(n)-0.1(,)-675.5(i)2.2(f)-675.3(p)-0.1(articipation)-672.6(in)-672.6(the)]TJ 0 -1.2571 TD 0 Tc [(research)-459.8(might)-465.5(be)-463.2(hazardous)-459.4(to)-460.4(a)-461.9(fetus)-462.2(or)-464.7(a)-461.9(woman)-459.7(if)-468.5(she)]TJ 0 -1.2623 TD 0.0418 Tc [(becomes)-704.7(p)4.3(regnant,)-707.3(t)1.7(he)-704.7(sp)4.3(ons)]TJ 16.2955 0 TD 0.0422 Tc [(ors/in)4.7(vestigato)4.7(rs)-704.3(should)]TJ -16.2955 -1.2571 TD 0 Tc (g)Tj 0.6104 0 TD [(uar)-11(ant)-6.7(e)-6.7(e)-668.9(the)-674.1(p)-6.4(ros)-11(pec)-9.5(ti)-8.1(ve)-670.4(su)-8(bje)-7(c)-6.7(t)-671.2(a)-668.9(pre)-11(gna)-9.2(ncy)-676.8(tes)-7(t)-671.2(a)0(n)-8(d)]TJ -0.6104 -1.2571 TD [(access)-242(to)-243.1(effective)-246.1(contraceptive)-240.1(methods)-238(before)-240.1(the)-244.7(research)]TJ 0 -1.2623 TD [(commences.)-360.3(Where)-363.6(such)-362.6(access)-361(is)-362.7(not)-363.4(possible,)-362.4(for)-365.1(legal)-359.3(or)]TJ 0 -1.2571 TD [(religious)-477.7(reasons,)-471.1(investigators)-475.6(should)-471.2(not)-472(recruit)-478.8(for)-473.8(such)]TJ 0 -1.2623 TD 0.0069 Tc [(po)6.9(s)]TJ 1.7744 0 TD 0 Tc [(sib)-12.2(ly)-678.2(haz)-9.8(ard)-11(ou)-7.7(s)-668.9(r)-8.2(es)-8.2(ear)-11.2(ch)-675.3(wo)-7.2(me)-6.3(n)-668.6(w)0(h)-12.4(o)-668.6(mi)-9(g)-6.4(h)0(t)-672.5(b)-6.4(ec)-8.2(om)-6.1(e)]TJ -1.7744 -1.2571 TD (pregnant.)Tj 9.9626 0 2.9888 9.9626 95.6409 255.5716 Tm [(Comm)-9.3(ent)-7.2(ary)-269.4(on)-277.2(Guidelin)-10.9(e)-267.4(1)0(6)]TJ /F2 1 Tf 10.959 0 0 10.959 95.6409 237.4866 Tm [(Women)-217.5(in)-212.6(most)-215.3(societies)-213.6(have)-214.8(been)-215.4(discriminated)-210.1(against)-214(with)-217(regard)]TJ T* [(to)-625.6(their)-620(involvement)-620.8(in)-621.3(research.)-619.6(Women)-621(who)-619.8(are)-618(biologically)]TJ 0 -1.2623 TD [(capable)-280.1(of)-284.1(becoming)-275.2(pregnant)-281(have)-276.9(been)-277.5(customarily)-281(excluded)-277.4(from)]TJ 0 -1.2571 TD [(formal)-267.8(clinical)-268.7(trials)-262.5(of)-268.6(drugs,)-263.4(vaccines)-263.6(and)-268.7(medical)-266(devices)-261.8(owing)-268.8(to)]TJ T* 0.0081 Tc [(conc)8.1(er)8.1(n)-643.1(a)8.1(bout)-636.6(u)8.1(n)-0.1(det)8.1(e)-3.1(r)8.1(m)-0.6(in)8.1(ed)-634.9(ri)8.1(s)-4.2(k)]TJ 15.3954 0 TD 0.6445 Tc [(st)644.5(o)-6.9(t)644.5(h)634.5(e)0.3(f)636.1(e)644.5(t)633.3(u)644.5(s)634.8(.)-1.2(C)638.3(o)]TJ 8.8099 0 TD 0 Tc [(ns)-9.7(e)-7.9(q)0(u)-8.2(e)-7.9(nt)-10(ly)-11.2(,)]TJ -24.2053 -1.2623 TD [(relatively)-267.6(little)-270.1(is)-271(known)-260.7(about)-268.3(the)-266.2(safety)-264.2(and)-268.7(efficacy)-265.6(of)-268.6(most)-267(drugs,)]TJ 0 -1.2571 TD [(vaccines)-294.7(or)-294.2(devices)-298(for)-292.3(such)-293.3(women,)-296.1(and)-289.4(this)-296.5(lack)-294.8(of)-294.5(knowledge)-292.8(can)]TJ 0 -1.2623 TD [(be)-304.3(dangerous.)]TJ 1.2933 -1.2571 TD (A)Tj 1.2364 0 TD [(general)-462.7(policy)-466(of)-460(excluding)-461.8(from)-463.6(such)-464(clinical)-465.2(trials)-464.3(women)]TJ -2.5297 -1.2571 TD [(biologically)-214.7(capable)-212.9(of)-211.7(becoming)-213.2(pregnant)-213.8(is)-214.1(unjust)-211.6(in)-212.6(that)-216.8(it)-214.4(deprives)]TJ 0 -1.2623 TD [(women)-379.9(as)-377.3(a)-379.4(class)-376.8(of)-382.4(persons)-373.3(of)-377.3(the)-380(benefits)-379.2(of)-377.3(the)-380(new)-377.8(knowledge)]TJ ET 95.641 646.809 318.898 -0.51 re f BT /F6 1 Tf 7.9702 0 0 7.9702 191.1118 649.1337 Tm [(INTERNA)13.4(TIONAL)-327.4(ETHICAL)-327.5(GUIDELINES)-319.8(FOR)-332.5(BIOMED)13.7(ICAL)-331.1(RESEARCH)]TJ /F7 1 Tf 11.9551 0 0 11.9551 95.6409 649.1337 Tm (72)Tj ET endstream endobj 214 0 obj << /Type /Page /Parent 398 0 R /Resources 215 0 R /Contents 216 0 R /MediaBox [ 0 0 595 842 ] /CropBox [ 0 0 595 842 ] /Rotate 0 >> endobj 215 0 obj << /ProcSet [ /PDF /Text ] /Font << /F2 337 0 R /F5 340 0 R /F6 341 0 R /F7 342 0 R >> /ExtGState << /GS1 434 0 R >> /ColorSpace << /DefaultCMYK 417 0 R /Cs6 416 0 R >> >> endobj 216 0 obj << /Length 5810 >> stream q 1 i 0.015 737.008 510.221 -737.008 re W n /Cs6 cs 0 0 0 scn /GS1 gs 0.015 709.001 25.44 -0.284 re f Q /Cs6 cs 0 0 0 scn /GS1 gs 28.006 737.008 0.283 -25.455 re f 481.89 737.008 0.283 -25.455 re f 484.724 709.001 25.512 -0.284 re f 484.724 28.346 25.512 -0.283 re f 481.89 25.512 0.283 -25.512 re f q 1 i 0.015 737.008 510.221 -737.008 re W n 28.006 25.512 0.283 -25.512 re f 0.015 28.346 25.44 -0.283 re f Q BT /F2 1 Tf 10.959 0 0 10.959 95.6409 609.8455 Tm 0 Tc 0 Tw [(derived)-286.5(from)-287.7(the)-286.9(trials.)-287.4(Further,)-284.4(it)-286.8(is)-286.5(an)-282.7(affront)-286.7(to)-284.1(their)-288.9(right)-282.8(of)-289.3(self-)]TJ 0 -1.2623 TD [(determination.)-398.1(Neverthele)5.8(ss,)-398.2(although)-389.7(women)-395.4(of)-398(child-bearing)-391(age)]TJ 0 -1.2571 TD [(should)-178.9(be)-180.1(given)-177.6(the)-183.4(opportunity)-174.7(to)-180.7(participate)-174.9(in)-181.6(research,)-179.9(they)-180(should)]TJ 0 -1.2623 TD [(be)-314.6(helped)-314.3(to)-315.2(understand)-311.2(that)-315.1(the)-312.7(research)-315.4(could)-311.6(include)-313.3(risks)-314.7(to)-315.2(the)]TJ 0 -1.2571 TD [(fetus)-272.4(if)-271.3(they)-268(become)-265.3(pregnant)-270.7(during)-267.1(the)-266.2(research.)]TJ 1.2933 -1.2571 TD [(Although)-171.4(this)-177.5(general)-173(presumption)-169.2(favours)-171.1(the)-173.1(inclusion)-174.4(of)-170.3(women)]TJ -1.2933 -1.2623 TD [(in)-269.5(research,)-262.6(it)-266.1(must)-261.8(be)-268.1(acknowledged)-257.5(that)-268.5(in)-264.4(some)-261.3(parts)-266.1(of)-263.5(the)-266.2(world)]TJ 0 -1.2571 TD [(women)-245.4(are)-245.5(vulnerable)-247.5(to)-242.8(neglect)-246.6(or)-242.5(harm)-244.8(in)-248.9(research)-242.9(because)-243.7(of)-242.8(their)]TJ T* [(social)-198.5(conditioning)-195.1(to)-196.2(submit)-200.3(to)-196.2(authority,)-196.8(to)-196.2(ask)-192.6(no)-199.6(questions,)-197.2(and)-196.3(to)]TJ 0 -1.2623 TD [(tolerate)-508.8(pain)-505.7(and)-501.5(suffering.)-504.4(When)-506.7(women)-504(in)-507.5(such)-505.4(situations)-503.2(are)]TJ 0 -1.2571 TD [(potential)-370.6(subjects)-363.4(in)-367.8(research,)-371.3(investigato)7.1(rs)-368.1(need)-370.6(to)-366.9(exercise)-364.3(special)]TJ 0 -1.2623 TD [(care)-175.8(in)-171.3(the)-173.1(informed)-173.5(consent)-171.5(process)-167.5(to)-175.5(ensure)-169.7(that)-170.2(they)-174.9(have)-168.2(adequate)]TJ 0 -1.2571 TD [(time)-207.3(and)-206.6(a)-203.6(proper)-204.7(environment)-205.4(in)-207.5(which)-202.5(to)-206.5(take)-205.9(decisions)-205.5(on)-204.8(the)-204.1(basis)]TJ T* [(of)-273.8(clearly)-268.7(given)-265.5(information.)]TJ /F5 1 Tf 0 -2.3538 TD 0.0121 Tc [(Individual)-612.9(consent)-617.1(o)5.1(f)-617.1(w)0.4(omen.)]TJ /F2 1 Tf 13.9572 0 TD 0.0129 Tc [(In)-614.6(re)5(searc)5(h)-614.6(invo)6.2(lvin)6.2(g)-614.9(w)1.5(omen)-614.6(of)]TJ -13.9572 -1.2571 TD 0.0079 Tc [(repr)7.9(odu)7.9(c)-1.5(ti)7.9(ve)-605.3(age)7.9(,)-614.6(w)1.7(he)7.9(the)7.9(r)-613.4(p)7.9(r)-1.8(eg)7.9(nant)-605.8(or)-605.5(non-)7.9(pr)7.9(egna)7.9(nt,)-606.7(onl)7.9(y)-613.7(t)7.9(he)]TJ T* 0 Tc [(informed)-282.1(consent)-280.1(of)-279(the)-281.7(woman)-275.5(herself)-284.2(is)-281.4(required)-278.9(for)-276.8(her)-281.4(participa-)]TJ 0 -1.2623 TD [(tion.)-268.2(In)-268.4(no)-261.7(case)-263.7(should)-266.8(the)-266.2(permission)-263.2(of)-268.6(a)-265.6(spouse)-261.6(or)-268.4(partner)-260(replace)]TJ 0 -1.2571 TD [(the)-380(requirement)-378.5(of)-382.4(individual)-378.3(informed)-380.4(consent.)-377.4(If)-378.7(women)-379.9(wish)-382.3(to)]TJ 0 -1.2623 TD [(consult)-260.9(with)-263.5(their)-257.8(husbands)-258.6(or)-263.2(partners)-257.8(or)-258(seek)-263.5(voluntarily)-256.4(to)-263.5(obtain)]TJ 0 -1.2571 TD [(their)-263(permission)-263.2(before)-257.9(deciding)-263.4(to)-258.3(enrol)-261.3(in)-264.4(research,)-262.6(that)-258.2(is)-260.7(not)-265(only)]TJ T* [(ethically)-352.3(permissible)-356.5(but)-347.8(in)-352.3(some)-354.4(contexts)-350.9(highly)-351.3(desirable.)-349.6(A)-352.6(strict)]TJ 0 -1.2623 TD [(requirement)-259.6(of)-263.5(authorizati)7.4(on)-261.7(of)-258.3(spouse)-261.6(or)-258(partner,)-259(however,)-256.5(violates)]TJ 0 -1.2571 TD [(the)-271.3(substantive)-265.6(principle)-268.7(of)-273.8(respect)-267.3(for)-266.4(persons.)]TJ 1.2933 -1.2571 TD (A)Tj 1.0295 0 TD [(thorough)-258.9(discussion)-253.8(of)-258.3(risks)-257.8(to)-258.3(the)-261(pregnant)-255.2(woman)-254.8(and)-258.4(to)-258.3(her)]TJ -2.3228 -1.2623 TD [(fetus)-438(is)-431.4(a)-436.3(prerequisite)-431.7(for)-432(the)-436.9(womans)-427.5(ability)-434.8(to)-434.2(make)-430.8(a)-436.3(rational)]TJ 0 -1.2571 TD [(decision)-218(to)-211.7(enrol)-214.7(in)-217.8(a)-213.9(clinical)-211.8(study.)-217.1(For)-212.8(women)-214.3(who)-211.1(are)-214.4(not)-218.4(pregnant)]TJ 0 -1.2623 TD [(at)-320.6(the)-312.7(outset)-320.5(of)-315.2(a)-317.4(study)-316.3(but)-311.5(who)-319.7(might)-316.5(become)-311.8(pregnant)-317.2(while)-318.9(they)]TJ 0 -1.2571 TD [(are)-338.6(still)-334.4(subjects,)-331.4(the)-333.4(consent)-331.9(discussion)-336.6(should)-328.9(include)-334(information)]TJ T* [(about)-252.8(the)-250.7(alternative)-247.5(of)-247.9(voluntarily)-251.3(withdrawing)-247.4(from)-251.5(the)-250.7(study)-249.1(and,)]TJ 0 -1.2623 TD [(where)-461.1(legally)-455.2(permissible,)-459(terminating)-457.2(the)-457.6(pregnancy.)-452(Also,)-458.6(if)-457.5(the)]TJ 0 -1.2571 TD [(pregnancy)-385.8(is)-395.2(not)-384(terminated,)-390.9(they)-387(should)-385.8(be)-392.2(guaranteed)-383.8(a)-389.8(medical)]TJ 0 -1.2623 TD (follow-up.)Tj 0 -2.3486 TD [(\(See)-274.1(also)-269.2(Guideline)-266.3(17:)]TJ /F5 1 Tf 9.979 0 TD [(Pregnant)-265.9(women)-267.1(as)-268.6(research)-269.1(subjects)]TJ /F2 1 Tf 15.3591 0 TD (.\))Tj ET 95.641 646.809 318.898 -0.51 re f BT /F6 1 Tf 7.9702 0 0 7.9702 95.6409 649.1337 Tm [(THE)-330.8(GUIDELINES)]TJ /F7 1 Tf 11.9551 0 0 11.9551 401.3857 649.1337 Tm (73)Tj ET endstream endobj 217 0 obj << /Type /Page /Parent 398 0 R /Resources 218 0 R /Contents 219 0 R /MediaBox [ 0 0 595 842 ] /CropBox [ 0 0 595 842 ] /Rotate 0 >> endobj 218 0 obj << /ProcSet [ /PDF /Text ] /Font << /F2 337 0 R /F6 341 0 R /F7 342 0 R /F8 343 0 R /F10 345 0 R /F11 346 0 R >> /ExtGState << /GS1 434 0 R >> /ColorSpace << /DefaultCMYK 417 0 R /Cs6 416 0 R >> >> endobj 219 0 obj << /Length 6057 >> stream q 1 i 0.015 737.008 510.221 -737.008 re W n /Cs6 cs 0 0 0 scn /GS1 gs 0.015 709.001 25.44 -0.284 re f Q /Cs6 cs 0 0 0 scn /GS1 gs 28.006 737.008 0.283 -25.455 re f 481.89 737.008 0.283 -25.455 re f 484.724 709.001 25.512 -0.284 re f 484.724 28.346 25.512 -0.283 re f 481.89 25.512 0.283 -25.512 re f q 1 i 0.015 737.008 510.221 -737.008 re W n 28.006 25.512 0.283 -25.512 re f 0.015 28.346 25.44 -0.283 re f Q 1 1 1 scn 95.641 603.439 14.173 -2.835 re f 0 0 0 scn 95.641 623.622 318.898 -20.183 re f 1 1 1 scn 95.641 580.422 14.173 -2.835 re f 0.8 0.8 0.8 scn 95.641 600.605 318.898 -20.183 re f BT /F11 1 Tf 11.9551 0 3.5865 11.9551 214.8661 608.9951 Tm 1 1 1 scn 0 Tc 0 Tw [(Guideline)-278.6(17)]TJ 11.9551 0 0 11.9551 131.5275 585.9778 Tm 0 0 0 scn [(Pregnant)-280.2(women)-271.3(as)-271.2(rese)-7.6(arch)-272.8(subjects)]TJ /F8 1 Tf 10.959 0 0 10.959 95.6409 564.3778 Tm 0.0169 Tc (Pr)Tj 1.0812 0 TD 0.0126 Tc [(egnant)-617.3(women)-619.8(s)0.7(hould)-619.8(b)1(e)-614.9(p)1(resumed)-614.6(t)-1.7(o)-614.6(b)-4.2(e)-614.9(e)0.7(ligible)-614.9(for)]TJ -1.0812 -1.2571 TD 0 Tc [(participation)-291.7(in)-290(biomedical)-284.4(research.)-288.1(Investigators)-284.2(and)-288.6(ethical)]TJ T* [(review)-452.3(committees)-442.9(should)-450.5(ensure)-444.7(that)-450.3(prospective)-441.6(subjects)]TJ 0 -1.2623 TD [(who)-256.8(are)-254.4(pregnant)-258.2(are)-254.4(adequately)-252.4(informed)-254(about)-252.4(the)-260.2(risks)-254.9(and)]TJ 0 -1.2571 TD [(benefits)-350.2(to)-346.6(themselves,)-348.3(their)-345(pregnancies,)-344.9(the)-348.1(fetus)-348.4(and)-345.5(their)]TJ T* [(subsequent)-269.9(offspring,)-263.8(and)-273.1(to)-269(their)-267.4(fertility.)]TJ 0 -1.7485 TD [(Research)-364.8(in)-367.6(this)-362.7(population)-368(should)-362.6(be)-364.9(performed)-363(only)-365.2(if)-365(it)-370.2(is)]TJ 0 -1.2571 TD [(relevant)-256.5(to)-253.5(the)-255(particular)-253(health)-251.7(needs)-255.5(of)-253.5(a)-255(pregnant)-253(woman)-247.6(or)]TJ 0 -1.2623 TD [(her)-233.4(fetus,)-233.6(or)-231.9(to)-232.8(the)-229.2(health)-236.1(needs)-229.6(of)-232.8(pregnant)-227.2(women)-232.1(in)-233.1(general,)]TJ 0 -1.2571 TD [(and,)-354.9(when)-346.3(appropriate,)-348.7(if)-354.7(it)-349.5(is)-352.3(supported)-347.4(by)-349.4(reliable)-352.5(evidence)]TJ T* [(from)-504.4(animal)-503.8(experiments,)-501(particularly)-501.9(as)-504.9(to)-507(risks)-503.2(of)-501.8(terato-)]TJ 0 -1.2623 TD [(genicity)-272.9(and)-267.9(mutagenicit)6.8(y.)]TJ 9.9626 0 2.9888 9.9626 95.6409 366.9164 Tm [(Comm)-9.3(ent)-7.2(ary)-269.4(on)-277.2(Guidelin)-10.9(e)-267.4(1)0(7)]TJ /F2 1 Tf 10.959 0 0 10.959 95.6409 348.8314 Tm [(The)-409.1(justification)-405.9(of)-403.1(research)-403.3(involving)-405.4(pregnant)-400(women)-405.8(is)-405.5(compli-)]TJ 0 -1.2571 TD [(cated)-193.1(by)-189.6(the)-188.6(fact)-192.1(that)-190.9(it)-193.7(may)-185.2(present)-193.7(risks)-190.6(and)-185.9(potential)-189.6(benefits)-192.9(to)-191(two)]TJ 0 -1.2623 TD [(beings)-206.2()-205.3(the)-204.1(woman)-203.1(and)-206.6(the)-204.1(fetus)-205.2()-205.4(a)0(s)-206.5(well)-208.7(as)-201.4(to)-206.5(the)-204.1(person)-204.7(the)-204.1(fetus)]TJ 0 -1.2571 TD [(is)-208.9(destined)-201.6(to)-201.4(become.)-202.2(Though)-200.7(the)-204.1(decision)-202.5(about)-201.1(acceptability)-201.3(of)-206.5(risk)]TJ T* [(should)-173.7(be)-175(made)-172.1(by)-168.9(the)-173.1(mother)-173(as)-170.3(part)-175.1(of)-170.3(the)-173.1(informed)-173.5(consent)-171.5(process,)]TJ 0 -1.2623 TD [(it)-281.6(is)-281.3(desirable)-278.2(in)-279.9(research)-274(directed)-280.3(at)-279.2(the)-276.5(health)-278.9(of)-279(the)-276.5(fetus)-282.8(to)-279(obtain)]TJ 0 -1.2571 TD 0.0129 Tc [(th)6.2(e)-610.6(f)4.5(at)4.5(h)6.2(e)-0.2(r)]TJ /F10 1 Tf 4.5627 0 TD 0 Tc ()Tj /F2 1 Tf 0.2276 0 TD 0.6238 Tc [(so)617.1(p)611.9(i)614.4(n)617.1(i)]TJ 3.2539 0 TD 0.0076 Tc [(on)-614.7(al)-6.9(so,)-617.4(w)-3.8(hen)-614.7(p)-4.3(os)-5.7(sibl)-6.9(e.)-617.4(Ev)-4.5(en)-614.7(when)-614.7(e)-5.5(v)0.6(id)-4.3(enc)-5.5(e)]TJ -8.0443 -1.2623 TD 0 Tc [(concerning)-576.8(risks)-578.6(is)-576.2(unknown)-574.2(or)-578.7(ambiguous,)-575.2(the)-576.6(decision)-574.9(about)]TJ 0 -1.2571 TD [(acceptability)-206.4(of)-201.4(risk)-208.3(to)-201.4(the)-204.1(fetus)-205.2(should)-204.7(be)-200.8(made)-203.2(by)-205.1(the)-204.1(woman)-203.1(as)-206.5(part)]TJ T* [(of)-273.8(the)-266.2(informed)-266.6(consent)-269.8(process.)]TJ 1.2933 -1.2623 TD [(Especially)-436.2(in)-440.3(communities)-434.4(or)-433.9(societies)-436(in)-440.3(which)-435.3(cultural)-436.1(beliefs)]TJ -1.2933 -1.2571 TD [(accord)-432.3(more)-437.2(importance)-431.5(to)-434.2(the)-431.7(fetus)-432.8(than)-432.3(to)-434.2(the)-431.7(womans)-432.7(life)-433.4(or)]TJ T* 0.0083 Tc [(he)8.3(alth,)-611.5(w)2.1(omen)-608.8(m)8.3(a)-4.4(y)-609.1(f)-0.1(eel)-611.5(const)8.3(r)-3.1(ai)]TJ 15.354 0 TD 0.0079 Tc [(ned)-609.2(t)-0.5(o)-609.2(p)1.2(artici)7.9(pate,)-611.9(o)1.2(r)-610.7(not)-611(to)]TJ -15.354 -1.2623 TD 0 Tc [(participate,)-339.4(in)-336.8(research.)-340.2(Special)-334.3(safeguards)-333.8(should)-339.2(be)-335.3(established)-339.9(to)]TJ 0 -1.2571 TD [(prevent)-533.9(undue)-531.4(inducement)-534.5(to)-532.5(pregnant)-534.5(women)-529.9(to)-532.5(participate)-537(in)]TJ 0 -1.2623 TD [(research)-217.1(in)-212.6(which)-218(interventions)-210.2(hold)-215.7(out)-213.3(the)-214.4(prospect)-215.9(of)-211.7(direct)-214(benefit)]TJ 0 -1.2571 TD [(to)-610.1(the)-607.6(fetus.)-607.7(Where)-609.2(fetal)-610.1(abnormality)-609.7(is)-607.3(not)-606.4(recogn)-8.1(ized)-606.1(as)-604.9(an)]TJ T* [(indication)-455.9(for)-447.5(abortion,)-451.9(pregnant)-451.7(women)-447.1(should)-453(not)-451.2(be)-449.2(recruited)]TJ 0 -1.2623 TD [(for)-344(research)-336.1(in)-342(which)-337(there)-339.1(is)-338.3(a)-343.2(realistic)-339.4(basis)-339.4(for)-338.9(concern)-336.5(that)-335.8(fetal)]TJ ET 95.641 646.809 318.898 -0.51 re f BT /F6 1 Tf 7.9702 0 0 7.9702 191.1118 649.1337 Tm [(INTERNA)13.4(TIONAL)-327.4(ETHICAL)-327.5(GUIDELINES)-319.8(FOR)-332.5(BIOMED)13.7(ICAL)-331.1(RESEARCH)]TJ /F7 1 Tf 11.9551 0 0 11.9551 95.6409 649.1337 Tm (74)Tj ET endstream endobj 220 0 obj << /Type /Page /Parent 398 0 R /Resources 221 0 R /Contents 222 0 R /MediaBox [ 0 0 595 842 ] /CropBox [ 0 0 595 842 ] /Rotate 0 >> endobj 221 0 obj << /ProcSet [ /PDF /Text ] /Font << /F2 337 0 R /F5 340 0 R /F6 341 0 R /F7 342 0 R /F8 343 0 R /F11 346 0 R >> /ExtGState << /GS1 434 0 R >> /ColorSpace << /DefaultCMYK 417 0 R /Cs6 416 0 R >> >> endobj 222 0 obj << /Length 5199 >> stream q 1 i 0.015 737.008 510.221 -737.008 re W n /Cs6 cs 0 0 0 scn /GS1 gs 0.015 709.001 25.44 -0.284 re f Q /Cs6 cs 0 0 0 scn /GS1 gs 28.006 737.008 0.283 -25.455 re f 481.89 737.008 0.283 -25.455 re f 484.724 709.001 25.512 -0.284 re f 484.724 28.346 25.512 -0.283 re f 481.89 25.512 0.283 -25.512 re f q 1 i 0.015 737.008 510.221 -737.008 re W n 28.006 25.512 0.283 -25.512 re f 0.015 28.346 25.44 -0.283 re f Q 1 1 1 scn 95.641 489.6 14.173 -2.835 re f 0 0 0 scn 95.641 509.783 318.898 -20.183 re f 1 1 1 scn 95.641 466.583 14.173 -2.835 re f 0.8 0.8 0.8 scn 95.641 486.765 318.898 -20.183 re f BT /F2 1 Tf 10.959 0 0 10.959 95.6409 609.8455 Tm 0 0 0 scn 0 Tc 0 Tw [(abnormality)-221.8(may)-221.4(occur)-223.6(as)-222.1(a)-224.2(consequence)-220.9(of)-222.1(participation)-220.8(as)-227.2(a)-219.1(subject)]TJ 0 -1.2623 TD [(in)-274.7(research.)]TJ 1.2933 -1.2571 TD 0.0167 Tc [(In)4.8(v)4.6(e)3.6(sti)]TJ 2.9642 0 TD 0.013 Tc [(gato)-4(r)-0.3(s)-615.9(s)-0.3(h)-4(ould)-619.7(i)-1.5(n)-4(c)-0.1(lude)-620.8(in)-619.7(pro)-4(t)-0.6(ocols)-621.1(o)1.1(n)-619.7(r)-0.3(es)-5.5(earch)-619.7(w)-3.6(ith)]TJ -4.2575 -1.2623 TD 0 Tc [(pregnant)-213.8(women)-214.3(a)-219.1(plan)-216(for)-214.7(monitoring)-214.5(the)-214.4(outcome)-215.6(of)-216.9(the)-214.4(pregnancy)]TJ 0 -1.2571 TD [(with)-273.9(regard)-267.3(to)-268.6(both)-271.7(the)-266.2(health)-268.5(of)-273.8(the)-266.2(woman)-270.3(and)-268.7(the)-271.3(short-term)-268.2(and)]TJ T* [(long-term)-270.2(health)-268.5(of)-268.6(the)-271.3(child.)]TJ /F11 1 Tf 11.9551 0 3.5865 11.9551 214.8661 495.2125 Tm 1 1 1 scn [(Guideline)-278.6(18)]TJ 11.9551 0 0 11.9551 163.6724 472.1952 Tm 0 0 0 scn [(Safeguarding)-283.7(confidentiality)]TJ /F8 1 Tf 10.959 0 0 10.959 95.6409 450.5952 Tm [(The)-604.2(investigator)-608.5(must)-601.3(establish)-605.5(secure)-605.3(safeguards)-603(of)-605.3(the)]TJ 0 -1.2623 TD [(confidentiality)-329.4(of)-325.9(subjects)-326.2(research)-320.2(data.)-328(Subjects)-327(should)-321.2(be)]TJ 0 -1.2571 TD [(told)-445.2(the)-441.3(limits,)-446(legal)-442.1(or)-444(other,)-439.4(to)-444.9(the)-441.3(investigators)-443.5(ability)-439.8(to)]TJ 0 -1.2623 TD [(safeguard)-441.1(confidentiality)-443.2(and)-443.8(the)-441.3(possible)-441(consequences)-441.3(of)]TJ 0 -1.2571 TD [(breaches)-266.7(of)-269(confidentiality.)]TJ 9.9626 0 2.9888 9.9626 95.6409 352.1763 Tm [(Comm)-9.3(ent)-7.2(ary)-269.4(on)-277.2(Guidelin)-10.9(e)-267.4(1)0(8)]TJ /F5 1 Tf 10.959 0 0 10.959 95.6409 334.0913 Tm [(Confidentiality)-294.6(between)-290.6(investigator)-292.2(and)-289.9(subject.)]TJ /F2 1 Tf 20.4858 0 TD [(Research)-287.3(relating)-296.7(to)]TJ -20.4858 -1.2571 TD [(individuals)-443.3(and)-444.6(groups)-441.8(may)-438.7(involve)-447.1(the)-442.1(collection)-442.4(and)-439.4(storage)-446.5(of)]TJ 0 -1.2623 TD [(information)-357.5(that,)-355.5(if)-359.2(disclosed)-360.7(to)-356.6(third)-354.9(parties,)-359.9(could)-352.9(cause)-358.4(harm)-358.6(or)]TJ 0 -1.2571 TD [(distress.)-224.4(Investigators)-220.1(should)-225.4(arrange)-217.4(to)-227.2(protect)-219.8(the)-224.8(confidentiality)-222.8(of)]TJ 0 -1.2623 TD [(such)-345(information)-336.8(by,)-343.8(for)-338.9(example,)-340.2(omitting)-341(information)-341.9(that)-340.9(might)]TJ 0 -1.2571 TD [(lead)-263.7(to)-258.3(the)-261(identification)-262.4(of)-258.3(individual)-259.3(subjects,)-258.9(limiting)-261.8(access)-264.3(to)-258.3(the)]TJ T* [(information,)-294.4(anonymizing)-292.2(data,)-297.1(or)-294.2(other)-291.4(means.)-293.1(During)-297.1(the)-292(process)]TJ 0 -1.2623 TD [(of)-444.5(obtaining)-445.6(informed)-442.5(consent)-440.5(the)-447.2(investigator)-440.8(should)-442.7(inform)-443.4(the)]TJ 0 -1.2571 TD [(prospective)-519.5(subjects)-513.4(about)-516.6(the)-519.7(precautions)-513.1(that)-516.8(will)-520.6(be)-516.4(taken)-517.8(to)]TJ T* -0.0002 Tc [(protect)-271.7(confidentiality.)]TJ 1.2933 -1.2623 TD 0 Tc [(Prospective)-281.2(subjects)-275.4(should)-277.1(be)-278.4(informed)-282.1(of)-279(limits)-278(to)-279(the)-281.7(ability)-279.6(of)]TJ -1.2933 -1.2571 TD [(investigators)-402.4(to)-408.3(ensure)-402.5(strict)-402.2(confidentiality)-403.8(and)-403.2(of)-403.1(the)-400.7(foreseeable)]TJ 0 -1.2623 TD [(adverse)-508(social)-503.7(consequences)-503.2(of)-501.4(breaches)-505.3(of)-501.4(confidentiality.)-506.3(Some)]TJ 0 -1.2571 TD [(jurisdictions)-472.4(require)-463.6(the)-467.9(reporting)-467.5(to)-465.2(appropriate)-465.6(agencies)-465.4(of,)-469.4(for)]TJ T* [(instance,)-226.7(certain)-221(communicable)-222.2(diseases)-223.7(or)-221.8(evidence)-226.9(of)-222.1(child)-226.3(abuse)-222.7(or)]TJ 0 -1.2623 TD [(neglect.)-235.2(Drug)-229.3(regulatory)-231.6(authorities)-231.8(have)-230.3(the)-230(right)-231.1(to)-232.4(inspect)-231.1(clinical-)]TJ 0 -1.2571 TD [(trial)-471.7(records,)-466.6(and)-465.3(a)-467.4(sponsors)-467.2(clinical-compliance)-468.3(audit)-467.6(staff)-469.8(may)]TJ 0 -1.2623 TD [(require)-173.9(and)-170.4(obtain)-169(access)-171.2(to)-170.3(confidential)-172.1(data.)-167.8(These)-171.7(and)-170.4(similar)-170.9(limits)]TJ ET 95.641 646.809 318.898 -0.51 re f BT /F6 1 Tf 7.9702 0 0 7.9702 95.6409 649.1337 Tm [(THE)-330.8(GUIDELINES)]TJ /F7 1 Tf 11.9551 0 0 11.9551 401.3857 649.1337 Tm (75)Tj ET endstream endobj 223 0 obj << /Type /Page /Parent 398 0 R /Resources 224 0 R /Contents 225 0 R /MediaBox [ 0 0 595 842 ] /CropBox [ 0 0 595 842 ] /Rotate 0 >> endobj 224 0 obj << /ProcSet [ /PDF /Text ] /Font << /F2 337 0 R /F5 340 0 R /F6 341 0 R /F7 342 0 R >> /ExtGState << /GS1 434 0 R >> /ColorSpace << /DefaultCMYK 417 0 R /Cs6 416 0 R >> >> endobj 225 0 obj << /Length 6031 >> stream q 1 i 0.015 737.008 510.221 -737.008 re W n /Cs6 cs 0 0 0 scn /GS1 gs 0.015 709.001 25.44 -0.284 re f Q /Cs6 cs 0 0 0 scn /GS1 gs 28.006 737.008 0.283 -25.455 re f 481.89 737.008 0.283 -25.455 re f 484.724 709.001 25.512 -0.284 re f 484.724 28.346 25.512 -0.283 re f 481.89 25.512 0.283 -25.512 re f q 1 i 0.015 737.008 510.221 -737.008 re W n 28.006 25.512 0.283 -25.512 re f 0.015 28.346 25.44 -0.283 re f Q BT /F2 1 Tf 10.959 0 0 10.959 95.6409 609.8455 Tm 0 Tc 0 Tw [(to)-356.6(the)-348.9(ability)-352(to)-351.4(maintain)-355.1(confidentialit)6.6(y)-353.6(should)-349.6(be)-356(anticipated)-349.3(and)]TJ 0 -1.2623 TD [(disclosed)-272.7(to)-268.6(prospective)-266(subjects.)]TJ 1.2933 -1.314 TD [(Participation)-365.4(in)-367.8(HIV/AIDS)-370.7(drug)-364.8(and)-367(vaccine)-364.1(trials)-366(may)-366.3(impose)]TJ -1.2933 -1.2622 TD [(upon)-585.5(the)-586.9(research)-579.2(subjects)-585.8(significant)-585(associated)-584.3(risks)-583.7(of)-584.2(social)]TJ 0 -1.2571 TD [(discrimination)-295.9(or)-294.2(harm;)-295.6(such)-293.3(risks)-294(merit)-293.1(consideration)-291.2(equal)-296.3(to)-294.5(that)]TJ 0 -1.2623 TD [(given)-420.7(to)-423.8(adverse)-420.1(medical)-421.2(consequences)-420.5(of)-418.6(the)-421.4(drugs)-419.5(and)-418.7(vaccines.)]TJ 0 -1.2571 TD [(Efforts)-406.6(must)-406.7(be)-407.8(made)-404.9(to)-408.3(reduce)-402.2(their)-407.9(likelihood)-404.8(and)-403.2(severity.)-409.5(For)]TJ T* [(example,)-371.3(subjects)-368.6(in)-367.8(vaccine)-364.1(trials)-371.2(must)-370.5(be)-366.4(enabled)-367.8(to)-366.9(demonstrate)]TJ 0 -1.2623 TD [(that)-335.8(their)-335.4(HIV)-330.5(seropositivity)-333.9(is)-333.1(due)-331.7(to)-335.9(their)-330.3(having)-333.4(been)-334.4(vaccinated)]TJ 0 -1.2571 TD [(rather)-568.8(than)-561.7(to)-568.7(natural)-565.5(infection.)-562(This)-568.8(may)-562.9(be)-568.1(accomplished)-560.9(by)]TJ 0 -1.2623 TD [(providing)-440.1(them)-437.4(with)-434.3(documents)-437.4(attesting)-438.7(to)-434.2(their)-438.9(participation)-438(in)]TJ 0 -1.2571 TD [(vaccine)-571(trials,)-566.8(or)-568.4(by)-567.2(maintaining)-569.6(a)-565.7(confidential)-565.3(register)-572(of)-568.7(trial)]TJ T* [(subjects,)-357.2(from)-354.9(which)-352.5(information)-352.3(can)-352.7(be)-356(made)-353.2(available)-355.1(to)-351.4(outside)]TJ 0 -1.2623 TD [(agencies)-268.8(at)-268.9(a)-270.8(subjects)-269.3(request.)]TJ /F5 1 Tf 0 -2.4055 TD [(Confidentiality)-289.5(between)-285.4(physician)-281.8(and)-289.9(patient.)]TJ /F2 1 Tf 19.477 0 TD [(Patients)-290(have)-282(the)-286.9(right)]TJ -19.477 -1.2623 TD [(to)-196.2(expect)-190.7(that)-196.1(their)-190.6(physicians)-196(and)-191.1(other)-193.1(health-care)-188.9(professionals)-194.6(will)]TJ 0 -1.2571 TD [(hold)-339.9(all)-336.1(information)-336.8(about)-330.4(them)-339.1(in)-336.8(strict)-335(confidence)-334.9(and)-336(disclose)-338.4(it)]TJ T* [(only)-216(to)-211.7(those)-213.8(who)-216.2(need,)-214.5(or)-211.5(have)-214.8(a)-213.9(legal)-211.3(right)-215.5(to,)-210.7(the)-214.4(information,)-216.8(such)]TJ 0 -1.2623 TD [(as)-372.1(other)-369(attending)-363.1(physicians,)-370.9(nurses,)-365.6(or)-371.8(other)-363.8(health-care)-370(workers)]TJ 0 -1.2571 TD [(who)-231.8(perform)-232.9(tasks)-235(related)-231.3(to)-232.4(the)-230(diagnosis)-229.5(and)-232.5(treatment)-234.2(of)-232.4(patients.)]TJ 0 -1.2623 TD (A)Tj 1.045 0 TD [(treating)-269.9(physician)-275.8(should)-266.8(not)-275.3(disclose)-271.2(any)-269(identifying)-273.1(information)]TJ -1.045 -1.2571 TD [(about)-190.7(patients)-186.8(to)-185.9(an)-184.4(investigator)-187.3(unless)-186.7(each)-189.8(patient)-183.8(has)-187.4(given)-187.9(consent)]TJ T* [(to)-604.9(such)-598.5(disclosure)-601.6(and)-599.8(unless)-595.4(an)-603.4(ethical)-599.8(review)-600.1(committee)-600.9(has)]TJ 0 -1.2623 TD [(approved)-269(such)-267.4(disclosure.)]TJ 1.2933 -1.314 TD [(Physicians)-206.1(and)-201.5(other)-203.5(health)-201.3(care)-201.7(professionals)-205(record)-200.7(the)-204.1(details)-206.9(of)]TJ -1.2933 -1.2623 TD [(their)-402.7(observations)-396.2(and)-398(interventio)6.5(ns)-402.9(in)-398.9(medical)-395.3(and)-398(other)-400(records.)]TJ 0 -1.2571 TD [(Epidemiological)-405.3(studies)-402(often)-405.5(make)-404.9(use)-400.4(of)-403.1(such)-407.1(records.)-404.5(For)-399(such)]TJ 0 -1.2623 TD [(studies)-314.1(it)-317.8(is)-312.4(usually)-312.9(impracticable)-313.6(to)-315.2(obtain)-308.7(the)-312.7(informed)-313.2(consent)-316.4(of)]TJ 0 -1.2571 TD [(each)-283(identifiable)-283.4(patient;)-281.1(an)-282.7(ethical)-284.2(review)-284.5(committee)-280.2(may)-283.5(waive)-280.6(the)]TJ T* [(requirement)-404.4(for)-406.1(informed)-401.1(consent)-404.3(when)-400(this)-405.1(is)-405.5(consistent)-404.4(with)-403.2(the)]TJ 0 -1.2623 TD [(requirements)-402.2(of)-403.1(applicable)-403.9(law)-400.2(and)-403.2(provided)-400.7(that)-403(there)-401.2(are)-405.8(secure)]TJ 0 -1.2571 TD -0.0001 Tc [(safeguards)-463.3(of)-465.3(confidentiality.)-464.7(\(See)-465.6(also)-460.7(Guideline)-463(4)-462.3(Commentary:)]TJ /F5 1 Tf T* 0 Tc [(Waiver)-329.1(of)-331(the)-328.5(consent)-327.5(requirement.\))]TJ /F2 1 Tf 15.5816 0 TD [(In)-325.3(institutions)-329.3(in)-331.6(which)-326.6(records)]TJ -15.5816 -1.2623 TD [(may)-314.5(be)-309.5(used)-314(for)-307.8(research)-310.2(purposes)-312.7(without)-311.3(the)-307.6(informed)-313.2(consent)-311.2(of)]TJ 0 -1.2571 TD [(patients,)-279(it)-281.6(is)-281.3(advisable)-276.1(to)-279(notify)-279.4(patients)-280(generally)-277.2(of)-279(such)-277.8(practices;)]TJ 0 -1.2623 TD [(notification)-219.2(is)-214.1(usually)-219.8(by)-215.4(means)-216.5(of)-216.9(a)-213.9(statement)-218.7(in)-217.8(patient-infor)6.3(mation)]TJ 0 -1.2571 TD [(brochures.)-340.3(For)-342.1(research)-341.2(limited)-341.3(to)-341(patients)-341(medical)-343.6(records,)-342.4(access)]TJ ET 95.641 646.809 318.898 -0.51 re f BT /F6 1 Tf 7.9702 0 0 7.9702 191.1118 649.1337 Tm [(INTERNA)13.4(TIONAL)-327.4(ETHICAL)-327.5(GUIDELINES)-319.8(FOR)-332.5(BIOMED)13.7(ICAL)-331.1(RESEARCH)]TJ /F7 1 Tf 11.9551 0 0 11.9551 95.6409 649.1337 Tm (76)Tj ET endstream endobj 226 0 obj << /Type /Page /Parent 398 0 R /Resources 227 0 R /Contents 228 0 R /MediaBox [ 0 0 595 842 ] /CropBox [ 0 0 595 842 ] /Rotate 0 >> endobj 227 0 obj << /ProcSet [ /PDF /Text ] /Font << /F2 337 0 R /F5 340 0 R /F6 341 0 R /F7 342 0 R >> /ExtGState << /GS1 434 0 R >> /ColorSpace << /DefaultCMYK 417 0 R /Cs6 416 0 R >> >> endobj 228 0 obj << /Length 5515 >> stream q 1 i 0.015 737.008 510.221 -737.008 re W n /Cs6 cs 0 0 0 scn /GS1 gs 0.015 709.001 25.44 -0.284 re f Q /Cs6 cs 0 0 0 scn /GS1 gs 28.006 737.008 0.283 -25.455 re f 481.89 737.008 0.283 -25.455 re f 484.724 709.001 25.512 -0.284 re f 484.724 28.346 25.512 -0.283 re f 481.89 25.512 0.283 -25.512 re f q 1 i 0.015 737.008 510.221 -737.008 re W n 28.006 25.512 0.283 -25.512 re f 0.015 28.346 25.44 -0.283 re f Q BT /F2 1 Tf 10.959 0 0 10.959 95.6409 609.8455 Tm 0 Tc 0 Tw [(must)-204.9(be)-206(approved)-201.7(or)-206.3(cleared)-204.9(by)-199.9(an)-205.1(ethical)-206.6(review)-206.9(committee)-202.6(and)-201.5(must)]TJ 0 -1.2623 TD [(be)-361.2(supervised)-356.1(by)-355.1(a)-358.7(person)-354.7(who)-361.1(is)-358.9(fully)-356.4(aware)-357(of)-356.6(the)-359.3(confidentiality)]TJ 0 -1.2571 TD (requirements.)Tj /F5 1 Tf 0 -2.3486 TD [(Issues)-487.3(of)-486.2(confidentialit)5.6(y)-488.1(i)0(n)-481.9(genetics)-487.8(research.)]TJ /F2 1 Tf 19.9736 0 TD [(An)-483.4(investigator)-487.3(who)]TJ -19.9736 -1.2623 TD [(proposes)-193.7(to)-191(perform)-191.5(genetic)-194.8(tests)-191.1(of)-196.2(known)-188.3(clinical)-196.2(or)-190.8(predictive)-193.2(value)]TJ 0 -1.2571 TD [(on)-266.9(biological)-265.6(samples)-265.1(that)-263.3(can)-264.7(be)-262.9(linked)-264(to)-263.5(an)-267.2(identifiable)-262.7(individual)]TJ 0 -1.2623 TD 0.008 Tc [(mus)8(t)-613.9(obt)8(ain)-609.1(t)8(he)-610.3(inf)8(o)-2(rm)8(e)-5.6(d)-609.1(c)8(o)-1.4(nsent)-605.7(o)1.3(f)-610.9(t)-0.4(h)8(e)-611.9(indi)8(vidu)8(al)-611.8(or)8(,)-614.8(w)1.8(hen)]TJ 0 -1.2571 TD 0 Tc [(indicated,)-586.4(the)-581.7(permission)-583.9(of)-584.2(a)-581.2(legally)-584.6(authorized)-582.5(representative.)]TJ T* [(Conversel)-11.2(y,)-600.9(befor)-6.9(e)-602.8(performing)-612.9(a)-601.9(genetic)-608.7(test)-607.2(that)-609.9(is)-607.3(of)-604.9(known)]TJ 0 -1.2623 TD [(predictive)-198.4(value)-193.1(or)-195.9(gives)-194.6(reliable)-195(information)-191.9(about)-190.7(a)-198.4(known)-193.5(heritable)]TJ 0 -1.2571 TD 0.0077 Tc [(condit)7.7(i)-4.9(on,)-606.9(and)-609.4(i)-1.7(nd)7.7(ivid)7.7(ual)-612.1(c)-0.2(on)7.7(sent)-611.2(o)7.7(r)-612.4(perm)7.7(issi)7.7(on)-609.4(has)-610.9(not)-606(been)]TJ T* 0 Tc [(obtained,)-482.7(investigators)-480(must)-479.1(see)-479.2(that)-480.6(biological)-477.7(samples)-482.4(are)-478.3(fully)]TJ 0 -1.2623 TD [(anonymized)-402.7(and)-403.2(unlinked;)-400.6(this)-400(ensures)-405.5(that)-397.8(no)-406.6(information)-398.8(about)]TJ 0 -1.2571 TD [(specific)-241.6(individuals)-236.4(can)-238.9(be)-237.1(derived)-234.8(from)-235.9(such)-236.4(research)-237.8(or)-237.3(passed)-236(back)]TJ 0 -1.2623 TD [(to)-273.8(them.)]TJ 1.2933 -1.2571 TD [(When)-279.1(biological)-276(samples)-280.6(are)-276.5(not)-275.3(fully)-278.8(anonymized)-273.4(and)-279(when)-275.9(it)-281.6(is)]TJ -1.2933 -1.2571 TD [(anticipated)-370(that)-366.8(there)-365(may)-366.3(be)-371.6(valid)-365.3(clinical)-366.9(or)-371.8(research)-367.1(reasons)-363.2(for)]TJ 0 -1.2623 TD [(linking)-200(the)-198.9(results)-196.6(of)-201.4(genetic)-194.8(tests)-201.5(to)-196.2(research)-196.4(subjects,)-196.8(the)-198.9(investigator)]TJ 0 -1.2571 TD [(in)-326.4(seeking)-322.7(informed)-323.5(consent)-321.5(should)-318.5(assure)-325.4(prospective)-322.9(subjects)-322(that)]TJ 0 -1.2623 TD [(their)-459.6(identity)-457(will)-463.7(be)-459.5(protected)-451.7(by)-458.6(secure)-460.6(coding)-458.2(of)-454.9(their)-459.6(samples)]TJ 0 -1.2571 TD [(\(encryption\))-289(and)-284.2(by)-287.9(restricted)-288.1(access)-285(to)-289.3(the)-286.9(database,)-285.5(and)-289.4(explain)-286.8(to)]TJ T* [(them)-271.9(this)-270.6(process.)]TJ 1.2933 -1.2623 TD [(When)-299.8(it)-297.1(is)-302(clear)-299(that)-294.4(for)-297.5(medical)-297.1(or)-299.4(possibly)-300.1(research)-294.7(reasons)-295.9(the)]TJ -1.2933 -1.2571 TD [(results)-196.6(of)-196.2(genetic)-194.8(tests)-196.3(will)-199.9(be)-195.7(reported)-190(to)-196.2(the)-198.9(subject)-194.8(or)-195.9(to)-191(the)-198.9(subjects)]TJ T* [(physician,)-378.3(the)-374.8(subject)-370.7(should)-375.4(be)-376.7(informed)-375.3(that)-372(such)-376.1(disclosure)-374(will)]TJ 0 -1.2623 TD [(occur)-270.2(and)-268.7(that)-268.5(the)-271.3(samples)-265.1(to)-268.6(be)-273.3(tested)-264.8(will)-272.3(be)-273.3(clearly)-268.7(labelled.)]TJ 1.2933 -1.2571 TD [(Investigators)-235.6(should)-235.8(not)-234(disclose)-235(results)-238(of)-232.4(diagnostic)-237.7(genetic)-236.2(tests)]TJ -1.2933 -1.2623 TD [(to)-268.6(relatives)-264.6(of)-263.5(subjects)-265.1(without)-264.7(the)-261(subjects)-269.3(consent.)-263.6(In)-263.2(places)-264.3(where)]TJ 0 -1.2571 TD [(immediate)-383.6(family)-377.9(relatives)-378.4(would)-382.3(usually)-375(expect)-382.1(to)-377.3(be)-381.9(informed)-380.4(of)]TJ T* [(such)-417.5(results,)-418(the)-421.4(research)-413.7(protocol,)-416.7(as)-418.6(approved)-413.8(or)-418.4(cleared)-417(by)-417.2(the)]TJ 0 -1.2623 TD [(ethical)-273.9(review)-274.2(committee,)-274(should)-266.8(indicate)-275.4(the)-271.3(precautions)-270(in)-269.5(place)-276.8(to)]TJ 0 -1.2571 TD [(prevent)-270.1(such)-272.6(disclosure)-265.4(of)-273.8(results)-269(without)-269.9(the)-266.2(subjects)-269.3(consent;)-268.8(such)]TJ 0 -1.2623 TD [(plans)-436.3(should)-432.3(be)-428.5(clearly)-434.3(explained)-430.7(during)-432.6(the)-431.7(process)-431.4(of)-434.2(obtaining)]TJ 0 -1.2571 TD [(informed)-271.8(consent.)]TJ ET 95.641 646.809 318.898 -0.51 re f BT /F6 1 Tf 7.9702 0 0 7.9702 95.6409 649.1337 Tm [(THE)-330.8(GUIDELINES)]TJ /F7 1 Tf 11.9551 0 0 11.9551 401.3857 649.1337 Tm (77)Tj ET endstream endobj 229 0 obj << /Type /Page /Parent 398 0 R /Resources 230 0 R /Contents 231 0 R /MediaBox [ 0 0 595 842 ] /CropBox [ 0 0 595 842 ] /Rotate 0 >> endobj 230 0 obj << /ProcSet [ /PDF /Text ] /Font << /F2 337 0 R /F5 340 0 R /F6 341 0 R /F7 342 0 R /F8 343 0 R /F11 346 0 R >> /ExtGState << /GS1 434 0 R >> /ColorSpace << /DefaultCMYK 417 0 R /Cs6 416 0 R >> >> endobj 231 0 obj << /Length 5674 >> stream q 1 i 0.015 737.008 510.221 -737.008 re W n /Cs6 cs 0 0 0 scn /GS1 gs 0.015 709.001 25.44 -0.284 re f Q /Cs6 cs 0 0 0 scn /GS1 gs 28.006 737.008 0.283 -25.455 re f 481.89 737.008 0.283 -25.455 re f 484.724 709.001 25.512 -0.284 re f 484.724 28.346 25.512 -0.283 re f 481.89 25.512 0.283 -25.512 re f q 1 i 0.015 737.008 510.221 -737.008 re W n 28.006 25.512 0.283 -25.512 re f 0.015 28.346 25.44 -0.283 re f Q 1 1 1 scn 95.641 603.439 14.173 -2.835 re f 0 0 0 scn 95.641 623.622 318.898 -20.183 re f 1 1 1 scn 95.641 566.646 14.173 -2.835 re f 0.8 0.8 0.8 scn 95.641 600.605 318.898 -33.959 re f BT /F11 1 Tf 11.9551 0 3.5865 11.9551 214.8661 608.9951 Tm 1 1 1 scn 0 Tc 0 Tw [(Guideline)-278.6(19)]TJ 11.9551 0 0 11.9551 134.4756 585.9778 Tm 0 0 0 scn [(Right)-273.6(of)-272.1(injured)-276.4(subjec)-9.3(ts)-267.8(to)-272.2(treatmen)-9.1(t)]TJ 5.1025 -1.1523 TD [(and)-273.5(compen)-9.1(sation)]TJ /F8 1 Tf 10.959 0 0 10.959 95.6409 550.6014 Tm [(Investigators)-263.5(should)-259.1(ensure)-258.4(that)-258.9(research)-258.1(subjects)-259.9(who)-262(suffer)]TJ 0 -1.2571 TD [(injury)-543.1(as)-535.9(a)-539.5(result)-537.9(of)-538(their)-536.4(participation)-540(are)-533.7(entitled)-539.1(to)-543.2(free)]TJ 0 -1.2623 TD [(medical)-215.6(treatment)-216.8(for)-220.3(such)-212.5(injury)-217.2(and)-216.2(to)-217.3(such)-217.7(financial)-215(or)-216.4(other)]TJ 0 -1.2571 TD (a)Tj 0.5639 0 TD 0.0075 Tc [(ssi)7.5(stance)-609.6(as)-609.6(woul)7.5(d)-618.7(c)0.8(om)7.5(pensate)-609.6(t)-1.6(hem)-607.7(e)0.8(qui)7.5(t)-5.8(ably)-609.6(for)-611.1(a)0.8(ny)]TJ -0.5639 -1.2571 TD 0 Tc [(resultant)-498.1(impairment,)-500.2(disability)-498.5(or)-500.9(handicap.)-494(In)-496.9(the)-503.3(case)-497.6(of)]TJ 0 -1.2623 TD [(death)-413(as)-411.7(a)-415.4(result)-413.8(of)-413.9(their)-412.2(participation,)-414.9(their)-412.2(dependants)-409.6(are)]TJ 0 -1.2571 TD [(entitled)-239.1(to)-232.8(compensation.)-231.3(Subjects)-228.7(must)-234(not)-234.1(be)-235.6(asked)-229.9(to)-238(waive)]TJ 0 -1.2623 TD [(the)-270.5(right)-272.3(to)-269(compensation.)]TJ 9.9626 0 2.9888 9.9626 95.6409 419.3007 Tm [(Comm)-9.3(ent)-7.2(ary)-269.4(on)-277.2(Guidelin)-10.9(e)-267.4(1)0(9)]TJ /F2 1 Tf 10.959 0 0 10.959 95.6409 401.2157 Tm [(Guideline)-571.5(19)-572.7(is)-571(concerned)-568.4(with)-568.8(two)-569.7(distinct)-572(but)-570.2(closely)-568.5(related)]TJ 0 -1.2571 TD [(entitlements.)-554.4(The)-554(first)-549.5(is)-555.5(the)-550.7(uncontroversial)-549.5(entitlement)-552.4(to)-553.1(free)]TJ T* [(medical)-193.6(treatment)-192.8(and)-196.3(compensatio)6.7(n)-192.9(for)-194(accidental)-192(injury)-192.1(inflicted)-193.1(by)]TJ 0 -1.2623 TD [(procedures)-276.8(or)-278.7(interventions)-277.4(performed)-273.3(exclusively)-279(to)-273.8(accomplish)-277.3(the)]TJ 0 -1.2571 TD [(purposes)-245.5(of)-247.9(research)-248.1(\(non-therape)8.5(utic)-249.7(procedures\).)-242.8(The)-248.7(second)-245.8(is)-245.1(the)]TJ 0 -1.2623 TD [(entitlement)-459.3(of)-460(dependants)-455.7(to)-460(material)-456(compensation)-455.3(for)-457.9(death)-460.9(or)]TJ 0 -1.2571 TD 0.0187 Tc [(disability)-619.4(o)1.7(ccurring)-624.6(as)-620.6(a)-619.4(d)-3.5(irect)-620.9(result)-626(of)-620.9(study)-619.4(p)1.6(articipation.)]TJ T* 0 Tc [(Implementing)-451.8(a)-451.9(compensation)-450.1(system)-454(for)-452.7(research-re)6.7(lated)-453.2(injuries)]TJ 0 -1.2623 TD [(or)-273.5(death)-264.3(is)-271(likely)-272.1(to)-268.6(be)-268.1(complex,)-267.5(however.)]TJ /F5 1 Tf 0 -2.3486 TD [(Equitable)-255.7(compensation)-255.1(and)-253.7(free)-254.8(medical)-256.2(treatment.)]TJ /F2 1 Tf 21.9705 0 TD [(Compensation)-251.9(is)]TJ -21.9705 -1.2571 TD [(owed)-208.6(to)-211.7(research)-206.7(subjects)-213.4(who)-205.9(are)-209.3(disabled)-206.7(as)-211.7(a)-208.7(consequence)-205.4(of)-211.7(injury)]TJ 0 -1.2623 TD [(from)-479.1(procedures)-473.4(performed)-469.9(solely)-477.8(to)-475.5(accomplish)-473.8(the)-473.1(purposes)-478.3(of)]TJ 0 -1.2571 TD [(research.)-236.8(Compensation)-231.2(and)-232.5(free)-234.1(medical)-229.8(treatment)-234.2(are)-235.1(generally)-230.7(not)]TJ 0 -1.2623 TD [(owed)-389.7(to)-392.8(research)-387.8(subjects)-389.2(who)-392.1(suffer)-389.2(expected)-386.3(or)-392.5(foreseen)-387.8(adverse)]TJ 0 -1.2571 TD [(reactions)-566.9(to)-568.7(investigational)-563.3(therapeutic,)-565.3(diagnostic)-563.6(or)-568.4(preventive)]TJ T* [(interventions)-205(when)-198.3(such)-205.4(reactions)-199.6(are)-198.9(not)-202.9(different)-201.4(in)-202.3(kind)-205.4(from)-199.7(those)]TJ 0 -1.2623 TD [(known)-410.7(to)-408.3(be)-407.8(associated)-408.4(with)-408.4(established)-407.1(interventions)-406.7(in)-414.4(standard)]TJ 0 -1.2571 TD [(medical)-229.8(practice.)-227.9(In)-227(the)-230(early)-225.6(stages)-227.7(of)-227.2(drug)-225.1(testing)-226.7(\(Phase)-225.7(I)-230.6(and)-222.1(early)]TJ T* [(Phase)-367.3(II\),)-365.2(it)-369.6(is)-364.1(generally)-365.2(unreasonable)-363.2(to)-366.9(assume)-364.4(that)-361.6(an)-365.5(investiga-)]TJ 0 -1.2623 TD [(tional)-259.6(drug)-256.2(holds)-260.1(out)-259.8(the)-255.8(prospect)-257.3(of)-258.3(direct)-260.6(benefit)-257.2(for)-261.3(the)-255.8(individual)]TJ 0 -1.2571 TD [(subject;)-173.2(accordingly,)-170.7(compensation)-170.8(is)-172.7(usually)-173.2(owed)-172.4(to)-170.3(individuals)-174.3(who)]TJ 0 -1.2623 TD [(become)-270.5(disabled)-268.8(as)-268.6(a)-270.8(result)-266(of)-273.8(serving)-266.3(as)-268.6(subjects)-270.3(in)-269.5(such)-267.4(studies.)]TJ ET 95.641 646.809 318.898 -0.51 re f BT /F6 1 Tf 7.9702 0 0 7.9702 191.1118 649.1337 Tm [(INTERNA)13.4(TIONAL)-327.4(ETHICAL)-327.5(GUIDELINES)-319.8(FOR)-332.5(BIOMED)13.7(ICAL)-331.1(RESEARCH)]TJ /F7 1 Tf 11.9551 0 0 11.9551 95.6409 649.1337 Tm (78)Tj ET endstream endobj 232 0 obj << /Type /Page /Parent 398 0 R /Resources 233 0 R /Contents 234 0 R /MediaBox [ 0 0 595 842 ] /CropBox [ 0 0 595 842 ] /Rotate 0 >> endobj 233 0 obj << /ProcSet [ /PDF /Text ] /Font << /F2 337 0 R /F5 340 0 R /F6 341 0 R /F7 342 0 R >> /ExtGState << /GS1 434 0 R >> /ColorSpace << /DefaultCMYK 417 0 R /Cs6 416 0 R >> >> endobj 234 0 obj << /Length 6286 >> stream q 1 i 0.015 737.008 510.221 -737.008 re W n /Cs6 cs 0 0 0 scn /GS1 gs 0.015 709.001 25.44 -0.284 re f Q /Cs6 cs 0 0 0 scn /GS1 gs 28.006 737.008 0.283 -25.455 re f 481.89 737.008 0.283 -25.455 re f 484.724 709.001 25.512 -0.284 re f 484.724 28.346 25.512 -0.283 re f 481.89 25.512 0.283 -25.512 re f q 1 i 0.015 737.008 510.221 -737.008 re W n 28.006 25.512 0.283 -25.512 re f 0.015 28.346 25.44 -0.283 re f Q BT /F2 1 Tf 10.959 0 0 10.959 109.8142 609.8455 Tm 0 Tc 0 Tw [(The)-290.1(ethical)-284.2(review)-289.7(committee)-285.3(should)-287.5(determine)-286.1(in)-285.1(advance:)-287.1(i\))-286.8(the)]TJ -1.2933 -1.2623 TD [(injuries)-303.7(for)-307.8(which)-300.8(subjects)-301.3(will)-303.3(receive)-304.4(free)-306.6(treatment)-301.5(and,)-298.8(in)-305.8(case)-305.1(of)]TJ 0 -1.2571 TD [(impairment,)-384.4(disability)-381.4(or)-382.2(handicap)-378.8(resulting)-382.2(from)-380.8(such)-381.3(injuries,)-380.3(be)]TJ 0 -1.2623 TD 0.0128 Tc [(compensated;)-617.3(and)-614.7(ii\))-616.4(the)-615.9(i)3.5(njuries)-616.1(f)4.4(or)-616.1(which)-614.7(t)-0.8(hey)-615(w)1.4(ill)-617.3(not)-616.4(be)]TJ 0 -1.2571 TD 0.0162 Tc [(co)4.3(mp)4.3(en)4.3(sate)3.1(d.)-613.9(Pro)4.3(s)-2.3(p)4.3(e)]TJ 9.6221 0 TD 0.0151 Tc [(ctive)-618.7(s)-3.4(u)3.2(b)3.2(j)-4.6(ects)-619(s)1.8(ho)3.2(ul)]TJ 9.141 0 TD 0.6333 Tc [(db)621.4(ei)618.8(n)621.4(f)]TJ 4.0196 0 TD 0.0136 Tc [(ormed)-619.1(o)-3.5(f)-615.6(t)0(h)-3.4(e)]TJ -22.7827 -1.2571 TD 0 Tc [(committees)-401.2(decisions,)-401.1(as)-398(part)-397.6(of)-403.1(the)-395.5(process)-400.3(of)-398(informed)-401.1(consent.)]TJ 0 -1.2623 TD 0.0272 Tc [(As)-632.8(an)-626.1(ethical)-628.8(r)-1.7(eview)-630.9(c)-1.4(o)5(m)0.8(mittee)-627.3(cannot)-627.9(make)-627.3(su)5(ch)-631.3(advan)5(ce)]TJ 0 -1.2571 TD 0.0122 Tc [(dete)4.3(rmination)-610.1(i)-2.3(n)-615.3(r)4(esp)5.5(ect)-611.8(of)-611.8(unex)5.2(p)0.3(ected)-610.1(or)-616.7(u)5.5(n)0.3(forese)4.3(en)-615.3(a)5.2(d)0.3(verse)]TJ T* 0 Tc [(reactions,)-255.6(such)-257.1(reactions)-256.5(must)-251.5(be)-257.7(presumed)-254.6(compensable)-251.5(and)-258.4(should)]TJ 0 -1.2623 TD [(be)-273.3(reported)-267.6(to)-268.6(the)-266.2(committee)-269.8(for)-271.6(prompt)-264.9(review)-269(as)-273.8(they)-268(occur.)]TJ 1.2933 -1.2571 TD [(Subjects)-170.5(must)-173.9(not)-166.7(be)-169.8(asked)-171(to)-170.3(waive)-166.8(their)-175.1(rights)-166.8(to)-170.3(compensation)-170.8(or)]TJ -1.2933 -1.2623 TD [(required)-242.7(to)-242.8(show)-245.1(negligence)-243.2(or)-242.5(lack)-243(of)-242.8(a)-239.8(reasonable)-241.1(degree)-242.1(of)-242.8(skill)-244.7(on)]TJ 0 -1.2571 TD [(the)-214.4(part)-206.2(of)-211.7(the)-209.3(investigator)-208(in)-212.6(order)-208.4(to)-211.7(claim)-210(free)-208.3(medical)-209.1(treatment)-213.5(or)]TJ T* [(compensation.)-231.9(The)-233.2(informed)-235.6(consent)-228.4(process)-234.8(or)-232.1(form)-235.9(should)-230.6(contain)]TJ 0 -1.2622 TD [(no)-184.1(words)-186(that)-180.6(would)-185.8(absolve)-182.1(an)-179.2(investigator)-182.1(from)-184.2(responsibility)-184.5(in)-181.6(the)]TJ 0 -1.2571 TD [(case)-398.2(of)-392.8(accidental)-393.8(injury,)-398.1(or)-392.5(that)-392.7(would)-392.7(imply)-395.1(that)-397.8(subjects)-394.4(would)]TJ 0 -1.2623 TD [(waive)-301.3(their)-299.2(right)-303.5(to)-299.7(seek)-299.7(compensatio)6.7(n)-301.6(for)-302.7(impairmen)5.8(t,)-302.3(disability)-298.7(or)]TJ 0 -1.2571 TD [(handicap.)-269.2(Prospective)-265.7(subjects)-270.3(should)-266.8(be)-268.1(informed)-266.6(that)-268.5(they)-268(will)-272.3(not)]TJ T* [(need)-458.6(to)-454.9(take)-454.2(legal)-454.4(action)-454.8(to)-454.9(secure)-455.4(the)-457.6(free)-451.4(medical)-457.4(treatment)-456.7(or)]TJ 0 -1.2623 TD [(compensation)-284.6(for)-282(injury)-285.2(to)-284.1(which)-285.2(they)-283.5(may)-283.5(be)-283.6(entitled.)-286.2(They)-281.6(should)]TJ 0 -1.2571 TD [(also)-336.4(be)-340.5(told)-336.4(what)-333.6(medical)-338.4(service)-335.7(or)-335.6(organization)-334.1(or)-335.6(individual)-336.9(will)]TJ T* 0.0116 Tc [(provide)-611.9(t)-2(he)-611.9(medical)-613.4(t)-2(reatment)-612.4(and)-615.9(w)5.4(hat)-612.4(o)-0.3(rganization)-615.9(w)0.2(ill)-613.4(b)-0.3(e)]TJ 0 -1.2623 TD 0 Tc [(responsible)-272.1(for)-266.4(providing)-269.4(compensatio)6.7(n.)]TJ /F5 1 Tf 0 -2.3486 TD [(Obligation)-455(of)-455.1(the)-457.9(sponsor)-450.7(with)-455.5(regard)-453.8(to)-455.1(compensation.)]TJ /F2 1 Tf 24.5157 0 TD [(Before)-454.3(the)]TJ -24.5157 -1.2571 TD [(research)-294.7(begins,)-298.3(the)-292(sponsor,)-293.5(whether)-295.2(a)-291.5(pharmaceutical)-292(company)-290.8(or)]TJ 0 -1.2623 TD [(other)-177.6(organization)-173.7(or)-170.1(institution,)-175.3(or)-175.2(a)-177.7(government)-170.5(\(where)-174.7(government)]TJ 0 -1.2571 TD 0.0163 Tc [(insurance)-617.5(i)1.8(s)-623(n)-0.7(o)4.4(t)-623.3(p)4.4(r)-2.2(eclu)4.4(ded)-616.4(b)-0.7(y)-616.6(l)-3.4(aw\),)-619(sh)4.4(ould)-621.5(a)-1(gree)-622.7(to)-621.5(provide)]TJ 0 -1.2623 TD 0 Tc [(compensation)-300.1(for)-297.5(any)-294.8(physical)-300.1(injury)-300.8(for)-297.5(which)-295.6(subjects)-301.3(are)-297.2(entitled)]TJ 0 -1.2571 TD [(to)-475.5(compensation,)-475(or)-475.3(come)-473.1(to)-475.5(an)-474.1(agreement)-470.2(with)-475.6(the)-473.1(investigator)]TJ T* [(concerning)-302.7(the)-297.2(circumstances)-296.6(in)-300.6(which)-300.8(the)-302.4(investigator)-295.9(must)-303.2(rely)-296.2(on)]TJ 0 -1.2623 TD [(his)-396.7(or)-397.7(her)-395.2(own)-397.3(insurance)-394.5(coverage)-390.6(\(for)-399(example,)-392(for)-395.8(negligence)-398.4(or)]TJ 0 -1.2571 TD [(failure)-181(of)-180.7(the)-178.2(investigator)-176.9(to)-180.7(follow)-181.3(the)-178.2(protocol,)-178.7(or)-180.4(where)-176.6(government)]TJ 0 -1.2623 TD [(insurance)-254.8(coverage)-245.7(is)-255.5(limited)-253.4(to)-253.1(negligence\))7(.)-257.7(I)0(n)-247.7(certain)-252(circumstances)]TJ 0 -1.2571 TD [(it)-421.3(may)-412.8(be)-418.1(advisable)-415.7(to)-418.6(follow)-414.1(both)-416.5(courses.)-414.8(Sponsors)-415(should)-416.8(seek)]TJ T* [(adequate)-218.7(insurance)-213.4(against)-219.1(risks)-216.4(to)-216.9(cover)-218.7(compensation,)-216.3(independent)]TJ 0 -1.2623 TD [(of)-273.8(proof)-264.3(of)-268.6(fault.)]TJ ET 95.641 646.809 318.898 -0.51 re f BT /F6 1 Tf 7.9702 0 0 7.9702 95.6409 649.1337 Tm [(THE)-330.8(GUIDELINES)]TJ /F7 1 Tf 11.9551 0 0 11.9551 401.3857 649.1337 Tm (79)Tj ET endstream endobj 235 0 obj << /Type /Page /Parent 398 0 R /Resources 236 0 R /Contents 237 0 R /MediaBox [ 0 0 595 842 ] /CropBox [ 0 0 595 842 ] /Rotate 0 >> endobj 236 0 obj << /ProcSet [ /PDF /Text ] /Font << /F2 337 0 R /F6 341 0 R /F7 342 0 R /F8 343 0 R /F10 345 0 R /F11 346 0 R >> /ExtGState << /GS1 434 0 R >> /ColorSpace << /DefaultCMYK 417 0 R /Cs6 416 0 R >> >> endobj 237 0 obj << /Length 5503 >> stream q 1 i 0.015 737.008 510.221 -737.008 re W n /Cs6 cs 0 0 0 scn /GS1 gs 0.015 709.001 25.44 -0.284 re f Q /Cs6 cs 0 0 0 scn /GS1 gs 28.006 737.008 0.283 -25.455 re f 481.89 737.008 0.283 -25.455 re f 484.724 709.001 25.512 -0.284 re f 484.724 28.346 25.512 -0.283 re f 481.89 25.512 0.283 -25.512 re f q 1 i 0.015 737.008 510.221 -737.008 re W n 28.006 25.512 0.283 -25.512 re f 0.015 28.346 25.44 -0.283 re f Q 1 1 1 scn 95.641 603.439 14.173 -2.835 re f 0 0 0 scn 95.641 623.622 318.898 -20.183 re f 1 1 1 scn 95.641 566.646 14.173 -2.835 re f 0.8 0.8 0.8 scn 95.641 600.605 318.898 -33.959 re f BT /F11 1 Tf 11.9551 0 3.5865 11.9551 214.8661 608.9951 Tm 1 1 1 scn 0 Tc 0 Tw [(Guideline)-278.6(20)]TJ 11.9551 0 0 11.9551 131.3008 585.9778 Tm 0 0 0 scn [(Strengthening)-283.2(capacity)-276.8(for)-271.4(ethical)-276.4(and)]TJ -0.9295 -1.1523 TD [(scientifi)-10.8(c)-268.2(review)-275.6(and)-273.5(biomedic)-10(al)-268.7(rese)-7.6(arch)]TJ /F8 1 Tf 10.959 0 0 10.959 95.6409 550.6014 Tm [(Many)-537.7(countries)-531.6(lack)-536.4(the)-534.4(capacity)-534.4(to)-538(assess)-531.7(or)-537.1(ensure)-532.6(the)]TJ 0 -1.2571 TD [(scientific)-198.5(quality)-193.8(or)-190.5(ethical)-194(acceptability)-192.5(of)-196.6(biomedical)-191.3(research)]TJ 0 -1.2623 TD [(proposed)-519.4(or)-516.4(carried)-523(out)-518.6(in)-517.6(their)-520.9(jurisdictions.)-518.6(In)-522.8(externally)]TJ 0 -1.2571 TD [(sponsored)-241.6(collaborativ)6.8(e)-244.7(research,)-236.4(sponsors)-235.1(and)-242(investigators)]TJ T* [(have)-326.6(an)-323.5(ethical)-323.4(obligation)-324.4(to)-325.9(ensure)-320.5(that)-326.2(biomedical)-320.6(research)]TJ 0 -1.2623 TD [(projects)-556.2(for)-561.7(which)-557.4(they)-556.6(are)-554.4(responsible)-555.4(in)-553.8(such)-559.1(countries)]TJ 0 -1.2571 TD [(contribute)-188.7(effectively)-189.7(to)-191.4(national)-184.7(or)-190.5(local)-188.6(capacity)-187.8(to)-191.4(design)-186.9(and)]TJ 0 -1.2623 TD [(conduct)-488(biomedical)-486.2(research,)-484.7(and)-490.3(to)-486.3(provide)-490(scientific)-488.2(and)]TJ 0 -1.2571 TD [(ethical)-271.6(review)-266.1(and)-267.9(monitoring)-269.6(of)-269(such)-269.4(research.)]TJ 0 -1.7434 TD 0.0109 Tc [(Cap)4.5(a)-1(city-b)4.5(uilding)-611.1(m)0.9(ay)-611.4(in)4.5(clu)4.5(d)-0.7(e,)-608.9(but)-608.6(is)-611.4(n)4.5(o)-0.7(t)-613.8(l)1.5(imited)-611.1(to,)-614.1(t)1.8(he)]TJ 0 -1.2623 TD 0 Tc [(following)-270.7(activities:)]TJ /F10 1 Tf 8.9663 0 0 8.9663 109.8142 389.0267 Tm (.)Tj /F8 1 Tf 10.959 0 0 10.959 123.9874 388.1763 Tm [(establishing)-255.3(and)-257.6(strengtheni)6.3(ng)-256(independent)-253.1(and)-257.6(compe-)]TJ T* [(tent)-274.5(ethical)-266.5(review)-266.1(processes/)-267.2(committees)]TJ /F10 1 Tf 8.9663 0 0 8.9663 109.8142 361.4172 Tm (.)Tj /F8 1 Tf 10.959 0 0 10.959 123.9874 360.5668 Tm [(strengthening)-270.4(research)-263.2(capacity)]TJ /F10 1 Tf 8.9663 0 0 8.9663 109.8142 347.6409 Tm (.)Tj /F8 1 Tf 10.959 0 0 10.959 123.9874 346.7905 Tm [(developing)-365.9(technologies)-361(appropriate)-365.2(to)-367.3(health-care)-366.6(and)]TJ T* [(biomedical)-268.9(research)]TJ /F10 1 Tf 8.9663 0 0 8.9663 109.8142 320.0314 Tm (.)Tj /F8 1 Tf 10.959 0 0 10.959 123.9874 319.181 Tm [(training)-268.9(of)-274.2(research)-263.2(and)-267.9(health-care)-268.4(staff)]TJ /F10 1 Tf 8.9663 0 0 8.9663 109.8142 306.1984 Tm (.)Tj /F8 1 Tf 10.959 0 0 10.959 123.9874 305.348 Tm [(educating)-328.2(the)-327.4(community)-324.6(from)-328.5(which)-324.6(research)-325.3(subjects)]TJ 0 -1.2571 TD [(will)-272(be)-271.8(drawn.)]TJ 9.9626 0 2.9888 9.9626 95.6409 255.4582 Tm [(Comm)-9.3(ent)-7.2(ary)-269.4(on)-277.2(Guidelin)-10.9(e)-267.4(2)0(0)]TJ /F2 1 Tf 10.959 0 0 10.959 95.6409 237.3731 Tm [(External)-454.2(sponsors)-452.7(and)-454.9(investigators)-454.1(have)-452.8(an)-453.4(ethical)-455(obligation)-454.9(to)]TJ T* [(contribute)-346(to)-346.2(a)-348.4(host)-345.6(countrys)-343.3(sustainable)-349.3(capacity)-340.6(for)-349.2(independent)]TJ 0 -1.2623 TD [(scientific)-321.5(and)-320.4(ethical)-320.5(review)-315.5(and)-320.4(biomedical)-319.8(research.)-319.6(Before)-319.8(under-)]TJ 0 -1.2571 TD [(taking)-443.5(research)-444.7(in)-440.3(a)-446.7(host)-438.7(country)-439.6(with)-444.6(little)-446(or)-444.2(no)-442.8(such)-438.2(capacity,)]TJ T* [(external)-419.4(sponsors)-416.5(and)-418.7(investigators)-412.7(should)-416.8(include)-421.9(in)-414.4(the)-421.4(research)]TJ 0 -1.2623 TD [(protocol)-365.9(a)-358.7(plan)-360.8(that)-361.6(specifies)-363.6(the)-364.5(contribution)-360.9(they)-361.1(will)-365.4(make.)-362.6(The)]TJ 0 -1.2571 TD [(amount)-299.9(of)-299.7(capacity)-294(building)-299.8(reasonably)-291.9(expected)-298.4(should)-297.8(be)-299.1(propor-)]TJ 0 -1.2623 TD [(tional)-373.4(to)-366.9(the)-369.6(magnitude)-370.7(of)-366.9(the)-369.6(research)-372.3(project.)-369.7(A)-368.1(brief)-371.6(epidemiol-)]TJ 0 -1.2571 TD [(ogical)-337(study)-337(involving)-338.1(only)-335(review)-336.2(of)-335.9(medical)-338.4(records,)-337.2(for)-333.7(example,)]TJ T* [(would)-449.6(entail)-447.1(relatively)-448.7(little,)-450.2(if)-447.2(any,)-449(such)-448.5(development,)-447.3(whereas)-445.2(a)]TJ 0 -1.2623 TD [(considerable)-237.4(contribution)-231.6(is)-234.8(to)-237.6(be)-237.1(expected)-231.1(of)-237.6(an)-236.1(external)-233.1(sponsor)-232.4(of,)]TJ ET 95.641 646.809 318.898 -0.51 re f BT /F6 1 Tf 7.9702 0 0 7.9702 191.1118 649.1337 Tm [(INTERNA)13.4(TIONAL)-327.4(ETHICAL)-327.5(GUIDELINES)-319.8(FOR)-332.5(BIOMED)13.7(ICAL)-331.1(RESEARCH)]TJ /F7 1 Tf 11.9551 0 0 11.9551 95.6409 649.1337 Tm (80)Tj ET endstream endobj 238 0 obj << /Type /Page /Parent 399 0 R /Resources 239 0 R /Contents 240 0 R /MediaBox [ 0 0 595 842 ] /CropBox [ 0 0 595 842 ] /Rotate 0 >> endobj 239 0 obj << /ProcSet [ /PDF /Text ] /Font << /F2 337 0 R /F5 340 0 R /F6 341 0 R /F7 342 0 R /F8 343 0 R /F10 345 0 R /F11 346 0 R >> /ExtGState << /GS1 434 0 R >> /ColorSpace << /DefaultCMYK 417 0 R /Cs6 416 0 R >> >> endobj 240 0 obj << /Length 5214 >> stream q 1 i 0.015 737.008 510.221 -737.008 re W n /Cs6 cs 0 0 0 scn /GS1 gs 0.015 709.001 25.44 -0.284 re f Q /Cs6 cs 0 0 0 scn /GS1 gs 28.006 737.008 0.283 -25.455 re f 481.89 737.008 0.283 -25.455 re f 484.724 709.001 25.512 -0.284 re f 484.724 28.346 25.512 -0.283 re f 481.89 25.512 0.283 -25.512 re f q 1 i 0.015 737.008 510.221 -737.008 re W n 28.006 25.512 0.283 -25.512 re f 0.015 28.346 25.44 -0.283 re f Q 1 1 1 scn 95.641 374.967 14.173 -2.835 re f 0 0 0 scn 95.641 395.15 318.898 -20.183 re f 1 1 1 scn 95.641 338.116 14.173 -2.835 re f 0.8 0.8 0.8 scn 95.641 372.132 318.898 -34.016 re f BT /F2 1 Tf 10.959 0 0 10.959 95.6409 609.8455 Tm 0 0 0 scn 0 Tc 0 Tw [(for)-349.2(instance,)-345.7(a)-343.2(large-scale)-346.8(vaccine)-343.4(field-trial)-346(expected)-344.9(to)-346.2(last)-348.5(two)-342.1(or)]TJ 0 -1.2623 TD [(three)-271.9(years.)]TJ 1.2933 -1.2571 TD [(The)-181.5(specific)-179.5(capacity-building)-172.9(objectives)-182.9(should)-173.7(be)-180.1(determined)-179(and)]TJ -1.2933 -1.2623 TD [(achieved)-184.6(through)-179.7(dialogue)-184.8(and)-180.8(negotiation)-182.6(between)-181.1(external)-186.6(sponsors)]TJ 0 -1.2571 TD [(and)-201.5(host-country)-198.7(authorities.)-199.7(External)-200.7(sponsors)-199.2(would)-201.3(be)-200.8(expected)-200.1(to)]TJ T* [(employ)-571(and,)-567.8(if)-566.1(necessary,)-569.7(train)-567.3(local)-568(individuals)-567.5(to)-568.7(function)-567.9(as)]TJ 0 -1.2623 TD [(investigators,)-256.5(research)-258.5(assistants)-255.4(or)-258(data)-251.5(managers,)-258.4(for)-256.1(example,)-257.5(and)]TJ 0 -1.2571 TD [(to)-185.9(provide,)-186(as)-180.7(necessary,)-186.8(reasonable)-179(amounts)-183.9(of)-180.7(financial,)-184.6(educational)]TJ T* [(and)-563.6(other)-555.2(assistance)-559.9(for)-561.3(capacity-buildi)6.3(ng.)-561(To)-561.6(avoid)-559.2(conflict)-561.4(of)]TJ 0 -1.2623 TD [(in)-10.9(ter)-9(est)-614.2(and)-615.3(saf)-8.1(egu)-6.1(ard)-616.8(the)-612.8(ind)-7.2(ep)-9.4(ende)-8.5(nce)-617.4(of)-610.1(rev)-7.5(ie)-6.9(w)-611.5(com)-10(mit)-8(tee)-8.7(s,)]TJ 0 -1.2571 TD [(financial)-314.9(assistance)-311.5(should)-308.2(not)-311.5(be)-309.5(provided)-312.7(directly)-307.9(to)-315.2(them;)-307.1(rather,)]TJ 0 -1.2623 TD [(funds)-202.3(should)-199.6(be)-200.8(made)-198(available)-199.9(to)-196.2(appropriate)-201.8(authorities)-195.6(in)-202.3(the)-198.9(host-)]TJ 0 -1.2571 TD [(country)-268.9(government)-268.8(or)-268.4(to)-268.6(the)-271.4(host)-268(research)-268.8(institution.)]TJ 1.2933 -1.2571 TD [(\(See)-367.2(also)-362.3(Guideline)-364.6(10:)]TJ /F5 1 Tf 10.3567 0 TD [(Research)-365.5(in)-362.9(populations)-363.5(and)-362.4(communities)]TJ -11.65 -1.2622 TD [(with)-274.4(limited)-269.5(resources)]TJ /F2 1 Tf 9.0117 0 TD (\).)Tj /F11 1 Tf 11.9551 0 3.5865 11.9551 214.8661 380.5227 Tm 1 1 1 scn [(Guideline)-278.6(21)]TJ 11.9551 0 0 11.9551 130.7905 357.5054 Tm 0 0 0 scn [(Ethical)-276.5(obligation)-282.2(of)-272.1(external)-277.8(sponsors)]TJ 2.0439 -1.1523 TD [(to)-272.2(provide)-274.2(health-ca)-11.4(re)-272.2(services)]TJ /F8 1 Tf 10.959 0 0 10.959 95.6409 322.1291 Tm 0.0379 Tc [(Exte)5.3(rnal)-638.8(spo)5.6(n)0.4(sors)-636.1(are)-636.1(e)0.2(thica)5.3(l)-2.5(ly)-641.3(oblig)5.6(ed)-641(to)-641(ens)5.3(u)0.4(re)-636.1(the)]TJ 0 -1.2623 TD 0 Tc [(availability)-271.7(of:)]TJ /F10 1 Tf 1.2933 -1.5468 TD (7)Tj /F8 1 Tf 1.2933 0 TD [(health-care)-195.9(services)-187.1(that)-196.9(are)-192.3(essential)-191.9(to)-196.6(the)-192.9(safe)-189.6(conduct)]TJ 0 -1.2623 TD [(of)-274.2(the)-265.4(research;)]TJ /F10 1 Tf -1.2933 -1.2571 TD (7)Tj /F8 1 Tf 1.2933 0 TD [(treatment)-558.2(for)-561.7(subjects)-554.8(who)-556.9(suffer)-558.3(injury)-553.4(as)-561.8(a)-555.1(conse-)]TJ 0 -1.2571 TD [(quence)-267.1(of)-269(research)-268.4(interventions;)-267.1(and,)]TJ /F10 1 Tf -1.2933 -1.2623 TD (7)Tj /F8 1 Tf 1.2933 0 TD [(services)-223.3(that)-222.7(are)-223.3(a)-224(necessary)-221.9(part)-221.8(of)-222.5(the)-224(commitment)-223.4(of)-222.5(a)]TJ 0 -1.2571 TD [(sponsor)-533.6(to)-538(make)-531.9(a)-534.4(beneficial)-532.1(intervention)-535.8(or)-537.1(product)]TJ 0 -1.2623 TD [(developed)-372.4(as)-375.5(a)-379.2(result)-372.4(of)-377.6(the)-374(research)-377.1(reasonabl)8.7(y)-379.2(avail-)]TJ 0 -1.2571 TD [(able)-272.4(to)-269(the)-270.5(population)-264.6(or)-268.1(community)-267.7(concerned.)]TJ 9.9626 0 2.9888 9.9626 95.6409 160.2708 Tm [(Comm)-9.3(ent)-7.2(ary)-269.4(on)-277.2(Guidelin)-10.9(e)-267.4(2)0(1)]TJ /F2 1 Tf 10.6302 0 0 10.959 95.6409 142.1858 Tm [(Obligations)-165.9(of)-165.6(external)-164.6(sponsors)-161.2(to)-165.6(provide)-165.2(health-care)-165.2(services)-166.6(will)-168(vary)]TJ T* [(with)-494.9(the)-486(circumstances)-489.2(of)-491(particular)-487.9(studies)-488.6(and)-491.9(the)-491.3(needs)-484.9(of)-491(host)]TJ 0 -1.2623 TD [(countries.)-456.2(The)-456.9(sponsors)-456.6(obligations)-453.2(in)-458(particular)-455.9(studies)-456.6(should)-454.3(be)]TJ 0 -1.2571 TD [(clarified)-428.6(before)-423.9(the)-427.3(research)-423.2(is)-427.6(begun.)-422.2(The)-424.9(research)-428.6(protocol)-420.2(should)]TJ ET 95.641 646.809 318.898 -0.51 re f BT /F6 1 Tf 7.9702 0 0 7.9702 95.6409 649.1337 Tm [(THE)-330.8(GUIDELINES)]TJ /F7 1 Tf 11.9551 0 0 11.9551 401.3857 649.1337 Tm (81)Tj ET endstream endobj 241 0 obj << /Type /Page /Parent 399 0 R /Resources 242 0 R /Contents 243 0 R /MediaBox [ 0 0 595 842 ] /CropBox [ 0 0 595 842 ] /Rotate 0 >> endobj 242 0 obj << /ProcSet [ /PDF /Text ] /Font << /F2 337 0 R /F5 340 0 R /F6 341 0 R /F7 342 0 R >> /ExtGState << /GS1 434 0 R >> /ColorSpace << /DefaultCMYK 417 0 R /Cs6 416 0 R >> >> endobj 243 0 obj << /Length 5874 >> stream q 1 i 0.015 737.008 510.221 -737.008 re W n /Cs6 cs 0 0 0 scn /GS1 gs 0.015 709.001 25.44 -0.284 re f Q /Cs6 cs 0 0 0 scn /GS1 gs 28.006 737.008 0.283 -25.455 re f 481.89 737.008 0.283 -25.455 re f 484.724 709.001 25.512 -0.284 re f 484.724 28.346 25.512 -0.283 re f 481.89 25.512 0.283 -25.512 re f q 1 i 0.015 737.008 510.221 -737.008 re W n 28.006 25.512 0.283 -25.512 re f 0.015 28.346 25.44 -0.283 re f Q BT /F2 1 Tf 10.6302 0 0 10.959 95.6409 609.8455 Tm 0 Tc 0 Tw [(specify)-173.9(what)-168.9(health-care)-170.5(services)-171.9(will)-173.3(be)-173.6(made)-168.9(available,)-170.9(during)-170.3(and)-172(after)]TJ 0 -1.2623 TD [(the)-288.6(research,)-281.2(to)-283(the)-283.3(subjects)-286.2(themselves,)-281.2(to)-288.3(the)-283.3(community)-279.9(from)-286.6(which)]TJ 0 -1.2571 TD [(the)-310(subjects)-307.6(are)-304.6(drawn,)-308.2(or)-305.6(to)-309.6(the)-304.6(host)-305.9(country,)-306.9(and)-305.3(for)-308.6(how)-305.9(long.)-303.9(The)]TJ 0 -1.2623 TD [(details)-244.9(of)-240.3(these)-245.3(arrangements)-238.5(should)-240.9(be)-243(agreed)-239.6(by)-244(the)-240.6(sponsor,)-244.2(officials)]TJ 0 -1.2571 TD [(of)-219(the)-214(host)-209.9(country,)-216.2(other)-210.3(interested)-214.9(parties,)-217.3(and,)-211.3(when)-215.6(appropriate,)-210.5(the)]TJ T* 0.023 Tc [(commu)4.3(n)-1(ity)-607.6(f)-1.3(rom)-605.6(w)-0.3(hich)-609(subjects)-610.6(are)-606.6(t)-1.3(o)-609(b)-1(e)-606.6(d)4.4(rawn.)-608.3(T)1(he)-606.6(agreed)]TJ 0 -1.2623 TD 0 Tc [(arrangements)-227.8(should)-230.3(be)-227(specified)-230.9(in)-228.6(the)-230(consent)-223.9(process)-232.3(and)-225.3(document.)]TJ 10.959 0 0 10.959 109.8142 513.2408 Tm [(Although)-280(sponsors)-281.9(are,)-285.9(in)-279.9(general,)-280.6(not)-285.7(obliged)-281.3(to)-279(provide)-280.1(health-)]TJ -1.2933 -1.2571 TD [(care)-351.7(services)-349(beyond)-346.9(that)-346.1(which)-347.3(is)-348.6(necessary)-348.2(for)-349.2(the)-348.9(conduct)-345.9(of)-346.2(the)]TJ 0 -1.2623 TD [(research,)-304(it)-307.5(is)-302(morally)-301.6(praiseworthy)-302.6(to)-304.8(do)-303.1(so.)-303.6(Such)-297(services)-307.7(typically)]TJ 0 -1.2571 TD [(include)-215(treatment)-213.5(for)-214.7(diseases)-213.4(contracted)-210.3(in)-217.8(the)-214.4(course)-211.1(of)-216.9(the)-209.3(study.)-217.1(It)]TJ 0 -1.2623 TD [(might,)-315.6(for)-318.2(example,)-309.2(be)-314.6(agreed)-313.6(to)-315.2(treat)-314.1(cases)-313.3(of)-315.2(an)-313.7(infectious)-312.5(disease)]TJ 0 -1.2571 TD [(contracted)-200(during)-194.6(a)-198.4(trial)-197.5(of)-201.4(a)-198.4(vaccine)-193.4(designed)-200.1(to)-196.2(provide)-197.4(immunity)-198.7(to)]TJ T* 0.0106 Tc [(th)3.9(at)-613.4(d)3.9(i)1.2(sease,)-614.4(or)-613.2(to)-611.7(pro)3.9(v)-1.5(ide)-612.9(t)2.2(rea)3.6(t)]TJ 15.3591 0 TD 0 Tc [(me)-18.8(n)-6.7(t)-624(o)-11.9(f)-624(i)-9.4(n)-6.7(c)-13.1(i)]TJ 5.8819 0 TD 0.0083 Tc [(den)1.6(t)-5.3(al)-616.7(co)]TJ 4.3248 0 TD 0.0102 Tc (nditions)Tj -25.5658 -1.2622 TD 0 Tc [(unrelated)-270.6(to)-268.6(the)-271.3(study.)]TJ 1.2933 -1.2571 TD [(The)-497.1(obligation)-491.1(to)-496.2(ensure)-490.4(that)-496.1(subjects)-492.7(who)-495.6(suffer)-492.7(injury)-492.2(as)-496.2(a)]TJ -1.2933 -1.2623 TD [(consequence)-293.3(of)-289.3(research)-294.7(interventions)-287.8(obtain)-293.2(medical)-291.9(treatment)-291.1(free)]TJ 0 -1.2571 TD [(of)-263.5(charge,)-260.9(and)-258.4(that)-258.2(compensation)-258.7(be)-262.9(provided)-255.8(for)-261.3(death)-259.2(or)-258(disability)]TJ T* 0.0157 Tc [(occurring)-612.1(as)-613.2(a)-617.2(c)2.6(on)3.8(seq)3.8(u)3.8(e)-2.5(n)3.8(c)2.6(e)-618.1(o)3.8(f)-618.7(s)]TJ 15.5143 0 TD 0.0126 Tc [(uc)-5.6(h)-614.9(i)-7.1(njur)-5.9(y,)-617.5(i)-7.1(s)-616.3(th)-4.4(e)-616.1(s)-5.9(ubje)-5.6(c)-0.5(t)-616.6(o)-4.4(f)]TJ -15.5143 -1.2623 TD 0 Tc [(Guideline)-333.5(19,)-271.6(on)-266.9(the)-271.4(scope)-265(and)-268.7(limits)-272.8(of)-268.6(such)-267.4(obligations.)]TJ 1.2933 -1.2571 TD [(When)-387.7(prospective)-385(or)-387.3(actual)-382.6(subjects)-389.2(are)-385.2(found)-381.9(to)-387.6(have)-385.5(diseases)]TJ -1.2933 -1.2571 TD [(unrelated)-348.2(to)-351.4(the)-348.9(research,)-350.6(or)-346(cannot)-348.7(be)-350.9(enrolled)-347.3(in)-352.3(a)-348.4(study)-347.4(because)]TJ 0 -1.2623 TD 0.0106 Tc [(th)3.9(ey)-612(d)3.9(o)-611.7(no)3.9(t)-613.4(m)-0.3(eet)-613.4(t)2.2(he)-612.9(h)3.9(e)-2.5(alth)-611.7(criteria,)-614.4(i)1.3(nvestigators)-613.2(sho)3.9(u)-1.3(ld,)-609.2(a)-1.5(s)]TJ 0 -1.2571 TD 0 Tc [(appropriate,)-319.8(advise)-320.3(them)-318.4(to)-320.4(obtain,)-318.1(or)-320.1(refer)-319.9(them)-318.4(for,)-322.4(medical)-317.7(care.)]TJ 0 -1.2622 TD [(In)-268.4(general,)-265.1(also,)-268.2(in)-264.4(the)-266.2(course)-262.8(of)-268.6(a)-265.6(study,)-263.6(sponsors)-261.3(should)-266.8(disclose)-266(to)]TJ 0 -1.2571 TD [(the)-385.2(proper)-385.8(health)-382.3(authorities)-381.8(information)-383.3(of)-382.4(public)-388.2(health)-382.3(concern)]TJ T* [(arising)-273(from)-267(the)-271.4(research.)]TJ 1.2933 -1.2623 TD [(The)-202.2(obligation)-201.4(of)-201.4(the)-204.1(sponsor)-201.4(to)-201.4(make)-198(reasonably)-198.8(available)-205.1(for)-199.2(the)]TJ -1.2933 -1.2571 TD [(benefit)-169.2(of)-170.3(the)-173.1(population)-162.3(or)-170.1(community)-167.7(concerned)-170.1(any)-165.5(intervention)-171(or)]TJ 0 -1.2623 TD [(product)-180.7(developed,)-179.7(or)-180.4(knowledge)-179(generated,)-175.3(as)-180.7(a)-182.9(result)-178.1(of)-180.7(the)-183.4(research)]TJ 0 -1.2571 TD [(is)-188.2(considered)-179.7(in)-181.6(Guideline)-183.5(10:)]TJ /F5 1 Tf 12.3794 0 TD [(Research)-184.4(in)-181.9(populations)-177.3(and)-181.3(communities)]TJ -12.3794 -1.2571 TD [(with)-274.4(limited)-269.5(resources.)]TJ ET 95.641 646.809 318.898 -0.51 re f BT /F6 1 Tf 7.9702 0 0 7.9702 191.1118 649.1337 Tm [(INTERNA)13.4(TIONAL)-327.4(ETHICAL)-327.5(GUIDELINES)-319.8(FOR)-332.5(BIOMED)13.7(ICAL)-331.1(RESEARCH)]TJ /F7 1 Tf 11.9551 0 0 11.9551 95.6409 649.1337 Tm (82)Tj ET endstream endobj 244 0 obj << /Type /Page /Parent 399 0 R /Resources 245 0 R /Contents 246 0 R /MediaBox [ 0 0 595 842 ] /CropBox [ 0 0 595 842 ] /Rotate 0 >> endobj 245 0 obj << /ProcSet [ /PDF /Text ] /Font << /F2 337 0 R /F4 339 0 R /F5 340 0 R /F11 346 0 R >> /ExtGState << /GS1 434 0 R >> /ColorSpace << /DefaultCMYK 417 0 R /Cs6 416 0 R >> >> endobj 246 0 obj << /Length 4668 >> stream q 1 i 0.015 737.008 510.221 -737.008 re W n /Cs6 cs 0 0 0 scn /GS1 gs 0.015 709.001 25.44 -0.284 re f Q /Cs6 cs 0 0 0 scn /GS1 gs 28.006 737.008 0.283 -25.455 re f 481.89 737.008 0.283 -25.455 re f 484.724 709.001 25.512 -0.284 re f 484.724 28.346 25.512 -0.283 re f 481.89 25.512 0.283 -25.512 re f q 1 i 0.015 737.008 510.221 -737.008 re W n 28.006 25.512 0.283 -25.512 re f 0.015 28.346 25.44 -0.283 re f Q 1 1 1 scn 95.641 492.491 14.173 -2.835 re f 0 0 0 scn 95.641 554.06 318.898 -61.568 re f BT /F4 1 Tf 19.9253 0 0 19.9253 207.0425 588.3589 Tm 0 Tc 0 Tw (Appendix)Tj /F2 1 Tf 4.3248 0 TD (1)Tj /F11 1 Tf 11.9551 0 0 11.9551 123.8173 539.4329 Tm 1 1 1 scn [(ITEMS)-275.1(TO)-271.5(BE)-276.1(INCLUDED)-275.9(IN)-272.6(A)-273.3(PROTOCOL)]TJ 2.39 -1.1523 TD [(\(OR)-275.5(ASSOCIATED)-281.5(DOCUMENTS\))]TJ -2.6129 -1.1523 TD [(FOR)-269.6(BIOMEDIC)-10.3(AL)-271.2(RESEA)-9.7(RCH)-269.9(INVO)-8.4(LVING)]TJ 6.0273 -1.1571 TD [(HUMAN)-275.2(SUBJECT)-10.7(S)]TJ /F2 1 Tf 10.959 0 0 10.959 95.6409 465.5054 Tm 0 0 0 scn [(\(Include)-268.8(the)-271.3(items)-272.4(relevant)-264.2(to)-268.6(the)-271.3(study/project)-266.1(in)-269.5(question\))]TJ 0.5018 -1.8416 TD [(1.)-797.5(Title)-274.4(of)-268.6(the)-266.2(study;)]TJ 0 -1.2623 TD [(2.)-797.5(A)-611.2(s)0(u)-9.7(mma)-8.1(ry)-615.2(of)-610.1(the)-618(pro)-6.1(p)-6.7(ose)-7.2(d)-612(res)-8.7(ear)-7.5(c)-7.9(h)-606.8(in)-616.1(lay)-7.8(/no)-11.5(n-t)-8.1(ech)-7(n)-6.7(i)0(c)-6.9(a)0(l)]TJ 1.5675 -1.2571 TD (language;)Tj -1.5675 -1.2623 TD [(3.)-797.5(A)-507.8(clear)-505.9(statement)-508.4(of)-506.6(the)-504.1(justification)-504.2(for)-509.6(the)-504.1(study,)-506.8(and)-501.5(its)]TJ 1.5675 -1.2571 TD [(significance)-463(in)-461(development)-463.8(and)-460.1(in)-461(meeting)-461.7(the)-462.8(needs)-461.6(of)-460(the)]TJ T* [(country/population)-263.8(in)-269.5(which)-269.7(the)-271.3(research)-268.8(is)-271(carried)-267.3(out;)]TJ -1.5675 -1.2623 TD [(4.)-797.5(The)-279.8(investigators)-272.1(views)-276.6(of)-279(the)-276.5(ethical)-279.1(issues)-276.1(and)-273.9(considerations)]TJ 1.5675 -1.2571 TD [(raised)-197.3(by)-194.7(the)-198.9(study)-192.2(and,)-200.5(if)-193.7(appropriate,)-195.6(how)-195.6(it)-198.8(is)-193.4(proposed)-197.4(to)-196.2(deal)]TJ 0 -1.2623 TD [(with)-273.9(them;)]TJ -1.5675 -1.2571 TD [(5.)-797.5(S)-17.1(u)]TJ 2.7004 0 TD 0.0156 Tc [(mmary)-617.3(o)3.7(f)-618.8(all)-614.5(p)-1.4(reviou)3.7(s)-618.5(s)2.3(tu)3.7(dies)-618.5(on)-617.1(th)3.7(e)-618.2(t)-3.2(o)3.7(p)-1.4(ic,)-619.7(i)1.1(nclud)3.7(i)1.1(ng)]TJ -1.1329 -1.2571 TD 0 Tc [(unpublished)-392.1(studies)-391.7(known)-390(to)-392.8(the)-390.3(investigators)-392(and)-387.7(sponsors,)]TJ 0 -1.2623 TD [(and)-294.6(information)-285(on)-292.8(previously)-289.1(published)-290.8(research)-289.5(on)-287.6(the)-292(topic,)]TJ 0 -1.2571 TD [(including)-250.8(the)-255.8(nature,)-250.8(extent)-248.1(and)-253.2(relevance)-245.7(of)-253.1(animal)-252(studies)-252(and)]TJ T* [(other)-270.7(preclinical)-270.7(and)-268.7(clinical)-268.7(studies;)]TJ -1.5675 -1.2623 TD [(6.)-797.5(A)-218.1(statement)-213.5(that)-211.6(the)-214.4(principles)-214.8(set)-215.9(out)-213.3(in)-212.6(these)-215(Guidelines)-212.4(will)-215.4(be)]TJ 1.5675 -1.2571 TD (implemented;)Tj -1.5675 -1.2623 TD [(7.)-797.5(An)-312.7(account)-315.2(of)-310(previous)-314.2(submissions)-311.6(of)-310(the)-312.7(protocol)-314.2(for)-313(ethical)]TJ 1.5675 -1.2571 TD [(review)-274.2(and)-263.5(their)-273.4(outcome;)]TJ -1.5675 -1.2571 TD [(8.)-797.5(A)-456(brief)-454.4(description)-448.2(of)-454.9(the)-452.4(site\(s\))-452(where)-450.8(the)-452.4(research)-455(is)-452.1(to)-449.7(be)]TJ 1.5675 -1.2623 TD 0.0173 Tc [(con)-4.9(ducted,)-623.2(including)-626(information)-620.5(a)0(bout)-622.3(the)-621.7(a)0(dequacy)-620.8(o)0.3(f)]TJ 0 -1.2571 TD 0 Tc [(facilities)-364.6(for)-364.7(the)-359.3(safe)-362.6(and)-356.6(appropriate)-362.2(conduct)-356.3(of)-361.7(the)-359.3(research,)]TJ 0 -1.2623 TD 0.007 Tc [(an)7(d)]TJ /F5 1 Tf 2.2193 0 TD 0 Tc [(rel)-9.9(eva)-7.2(nt)]TJ /F2 1 Tf 3.9264 0 TD [(demog)-8.1(rap)-6.3(hic)-613.7(and)-615.3(epi)-8.4(demi)-9(olo)-7.3(gic)-8.7(al)-611.2(info)-10.5(rmat)-8.6(ion)]TJ -6.1457 -1.2571 TD [(about)-268.3(the)-271.3(country)-268.9(or)-268.4(region)-268.3(concerned;)]TJ -1.5675 -1.2571 TD [(9.)-797.5(Name)-269.5(and)-268.7(address)-270.1(of)-268.6(the)-271.4(sponsor;)]TJ -0.5018 -1.2623 TD [(10.)-799.3(Names,)-426.6(addresses,)-424.8(institutional)-420.3(affiliations)]TJ /F5 1 Tf 20.6047 0 TD (,)Tj /F2 1 Tf 0.6984 0 TD [(qualification)5.7(s)-427.2(and)]TJ -19.2339 -1.2571 TD [(experience)-268.8(of)-268.6(the)-271.4(principal)-267.8(investigator)-270.1(and)-268.7(other)-265.5(investigators;)]TJ ET endstream endobj 247 0 obj << /Type /Page /Parent 399 0 R /Resources 248 0 R /Contents 249 0 R /MediaBox [ 0 0 595 842 ] /CropBox [ 0 0 595 842 ] /Rotate 0 >> endobj 248 0 obj << /ProcSet [ /PDF /Text ] /Font << /F2 337 0 R /F6 341 0 R /F7 342 0 R >> /ExtGState << /GS1 434 0 R >> /ColorSpace << /DefaultCMYK 417 0 R /Cs6 416 0 R >> >> endobj 249 0 obj << /Length 6158 >> stream q 1 i 0.015 737.008 510.221 -737.008 re W n /Cs6 cs 0 0 0 scn /GS1 gs 0.015 709.001 25.44 -0.284 re f Q /Cs6 cs 0 0 0 scn /GS1 gs 28.006 737.008 0.283 -25.455 re f 481.89 737.008 0.283 -25.455 re f 484.724 709.001 25.512 -0.284 re f 484.724 28.346 25.512 -0.283 re f 481.89 25.512 0.283 -25.512 re f q 1 i 0.015 737.008 510.221 -737.008 re W n 28.006 25.512 0.283 -25.512 re f 0.015 28.346 25.44 -0.283 re f Q BT /F2 1 Tf 10.959 0 0 10.959 95.6409 609.8455 Tm 0 Tc 0 Tw [(11.)-799.3(The)-362.6(objectives)-353.6(of)-361.7(the)-359.3(trial)-357.8(or)-356.3(study,)-361.9(its)-357(hypotheses)-353.7(or)-361.5(research)]TJ 2.0693 -1.2623 TD [(questions,)-269.6(its)-269.1(assumptions,)-267.1(and)-268.7(its)-274.3(variables;)]TJ -2.0693 -1.2571 TD (12.)Tj 10.6302 0 0 10.959 118.3181 582.2361 Tm (A)Tj 0.976 0 TD [(detailed)-195.6(description)-202.9(of)-197.6(the)-203.3(design)-199.9(of)-197.6(the)-203.3(trial)-199.3(or)-204.3(study.)-197.3(In)-199(the)-203.3(case)]TJ -0.976 -1.2623 TD [(of)-267(controlled)-262.5(clinical)-263.2(trials)-267.6(the)-262(description)-261.5(should)-262.3(include,)-265.2(but)-259(not)]TJ 0 -1.2571 TD [(be)-467(limited)-459.2(to,)-466.3(whether)-457.9(assignment)-463.9(to)-459(treatment)-465.2(groups)-460.6(will)-461.3(be)]TJ T* [(randomized)-167.5(\(including)-165.2(the)-171.3(method)-165.2(of)-171(randomizatio)7.8(n\),)-173(and)-166.6(whether)]TJ 0 -1.2623 TD [(the)-251.3(study)-248.6(will)-248(be)-253.6(blinded)-244.2(\(single)-250.3(blind,)-248.6(double)-247.6(blind\),)-251.6(or)-247(open;)]TJ 10.959 0 0 10.959 95.6409 513.2408 Tm [(13.)-799.3(The)-414.3(number)-409.2(of)-408.3(research)-413.7(subjects)-409.9(needed)-411.1(to)-408.3(achieve)-410.7(the)-411(study)]TJ 2.0693 -1.2571 TD [(objective,)-272(and)-268.7(how)-268(this)-270.6(was)-269.7(statistically)-268.3(determined;)]TJ -2.0693 -1.2623 TD [(14.)-799.3(The)-274.6(criteria)-273.2(for)-271.6(inclusion)-272.7(or)-273.5(exclusion)-271.5(of)-268.6(potential)-272.3(subjects,)-274.4(and)]TJ 2.0693 -1.2571 TD [(justification)-271.4(for)-266.4(the)-271.3(exclusion)-266.4(of)-268.6(any)-269(groups)-265.9(on)-272.1(the)-266.2(basis)-272.2(of)-268.6(age,)]TJ 0 -1.2623 TD [(sex,)-270.4(social)-270.9(or)-268.4(economic)-271(factors,)-265.9(or)-268.4(for)-271.6(other)-270.7(reasons;)]TJ -2.0693 -1.2571 TD [(15.)-799.3(The)-321.2(justification)-312.8(for)-318.2(involving)-317.4(as)-315.2(research)-315.4(subjects)-316.8(any)-315.5(persons)]TJ 2.0693 -1.2571 TD [(with)-227.3(limited)-222.4(capacity)-226.8(to)-222.1(consent)-223.2(or)-221.8(members)-226.2(of)-222.1(vulnerable)-221.6(social)]TJ 0 -1.2622 TD [(groups,)-290.8(and)-294.6(a)-291.5(description)-287.9(of)-294.5(special)-294.3(measures)-287.3(to)-294.5(minimize)-289.6(risks)]TJ 0 -1.2571 TD [(and)-268.7(discomfort)-267.7(to)-273.8(such)-267.4(subjects;)]TJ -2.0693 -1.2623 TD [(16.)-799.3(The)-212.5(process)-208.9(of)-211.7(recruitment,)-213.7(e.g.,)-213.7(advertisem)6.5(ents,)-211.3(and)-211.8(the)-209.3(steps)-215.3(to)]TJ 2.0693 -1.2571 TD [(be)-366.4(taken)-362.6(to)-361.7(protect)-364.6(privacy)-363.4(and)-361.8(confidentiality)-362.4(during)-360.2(recruit-)]TJ T* (ment;)Tj -2.0693 -1.2623 TD [(17.)-799.3(Description)-271.4(and)-268.7(explanation)-263.9(of)-268.6(all)-268.8(interventions)-267.1(\(the)-269.4(method)-269.8(of)]TJ 2.0693 -1.2571 TD [(treatment)-544.6(administration,)-541.3(including)-540.5(route)-544.9(of)-542.8(administration)6(,)]TJ T* [(dose,)-261.3(dose)-262.3(interval)-260.5(and)-258.4(treatment)-260.1(period)-262.8(for)-261.3(investigation)6.6(al)-264.6(and)]TJ 0 -1.2623 TD [(comparator)-269.1(products)-266.4(used\);)]TJ -2.0693 -1.2571 TD [(18.)-799.3(Plans)-234.2(and)-232.5(justification)-230(for)-235.4(withdrawing)-231.9(or)-232.1(withholding)-233.3(standard)]TJ 2.0693 -1.2622 TD [(therapies)-344.5(in)-347.1(the)-343.8(course)-345.6(of)-346.2(the)-343.8(research,)-345.4(including)-344(any)-346.6(resulting)]TJ 0 -1.2571 TD [(risks)-273.4(to)-268.6(subjects;)]TJ -2.0693 -1.2571 TD [(19.)-799.3(A)-11.1(n)0(y)-618.9(o)-6.7(t)-8.4(h)0(e)-9.4(r)-618.6(tr)-11.4(e)-7.9(a)0(t)-10.2(m)0(e)-13.6(n)-6.7(t)-613.7(t)-8.4(h)-6.7(a)-7(t)-613.7(m)0(a)-12.7(y)-617.4(be)-619.9(g)-7(i)0(v)-11.2(e)-7.9(n)-617.1(o)0(r)-620.1(p)-6.7(e)-7.9(r)0(m)-8.7(i)-9.3(t)-8.4(t)0(e)-11.2(d)-6.7(,)-614.6(o)-6.7(r)]TJ 2.0693 -1.2623 TD [(contraindicated,)-269.2(during)-267.1(the)-271.3(study;)]TJ -2.0693 -1.2571 TD [(20.)-799.3(Clinical)-194.6(and)-196.3(laboratory)-189(tests)-191.1(and)-196.3(other)-193.1(tests)-191.1(that)-190.9(are)-193.8(to)-196.2(be)-190.5(carried)]TJ 2.0693 -1.2623 TD (out;)Tj -2.0693 -1.2571 TD (21.)Tj 10.6302 0 0 10.959 118.3181 195.8739 Tm [(Samples)-455.2(of)-453.6(the)-454(standardized)-454.2(case-report)-447.9(forms)-456.3(to)-453.6(be)-456.3(used,)-454.6(the)]TJ T* 0.0135 Tc [(metho)5.5(d)0.2(s)-577.5(o)0.2(f)-576.1(r)-1.5(ecording)-574.5(therapeutic)-578.8(r)-1.5(esponse)-578.8(\()-0.2(description)-575.8(a)1.5(nd)]TJ 0 -1.2623 TD 0.0129 Tc [(evaluation)-576.4(of)-571.4(metho)4.9(d)-0.4(s)-578.1(a)0.9(n)4.9(d)-576.4(freq)4.9(uency)-575.1(o)-0.4(f)-576.7(m)2.9(easurement\),)-575.7(th)4.9(e)]TJ 0 -1.2571 TD 0 Tc [(follow-up)-358.6(procedures,)-362.5(and,)-355.3(if)-362.3(applicable,)-360.5(the)-358(measures)-358.2(proposed)]TJ T* [(to)-133.6(determine)-126.9(the)-134(extent)-127.9(of)-128.3(compliance)-130.9(of)-128.3(subjects)-131.6(with)-126.9(the)-134(treatment;)]TJ 10.959 0 0 10.959 95.6409 126.8787 Tm [(22.)-799.3(Rules)-358.8(or)-361.5(criteria)-355.9(according)-357.1(to)-356.6(which)-357.7(subjects)-358.2(may)-355.9(be)-361.2(removed)]TJ 2.0693 -1.2571 TD [(from)-401.5(the)-405.9(study)-399.1(or)-397.7(clinical)-403.2(trial,)-403.4(or)-402.9(\(in)-402.1(a)-400.1(multi-centre)-400.2(study\))-402.4(a)]TJ 0 -1.2623 TD [(centre)-269.5(may)-273.2(be)-268.1(discontinued)6.9(,)-273.2(o)0(r)-268.4(the)-271.3(study)-264.6(may)-268(be)-273.3(terminated;)]TJ ET 95.641 646.809 318.898 -0.51 re f BT /F6 1 Tf 7.9702 0 0 7.9702 191.1118 649.1337 Tm [(INTERNA)13.4(TIONAL)-327.4(ETHICAL)-327.5(GUIDELINES)-319.8(FOR)-332.5(BIOMED)13.7(ICAL)-331.1(RESEARCH)]TJ /F7 1 Tf 11.9551 0 0 11.9551 95.6409 649.1337 Tm (84)Tj ET endstream endobj 250 0 obj << /Type /Page /Parent 399 0 R /Resources 251 0 R /Contents 252 0 R /MediaBox [ 0 0 595 842 ] /CropBox [ 0 0 595 842 ] /Rotate 0 >> endobj 251 0 obj << /ProcSet [ /PDF /Text ] /Font << /F2 337 0 R /F6 341 0 R /F7 342 0 R >> /ExtGState << /GS1 434 0 R >> /ColorSpace << /DefaultCMYK 417 0 R /Cs6 416 0 R >> >> endobj 252 0 obj << /Length 5561 >> stream q 1 i 0.015 737.008 510.221 -737.008 re W n /Cs6 cs 0 0 0 scn /GS1 gs 0.015 709.001 25.44 -0.284 re f Q /Cs6 cs 0 0 0 scn /GS1 gs 28.006 737.008 0.283 -25.455 re f 481.89 737.008 0.283 -25.455 re f 484.724 709.001 25.512 -0.284 re f 484.724 28.346 25.512 -0.283 re f 481.89 25.512 0.283 -25.512 re f q 1 i 0.015 737.008 510.221 -737.008 re W n 28.006 25.512 0.283 -25.512 re f 0.015 28.346 25.44 -0.283 re f Q BT /F2 1 Tf 10.959 0 0 10.959 95.6409 609.8455 Tm 0 Tc 0 Tw [(23.)-799.3(Methods)-229.9(of)-227.2(recording)-223.8(and)-227.3(reporting)-224.3(adverse)-223.5(events)-227.1(or)-227(reactions,)]TJ 2.0693 -1.2623 TD [(and)-268.7(provisions)-268.4(for)-271.6(dealing)-266.1(with)-268.7(complications;)]TJ -2.0693 -1.2571 TD [(24.)-799.3(The)-285(known)-281.4(or)-283.9(foreseen)-279.2(risks)-283.7(of)-284.1(adverse)-280.4(reactions,)-281.4(including)-281.9(the)]TJ 2.0693 -1.2623 TD [(risks)-356.1(attached)-349.7(to)-351.4(each)-350.2(proposed)-352.6(interventio)6.5(n)-353.3(and)-351.5(to)-351.4(any)-351.7(drug,)]TJ 0 -1.2571 TD [(vaccine)-271(or)-268.4(procedure)-268.6(to)-268.6(be)-268.1(tested;)]TJ -2.0693 -1.2623 TD [(25.)-799.3(For)-223.1(research)-222.2(carrying)-221.6(more)-225.1(than)-220.2(minimal)-223.9(risk)-223.8(of)-222.1(physical)-222.5(injury,)]TJ 2.0693 -1.2571 TD 0.008 Tc [(details)-610.6(of)-616(plans,)-611.8(including)-609.4(i)-1.4(nsurance)-615.5(coverag)-4.1(e)0.1(,)-611.8(t)-0.4(o)-609.1(p)1.3(r)-5.3(o)1.3(vide)]TJ T* 0 Tc [(treatment)-379.1(for)-380.3(such)-381.3(injury,)-377.4(including)-380.2(the)-380(funding)-372.3(of)-382.4(treatment,)]TJ 0 -1.2623 TD [(and)-356.6(to)-356.6(provide)-352.6(compensatio)6.7(n)-358.5(for)-354.4(research-relate)5.1(d)-358.5(disability)-355.6(or)]TJ 0 -1.2571 TD (death;)Tj -2.0693 -1.2623 TD [(26.)-799.3(Provision)-234.1(for)-235.4(continuing)-235.9(access)-233.2(of)-232.4(subjects)-239.2(to)-232.4(the)-235.1(investigational)]TJ 2.0693 -1.2571 TD [(treatment)-187.7(after)-189.9(the)-188.6(study,)-186(indicating)-187.1(its)-191.5(modalities,)-186.3(the)-188.6(individual)]TJ T* [(or)-227(organization)-220.3(responsible)-220.3(for)-225.1(paying)-219.6(for)-225.1(it,)-223.7(and)-227.3(for)-219.9(how)-226.6(long)-221.2(it)]TJ 0 -1.2623 TD [(will)-272.3(continue;)]TJ -2.0693 -1.2571 TD [(27.)-799.3(For)-430.1(research)-424(on)-427.3(pregnant)-425.9(women,)-425.5(a)-431.2(plan,)-421.9(if)-431.6(appropriate,)-423.3(for)]TJ 2.0693 -1.2623 TD [(monitoring)-178.3(the)-183.4(outcome)-174.2(of)-180.7(the)-178.2(pregnancy)-178.8(with)-180.8(regard)-174.2(to)-180.7(both)-178.6(the)]TJ 0 -1.2571 TD [(health)-232.3(of)-227.2(the)-224.8(woman)-228.9(and)-227.3(the)-230(short-term)-226.8(and)-227.3(long-term)-228.8(health)-227.1(of)]TJ 0 -1.2623 TD [(the)-271.3(child;)]TJ -2.0693 -1.2571 TD [(28.)-799.3(The)-269.4(potential)-272.3(benefits)-265.4(of)-268.6(the)-271.3(research)-268.8(to)-268.6(subjects)-270.3(and)-268.7(to)-268.6(others;)]TJ 0 -1.2623 TD [(29.)-799.3(The)-176.3(expected)-169.1(benefits)-172.2(of)-175.5(the)-173.1(research)-170.5(to)-175.5(the)-173.1(population)8.4(,)-174.9(including)]TJ 2.0693 -1.2571 TD [(new)-269.2(knowledge)-267(that)-268.5(the)-271.4(study)-269.8(might)-264.8(generate;)]TJ -2.0693 -1.2623 TD [(30.)-799.3(The)-259.1(means)-252.7(proposed)-249.2(to)-258.3(obtain)-251.8(individual)-254.1(informed)-251.1(consent)-254.3(and)]TJ 2.0693 -1.2571 TD [(the)-255.8(procedure)-253.1(planned)-252.8(to)-253.1(communicate)-250.7(information)-254(to)-253.1(prospec-)]TJ T* [(tive)-462(subjects,)-460.7(including)-462.9(the)-457.6(name)-461.8(and)-460.1(position)-460.5(of)-460(the)-457.6(person)]TJ 0 -1.2623 TD [(responsible)-272.1(for)-266.4(obtaining)-269.7(consent;)]TJ -2.0693 -1.2571 TD [(31.)-799.3(When)-284.2(a)-286.3(prospective)-281.5(subject)-282.8(is)-286.5(not)-280.5(capable)-285.3(of)-284.1(informed)-282.1(consent,)]TJ 2.0693 -1.2623 TD [(satisfactory)-353.4(assurance)-347(that)-351.3(permission)-346(will)-355.1(be)-350.9(obtained)-349.2(from)-349.8(a)]TJ 0 -1.2571 TD [(duly)-583.3(authorized)-582.5(person,)-581.4(or,)-577.8(in)-585.1(the)-581.7(case)-584.5(of)-579(a)-581.2(child)-583.2(who)-583.5(is)]TJ T* [(sufficiently)-335.7(mature)-328.4(to)-335.9(understand)-326.7(the)-333.4(implications)-332.7(of)-330.7(informed)]TJ 0 -1.2623 TD [(consent)-533.6(but)-528.8(has)-534(not)-534(reached)-528.2(the)-530(legal)-532(age)-534(of)-532.5(consent,)-532.6(that)]TJ 0 -1.2571 TD [(knowing)-354.6(agreement,)-355.4(or)-351.1(assent,)-355.7(will)-355.1(be)-356(obtained,)-353.4(as)-351.4(well)-358.8(as)-351.4(the)]TJ 0 -1.2623 TD [(permission)-573.6(of)-573.8(a)-570.8(parent,)-571.6(or)-568.4(a)-570.8(legal)-573.4(guardian)-570.7(or)-568.4(other)-570.8(duly)]TJ 0 -1.2571 TD [(authorized)-267(representative;)]TJ -2.0693 -1.2571 TD [(32.)-799.3(An)-250.7(account)-242.7(of)-247.9(any)-248.3(economic)-245.1(or)-247.7(other)-244.8(inducements)-242.6(or)-247.7(incentives)]TJ 2.0693 -1.2623 TD [(to)-475.5(prospective)-467.7(subjects)-472(to)-470.4(participate,)-468.7(such)-469.2(as)-475.5(offers)-466.8(of)-475.6(cash)]TJ 0 -1.2571 TD [(payments,)-237.7(gifts,)-242.1(or)-237.3(free)-239.3(services)-240.4(or)-237.3(facilities,)-239.4(and)-237.7(of)-242.8(any)-237.9(financial)]TJ 0 -1.2623 TD [(obligations)-178.6(assumed)-179.7(by)-179.2(the)-178.2(subjects,)-176.2(such)-179.5(as)-175.5(payment)-178.8(for)-178.5(medical)]TJ 0 -1.2571 TD (services;)Tj ET 95.641 646.809 318.898 -0.51 re f BT /F6 1 Tf 7.9702 0 0 7.9702 95.6409 649.1337 Tm [(APPENDIX)-323.7(1)]TJ /F7 1 Tf 11.9551 0 0 11.9551 401.3857 649.1337 Tm (85)Tj ET endstream endobj 253 0 obj << /Type /Page /Parent 399 0 R /Resources 254 0 R /Contents 255 0 R /MediaBox [ 0 0 595 842 ] /CropBox [ 0 0 595 842 ] /Rotate 0 >> endobj 254 0 obj << /ProcSet [ /PDF /Text ] /Font << /F2 337 0 R /F6 341 0 R /F7 342 0 R >> /ExtGState << /GS1 434 0 R >> /ColorSpace << /DefaultCMYK 417 0 R /Cs6 416 0 R >> >> endobj 255 0 obj << /Length 6385 >> stream q 1 i 0.015 737.008 510.221 -737.008 re W n /Cs6 cs 0 0 0 scn /GS1 gs 0.015 709.001 25.44 -0.284 re f Q /Cs6 cs 0 0 0 scn /GS1 gs 28.006 737.008 0.283 -25.455 re f 481.89 737.008 0.283 -25.455 re f 484.724 709.001 25.512 -0.284 re f 484.724 28.346 25.512 -0.283 re f 481.89 25.512 0.283 -25.512 re f q 1 i 0.015 737.008 510.221 -737.008 re W n 28.006 25.512 0.283 -25.512 re f 0.015 28.346 25.44 -0.283 re f Q BT /F2 1 Tf 10.959 0 0 10.959 95.6409 609.8455 Tm 0 Tc 0 Tw [(33.)-799.3(Plans)-275.6(and)-268.7(procedures,)-270.6(and)-268.7(the)-271.4(persons)-269.8(responsible,)-271.1(for)-271.6(commu-)]TJ 2.0693 -1.2623 TD [(nicating)-222.8(to)-216.9(subjects)-218.5(information)-217.8(arising)-221.2(from)-215.3(the)-219.6(study)-218.1(\(on)-218.4(harm)]TJ 0 -1.2571 TD [(or)-418.4(benefit,)-411.4(for)-416.5(example\),)-415.9(or)-413.2(from)-411.8(other)-415.6(research)-413.7(on)-416.9(the)-411(same)]TJ 0 -1.2623 TD [(topic,)-358.9(that)-356.5(could)-358.1(affect)-358.5(subjects)-357.2(willingness)-357.3(to)-361.7(continue)-355.3(in)-357.5(the)]TJ 0 -1.2571 TD (study;)Tj -2.0693 -1.2571 TD [(34.)-799.3(Plans)-270.4(to)-268.6(inform)-267.5(subjects)-270.3(about)-268.3(the)-271.4(results)-269(of)-268.6(the)-266.2(study;)]TJ 0 -1.2623 TD [(35.)-799.3(The)-481.5(provisions)-480.5(for)-478.5(protecting)-475.6(the)-483.4(confidentialit)6.6(y)-482.9(o)0(f)-480.7(personal)]TJ 2.0693 -1.2571 TD [(data,)-592(and)-594.6(respecting)-590.4(the)-592.1(privacy)-591.1(of)-594.5(subjects,)-590(including)-592.3(the)]TJ 0 -1.2623 TD [(precautions)-171.7(that)-170.2(are)-167.9(in)-171.3(place)-173.3(to)-170.3(prevent)-166.6(disclosure)-172.3(of)-170.3(the)-173.1(results)-170.7(of)]TJ 0 -1.2571 TD (a)Tj 0.7139 0 TD [(subjects)-212.4(genetic)-210.4(tests)-211.8(to)-211.7(immediate)-207.7(family)-212.4(relatives)-212.9(without)-207.8(the)]TJ -0.7139 -1.2623 TD [(consent)-269.8(of)-268.6(the)-271.4(subject;)]TJ -2.0693 -1.2571 TD [(36.)-799.3(Information)-201.1(about)-206.3(how)-200.7(the)-204.1(code,)-204.1(if)-204(any,)-200.7(for)-204.4(the)-204.1(subjects)-202(identity)]TJ 2.0693 -1.2571 TD [(is)-224.4(established,)-219.9(where)-223.2(it)-219.5(will)-225.7(be)-221.5(kept)-221.2(and)-222.1(when,)-218(how)-221.4(and)-222.1(by)-220.6(whom)]TJ 0 -1.2623 TD [(it)-271.3(can)-269.9(be)-268.1(broken)-270.5(in)-269.5(the)-266.2(event)-270.7(of)-268.6(an)-267.2(emergency;)]TJ -2.0693 -1.2571 TD [(37.)-799.3(A)-16.3(n)-6.7(y)-627.8(f)-8.4(o)-11.9(r)-13.3(e)-7.9(s)-13.3(e)-13.1(e)-7.9(n)-627.5(f)-13.6(u)-6.7(r)-13.3(t)-13.6(h)]TJ 10.9723 0 TD 0.0117 Tc [(er)-612.1(uses)-617.2(of)-612.3(perso)5(nal)-613.3(d)-0.2(ata)-616.1(o)-0.2(r)-612.1(b)-0.2(iolo)5(gical)]TJ -8.903 -1.2623 TD 0 Tc (materials;)Tj -2.0693 -1.2571 TD [(38.)-799.3(A)-368.1(description)-360.3(of)-361.7(the)-364.5(plans)-358.7(for)-364.7(statistical)-360.6(analysis)-362.7(of)-361.7(the)-364.5(study,)]TJ 2.0693 -1.2623 TD [(including)-488.8(plans)-482.8(for)-483.7(interim)-485(analyses,)-484.4(if)-488.5(any,)-480.1(and)-486(criteria)-485.3(for)]TJ 0 -1.2571 TD [(prematurely)-269.2(terminating)-271(the)-266.2(study)-269.8(as)-268.6(a)-270.8(whole)-264.5(if)-271.3(necessary;)]TJ -2.0693 -1.2623 TD [(39.)-799.3(Plans)-425.6(for)-426.8(monitoring)-426.6(the)-426.5(continuing)-422.2(safety)-424.5(of)-429(drugs)-424.7(or)-423.6(other)]TJ 2.0693 -1.2571 TD [(interventions)-205(administered)-195.6(for)-204.4(purposes)-198.9(of)-201.4(the)-204.1(study)-197.4(or)-206.3(trial)-202.7(and,)]TJ T* 0.0268 Tc [(if)-628.3(ap)4.6(propriate,)-629.2(t)2.8(he)-627.7(ap)4.6(pointment)-628.3(fo)4.6(r)-628(t)-2.3(h)4.6(i)-3.2(s)-628(p)-0.6(u)4.6(r)-2.1(p)4.6(o)-0.6(se)-632.9(o)4.6(f)-628.3(an)]TJ 0 -1.2623 TD 0.0078 Tc [(indep)7.8(e)-1.6(ndent)-605.9(dat)7.8(a)-2.4(-m)7.8(o)-4.6(n)1.1(i)7.8(t)-4.8(ori)7.8(n)-3.1(g)-609.6(\()7.8(data)-604.4(and)-609.3(s)-0.4(a)7.8(f)-2.4(et)7.8(y)-612.9(m)7.8(o)-4.6(n)1.1(it)7.8(ori)7.8(n)-3.1(g\))]TJ 0 -1.2571 TD 0 Tc (committee;)Tj -2.0693 -1.2623 TD [(40.)-799.3(A)-269.8(list)-273.3(of)-268.6(the)-271.3(references)-265.4(cited)-273.1(in)-269.5(the)-266.2(protocol;)]TJ 0 -1.2571 TD [(41.)-799.3(T)-16.9(h)-17(e)-628.7(s)-18.5(o)-11.9(u)-17(r)-13.3(c)-13.1(e)-633.8(a)]TJ 8.3598 0 TD 0.0125 Tc [(nd)-620.2(a)-4.8(m)-3.6(oun)-4.5(t)-621.9(o)0.6(f)-621.9(f)-1.1(u)-4.5(n)0.6(d)-4.6(i)-2(ng)-620.4(o)-4.5(f)-621.9(the)-621.3(r)-6(ese)-5.7(a)0.4(rc)-5.7(h:)-622.8(th)-4.5(e)]TJ -6.2906 -1.2623 TD 0 Tc [(organization)-535.9(that)-532.4(is)-540(sponsoring)-529.6(the)-535.2(research)-532.6(and)-537.7(a)-534.6(detailed)]TJ 0 -1.2571 TD [(account)-284.1(of)-284.1(the)-286.9(sponsors)-281(financial)-283.9(commitments)-282.5(to)-284.1(the)-286.9(research)]TJ T* [(institution,)-397.8(the)-395.5(investigators,)-396.2(the)-395.5(research)-398.1(subjects,)-393.4(and,)-397(when)]TJ 0 -1.2623 TD [(relevant,)-273.5(the)-266.2(community;)]TJ -2.0693 -1.2571 TD [(42.)-799.3(The)-228.1(arrangements)-223.3(for)-225.1(dealing)-224.7(with)-227.3(financial)-227(or)-227(other)-224.2(conflicts)-228.2(of)]TJ 2.0693 -1.2623 TD [(interest)-235.8(that)-227.1(might)-228.6(affect)-234.3(the)-230(judgement)-226.8(of)-232.4(investigators)-226.5(or)-232.1(other)]TJ 0 -1.2571 TD 0.0106 Tc [(research)-616.9(personn)3.9(el:)-614.4(i)-3.9(nformin)3.9(g)-617.2(th)]TJ 15.1884 0 TD 0.6235 Tc [(ei)609(n)616.8(s)610.2(t)615.1(i)]TJ 2.928 0 TD 0.0101 Tc [(tuti)-4.4(onal)-614.9(confl)-4.4(i)0.7(ct-)-3.5(o)3.4(f)-3.5(-)]TJ -18.1164 -1.2571 TD 0 Tc [(interest)-277.2(committee)-275(of)-273.8(such)-272.6(conflicts)-274.7(of)-273.8(interest;)-271(the)-276.5(communica-)]TJ 0 -1.2623 TD [(tion)-201.9(by)-194.7(that)-201.3(committee)-197.4(of)-196.2(the)-198.9(pertinent)-199.6(details)-196.6(of)-196.2(the)-198.9(information)]TJ 0 -1.2571 TD [(to)-387.6(the)-390.3(ethical)-382.5(review)-388(committee;)-387.8(and)-387.7(the)-385.2(transmission)-387.5(by)-386.2(that)]TJ 0 -1.2623 TD [(committee)-187(to)-180.7(the)-183.4(research)-180.9(subjects)-182.3(of)-180.7(the)-183.4(parts)-183.3(of)-180.7(the)-183.4(information)]TJ 0 -1.2571 TD [(that)-268.5(it)-271.3(decides)-271.9(should)-266.8(be)-268.1(passed)-267.1(on)-272.1(to)-268.6(them;)]TJ ET 95.641 646.809 318.898 -0.51 re f BT /F6 1 Tf 7.9702 0 0 7.9702 191.1118 649.1337 Tm [(INTERNA)13.4(TIONAL)-327.4(ETHICAL)-327.5(GUIDELINES)-319.8(FOR)-332.5(BIOMED)13.7(ICAL)-331.1(RESEARCH)]TJ /F7 1 Tf 11.9551 0 0 11.9551 95.6409 649.1337 Tm (86)Tj ET endstream endobj 256 0 obj << /Type /Page /Parent 399 0 R /Resources 257 0 R /Contents 258 0 R /MediaBox [ 0 0 595 842 ] /CropBox [ 0 0 595 842 ] /Rotate 0 >> endobj 257 0 obj << /ProcSet [ /PDF /Text ] /Font << /F2 337 0 R /F6 341 0 R /F7 342 0 R >> /ExtGState << /GS1 434 0 R >> /ColorSpace << /DefaultCMYK 417 0 R /Cs6 416 0 R >> >> endobj 258 0 obj << /Length 3891 >> stream q 1 i 0.015 737.008 510.221 -737.008 re W n /Cs6 cs 0 0 0 scn /GS1 gs 0.015 709.001 25.44 -0.284 re f Q /Cs6 cs 0 0 0 scn /GS1 gs 28.006 737.008 0.283 -25.455 re f 481.89 737.008 0.283 -25.455 re f 484.724 709.001 25.512 -0.284 re f 484.724 28.346 25.512 -0.283 re f 481.89 25.512 0.283 -25.512 re f q 1 i 0.015 737.008 510.221 -737.008 re W n 28.006 25.512 0.283 -25.512 re f 0.015 28.346 25.44 -0.283 re f Q BT /F2 1 Tf 10.959 0 0 10.959 95.6409 609.8455 Tm 0 Tc 0 Tw [(43.)-799.3(The)-269.4(time)-274.5(schedule)-268.3(for)-266.4(completion)-266.9(of)-268.6(the)-271.4(study;)]TJ 0 -1.2623 TD [(44.)-799.3(For)-259.4(research)-253.3(that)-258.2(is)-255.5(to)-258.3(be)-252.6(carried)-256.9(out)-254.6(in)-259.2(a)-255.3(developing)-251.2(country)-258.5(or)]TJ 2.0693 -1.2571 TD [(community,)-518.5(the)-514.5(contribution)-516.1(that)-516.8(the)-519.7(sponsor)-511.7(will)-520.6(make)-518.8(to)]TJ 0 -1.2623 TD 0.0078 Tc [(capacit)7.8(y)-2.4(-buil)7.8(d)-3.1(ing)-609.6(f)-0.6(or)-610.8(s)7.8(c)-3.1(ient)7.8(i)-4.8(f)-0.6(ic)-605.4(and)-609.3(e)-0.1(thic)7.8(al)-612(revi)7.8(e)-4.3(w)-608.9(and)-609.3(f)-0.6(or)]TJ 0 -1.2571 TD 0 Tc [(biomedical)-314.7(research)-310.2(in)-310.9(the)-312.7(host)-309.4(country,)-309.3(and)-310.1(an)-313.7(assurance)-310.8(that)]TJ T* [(the)-364.5(capacity-buil)6.8(ding)-360.8(objectives)-358.8(are)-359.3(in)-362.7(keeping)-357.5(with)-361.8(the)-359.3(values)]TJ 0 -1.2623 TD [(and)-268.7(expectations)-268.1(of)-268.6(the)-271.3(subjects)-270.3(and)-263.5(their)-273.4(communities)5.3(;)]TJ -2.0693 -1.2571 TD [(45.)-799.3(Particularly)-498.3(in)-492(the)-499(case)-496.5(of)-491.1(an)-494.8(industrial)-499(sponsor,)-490.1(a)-498.4(contract)]TJ 2.0693 -1.2571 TD [(stipulating)-314.8(who)-314.5(possesses)-313.2(the)-312.7(right)-313.8(to)-310(publish)-317.5(the)-312.7(results)-310.4(of)-315.2(the)]TJ 0 -1.2623 TD [(study,)-279.1(and)-279.1(a)-276(mandatory)-275.5(obligation)-273.9(to)-279(prepare)-280.1(with,)-278.1(and)-273.9(submit)]TJ 0 -1.2571 TD [(to,)-288.3(the)-281.7(principal)-288.5(investigato)7.1(rs)-285.3(the)-286.9(draft)-281.9(of)-284.1(the)-286.9(text)-285.2(reporting)-281.2(the)]TJ 0 -1.2623 TD (results;)Tj -2.0693 -1.2571 TD [(46.)-799.3(In)-289(the)-292(case)-289.6(of)-289.3(a)-286.3(negative)-288.8(outcome,)-287.1(an)-287.9(assurance)-284.9(that)-289.2(the)-292(results)]TJ 2.0693 -1.2571 TD [(will)-194.7(be)-190.5(made)-187.7(available,)-193.7(as)-185.9(appropriate,)-190.5(through)-184.9(publication)-188.4(or)-190.8(by)]TJ 0 -1.2622 TD [(reporting)-270.9(to)-268.6(the)-271.3(drug)-266.5(registration)-266.1(authority;)]TJ -2.0693 -1.2571 TD [(47.)-799.3(Circumstances)-263.9(in)-269.5(which)-264.5(it)-266.1(might)-264.8(be)-262.9(considered)-262.5(inappropriate)-264.4(to)]TJ 2.0693 -1.2623 TD [(publish)-296.9(findings,)-294.2(such)-293.3(as)-299.7(when)-291.4(the)-297.2(findings)-295.2(of)-294.5(an)-293(epidemiologi-)]TJ 0 -1.2571 TD [(cal,)-545.7(sociological)-540.4(or)-537.4(genetics)-539.3(study)-538.8(may)-542.2(present)-540.3(risks)-542.4(to)-537.6(the)]TJ T* [(interests)-528.5(of)-532.5(a)-524.3(community)-529.8(or)-527(population)-524.4(or)-527(of)-527.3(a)-529.5(racially)-525.5(or)]TJ 0 -1.2623 TD [(ethnically)-271.1(defined)-271(group)-262.9(of)-268.6(people;)]TJ -2.0693 -1.2571 TD [(48.)-799.3(A)-212.9(statement)-203.2(that)-206.4(any)-206.9(proven)-208.7(evidence)-206.2(of)-206.6(falsification)-204.4(of)-211.7(data)-205(will)]TJ 2.0693 -1.2571 TD [(be)-206(dealt)-199.7(with)-201.5(in)-202.3(accordance)-198(with)-201.5(the)-204.1(policy)-197(of)-201.4(the)-204.1(sponsor)-201.4(to)-201.4(take)]TJ 0 -1.2623 TD [(appropriate)-269.1(action)-268.5(against)-265.7(such)-272.6(unacceptable)-266.1(procedures)7.7(.)]TJ ET 95.641 646.809 318.898 -0.51 re f BT /F6 1 Tf 7.9702 0 0 7.9702 95.6409 649.1337 Tm [(APPENDIX)-323.7(1)]TJ /F7 1 Tf 11.9551 0 0 11.9551 401.3857 649.1337 Tm (87)Tj ET endstream endobj 259 0 obj << /Type /Page /Parent 399 0 R /Resources 260 0 R /Contents 261 0 R /MediaBox [ 0 0 595 842 ] /CropBox [ 0 0 595 842 ] /Rotate 0 >> endobj 260 0 obj << /ProcSet [ /PDF ] /ExtGState << /GS1 434 0 R >> /ColorSpace << /DefaultCMYK 417 0 R /Cs6 416 0 R >> >> endobj 261 0 obj << /Length 412 >> stream q 1 i 0.015 737.008 510.221 -737.008 re W n /Cs6 cs 0 0 0 scn /GS1 gs 0.015 709.001 25.44 -0.284 re f Q /Cs6 cs 0 0 0 scn /GS1 gs 28.006 737.008 0.283 -25.455 re f 481.89 737.008 0.283 -25.455 re f 484.724 709.001 25.512 -0.284 re f 484.724 28.346 25.512 -0.283 re f 481.89 25.512 0.283 -25.512 re f q 1 i 0.015 737.008 510.221 -737.008 re W n 28.006 25.512 0.283 -25.512 re f 0.015 28.346 25.44 -0.283 re f Q endstream endobj 262 0 obj << /Type /Page /Parent 399 0 R /Resources 263 0 R /Contents 264 0 R /MediaBox [ 0 0 595 842 ] /CropBox [ 0 0 595 842 ] /Rotate 0 >> endobj 263 0 obj << /ProcSet [ /PDF /Text ] /Font << /F2 337 0 R /F4 339 0 R /F11 346 0 R /F12 347 0 R >> /ExtGState << /GS1 434 0 R >> /ColorSpace << /DefaultCMYK 417 0 R /Cs6 416 0 R >> >> endobj 264 0 obj << /Length 3633 >> stream q 1 i 0.015 737.008 510.221 -737.008 re W n /Cs6 cs 0 0 0 scn /GS1 gs 0.015 709.001 25.44 -0.284 re f Q /Cs6 cs 0 0 0 scn /GS1 gs 28.006 737.008 0.283 -25.455 re f 481.89 737.008 0.283 -25.455 re f 484.724 709.001 25.512 -0.284 re f 484.724 28.346 25.512 -0.283 re f 481.89 25.512 0.283 -25.512 re f q 1 i 0.015 737.008 510.221 -737.008 re W n 28.006 25.512 0.283 -25.512 re f 0.015 28.346 25.44 -0.283 re f Q 1 1 1 scn 95.641 458.759 14.173 -2.835 re f 0 0 0 scn 95.641 553.266 318.898 -94.507 re f BT /F4 1 Tf 19.9253 0 0 19.9253 207.0425 588.3589 Tm 0 Tc 0 Tw (Appendix)Tj /F2 1 Tf 4.3248 0 TD (2)Tj /F11 1 Tf 11.9551 0 0 11.9551 151.6535 538.6959 Tm 1 1 1 scn [(WORLD)-273.2(MEDICAL)-281(ASSOCIATION)]TJ 0.9674 -1.3325 TD [(DECLA)-9.7(RATION)-275(OF)-271.3(HELSINKI)]TJ 2.9496 -2.3094 TD [(Ethical)-276.5(Princip)-11(les)]TJ 3.9929 -1.1523 TD (for)Tj -11.2389 -1.1571 TD [(Medical)-279.1(Research)-274.6(Involving)-277.5(Hum)-6.4(an)-270.9(Subjects)]TJ /F2 1 Tf 10.959 0 0 10.959 146.1543 430.2991 Tm 0 0 0 scn [(Adopted)-266.4(by)-267.2(the)-271.3(18th)-267.1(WMA)-268(General)-270(Assembly)]TJ 4.4696 -1.3295 TD [(Helsinki,)-269.2(Finland,)-268.6(June)-267.2(1964)]TJ 1.8054 -1.3295 TD [(and)-263.5(amended)-271.1(by)-267.2(the)]TJ -8.5202 -1.3295 TD [(29th)-267.1(WMA)-268(General)-270(Assembly,)-270.1(Tokyo,)-265.4(Japan,)-267.1(October)-269.1(1975)]TJ 0.2587 -1.3295 TD [(35th)-267.1(WMA)-268(General)-270(Assembly,)-270.1(Venice,)-267.5(Italy,)-271.7(October)-269.1(1983)]TJ -0.3052 -1.3243 TD [(41st)-268.5(WMA)-268(General)-270(Assembly,)-264.9(Hong)-269.3(Kong,)-268.3(September)-267.9(1989)]TJ 2.8401 -1.3295 TD [(48th)-267.1(WMA)-268(General)-270(Assembly,)-264.9(Somerset)-271.8(West,)]TJ 0.8743 -1.2623 TD [(Republic)-267.5(of)-273.8(South)-262.9(Africa,)-273.4(October)-269.1(1996)]TJ 7.5684 -1.3243 TD [(and)-268.7(the)]TJ -10.336 -1.2623 TD (52)Tj 8.2191 0 0 7.3052 142.3559 305.6314 Tm (nd)Tj 10.959 0 0 10.959 154.3748 300.7558 Tm [(WMA)-268(General)-270(Assembly,)-270.1(Edinburgh,)-265.3(Scotland,)]TJ 6.3268 -1.2571 TD [(October)-269.1(2000)]TJ /F12 1 Tf -11.6862 -2.5866 TD [(A.)-2374.6(INTRODUCTION)]TJ /F2 1 Tf 1.7951 -1.8158 TD [(1.)-797.5(The)-310.8(World)-304.2(Medical)-305.9(Association)-306.9(has)-306.4(developed)-304.8(the)-307.6(Declara-)]TJ 1.5675 -1.2623 TD [(tion)-217.4(of)-211.7(Helsinki)-218.5(as)-211.7(a)-219.1(statement)-208.3(of)-216.9(ethical)-217(principles)-214.8(to)-211.7(provide)]TJ 0 -1.2571 TD [(guidance)-514.5(to)-516.9(physicians)-516.7(and)-517(other)-513.8(participants)-512.9(in)-517.9(medical)]TJ T* [(research)-372.3(involving)-364(human)-369.1(subjects.)-367.6(Medical)-368(research)-367.1(invol-)]TJ 0 -1.2623 TD [(ving)-252.5(human)-250.1(subjects)-254.7(includes)-249(research)-253.3(on)-251.4(identifiable)-247.2(human)]TJ 0 -1.2571 TD [(material)-269.8(or)-273.5(identifiable)-267.9(data.)]TJ -1.5675 -1.3295 TD [(2.)-797.5(It)-301.1(is)-302(the)-302.4(duty)-297.8(of)-299.7(the)-297.2(physician)-301.6(to)-299.7(promote)-298.7(and)-299.7(safeguard)-294.6(the)]TJ 1.5675 -1.2571 TD 0.0225 Tc [(health)-625.7(of)-622.2(th)5.5(e)-626.9(p)0.3(eo)5.5(ple.)-623.2(The)-621.7(physicians)-622(knowledge)-626.9(a)0(nd)]TJ 0 -1.2623 TD 0 Tc [(conscience)-268.6(are)-271.3(dedicated)-265.2(to)-273.8(the)-266.2(fulfillment)-270.8(of)-268.6(this)-270.6(duty.)]TJ -1.5675 -1.3295 TD [(3.)-797.5(The)-186.7(Declaration)-182.5(of)-185.9(Geneva)-187(of)-185.9(the)-183.4(World)-185.2(Medical)-181.8(Association)]TJ 1.5675 -1.2571 TD [(binds)-203.2(the)-198.9(physician)-203.4(with)-201.5(the)-198.9(words,)-200.6(The)-200.2(health)-201.3(of)-201.4(my)-198.9(patient)]TJ ET endstream endobj 265 0 obj << /Type /Page /Parent 399 0 R /Resources 266 0 R /Contents 267 0 R /MediaBox [ 0 0 595 842 ] /CropBox [ 0 0 595 842 ] /Rotate 0 >> endobj 266 0 obj << /ProcSet [ /PDF /Text ] /Font << /F2 337 0 R /F6 341 0 R /F7 342 0 R >> /ExtGState << /GS1 434 0 R >> /ColorSpace << /DefaultCMYK 417 0 R /Cs6 416 0 R >> >> endobj 267 0 obj << /Length 5370 >> stream q 1 i 0.015 737.008 510.221 -737.008 re W n /Cs6 cs 0 0 0 scn /GS1 gs 0.015 709.001 25.44 -0.284 re f Q /Cs6 cs 0 0 0 scn /GS1 gs 28.006 737.008 0.283 -25.455 re f 481.89 737.008 0.283 -25.455 re f 484.724 709.001 25.512 -0.284 re f 484.724 28.346 25.512 -0.283 re f 481.89 25.512 0.283 -25.512 re f q 1 i 0.015 737.008 510.221 -737.008 re W n 28.006 25.512 0.283 -25.512 re f 0.015 28.346 25.44 -0.283 re f Q BT /F2 1 Tf 10.959 0 0 10.959 132.4913 609.8455 Tm 0 Tc 0 Tw [(will)-215.4(be)-216.4(my)-214.4(first)-213.3(consideration,)5.6()-216.3(and)-211.8(the)-214.4(International)-209.2(Code)-213.8(of)]TJ 0 -1.2623 TD [(Medical)-331.8(Ethics)-331.6(declares)-332.1(that,)-329.6(A)-335.1(physician)-327.5(shall)-330.3(act)-333.7(only)-329.8(in)]TJ 0 -1.2571 TD [(the)-530(patients)-527.3(interest)-525.5(when)-524.2(providing)-528.1(medical)-524.7(care)-527.6(which)]TJ 0 -1.2623 TD [(might)-326.9(have)-328.6(the)-323.1(effect)-328.3(of)-325.5(weakening)-324.1(the)-328.3(physical)-320.8(and)-325.6(mental)]TJ 0 -1.2571 TD [(condition)-270.3(of)-268.6(the)-271.3(patient.)]TJ -1.5675 -1.4692 TD [(4.)-797.5(Medical)-264.6(progress)-257.5(is)-265.8(based)-258.9(on)-261.7(research)-263.6(which)-259.4(ultimately)-260.3(must)]TJ 1.5675 -1.2571 TD [(rest)-270.6(in)-269.5(part)-268.3(on)-272.1(experimentatio)6.6(n)-270.5(involving)-270.9(human)-265.6(subjects.)]TJ -1.5675 -1.4744 TD [(5.)-797.5(In)-175.2(medical)-178.1(research)-170.5(on)-173.8(human)-172.5(subjects,)-176.2(considerations)-170(related)]TJ 1.5675 -1.2571 TD [(to)-191(the)-188.6(well-being)-187.6(of)-191(the)-188.6(human)-188(subject)-184.5(should)-189.2(take)-190.4(precedence)]TJ T* [(over)-272.9(the)-266.2(interests)-269.8(of)-268.6(science)-273.1(and)-263.5(society.)]TJ -1.5675 -1.4744 TD [(6.)-797.5(The)-378.1(primary)-372.8(purpose)-371.8(of)-377.3(medical)-374.6(research)-377.4(involving)-369.2(human)]TJ 1.5675 -1.2571 TD [(subjects)-244.4(is)-240(to)-242.8(improve)-242.9(prophylact)8.1(ic,)-243.9(diagnostic)-242.8(and)-237.7(therapeu-)]TJ T* [(tic)-413.7(procedures)-400.9(and)-408.4(the)-405.9(understanding)-406.6(of)-403.1(the)-411(aetiology)-405.6(and)]TJ 0 -1.2623 TD [(pathogenesis)-344.2(of)-341(disease.)-343.9(Even)-338.5(the)-343.8(best)-341.6(proven)-343.2(prophylact)8.1(ic,)]TJ 0 -1.2571 TD [(diagnostic,)-417.7(and)-418.7(therapeutic)-416.3(methods)-417.6(must)-422.2(continuously)-411.2(be)]TJ 0 -1.2623 TD [(challenged)-205.8(through)-200.4(research)-201.6(for)-204.4(their)-206.1(effectiveness,)-201.5(efficiency,)]TJ 0 -1.2571 TD [(accessibility)-272.1(and)-268.7(quality.)]TJ -1.5675 -1.4692 TD [(7.)-797.5(In)-439.1(current)-436.8(medical)-436.7(practice)-430.6(and)-439.4(in)-435.1(medical)-436.7(research,)-433.4(most)]TJ 1.5675 -1.2571 TD [(prophylactic,)-328.9(diagnostic)-325.6(and)-325.6(therapeutic)-328.3(procedures)-323.3(involve)]TJ 0 -1.2623 TD [(risks)-273.4(and)-268.7(burdens.)]TJ -1.5675 -1.4692 TD [(8.)-797.5(Medical)-249(research)-242.9(is)-250.3(subject)-246.6(to)-242.8(ethical)-248(standards)-242.9(that)-247.8(promote)]TJ 1.5675 -1.2571 TD [(respect)-438(for)-437.2(all)-439.5(human)-436.3(beings)-433.8(and)-439.4(protect)-437.1(their)-433.7(health)-439.2(and)]TJ 0 -1.2623 TD [(rights.)-393.4(Some)-389.2(research)-393(populations)-387.8(are)-390.3(vulnerable)-392.3(and)-387.7(need)]TJ 0 -1.2571 TD [(special)-320.2(protection.)-314(The)-316(particular)-311.5(needs)-316.7(of)-315.2(the)-317.9(economically)]TJ 0 -1.2623 TD [(and)-506.7(medically)-499.6(disadvantaged)-499.1(must)-505(be)-506.1(recognized.)-499.4(Special)]TJ 0 -1.2571 TD [(attention)-250.7(is)-250.3(also)-248.5(required)-253(for)-245.8(those)-250(who)-252.5(cannot)-245.2(give)-248.5(or)-252.8(refuse)]TJ T* [(consent)-181.9(for)-178.5(themselves,)-179.7(for)-178.5(those)-177.6(who)-180(may)-174.9(be)-180.1(subject)-179.3(to)-180.7(giving)]TJ 0 -1.2623 TD (c)Tj 0.4604 0 TD 0.0185 Tc [(ons)-5.2(ent)-626.2(u)1.5(nder)-626(dur)-5.2(ess,)-627.1(for)-626(t)-0.3(hose)-625.7(who)-624.5(w)-3.3(ill)-622(not)-626.2(b)1.5(enefit)]TJ -0.4604 -1.2571 TD 0 Tc [(personally)-449.5(from)-448(the)-447.2(research)-449.9(and)-449.8(for)-447.5(those)-446.6(for)-447.5(whom)-449.6(the)]TJ T* [(research)-268.8(is)-271(combined)-269.8(with)-268.7(care.)]TJ -1.5675 -1.4744 TD [(9.)-797.5(Research)-333.9(Investigators)-333.9(should)-334.1(be)-335.3(aware)-331.1(of)-335.9(the)-333.4(ethical,)-335(legal)]TJ 1.5675 -1.2571 TD [(and)-279.1(regulatory)-278.1(requirements)-283.2(for)-276.8(research)-279.2(on)-282.4(human)-276(subjects)]TJ T* [(in)-492(their)-485.5(own)-490.4(countries)-483.9(as)-491.1(well)-488.1(as)-491.1(applicable)-486.6(international)]TJ 0 -1.2623 TD 0.0099 Tc [(requ)3.2(irements.)-697.8(N)-1(o)-690(n)-2(ational)-692.7(e)]TJ 13.4761 0 TD 0.008 Tc [(thi)-6.5(c)0.1(al)-6.5(,)-694.6(l)-1.3(eg)-4.1(al)-699.7(or)-693.4(r)-5.3(e)0.1(g)-4.1(u)1.3(la)-4.1(tory)]TJ -13.4761 -1.2571 TD 0 Tc [(requirement)-419.9(should)-422(be)-418.1(allowed)-420.6(to)-423.8(reduce)-417.7(or)-418.4(eliminate)-423.5(any)]TJ 0 -1.2623 TD [(of)-610.1(the)-607.6(protections)-607.7(for)-607.9(human)-607(subjects)-606.5(set)-609.1(forth)-607.5(in)-611(this)]TJ 0 -1.2571 TD (Declaration.)Tj ET 95.641 646.809 318.898 -0.51 re f BT /F6 1 Tf 7.9702 0 0 7.9702 323.8866 649.1337 Tm [(DECLARATION)-318(OF)-331.8(HELSINKI)]TJ /F7 1 Tf 11.9551 0 0 11.9551 95.6409 649.1337 Tm (90)Tj ET endstream endobj 268 0 obj << /Type /Page /Parent 400 0 R /Resources 269 0 R /Contents 270 0 R /MediaBox [ 0 0 595 842 ] /CropBox [ 0 0 595 842 ] /Rotate 0 >> endobj 269 0 obj << /ProcSet [ /PDF /Text ] /Font << /F2 337 0 R /F6 341 0 R /F7 342 0 R /F12 347 0 R >> /ExtGState << /GS1 434 0 R >> /ColorSpace << /DefaultCMYK 417 0 R /Cs6 416 0 R >> >> endobj 270 0 obj << /Length 5762 >> stream q 1 i 0.015 737.008 510.221 -737.008 re W n /Cs6 cs 0 0 0 scn /GS1 gs 0.015 709.001 25.44 -0.284 re f Q /Cs6 cs 0 0 0 scn /GS1 gs 28.006 737.008 0.283 -25.455 re f 481.89 737.008 0.283 -25.455 re f 484.724 709.001 25.512 -0.284 re f 484.724 28.346 25.512 -0.283 re f 481.89 25.512 0.283 -25.512 re f q 1 i 0.015 737.008 510.221 -737.008 re W n 28.006 25.512 0.283 -25.512 re f 0.015 28.346 25.44 -0.283 re f Q BT /F12 1 Tf 10.959 0 0 10.959 95.6409 609.8455 Tm 0 Tc 0 Tw [(B.)-2426.6(BASIC)-271.6(PRINCIPLES)-269.1(FOR)-266.7(ALL)-267.6(MEDICAL)-271.6(RESEARCH)]TJ /F2 1 Tf 1.2933 -1.8779 TD [(10.)-799.3(It)-306.3(is)-307.2(the)-302.4(duty)-303(of)-304.8(the)-302.4(physician)-301.6(in)-305.8(medical)-302.2(research)-299.8(to)-304.8(protect)]TJ 2.0693 -1.2571 TD [(the)-271.3(life,)-272(health,)-267.5(privacy,)-269.3(and)-268.7(dignity)-266.6(of)-268.6(the)-271.4(human)-265.6(subject.)]TJ -2.0693 -1.3916 TD [(11.)-799.3(Medical)-269.7(research)-263.6(involving)-265.7(human)-265.6(subjects)-265.1(must)-267(conform)-267.6(to)]TJ 2.0693 -1.2571 TD 0.0146 Tc [(ge)-3.6(ne)-3.6(rall)-5.1(y)-618.3(a)-2.7(cc)-3.6(epte)-3.6(d)-618.1(s)-3.9(ci)-5.1(enti)-5.1(fi)-5.1(c)-619.2(p)-2.4(rinc)-3.6(iple)-3.6(s,)-620.7(be)-619.2(bas)-3.9(e)1.5(d)-623.2(o)2.7(n)-623.2(a)]TJ 0 -1.2623 TD 0 Tc [(thorough)-202(knowledge)-199.7(of)-201.4(the)-204.1(scientific)-202.5(literature,)-204.6(other)-203.5(relevant)]TJ 0 -1.2571 TD [(sources)-483.1(of)-480.7(information,)-480.6(and)-475.6(on)-484.2(adequate)-477.3(laboratory)-478.7(and,)]TJ T* [(where)-269.7(appropriate,)-268.1(animal)-267.5(experimentation.)]TJ -2.0693 -1.3916 TD [(12.)-799.3(Appropriate)-485.3(caution)-487.3(must)-484.3(be)-490.5(exercised)-484.8(in)-486.8(the)-488.6(conduct)-485.6(of)]TJ 2.0693 -1.2571 TD [(research)-180.9(which)-181.8(may)-180(affect)-182.6(the)-178.2(environment,)-178.6(and)-180.8(the)-178.2(welfare)-184.3(of)]TJ 0 -1.2623 TD [(animals)-270.5(used)-267.4(for)-271.6(research)-268.8(must)-267(be)-268.1(respected.)]TJ -2.0693 -1.3864 TD (13.)Tj 10.7396 0 0 10.959 132.4913 447.0235 Tm [(The)-335.1(design)-334.1(and)-328.1(performance)-330.3(of)-334.4(each)-333.3(experimental)-332.9(procedure)]TJ 0 -1.2623 TD [(involving)-341.6(human)-337.1(subjects)-338.9(should)-336(be)-341.3(clearly)-336.6(formulated)-337(in)-339.3(an)]TJ 0 -1.2571 TD [(experimental)-285.4(protocol.)-288.4(This)-286.1(protocol)-283.9(should)-288.5(be)-288.5(submitted)-282.7(for)]TJ T* [(consideration,)-504.1(comment,)-499.6(guidance,)-501.5(and)-497(where)-501.1(appropriate,)]TJ 0 -1.2623 TD [(approval)-412.1(to)-413.6(a)-413.2(specially)-412.1(appointed)-414(ethical)-410.5(review)-415(committee,)]TJ 0 -1.2571 TD [(which)-258.2(must)-257.1(be)-262.1(independent)-253.5(of)-255.2(the)-256.4(investigator,)-255.8(the)-261.7(sponsor)-253(or)]TJ T* [(any)-168.9(other)-169.3(kind)-169.7(of)-170.8(undue)-163.4(influence.)-171.2(This)-169.9(independent)-163.7(committee)]TJ 0 -1.2623 TD [(should)-325.4(be)-325.4(in)-323.5(conformity)-321.2(with)-328.3(the)-325(laws)-323(and)-322.8(regulations)-321.2(of)-323.9(the)]TJ 0 -1.2571 TD [(country)-373.6(in)-381.6(which)-374.4(the)-372.5(research)-377.8(experiment)-374.4(is)-374.4(performed.)-374.4(The)]TJ 0 -1.2623 TD 0.0125 Tc [(co)4.9(mmittee)-574.6(has)-573.8(t)2.4(he)-574.6(right)-573(t)2.4(o)-575.7(m)0.4(on)4.9(itor)-573.8(o)4.9(n)-0.3(going)-574.9(t)2.4(ria)5.7(l)-2.6(s.)-572.7(The)]TJ 0 -1.2571 TD 0 Tc [(researcher)-310.7(has)-305(the)-309.2(obligation)-305(to)-308(provide)-304.7(monitoring)-306.1(informa-)]TJ T* [(tion)-145.9(to)-144.4(the)-145.5(committee,)-143.6(especially)-144(any)-142.5(serious)-143.3(adverse)-145.5(events.)-142.5(The)]TJ 0 -1.2623 TD [(researcher)-405.7(should)-404.6(also)-404.5(submit)-401.1(to)-403(the)-404.2(committee,)-407.5(for)-403.4(review,)]TJ 0 -1.2571 TD [(information)-300.4(regarding)-295.2(funding,)-293.7(sponsors,)-294.8(institutional)-296.9(affilia-)]TJ 0 -1.2623 TD [(tions,)-404.1(other)-401.5(potential)-403(conflicts)-400.7(of)-397.8(interest)-404.8(and)-402(incentives)-398.5(for)]TJ 0 -1.2571 TD (subjects.)Tj 10.959 0 0 10.959 109.8142 224.844 Tm (14.)Tj 10.7396 0 0 10.959 132.4913 224.844 Tm [(The)-192.6(research)-187.8(protocol)-183.6(should)-188.2(always)-188.7(contain)-182.5(a)-191.5(statement)-186.1(of)-186.6(the)]TJ 0 -1.2623 TD [(ethical)-289.1(consideration)7.2(s)-290.7(involved)-283.9(and)-280.6(should)-283.2(indicate)-286.1(that)-288(there)]TJ 0 -1.2571 TD [(is)-353.3(compliance)-349.6(with)-354.7(the)-351.4(principles)-350.6(enunciated)-345.4(in)-355.2(this)-349.8(Declara-)]TJ 0 -1.2623 TD (tion.)Tj 10.959 0 0 10.959 109.8142 168.2078 Tm [(15.)-799.3(M)-19.8(e)-23.4(d)-17(i)-19.7(c)-23.4(a)-17.3(l)-645.6(r)]TJ 6.6941 0 TD 0.0207 Tc [(ese)2.5(a)-1.8(rc)2.5(h)-622.3(i)-4.2(n)3.7(v)3.4(olvi)]TJ 6.9527 0 TD 0.018 Tc [(ng)-625.3(h)-4.2(u)1(man)-625(s)-5.7(ub)-4.2(ject)-5.9(s)-626.5(s)-0.5(ho)-4.2(uld)-625(b)-4.2(e)]TJ -11.5776 -1.2571 TD 0 Tc [(conducted)-298.5(only)-298.8(by)-293(scientifically)-302.4(qualified)-293.9(persons)-295.7(and)-299.7(under)]TJ 0 -1.2623 TD [(the)-240.3(supervision)-229.8(of)-237.6(a)-234.6(clinically)-238.4(competent)-237.1(medical)-235(person.)-234.8(The)]TJ 0 -1.2571 TD [(responsibility)-293.1(for)-287.1(the)-292(human)-291.5(subject)-288(must)-287.7(always)-293(rest)-291.3(with)-289.4(a)]TJ 0 -1.2623 TD [(medically)-204.7(qualified)-206(person)-199.6(and)-201.5(never)-203.2(rest)-203.4(on)-199.6(the)-204.1(subject)-205.2(of)-201.4(the)]TJ 0 -1.2571 TD [(research,)-273(even)-267.4(though)-264.7(the)-271.3(subject)-267.3(has)-270.2(given)-265.5(consent.)]TJ ET 95.641 646.809 318.898 -0.51 re f BT /F6 1 Tf 7.9702 0 0 7.9702 95.6409 649.1337 Tm [(APPENDIX)-323.7(2)]TJ /F7 1 Tf 11.9551 0 0 11.9551 401.3857 649.1337 Tm (91)Tj ET endstream endobj 271 0 obj << /Type /Page /Parent 400 0 R /Resources 272 0 R /Contents 273 0 R /MediaBox [ 0 0 595 842 ] /CropBox [ 0 0 595 842 ] /Rotate 0 >> endobj 272 0 obj << /ProcSet [ /PDF /Text ] /Font << /F2 337 0 R /F6 341 0 R /F7 342 0 R >> /ExtGState << /GS1 434 0 R >> /ColorSpace << /DefaultCMYK 417 0 R /Cs6 416 0 R >> >> endobj 273 0 obj << /Length 5898 >> stream q 1 i 0.015 737.008 510.221 -737.008 re W n /Cs6 cs 0 0 0 scn /GS1 gs 0.015 709.001 25.44 -0.284 re f Q /Cs6 cs 0 0 0 scn /GS1 gs 28.006 737.008 0.283 -25.455 re f 481.89 737.008 0.283 -25.455 re f 484.724 709.001 25.512 -0.284 re f 484.724 28.346 25.512 -0.283 re f 481.89 25.512 0.283 -25.512 re f q 1 i 0.015 737.008 510.221 -737.008 re W n 28.006 25.512 0.283 -25.512 re f 0.015 28.346 25.44 -0.283 re f Q BT /F2 1 Tf 10.959 0 0 10.959 109.8142 609.8455 Tm 0 Tc 0 Tw [(16.)-799.3(Every)-533.2(medical)-529.8(research)-532.6(project)-531.1(involving)-529.5(human)-529.4(subjects)]TJ 2.0693 -1.2623 TD [(should)-240.9(be)-242.2(preceded)-240.9(by)-241.3(careful)-236.5(assessment)-241.8(of)-242.8(predictable)-236.1(risks)]TJ 0 -1.2571 TD [(and)-351.5(burdens)-345.9(in)-347.1(comparison)-347.3(with)-351.5(foreseeable)-344.8(benefits)-353.3(to)-346.2(the)]TJ 0 -1.2623 TD [(subject)-262.1(or)-263.2(to)-263.5(others.)-257.2(This)-263.5(does)-262.3(not)-259.8(preclude)-263.1(the)-261(participation)]TJ 0 -1.2571 TD [(of)-351.4(healthy)-347.9(volunteers)-346(in)-347.1(medical)-348.8(research.)-345.4(The)-352.2(design)-345.9(of)-346.2(all)]TJ T* [(studies)-272.7(should)-266.8(be)-268.1(publicly)-270(available.)]TJ -2.0693 -1.2623 TD [(17.)-799.3(Physicians)-247.5(should)-251.3(abstain)-244.7(from)-251.5(engaging)-244.8(in)-248.8(research)-248.1(projects)]TJ 2.0693 -1.2571 TD [(involving)-333(human)-332.9(subjects)-332.3(unless)-331.5(they)-335.2(are)-333.4(confident)-332.7(that)-330.6(the)]TJ 0 -1.2623 TD [(risks)-501(involved)-495.2(have)-499.3(been)-500(adequately)-493.7(assessed)-496.7(and)-496.3(can)-497.5(be)]TJ 0 -1.2571 TD [(satisfactorily)-335.9(managed.)-336.7(Physicians)-330.2(should)-334.1(cease)-338.9(any)-331(investi-)]TJ T* [(gation)-205.5(if)-209.2(the)-204.1(risks)-206.1(are)-204.1(found)-200.8(to)-206.5(outweigh)-203.9(the)-204.1(potential)-205.1(benefits)]TJ 0 -1.2623 TD [(or)-180.4(if)-178.2(there)-178.8(is)-177.9(conclusive)-176(proof)-171.2(of)-180.7(positive)-177.4(and)-175.6(beneficial)-173.7(results.)]TJ -2.0693 -1.2571 TD [(18.)-799.3(Medical)-393.9(research)-393(involving)-389.9(human)-394.9(subjects)-389.2(should)-391(only)-391.9(be)]TJ 2.0693 -1.2623 TD [(conducted)-370.9(if)-369.6(the)-369.6(importance)-369.4(of)-366.9(the)-369.6(objective)-371.3(outweighs)-367.3(the)]TJ 0 -1.2571 TD [(inherent)-356.8(risks)-356.1(and)-351.5(burdens)-356.3(to)-356.6(the)-354.1(subject.)-354.2(This)-356.7(is)-353.8(especially)]TJ 0 -1.2623 TD [(important)-269(when)-270.7(the)-266.2(human)-270.8(subjects)-265.1(are)-271.3(healthy)-265.2(volunteers.)]TJ -2.0693 -1.2571 TD [(19.)-799.3(Medical)-487(research)-486.1(is)-483.1(only)-485(justified)-483.1(if)-488.5(there)-484(is)-483.1(a)-488.1(reasonable)]TJ 2.0693 -1.2623 TD [(likelihood)-172(that)-170.2(the)-173.1(populations)-170.5(in)-171.3(which)-171.4(the)-167.9(research)-170.5(is)-172.7(carried)]TJ 0 -1.2571 TD [(out)-270.2(stand)-269.8(to)-268.6(benefit)-267.5(from)-272.2(the)-266.2(results)-269(of)-268.6(the)-271.3(research.)]TJ -2.0693 -1.2623 TD [(20.)-297.5(The)-295.3(subjects)-296.1(must)-292.9(be)-294(volunteers)-294.3(and)-294.6(informed)-292.5(participants)-295.6(in)]TJ 2.0693 -1.2571 TD [(the)-271.3(research)-268.8(project.)]TJ -2.0693 -1.2623 TD [(21.)-799.3(The)-181.5(right)-179.3(of)-180.7(research)-175.7(subjects)-182.3(to)-180.7(safeguard)-175.7(their)-180.2(integrity)-175.8(must)]TJ 2.0693 -1.2571 TD [(always)-437.9(be)-433.6(respected.)-436.1(Every)-434.9(precaution)-437.7(should)-432.3(be)-438.8(taken)-435.1(to)]TJ T* [(respect)-355.2(the)-354.1(privacy)-347.9(of)-356.6(the)-348.9(subject,)-354.2(the)-354.1(confidentiality)-352.1(of)-351.4(the)]TJ 0 -1.2623 TD [(patients)-206.5(information)-207.4(and)-201.5(to)-206.5(minimize)-206.9(the)-209.3(impact)-205.5(of)-206.5(the)-204.1(study)]TJ 0 -1.2571 TD [(on)-458.3(the)-457.6(subjects)-455.5(physical)-450.1(and)-454.9(mental)-458.9(integrity)-455.1(and)-454.9(on)-453.1(the)]TJ 0 -1.2623 TD [(personality)-271.7(of)-268.6(the)-266.2(subject.)]TJ -1.7951 -1.2571 TD [(22.)-525.1(In)-216.6(any)-206.9(research)-211.9(on)-210(human)-213.9(beings,)-210.4(each)-210.5(potential)-210.3(subject)-210.4(must)]TJ 1.7951 -1.2623 TD [(be)-485.4(adequately)-473(informed)-478.7(of)-480.7(the)-483.4(aims,)-479.3(methods,)-478.7(sources)-483.1(of)]TJ 0 -1.2571 TD 0.012 Tc [(fu)5.3(nd)5.3(ing)5(,)]TJ 4.273 0 TD 0.0079 Tc [(an)-4(y)-614.7(p)1.2(o)-4(ssi)-6.6(ble)-615.6(c)-5.2(on)-4(flic)-5.2(ts)-615.9(of)]TJ 12.0742 0 TD 0.0089 Tc [(interest,)-616.1(i)-0.5(nsti)-5.6(tut)-4.7(i)-0.4(onal)]TJ -16.3472 -1.2571 TD 0 Tc [(affiliations)-486.2(of)-485.9(the)-483.5(researcher,)-485.6(the)-483.4(anticipated)-483.8(benefits)-487.8(and)]TJ 0 -1.2623 TD [(potential)-282.7(risks)-283.7(of)-284.1(the)-281.7(study)-285.3(and)-279(the)-286.9(discomfort)-278.1(it)-286.8(may)-283.5(entail.)]TJ 0 -1.2571 TD [(The)-305.7(subject)-308.7(should)-303(be)-304.3(informed)-302.8(of)-304.8(the)-307.6(right)-303.5(to)-304.8(abstain)-301.6(from)]TJ T* 0.0189 Tc [(participation)-618.9(i)-0.8(n)-624.1(t)0.1(he)-620.1(study)-619.2(o)-3.3(r)-620.4(t)0.1(o)-624.1(w)2.3(ithdraw)-618.5(consent)-625.8(t)0.1(o)]TJ 0 -1.2623 TD 0 Tc [(participate)-319.7(at)-320.6(any)-315.5(time)-321.1(without)-316.4(reprisal.)-322.5(After)-318.3(ensuring)-319.3(that)]TJ 0 -1.2571 TD [(the)-447.2(subject)-443.2(has)-446(understood)-440.2(the)-447.2(information,)-444.4(the)-442.1(physician)]TJ 0 -1.2623 TD 0.0157 Tc [(should)-617(then)-617(obtai)-4(n)-617(the)-618.1(s)2.4(ubject)-4(s)-618.4(freely-gi)-4(v)3.6(en)-617(informed)]TJ 0 -1.2571 TD 0 Tc [(consent,)-568.9(preferably)-568.7(in)-569.6(writing.)-566.4(If)-570.1(the)-571.4(consent)-564.7(cannot)-565.9(be)]TJ ET 95.641 646.809 318.898 -0.51 re f BT /F6 1 Tf 7.9702 0 0 7.9702 323.8866 649.1337 Tm [(DECLARATION)-318(OF)-331.8(HELSINKI)]TJ /F7 1 Tf 11.9551 0 0 11.9551 95.6409 649.1337 Tm (92)Tj ET endstream endobj 274 0 obj << /Type /Page /Parent 400 0 R /Resources 275 0 R /Contents 276 0 R /MediaBox [ 0 0 595 842 ] /CropBox [ 0 0 595 842 ] /Rotate 0 >> endobj 275 0 obj << /ProcSet [ /PDF /Text ] /Font << /F2 337 0 R /F6 341 0 R /F7 342 0 R >> /ExtGState << /GS1 434 0 R >> /ColorSpace << /DefaultCMYK 417 0 R /Cs6 416 0 R >> >> endobj 276 0 obj << /Length 5903 >> stream q 1 i 0.015 737.008 510.221 -737.008 re W n /Cs6 cs 0 0 0 scn /GS1 gs 0.015 709.001 25.44 -0.284 re f Q /Cs6 cs 0 0 0 scn /GS1 gs 28.006 737.008 0.283 -25.455 re f 481.89 737.008 0.283 -25.455 re f 484.724 709.001 25.512 -0.284 re f 484.724 28.346 25.512 -0.283 re f 481.89 25.512 0.283 -25.512 re f q 1 i 0.015 737.008 510.221 -737.008 re W n 28.006 25.512 0.283 -25.512 re f 0.015 28.346 25.44 -0.283 re f Q BT /F2 1 Tf 10.959 0 0 10.959 132.4913 609.8455 Tm 0 Tc 0 Tw [(obtained)-199.2(in)-197.1(writing,)-193.9(the)-198.9(non-written)-192.4(consent)-197.4(must)-194.6(be)-200.8(formally)]TJ 0 -1.2623 TD [(documented)-268(and)-268.7(witnessed.)]TJ -2.0693 -1.2571 TD [(23.)-799.3(When)-201.5(obtaining)-192.1(informed)-199.4(consent)-197.4(for)-199.2(the)-193.8(research)-201.6(project)-194.8(the)]TJ 2.0693 -1.2623 TD [(physician)-249.9(should)-240.9(be)-247.4(particularly)-245.1(cautious)-247.2(if)-250.6(the)-245.5(subject)-246.6(is)-245.1(in)-248.8(a)]TJ 0 -1.2571 TD [(dependent)-438.2(relationship)-436(with)-439.4(the)-436.9(physician)-436.1(or)-433.9(may)-438.7(consent)]TJ 0 -1.2623 TD [(under)-398.3(duress.)-391.4(In)-397.7(that)-397.8(case)-393.1(the)-395.5(informed)-396(consent)-394(should)-391(be)]TJ 0 -1.2571 TD -0.0001 Tc [(obtained)-256.2(by)-251.7(a)-255.4(well-informed)-255.1(physician)-250(who)-252.6(is)-255.6(not)-254.7(engaged)-252(in)]TJ T* 0 Tc [(the)-328.3(investigation)-329.7(and)-325.6(who)-330.1(is)-327.9(completely)-325.3(independent)-324.9(of)-330.7(this)]TJ 0 -1.2623 TD (relationship.)Tj -2.0693 -1.2571 TD (24.)Tj 10.7396 0 0 10.959 132.4913 485.6314 Tm [(For)-197.1(a)-191.5(research)-193(subject)-190.8(who)-194.5(is)-189.6(legally)-193.3(incompetent,)-191.1(physically)-193(or)]TJ 0 -1.2623 TD [(mentally)-185.4(incapable)-184.8(of)-186.6(giving)-184.7(consent)-188.5(or)-182.1(is)-189.6(a)-186.3(legally)-182.8(incompetent)]TJ 0 -1.2571 TD [(minor,)-210.7(the)-208.9(investigator)-203.8(must)-209.6(obtain)-207.7(informed)-204(consent)-209.7(from)-204.3(the)]TJ 0 -1.2623 TD [(legally)-198.6(authorized)-196.8(representative)-196.3(in)-196.8(accordance)-194.3(with)-201.6(applicable)]TJ 0 -1.2571 TD [(law.)-200.5(These)-194.1(groups)-193.8(should)-193.5(not)-194.2(be)-193.5(included)-194.6(in)-196.8(research)-193(unless)-195.7(the)]TJ T* [(research)-303.9(is)-300.5(necessary)-300.1(to)-297.5(promote)-299.8(the)-298.6(health)-301.6(of)-297.5(the)-303.9(population)]TJ 0 -1.2623 TD [(represented)-276(and)-275.3(this)-281.2(research)-272.2(cannot)-278.3(instead)-275.6(be)-277.9(performed)-274.9(on)]TJ 0 -1.2571 TD [(legally)-251.4(competent)-248.5(persons.)]TJ 10.959 0 0 10.959 109.8142 375.1936 Tm [(25.)-799.3(When)-258.4(a)-260.5(subject)-256.9(deemed)-254.9(legally)-258.6(incompetent,)-257.4(such)-257.1(as)-258.3(a)-260.5(minor)]TJ 2.0693 -1.2571 TD [(child,)-230.4(is)-224.4(able)-222.3(to)-227.2(give)-222.6(assent)-227.4(to)-222.1(decisions)-226.2(about)-221.8(participation)-225.9(in)]TJ 0 -1.2623 TD [(research,)-257.5(the)-255.8(investigator)-254.5(must)-256.6(obtain)-257(that)-258.2(assent)-253.3(in)-259.2(addition)]TJ 0 -1.2571 TD [(to)-273.8(the)-266.2(consent)-269.8(of)-268.6(the)-271.3(legally)-269(authorized)-267(representativ)6.8(e.)]TJ -2.0693 -1.2623 TD [(26.)-799.3(Research)-483.9(on)-484.2(individuals)-479.5(from)-479.1(whom)-485.8(it)-483.4(is)-483.1(not)-482.3(possible)-482.1(to)]TJ 2.0693 -1.2571 TD [(obtain)-319.1(consent,)-320.5(including)-318.1(proxy)-314.9(or)-320.1(advance)-314(consent,)-315.4(should)]TJ T* [(be)-350.9(done)-343.6(only)-350.5(if)-348.9(the)-348.9(physical/m)6.5(ental)-349.8(condition)-347.9(that)-346.1(prevents)]TJ 0 -1.2623 TD [(obtaining)-181.7(informed)-183.9(consent)-181.9(is)-188.2(a)-182.9(necessary)-182.7(characteristic)-179.6(of)-185.9(the)]TJ 0 -1.2571 TD 0.0133 Tc [(re)5.4(s)5.1(e)5.4(a)6.3(r)5.1(c)5.4(h)-603.8(p)6.6(o)]TJ 5.318 0 TD 0.0077 Tc [(pulation.)-612.1(The)-610.6(s)-0.5(pecific)-610.6(r)-0.5(easo)-4.2(ns)-610.9(for)-610.9(i)-1.6(nv)-4.4(olving)]TJ -5.318 -1.2571 TD 0 Tc [(research)-325.7(subjects)-316.8(with)-325.6(a)-322.5(condition)-316.9(that)-320.2(renders)-322.7(them)-318.5(unable)]TJ 0 -1.2623 TD [(to)-222.1(give)-217.4(informed)-220.1(consent)-218.1(should)-215.1(be)-216.4(stated)-222.5(in)-217.8(the)-219.6(experimental)]TJ 0 -1.2571 TD 0.0101 Tc [(pro)3.4(t)]TJ 1.8623 0 TD 0.0076 Tc [(ocol)-617.4(for)-616.2(c)-0.3(o)-4.3(n)0.9(sid)-4.3(e)-0.3(rati)-6.9(on)-614.7(and)-614.7(a)0.6(p)-4.3(p)0.9(ro)-4.3(val)-617.4(of)-616.4(the)-615.9(r)-0.6(evie)-5.5(w)]TJ -1.8623 -1.2623 TD 0 Tc [(committee.)-263.7(The)-259.1(protocol)-257.3(should)-256.5(state)-257.2(that)-263.3(consent)-254.3(to)-258.3(remain)]TJ 0 -1.2571 TD [(in)-321.3(the)-317.9(research)-315.4(should)-318.5(be)-314.6(obtained)-318.2(as)-315.2(soon)-318(as)-315.2(possible)-316.6(from)]TJ T* [(the)-271.3(individual)-269.6(or)-268.4(a)-270.8(legally)-269(authorized)-267(surrogate.)]TJ -2.0693 -1.2623 TD [(27.)-799.3(Both)-530.2(authors)-527.8(and)-527.4(publishers)-533.2(have)-525.2(ethical)-532.6(obligations.)-524.2(In)]TJ 2.0693 -1.2571 TD [(publication)-405.7(of)-403.1(the)-400.7(results)-403.5(of)-408.3(research,)-402.3(the)-400.7(investigators)-402.4(are)]TJ 0 -1.2623 TD [(obliged)-358.9(to)-361.7(preserve)-356.8(the)-359.3(accuracy)-354.4(of)-361.7(the)-354.1(results.)-361.1(Negative)-360.3(as)]TJ 0 -1.2571 TD [(well)-519.1(as)-516.9(positive)-518.8(results)-517.3(should)-515.1(be)-516.4(published)-513.2(or)-516.7(otherwise)]TJ 0 -1.2623 TD [(publicly)-425.2(available.)-416.2(Sources)-419.6(of)-418.6(funding,)-423.1(institutional)-420.3(affilia-)]TJ 0 -1.2571 TD [(tions)-236(and)-227.3(any)-232.8(possible)-228.6(conflicts)-233.3(of)-232.4(interest)-230.6(should)-230.6(be)-231.9(declared)]TJ ET 95.641 646.809 318.898 -0.51 re f BT /F6 1 Tf 7.9702 0 0 7.9702 95.6409 649.1337 Tm [(APPENDIX)-323.7(2)]TJ /F7 1 Tf 11.9551 0 0 11.9551 401.3857 649.1337 Tm (93)Tj ET endstream endobj 277 0 obj << /Type /Page /Parent 400 0 R /Resources 278 0 R /Contents 279 0 R /MediaBox [ 0 0 595 842 ] /CropBox [ 0 0 595 842 ] /Rotate 0 >> endobj 278 0 obj << /ProcSet [ /PDF /Text ] /Font << /F2 337 0 R /F6 341 0 R /F7 342 0 R /F12 347 0 R >> /ExtGState << /GS1 434 0 R >> /ColorSpace << /DefaultCMYK 417 0 R /Cs6 416 0 R >> >> endobj 279 0 obj << /Length 5356 >> stream q 1 i 0.015 737.008 510.221 -737.008 re W n /Cs6 cs 0 0 0 scn /GS1 gs 0.015 709.001 25.44 -0.284 re f Q /Cs6 cs 0 0 0 scn /GS1 gs 28.006 737.008 0.283 -25.455 re f 481.89 737.008 0.283 -25.455 re f 484.724 709.001 25.512 -0.284 re f 484.724 28.346 25.512 -0.283 re f 481.89 25.512 0.283 -25.512 re f q 1 i 0.015 737.008 510.221 -737.008 re W n 28.006 25.512 0.283 -25.512 re f 0.015 28.346 25.44 -0.283 re f Q BT /F2 1 Tf 10.959 0 0 10.959 132.4913 609.8455 Tm 0.0197 Tc 0 Tw [(in)-613(t)6.1(h)7.8(e)-614.1(p)2.7(u)7.8(b)]TJ 5.1577 0 TD 0.0147 Tc [(lication.)-620.6(Reports)-614.2(o)-2.3(f)-619.7(e)1.6(xperimentation)-618(not)-619.7(i)0.2(n)]TJ -5.1577 -1.2623 TD 0 Tc [(accordance)-280.8(with)-284.2(the)-281.7(principles)-282.1(laid)-285.9(down)-279.9(in)-285.1(this)-281(Declaration)]TJ 0 -1.2571 TD [(should)-272(not)-265(be)-273.3(accepted)-267.3(for)-266.4(publication.)]TJ /F12 1 Tf -3.3626 -2.6487 TD [(C.)-2374.6(ADDITIONAL)-272.5(PRINCIPLES)-263.9(FOR)-271.9(MEDICAL)]TJ 3.3626 -1.2571 TD [(RESEARCH)-272.7(COMBINED)-266.7(WITH)-267.8(MEDICAL)-266.4(CARE)]TJ /F2 1 Tf -2.0693 -1.8779 TD [(28.)-799.3(The)-383.2(physician)-379.2(may)-376.6(combine)-376.9(medical)-379.8(research)-382.6(with)-377.3(medical)]TJ 2.0693 -1.2571 TD [(care,)-402.4(only)-397(to)-398(the)-395.5(extent)-398.1(that)-397.8(the)-400.7(research)-398.1(is)-395.2(justified)-400.3(by)-396.5(its)]TJ 0 -1.2623 TD [(potential)-199.9(prophylactic,)-199.5(diagnostic)-201.4(or)-195.9(therapeutic)-199(value.)-202.5(When)]TJ 0 -1.2571 TD [(medical)-369.5(research)-367.1(is)-364.1(combined)-368.1(with)-361.8(medical)-369.5(care,)-366.2(additional)]TJ 0 -1.2623 TD [(standards)-496.4(apply)-492(to)-496.2(protect)-499.1(the)-493.8(patients)-492.1(who)-495.6(are)-499(research)]TJ 0 -1.2571 TD (subjects.)Tj -2.0693 -1.3864 TD [(29.)-799.3(The)-186.7(benefits,)-181.6(risks,)-179.2(burdens)-180.4(and)-180.8(effectiveness)-181.8(of)-180.7(a)-182.9(new)-181.2(method)]TJ 2.0693 -1.2623 TD [(should)-277.1(be)-278.4(tested)-275.2(against)-276(those)-275.9(of)-273.8(the)-276.5(best)-279.5(current)-276.4(prophylac-)]TJ 0 -1.2571 TD [(ti)-7.4(c,)-607(diagnostic,)-614.3(and)-605(therapeu)-7.8(tic)-605.1(methods)-9(.)-604.3(This)-610.1(does)-603.7(not)]TJ 0 -1.2623 TD [(exclude)-270.7(the)-271.4(use)-271.1(of)-268.6(placebo,)-268.5(or)-268.4(no)-266.9(treatment,)-269.4(in)-269.5(studies)-272.7(where)]TJ 0 -1.2571 TD [(no)-458.3(proven)-451.8(prophylactic,)-453(diagnostic)-454.9(or)-454.6(therapeutic)-452.5(method)]TJ T* (exists.)Tj -2.0693 -1.3916 TD [(30.)-799.3(At)-257.6(the)-255.8(conclusion)-257.3(of)-253.1(the)-255.8(study,)-258.4(every)-255.2(patient)-256.3(entered)-255.5(into)-253.7(the)]TJ 2.0693 -1.2571 TD 0.0117 Tc [(stud)5(y)-616.1(s)-1.6(h)5(ould)-610.6(b)-0.2(e)-617(a)-0.4(ssured)-615.8(of)-612.3(access)-612.1(t)-1.9(o)-610.6(t)-1.9(he)-611.8(best)-617.5(proven)]TJ 0 -1.2623 TD 0 Tc [(prophylactic,)-349.6(diagnostic)-351.5(and)-351.5(therapeutic)-343.8(methods)-350.4(identified)]TJ 0 -1.2571 TD [(by)-272.3(the)-266.2(study.)]TJ -2.0693 -1.3864 TD [(31.)-799.3(The)-181.5(physician)-182.7(should)-178.9(fully)-180.5(inform)-179.6(the)-178.2(patient)-183.8(which)-176.6(aspects)-183.6(of)]TJ 2.0693 -1.2623 TD [(the)-224.8(care)-222.3(are)-219.6(related)-221(to)-222.1(the)-224.8(research.)-221.3(The)-222.9(refusal)-221.2(of)-222.1(a)-219.1(patient)-225.2(to)]TJ 0 -1.2571 TD [(participate)-340.4(in)-342(a)-338.1(study)-337(must)-339.4(never)-337.7(interfere)-336.8(with)-341.1(the)-338.6(patient-)]TJ 0 -1.2623 TD [(physician)-270.6(relationship.)]TJ -2.0693 -1.3864 TD [(32.)-799.3(In)-454.6(the)-447.2(treatment)-451.5(of)-449.7(a)-451.9(patient,)-446.7(where)-450.8(proven)-451.8(prophylact)8.1(ic,)]TJ 2.0693 -1.2623 TD [(diagnostic)-222.1(and)-222.1(therapeutic)-219.7(methods)-221.1(do)-220.3(not)-223.6(exist)-221.9(or)-221.8(have)-220(been)]TJ 0 -1.2571 TD [(ineffective,)-445.3(the)-436.9(physician,)-440.3(with)-439.4(informed)-442.5(consent)-440.5(from)-437.7(the)]TJ T* [(patient,)-358.7(must)-360.1(be)-361.2(free)-358.3(to)-356.6(use)-359(unproven)-356.6(or)-356.3(new)-362.3(prophylact)8.1(ic,)]TJ 0 -1.2623 TD [(diagnostic)-486(and)-486(therapeutic)-483.5(measures,)-488.1(if)-488.5(in)-486.8(the)-488.6(physicians)]TJ 0 -1.2571 TD [(judgement)-273.3(it)-276.4(offers)-270.3(hope)-276.3(of)-273.8(saving)-267.6(life,)-277.2(re-establishing)-274.5(health)]TJ T* 0.0067 Tc (or)Tj 1.5571 0 TD 0 Tc [(all)-10.2(e)-7.9(via)-13(ti)-7.4(n)-6.7(g)-607.1(s)-8.2(uff)-13.2(eri)-9.9(n)-6.7(g)0(.)-616.4(Whe)-13.7(re)-616.1(po)-8.2(ssi)-10.2(b)-6.7(l)0(e)-6.9(,)-614.6(th)-10(ese)-618.9(me)-8.4(a)-7(sur)-12.7(es)]TJ -1.5571 -1.2623 TD [(should)-323.7(be)-325(made)-322.2(the)-323.1(object)-321.2(of)-320.4(research,)-324.7(designed)-319.1(to)-325.5(evaluate)]TJ 0 -1.2571 TD [(their)-232(safety)-233.1(and)-227.3(efficacy.)-228.4(In)-232.1(all)-232.6(cases,)-229.5(new)-227.8(information)-228.1(should)]TJ 0 -1.2623 TD [(be)-433.6(recorded)-432.6(and,)-428.1(where)-430.1(appropriate,)-433.6(published.)-429.5(The)-429.8(other)]TJ 0 -1.2571 TD [(relevant)-269.3(guidelines)-270.5(of)-268.6(this)-270.6(Declaration)-265.3(should)-272(be)-268.1(followed.)]TJ ET 95.641 646.809 318.898 -0.51 re f BT /F6 1 Tf 7.9702 0 0 7.9702 323.8866 649.1337 Tm [(DECLARATION)-318(OF)-331.8(HELSINKI)]TJ /F7 1 Tf 11.9551 0 0 11.9551 95.6409 649.1337 Tm (94)Tj ET endstream endobj 280 0 obj << /Type /Page /Parent 400 0 R /Resources 281 0 R /Contents 282 0 R /MediaBox [ 0 0 595 842 ] /CropBox [ 0 0 595 842 ] /Rotate 0 >> endobj 281 0 obj << /ProcSet [ /PDF /Text ] /Font << /F2 337 0 R /F6 341 0 R /F7 342 0 R /F10 345 0 R /F12 347 0 R >> /ExtGState << /GS1 434 0 R >> /ColorSpace << /DefaultCMYK 417 0 R /Cs6 416 0 R >> >> endobj 282 0 obj << /Length 3227 >> stream q 1 i 0.015 737.008 510.221 -737.008 re W n /Cs6 cs 0 0 0 scn /GS1 gs 0.015 709.001 25.44 -0.284 re f Q /Cs6 cs 0 0 0 scn /GS1 gs 28.006 737.008 0.283 -25.455 re f 481.89 737.008 0.283 -25.455 re f 484.724 709.001 25.512 -0.284 re f 484.724 28.346 25.512 -0.283 re f 481.89 25.512 0.283 -25.512 re f q 1 i 0.015 737.008 510.221 -737.008 re W n 28.006 25.512 0.283 -25.512 re f 0.015 28.346 25.44 -0.283 re f Q BT /F12 1 Tf 10.959 0 0 10.959 95.6409 609.8455 Tm 0 Tc 0 Tw [(NOTE)-273.1(OF)-265.6(CLARIFICATION)-268(ON)-270.4(PARAGRAPH)-268.1(29)]TJ 0 -1.2623 TD [(OF)-270.8(THE)-272.2(WMA)-268.3(DECLARATION)-267(OF)-270.8(HELSINK)6.1(I)]TJ /F2 1 Tf 0 -1.7434 TD [(The)-238.4(WMA)-231.8(is)-234.8(concerned)-232.1(that)-232.3(paragraph)-229.9(29)-231.2(of)-232.4(the)-235.1(revised)-231.1(Declaration)]TJ 0 -1.2623 TD [(of)-460(Helsinki)-456.4(\(October)-453.4(2000\))-455.4(has)-456.4(led)-453.3(to)-454.9(diverse)-458.7(interpretations)-454.4(and)]TJ 0 -1.2571 TD [(possible)-285.5(confusion.)-278.5(It)-280.4(hereby)-282.3(reaffirms)-278.2(its)-284.6(position)-279.4(that)-284(extreme)-280.6(care)]TJ T* [(must)-251.5(be)-252.6(taken)-248.8(in)-248.9(making)-249.4(use)-250.4(of)-247.9(a)-250.1(placebo-controll)5.3(ed)-252.6(trial)-249.2(and)-248(that)-253(in)]TJ 0 -1.2623 TD [(general)-488.5(this)-487.9(methodology)-487.6(should)-484.1(only)-490.2(be)-490.5(used)-484.7(in)-492(the)-488.6(absence)-486.8(of)]TJ 0 -1.2571 TD [(existing)-276(proven)-270.8(therapy.)-273.3(However,)-271.1(a)-276(placebo-controll)5.3(ed)-278.4(trial)-269.9(may)-273.2(be)]TJ T* [(ethically)-393.7(acceptable,)-391.3(even)-391.6(if)-390.3(proven)-389.8(therapy)-388.1(is)-395.2(available,)-390.3(under)-388(the)]TJ 0 -1.2623 TD [(following)-271.6(circumstances:)]TJ /F10 1 Tf 1.2933 -1.2571 TD (7)Tj /F2 1 Tf 1.2933 0 TD [(Where)-350.5(for)-344(compelling)-345.7(and)-346.3(scientifically)-343.8(sound)-345.4(methodolo-)]TJ 0 -1.2623 TD [(gical)-242.3(reasons)-239(its)-238.1(use)-240(is)-245.1(necessary)-234.4(to)-242.8(determine)-239.5(the)-240.3(efficacy)-239.8(or)]TJ 0 -1.2571 TD [(safety)-310.7(of)-304.8(a)-307(prophylactic,)-308.2(diagnostic)-304.9(or)-304.6(therapeutic)-307.6(method;)]TJ T* (or)Tj /F10 1 Tf -1.2933 -1.2622 TD (7)Tj /F2 1 Tf 1.2933 0 TD [(Where)-335(a)-332.9(prophylactic,)-334.1(diagnostic)-330.8(or)-335.6(therapeutic)-333.5(method)-331.9(is)]TJ 0 -1.2571 TD [(being)-394.6(investigated)-388.8(for)-395.8(a)-389.8(minor)-393.6(condition)-389.3(and)-392.9(the)-390.3(patients)]TJ 0 -1.2623 TD [(who)-190.4(receive)-190.6(placebo)-186.8(will)-194.7(not)-187.4(be)-190.5(subject)-189.7(to)-191(any)-186.2(additional)-191.1(risk)]TJ 0 -1.2571 TD [(of)-273.8(serious)-267.3(or)-268.4(irreversible)-268.8(harm.)]TJ -1.2933 -1.2571 TD [(All)-562.7(other)-560.4(provisions)-563.3(of)-558.3(the)-561(Declaration)-560.1(of)-558.3(Helsinki)-565.1(must)-556.7(be)]TJ -1.2933 -1.2623 TD [(adhered)-309.7(to,)-303.8(especially)-308.2(the)-307.6(need)-303.4(for)-307.8(appropriate)-305.3(ethical)-304.9(and)-310.1(scientific)]TJ 0 -1.2571 TD (review.)Tj ET 95.641 646.809 318.898 -0.51 re f BT /F6 1 Tf 7.9702 0 0 7.9702 95.6409 649.1337 Tm [(APPENDIX)-323.7(2)]TJ /F7 1 Tf 11.9551 0 0 11.9551 401.3857 649.1337 Tm (95)Tj ET endstream endobj 283 0 obj << /Type /Page /Parent 400 0 R /Resources 284 0 R /Contents 285 0 R /MediaBox [ 0 0 595 842 ] /CropBox [ 0 0 595 842 ] /Rotate 0 >> endobj 284 0 obj << /ProcSet [ /PDF ] /ExtGState << /GS1 434 0 R >> /ColorSpace << /DefaultCMYK 417 0 R /Cs6 416 0 R >> >> endobj 285 0 obj << /Length 412 >> stream q 1 i 0.015 737.008 510.221 -737.008 re W n /Cs6 cs 0 0 0 scn /GS1 gs 0.015 709.001 25.44 -0.284 re f Q /Cs6 cs 0 0 0 scn /GS1 gs 28.006 737.008 0.283 -25.455 re f 481.89 737.008 0.283 -25.455 re f 484.724 709.001 25.512 -0.284 re f 484.724 28.346 25.512 -0.283 re f 481.89 25.512 0.283 -25.512 re f q 1 i 0.015 737.008 510.221 -737.008 re W n 28.006 25.512 0.283 -25.512 re f 0.015 28.346 25.44 -0.283 re f Q endstream endobj 286 0 obj << /Type /Page /Parent 400 0 R /Resources 287 0 R /Contents 288 0 R /MediaBox [ 0 0 595 842 ] /CropBox [ 0 0 595 842 ] /Rotate 0 >> endobj 287 0 obj << /ProcSet [ /PDF /Text ] /Font << /F2 337 0 R /F4 339 0 R /F11 346 0 R /F12 347 0 R >> /ExtGState << /GS1 434 0 R >> /ColorSpace << /DefaultCMYK 417 0 R /Cs6 416 0 R >> >> endobj 288 0 obj << /Length 4295 >> stream q 1 i 0.015 737.008 510.221 -737.008 re W n /Cs6 cs 0 0 0 scn /GS1 gs 0.015 709.001 25.44 -0.284 re f Q /Cs6 cs 0 0 0 scn /GS1 gs 28.006 737.008 0.283 -25.455 re f 481.89 737.008 0.283 -25.455 re f 484.724 709.001 25.512 -0.284 re f 484.724 28.346 25.512 -0.283 re f 481.89 25.512 0.283 -25.512 re f q 1 i 0.015 737.008 510.221 -737.008 re W n 28.006 25.512 0.283 -25.512 re f 0.015 28.346 25.44 -0.283 re f Q 1 1 1 scn 95.641 519.023 14.173 -2.835 re f 0 0 0 scn 95.641 552.983 318.898 -33.959 re f BT /F4 1 Tf 19.9253 0 0 19.9253 207.0425 588.3589 Tm 0 Tc 0 Tw (Appendix)Tj /F2 1 Tf 4.3248 0 TD (3)Tj /F11 1 Tf 11.9551 0 0 11.9551 144.0567 538.3558 Tm 1 1 1 scn [(THE)-274.3(PHASES)-278.2(OF)-271.3(CLINICAL)-276.4(TRIA)-7.9(LS)]TJ 2.134 -1.1523 TD [(OF)-276.1(VACCINES)-275.9(AND)-274.7(DRUGS)]TJ /F12 1 Tf 10.959 0 0 10.959 95.6409 476.107 Tm 0 0 0 scn [(VACCINE)-273.3(DEVELOPMEN)6.4(T)]TJ /F2 1 Tf 0 -1.8468 TD [(Phase)-315.5(I)-313.4(refers)-317.7(to)-310(the)-317.9(first)-311.6(introduction)-314.3(of)-315.2(a)-312.2(candidate)-310.8(vaccine)-312.4(into)-315.7(a)]TJ 0 -1.2571 TD [(human)-177.7(population)-172.7(for)-173.3(initial)-178.5(determinat)6.5(ion)-178(of)-175.5(its)-176(safety)-171(and)-175.6(biological)]TJ T* [(effects,)-257.9(including)-256(immunogenicity.)-258.7(This)-258.4(phase)-253.7(may)-257.6(include)-256.4(studies)-257.2(of)]TJ 0 -1.2623 TD [(dose)-396.8(and)-392.9(route)-389.7(of)-392.8(administration,)-396.5(and)-387.7(usually)-395.7(involves)-393.2(fewer)-390.4(than)]TJ 0 -1.2571 TD [(100)-331.3(volunteers.)]TJ 1.2933 -1.3554 TD [(Phase)-439.7(II)-440.5(refers)-436.7(to)-439.3(the)-436.9(initial)-437.2(trials)-438.4(examining)-439.1(effectiveness)-435.3(in)-440.3(a)]TJ -1.2933 -1.2623 TD [(limited)-196.5(number)-197.1(of)-196.2(volunteers)-190.8(\(usually)-192(between)-196.6(200)-191.6(and)-196.3(500\);)-193.9(the)-193.7(focus)]TJ 0 -1.2571 TD [(of)-273.8(this)-265.5(phase)-269.3(is)-271(immunogenicity.)]TJ 1.2933 -1.3554 TD [(Phase)-372.4(III)-371.1(trials)-371.2(are)-374.8(intended)-370.8(for)-369.9(a)-369.1(more)-375.1(complete)-371(assessment)-371.2(of)]TJ -1.2933 -1.2623 TD [(safety)-196.9(and)-196.3(effectiveness)-192.1(in)-197.1(the)-198.9(prevention)-194.5(of)-196.2(disease,)-193.9(involving)-193.3(a)-198.4(larger)]TJ 0 -1.2571 TD [(number)-269.5(of)-268.6(volunteers)-268.4(in)-269.5(a)-270.8(multicentre)-267.6(adequately)-266.1(controlled)-269.4(study.)]TJ /F12 1 Tf 0 -2.6176 TD [(DRUG)-272.5(DEVELOPMENT)]TJ /F2 1 Tf 0 -1.8417 TD [(Phase)-217.3(I)-209.9(refers)-214.3(to)-216.9(the)-209.3(first)-218.4(introduction)-210.9(of)-211.7(a)-213.9(drug)-214.8(into)-212.3(humans.)-210.7(Normal)]TJ 0 -1.2571 TD [(volunteer)-281(subjects)-280.6(are)-281.7(usually)-276.7(studied)-281.6(to)-279(determine)-280.9(levels)-277.3(of)-284.1(drugs)-279.9(at)]TJ 0 -1.2623 TD [(which)-233.5(toxicity)-229.7(is)-229.6(observed.)-229(Such)-229.8(studies)-231.3(are)-230(followed)-232.1(by)-231(dose-ranging)]TJ 0 -1.2571 TD [(studies)-396.9(in)-393.7(patients)-393.8(for)-395.8(safety)-393.5(and,)-397(in)-393.7(some)-395.8(cases,)-395.1(early)-391.1(evidence)-397.6(of)]TJ T* (effectiveness.)Tj 1.2933 -1.3554 TD [(Phase)-222.4(II)-218.1(investigation)-215.9(consists)-218.8(of)-216.9(controlled)-217.6(clinical)-222.1(trials)-221.2(designed)]TJ -1.2933 -1.2623 TD [(to)-289.3(demonstrate)-288.7(effectiveness)-285.2(and)-289.4(relative)-287.5(safety.)-289(Normally,)-285.6(these)-287.4(are)]TJ 0 -1.2571 TD [(performed)-268.2(on)-272.1(a)-265.6(limited)-274.1(number)-264.4(of)-273.8(closely)-268.5(monitored)-268.2(patients.)]TJ 1.2933 -1.3554 TD [(Phase)-398.3(III)-397(trials)-402.2(are)-395.5(performed)-397.5(after)-396.9(a)-400.1(reasonable)-396.3(probability)-395.8(of)]TJ -1.2933 -1.2623 TD [(effectiveness)-197.3(of)-196.2(a)-198.4(drug)-199.3(has)-192.6(been)-199.9(established)-195(and)-196.3(are)-193.8(intended)-194.9(to)-201.4(gather)]TJ 0 -1.2571 TD [(additional)-263.5(evidence)-263.1(of)-263.5(effectiveness)-264.5(for)-261.3(specific)-262.3(indications)-262.3(and)-263.5(more)]TJ 0 -1.2623 TD [(precise)-257.8(definition)-255.6(of)-258.3(drug-relate)7.4(d)-260.2(adverse)-254.5(effects.)-252.8(This)-258.4(phase)-253.7(includes)]TJ 0 -1.2571 TD [(both)-271.7(controlled)-269.4(and)-263.5(uncontrolled)-267.3(studies.)]TJ ET endstream endobj 289 0 obj << /Type /Page /Parent 400 0 R /Resources 290 0 R /Contents 291 0 R /MediaBox [ 0 0 595 842 ] /CropBox [ 0 0 595 842 ] /Rotate 0 >> endobj 290 0 obj << /ProcSet [ /PDF /Text ] /Font << /F2 337 0 R /F6 341 0 R /F7 342 0 R >> /ExtGState << /GS1 434 0 R >> /ColorSpace << /DefaultCMYK 417 0 R /Cs6 416 0 R >> >> endobj 291 0 obj << /Length 3263 >> stream q 1 i 0.015 737.008 510.221 -737.008 re W n /Cs6 cs 0 0 0 scn /GS1 gs 0.015 709.001 25.44 -0.284 re f Q /Cs6 cs 0 0 0 scn /GS1 gs 28.006 737.008 0.283 -25.455 re f 481.89 737.008 0.283 -25.455 re f 484.724 709.001 25.512 -0.284 re f 484.724 28.346 25.512 -0.283 re f 481.89 25.512 0.283 -25.512 re f q 1 i 0.015 737.008 510.221 -737.008 re W n 28.006 25.512 0.283 -25.512 re f 0.015 28.346 25.44 -0.283 re f Q BT /F2 1 Tf 10.959 0 0 10.959 109.8142 609.8455 Tm 0 Tc 0 Tw [(Phase)-170.7(II)-171.5(and)-170.4(Phase)-165.5(III)-174.5(drug)-168.2(trials)-169.4(should)-168.5(be)-169.8(conducted)-169.1(according)-170.9(to)]TJ -1.2933 -1.2623 TD [(Section)-302(C)-306.3(\(Paragraphs)-298(2832\))-296.8(of)-304.8(the)-302.4(Declaration)-301.5(of)-299.7(Helsinki,)-305.4(which)]TJ 0 -1.2571 TD [(refers)-271.2(to)-268.6(medical)-271.2(research)-268.8(combined)-264.6(with)-273.9(medical)-266(care.)]TJ 1.2933 -1.2623 TD [(Phase)-294.8(IV)-293.8(trials)-293.6(are)-292(conducted)-288.1(after)-293.4(the)-292(national)-294(drug)-287.2(registration)]TJ -1.2933 -1.2571 TD [(authority)-316.8(has)-321.9(approved)-315.5(a)-317.4(drug)-318.3(for)-318.2(distribution)-317.3(or)-314.9(marketing.)-319.4(These)]TJ T* [(trials)-293.6(may)-283.5(include)-292.6(research)-284.3(designed)-288(to)-289.3(explore)-286.5(a)-286.3(specific)-293.3(pharmaco-)]TJ 0 -1.2623 TD [(logical)-387.7(effect,)-389.4(to)-387.6(establish)-382.2(the)-390.3(incidence)-386(of)-382.4(adverse)-389(reactions,)-384.9(or)-387.3(to)]TJ 0 -1.2571 TD [(determine)-229.2(the)-230(effects)-233(of)-227.2(long-term)-228.8(administration)-226.8(of)-227.2(a)-229.4(drug.)-229.3(Phase)-227.6(IV)]TJ T* [(trials)-371.2(may)-366.3(also)-367.5(be)-371.6(designed)-365.6(to)-366.9(evaluate)-366.4(a)-369.1(drug)-364.8(in)-367.8(a)-369.1(population)-364.1(not)]TJ 0 -1.2623 TD [(studied)-317.8(adequately)-312.6(in)-316.1(the)-317.9(pre-marketing)-315.4(phases)-313.6(\(such)-312.1(as)-320.4(children)-316.3(or)]TJ 0 -1.2571 TD [(the)-292(elderly\))-287.2(or)-289(to)-289.3(establish)-289(a)-291.5(new)-284.7(clinical)-294.5(indication)-285.1(for)-287.1(a)-291.5(drug.)-286.2(Such)]TJ 0 -1.2623 TD 0.0081 Tc [(resea)8.1(r)-1.9(ch)-609(i)8.1(s)-614.7(to)]TJ 6.9734 0 TD 0 Tc [(be)-619.9(d)-6.7(i)-9.3(st)-11.4(i)-9.4(n)-6.7(gu)-8.5(i)-9.4(s)-8.2(h)-6.7(e)0(d)-619.9(f)-8.4(r)-8.2(o)-6.7(m)-616.1(m)0(a)-12.7(r)0(k)-9.7(e)-7.9(t)-8.4(i)0(n)-10.9(g)-617.4(r)-8.2(e)-7.9(se)-10.9(a)-7(r)-8.2(c)-7.9(h)0(,)-621.3(s)-8.2(a)-7(l)0(e)-12.1(s)]TJ -6.9734 -1.2571 TD 0.0074 Tc [(pr)7.4(om)7.4(ot)7.4(ion)-604.6(s)7.4(tud)7.4(i)]TJ 7.3356 0 TD 0 Tc [(es,)-620.3(an)-8.5(d)-612(r)0(o)-9.7(uti)-9(n)-6.7(e)-613.2(po)-8.2(st)-6.2(-)-8.4(m)0(a)-7.5(rke)-12.4(ti)-7.4(n)-6.7(g)-612.2(sur)-12.7(ve)-9.7(il)-8.4(lan)-12.7(ce)-615.9(fo)-10(r)]TJ -7.3356 -1.2571 TD [(adverse)-389(drug)-390.7(reactions)-385.9(in)-388.5(that)-387.5(these)-390.9(categories)-388.9(ordinarily)-388.9(need)-386.2(not)]TJ 0 -1.2622 TD [(be)-273.3(reviewed)-268.1(by)-267.2(ethical)-268.7(review)-269(committees)-272.8(\(see)-265.2(Guideline)-271.5(2\).)]TJ ET 95.641 646.809 318.898 -0.51 re f BT /F6 1 Tf 7.9702 0 0 7.9702 318.1039 649.1337 Tm [(PHASES)-322.8(OF)-331.8(CLINICAL)-325.6(TRIALS)]TJ /F7 1 Tf 11.9551 0 0 11.9551 95.6409 649.1337 Tm (98)Tj ET endstream endobj 292 0 obj << /Type /Page /Parent 400 0 R /Resources 293 0 R /Contents 294 0 R /MediaBox [ 0 0 595 842 ] /CropBox [ 0 0 595 842 ] /Rotate 0 >> endobj 293 0 obj << /ProcSet [ /PDF /Text ] /Font << /F2 337 0 R /F4 339 0 R /F11 346 0 R >> /ExtGState << /GS1 434 0 R >> /ColorSpace << /DefaultCMYK 417 0 R /Cs6 416 0 R >> >> endobj 294 0 obj << /Length 2579 >> stream q 1 i 0.015 737.008 510.221 -737.008 re W n /Cs6 cs 0 0 0 scn /GS1 gs 0.015 709.001 25.44 -0.284 re f Q /Cs6 cs 0 0 0 scn /GS1 gs 28.006 737.008 0.283 -25.455 re f 481.89 737.008 0.283 -25.455 re f 484.724 709.001 25.512 -0.284 re f 484.724 28.346 25.512 -0.283 re f 481.89 25.512 0.283 -25.512 re f q 1 i 0.015 737.008 510.221 -737.008 re W n 28.006 25.512 0.283 -25.512 re f 0.015 28.346 25.44 -0.283 re f Q 1 1 1 scn 95.641 533.877 14.173 -2.835 re f 0 0 0 scn 95.641 554.06 318.898 -20.183 re f BT /F4 1 Tf 19.9253 0 0 19.9253 207.0425 588.3589 Tm 0 Tc 0 Tw (Appendix)Tj /F2 1 Tf 4.3248 0 TD (4)Tj /F11 1 Tf 11.9551 0 0 11.9551 118.7149 539.4329 Tm 1 1 1 scn [(MEMBERS)-279.1(OF)-271.3(THE)-274.3(STEERING)-275.7(COM)-8.1(MITTEE)]TJ /F2 1 Tf 10.959 0 0 10.959 95.6409 501.9589 Tm 0 0 0 scn [(ABDUSSALAM,)-271.2(Mohamed)]TJ 1.2933 -1.1795 TD [(Former)-270.8(Chairman,)-268(WHO)-269.4(Advisory)-266(Committee)]TJ 0 -1.1847 TD [(for)-271.6(Health)-267.5(Research)-271.8(for)-266.4(the)-271.3(Eastern)-265(Mediterranean)]TJ 0 -1.1795 TD [(Geneva,)-268.8(Switzerland)]TJ -1.2933 -1.764 TD [(BANKOWSKI,)-271.1(Zbigniew)]TJ 1.2933 -1.1847 TD (Secretary-General)Tj 0 -1.1795 TD [(Council)-270.3(for)-271.6(International)-266.1(Organizations)-264(of)-268.6(Medical)-269.7(Sciences)]TJ 0 -1.1847 TD [(Geneva,)-268.8(Switzerland)]TJ -1.2933 -1.7641 TD [(BENATAR,)-269.9(Solomon)]TJ 1.2933 -1.1847 TD [(Department)-269.2(of)-268.6(Medicine)]TJ 0 -1.1795 TD [(University)-269.2(of)-268.6(Cape)-271(Town,)]TJ T* [(Observatory,)-271.6(South)-262.9(Africa)]TJ -1.2933 -1.7692 TD [(BIROS,)-270.3(Nicole)]TJ 1.2933 -1.1795 TD [(Research)-271.8(Policy)-269.2(and)-268.7(Cooperation)]TJ 0 -1.1847 TD [(World)-273.2(Health)-267.5(Organization)]TJ 0 -1.1795 TD [(Geneva,)-268.8(Switzerland)]TJ -1.2933 -1.7641 TD [(BRYANT,)-273.7(John)-266(H.)]TJ 1.2933 -1.1847 TD [(President,)-270.5(Council)-270.3(for)-266.4(International)-266.1(Organizations)]TJ 0 -1.1795 TD [(of)-273.8(Medical)-264.6(Sciences)]TJ 0 -1.1847 TD [(Moscow,)-271.8(Vermont,)-266.2(USA)]TJ -1.2933 -1.7641 TD [(DOLIN,)-274.3(Paul)]TJ 1.2933 -1.1795 TD [(HIV/AIDS/Sexually)-269.4(Transmitted)-269.3(Infections)]TJ 0 -1.1847 TD [(World)-273.2(Health)-267.5(Organization)]TJ 0 -1.1795 TD [(Geneva,)-268.8(Switzerland)]TJ -1.2933 -1.7692 TD [(ENGERS,)-269(Howard)-268.2(D.)]TJ 1.2933 -1.1795 TD [(Special)-272.2(Programme)-264.5(for)-271.6(Research)-266.6(and)-268.7(Training)]TJ 0 -1.1847 TD [(in)-274.7(Tropical)-268.6(Diseases)]TJ 0 -1.1795 TD [(World)-273.2(Health)-267.5(Organization)]TJ T* [(Geneva,)-268.8(Switzerland)]TJ ET endstream endobj 295 0 obj << /Type /Page /Parent 400 0 R /Resources 296 0 R /Contents 297 0 R /MediaBox [ 0 0 595 842 ] /CropBox [ 0 0 595 842 ] /Rotate 0 >> endobj 296 0 obj << /ProcSet [ /PDF /Text ] /Font << /F2 337 0 R /F6 341 0 R /F7 342 0 R >> /ExtGState << /GS1 434 0 R >> /ColorSpace << /DefaultCMYK 417 0 R /Cs6 416 0 R >> >> endobj 297 0 obj << /Length 2862 >> stream q 1 i 0.015 737.008 510.221 -737.008 re W n /Cs6 cs 0 0 0 scn /GS1 gs 0.015 709.001 25.44 -0.284 re f Q /Cs6 cs 0 0 0 scn /GS1 gs 28.006 737.008 0.283 -25.455 re f 481.89 737.008 0.283 -25.455 re f 484.724 709.001 25.512 -0.284 re f 484.724 28.346 25.512 -0.283 re f 481.89 25.512 0.283 -25.512 re f q 1 i 0.015 737.008 510.221 -737.008 re W n 28.006 25.512 0.283 -25.512 re f 0.015 28.346 25.44 -0.283 re f Q BT /F2 1 Tf 10.959 0 0 10.959 95.6409 610.6959 Tm 0 Tc 0 Tw [(ESPARZA,)-270.8(Jose)]TJ 6.9321 0.0104 TD ()Tj -5.6388 -1.195 TD [(Joint)-271.9(United)-267.3(Nations)-269.3(Programme)-264.5(on)-272.1(HIV/AIDS)]TJ 0 -1.1795 TD [(Geneva,)-268.8(Switzerland)]TJ -1.2933 -1.7692 TD -0.0001 Tc [(FAGOT-LARGEAULT,)-271.4(Anne)]TJ 1.2933 -1.1795 TD 0 Tc (Comite)Tj 2.9177 0.0104 TD ()Tj 0.4863 -0.0104 TD [(consultatif)-268.2(national)-268.2(dEthique)]TJ -3.4039 -1.1847 TD [(Paris,)-270.9(France)]TJ -1.2933 -1.764 TD [(FLUSS,)-269.2(Sev)-269.9(S.)]TJ 1.2933 -1.1795 TD [(Council)-270.3(for)-271.6(International)-266.1(Organizations)-264(of)-268.6(Medical)-269.7(Sciences)]TJ 0 -1.1847 TD [(Geneva,)-268.8(Switzerland)]TJ -1.2933 -1.764 TD [(GALLAGHER,)-271(James)]TJ 1.2933 -1.1795 TD [(Council)-270.3(for)-271.6(International)-266.1(Organizations)-264(of)-268.6(Medical)-269.7(Sciences)]TJ 0 -1.1847 TD [(Geneva,)-268.8(Switzerland)]TJ -1.2933 -1.764 TD [(GOROVITZ,)-272.6(Samuel)]TJ 1.2933 -1.1847 TD [(Syracuse)-271.6(University,)]TJ 0 -1.1795 TD [(Syracuse,)-270.6(New)-268.2(York,)-269.7(USA)]TJ -1.2933 -1.7641 TD [(HUMAN,)-269.6(Delon)]TJ 1.2933 -1.1847 TD (Secretary-General)Tj 0 -1.1795 TD [(World)-273.2(Medical)-264.6(Association,)]TJ 0 -1.1847 TD [(Ferney)-271.8(Voltaire,)-269.1(France)]TJ -1.2933 -1.7641 TD (IDA)Tj 1.5933 0.2173 TD ()Tj 0.388 -0.2173 TD (NPA)Tj 1.8106 0.2173 TD ()Tj 0.3828 -0.2173 TD (A)Tj 0.3828 0.2173 TD ()Tj 0.388 -0.2173 TD (N-HEIKKILA)Tj 6.1043 0.2173 TD ()Tj 0.388 -0.2173 TD (,)Tj 0.538 0 TD [(Juhana)-264.4(E.)]TJ -10.6826 -1.1795 TD [(Health)-272.7(Technology)-263.9(and)-268.7(Pharmaceuticals)]TJ 0 -1.1847 TD [(World)-273.2(Health)-267.5(Organization)]TJ 0 -1.1795 TD [(Geneva,)-268.8(Switzerland)]TJ -1.2933 -1.7692 TD [(KHAN,)-270.5(Kausar)-270.3(S.)]TJ 1.2933 -1.1795 TD [(Department)-269.2(of)-268.6(Community)-269.5(Health)-267.5(Sciences)]TJ 0 -1.1847 TD [(Aga)-273.4(Khan)-264.1(University)]TJ 0 -1.1795 TD [(Karachi,)-273.3(Pakistan)]TJ -1.2933 -1.764 TD [(LEVINE,)-271.5(Robert)-266.3(J.)-270.7(\(Chair\))]TJ 1.2933 -1.1847 TD [(School)-271.7(of)-268.6(Medicine)]TJ 0 -1.1795 TD [(Yale)-273.4(University)]TJ 0 -1.1847 TD [(New)-273.3(Haven,)-266.1(Connecticut,)-268.3(USA)]TJ ET 95.641 646.809 318.898 -0.51 re f BT /F6 1 Tf 7.9702 0 0 7.9702 276.7747 649.1337 Tm [(MEMBERS)-325.8(OF)-331.8(THE)-323.7(STEERING)-326(COMMITTE)13.2(E)]TJ /F7 1 Tf 11.9551 0 0 11.9551 95.6409 649.1337 Tm (100)Tj ET endstream endobj 298 0 obj << /Type /Page /Parent 402 0 R /Resources 299 0 R /Contents 300 0 R /MediaBox [ 0 0 595 842 ] /CropBox [ 0 0 595 842 ] /Rotate 0 >> endobj 299 0 obj << /ProcSet [ /PDF /Text ] /Font << /F2 337 0 R /F6 341 0 R /F7 342 0 R >> /ExtGState << /GS1 434 0 R >> /ColorSpace << /DefaultCMYK 417 0 R /Cs6 416 0 R >> >> endobj 300 0 obj << /Length 2778 >> stream q 1 i 0.015 737.008 510.221 -737.008 re W n /Cs6 cs 0 0 0 scn /GS1 gs 0.015 709.001 25.44 -0.284 re f Q /Cs6 cs 0 0 0 scn /GS1 gs 28.006 737.008 0.283 -25.455 re f 481.89 737.008 0.283 -25.455 re f 484.724 709.001 25.512 -0.284 re f 484.724 28.346 25.512 -0.283 re f 481.89 25.512 0.283 -25.512 re f q 1 i 0.015 737.008 510.221 -737.008 re W n 28.006 25.512 0.283 -25.512 re f 0.015 28.346 25.44 -0.283 re f Q BT /F2 1 Tf 10.959 0 0 10.959 95.6409 610.6959 Tm 0 Tc 0 Tw [(LOLAS)-269.7(STEPKE,)-270.2(Fernando)]TJ 1.2933 -1.1847 TD [(Regional)-272.1(Program)-266.4(on)-266.9(Bioethics)]TJ 0 -1.1795 TD [(Pan)-268.4(American)-270.8(Health)-267.5(Organization)]TJ 0 -1.1847 TD [(World)-273.2(Health)-267.5(Organization)]TJ 0 -1.1795 TD [(Santiago,)-270(Chile)]TJ -1.2933 -1.7692 TD [(LUNA,)-271.3(Florencia)]TJ 1.2933 -1.1795 TD [(University)-269.2(of)-268.6(Buenos)-270.3(Aires,)-271.4(and)]TJ T* [(PAHO/WHO)-271(Regional)-266.9(Program)-266.4(on)-272.1(Bioethics,)]TJ 0 -1.1847 TD [(Buenos)-270.3(Aires,)-271.4(Argentina)]TJ -1.2933 -1.764 TD [(NATTH,)-272.6(Bhamarapravati)]TJ 1.2933 -1.1847 TD [(Center)-273(for)-266.4(Vaccine)-270.3(Development)]TJ 0 -1.1795 TD [(Mahidol)-272.5(University,)]TJ 0 -1.1847 TD [(Bangkok,)-268.8(Thailand)]TJ -1.2933 -1.7641 TD [(OSMANOV,)-272.7(Saladin)]TJ 1.2933 -1.1795 TD [(Joint)-271.9(United)-267.3(Nations)-269.3(Programme)-264.5(on)-272.1(HIV/AIDS)]TJ 0 -1.1847 TD [(Geneva,)-268.8(Switzerland)]TJ -1.2933 -1.7641 TD [(PATTOU,)-269(Claire)]TJ 1.2933 -1.1795 TD [(Joint)-271.9(United)-267.3(Nations)-269.3(Programme)-264.5(on)-272.1(HIV/AIDS)]TJ 0 -1.1847 TD [(Geneva,)-268.8(Switzerland)]TJ -1.2933 -1.7641 TD [(VAN)-271.4(PRAAG,)-272.3(Eric)]TJ 1.2933 -1.1847 TD [(HIV/AIDS/Sexually)-269.4(Transmitted)-269.3(Infections)]TJ 0 -1.1795 TD [(World)-273.2(Health)-267.5(Organization)]TJ 0 -1.1847 TD [(Geneva,)-268.8(Switzerland)]TJ -1.2933 -1.7641 TD [(REITER-THEIL,)-272(Stella)]TJ 1.2933 -1.1795 TD [(Centre)-273(for)-266.4(Ethics)-269.5(and)-268.7(Law)-268.1(in)-269.5(Medicine)]TJ 0 -1.1847 TD [(University)-269.2(of)-268.6(Freiburg,)]TJ 0 -1.1795 TD [(Freiburg,)-271.6(Germany)]TJ -1.2933 -1.7641 TD [(WEIJER,)-271.2(Charles)]TJ 1.2933 -1.1847 TD [(Department)-269.2(of)-268.6(Bioethics)]TJ 0 -1.1795 TD [(Dalhousie)-269.4(University,)]TJ 0 -1.1847 TD [(Halifax,)-270.1(Nova)-269.5(Scotia,)-267.5(Canada)]TJ -1.2933 -1.7641 TD [(WIKLER,)-269(Daniel)]TJ 1.2933 -1.1847 TD [(Global)-272.4(Programme)-264.5(on)-272.1(Evidence)-266.9(for)-266.4(Health)-272.7(Policy)]TJ 0 -1.1795 TD [(World)-273.2(Health)-267.5(Organization)]TJ T* [(Geneva,)-268.8(Switzerland)]TJ ET 95.641 646.809 318.898 -0.51 re f BT /F6 1 Tf 7.9702 0 0 7.9702 95.6409 649.1337 Tm [(APPENDIX)-323.7(4)]TJ /F7 1 Tf 11.9551 0 0 11.9551 394.7527 649.1337 Tm (101)Tj ET endstream endobj 301 0 obj << /Type /Page /Parent 402 0 R /Resources 302 0 R /Contents 303 0 R /MediaBox [ 0 0 595 842 ] /CropBox [ 0 0 595 842 ] /Rotate 0 >> endobj 302 0 obj << /ProcSet [ /PDF ] /ExtGState << /GS1 434 0 R >> /ColorSpace << /DefaultCMYK 417 0 R /Cs6 416 0 R >> >> endobj 303 0 obj << /Length 412 >> stream q 1 i 0.015 737.008 510.221 -737.008 re W n /Cs6 cs 0 0 0 scn /GS1 gs 0.015 709.001 25.44 -0.284 re f Q /Cs6 cs 0 0 0 scn /GS1 gs 28.006 737.008 0.283 -25.455 re f 481.89 737.008 0.283 -25.455 re f 484.724 709.001 25.512 -0.284 re f 484.724 28.346 25.512 -0.283 re f 481.89 25.512 0.283 -25.512 re f q 1 i 0.015 737.008 510.221 -737.008 re W n 28.006 25.512 0.283 -25.512 re f 0.015 28.346 25.44 -0.283 re f Q endstream endobj 304 0 obj << /Type /Page /Parent 402 0 R /Resources 305 0 R /Contents 306 0 R /MediaBox [ 0 0 595 842 ] /CropBox [ 0 0 595 842 ] /Rotate 0 >> endobj 305 0 obj << /ProcSet [ /PDF /Text ] /Font << /F2 337 0 R /F4 339 0 R /F11 346 0 R /F12 347 0 R >> /ExtGState << /GS1 434 0 R >> /ColorSpace << /DefaultCMYK 417 0 R /Cs6 416 0 R >> >> endobj 306 0 obj << /Length 2675 >> stream q 1 i 0.015 737.008 510.221 -737.008 re W n /Cs6 cs 0 0 0 scn /GS1 gs 0.015 709.001 25.44 -0.284 re f Q /Cs6 cs 0 0 0 scn /GS1 gs 28.006 737.008 0.283 -25.455 re f 481.89 737.008 0.283 -25.455 re f 484.724 709.001 25.512 -0.284 re f 484.724 28.346 25.512 -0.283 re f 481.89 25.512 0.283 -25.512 re f q 1 i 0.015 737.008 510.221 -737.008 re W n 28.006 25.512 0.283 -25.512 re f 0.015 28.346 25.44 -0.283 re f Q 1 1 1 scn 95.641 492.491 14.173 -2.835 re f 0 0 0 scn 95.641 554.06 318.898 -61.568 re f BT /F4 1 Tf 19.9253 0 0 19.9253 207.0425 588.3589 Tm 0 Tc 0 Tw (Appendix)Tj /F2 1 Tf 4.3248 0 TD (5)Tj /F11 1 Tf 11.9551 0 0 11.9551 109.8142 539.4329 Tm 1 1 1 scn [(CONSU)-10.5(LTATION)-268(ON)-267.1(REVISING)-11.4(/UPDATING)-271.8(OF)]TJ 1.4369 -1.1523 TD [(INTERNATIONAL)-282.2(ETHI)-7.9(CAL)-269.4(GUID)-8.4(ELINES)]TJ -0.4884 -1.1523 TD [(FOR)-269.6(BIOMEDIC)-10.3(AL)-271.2(RESEA)-9.7(RCH)-269.9(INVO)-8.4(LVING)]TJ 2.2241 -1.1571 TD [(HUMAN)-275.2(SUBJECT)-10.7(S,)-268.8(MARCH)-279.6(2000)]TJ /F12 1 Tf 10.959 0 0 10.959 95.6409 469.9274 Tm 0 0 0 scn (PARTICIPANTS)Tj /F2 1 Tf 0 -1.8417 TD [(ABDUSSALAM,)-271.2(Mohamed)]TJ 1.2933 -1.1795 TD [(Former)-270.8(Chairman,)]TJ 0 -1.1847 TD [(WHO)-269.4(Advisory)-271.1(Committee)-268.2(for)-266.4(Health)-272.7(Research)]TJ 0 -1.1795 TD [(for)-271.6(the)-271.4(Eastern)-265(Mediterranean,)]TJ 0 -1.1847 TD [(Geneva,)-268.8(Switzerland)]TJ -1.2933 -1.6658 TD [(ANDREOPOULOS,)-268.9(George)]TJ 1.2933 -1.1847 TD [(John)-271.2(Jay)-270.2(College)-266.5(of)-268.6(Criminal)-268.8(Justice,)]TJ 0 -1.1795 TD [(Department)-269.2(of)-268.6(Government,)]TJ T* [(The)-269.4(City)-274.2(University)-264(of)-273.8(New)-268.2(York,)]TJ 0 -1.1847 TD [(New)-273.3(York,)-269.7(USA)]TJ -1.2933 -1.6658 TD [(AN-NAIM,)-269.9(Abdullahi)]TJ 1.2933 -1.1847 TD [(Emory)-272.1(University)-269.2(School)-266.5(of)-268.6(Law,)]TJ 0 -1.1795 TD [(Atlanta,)-269.2(Georgia,)-273.3(USA)]TJ -1.2933 -1.6709 TD [(ASHCROFT,)-271.1(Richard)]TJ 1.2933 -1.1795 TD [(Centre)-273(for)-266.4(Ethics)-269.5(in)-269.5(Medicine,)]TJ 0 -1.1847 TD [(University)-269.2(of)-268.6(Bristol,)]TJ 0 -1.1795 TD [(Bristol,)-273(England)]TJ -1.2933 -1.6709 TD [(BANKOWSKI,)-271.1(Zbigniew)]TJ 1.2933 -1.1795 TD [(Secretary-General)-270(Emeritus,)]TJ 0 -1.1847 TD [(Council)-270.3(for)-271.6(International)-266.1(Organizations)-264(of)-268.6(Medical)-269.7(Sciences,)]TJ 0 -1.1795 TD [(Geneva,)-268.8(Switzerland)]TJ -1.2933 -1.6658 TD [(BENATAR,)-269.9(Solomon)]TJ 1.2933 -1.1847 TD [(Department)-269.2(of)-268.6(Medicine,)]TJ 0 -1.1795 TD [(Medical)-269.7(School,)]TJ 0 -1.1847 TD [(University)-269.2(of)-268.6(Cape)-271(Town,)]TJ 0 -1.1795 TD [(South)-268.1(Africa)]TJ ET endstream endobj 307 0 obj << /Type /Page /Parent 402 0 R /Resources 308 0 R /Contents 309 0 R /MediaBox [ 0 0 595 842 ] /CropBox [ 0 0 595 842 ] /Rotate 0 >> endobj 308 0 obj << /ProcSet [ /PDF /Text ] /Font << /F2 337 0 R /F7 342 0 R >> /ExtGState << /GS1 434 0 R >> /ColorSpace << /DefaultCMYK 417 0 R /Cs6 416 0 R >> >> endobj 309 0 obj << /Length 2780 >> stream q 1 i 0.015 737.008 510.221 -737.008 re W n /Cs6 cs 0 0 0 scn /GS1 gs 0.015 709.001 25.44 -0.284 re f Q /Cs6 cs 0 0 0 scn /GS1 gs 28.006 737.008 0.283 -25.455 re f 481.89 737.008 0.283 -25.455 re f 484.724 709.001 25.512 -0.284 re f 484.724 28.346 25.512 -0.283 re f 481.89 25.512 0.283 -25.512 re f q 1 i 0.015 737.008 510.221 -737.008 re W n 28.006 25.512 0.283 -25.512 re f 0.015 28.346 25.44 -0.283 re f Q BT /F2 1 Tf 10.959 0 0 10.959 95.6409 610.6959 Tm 0 Tc 0 Tw [(BIROS,)-270.3(Nicole)]TJ 1.2933 -1.1847 TD [(Research)-271.8(Policy)-269.2(and)-268.7(Cooperation)7.3(,)]TJ 0 -1.1795 TD [(World)-273.2(Health)-267.5(Organization,)]TJ 0 -1.1847 TD [(Geneva,)-268.8(Switzerland)]TJ -1.2933 -1.764 TD [(BOULYJENKOV,)-269.6(Victor)]TJ 1.2933 -1.1847 TD [(Human)-269.8(Genetics,)]TJ 0 -1.1795 TD [(World)-273.2(Health)-267.5(Organization,)]TJ T* [(Geneva,)-268.8(Switzerland)]TJ -1.2933 -1.7692 TD [(BRUNET,)-274(Phillipe)]TJ 1.2933 -1.1795 TD [(DG)-270.1(Enterprise,)]TJ 0 -1.1847 TD [(European)-268.5(Commission,)]TJ 0 -1.1795 TD [(Brussels,)-274.3(Belgium)]TJ -1.2933 -1.7641 TD [(BRYANT,)-273.7(John)-266(H.)]TJ 1.2933 -1.1847 TD (President,)Tj 0 -1.1795 TD [(Council)-270.3(for)-271.6(International)-266.1(Organizations)-264(of)-268.6(Medical)-269.7(Sciences,)]TJ 0 -1.1847 TD [(Moscow,)-271.8(Vermont,)-266.2(USA)]TJ -1.2933 -1.7641 TD [(CAPRON,)-273.3(Alex)-268.2(M.)]TJ 1.2933 -1.1795 TD [(Pacific)-273.6(Center)-267.8(for)-266.4(Health)-272.7(Policy)-269.2(and)-268.7(Ethics,)]TJ 0 -1.1847 TD [(University)-269.2(of)-268.6(Southern)-270.1(California,)]TJ 0 -1.1795 TD [(Los)-269.7(Angeles,)-269.3(California,)-268.7(USA)]TJ -1.2933 -1.7692 TD [(De)-272.3(CASTRO,)-269.2(Leonardo)]TJ 1.2933 -1.1795 TD [(Department)-269.2(of)-268.6(Philosophy,)]TJ 0 -1.1847 TD [(University)-269.2(of)-268.6(the)-271.4(Philippines,)]TJ 0 -1.1795 TD [(Quezon)-269.5(City,)]TJ T* [(The)-269.4(Philippines)]TJ -1.2933 -1.7692 TD [(CLAYTON,)-269.6(Ellen)-272.6(W.)]TJ 1.2933 -1.1795 TD (Director,)Tj 0 -1.1847 TD [(Genetics)-274.2(and)-263.5(Health)-272.7(Policy)-269.2(Center,)-266.8(Vanderbilt)-268(University,)]TJ 0 -1.1795 TD [(Nashville,)-271.3(Tennessee,)-268.6(USA)]TJ -1.2933 -1.764 TD [(CRAWLEY,)-273.3(Francis)]TJ 1.2933 -1.1847 TD [(European)-268.5(Forum)-266.6(for)-271.6(Good)-269(Clinical)-267(Practice,)]TJ 0 -1.1795 TD [(Brussels,)-274.3(Belgium)]TJ -1.2933 -1.7692 TD [(EFFA,)-272.9(Pierre)]TJ 1.2933 -1.1795 TD (President,)Tj T* (Socie)Tj 2.0331 0.0104 TD ()Tj 0.2173 -0.0104 TD (te)Tj 0.5484 0.0104 TD ()Tj 0.4915 -0.0104 TD [(camerounaise)-265.1(de)-268.1(Bioe)]TJ 9.0582 0.0104 TD ()Tj 0.2173 -0.0104 TD (thique,)Tj -12.5656 -1.1847 TD [(Douala,)-269.1(Cameroon)]TJ ET 95.641 646.809 318.898 -0.51 re f BT /F7 1 Tf 11.9551 0 0 11.9551 95.6409 649.1337 Tm (104)Tj ET endstream endobj 310 0 obj << /Type /Page /Parent 402 0 R /Resources 311 0 R /Contents 312 0 R /MediaBox [ 0 0 595 842 ] /CropBox [ 0 0 595 842 ] /Rotate 0 >> endobj 311 0 obj << /ProcSet [ /PDF /Text ] /Font << /F2 337 0 R /F6 341 0 R /F7 342 0 R >> /ExtGState << /GS1 434 0 R >> /ColorSpace << /DefaultCMYK 417 0 R /Cs6 416 0 R >> >> endobj 312 0 obj << /Length 2914 >> stream q 1 i 0.015 737.008 510.221 -737.008 re W n /Cs6 cs 0 0 0 scn /GS1 gs 0.015 709.001 25.44 -0.284 re f Q /Cs6 cs 0 0 0 scn /GS1 gs 28.006 737.008 0.283 -25.455 re f 481.89 737.008 0.283 -25.455 re f 484.724 709.001 25.512 -0.284 re f 484.724 28.346 25.512 -0.283 re f 481.89 25.512 0.283 -25.512 re f q 1 i 0.015 737.008 510.221 -737.008 re W n 28.006 25.512 0.283 -25.512 re f 0.015 28.346 25.44 -0.283 re f Q BT /F2 1 Tf 10.959 0 0 10.959 95.6409 610.6959 Tm 0 Tc 0 Tw [(ELLIS,)-271.4(Gary)]TJ 1.2933 -1.1847 TD [(Office)-270.4(for)-271.6(Protection)-268.2(from)-267(Research)-266.6(Risks,)]TJ 0 -1.1795 TD [(Rockville,)-271(Maryland,)-267.2(USA)]TJ -1.2933 -1.7692 TD [(ENGERS,)-269(Howard)-268.2(D.)]TJ 1.2933 -1.1795 TD [(Special)-272.2(Programme)-264.5(for)-271.6(Research)]TJ 0 -1.1847 TD [(and)-268.7(Training)-267.7(in)-274.7(Tropical)-268.6(Diseases,)]TJ 0 -1.1795 TD [(World)-273.2(Health)-267.5(Organization,)]TJ T* [(Geneva,)-268.8(Switzerland)]TJ -1.2933 -1.7692 TD -0.0001 Tc [(FAGOT-LARGEAULT,)-271.4(Anne)]TJ 1.2933 -1.1795 TD 0 Tc (Universite)Tj 4.1747 0.0104 TD ()Tj 0.4863 -0.0104 TD [(de)-273.3(Paris)-266.7(I,)-271(Panthe)]TJ 7.3563 0.0104 TD ()Tj 0.2173 -0.0104 TD (on-Sorbonne,)Tj -12.2346 -1.1847 TD [(Institut)-271.3(dHistoire)-271.3(et)-269.8(Philosophie)-265.2(des)-271.1(Sciences)-269.5(et)-269.8(des)-265.9(Techniques,)]TJ 0 -1.1795 TD [(Paris,)-270.9(France)]TJ -1.2933 -1.7641 TD [(FLEET,)-269.6(Julian)]TJ 1.2933 -1.1847 TD [(Joint)-271.9(United)-267.3(Nations)-269.3(Programme)-264.5(on)-272.1(HIV/AIDS,)]TJ 0 -1.1795 TD [(Geneva,)-268.8(Switzerland)]TJ -1.2933 -1.7692 TD [(FLUSS,)-269.2(Sev)-269.9(S.)]TJ 1.2933 -1.1795 TD [(Council)-270.3(for)-271.6(International)-266.1(Organization)-266.1(of)-268.6(Medical)-269.7(Sciences,)]TJ T* [(Geneva,)-268.8(Switzerland)]TJ -1.2933 -1.7692 TD [(De)-272.3(FRANCISCO,)-268.7(Andres)]TJ 1.2933 -1.1795 TD [(Global)-272.4(Forum)-266.6(for)-271.6(Health)-267.5(Research,)]TJ 0 -1.1847 TD [(Geneva,)-268.8(Switzerland)]TJ -1.2933 -1.7641 TD [(GALLAGHER,)-271(James)]TJ 1.2933 -1.1795 TD [(Council)-270.3(for)-271.6(International)-266.1(Organizations)-264(of)-268.6(Medical)-269.7(Sciences,)]TJ 0 -1.1847 TD [(Geneva,)-268.8(Switzerland)]TJ -1.2933 -1.7641 TD [(GOROVITZ,)-272.6(Samuel)]TJ 1.2933 -1.1847 TD [(Syracuse)-271.6(University,)]TJ 0 -1.1795 TD (Syracuse,)Tj T* [(New)-273.3(York,)-269.7(USA)]TJ -1.2933 -1.7692 TD [(HIMMICH,)-269.2(Hakima)]TJ 1.2933 -1.1795 TD [(Faculty)-270.1(of)-268.6(Medicine)-272.2(and)-263.5(Pharmacy,)]TJ 0 -1.1847 TD [(Casablanca,)-268.6(Morocco)]TJ -1.2933 -1.7641 TD [(HUMAN,)-269.6(Delon)]TJ 1.2933 -1.1795 TD [(Secretary-General,)-269(World)-268(Medical)-269.7(Association,)]TJ 0 -1.1847 TD [(Ferney-Voltaire,)-270(France)]TJ ET 95.641 646.809 318.898 -0.51 re f BT /F6 1 Tf 7.9702 0 0 7.9702 95.6409 649.1337 Tm [(APPENDIX)-323.7(5)]TJ /F7 1 Tf 11.9551 0 0 11.9551 394.7527 649.1337 Tm (105)Tj ET endstream endobj 313 0 obj << /Type /Page /Parent 402 0 R /Resources 314 0 R /Contents 315 0 R /MediaBox [ 0 0 595 842 ] /CropBox [ 0 0 595 842 ] /Rotate 0 >> endobj 314 0 obj << /ProcSet [ /PDF /Text ] /Font << /F2 337 0 R /F7 342 0 R >> /ExtGState << /GS1 434 0 R >> /ColorSpace << /DefaultCMYK 417 0 R /Cs6 416 0 R >> >> endobj 315 0 obj << /Length 3049 >> stream q 1 i 0.015 737.008 510.221 -737.008 re W n /Cs6 cs 0 0 0 scn /GS1 gs 0.015 709.001 25.44 -0.284 re f Q /Cs6 cs 0 0 0 scn /GS1 gs 28.006 737.008 0.283 -25.455 re f 481.89 737.008 0.283 -25.455 re f 484.724 709.001 25.512 -0.284 re f 484.724 28.346 25.512 -0.283 re f 481.89 25.512 0.283 -25.512 re f q 1 i 0.015 737.008 510.221 -737.008 re W n 28.006 25.512 0.283 -25.512 re f 0.015 28.346 25.44 -0.283 re f Q BT /F2 1 Tf 10.959 0 0 10.959 95.6409 610.6959 Tm 0 Tc 0 Tw (IDA)Tj 1.5933 0.2173 TD ()Tj 0.388 -0.2173 TD (NPA)Tj 1.8106 0.2173 TD ()Tj 0.3828 -0.2173 TD (A)Tj 0.3828 0.2173 TD ()Tj 0.388 -0.2173 TD (N-HEIKKILA)Tj 6.1043 0.2173 TD ()Tj 0.388 -0.2173 TD (,)Tj 0.538 0 TD [(Juhana)-264.4(E.)]TJ -10.6826 -1.1847 TD [(Institute)-268.9(of)-273.8(Biomedicine,)]TJ 0 -1.1795 TD [(Department)-269.2(of)-268.6(Pharmacology)-266.7(and)-268.7(Toxicology,)]TJ 0 -1.1847 TD [(University)-269.2(of)-268.6(Helsinki,)]TJ 0 -1.1795 TD [(Helsinki,)-274.4(Finland)]TJ -1.2933 -1.6709 TD [(KARBWANG,)-272.5(Juntra)]TJ 1.2933 -1.1795 TD [(Communicable)-272.2(Disease)-266.3(Research)-266.6(and)-268.7(Development,)]TJ 0 -1.1847 TD [(World)-273.2(Health)-267.5(Organization,)]TJ 0 -1.1795 TD [(Geneva,)-268.8(Switzerland)]TJ -1.2933 -1.6709 TD [(KHAN,)-270.5(Kausar)-270.3(S.)]TJ 1.2933 -1.1795 TD [(Community)-269.5(Health)-267.5(Sciences,)]TJ T* [(Aga)-273.4(Khan)-264.1(University,)]TJ 0 -1.1847 TD [(Karachi,)-273.3(Pakistan)]TJ -1.2933 -1.6658 TD [(KSHIRSAGAR,)-268.6(Nilima)]TJ 1.2933 -1.1847 TD (Dean,)Tj 0 -1.1795 TD [(Medical)-269.7(College)-271.7(and)-268.7(BYL)-267.3(Nair)-268.2(Hospital,)]TJ 0 -1.1847 TD [(Mumbai,)-271.5(India)]TJ -1.2933 -1.6658 TD [(KUBAR,)-272.1(Olga)-267.3(I.)]TJ 1.2933 -1.1847 TD [(St.)-272.8(Petersburg)-267(Pasteur)-264.9(Institute,)]TJ 0 -1.1795 TD [(St.)-272.8(Petersburg,)-266(Russia)]TJ -1.2933 -1.6709 TD [(LEPAY,)-273.6(David)-268.5(A.)]TJ 1.2933 -1.1795 TD [(Division)-269.3(of)-273.8(Scientific)-268.3(Investigations,)]TJ T* [(Office)-270.4(of)-273.8(Medical)-264.6(Policy,)]TJ 0 -1.1847 TD [(Center)-273(for)-266.4(Drug)-270.7(Evaluation)-266.1(and)-268.7(Research,)]TJ 0 -1.1795 TD [(US)-271.1(Food)-269.8(and)-268.7(Drug)-265.5(Administration,)]TJ 0 -1.1847 TD [(Rockville,)-271(Maryland,)-267.2(USA)]TJ -1.2933 -1.6658 TD [(LEVINE,)-271.5(Robert)-266.3(J.)]TJ 1.2933 -1.1847 TD [(Yale)-273.4(University)-269.2(School)-266.5(of)-268.6(Medicine,)]TJ 0 -1.1795 TD [(New)-273.3(Haven,)-266.1(Connecticut,)-268.3(USA)]TJ -1.2933 -1.6709 TD [(LIE,)-273.7(Reidar)]TJ 1.2933 -1.1795 TD [(Department)-269.2(of)-268.6(Philosophy,)]TJ 0 -1.1847 TD [(University)-269.2(of)-268.6(Bergen,)]TJ 0 -1.1795 TD [(Bergen,)-270.8(Norway)]TJ -1.2933 -1.6709 TD [(LOLAS)-269.7(STEPKE,)-270.2(Fernando)]TJ 1.2933 -1.1795 TD [(Pan)-268.4(American)-270.8(Health)-267.5(Organization/World)-268.4(Health)-267.5(Organization,)]TJ T* [(Regional)-272.1(Program)-266.4(on)-266.9(Bioethics,)]TJ 0 -1.1847 TD [(Santiago,)-270(Chile)]TJ ET 95.641 646.809 318.898 -0.51 re f BT /F7 1 Tf 11.9551 0 0 11.9551 95.6409 649.1337 Tm (106)Tj ET endstream endobj 316 0 obj << /Type /Page /Parent 402 0 R /Resources 317 0 R /Contents 318 0 R /MediaBox [ 0 0 595 842 ] /CropBox [ 0 0 595 842 ] /Rotate 0 >> endobj 317 0 obj << /ProcSet [ /PDF /Text ] /Font << /F2 337 0 R /F6 341 0 R /F7 342 0 R >> /ExtGState << /GS1 434 0 R >> /ColorSpace << /DefaultCMYK 417 0 R /Cs6 416 0 R >> >> endobj 318 0 obj << /Length 3000 >> stream q 1 i 0.015 737.008 510.221 -737.008 re W n /Cs6 cs 0 0 0 scn /GS1 gs 0.015 709.001 25.44 -0.284 re f Q /Cs6 cs 0 0 0 scn /GS1 gs 28.006 737.008 0.283 -25.455 re f 481.89 737.008 0.283 -25.455 re f 484.724 709.001 25.512 -0.284 re f 484.724 28.346 25.512 -0.283 re f 481.89 25.512 0.283 -25.512 re f q 1 i 0.015 737.008 510.221 -737.008 re W n 28.006 25.512 0.283 -25.512 re f 0.015 28.346 25.44 -0.283 re f Q BT /F2 1 Tf 10.959 0 0 10.959 95.6409 610.6959 Tm 0 Tc 0 Tw [(LUNA,)-271.3(Florencia)]TJ 1.2933 -1.1847 TD [(University)-269.2(of)-268.6(Buenos)-270.3(Aires,)]TJ 0 -1.1795 TD [(PAHO/WHO)-271(Regional)-266.9(Program)-266.4(on)-272.1(Bioethics,)]TJ 0 -1.1847 TD [(Buenos)-270.3(Aires,)-271.4(Argentina)]TJ -1.2933 -1.764 TD [(MACKLIN,)-269.3(Ruth)]TJ 1.2933 -1.1847 TD [(Department)-269.2(of)-268.6(Epidemiology)-270.1(and)-268.7(Social)-264.3(Medicine,)]TJ 0 -1.1795 TD [(Albert)-274.2(Einstein)-264.9(College)-271.7(of)-268.6(Medicine,)]TJ T* [(Bronx,)-272.1(New)-268.2(York,)-269.7(USA)]TJ -1.2933 -1.7692 TD [(MALUWA,)-269.7(Miriam)]TJ 1.2933 -1.1795 TD [(Joint)-271.9(United)-267.3(Nations)-269.3(Programme)-264.5(on)-272.1(HIV/AIDS,)]TJ 0 -1.1847 TD [(Geneva,)-268.8(Switzerland)]TJ -1.2933 -1.7641 TD [(MANSOURIAN,)-271.3(Pierre)-270.4(B.)]TJ 1.2933 -1.1795 TD [(Council)-270.3(for)-271.6(International)-266.1(Organizations)-264(of)-268.6(Medical)-269.7(Sciences,)]TJ 0 -1.1847 TD [(Rolle,)-271.1(Switzerland)]TJ -1.2933 -1.764 TD [(MARSHALL,)-269.2(Patricia)]TJ 1.2933 -1.1847 TD [(Medical)-269.7(Humanities)-271.6(Program,)]TJ 0 -1.1795 TD [(Department)-269.2(of)-268.6(Medicine,)]TJ T* [(Loyola)-270.9(University)-269.2(Chicago)-268.2(Stritch)-267.8(School)-266.5(of)-268.6(Medicine,)]TJ 0 -1.1847 TD [(Maywood,)-271.2(Illinois,)-267.9(USA)]TJ -1.2933 -1.7641 TD -0.0001 Tc [(MPANJU-SHUMBUSHO,)-271(Winnie)-272(K.)]TJ 1.2933 -1.1847 TD 0 Tc [(HIV/AIDS/)-270.5(Sexually)-267.9(Transmitted)-269.3(Infections,)]TJ 0 -1.1795 TD [(World)-273.2(Health)-267.5(Organization,)]TJ 0 -1.1847 TD [(Geneva,)-268.8(Switzerland)]TJ -1.2933 -1.7641 TD [(MWINGA,)-271.1(Alwyn)]TJ 1.2933 -1.1795 TD [(University)-269.2(Teaching)-271.1(Hospital,)]TJ 0 -1.1847 TD [(Lusaka,)-268.7(Zambia)]TJ -1.2933 -1.7641 TD [(OSMANOV,)-272.7(Saladin)]TJ 1.2933 -1.1795 TD [(Joint)-271.9(United)-267.3(Nations)-269.3(Programme)-264.5(on)-272.1(HIV/AIDS,)]TJ 0 -1.1847 TD [(Geneva,)-268.8(Switzerland)]TJ -1.2933 -1.764 TD [(PANGESTU,)-270.8(Tiki)-269.9(E.)]TJ 1.2933 -1.1847 TD [(Research)-271.8(Policy)-269.2(and)-268.7(Cooperation)7.3(,)]TJ 0 -1.1795 TD [(World)-273.2(Health)-267.5(Organization,)]TJ 0 -1.1847 TD [(Geneva,)-268.8(Switzerland)]TJ -1.2933 -1.764 TD [(PATTOU,)-269(Claire)]TJ 1.2933 -1.1795 TD [(Joint)-271.9(United)-267.3(Nations)-269.3(Programme)-264.5(on)-272.1(HIV/AIDS,)]TJ 0 -1.1847 TD [(Geneva,)-268.8(Switzerland)]TJ ET 95.641 646.809 318.898 -0.51 re f BT /F6 1 Tf 7.9702 0 0 7.9702 95.6409 649.1337 Tm [(APPENDIX)-323.7(5)]TJ /F7 1 Tf 11.9551 0 0 11.9551 394.7527 649.1337 Tm (107)Tj ET endstream endobj 319 0 obj << /Type /Page /Parent 402 0 R /Resources 320 0 R /Contents 321 0 R /MediaBox [ 0 0 595 842 ] /CropBox [ 0 0 595 842 ] /Rotate 0 >> endobj 320 0 obj << /ProcSet [ /PDF /Text ] /Font << /F2 337 0 R /F7 342 0 R >> /ExtGState << /GS1 434 0 R >> /ColorSpace << /DefaultCMYK 417 0 R /Cs6 416 0 R >> >> endobj 321 0 obj << /Length 2715 >> stream q 1 i 0.015 737.008 510.221 -737.008 re W n /Cs6 cs 0 0 0 scn /GS1 gs 0.015 709.001 25.44 -0.284 re f Q /Cs6 cs 0 0 0 scn /GS1 gs 28.006 737.008 0.283 -25.455 re f 481.89 737.008 0.283 -25.455 re f 484.724 709.001 25.512 -0.284 re f 484.724 28.346 25.512 -0.283 re f 481.89 25.512 0.283 -25.512 re f q 1 i 0.015 737.008 510.221 -737.008 re W n 28.006 25.512 0.283 -25.512 re f 0.015 28.346 25.44 -0.283 re f Q BT /F2 1 Tf 10.959 0 0 10.959 95.6409 610.6959 Tm 0 Tc 0 Tw [(QIU,)-272.4(Ren-Zong.)]TJ 1.2933 -1.1847 TD [(Chinese)-270.3(Academy)-270.6(of)-268.6(Social)-269.5(Sciences,)]TJ 0 -1.1795 TD [(Program)-271.6(in)-269.5(Bioethics,)]TJ 0 -1.1847 TD [(Beijing,)-272.5(China)]TJ -1.2933 -1.764 TD [(RAGO,)-271(Lembit)]TJ 1.2933 -1.1847 TD [(Quality)-271.1(Assurance)-268.4(and)-268.7(Safety:)-266.9(Medicines,)]TJ 0 -1.1795 TD [(World)-273.2(Health)-267.5(Organization,)]TJ T* [(Geneva,)-268.8(Switzerland)]TJ -1.2933 -1.7692 TD [(REITER-THEIL,)-272(Stella)]TJ 1.2933 -1.1795 TD [(Center)-273(for)-266.4(Ethics)-269.5(and)-268.7(Law)-268.1(in)-269.5(Medicine,)]TJ 0 -1.1847 TD [(University)-269.2(of)-268.6(Freiburg,)]TJ 0 -1.1795 TD (Germany)Tj -1.2933 -1.7641 TD [(SARACCI,)-272(Rodolfo)]TJ 1.2933 -1.1847 TD [(International)-271.3(Agency)-264.9(for)-271.6(Research)-266.6(on)-266.9(Cancer/WHO,)]TJ 0 -1.1795 TD [(Lyon,)-269.1(France)]TJ -1.2933 -1.7692 TD [(SPRUMONT,)-268.8(Dominique)]TJ 1.2933 -1.1795 TD [(Institut)-271.3(de)-268.1(Droit)-271.2(de)-268.1(la)-269.8(Sante)]TJ 11.7534 0.0104 TD ()Tj 0.2224 -0.0104 TD (,)Tj -11.9759 -1.1795 TD (Neucha)Tj 3.0522 0 TD ()Tj 0.2483 0 TD [(tel,)-273(Switzerland)]TJ -4.5938 -1.7692 TD [(VENULET,)-270.4(Jan)]TJ 1.2933 -1.1795 TD [(Council)-270.3(for)-271.6(International)-266.1(Organizations)-264(of)-268.6(Medical)-269.7(Sciences,)]TJ 0 -1.1847 TD [(Geneva,)-268.8(Switzerland)]TJ -1.2933 -1.7641 TD [(WEIJER,)-271.2(Charles)]TJ 1.2933 -1.1795 TD [(Office)-270.4(of)-273.8(Bioethics)-267.6(Education)-267.8(and)-268.7(Research,)]TJ 0 -1.1847 TD [(Dalhousie)-269.4(University,)-268.2(Halifax,)]TJ 0 -1.1795 TD [(Nova)-269.5(Scotia,)-267.5(Canada)]TJ -1.2933 -1.7692 TD [(WENDLER,)-273.1(David)]TJ 1.2933 -1.1795 TD [(Department)-269.2(of)-268.6(Clinical)-272.2(Bioethics,)]TJ T* [(National)-272.3(Institutes)-266.7(of)-268.6(Health,)]TJ 0 -1.1847 TD [(Bethesda,)-270.4(Maryland,)-267.2(USA)]TJ -1.2933 -1.764 TD [(WIKLER,)-269(Daniel)]TJ 1.2933 -1.1847 TD [(Global)-272.4(Programme)-264.5(on)-272.1(Evidence)-266.9(for)-266.4(Health)-272.7(Policy,)]TJ 0 -1.1795 TD [(World)-273.2(Health)-267.5(Organization,)]TJ 0 -1.1847 TD [(Geneva,)-268.8(Switzerland)]TJ ET 95.641 646.809 318.898 -0.51 re f BT /F7 1 Tf 11.9551 0 0 11.9551 95.6409 649.1337 Tm (108)Tj ET endstream endobj 322 0 obj << /Type /Page /Parent 402 0 R /Resources 323 0 R /Contents 324 0 R /MediaBox [ 0 0 595 842 ] /CropBox [ 0 0 595 842 ] /Rotate 0 >> endobj 323 0 obj << /ProcSet [ /PDF /Text ] /Font << /F2 337 0 R /F4 339 0 R /F11 346 0 R /F12 347 0 R >> /ExtGState << /GS1 434 0 R >> /ColorSpace << /DefaultCMYK 417 0 R /Cs6 416 0 R >> >> endobj 324 0 obj << /Length 3019 >> stream q 1 i 0.015 737.008 510.221 -737.008 re W n /Cs6 cs 0 0 0 scn /GS1 gs 0.015 709.001 25.44 -0.284 re f Q /Cs6 cs 0 0 0 scn /GS1 gs 28.006 737.008 0.283 -25.455 re f 481.89 737.008 0.283 -25.455 re f 484.724 709.001 25.512 -0.284 re f 484.724 28.346 25.512 -0.283 re f 481.89 25.512 0.283 -25.512 re f q 1 i 0.015 737.008 510.221 -737.008 re W n 28.006 25.512 0.283 -25.512 re f 0.015 28.346 25.44 -0.283 re f Q 1 1 1 scn 95.641 533.877 14.173 -2.835 re f 0 0 0 scn 95.641 554.06 318.898 -20.183 re f BT /F4 1 Tf 19.9253 0 0 19.9253 207.0425 588.3589 Tm 0 Tc 0 Tw (Appendix)Tj /F2 1 Tf 4.3248 0 TD (6)Tj /F11 1 Tf 11.9551 0 0 11.9551 120.4157 539.4329 Tm 1 1 1 scn [(COMMEN)-11.2(TATORS)-273.6(ON)-276.6(DRAFT)-275.2(GUIDELINES)]TJ /F2 1 Tf 10.959 0 0 10.959 95.6409 506.8912 Tm 0 0 0 scn 0.0111 Tc [(CIOMS)-616.4(e)-2(xtends)-612.7(its)-617.8(a)-1(p)4.4(p)-0.8(reciation)-616.4(a)4.1(nd)-616.4(thank)4.4(s)-617.8(to)-616.4(the)-617.6(f)2.7(ollowing)]TJ 0 -1.2571 TD 0 Tc [(organizations)-269.9(and)-273.9(individuals)-267.4(for)-276.8(their)-268.2(responses)-270.3(to)-273.8(the)-271.4(two)-274.9(versions)]TJ 0 -1.2623 TD [(of)-558.3(the)-561(draft)-556(guidelines)-555.1(posted)-556.8(on)-556.6(its)-558.8(website)-556.5(in)-559.2(June)-556.9(2000)-555.6(and)]TJ 0 -1.2571 TD [(January)-329.8(2002.)]TJ /F12 1 Tf 0 -2.5193 TD (ORGANIZATIONS)Tj /F2 1 Tf 0 -1.6865 TD [(American)-270.8(Medical)-269.7(Association)-265.5(Council)-270.3(on)-266.9(Ethical)-272.5(and)-268.7(Judicial)]TJ 1.2933 -1.1847 TD (Affairs)Tj -1.2933 -1.7641 TD [(Australian)-268.2(Health)-272.7(Ethics)-269.5(Committee)]TJ T* [(British)-274(Medical)-269.7(Association)]TJ 0 -1.7692 TD [(Centers)-270.8(for)-271.6(Disease)-266.3(Control)-269.6(and)-268.7(Prevention,)-265.7(Atlanta,)-269.2(USA)]TJ 0 -1.7641 TD [(Denmark:)-269.4(Danish)-271.3(Ethical)-267.3(Council,)-269.3(Copenhagen,)-265.1(Denmark)]TJ T* [(European)-268.5(College)-271.7(of)-268.6(Neuropsychop)8(harmacology)]TJ T* [(European)-258.2(Forum)-256.3(for)-261.3(Good)-253.5(Clinical)-261.8(Practice)-254.5(\(Ethics)-262.4(Working)-255.8(Party\))]TJ 0 -1.7692 TD [(European)-268.5(Agency)-270.1(for)-266.4(the)-271.3(Evaluation)-266.1(of)-268.6(Medicinal)-270.3(Products)]TJ 0 -1.7641 TD [(International)-271.3(Federation)-266.8(of)-268.6(Pharmaceutica)7.3(l)-273.2(Manufacturers)]TJ 1.2933 -1.1795 TD [(Associations,)-272.7(Geneva)]TJ -1.2933 -1.7692 TD [(International)-271.3(Society)-266.1(for)-271.6(Clinical)-267(Biostatistics,)-270.5(Singapore)]TJ 0 -1.7641 TD [(International)-271.3(Society)-266.1(of)-268.6(Drug)-270.7(Bulletins)]TJ T* [(Medical)-269.7(Research)-271.8(Council)-265.1(\(United)-270.5(Kingdom\).)]TJ 0 -1.7692 TD [(National)-272.3(Institutes)-266.7(of)-268.6(Health,)-271.7(USA)]TJ 0 -1.7641 TD [(Netherlands:)-268(Ministry)-273.5(of)-268.6(Health,)-266.5(Welfare)-270.3(and)-268.7(Sport)]TJ T* [(Netherlands:)-268(Medical)-269.7(Commission,)-268.5(Royal)-268.8(Netherlands)-269(Academy)-265.4(of)]TJ 1.2933 -1.1847 TD [(Arts)-273.9(and)-268.7(Sciences)]TJ ET endstream endobj 325 0 obj << /Type /Page /Parent 402 0 R /Resources 326 0 R /Contents 327 0 R /MediaBox [ 0 0 595 842 ] /CropBox [ 0 0 595 842 ] /Rotate 0 >> endobj 326 0 obj << /ProcSet [ /PDF /Text ] /Font << /F2 337 0 R /F7 342 0 R /F12 347 0 R >> /ExtGState << /GS1 434 0 R >> /ColorSpace << /DefaultCMYK 417 0 R /Cs6 416 0 R >> >> endobj 327 0 obj << /Length 3914 >> stream q 1 i 0.015 737.008 510.221 -737.008 re W n /Cs6 cs 0 0 0 scn /GS1 gs 0.015 709.001 25.44 -0.284 re f Q /Cs6 cs 0 0 0 scn /GS1 gs 28.006 737.008 0.283 -25.455 re f 481.89 737.008 0.283 -25.455 re f 484.724 709.001 25.512 -0.284 re f 484.724 28.346 25.512 -0.283 re f 481.89 25.512 0.283 -25.512 re f q 1 i 0.015 737.008 510.221 -737.008 re W n 28.006 25.512 0.283 -25.512 re f 0.015 28.346 25.44 -0.283 re f Q BT /F2 1 Tf 10.959 0 0 10.959 95.6409 610.6959 Tm 0 Tc 0 Tw [(Norway:)-272.6(The)-269.4(National)-267.2(Committee)-268.2(for)-266.4(Medical)-269.7(Research)-271.8(Ethics)-269.5(and)]TJ 1.2933 -1.1847 TD [(the)-271.3(Regional)-266.9(Committees)-271.2(of)-268.6(Medical)-269.7(Research)-266.6(Ethics)-269.5(in)-269.5(Norway)]TJ -1.2933 -1.764 TD [(Pharmaceutical)-271.1(Research)-266.6(and)-268.7(Manufacturers)-266.2(of)-268.6(America,)-268.3(Washing-)]TJ 1.2933 -1.1847 TD [(ton)-270.2(DC)]TJ -1.2933 -1.7641 TD [(Public)-274.1(Citizens)-270(Health)-267.5(Research)-266.6(Group,)-271(Washingto)8.1(n)-270.5(DC,)-269.6(USA)]TJ T* [(Faculty)-270.1(of)-268.6(Pharmaceutical)-265.9(Medicine)-272.2(of)-268.6(the)-266.2(Royal)-268.8(Colleges)-269.5(of)]TJ 1.2933 -1.1847 TD [(Physicians)-268.2(of)-268.6(the)-271.4(United)-267.3(Kingdom)]TJ -1.2933 -1.764 TD [(Royal)-268.8(Colleges)-269.5(of)-268.6(Physicians)-268.2(of)-268.6(the)-271.4(United)-267.3(Kingdom)]TJ T* [(Swedish)-269.1(International)-266.1(Development)-271.4(Cooperation)-266.9(Agency/Depar)6.8(t-)]TJ 1.2933 -1.1847 TD [(ment)-271.9(for)-266.4(Research)-271.8(Cooperation)-266.9(\(SIDA/SAREC\))]TJ -1.2933 -1.764 TD [(Swedish)-196.6(Society)-193.7(of)-191(Medicine:)-193.6(The)-197(Delegation)-189.8(of)-196.2(Medical)-192.1(Ethics)-197.1(of)-191(the)]TJ 1.2933 -1.1795 TD [(Swedish)-269.1(Society)-271.3(of)-268.6(Medicine)]TJ -1.2933 -1.7692 TD [(Swedish)-269.1(Institute)-268.9(of)-268.6(Biomedical)-273.1(Laboratory)-263.8(Science)-266.5(and)-268.7(its)-274.3(Ethical)]TJ 1.2933 -1.1795 TD (Council)Tj -1.2933 -1.764 TD [(Swedish)-269.1(Research)-271.8(Council)-265.1()-272.6(Medicine)]TJ 0 -1.7692 TD [(Swiss)-271.4(Academy)-270.6(of)-268.6(Medical)-264.6(Sciences)]TJ 0 -1.7641 TD [(United)-272.4(Kingdom:)-269.4(Department)-264.1(of)-268.6(Health,)-271.7(London.)]TJ /F12 1 Tf 0 -2.4986 TD (INDIVIDUALS)Tj 0 -1.6865 TD [(Abdool)-271.1(Karim,)-268.5(Saleem)-267(S.)]TJ /F2 1 Tf 10.874 0 TD [(Deputy)-264.9(Vice-Chancellor,)-270.1(Research)-266.6(and)]TJ -9.5807 -1.1847 TD [(Development,)-270.4(University)-269.2(of)-268.6(Natal,)-269.3(Durban,)-267.6(South)-268.1(Africa)]TJ /F12 1 Tf -1.2933 -1.7641 TD [(Abratt,)-271.9(Raymond)]TJ /F2 1 Tf 7.2942 0 TD (,)Tj 0.5432 0 TD [(Groote)-266.1(Schuur)-265.3(Hospital,)-272.5(Observatory,)-266.4(South)]TJ -6.5441 -1.1795 TD (Africa)Tj /F12 1 Tf -1.2933 -1.7692 TD [(Ashcroft,)-272.4(Richard.)]TJ /F2 1 Tf 7.9822 0 TD [(Imperial)-269.3(College)-266.5(of)-268.6(Science,)-270.6(Technology)-269(and)]TJ -6.6889 -1.1795 TD [(Medicine,)-271.2(University)-269.2(of)-268.6(London,)-266.7(London,)-266.7(England)]TJ /F12 1 Tf -1.2933 -1.764 TD [(Benatar,)-268.2(Solomon.)]TJ /F2 1 Tf 8.0443 0 TD [(University)-269.2(of)-268.6(Cape)-265.8(Town,)-268.3(Observatory,)-266.4(South)]TJ -6.751 -1.1847 TD (Africa)Tj /F12 1 Tf -1.2933 -1.7641 TD [(Box,)-272.7(Joan.)]TJ /F2 1 Tf 4.8473 0 TD [(Medical)-269.7(Research)-271.8(Council,)-269.3(United)-267.3(Kingdom)]TJ /F12 1 Tf -4.8473 -1.764 TD [(Byk,)-215.8(Christian.)]TJ /F2 1 Tf 6.5492 0 TD [(Association)-208.6(Internationale,)-216.1(Droit,)-213.3(Ethique)-212.7(et)-212.9(Science,)]TJ -5.2559 -1.1847 TD [(Paris,)-270.9(France)]TJ /F12 1 Tf -1.2933 -1.7641 TD [(Caine,)-274.4(Marco.)]TJ /F2 1 Tf 6.3164 0 TD [(The)-269.4(Helsinki)-270.2(Committee)-268.2(at)-268.9(the)-271.3(Hebrew)-265.1(University)-269.2(of)]TJ -5.0231 -1.1847 TD (Jerusalem)Tj ET 95.641 646.809 318.898 -0.51 re f BT /F7 1 Tf 11.9551 0 0 11.9551 95.6409 649.1337 Tm (110)Tj ET endstream endobj 328 0 obj << /Type /Page /Parent 404 0 R /Resources 329 0 R /Contents 330 0 R /MediaBox [ 0 0 595 842 ] /CropBox [ 0 0 595 842 ] /Rotate 0 >> endobj 329 0 obj << /ProcSet [ /PDF /Text ] /Font << /F2 337 0 R /F6 341 0 R /F7 342 0 R /F12 347 0 R >> /ExtGState << /GS1 434 0 R >> /ColorSpace << /DefaultCMYK 417 0 R /Cs6 416 0 R >> >> endobj 330 0 obj << /Length 4566 >> stream q 1 i 0.015 737.008 510.221 -737.008 re W n /Cs6 cs 0 0 0 scn /GS1 gs 0.015 709.001 25.44 -0.284 re f Q /Cs6 cs 0 0 0 scn /GS1 gs 28.006 737.008 0.283 -25.455 re f 481.89 737.008 0.283 -25.455 re f 484.724 709.001 25.512 -0.284 re f 484.724 28.346 25.512 -0.283 re f 481.89 25.512 0.283 -25.512 re f q 1 i 0.015 737.008 510.221 -737.008 re W n 28.006 25.512 0.283 -25.512 re f 0.015 28.346 25.44 -0.283 re f Q BT /F12 1 Tf 10.959 0 0 10.959 95.6409 610.6959 Tm 0 Tc 0 Tw [(Crawley,)-273.6(Francis.)]TJ /F2 1 Tf 7.6356 0 TD [(European)-268.5(Forum)-266.6(for)-271.6(Good)-269(Clinical)-267(Practice,)]TJ -6.3423 -1.1847 TD [(Brussels,)-274.3(Belgium)]TJ /F12 1 Tf -1.2933 -1.764 TD [(Fagot-Largeault,)-266.7(Anne.)]TJ /F2 1 Tf 10.0929 0 TD (Universite)Tj 4.1696 0.0104 TD ()Tj 0.4915 -0.0104 TD [(de)-268.1(Paris)-266.7(I,)-271(Panthe)]TJ 7.3511 0.0104 TD ()Tj 0.2173 -0.0104 TD (on-Sorbonne,)Tj -21.0289 -1.1847 TD [(Institut)-271.3(dHistoire)-271.3(et)-269.8(Philosophie)-265.2(des)-271.1(Sciences)-269.5(et)-269.8(des)-265.9(Techniques,)]TJ 0 -1.1795 TD [(Paris,)-270.9(France)]TJ /F12 1 Tf -1.2933 -1.7641 TD [(Gadd,)-269.1(Elaine.)]TJ /F2 1 Tf 5.9957 0 TD [(Department)-264.1(of)-268.6(Health,)-271.7(London)]TJ /F12 1 Tf -5.9957 -1.7692 TD [(Gallacher,)-270.4(Thomas.)]TJ /F2 1 Tf 8.4685 0 TD [(International)-266.1(Federation)-266.8(of)-273.8(Pharmaceuti)6.6(cal)]TJ -7.1752 -1.1795 TD [(Manufacturers)-266.2(Associations)]TJ /F12 1 Tf -1.2933 -1.764 TD [(Gorovitz,)-272.8(Samuel.)]TJ /F2 1 Tf 7.796 0 TD [(Syracuse)-266.4(University,)-268.2(Syracuse,)-265.4(New)-268.2(York,)-269.7(USA)]TJ /F12 1 Tf -7.796 -1.7692 TD [(Greco,)-191.1(Dirceu)-186(B.)]TJ /F2 1 Tf 7.0976 0 TD [(Federal)-188(University)-186.4(of)-185.9(Minas)-185.5(Gerais,)-185(Belo)-190.8(Horizonte,)]TJ -5.8043 -1.1795 TD (Brazil)Tj /F12 1 Tf -1.2933 -1.764 TD [(Griffin,)-273(David.)]TJ /F2 1 Tf 6.4199 0 TD [(World)-268(Health)-267.5(Organization,)-270.3(Geneva,)-268.8(Switzerland)]TJ /F12 1 Tf -6.4199 -1.7692 TD [(Hillstrom,)-272.3(Scott)-271(C.)]TJ /F2 1 Tf 8.2822 0 TD [(Cry)-269.7(for)-266.4(the)-271.3(World)-268(Foundation,)-267.1(New)-268.2(Zealand)]TJ /F12 1 Tf -8.2822 -1.7641 TD [(Huston,)-269.9(Patricia.)]TJ /F2 1 Tf 7.4804 0 TD [(National)-267.2(Placebo)-269.3(Initiative,)-272.1(Bureau)-265.4(of)-268.6(Pharma-)]TJ -6.1871 -1.1795 TD [(ceutical)-271.5(Assessment,)-270.9(Health)-267.5(Canada,)-267.2(Ottawa,)-269.7(Canada)]TJ /F12 1 Tf -1.2933 -1.7692 TD [(Illingworth,)-272.5(Patricia.)]TJ /F2 1 Tf 9.022 0 TD [(Department)-264.1(of)-273.8(Philosophy,)-264.3(Northeastern)]TJ -7.7287 -1.1795 TD [(University,)-273.3(Boston,)-264.7(USA)]TJ /F12 1 Tf -1.2933 -1.7641 TD [(Khan,)-269.3(Kausar.)]TJ /F2 1 Tf 6.2854 0 TD [(Aga)-268.2(Khan)-269.2(University,)-268.2(Karachi,)-268.1(Pakistan)]TJ /F12 1 Tf -6.2854 -1.7692 TD [(Kitua,)-269.8(Andrew)-270.4(Y.)]TJ /F2 1 Tf 7.5942 0 TD [(National)-267.2(Institute)-268.9(for)-271.6(Medical)-269.7(Research,)-265.6(Dar)-269.2(es)]TJ -6.3009 -1.1795 TD [(Salaam,)-269.3(Tanzania)]TJ /F12 1 Tf -1.2933 -1.7641 TD [(Kutukdjian,)-270.6(Georges.)]TJ /F2 1 Tf 9.1358 0 TD [(Director,)-268.3(Division)-269.3(of)-268.6(Human)-269.8(Sciences,)-268.5(Philo-)]TJ -7.8425 -1.1847 TD [(sophy)-268.1(and)-268.7(Ethics)-269.5(of)-268.6(Science)-271.6(and)-268.7(Technology,)-262.9(UNESCO,)-268.7(Paris,)]TJ 0 -1.1795 TD (France)Tj /F12 1 Tf -1.2933 -1.7692 TD [(Lane,)-270.5(Ron.)]TJ /F2 1 Tf 4.899 0 TD [(Department)-269.2(of)-268.6(Health,)-271.7(London,)-266.7(United)-267.3(Kingdom)]TJ /F12 1 Tf -4.899 -1.7641 TD [(Loedin,)-271.3(Agustinus)-264.9(A.)]TJ /F2 1 Tf 9.0324 0 TD [(Research)-266.6(Ethics)-269.5(Committee)-268.2(of)-268.6(the)-271.3(Eijkman)]TJ -7.7391 -1.1795 TD [(Institute)-268.9(for)-271.6(Molecular)-269.1(Biology,)-268.9(Jakarta,)-268.4(Indonesia)]TJ /F12 1 Tf -1.2933 -1.7692 TD [(Lurie,)-270.7(Peter.)]TJ /F2 1 Tf 5.5974 0 TD [(Public)-268.9(Citizens)-270(Health)-272.7(Research)-266.6(Group,)-265.8(Washington)]TJ -4.3041 -1.1795 TD [(DC,)-274.8(USA)]TJ /F12 1 Tf -1.2933 -1.7641 TD [(Mitsuishi,)-271.8(Tadahiro.)]TJ /F2 1 Tf 8.8047 0 TD [(Attorney-at-)6.7(Law,)-272.2(Japan.)]TJ /F12 1 Tf -8.8047 -1.7692 TD [(Moolten,)-272.3(Frederick.)]TJ /F2 1 Tf 8.6133 0 TD (USA)Tj /F12 1 Tf -8.6133 -1.7641 TD [(Navarrete,)-269.2(Maria)-268.5(S.)]TJ /F2 1 Tf 8.7789 0 TD [(Institute)-268.9(of)-273.8(Public)-268.9(Health,)-266.5(Santiago,)-270(Chile.)]TJ ET 95.641 646.809 318.898 -0.51 re f BT /F6 1 Tf 7.9702 0 0 7.9702 95.6409 649.1337 Tm [(APPENDIX)-323.7(6)]TJ /F7 1 Tf 11.9551 0 0 11.9551 394.7527 649.1337 Tm (111)Tj ET endstream endobj 331 0 obj << /Type /Page /Parent 404 0 R /Resources 332 0 R /Contents 333 0 R /MediaBox [ 0 0 595 842 ] /CropBox [ 0 0 595 842 ] /Rotate 0 >> endobj 332 0 obj << /ProcSet [ /PDF /Text ] /Font << /F2 337 0 R /F7 342 0 R /F12 347 0 R >> /ExtGState << /GS1 434 0 R >> /ColorSpace << /DefaultCMYK 417 0 R /Cs6 416 0 R >> >> endobj 333 0 obj << /Length 3464 >> stream q 1 i 0.015 737.008 510.221 -737.008 re W n /Cs6 cs 0 0 0 scn /GS1 gs 0.015 709.001 25.44 -0.284 re f Q /Cs6 cs 0 0 0 scn /GS1 gs 28.006 737.008 0.283 -25.455 re f 481.89 737.008 0.283 -25.455 re f 484.724 709.001 25.512 -0.284 re f 484.724 28.346 25.512 -0.283 re f 481.89 25.512 0.283 -25.512 re f q 1 i 0.015 737.008 510.221 -737.008 re W n 28.006 25.512 0.283 -25.512 re f 0.015 28.346 25.44 -0.283 re f Q BT /F12 1 Tf 10.959 0 0 10.959 95.6409 610.6959 Tm 0 Tc 0 Tw [(Pfleger,)-271.5(Bruce.)]TJ /F2 1 Tf 6.5337 0 TD [(World)-268(Health)-272.7(Organization)8(,)-273.2(Geneva,)-268.8(Switzerland)]TJ /F12 1 Tf -6.5337 -1.7692 TD [(Saracci,)-270(Rodolfo.)]TJ /F2 1 Tf 7.5321 0 TD [(International)-266.1(Agency)-270.1(for)-266.4(Research)-271.8(on)-266.9(Cancer/)]TJ -6.2388 -1.1795 TD [(WHO,)-273.6(Lyon,)-269.1(France)]TJ /F12 1 Tf -1.2933 -1.7641 TD [(Saunders,)-243.8(John.)]TJ /F2 1 Tf 6.8907 0 TD [(Multi-Centre)-241.9(Research)-240.8(Ethics)-243.7(Committee)-242.3(for)-245.8(Wales;)]TJ -5.5974 -1.1847 TD [(Committee)-185.4(on)-179(Ethical)-184.6(Affairs)-179.7(at)-186.1(the)-178.2(Royal)-186(College)-178.6(of)-185.9(Physicians)-180.2(of)]TJ 0 -1.1795 TD (London.)Tj /F12 1 Tf -1.2933 -1.7692 TD (Schu)Tj 1.7899 0.0104 TD ()Tj 0.2535 -0.0104 TD [(klenk,)-269.4(Udo.)]TJ /F2 1 Tf 5.1577 0 TD [(University)-269.2(of)-268.6(the)-266.2(Witwatersrand,)-271.4(Johannesbur)8.6(g,)]TJ -5.9078 -1.1795 TD [(South)-268.1(Africa.)]TJ /F12 1 Tf -1.2933 -1.764 TD [(Spilker,)-271.2(Bertram)-269.4(A.)]TJ /F2 1 Tf 8.5616 0 TD [(Pharmaceutical)-265.9(Research)-271.8(and)-268.7(Manufacture)8.8(rs)-269.8(of)]TJ -7.2683 -1.1847 TD [(America,)-273.5(Washington)-262.4(DC,)-274.8(USA)]TJ /F12 1 Tf -1.2933 -1.7641 TD [(Sprumont,)-268(Dominique.)]TJ /F2 1 Tf 9.6842 0 TD [(Institute)-268.9(of)-273.8(Health)-267.5(Law,)-267.1(University)-269.2(of)]TJ -8.3909 -1.1847 TD (Neucha)Tj 3.0522 0 TD ()Tj 0.2483 0 TD [(tel,)-273(Switzerland)]TJ /F12 1 Tf -4.5938 -1.764 TD [(Temple,)-271.3(Robert)-267.2(J.)]TJ /F2 1 Tf 7.8529 0 TD [(Center)-273(for)-266.4(Drug)-270.7(Evaluation)-266.1(and)-268.7(Research,)-265.6(US)]TJ -6.5596 -1.1795 TD -0.0002 Tc [(Food)-270(and)-268.9(Drug)-270.9(Administration)]TJ /F12 1 Tf -1.2933 -1.7692 TD 0 Tc [(Tomori,)-270.6(Oyewale.)]TJ /F2 1 Tf 7.8063 0 TD (Nigeria)Tj /F12 1 Tf -7.8063 -1.7641 TD [(Urquhart,)-269.8(John.)]TJ /F2 1 Tf 7.0045 0 TD [(Department)-264.1(of)-268.6(Epidemiology,)-269.1(Maastricht)]TJ -5.7112 -1.1795 TD [(University,)-273.3(Maastricht,)-265.8(Netherlands;)-268(and)-268.7(Palo)-267.4(Alto,)-272.6(California,)]TJ 0 -1.1847 TD (USA)Tj /F12 1 Tf -1.2933 -1.7641 TD [(Vallotton,)-270.5(Michel.)]TJ /F2 1 Tf 7.9098 0 TD [(Swiss)-266.3(Academy)-270.6(of)-268.6(Medical)-269.7(Sciences)]TJ /F12 1 Tf -7.9098 -1.7641 TD [(Vrhovac,)-272.6(Bozidar.)]TJ /F2 1 Tf 7.8167 0 TD [(Zagreb,)-264.7(Croatia.)]TJ /F12 1 Tf -7.8167 -1.7692 TD [(Weibel,)-272.4(Ewald.)]TJ /F2 1 Tf 6.8545 0 TD [(Swiss)-271.4(Academy)-265.4(of)-273.8(Medical)-264.6(Sciences)]TJ /F12 1 Tf -6.8545 -1.7641 TD [(Wendler,)-273(Dave.)]TJ /F2 1 Tf 7.0148 0 TD [(National)-267.2(Institutes)-266.7(of)-268.6(Health,)-271.7(USA)]TJ /F12 1 Tf -7.0148 -1.7641 TD [(Wolfe,)-273.9(Sidney)-267.1(M.)]TJ /F2 1 Tf 7.677 0 TD [(Public)-268.9(Citizens)-270(Health)-272.7(Research)-266.6(Group,)-265.8(Wa-)]TJ -6.3837 -1.1847 TD [(shington)-271.9(DC,)-269.6(USA)]TJ ET 95.641 646.809 318.898 -0.51 re f BT /F7 1 Tf 11.9551 0 0 11.9551 95.6409 649.1337 Tm (112)Tj ET endstream endobj 334 0 obj << /Type /Page /Parent 404 0 R /Resources 335 0 R /Contents 336 0 R /MediaBox [ 0 0 595 842 ] /CropBox [ 0 0 595 842 ] /Rotate 0 >> endobj 335 0 obj << /ProcSet [ /PDF ] /ExtGState << /GS1 434 0 R >> /ColorSpace << /DefaultCMYK 417 0 R /Cs6 416 0 R >> >> endobj 336 0 obj << /Length 446 >> stream q 1 i 0.015 737.008 510.221 -737.008 re W n /Cs6 cs 0 0 0 scn /GS1 gs 0.015 709.001 25.44 -0.284 re f Q /Cs6 cs 0 0 0 scn /GS1 gs 28.006 737.008 0.283 -25.455 re f 481.89 737.008 0.283 -25.455 re f 484.724 709.001 25.512 -0.284 re f 484.724 28.346 25.512 -0.283 re f 481.89 25.512 0.283 -25.512 re f q 1 i 0.015 737.008 510.221 -737.008 re W n 28.006 25.512 0.283 -25.512 re f 0.015 28.346 25.44 -0.283 re f Q 95.641 646.809 318.898 -0.51 re f endstream endobj 337 0 obj << /Type /Font /Subtype /Type1 /FirstChar 40 /LastChar 144 /Widths [ 333 333 0 0 270 333 270 333 500 500 500 500 500 500 500 500 500 500 270 270 0 0 0 385 0 770 666 718 822 666 666 822 822 385 437 822 666 989 822 770 604 770 770 552 666 822 718 989 0 770 666 270 0 270 0 0 0 500 552 437 552 437 333 500 552 270 270 552 270 822 552 552 552 552 385 385 333 552 500 718 500 500 437 0 0 0 0 0 0 0 0 0 1000 500 0 0 0 0 0 0 0 0 0 270 270 ] /Encoding 370 0 R /BaseFont /GHKFJK+AdvTimes /FontDescriptor 348 0 R /ToUnicode 371 0 R >> endobj 338 0 obj << /Type /Font /Subtype /Type1 /FirstChar 35 /LastChar 35 /Widths [ 1000 ] /Encoding /WinAnsiEncoding /BaseFont /GHKFKM+AdvPi3 /FontDescriptor 350 0 R >> endobj 339 0 obj << /Type /Font /Subtype /Type1 /FirstChar 65 /LastChar 120 /Widths [ 718 666 666 0 604 0 718 0 322 0 0 0 0 0 0 552 0 0 0 604 0 0 0 0 0 0 0 0 0 0 0 0 552 500 500 552 500 0 552 604 270 0 552 500 666 604 552 437 0 500 385 500 604 0 770 552 ] /Encoding 372 0 R /BaseFont /GHKGBB+AdvP836F /FontDescriptor 352 0 R /ToUnicode 373 0 R >> endobj 340 0 obj << /Type /Font /Subtype /Type1 /FirstChar 40 /LastChar 144 /Widths [ 500 500 0 0 270 333 270 0 500 500 500 0 0 500 500 500 500 0 333 333 0 0 0 0 0 718 666 718 770 666 0 718 822 385 500 0 666 989 770 770 666 0 718 604 666 770 718 989 0 0 0 0 0 0 0 0 0 500 500 437 500 437 333 500 500 270 270 531 270 770 500 500 500 500 385 385 333 500 437 666 552 500 437 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 270 270 ] /Encoding 374 0 R /BaseFont /GHKHCN+AdvTimes-i /FontDescriptor 354 0 R /ToUnicode 375 0 R >> endobj 341 0 obj << /Type /Font /Subtype /Type1 /FirstChar 49 /LastChar 88 /Widths [ 500 500 0 500 500 500 0 0 0 0 0 0 0 0 0 0 552 552 552 604 500 437 604 604 270 0 552 500 770 604 604 552 0 604 552 500 604 0 0 552 ] /Encoding 376 0 R /BaseFont /GHKHDP+AdvP1905 /FontDescriptor 356 0 R /ToUnicode 377 0 R >> endobj 342 0 obj << /Type /Font /Subtype /Type1 /FirstChar 48 /LastChar 57 /Widths [ 552 552 552 552 552 552 552 552 552 552 ] /Encoding 378 0 R /BaseFont /GHKHFA+AdvP159C /FontDescriptor 358 0 R /ToUnicode 379 0 R >> endobj 343 0 obj << /Type /Font /Subtype /Type1 /FirstChar 40 /LastChar 144 /Widths [ 322 322 0 0 270 322 270 270 552 552 552 552 552 552 552 552 552 552 322 322 0 0 0 0 968 718 718 718 718 666 604 770 718 270 0 0 0 822 0 770 666 0 718 666 604 0 0 937 0 0 0 0 0 0 0 0 0 552 604 552 604 552 322 604 604 270 270 552 270 885 604 604 604 604 385 552 322 604 552 770 552 552 500 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 270 270 ] /Encoding 380 0 R /BaseFont /GHKIMA+AdvP640B /FontDescriptor 360 0 R /ToUnicode 381 0 R >> endobj 344 0 obj << /Type /Font /Subtype /Type1 /FirstChar 44 /LastChar 118 /Widths [ 270 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 666 0 0 0 0 0 0 0 500 0 0 0 0 0 0 0 718 0 0 0 0 0 0 0 0 0 0 0 0 0 0 500 500 437 500 437 333 0 0 270 270 0 270 770 500 500 500 0 385 385 333 500 437 ] /Encoding 382 0 R /BaseFont /GHKKLF+AdvTimes-bi /FontDescriptor 362 0 R /ToUnicode 383 0 R >> endobj 345 0 obj << /Type /Font /Subtype /Type1 /FirstChar 46 /LastChar 146 /Widths [ 500 1000 1000 1000 0 0 1000 1000 1000 1000 385 1000 1000 1000 666 1000 666 1000 385 0 437 822 666 437 718 666 666 0 0 552 718 0 0 718 822 0 552 666 0 718 1000 552 666 822 666 437 822 437 1000 1000 0 552 552 666 500 437 666 500 885 333 666 552 552 552 500 666 552 500 552 666 437 500 0 552 500 500 437 500 0 385 822 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 218 ] /Encoding /WinAnsiEncoding /BaseFont /GHKLHO+AdvPi1 /FontDescriptor 364 0 R >> endobj 346 0 obj << /Type /Font /Subtype /Type1 /FirstChar 40 /LastChar 121 /Widths [ 385 385 0 0 322 322 0 270 666 666 666 666 666 666 666 666 666 666 322 0 0 0 0 0 0 770 770 770 770 718 666 822 822 385 666 822 666 937 822 822 718 0 770 718 718 822 770 1000 0 0 0 0 0 0 0 0 0 666 666 666 666 666 385 666 666 322 322 666 322 1000 666 666 666 666 437 604 437 666 604 937 666 604 ] /Encoding 384 0 R /BaseFont /GHKMFI+AdvP15A2 /FontDescriptor 366 0 R /ToUnicode 385 0 R >> endobj 347 0 obj << /Type /Font /Subtype /Type1 /FirstChar 44 /LastChar 122 /Widths [ 270 333 270 0 0 0 500 0 0 0 0 0 0 500 0 270 0 0 0 0 0 718 666 718 770 666 604 770 822 385 552 718 666 989 770 822 666 0 718 604 666 770 718 989 0 718 718 0 0 0 0 0 0 500 500 437 500 437 333 500 500 270 270 552 270 770 500 500 500 500 385 385 333 500 437 666 552 500 437 ] /Encoding 386 0 R /BaseFont /GHLFBC+AdvTimes-b /FontDescriptor 368 0 R /ToUnicode 387 0 R >> endobj 348 0 obj << /Type /FontDescriptor /Ascent 715 /CapHeight 683 /Descent -207 /Flags 6 /FontBBox [ -217 -212 1005 766 ] /FontName /GHKFJK+AdvTimes /ItalicAngle 0 /StemV 0 /XHeight 461 /CharSet (/I/S/B/N/nine/two/zero/three/six/seven/five/C/o/p/y/r/i/g/h/t/b/e/u/n/c/\ l/f/a/O/z/s/M/d/parenleft/parenright/A/K/W/L/E/D/G/T/period/R/U/one/H/P/\ j/v/m/w/four/x/colon/eight/k/q/hyphen/V/slash/J/comma/F/Y/quoteleft/quot\ eright/emdash/semicolon/endash/Q/Z/bracketleft/bracketright/question/acu\ te/dieresis/circumflex) /FontFile3 349 0 R >> endobj 349 0 obj << /Filter /FlateDecode /Length 15281 /Subtype /Type1C >> stream H<[Vǽ;Uɶi;)lBB4Bɶ VQ!HHAiV|;>mްϑ*@<7~ruZz觮_}ޞ93snf~}m31;OUL@(Pjq`DFlOix6xwuנ؁6$*Q PTUMVV~neq$^8۱Y)'ZB-T2*ńXg+bS\r2:iujȸ׌YX Uj]wj-{Kp9Fd%nhnr!JOYP˱S򍼑7Va P .<n -'&;a?$=f-ˮeqaUjV6;WvNJš`]r"]EpYykg[39<5`aKi"EEYTl2g%ʲb-_5Z{nЮNA(8%(RJd[umtM\\SR)ӕF(`wKXmR!b@-2mF|Pzk3\޵X牣S4R4C% i (cU^A7i&Qe;0%4D ]]E 9! 빾8!}LlC^3u?`D*7y~{W'zStL s"2[:Ja Q:Y:iYL+d/%Fj~_Ű7VMTTKqb)%iw"Γ,ͺy/%x@h5\ּ aoڛuk憱nyF_*qIqj*%rr(P6@˖dJFH/T8w\OAf8"=kmo.-;%aYf,y|@j2ڸE TTU &E + jh0bpOO_76My׺|LCF5wKXaf+:1i6axيZwE0U##QKx=t^z|=GHEVg-,reEaCkԛ[vX,C,G'~',Qi)[,ejS)SHT*ӎ-I6z`i-.7M\n-c48iy3?0eVkQ^в00 RlmmG?nܸFj_Ka/͝@&L`&fbzZsUR9v,'ni5Id@˜9vx*&j]Ģm#zY$I:"͏Y ̠G5#H  ,ɐu uFhAJHF.cf$3=L0VcC_nmٖlɦhHL2UV;VtBd1@[A䪮F[a+'FI,#&6L4sكȖay DM43PD   uޙsV:E9Uugu5YD1qELD0Pla7LCwz}SA%%+ST7EUtɴzu/wZbfj~黡Z C/,F>#tp;]K Ǐ*l-ajFۉ.Y Ɉk֡_ꨎV2 pcF<=w_=J/{#{YLZL>pVB\A.J(W /ύs(AzSq j&_QM }( 9Ϲ (O@X]fhq61N`0Q؋A95T@Eԩ\YSS7e]\zUFCYݒ *p xvvy\}T&?X}gr W'MWxB5ȯ hae m 7̀|}q@<OݔjcnMsnJڠ۰dNwE/ޕ$Xrqg2Y@gugw┟aC!!.豽 OS 3{d4L!hY5!nۻ_e\<͓5cv4֪/sH)ۮ|wޤSIO$'ы~Y3]4Y 2`׾J]k8>Ď49 1:VA.$rZM2A#gw «=Wj[^>_K<C cUVZeĬ~|7,y<|x-i.{o}=~-쓇/|u ,IcgXH$" dPf  d':)?|GO h`E >PG6ҬC˳ΐzt0WC9j[Sn+G݁[d##1^)qjƥq禯'9+h`*nD TPˆv!hD4HjށJldd/Y180)Nf-Y>A^K6uCWYֶete_C0[h*E9NJ0|asdH4UB> XE:3IZQg>D A3o) 5Em*~`p:}睘Qaի^M56 C)E6Żn?D!܇G8y#H7 61Th?M<#Sw5޻,gEv䄖▿Þg/{t ܺDs%hCUqձ@\ Jʴ8Vέ=VCQiZ9؝k}U^o˧;/v8 #v;B)ȑc*B3?<Թ<9H7P6O^A@ *-1oh (5DŀRtb<-̭f&sZR#Hf3J3B_}n yLuۚFt=5lpmPuf(r|ҕeM50Y 3U4kvbW T۫FPԤ6=bg,YF:ch1`͍U/jn,yYHNΥO&;r,-\zmlk{r=&s OTb !Org0t9z cp,j..˪*!i q+pM[6 ֺPZeak͚N,DUzKZ{v?Fىa oMR1Z v_S |$\M_Zڱ67Ysl-g`A` ܹ#%>^cHXqVhdUu %pRAB[+pwRUˆ%DFmC=`Y_^G^/ʎ#3+#߯ʬWw, ʮ+2o"e CS])j`! ! HCϜ-^q@2A btCu0=]eMs<{i̓fL}eґJl挲~A',.8:FOkڻ!s1pMzodcBX)8%^g/aĸf XGp ;bi8grMom-!kL׶G]g}"a"-d.9ȭڪ(Rj7m5S]n-R'*nv.B9MÔ%KicvD< 1?8SF5dmuT,i^vfVb c!r0gS$5F0)&tΜTo*K2DQyx[z M-PSՅ Eр+aARIp*Li:s~379]tœ/Q27EhF31S ==jLY7+fف{vw^] 6> k`4|_mvu߯Vj]TUWue'dĉerޒBabiܚLi:OPYY "W7"{]=dw Mi^ :A*~5t7&kR۠lmk`U!ѓȧ1 Ȃ H- $/Yfj >L͊Mi8 pog*k,Q}`Sr!}C`^~4U'kQ~Ҽ*}7fH͐ 6Ym]dk%(hv?q`XMi;>F%xmTd K{uqք X3WYBXƣ1?OL4K 6x)JZqTԨ&.a"Y!TxuA֣ij i34D0Ķ vxڥCh24=1ia3|y>{v߽/^&嚞l=I0.,ش0[ TZQҮmd?2jGn|>y!Un]Y$'wm]E(m\2QZVf̗ 7W !&Fxc?.KK.Ao./%=("] c1U )> xsn_kYUXǕ*Cd ƿ)t W38t73ǧkKN[y:PQĭ/;_yUT nF%ǧ E5EǿK9Nu[^W7 USTz$wB0 >ܪLETWd 0u18 N:3<E9'Q[Z4I>H[$㻖MD^x:~WQ*:D] K @C^|XF% _xa&w+^A c;&z|2!;9^ /O4:ǤPHO _>QԖ򴳸%ܥZ*Ģ(9$۴ڋ|ݲdިm<̝5; n3:d;PN%dJl*djlVd0 C؎}dnH& H X߅wܺնfX)Qc%"ZY8! w<.>0ٞvatA2'OJc4F0ɉ_)RΤ 8~I%uǵW$g 6qDtẺ5_ U ZTgXckhmxEvxu'Wd_WQ i',qVY;ni<)`zZ .:tx1=L@)C3`ϜwN4%c6S95}jƪ6ʶ.6i{+ka6?U;R0-[f""ǿK{{9|MXsF}TP;N6z]Yxjkif:75逃 Ly:`zڙlٲ.".c 9.Bh, `[ev#7J2 =F;cg?3bPјn=VMȍ5TP}f|`zWQpiS2 JyU̪E-*2Ncn&m[mKoꉍ8caj̧bJʬ@@[N6̻rwzkm_u j H.y!`_}#ڬ͊K Ї}ЛkQkBcK>/"2,9Cs; $H͵BFeq|SMXzڪ-%ir|)"t  ~ DWY8T !}K<JS۰wϒ8{> , ֦}|7n5j2 #W3 lh 3<1ڲ. Z1p2بt!g}0T 4ʼXND%lKdA dj~|ltMO@&)"B .L}^SZp7#B,90JuBta BaE!x /FP17muWWwU33uŨ$+ ވ^I`ڃqaatW~cnVU(<ʮU:عHE8g{AbGsƥK >y##{EHd!xC]CVZ!v3`@^=c]@NrP/W2}B O8SD@hg'ϾGP7 uXYբx*V2Ja^6D,BNfA ]L$탑;heNWaT|`.?]Hj.B]O j ʧS|?><~ᣇ7hߞv_&ȦO]$7:D3Quu_K#TG ,c Y4R/^OUYQMkZUYC7vEnr|쉡ߌnՈ YJR>{E\/-_tR"UH&%8`"tMv}7)9"; e1i<Џ8cC yb]CHOSU΁)F"( ^0<}tJ֧S.RԲi2EB>֪+ 9(e MTT冯y*~lCISH3 bsF+K}dU^}ٖD1 :2q-K,M~+?0{x~>AtMN,I3OEt7hL 0rB7|Ԏ,3+тy^IDeo5OCxsaG֦wP|?ZWKwtY{.kQHp -=2a݅D,T*jeza2Fb8" ANQ%e3r2uB DPSޔ@LK)}X¿e١6)˸JJr|zd gJ:SJTy&!JDD*Fxc.(&O_3ng{ u<ω0DWJ&[s =DƸAf틮ÎDjs4 $k0vuXCV#t#? 0,ZXER& %0 /b}vU# 022[ v|Pfs,~2s}b ]}z'=K$T#r=eբđ]|{L  A :cgݠ}_`搓sh!-및[O'&oVK%04e/dZ/6Ńꫫ0(/<5}n}?(("Ucקxׅ`ň819(uNN+wr |ni-%B(]'[y#k|ߦ`O!ϭ諆3pv QuQ禍]A5"4TQW!~(;!I! Ѩ~=l.!rb;] D&SI01Q%+G{,y G3ܩg^b9}@m}]taãƹIWld ӕ|C6pXpҤV*kLw=u(j>;(/(Y?C }mvL8 y ڥ]i}[D}⩌`qoHM,R:c&fvȘeVَ}Uա4u;AagX=URB9lUKm~ u'DAʄW*V1關e rziwZݵ&Nhy <2VW~/. ݍ5: u Kp92J  >r?v?™_aZ!^j*ϊL{ ^oy+.**d7$d-eurCмFnհ%0,oWAŬkQɊ/^ϣ<8 ӝh_֩ &yͷy}U &.2#l  -)684:Y4@ :tpz̲-'Z?&EHB&2'C"cfcU 8T)|+B1Ip)j"7wJt;{g=|FCV;^tTT-x.UOҥ; Ow"g 6/jFر7ӗϷĥnՒ. mn甎u?6iAz(i~q8h1)%TO $Tw|N%ZӫCG5H b`H LD π $?ݙXj`5Ǥ▻|f#/sA޸o._[A.TjJ#vU f$Ƞ'fA}wҁx1V1 ;թ?y)B_2(5m04)ޕXR矰 0uL.''E;O =-2j-k(xhQC OYj@> ڊ.Mə{~ݽ#kSuyF4[>e$C3En1m,b#\#aB\RnAAij0ďmQLِ.nc0|KLJm Bs |εRު/*Ed0#G`"d8\B,98J xJĘ! $FTuuLzoUUo]D7ƕF\0E](Out7w~ Q?kUmo|S{3͵vjfN0y+'wT̥TLɘ$12M4Nh7:B7:Xg8` .G Eq*v $۸+^0 tB7b2P61'Zj-Y0ljXp4]|\h:{YZNŰͽ3:<®L 6Y@bTM|ڷ/e^| I_Ha,Kj|(! ~͊fB|P^R+w۬-iuNkISBMܕAv,e0a%r88q 1d4ٌF _z )l5{ge0q%; G ^ك}oN*)ӳh?Pڐ6c+H){om?/h!z?*C514bM iC.ӞٛV o7 }rz dԯtvL˘8zGo7@nMe \vnf֜Ml Tp?pc˭oITTj=c}&*V {GAYǵ2P D s=wUC7 5t _S0` e*G!6nQ.AA*yOзkEML ߴ$穙vNrkЙ0#eIodhB_;ϻZ߃xU2|R'ȉ}a\AFN ( d,qp(E uhb%N`^Q LLbq8tv 820:߮ Rls?3RAk[~L 9LA(>…Q NiCo~뫠`Ү%M٥P/W 8XɌ`φ4_lxJAxCcNͫ|ҺQ)*Q%FT4y['ʇP+h!)&.d(^怐7q!)z,E ͼ\x:5(D2UA #<qPUS bZ ބU(% j#ckËIWz4l.K˛לKR\h^m`pՠj>Y6GM 4dJl+FGk ¸j75TmMvlYڱf mNVV@,6EPBURUkPvN[b8&T\7_ 18$b\{i3<v|1P0(Я򖎸?I lح," BȢ1| T-=qs䪒~D"mWtKB4.#(Pa /ôqЊ4N8auPh ȗ Bŵ1G;v"De-rNOIeÛAc5MmZ4E` nuu{yeB*dD] Sh=-z֬^#,fQJ$yso PTeI;MY]7 -l\ ?,<.-]8X냅vXal /hxJJ0D4tH88BHk4|7ۖ@?Yi8c$Оx= ;WZa8i,K4e)Wt)orH?G8r3ZX6RLi]HT/w$uW^# :⌮w.J6/~jI?HKַkiG3#g#Ko'-}WiLeN†IwPit(Qlj ׿/T5lFˠ64޼ڢ."eXEγnj;lk 0Z%5d\HLPPѡ8UA?5 ^p\o7>'߾4vb"v`M8; endstream endobj 350 0 obj << /Type /FontDescriptor /Ascent 685 /CapHeight 705 /Descent -12 /Flags 98 /FontBBox [ -11 -345 1373 718 ] /FontName /GHKFKM+AdvPi3 /ItalicAngle 0 /StemV 0 /XHeight 684 /CharSet (/numbersign) /FontFile3 351 0 R >> endobj 351 0 obj << /Filter /FlateDecode /Length 884 /Subtype /Type1C >> stream H,R;E=3 : KGr1!$ 'dqB$Dm7-ݙy켧y߳{F_w9D} 﫪oqthX_V.W/W/bY?_]l~s;:ɏ?N۳[zubEd%Kl @@ekPXgrr+SZ5j6j{w{Lt۰M)(,ɒ"*o@}@Y-Qt;U5C3dNHfd8)kٮfF7*!sF&5HY,@?Nʴ<4ʣ,B1Ma:jryʈViZQr1+0} ̳TbcgGa^8ơݟB1ve")tC|ԽbגޝaWGG\R,v2@ D*,z=]QYScxq6Foކt >q& D5lPF4ev1y=+7?S6U|%ԨEj~vcZ0{`^I 2?w:}&٧!gS>*zh.fy]ty "!j״3ٷlzܚ:}'uR]rzsBPq%̅ &`>l|AUZ_ endstream endobj 352 0 obj << /Type /FontDescriptor /Ascent 486 /CapHeight 662 /Descent -7 /Flags 6 /FontBBox [ -167 -217 994 747 ] /FontName /GHKGBB+AdvP836F /ItalicAngle 0 /StemV 0 /XHeight 486 /CharSet (/C/o/n/t/e/s/A/c/k/w/l/d/g/m/B/a/r/u/I/i/G/E/h/P/p/b/T/x) /FontFile3 353 0 R >> endobj 353 0 obj << /Filter /FlateDecode /Length 2249 /Subtype /Type1C >> stream HlTkPWEヴn"(OtGB&XPfaz`xCcF_ >(B5%LB&߸wj{bU69_(d#_ ݙjWws9g,D2H`9>Ieա QyVT;gҪR33kS2U5۵Tjw2~Ad|9KQ~P SPɩ 4AmQs%JdeŲ yGA%Ig@ 㧞i}QyiI+hNIΫytuIôٳuzXm6f:KC0hhCtcAk&U':؏]xvʺbpQhʾƐ A;3>M7x2 ,m[#Y,aԒMyEftM.#y}LYB@r&0%C碴ҴK9DK+`]n;dGf羆]{'wp0FA!LMښAfpdaM^2ݩn+h } ZQT^ltGMAUC:t^b$9cIoGcիX$/ Q/^y~}T )t*O(MO.N_0y?Mšr}"@"k>+D,ʳ=n62÷ɴʱJT%n5#+8F.96k,&=<%[OEDx#PG0͵D|Haksj:^r 3Xs|"ЮKd}6s\U(J'I&8*qV4TExӊE @6;EsIy~Vgj1VsoxZߙXdԡ~td~)^.<ѹp. `wC  QI_pNRتkCԢt9{H"yG?GI{(n& VTcRDæjW_=ē!B aS1?&z+M{+S!#J![ R,-O5ODޯȇ8ڔʋΥ0xy($+g/aHc]=7gj-43"1h4,S2?JP,vcoEeKr&g##H2,g;,}Cfފ@,7EVSkhf <~"_n׿/?Vf[ik CۅjĊ7 K}-/VgJuVnʰm0hzhLiJDm+/ YOhPZ/V?{R*PXZ^2 16/7x؂/7o4I.FFlѩ+r;gy/kpf0D6?ꎪSe TXZmA cؾ{p|-$g֪f_9X3󽎵mzRM\ 4)hڔ+Yc 頤ka[TmS}]֦J͞ҔS;cn8@sXckblYKfO6KwXWN(clI;r+~OlUK. `x endstream endobj 354 0 obj << /Type /FontDescriptor /Ascent 709 /CapHeight 670 /Descent -201 /Flags 6 /FontBBox [ -253 -211 1078 766 ] /FontName /GHKHCN+AdvTimes-i /ItalicAngle 0 /StemV 0 /XHeight 456 /CharSet (/I/n/t/e/r/a/i/o/l/E/h/c/G/u/d/s/f/B/m/R/v/g/H/S/b/j/P/p/period/w/colon/\ U/A/C/hyphen/y/N/comma/x/quoteright/T/V/one/k/O/parenleft/z/parenright/M\ /D/L/W/q/semicolon/five/six/seven/eight/two/quoteleft/zero/J) /FontFile3 355 0 R >> endobj 355 0 obj << /Filter /FlateDecode /Length 13935 /Subtype /Type1C >> stream HLUKG]9v6ʚ$QbKH@NIlbAB2yyxwggv^Ϫꇪ߯yήg$ƾ!@>ʅ¦ϲ?ܷ+/w ^|}z=Α_ǟ:8'|''=̽xʲ峾< ׂ˟~zxWɷ:{;?~?.|G;ϔ,zS6Mb!D I`[@-jzK+2n4ʃMYR4`%$3H(L]IjIMTZC[XYVq6FTesZ2]*Vܺr^o9ĕ<ї})lPX1!26v`mY#hn 3t?? 6Q4Q6I0A=逼&Z+jVE^;jA.4{ŮUb.%_WVUCJU&եյW+*kPe 6h4;OZz-NIx=m-:]BO}|B=sBn?G7nkp`3akJ#*·=*Y*v.vLPmbcd`b bk[E6x7N@ sD}s%Wb%RElKvۥ$LI1捈D\׾Dvf`խY$.ۺzI)Zkxq5$B@H Ҡ tP ͂l LPBFꀐ F:]wl3q9Ivr+I͟t+}w䳱A c`4 \Gua 5Utb&2 Pq+E~:|T82}˷} @S'a?SoqOm}-OFrIT$ITJܨt ^1( 0yY>8S+'P"@U1QD[4%s-V^m[8֦C-ץAURoٻoچsc|}rc; |tVM'7ƓkAlG\sc~93+KIG XveWtE&;@DBl)bĘo!-ofya]@m-`,ɔ "d P*kPF2 4Y@Bרp0̷LR Ļ3}u^Uu~y] (,b`\zz&so,UݯYCU<@^5",PhEK?f\zl#0M2=)<YEJߏ~|뛗 +Oɏ4 iNd3GxGMVvkEgyN'i@M).{^]/* |$1|_լX]5u? c;5S=PO/,tϯ2ϟ k{a?*wm9@ rz#1u\ \jId6jgR-~xf?J FhCWuj e^B A1=RHh͛ћ_ET1lj/yWev /_ߍw5YeovfTf:K/ÝGjxא~i0I|{p8Z~y/ lgm(j_LA#W￸E>%2BDyT&GJ R3U*dId-+t@Q'19 #ZSOm4)O OkQ+VjҎ)0xz+/m%TyN{ ,Z[Tˬ${D3{D:TAkQ',$x؀F?dJCWBu"?vLyvL3fl:Kӵo( Fo k*Rc}<@m}/Ih2DvT 9b7gQx5.&}]#SKx 94tCamrQg>PaWI=rx/mu_?90lX`osQ q4t{z)2q|/nZ \7OU Xa!i3F$ ^)䛟U d'HiqE ,5W @Ƈh'op['hx8dܾK[ r-Cdd5tIG1=6q\EGIM17e> ċ]2SޫR3>F|p/tHRai8AWh0q7F_Ay,HYG~@) v.6qRC_><}y|Go,q-@.1"T ? [4 ~ll^-7/Vu.晲ܹLc4- 1€;my[*,v`^ONN W7QկFb}o3q,*۩Vsj"X*68d('(nϔXR0EhY_[ŒqWH)S`.70?/|̈i`zw YI X?np,ɴч b!Fz ?!?wiq*}ky?v˺\ ~v-4je{oU|W+/ruĮ*sXN?1Th>"?ܳ㎉紳t)%mʸ2<4*/ҝbLv L|2&XPт%taC@T!<5PR=wk:\mR "ps/vr%kn8q~DYY#$NÔX qp̐~1C`lG`ÑYng `5͙LM% ]b/Gk&P,Xӆ9"7Zzmm)7qiERP3ȯ ϊOb#:;DWBY|J&*sT肍Qmi_p}5U@`xqD<>p= 2G͌ C. G2{@ O0-M N;dFU9=u ƣ3.l abƎz_zr[/+ ~RMIG+҅{Ie-2Ừ}3'OΪ(sUǒk=N?u%wdKsX *P#stn &Qb3g4˄M[pU"Hg|-.?Tہk߼~a^c`w`-o+>6"M0Ksy iq[8ZP> [|q#X.!~rxl]dpK;3ṳb&X" s@I3uc枣3'C>X2)L!TdZ-5$4nv'`,X]ʻ2 ꣦kWѦ[GI{nMy8ΎUܑpu!$KfߚKіUR'JR*/#tnM܉51ƁN^ܩ&&{ 7Y++t X!x ve:~I*.й22CŅp(J$( մɜuÑQ|I2 DDMiNs[}ivz,YnG*\xtl_-նf5˦G#b15%Dlplɐ0Q]1,"U5]$\XH.8B+XHR %s;PIqG1޴ q\mYU]VQRŘx)yxFj%WH&R,0XNaw"S>P|wAw>s%:VavnfF䠤j1r('" @)'8l_L6UQdYeMeS4$vȸ%yf"tlF C+/?~ _&!UwFɶ ?4s^- DHTC>/3㽱<ǫQŒ< YI~C6ZJ\B,0.B+k 8@gԅF|Eq102#ݣUܼssO[uЂt/T(YWjn!~r&} Pe 0K/?ΏU "{ճs޾skp]KQ|uΝcwl>/KQ%SLHD-1쇻 FYB)_$Dp.dYJu)OB'5zQ@"V|gdٽ/=Cvv>zX/?#!Cu~IdWwZ;wlM :Q6mαkۖ!$ 8ೠ$ Ҙ&4aG1:Vjz~& 0>r9밨cۗ/K%Y >+1A9KoNCYe=D kB.r-I^k zmШ F* e(<pazuc8c_AMxoTO'ni1wfM[-7 dU~飂HY\Qi(C,a1(A>ѕL<& :W!&-_w?9\/N;/x-vLsegfhfd'bJq# O4%r鰀]ec5Fei\ιV~2N b *bEgyPeXG5d,p٦ⓩ(Sgr#|8/n=,P8zZ(ZiA$Q-6#"LVJ1AƼg!FA) V஢_:<̦6]}9q +J5P=Zg<AS@p34u)aYE4͋$gARzɭA/"#(z{0&dsqYH fF祫zzٙz&z*3"~3,,|uhOg4ssx(0aj"*MB ʻb3ّn0e>5 lgaĜP?&3G'|MBda(Aǐl`ma6弄U!~nN laN !YTV!t{(7̑?Mǖ .:e8EYKol6^])PUv'Z{ҭEPqrD>Qk'J#fԔ,(QE",N=ivrm`wG]F[0q@'W5'xm! V jS+@.Iad-$2;X)Ij-j'3vIV0;kɆz{bdk)OE~SRFZ0q+epSeS.idreXH H:9ŊqWl$iovye8NdzdkǍu,y3!KI8;xv{2ztugSjSXV̷^~/t1kb;р+] mv]OJ@RJfA&JnBxS5 1evL{2=:Ί$~SZ{w%ߣ3[#ЬU[uՀJ+L>PXphP^FrWnsıpqg+# %ȼzkӀiSW3qMo .n11 ErBXS6Dvl)afVVfk5N0; Cg5LӞ3epuk|mskli N#s=WIwV*^%i|,|w2y fWvA瓂o.wҔ>޹R(KwtO"|u>y}zCLM(+1egEʏ7*RA++ۛC86Y@ĠZYozc(hA\L3 S;u\Ӥ)]]]-PцT mb6M /ڃ|&d\j~~~}p/s}'&Rr,0tLUo? l/>f־}}Xa@XJlUGFMM^ڋۗ_~!B3æ yJ! RO$J1F$U8`䱅OabV8(')Ft1KiK8.WźX'4N&snxQn-MNS'/xY˄ 0;1 >'?15~vyɵW<65 `,7HyYd2ОeQY?}B5G!ؓN)kE ztyg^erQG]̓[R붶>:nC]ԇ|'OOo?JD #JGw?\j'I SUͪ0Y] 6⃹{bxV8:"pcH;2sn[ K@B;Hrda{wcĬ~{MWl' _|Wӏu>*x%8_=?? D?՜$ty[jUmݕ)G[Ay.92 gS $f6 X$HxA2+gblzn3g؎b"[b $@lЃFB1W~|_| Mk7_|*TzzUãiٜVMa4 X԰@˝kxB 1#.'<*(&{H۲)2ѷ.Sv))[`t6L3 ]5)Rvw 9 9]~<5ifȞsϴzw/ )EGL=6bnh%ߛߖo˷$L'BB 8/qTQ$(/_xyћ7Ǽm7Y><,jڲ@R۔Do_Laהބd̎QF1-@ IGTP¶?]bmavKsq%?eET$EafQ!. 'T(h\(X`dESn;qUtv&tWo'{{X(Su6tY9s@- (v!\MLh,ڬ W27,*YdK*Vt\|ŗ|+=b][zݘ ^r#CMa6@J0sZl>⍮F(?(pcܲ,-<4<ٓXEDq3mݑLPzwx ʫuǍMiGM~~di}*a@TpEpnhP q'GlF@ȟ-/3; _TNR00d}nɶȮB5#}d5ݑ)tDX]+#*: lsfs<~$y8UTm03FbqxXj"IH\ AcXg/vQzZ?| ǘ49c#0R\Ց{ e&"Ϝ!F$㌸-ij컇,tCɼgيh |NOxK:e`t :jw3&k1[::f,T[\k3omvR'_ Cz= IJL8k._V.lDN~( xvLp1l )u1al-KzR"";: E҉^,h릩!Y)N ևk 3 [}m,6(BGJ e^y5FLB8QTdNfئFbCi19}]m=C(4r0܈`;-]T[j1yGϣ`.6LgDlmNf! g 9UAthDxtDQш=R2%<<>Oο-'Ow_Gҕ?yDsk6>_mS,ϑDILpKㄥN`[sBSS~hSQ.XW]]ðYWۢ>ڜ7BJ=l:chF:d@=vhSq 1>`H*"_a V,֏lӶd%" ^ ֟w[Fz}rmor7 Y8%30┼M4_|},6/5_Dɉ!'L! C3 h ;myp{CŤ ()ܕ!Ҁ-Z^eZGu]=A/Dvϰos gD+u[ #W ~><9zS︀r3|7y#cl{!Fs>IJZ(DcQTE0e J4N^.e)0EQڐݸ}aH3XfLP (2N)5_kz dtGY,SdYBrBo&DZm{;OӏO= v,BN{@vuY|mN|w Սhsbaj$E\` > endobj 357 0 obj << /Filter /FlateDecode /Length 1463 /Subtype /Type1C >> stream H<{PTu]qW؋{0d eUQ4 Xy#c{yZC>B1I !$ɁIQ:cヴs,Nw;9CS*-gfJ-4ft|e}_Ӣ auPK'R*2%/mRY3 4k^vrŚcHϷX 6,4kNU(HSg (J(<)jUAA8= WڠjWnydO1"]j B/wnP`!H/[oOLЭuoYUdRk$gˊ] rVtU"@ LQ/p;aqcQZsVr]68|xF]HlMN@5$I.-st|qqfhfXجՂFf) M5}(=2z 0 'Xr]-B:4PcVڈaL\,JebL)ePE`+ɰHDSZ}A)h$1 כCuvTNaM.S!X|=tVʛ[RcyāyaO ]U5?JKl$Ŷb60: U $Ôcޖ^BR+$@\fRs$CH0VU3PãȉZcpԁG:\cGK/T9 Dhr?l,sVlbDZCX @t%"+m_ ?0,Lwq̅|g١&AB QtK8/n#@_"gVIceZث %(/<{uMR\xuByDsiiYPq|g w1p)HDN" jr8J{0r]sW |$"eڲ2u.4궟zjϱoH]JDy)xJ/u =Hs=_Ńbs*5`z@]XfXVsq rlq *+Kj-^[PEb7TQ !h v7u w9|ǩvi]=靺%Xҥ:s5n+F#aÕx 9ݏ_tz/ժ6KBGe F*@*n2d64LЈh%hJ/OyZ endstream endobj 358 0 obj << /Type /FontDescriptor /Ascent 720 /CapHeight 720 /Descent -211 /Flags 4 /FontBBox [ -163 -211 1000 777 ] /FontName /GHKHFA+AdvP159C /ItalicAngle 0 /StemV 0 /XHeight 518 /CharSet (/four/six/eight/nine/one/zero/two/three/five/seven) /FontFile3 359 0 R >> endobj 359 0 obj << /Filter /FlateDecode /Length 822 /Subtype /Type1C >> stream Hc6߰ꎪքD2NV*&ɏtla/X , GVxCjQVڦ̌76q\l-$μ;:4=6Sy:DJm^ $zϝ?{Pk~X̤^> tǗv?/VWpDB~/=xwi)xۛ7DWF~qm51aJ0E@rG7A}bE4:*SǏۄ, |7 m8@p rl#R|n49mFsw3A@o/+dܛS0":E<ߋ~YvK1 )O Į)xk3ah^5#)4NI-')4c/?hLx7`esZ36}o¬?L~=}3wM!NW[-1Q4> endobj 361 0 obj << /Filter /FlateDecode /Length 4105 /Subtype /Type1C >> stream HTiXWN!R:(vPA)"(e-H@B"Qّ5@# RTT\ZtDG>9a.3?{K3ht:m?\w➹k͍Hy>3kbsi3Ny{vyIxacBAT"O(ċ$ %bޑIHbD8/IŋW3hKi hi4: vtuA|Z?m']Lg30*H=ތ~~-f?sw,Vu5 N0x$bɸ!ex𭑱QF K\ei>6Ng36ńf$ؤdS{aϽyLӳRrB kŷ8`b/`16uHPB&Kdm#?VW`O \ǯѧъh{*Svd +\lu.L,J'2d2Pg5S?ia \ dM`Xt1D(S,; "clhz[SU+@g;F'FP> BYպ[{I TZ+Λ܎ uTSc*ʨk%-.Hl-{ˊĈex|K?/֖F?mbJiƞܼ6m=*`場?J1v+pz.~ꮦJs3٣Ux@fnuJun`Y5᳛upP\P=X{rgCN=Zpe"CA6Gka!ZKab'=ǷwHޒaN/uSAlGDR*:L 3)'N6Jf lcb2\?z"=TA3Mv&_KJAZz STz$.RgWTqJ{Kq+=wȫubA%˱)eoh >w }xp\i'0!Zu:_Z+9~gB(S\ )N93 n],|d5a[X%dwq4Wbr.lgiTC79}у[.lH.Trt8{8GE+њngܱe+rzvBVPH2)T! :-]~tϠDLt\DI5Ku mmZQo,gAkcTz0ow$W~ߟ#8Z5&jrUYUaQZTSTG `kEk )uEQWvT -mmymm*Eu0'1C,r2BL.S[C še! @ m17NWjjw{o[]-%jtRI;2_ ^V&O/nCd)bƢ%֛lCsf7ҩEe񳕛ql}:a\>GP#gO~UΈ Oe+Ow{+"L8T8^i٫H~""/&;f_L8ZK O"&XcW Y,KUR37.ycC? h7z9Otr 9m ؂:ȔWlbOdcTB7t :m'ckŲ<\&/,Sg;%]:u#`lqڕ"(ZWZ,ԛ5SUgb?y(zaN@q`ۇ6sl-+x95:".')<~yF:`g:fj*=;IIzTsd';;9 }+0v3]>`@^8`b<n:ܤ°oC|w/vw\<6S^Օhf >DzUwf|W30-MDt}Wп84޲޻Nn\{otvUEv}`",/A$pC#@ @1#<. *m.]12'sљkw~Gl`?r5.X5W Z45U07+.s3̼j8/%Lu ;gn29p \{ړ\+C".ʃG-Wk_vT" X,HLѴMLi,SvhﲛݞEe_7W"#b%Y-oJou >i.X ]Po 7ٓ++cj%q4'9:~pGJfRJJx`gAkUImr㌵vv\5cMrnp 立:CHDW,,\v} }!MgSG=p^p\|pU& =G$7։ro6>=K6Ų:]+/0!6*XKg'w>Wӽ]rmgőӤLP 8"vfFXhcI!ȒR)2C:>_o6SNs#!xE9TR&+~o,}/ƒY}keO۩ɯ47 (”dC mzY{ac{s|`i= >+\.Kؑߧgk]ybV7V5F1/ E_M,%w90&΋,c ):)-l(851B޻BC KP$syҊ86tQ Usz~qpP!܎_**(Nju!ӻ6*yr6^"f0ɅH\DTIтK{[n:Y~J _&m>}2]%%`>\ׁ˗:b;K\~- yhڹG⇘s/| }VoMp;l?b:^lM1nnvfR)3Wf)T ,xvnl0-6- np7o(t8s{qP &GޜD( endstream endobj 362 0 obj << /Type /FontDescriptor /Ascent 698 /CapHeight 684 /Descent -206 /Flags 6 /FontBBox [ -276 -210 1076 766 ] /FontName /GHKKLF+AdvTimes-bi /ItalicAngle 0 /StemV 0 /XHeight 456 /CharSet (/R/e/s/p/c/t/f/o/r/n/B/i/m/a/l/J/u/d/b/v/j/comma) /FontFile3 363 0 R >> endobj 363 0 obj << /Filter /FlateDecode /Length 5681 /Subtype /Type1C >> stream HLV[$U=Uap@%b+фĨOb xA].2 03u?:U{Ꜫ:n=34x{0&GbLkcd:W}_k#7n'։xzsvsuckWtk5Zu[w kk_S>~SS[l4~y/lol~sg7oy啭g6l? o߾F7FNFF@o;2zN@7:2z:oO˟ y[%]=o>D,gUulQKbYK)M(,ċ|aܽ)GK-jͺv0ntWE[tsn֋w֤*NY1'tt"vUj&\ ]fID.51 >O^:Ccl->5 Uξ˽jfC3 `LWlFhp~Wte!jYȄ_1PJhygfjfMtmھ׭Zvi&mudPT ؕh,p:6oszVYa8p֤:QQJy$Be'~#,I#}qcGCS(7AsD氂+T%TTZE)uaus!54TKĝ8OD&R8 *X3@Q҆0OetLrVLO i7mvUsEi#-Zr˺ZՅ)ji#*&30_;^q*(\2tXDt^Cޓ>Gα]1$g(ȂhG/HFkYkevT^dodslv88-I.&MIX|J$/I:LfLۡk4okpԪ[[jNtinqMb7A^驱ڕr'o Z_>>{h%6kr+lj ڋAQ#7+mO@1 Kc"'@I#IdW~6 IxEH@y ȉ+bRxU% b.GզkC`f!/ Ȱ rKHP"7WxT۪7mNli兓˸De{SL(aZ8+r0\R3+?_ޱo5n.od(sD?$ȳ8J*QD2̼4NB "6.-/RX D P*ylL=A* h٪Pro~)Z n='.{͜3Şj^]eJ5kֳt33jJ< h (c@/& Pg|! (I$+kۋ۟6o6?[ ԡU9<@^nLaK[yK)<0.iATRc+I곋"ݡc$8pAsNSqs#Oذ Zore!Tʪ^u{.;tw^NLW5I&ɘ*aAsObn*X\UP6l`U#(EbeCN` ory*Z=@T@5 6@$!~GzW]wUz}un' ƀjIpn8\}wrϭ]c:[KB3(H6awQ, ꨁ:wiLJWAZn.u7{d༠V[mk.Mp^2",UqhڍjTkF*])9AJ;$&iƨȓIᒳ%K8Z/w&-zZ"0JxmJΗZO`cF4.flϽZ}.0x``Ke36e|*\tظ^PgujH 0B*SraխOc(աD2Vq@T T#)arM**$ 'rc`\,=y\Y((]e+>GҘv_- BCLwtnMpړ\q$ב"yrH::HЋ<;mOď, O4Y՞3h{t0UYS}"9opM\xe2 {p84I4yB؂p1=*+t/:@ LƼ|#S]*Fu5vojzt.ʼ28,2x Ɂ }ڠzo[?~fIӪu &-—RC= bi s{.lA"D)-7lĖ-{Z&U׀l ?e1 /Jt ՁCBEQABKdcIsuNݿU!%X. нG`'1= nq;)ɍV|+?I7N> -RuQ[#*2 [ÒggRc+ ]Ҙ'y'f'۔"۠#Q~maI@59^p?MO6zS#h%?^E~,%>EsVժ^wGj#[W wvA#@"gX~HQCJwᮠbj!>TJW5[?oESڙ.6l$,.{˗&T  %"zڀs@x5IUiz)Zs HiJxoGhq&7fBD 3N3UH ]cf XtTJ=}];^fb %qFlV"iVYcy?H_T} ywa\C#3@&kaIa$@Y:f¡ȟ9!wV{H˷=#FJ1j2&?+C`H |)t<齗&[fHC$OQ$N!@ ](Ub20PMH1|l Vep&,q\<]1It% G@Wfaqwfj]mVmlJ/}Q ~`(St heX^@R#.oizHız7`N XEX܁ 5aV*UΡA.?=O?}Ng7x, /%hP .Ci"TH@8ܫ*/9|.zC{Xes t<6a=jހj%]Va\1?3O>}کKdgwûG#^MSY#W 69o=~DZj,aSk1#"KOZ׶MߌReՇ ƽ\ŞLpS] y'G PP#H^ 5/cSbƲ(E>Ǥ/i`?$:1-DZ&澱f5r{?B? =T00pV yI'߿xsMq̦dXN.lie2r*& OQ2納lu|Fڪˑ;p]-jSal +$8=qZPJd]աa5FQS f/^>}" endstream endobj 364 0 obj << /Type /FontDescriptor /Ascent 712 /CapHeight 0 /Descent -207 /Flags 34 /FontBBox [ 13 -323 958 824 ] /FontName /GHKLHO+AdvPi1 /ItalicAngle 0 /StemV 0 /XHeight 714 /CharSet (/seven/period/quoteright) /FontFile3 365 0 R >> endobj 365 0 obj << /Filter /FlateDecode /Length 406 /Subtype /Type1C >> stream H,=O@ kH)APJL E|z jc_qϹ ܙҡ/ B"T}_yyEy^7joW|T=b/L^?o~\ɥWߋ\W>ln{{֩rtJP==ihڔgg寊v,M07s%n/żw,] O;8DAr_/ˤxE^ﺮ8@,|Jei-]5<=B܇c` +qmR{΍C=%A^qHQX0ŀ0iL4 ҋ8'z?z|P3c=6/ELl`+2#_hV[=1I!EA|`& endstream endobj 366 0 obj << /Type /FontDescriptor /Ascent 720 /CapHeight 720 /Descent -177 /Flags 4 /FontBBox [ -166 -231 1007 817 ] /FontName /GHKMFI+AdvP15A2 /ItalicAngle 0 /StemV 0 /XHeight 524 /CharSet (/G/u/i/d/e/l/n/one/E/t/h/c/a/j/s/f/o/v/y/b/m/r/g/two/w/three/x/p/four/I/\ five/O/colon/six/seven/eight/B/k/nine/S/zero/R/C/q/W/P/hyphen/T/M/N/L/U/\ D/A/parenleft/parenright/F/H/V/J/K/slash/comma) /FontFile3 367 0 R >> endobj 367 0 obj << /Filter /FlateDecode /Length 3136 /Subtype /Type1C >> stream HLa'Qc"EL vAlԘP|O}~'&OUy&cό|1Ôe\o4e{_c*2A.&:ɼ\dS쑲p#B Km5~_nn݀B{}}b"VaT3ۙ3lT+)T!bUr,vxx:NNNNN?899y9H:)ꠁL_DIٰ:ٲxA"&,+'9<;z0JٔM&KqYyYicnJ%XHin" u2"wOJS *#MS"5<}KPG@>%({qq0D܌,V[aPr՘I^hV=\5ѷ)3U:,fy=sv@1^EHY\B5Os:Z߭}Dt[8}D3ȗFDRf 'thO.M[qy@.u99kw(JX5#KXߧ*RZʡ0%ׅ+36Kũ VCY DC-Gڥ?I0+x2+aqnV Gݫ,'ܲԳٞӧ$ϭ4820(<$7SM%}rGpϙ=m9fj3siCٸ6xg XG_2`&ھ{f20R;ݕ+obQw$dSpfvX  %tjrUebr FCSx,(#@Hꥳ:feB­C"9y,#;a{x=FV4q0D0 :F^2 ȈѯK[% NJ蟽?$@o~E:%$n+JYfd!W L:bml3!9Xv>;ؗc] ů"*N=C+JJ.DɈɫ`$Is:] l}KS"J9gv Nfk0yC'KӮrJLf,'4h@vC"8/;95wIoa F|LA::$C{yפJwo8~n"voI"vݳM)ݕcdZ mlzZ8Ԛx0ŤZz% z #VHRG4P~v:n2uv{S[!D-è^`qs3-Rs[koV]_jTt#͡ Th+BgmNIA5668?$7Jt#׍ j{+A$+bRFi"^d0Ľ#|4$fa (i`8%L`)4qR`&e`m$vJg<{)$*.1Dj @>5k£6PR(iPyJ(ZoY9´]ʁ=&@h7û~? endstream endobj 368 0 obj << /Type /FontDescriptor /Ascent 681 /CapHeight 683 /Descent -208 /Flags 6 /FontBBox [ -168 -210 1002 766 ] /FontName /GHLFBC+AdvTimes-b /ItalicAngle 0 /StemV 0 /XHeight 462 /CharSet (/semicolon/A/period/I/N/T/R/O/D/U/C/B/S/P/L/E/F/M/H/W/G/two/nine/K/V/Z/b\ /d/o/l/a/r/i/m/comma/e/t/y/n/s/h/c/f/x/J/k/w/g/hyphen/u/v/z/Y/j/dieresis\ /p/q) /FontFile3 369 0 R >> endobj 369 0 obj << /Filter /FlateDecode /Length 11554 /Subtype /Type1C >> stream HLkWM{fJnLk붆bM-6IEhPbmf}~f̙9s;s}/{D FAIATލV_pTm]'?ϝx񗮾8{ܕCi|tjs=[my7CGvLޙ®ζ#WOpGgNϜ_]}řٹ/Y9s3^Y]|ewNgNgoybG0x_tBz;ot~=ubۗ+ځ~x/ُ<#;?woNү&ۻ1šp#7+qA@RrVɳHFy1A9E1!ؾ[l \LeS1ȇM]5E#i4Iբ5Ya~-p1pbr3KhMO~9yw-DnAn:#'*27TH*RRI$qf2I#LAA WBN O #WqYG)S]mYK-=0cHȪʲHJi<*x+V2l42=c=ґbC->~W%˯^8{: ) 9qٛ'5F<āa6H$M7_~RUׯ݈S4\mIJ#9(6 j8:[mzRK >qSzN@ Bfna؆cS*j ]e a`zY?ӊ~iTFc 4)aB)YQD*i#bAZpٺc9iif\2,h_Ƌ".a+c>% y-]Za5,c2׸^md]UtxUlk^cio Y!#wGUU&5S=!܊Lar+}E5 ݾM̊r.AaYy٩]8x>"U.Wհܨ3-Aĩ"-±܄*Դ5ܠوmװձ.ո< c]߁-F6 ԝǥєf,%Ky Egy$rg*Ͻ+pcGYMAef`0b 'c'qCAF%ssE!0*eq]ba {O %!]l%jdWEY&qY$uZ a5*mu\y[aP0άԍ (⅐gB&h2=8ta3/hW:Mи~A0G*(odAILSQu[Ʋv;#nA+q~a_76wg]u'sys%[2rښ 4;wte)hB"ys[ FefP#: \2]LɄu8GxъruYgeZ&E\iQZepڭ)(B:X@Oߗj>M+RViG!JSɲA7n%!2#Kh9B}]l! r%du ` Mn?e5XM+_y;+Kи#,1 q k|>zaw] VM-TͰdpE&í@}US=a\SP;mx GL%VjCۚ7 SMԭ>%vϹ {.j,z~$Rٗ4ި5mH^co[ VBW:C_jQ4JP&bTr"u%^a`$@,X$b/PP@MOOz?g?b JP$vE` B!P"e$/ߩqiF{si8NDޘipS6r2URaZ%ZYZ5dЏ˭qO$X'lOxyt%IV9̦jݲ]MXm$ ĵZwm5vCc,uD->CxcYB!edZYhԇ(cBHG;FbW>W^N d Y|P 4rR>nr]'uNw^m1Ό:ȿ/RRM |S !cSLDY ҿ:cNaxkgKsFԬʨаjF#ZLS9j% [pgxb,B1 n>3UQė9dLa+c =_A 57$pDliB|i'Ah˼{1+ ԑ!dSvdwOq0FZd5MP_;MY*c/S3H_ˆ`m_I [MqFt} 69 H!dkiTZˡ c.|]/-)^e"="?Jr3jXV@zE9bπS!׸I#rgNf~dA?XCH |P`HTMXcEǾ*0Rѝy5)vUҸڪM$n=72-r1jz}'|_- zGUI)4|zG8;lGTSEQTuh 1um{fvܩ7e(9JٴRNrhVl=[ik}enاcip7l)X.݋$o&yqgn”Hykb-Xw\7(NL5`xຏH3i ֖h:zkw0$_ l\$y8|]:.aC ۰vCPcn6 rZ$j萢pg֣C. " 3~i |s G߃,mfKc0 E,\NTG{&kAX: > X:'w LiˇHL1;ee̎͝qȢ|`>\'eRdXdE2)vD~MuhDv'ShB5iE˘0v@~Et_62Ʈ#,Y8i/-#ZY{&K.|ew/.hlpa6) O5h) ~=l8Z@^"XHd! znh9i`2ra^lq,\tmҥ-Ve8.r!Z'x)|:~]")eTL]O=%x%GϿE?pf'Pb"R.E*8MjBWgK@ H+լ66},?;2n(v+X֑ 6<~ӗe^?zZI欫3Y :NO*(Kb7xܹ$;nLW5ut0KKIQTiy[_teZ`fo<lcw+%1.mSafQ8.w[~&*xd>̩15&l}"TЏf͖%U̠ʩ*X `GJbD,EZgJQfwRu2,?jQqMnЅ dc@#&`6FWݘ <~?qN>;IABEQJs=f\LJF٧N6퉀:{7_9 A$-<ҵuGynjtr$?},TUY-U[n-V p'KNޤwӻ6]QvQ zy-eYE,A*H+%F[˰B_>;U56UUt#L϶" ;Wv:aoM 1[~n33[kkL-A#Wޢ7tK#E0 ؎(! @㈀XWgc %RedznFiV&7L9z-u!8>Nn';J%ae])6t[P5G7/ˆG~$@(HDIIrvO-2"" t!F3 ŝ"zYA&ݑfX+o(yYZUbQ)Cг̱[KmTWzJDb2|w_'R+w1J_+: =TJ,D-"A"k=˳t_s"KA͓;:To}MƇ Jj'A$tU!h(嫫kk;%q|6ڞswwajMߴmfeW.kS1+KJ[1G(*GuP 527;$ѐ/%~H3KfqvGS9 i8dUєH#ӷ\m!/讉fY6*ΎH PRBLo:7Vʢ])׎ݍ[D;4n=vQA0GX@ R ;\W= pTGr@(I.4zVga*ޛ=M2`hXӢeXjԄ_ʗȽuS b^ b7κ7DbziQܚ1[Qa {n˿^Xެoq$-;3-Ʋj8hޔBj6k3g!Is2x  ~BG, (ĊG "X[}[Y̥NL(>Ap_Ch @l@*dJVD4L' 5g ܉l/*`\);bAwhj蹅 I9_ N>IE()#HO@)V2UF. ``A@.Gp;1Ǖoe18빘ɮ(X bSDM6Z,e˼,J.~ݼJKa8i|P`sOD^NQtoFdmWMv-Bl۲-#9!+m*dU6u^QRGu7]I'OaYޠ2 [is 0}pcH.s +=#V+.E:|/j6糜Zb3.-i!$ӫ|hPW9QԶdAs;Q:=2nii¾*SZ>HeQ-6wAUPjv({ӥb|osZEg\ܼ -d`ĚǧO>VFR8{ 2v[UR^n/b;qE(nNX (Ad:7M6j3QT|͝~.&4p$.cہA b̳k~~z1LiBc*QݶP<φb) FܻJnˆˎ`eZ@Fٖ+z!4T5]z^(G{#4Oз5K3MTmqC3Љ: N`KrI)ӃW7emz2;X.w;2 #]- 2@A5Z9X$ ֌﫟ڪ}6 J<Z ,"$$Bdw;o{ڞG_9;7o-6E qx.YM:7IaeuC~X)ʅo+ouؚ6ҭwPMI#bnkJ֩:5o V`E?ɚɋb,x<@Id*/S{1ܠSB.y% ?~ G;Tco&ԏ[r4ڼc8Sf A5Q۸MT̨Z *=DAăbKN-䰮72/M+U2yj'M΅2E9q4b;<nVu`>}6CX9ªTfB!ʿ8MU=〾RyPMfWA2dS:&Sl:,r8 $ )t~{ kUW,n;OtvDl>6=H?!Kd'(I΋!\3- +*cC z9v6*!N;矟>E̶yn2}R%_B)W$2+FTm;p@U&Ո&A3*cBj4LqkUK$qJ- A$fX)F^eU@}c^:31j<g mpuCw$@CP=+WkY' oy;( ؛.0mEуpn=и,h+υYp%O$AA#s4١%p6HT'(ߛeDŽ"bWpUTQLC~+YMI4ȍ]&G9Asꛡ0ð lhFt`=αo]/pkgu@j|ۋ8:]KpTB Z/ep܀Hԩ[M֠xF ňռ*D{s#ܵSc7mUA](HI(LGyC06RW8YCc9: p,jYchԇZ>´(ɘ5U·)=¹#'^°^9)հ차6W6~ b?2qlR=h[)|b ŵ :#c'"s:(菾k]v:DPDK.2$m >MY"A`ްF:إƓWz*Ap>]OGԧԍ@WxH"0XPB^BPϿM {YxMh\'Y4gȋ+yȐ (~vkW:B]}vLeB"I:,G9P74]k+oi]u/:}ՃyLc!cm)8C"" Ɗ, En. oQ:Eb`CbP0:O/jVK} j&O"+E;1[";^gN]`zjpRzUR^"ɡ2h $<ɋs4f躭îV *mlQB D( '*sc|-59AELpYhY?DKqғΪY"P~!^~asf_5!n i.y 1=-UC?.C!@5^7F-V@"%.XG~œu.>hOy|Ͼk 6Y`8K4ͫ%GM d2"BĈg5Nb A#3̽tӟEG9};5(A1FApY(',|>z f1pz="ы0kM@ŎAO#-l7q =@Iᕓ24koQ).$Z]D5UWE^ gL~>{ΰGPcʮpyE~E 0=:K^t_8@ľ0?9O?G^a1 y X)fpH)8bqg"J~uׯV7Y5x 8ؚR-͡OF"C{ ~N&>xAIՃN.|?Uv½5ޤQ3Ny}Q==C݊.0WCZl[5vFcAn!({~+[''1\rJ>Ĩǒb&U6aGK&+#2b݅,h, G~A|L0?wci7lR, axsjd@6ӇZ0˳ CaP kz]^&(Dvͬ%$Ln|hԌeOn5.'.~M1Mho B]HFAÚ'nj:sp *އLϛl)9&`4$z>|{0'$STs)0'2;TS;:ɴfx..~\rayc۶ 8,%+9Nռ8[gn(1)3lmD BDTC8qnߺ{kAnwvc6zQ"dfDln >N7f$ohՐ_Jt|J[)VbKuvx& - =h@#+@$9y[V_ppFdI$P y@CpR(eD:?xT>P(χuon80kaÆx"2ؐ: Q&|"^k eUT%Zw.O<=cgſ"^޹UqjK VNP"N0^ȮqVG&V,7J-*&3+5aF`>4:T/o:$ 2f Q4H{'6lxx43WA`uՑw܆ >e*?MܕYڸX55ܷ+*ڕ.5ႏ<"JRpbm =R'|fv% -j\3b c[b-C;FDJ- u)ʤdXc{+``do:Σ-]*R]$IN1b9, v!ĸp߶nlj-v&hDjI|}x5"!CsE2'{>EJBix cuF>eբ:2:4ʤL!;țC<tz9ҭ{j=Jdȼ nqj Zq{ut8UX O u-axC4+]fv)q]{}ɌũL?+h  kI;<ՑRb%kc*N kSF*ф̼ DNQ=XTr P%Q@!UUHa )e,-Ϩ{5e䇤4$'%V)!Bʖt.|ޅc?pӡ[i@$Nh[;%ưꠎi }2&oJ7U]m6,n'oB",rØbUɇp0uӺ5ut{|R A?LxNKRTD#b ݖYڷu۪~J()/clf= ڪ.sc/] b~& 1@1p 0yH8W~ )/pva EuꦨBkт &fWǏ $$iNt>i+*(IoCV{ٗϯ} #L q<+ MmE[#+NLJdc$>!8 ITj0ygA$ rp񓑺:wq"*FKsQPDJAV초&{{o2F6/,XZNYs'ads9X {7<feYBy0 ꁣa&3T~yiU,ơ&|k^ǍaY*JDwBeI^ $O7r5vBZvFȲQ{==bll 7;4>WM&4ͪD'\EsǧqU*w0pCoP!V|,>(z\8^5͟mga 3@R1ّ+g-5BSRVc@HePy$ҷ&rR *U%`ɠ qN#sOxYoտe9酝LmQh|4No ǰވT<5{sb4Rw]1 gPWu4j7K-X;"iC߫󎞑 u&ELi7ݳ+>ú> endobj 371 0 obj << /Filter /FlateDecode /Length 317 >> stream HTMo0 ;B!mTz؇vL4B~v::caw0 gz:ƫ ^zri`fw^<&]o.:O ~f Z좸~QU 1N7 9]'4:e.2Uf]] M2uQE2똓lOqIIk> endobj 373 0 obj << /Filter /FlateDecode /Length 294 >> stream HTOO0|9P@(nB8Ƅ"H")po 5J__T?vX@I7@7XqVZ I f˾ھzT7yewڜSv߀x`{8O2չo.CU.g^Ԉ ;_B<,,+@kEyh;|Tf94..X>MD: :"w="೻!*Ɇ (!'[>q2PBbŎ@%G LSlqXq6<C endstream endobj 374 0 obj << /Type /Encoding /Differences [ 40 /parenleft /parenright 44 /comma /hyphen /period 48 /zero /one /two 53 /five /six /seven /eight 58 /colon /semicolon 65 /A /B /C /D /E 71 /G /H /I /J 76 /L /M /N /O /P 82 /R /S /T /U /V /W 97 /a /b /c /d /e /f /g /h /i /j /k /l /m /n /o /p /q /r /s /t /u /v /w /x /y /z 143 /quoteleft /quoteright ] >> endobj 375 0 obj << /Filter /FlateDecode /Length 298 >> stream HTMk0 :v`'L`t zk׻(%8IcW-z-kG'i]p`xkԭ(3%a'caPch VB4y$TdjK.v转],˗kt&%i&p Bz]D@bK@10 <7*J&wQ2*# -(Sʖke*]Ȝ^JNsw(v{~Y?6 endstream endobj 376 0 obj << /Type /Encoding /Differences [ 49 /one /two 52 /four /five /six 65 /A /B /C /D /E /F /G /H /I 75 /K /L /M /N /O /P 82 /R /S /T /U 88 /X ] >> endobj 377 0 obj << /Filter /FlateDecode /Length 267 >> stream HT=o0w~ō:Z 1$U%~ݍ}PKX $U=~;ߙڧhͲC62N"8jE JK,'aswY> endobj 379 0 obj << /Filter /FlateDecode /Length 217 >> stream HT;k0{)/|)Bp%NZAk܃Z4;YCܱOPlO g'4E,Dg{8oYmN&Be_DSC@T3s{}.ݱ΍~&RWDPk$7]Gs4HhtS b߻Oޞ6Z{W5]Drm-I?C,#˩~DYjA endstream endobj 380 0 obj << /Type /Encoding /Differences [ 40 /parenleft /parenright 44 /comma /hyphen /period /slash /zero /one /two /three /four /five /six /seven /eight /nine /colon /semicolon 64 /at /A /B /C /D /E /F /G /H /I 77 /M 79 /O /P 82 /R /S /T 87 /W 97 /a /b /c /d /e /f /g /h /i /j /k /l /m /n /o /p /q /r /s /t /u /v /w /x /y /z 143 /quoteleft /quoteright ] >> endobj 381 0 obj << /Filter /FlateDecode /Length 293 >> stream HT?o w>ō:8(RQv'pN,agnǏw>x;ns ـp ጗A!vfZVkzSq'@)?hs }(sX/Ǜأ@@]ŖEW#XNGi],v%VԀc2W[sՁҒSrW3$MűkMN s 2;HhIEHFPnsAz T.PRr|x=s Kt0Ϙ endstream endobj 382 0 obj << /Type /Encoding /Differences [ 44 /comma 66 /B 74 /J 82 /R 97 /a /b /c /d /e /f 105 /i /j 108 /l /m /n /o /p 114 /r /s /t /u /v ] >> endobj 383 0 obj << /Filter /FlateDecode /Length 274 >> stream HTQMo +Mj61&&흅ђT$y̼;=77= (˼:pQ PZ-Nm8ufŻNWi3|ѯ~CM ga_ĄCwY"xVX! 3"ԅlШw*,+چ"b:τO#rIuSRYLDdU6%կx s3w &kن׆~. endstream endobj 384 0 obj << /Type /Encoding /Differences [ 40 /parenleft /parenright 44 /comma /hyphen 47 /slash /zero /one /two /three /four /five /six /seven /eight /nine /colon 65 /A /B /C /D /E /F /G /H /I /J /K /L /M /N /O /P 82 /R /S /T /U /V /W 97 /a /b /c /d /e /f /g /h /i /j /k /l /m /n /o /p /q /r /s /t /u /v /w /x /y ] >> endobj 385 0 obj << /Filter /FlateDecode /Length 261 >> stream HTMo ;@vP.*-i!C :zؖslFb:p[cuܢAy.SġqR2A)vg!;o`E|~hgq@j@^PXlGWr=,*S;n ҒJeQ&0+H? < "Lf H3Zw`(N!|l/oO>c? '| endstream endobj 386 0 obj << /Type /Encoding /Differences [ 44 /comma /hyphen /period 50 /two 57 /nine 59 /semicolon 65 /A /B /C /D /E /F /G /H /I /J /K /L /M /N /O /P 82 /R /S /T /U /V /W 89 /Y /Z 97 /a /b /c /d /e /f /g /h /i /j /k /l /m /n /o /p /q /r /s /t /u /v /w /x /y /z 168 /dieresis ] >> endobj 387 0 obj << /Filter /FlateDecode /Length 286 >> stream HTQMo +qPtwc4Џ֤"A=M003aET~F] moӸ8PcH4],pW4Pv,c٭{Nmr5z^>kq@3Cy /ʾy^-t2s143_ʱN$)uďcoS_h# >%,@fQϓ*>K ӢZ^'V|?~P2 endstream endobj 388 0 obj << /S /D >> endobj 389 0 obj << /Nums [ 0 388 0 R ] >> endobj 390 0 obj << /Type /Pages /Kids [ 409 0 R 1 0 R 4 0 R 7 0 R 10 0 R 13 0 R 16 0 R 19 0 R 22 0 R 25 0 R ] /Count 10 /Parent 391 0 R >> endobj 391 0 obj << /Type /Pages /Kids [ 390 0 R 392 0 R 393 0 R 394 0 R 395 0 R 396 0 R 397 0 R 398 0 R 399 0 R 400 0 R ] /Count 100 /Parent 401 0 R >> endobj 392 0 obj << /Type /Pages /Kids [ 28 0 R 31 0 R 34 0 R 37 0 R 40 0 R 43 0 R 46 0 R 49 0 R 52 0 R 55 0 R ] /Count 10 /Parent 391 0 R >> endobj 393 0 obj << /Type /Pages /Kids [ 58 0 R 61 0 R 64 0 R 67 0 R 70 0 R 73 0 R 76 0 R 79 0 R 82 0 R 85 0 R ] /Count 10 /Parent 391 0 R >> endobj 394 0 obj << /Type /Pages /Kids [ 88 0 R 91 0 R 94 0 R 97 0 R 100 0 R 103 0 R 106 0 R 109 0 R 112 0 R 115 0 R ] /Count 10 /Parent 391 0 R >> endobj 395 0 obj << /Type /Pages /Kids [ 118 0 R 121 0 R 124 0 R 127 0 R 130 0 R 133 0 R 136 0 R 139 0 R 142 0 R 145 0 R ] /Count 10 /Parent 391 0 R >> endobj 396 0 obj << /Type /Pages /Kids [ 148 0 R 151 0 R 154 0 R 157 0 R 160 0 R 163 0 R 166 0 R 169 0 R 172 0 R 175 0 R ] /Count 10 /Parent 391 0 R >> endobj 397 0 obj << /Type /Pages /Kids [ 178 0 R 181 0 R 184 0 R 187 0 R 190 0 R 193 0 R 196 0 R 199 0 R 202 0 R 205 0 R ] /Count 10 /Parent 391 0 R >> endobj 398 0 obj << /Type /Pages /Kids [ 208 0 R 211 0 R 214 0 R 217 0 R 220 0 R 223 0 R 226 0 R 229 0 R 232 0 R 235 0 R ] /Count 10 /Parent 391 0 R >> endobj 399 0 obj << /Type /Pages /Kids [ 238 0 R 241 0 R 244 0 R 247 0 R 250 0 R 253 0 R 256 0 R 259 0 R 262 0 R 265 0 R ] /Count 10 /Parent 391 0 R >> endobj 400 0 obj << /Type /Pages /Kids [ 268 0 R 271 0 R 274 0 R 277 0 R 280 0 R 283 0 R 286 0 R 289 0 R 292 0 R 295 0 R ] /Count 10 /Parent 391 0 R >> endobj 401 0 obj << /Type /Pages /Kids [ 391 0 R 403 0 R ] /Count 113 >> endobj 402 0 obj << /Type /Pages /Kids [ 298 0 R 301 0 R 304 0 R 307 0 R 310 0 R 313 0 R 316 0 R 319 0 R 322 0 R 325 0 R ] /Count 10 /Parent 403 0 R >> endobj 403 0 obj << /Type /Pages /Kids [ 402 0 R 404 0 R ] /Count 13 /Parent 401 0 R >> endobj 404 0 obj << /Type /Pages /Kids [ 328 0 R 331 0 R 334 0 R ] /Count 3 /Parent 403 0 R >> endobj 405 0 obj << /CreationDate (D:20050712170350+02'00') /ModDate (D:20050712170350+02'00') /Producer (Acrobat Distiller 5.00 for Macintosh) >> endobj 406 0 obj << /Type /Metadata /Subtype /XML /Length 651 >> stream endstream endobj xref 0 407 0000000000 65535 f 0000923989 00000 n 0000924141 00000 n 0000924310 00000 n 0000925132 00000 n 0000925284 00000 n 0000925453 00000 n 0000929435 00000 n 0000929587 00000 n 0000929780 00000 n 0000934448 00000 n 0000934603 00000 n 0000934785 00000 n 0000940592 00000 n 0000940747 00000 n 0000940929 00000 n 0000943636 00000 n 0000943791 00000 n 0000943973 00000 n 0000949768 00000 n 0000949923 00000 n 0000950117 00000 n 0000956815 00000 n 0000956970 00000 n 0000957164 00000 n 0000963352 00000 n 0000963507 00000 n 0000963713 00000 n 0000969164 00000 n 0000969319 00000 n 0000969489 00000 n 0000975028 00000 n 0000975183 00000 n 0000975377 00000 n 0000982331 00000 n 0000982486 00000 n 0000982668 00000 n 0000985774 00000 n 0000985929 00000 n 0000986056 00000 n 0000986521 00000 n 0000986676 00000 n 0000986858 00000 n 0000992157 00000 n 0000992312 00000 n 0000992506 00000 n 0000997542 00000 n 0000997697 00000 n 0000997879 00000 n 0001003135 00000 n 0001003290 00000 n 0001003472 00000 n 0001009188 00000 n 0001009343 00000 n 0001009526 00000 n 0001014818 00000 n 0001014973 00000 n 0001015167 00000 n 0001021539 00000 n 0001021694 00000 n 0001021876 00000 n 0001024288 00000 n 0001024443 00000 n 0001024570 00000 n 0001025035 00000 n 0001025190 00000 n 0001025397 00000 n 0001030436 00000 n 0001030591 00000 n 0001030810 00000 n 0001036307 00000 n 0001036462 00000 n 0001036656 00000 n 0001042902 00000 n 0001043057 00000 n 0001043264 00000 n 0001049772 00000 n 0001049927 00000 n 0001050121 00000 n 0001056551 00000 n 0001056706 00000 n 0001056900 00000 n 0001063369 00000 n 0001063524 00000 n 0001063718 00000 n 0001070179 00000 n 0001070334 00000 n 0001070553 00000 n 0001076452 00000 n 0001076607 00000 n 0001076801 00000 n 0001083265 00000 n 0001083420 00000 n 0001083639 00000 n 0001089529 00000 n 0001089684 00000 n 0001089878 00000 n 0001095540 00000 n 0001095695 00000 n 0001095889 00000 n 0001102241 00000 n 0001102399 00000 n 0001102594 00000 n 0001108862 00000 n 0001109020 00000 n 0001109215 00000 n 0001115631 00000 n 0001115789 00000 n 0001116009 00000 n 0001121267 00000 n 0001121425 00000 n 0001121608 00000 n 0001127464 00000 n 0001127622 00000 n 0001127805 00000 n 0001133550 00000 n 0001133708 00000 n 0001133929 00000 n 0001139488 00000 n 0001139646 00000 n 0001139841 00000 n 0001146100 00000 n 0001146258 00000 n 0001146453 00000 n 0001152859 00000 n 0001153017 00000 n 0001153212 00000 n 0001159563 00000 n 0001159721 00000 n 0001159916 00000 n 0001166526 00000 n 0001166684 00000 n 0001166904 00000 n 0001172561 00000 n 0001172719 00000 n 0001172914 00000 n 0001178874 00000 n 0001179032 00000 n 0001179266 00000 n 0001185955 00000 n 0001186113 00000 n 0001186308 00000 n 0001192934 00000 n 0001193092 00000 n 0001193312 00000 n 0001199439 00000 n 0001199597 00000 n 0001199780 00000 n 0001206208 00000 n 0001206366 00000 n 0001206600 00000 n 0001212488 00000 n 0001212646 00000 n 0001212829 00000 n 0001219655 00000 n 0001219813 00000 n 0001220008 00000 n 0001226258 00000 n 0001226416 00000 n 0001226650 00000 n 0001232705 00000 n 0001232863 00000 n 0001233058 00000 n 0001239854 00000 n 0001240012 00000 n 0001240207 00000 n 0001246761 00000 n 0001246919 00000 n 0001247127 00000 n 0001253665 00000 n 0001253823 00000 n 0001254032 00000 n 0001260344 00000 n 0001260502 00000 n 0001260697 00000 n 0001267192 00000 n 0001267350 00000 n 0001267545 00000 n 0001274001 00000 n 0001274159 00000 n 0001274379 00000 n 0001280204 00000 n 0001280362 00000 n 0001280545 00000 n 0001287233 00000 n 0001287391 00000 n 0001287586 00000 n 0001293516 00000 n 0001293674 00000 n 0001293908 00000 n 0001299789 00000 n 0001299947 00000 n 0001300155 00000 n 0001306397 00000 n 0001306555 00000 n 0001306789 00000 n 0001312905 00000 n 0001313063 00000 n 0001313270 00000 n 0001319807 00000 n 0001319965 00000 n 0001320160 00000 n 0001326479 00000 n 0001326637 00000 n 0001326832 00000 n 0001332216 00000 n 0001332374 00000 n 0001332608 00000 n 0001337899 00000 n 0001338057 00000 n 0001338252 00000 n 0001344488 00000 n 0001344646 00000 n 0001344866 00000 n 0001350901 00000 n 0001351059 00000 n 0001351254 00000 n 0001357119 00000 n 0001357277 00000 n 0001357498 00000 n 0001363610 00000 n 0001363768 00000 n 0001363988 00000 n 0001369242 00000 n 0001369400 00000 n 0001369595 00000 n 0001375681 00000 n 0001375839 00000 n 0001376034 00000 n 0001381604 00000 n 0001381762 00000 n 0001381982 00000 n 0001387711 00000 n 0001387869 00000 n 0001388064 00000 n 0001394405 00000 n 0001394563 00000 n 0001394784 00000 n 0001400342 00000 n 0001400500 00000 n 0001400734 00000 n 0001406003 00000 n 0001406161 00000 n 0001406356 00000 n 0001412285 00000 n 0001412443 00000 n 0001412639 00000 n 0001417362 00000 n 0001417520 00000 n 0001417703 00000 n 0001423916 00000 n 0001424074 00000 n 0001424257 00000 n 0001429873 00000 n 0001430031 00000 n 0001430214 00000 n 0001436654 00000 n 0001436812 00000 n 0001436995 00000 n 0001440941 00000 n 0001441099 00000 n 0001441227 00000 n 0001441693 00000 n 0001441851 00000 n 0001442048 00000 n 0001445736 00000 n 0001445894 00000 n 0001446077 00000 n 0001451502 00000 n 0001451660 00000 n 0001451856 00000 n 0001457673 00000 n 0001457831 00000 n 0001458014 00000 n 0001463967 00000 n 0001464125 00000 n 0001464308 00000 n 0001470266 00000 n 0001470424 00000 n 0001470620 00000 n 0001476031 00000 n 0001476189 00000 n 0001476398 00000 n 0001479680 00000 n 0001479838 00000 n 0001479966 00000 n 0001480432 00000 n 0001480590 00000 n 0001480787 00000 n 0001485137 00000 n 0001485295 00000 n 0001485478 00000 n 0001488796 00000 n 0001488954 00000 n 0001489138 00000 n 0001491772 00000 n 0001491930 00000 n 0001492113 00000 n 0001495030 00000 n 0001495188 00000 n 0001495371 00000 n 0001498204 00000 n 0001498362 00000 n 0001498490 00000 n 0001498956 00000 n 0001499114 00000 n 0001499311 00000 n 0001502041 00000 n 0001502199 00000 n 0001502370 00000 n 0001505205 00000 n 0001505363 00000 n 0001505546 00000 n 0001508515 00000 n 0001508673 00000 n 0001508844 00000 n 0001511948 00000 n 0001512106 00000 n 0001512289 00000 n 0001515344 00000 n 0001515502 00000 n 0001515673 00000 n 0001518443 00000 n 0001518601 00000 n 0001518798 00000 n 0001521872 00000 n 0001522030 00000 n 0001522214 00000 n 0001526183 00000 n 0001526341 00000 n 0001526537 00000 n 0001531158 00000 n 0001531316 00000 n 0001531500 00000 n 0001535019 00000 n 0001535177 00000 n 0001535305 00000 n 0001535805 00000 n 0001536363 00000 n 0001536544 00000 n 0001536904 00000 n 0001537435 00000 n 0001537756 00000 n 0001537985 00000 n 0001538516 00000 n 0001538905 00000 n 0001539444 00000 n 0001539930 00000 n 0001540396 00000 n 0001540950 00000 n 0001556325 00000 n 0001556569 00000 n 0001557545 00000 n 0001557834 00000 n 0001560176 00000 n 0001560622 00000 n 0001574651 00000 n 0001574949 00000 n 0001576505 00000 n 0001576791 00000 n 0001577705 00000 n 0001578168 00000 n 0001582366 00000 n 0001582653 00000 n 0001588427 00000 n 0001588681 00000 n 0001589179 00000 n 0001589609 00000 n 0001592838 00000 n 0001593228 00000 n 0001604876 00000 n 0001605371 00000 n 0001605763 00000 n 0001605945 00000 n 0001606314 00000 n 0001606678 00000 n 0001607051 00000 n 0001607217 00000 n 0001607559 00000 n 0001607682 00000 n 0001607974 00000 n 0001608350 00000 n 0001608718 00000 n 0001608876 00000 n 0001609225 00000 n 0001609560 00000 n 0001609896 00000 n 0001610192 00000 n 0001610553 00000 n 0001610585 00000 n 0001610631 00000 n 0001610778 00000 n 0001610938 00000 n 0001611087 00000 n 0001611236 00000 n 0001611391 00000 n 0001611550 00000 n 0001611709 00000 n 0001611868 00000 n 0001612027 00000 n 0001612186 00000 n 0001612345 00000 n 0001612423 00000 n 0001612582 00000 n 0001612676 00000 n 0001612777 00000 n 0001612926 00000 n trailer << /Size 407 /ID[<7a9383a58eb64b73611e8d98e9f2efb4>] >> startxref 173 %%EOF